data_2l6d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l6d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? . . . . . 0 C--O 1.236 0.389 0 C-N-CA 124.921 1.288 . . . . 0.0 110.429 -172.103 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.82 61.25 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -85.71 -32.6 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.048 0.939 . . . . 0.0 111.466 168.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -67.91 -30.96 70.42 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.5 -0.75 . . . . 0.0 111.457 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.2 -15.91 60.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.238 1.415 . . . . 0.0 113.283 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.27 -15.47 30.17 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.159 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pp -102.9 153.79 19.86 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.274 1.537 . . . . 0.0 114.302 -168.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -99.11 -37.73 9.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.212 1.005 . . . . 0.0 113.284 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -159.88 110.96 1.95 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.211 1.404 . . . . 0.0 109.706 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.13 37.82 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.872 0.844 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.05 131.07 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 108.634 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.6 t -124.04 131.0 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.49 1.116 . . . . 0.0 109.521 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -105.27 113.52 27.16 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.994 1.317 . . . . 0.0 112.039 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -82.09 75.64 9.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.162 1.385 . . . . 0.0 110.607 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.24 166.74 22.81 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.866 0.866 . . . . 0.0 113.261 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.35 160.39 25.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.572 1.149 . . . . 0.0 112.31 173.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -74.4 -56.42 4.88 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.26 -64.96 0.79 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.694 1.198 . . . . 0.0 112.067 -170.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -51.21 121.97 17.43 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 127.027 2.131 . . . . 0.0 113.677 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.96 -23.06 76.49 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.402 3.401 . . . . 0.0 114.961 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -62.11 -45.04 95.24 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.925 0.89 . . . . 0.0 112.132 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 m -62.16 -34.63 76.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.605 1.162 . . . . 0.0 112.757 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -60.46 -25.23 65.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.743 1.617 . . . . 0.0 113.863 -171.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.9 -41.07 71.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -62.7 -29.29 70.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.053 0.941 . . . . 0.0 113.201 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -56.85 -43.09 80.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 111.885 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -68.8 -33.83 74.52 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.929 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.77 -48.07 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.709 1.604 . . . . 0.0 110.468 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.59 -34.97 79.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 0.0 112.593 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.31 -52.15 66.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 111.196 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -67.58 -32.66 73.56 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.85 0.86 . . . . 0.0 112.422 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.48 -38.1 80.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.836 1.254 . . . . 0.0 112.408 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.66 -27.8 41.18 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-N 118.911 0.778 . . . . 0.0 112.73 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.84 64.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.348 1.059 . . . . 0.0 113.607 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.43 10.66 37.18 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.769 1.628 . . . . 0.0 114.585 177.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.22 73.32 44.36 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.483 1.513 . . . . 0.0 112.324 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.64 -22.61 73.34 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.566 2.844 . . . . 0.0 115.701 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -86.62 -4.61 59.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -168.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.21 132.11 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.877 1.271 . . . . 0.0 111.057 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.39 105.34 15.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mt -107.86 135.08 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.958 0.903 . . . . 0.0 110.426 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.0 p -149.3 172.17 15.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 0.0 112.152 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.4 p -116.98 170.27 8.76 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.696 -1.253 . . . . 0.0 111.668 167.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.1 128.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.434 1.094 . . . . 0.0 110.074 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.2 111.04 1.8 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.692 1.197 . . . . 0.0 110.467 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.8 p -61.32 -26.55 67.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.131 0.972 . . . . 0.0 113.014 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -78.35 -20.4 51.41 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.879 0.763 . . . . 0.0 112.673 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.06 -26.13 20.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.384 1.074 . . . . 0.0 112.399 168.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -117.61 48.21 0.79 Allowed Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 126.055 1.742 . . . . 0.0 114.928 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.82 -17.08 14.19 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.932 2.421 . . . . 0.0 114.189 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -26.8 64.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.51 1.05 . . . . 0.0 112.616 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.75 -46.83 34.62 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.151 0.432 . . . . 0.0 110.738 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 mtm -55.61 -28.69 56.6 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.929 0.891 . . . . 0.0 113.143 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -60.22 -29.8 68.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.644 1.577 . . . . 0.0 113.361 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -91.33 -36.69 13.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.923 1.289 . . . . 0.0 111.164 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.87 -19.25 30.86 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.5 18.5 30.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.206 1.384 . . . . 0.0 114.835 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -79.36 151.55 30.92 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.265 1.033 . . . . 0.0 111.537 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -94.42 -72.49 0.61 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.761 1.225 . . . . 0.0 111.405 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.27 15.99 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.91 1.684 . . . . 0.0 113.147 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.31 157.3 34.35 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.349 1.46 . . . . 0.0 111.866 -157.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.31 91.28 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.757 2.972 . . . . 0.0 110.48 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.9 m -104.77 126.71 52.13 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 111.606 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.66 126.1 34.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 109.296 165.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.91 125.34 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.862 1.665 . . . . 0.0 108.74 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.58 121.29 44.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.511 1.124 . . . . 0.0 110.312 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.2 mm -108.99 120.73 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 108.978 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -118.47 126.24 51.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.912 1.685 . . . . 0.0 109.419 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.77 19.7 9.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.366 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 2.35 88.37 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.223 -0.923 . . . . 0.0 114.627 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -103.24 135.91 44.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.078 1.751 . . . . 0.0 109.208 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.76 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.018 -1.051 . . . . 0.0 110.284 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -95.49 -20.76 18.78 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.596 1.158 . . . . 0.0 113.386 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -162.85 148.83 12.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.935 2.094 . . . . 0.0 108.828 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -161.77 144.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 110.58 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -157.71 143.03 16.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.42 1.088 . . . . 0.0 112.091 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.3 m -101.88 131.01 48.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.099 0.959 . . . . 0.0 110.955 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.88 -166.84 23.5 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.503 1.525 . . . . 0.0 113.273 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -120.08 146.07 25.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.14 1.776 . . . . 0.0 110.036 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.1 ptp -150.18 163.18 38.9 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 165.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.31 158.89 86.51 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.521 1.128 . . . . 0.0 112.53 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.78 -16.43 26.39 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.677 2.251 . . . . 0.0 113.707 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -68.14 -47.53 67.84 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 110.237 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -79.05 -27.07 43.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.307 1.043 . . . . 0.0 112.79 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.1 tp -61.59 -22.99 65.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.467 -0.771 . . . . 0.0 113.056 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -63.2 -42.05 99.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.226 0.61 . . . . 0.0 111.509 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -33.41 70.74 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.44 0.696 . . . . 0.0 112.15 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -50.14 72.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.761 1.224 . . . . 0.0 109.852 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.02 -44.47 96.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.344 1.058 . . . . 0.0 112.935 172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.17 84.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.989 0.813 . . . . 0.0 111.834 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -55.68 -32.86 63.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.966 1.306 . . . . 0.0 112.849 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 124.578 1.151 . . . . 0.0 110.803 177.647 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 mm . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 127.173 2.189 . . . . 0.0 110.467 -172.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptp . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -29.63 68.49 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -75.34 -39.78 59.02 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.614 -0.679 . . . . 0.0 111.295 168.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.42 -13.34 61.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -91.46 -13.42 32.3 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.833 1.253 . . . . 0.0 113.417 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.64 -17.8 3.79 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 -170.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.11 165.91 22.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 114.206 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.2 m -83.54 -50.32 8.37 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -164.96 114.62 1.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.437 1.495 . . . . 0.0 109.955 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.74 160.81 42.84 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.18 122.63 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.916 1.286 . . . . 0.0 107.915 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.79 117.36 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.395 1.478 . . . . 0.0 109.383 -170.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -102.07 115.09 29.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.925 0.89 . . . . 0.0 112.894 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -81.22 78.04 8.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.871 1.268 . . . . 0.0 111.662 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -170.69 3.11 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.649 1.18 . . . . 0.0 113.265 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -142.83 164.91 28.82 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.847 1.659 . . . . 0.0 111.339 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -39.0 -94.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.407 2.283 . . . . 0.0 116.922 -164.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.01 -22.82 16.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 113.842 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 61.0 m -46.71 115.66 3.4 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 127.018 2.127 . . . . 0.0 113.242 -171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -55.2 -24.5 41.86 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.586 3.524 . . . . 0.0 116.196 -175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.94 -48.6 75.45 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.256 0.934 . . . . 0.0 112.186 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 94.4 m -70.13 -25.91 63.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.288 1.035 . . . . 0.0 113.318 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -65.4 -30.02 70.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.253 1.021 . . . . 0.0 112.816 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.24 -51.49 69.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 110.794 169.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.67 -41.22 97.24 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.741 1.216 . . . . 0.0 112.906 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.54 -37.19 65.13 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.502 -0.749 . . . . 0.0 111.766 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.01 -31.35 62.9 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.525 -1.359 . . . . 0.0 112.092 176.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.9 -44.17 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.706 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.42 -40.76 92.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.523 0.729 . . . . 0.0 112.584 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.35 -49.8 75.49 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.544 0.611 . . . . 0.0 112.61 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.14 -37.6 87.92 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.567 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.18 -38.01 89.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.821 1.248 . . . . 0.0 111.763 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.41 -19.11 67.18 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.37 0.986 . . . . 0.0 113.066 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.44 -32.24 68.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.097 0.959 . . . . 0.0 113.453 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 11.01 34.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.575 1.55 . . . . 0.0 114.232 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.68 45.44 0.37 Allowed Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 125.708 1.603 . . . . 0.0 114.328 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.42 -15.46 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.209 2.606 . . . . 0.0 114.088 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.46 -7.93 58.76 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.74 133.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.653 1.115 . . . . 0.0 108.048 163.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.62 85.25 4.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.831 0.824 . . . . 0.0 110.286 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.06 130.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.4 p -144.54 172.05 13.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.088 0.947 . . . . 0.0 112.085 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.6 p -128.28 154.27 46.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.14 -0.975 . . . . 0.0 110.343 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.0 t -139.9 126.32 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.828 1.251 . . . . 0.0 108.528 -169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.88 100.04 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.152 1.381 . . . . 0.0 110.832 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.0 p -54.44 -36.71 64.34 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.569 1.147 . . . . 0.0 113.146 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.61 -26.95 67.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.311 1.844 . . . . 0.0 114.088 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.09 -17.29 16.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.414 1.486 . . . . 0.0 112.994 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.13 51.05 2.28 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.54 1.936 . . . . 0.0 112.377 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.33 -24.25 43.64 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.737 1.624 . . . . 0.0 111.553 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.48 -26.3 67.87 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 113.073 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.16 -55.18 6.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 109.5 168.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 mtm -57.54 -24.01 53.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.479 1.112 . . . . 0.0 113.369 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -70.37 -28.47 65.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.748 1.619 . . . . 0.0 111.696 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -80.96 -38.05 28.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.255 1.022 . . . . 0.0 111.007 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.93 -22.5 21.94 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.04 22.84 16.35 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.65 1.595 . . . . 0.0 115.024 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.11 153.63 25.97 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.663 1.232 . . . . 0.0 111.76 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.58 -70.6 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.353 1.061 . . . . 0.0 112.377 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -157.34 3.58 0.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -165.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.48 156.88 38.78 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.07 1.748 . . . . 0.0 113.02 -162.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.66 93.33 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.034 3.156 . . . . 0.0 110.261 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.2 m -103.41 129.77 50.58 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.253 1.021 . . . . 0.0 110.429 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.5 tp -110.07 119.52 39.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.89 0.876 . . . . 0.0 110.061 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 t -117.13 129.15 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.343 1.457 . . . . 0.0 109.079 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -111.21 118.73 36.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.824 0.849 . . . . 0.0 109.901 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.426 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 30.1 mm -107.21 114.36 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.18 1.392 . . . . 0.0 109.148 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.426 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -108.28 118.57 37.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.771 1.228 . . . . 0.0 108.586 173.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.05 22.34 13.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.99 1.316 . . . . 0.0 113.209 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.63 10.47 70.15 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.372 0.987 . . . . 0.0 113.149 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -112.51 131.83 55.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.156 1.382 . . . . 0.0 109.37 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.16 106.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.625 -0.672 . . . . 0.0 109.419 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.01 -20.15 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -162.27 153.52 17.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.917 1.687 . . . . 0.0 110.448 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.13 144.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.96 1.304 . . . . 0.0 110.807 172.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.89 162.33 35.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.933 1.293 . . . . 0.0 109.814 165.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -130.98 140.91 50.21 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.411 0.685 . . . . 0.0 112.589 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.74 19.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.693 1.616 . . . . 0.0 112.386 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.1 mm -125.63 145.33 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.222 1.809 . . . . 0.0 110.135 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.8 ptp -147.36 -149.06 0.27 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.746 0.818 . . . . 0.0 111.473 164.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.85 160.06 38.97 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.519 1.528 . . . . 0.0 110.43 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.78 -34.49 11.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.612 1.542 . . . . 0.0 113.815 -153.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -59.14 -32.25 69.7 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.53 -32.55 32.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.083 0.953 . . . . 0.0 111.838 172.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.5 tp -65.62 -30.08 70.75 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.275 -0.891 . . . . 0.0 112.543 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.7 -37.55 73.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.05 0.841 . . . . 0.0 112.015 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.26 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.969 -1.082 . . . . 0.0 112.211 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.19 -39.96 90.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.726 -0.609 . . . . 0.0 111.37 175.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.58 -48.29 80.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.204 1.002 . . . . 0.0 112.123 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.7 -32.89 74.07 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.82 -1.175 . . . . 0.0 112.718 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.3 t -64.57 -13.53 53.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.787 1.635 . . . . 0.0 113.331 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.474 0.736 0 O-C-N 120.658 -1.276 . . . . 0.0 110.719 170.854 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.6 mm . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 120.268 0.08 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 C-N-CA 124.448 1.099 . . . . 0.0 112.558 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.8 -25.87 63.06 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -82.82 -32.76 27.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.662 . . . . 0.0 111.916 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.89 -28.83 68.64 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.807 -0.558 . . . . 0.0 111.221 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.41 -7.05 16.81 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.567 -1.333 . . . . 0.0 114.042 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.11 -4.72 61.16 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.151 1.358 . . . . 0.0 115.506 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.3 mt -77.65 159.27 29.29 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.625 1.713 . . . . 0.0 115.215 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -87.09 -51.65 5.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.014 143.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -161.55 135.23 6.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.16 1.784 . . . . 0.0 112.586 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.04 162.98 38.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.218 1.407 . . . . 0.0 112.916 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -139.33 132.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.057 1.343 . . . . 0.0 108.707 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.07 123.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.012 1.325 . . . . 0.0 109.631 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -102.77 110.72 22.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.646 1.178 . . . . 0.0 111.621 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.02 70.29 5.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.962 1.705 . . . . 0.0 110.845 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -171.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.182 0.993 . . . . 0.0 113.561 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -136.27 163.35 30.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.644 1.178 . . . . 0.0 111.329 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -72.39 -60.89 2.01 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.284 1.033 . . . . 0.0 112.716 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.91 -41.9 35.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.648 1.179 . . . . 0.0 112.342 -169.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.2 m -47.59 108.51 0.9 Allowed Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 126.667 1.987 . . . . 0.0 114.191 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -62.09 -30.27 82.32 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.377 2.718 . . . . 0.0 113.926 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.88 -38.26 90.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -61.81 -32.54 72.85 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.955 0.902 . . . . 0.0 113.109 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.67 -29.1 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.709 0.804 . . . . 0.0 112.758 -174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -63.58 -43.47 96.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.573 0.749 . . . . 0.0 111.626 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.9 mmm -66.31 -26.08 67.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.745 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -44.69 89.26 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.531 1.06 . . . . 0.0 111.512 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -62.23 -43.92 97.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.996 -1.065 . . . . 0.0 112.226 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.45 -48.38 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.342 1.057 . . . . 0.0 111.051 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.4 mt -63.47 -37.11 86.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.005 0.922 . . . . 0.0 112.961 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.72 -47.86 81.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.432 0.693 . . . . 0.0 111.119 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.05 -32.54 72.97 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.913 0.885 . . . . 0.0 113.17 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.11 -36.45 83.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.683 1.593 . . . . 0.0 111.782 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.19 -22.5 62.95 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-N 118.917 0.78 . . . . 0.0 112.445 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.09 -28.71 64.85 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.715 1.206 . . . . 0.0 113.904 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 9.79 29.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.503 1.521 . . . . 0.0 114.256 176.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.46 85.73 14.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.381 1.472 . . . . 0.0 111.338 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.02 -15.03 18.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.878 2.385 . . . . 0.0 114.52 -169.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.97 -12.62 24.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.11 1.323 . . . . 0.0 113.874 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.69 129.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 110.226 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.96 92.99 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.371 0.605 . . . . 0.0 110.36 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 mt -92.96 136.24 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 109.988 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.5 p -148.15 168.55 22.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 112.688 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -118.25 168.84 10.22 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.989 -1.069 . . . . 0.0 110.636 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.77 131.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.33 1.052 . . . . 0.0 109.487 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.45 115.51 9.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.875 1.27 . . . . 0.0 111.873 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.7 p -57.05 -27.72 61.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.824 1.25 . . . . 0.0 113.826 172.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.53 -23.32 50.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.306 0.957 . . . . 0.0 112.498 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.79 -39.94 9.2 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.912 1.285 . . . . 0.0 113.108 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -126.89 60.58 41.73 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.544 . . . . 0.0 112.71 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.42 -15.95 34.71 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.395 2.73 . . . . 0.0 111.777 167.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.11 -41.18 68.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.606 1.563 . . . . 0.0 112.156 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.56 -44.05 62.64 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.336 0.654 . . . . 0.0 111.675 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.5 mtp -56.41 -28.94 60.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.711 0.805 . . . . 0.0 112.184 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -17.95 60.77 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.634 1.174 . . . . 0.0 113.505 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -81.06 -40.65 23.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.13 1.372 . . . . 0.0 110.822 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.52 -26.16 38.28 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.325 0.65 . . . . 0.0 112.481 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 16.51 23.78 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.906 1.717 . . . . 0.0 114.791 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.56 140.61 38.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.086 1.443 . . . . 0.0 110.691 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -77.29 -77.17 0.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.955 0.502 . . . . 0.0 110.778 175.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -147.79 4.56 0.76 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.443 1.497 . . . . 0.0 114.88 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.9 m -86.29 155.89 57.17 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 126.579 1.952 . . . . 0.0 113.198 -166.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.43 82.96 2.36 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 124.533 3.489 . . . . 0.0 111.294 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.4 m -96.38 130.88 43.4 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 112.683 -169.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.47 122.96 36.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.79 1.236 . . . . 0.0 108.987 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.17 126.04 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.553 1.541 . . . . 0.0 108.745 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.04 117.11 32.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 109.856 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.1 mm -109.7 126.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.922 1.289 . . . . 0.0 110.101 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -114.31 121.15 42.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.964 1.706 . . . . 0.0 108.622 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.9 t70 60.73 27.71 17.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.666 1.121 . . . . 0.0 111.927 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 -3.14 83.1 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -99.56 132.05 45.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.499 1.52 . . . . 0.0 109.65 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.12 104.02 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.71 -20.49 21.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.252 1.021 . . . . 0.0 113.107 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -163.03 155.61 18.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.21 1.804 . . . . 0.0 110.717 -173.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.35 146.42 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.093 1.357 . . . . 0.0 111.031 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.45 149.49 30.87 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.3 1.44 . . . . 0.0 108.575 169.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -134.01 140.13 46.49 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.133 -0.979 . . . . 0.0 112.08 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.84 -144.53 18.22 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.671 1.129 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.7 mm -116.96 143.26 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.322 1.449 . . . . 0.0 111.399 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.1 ptp -155.73 169.87 23.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 113.185 160.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -83.53 162.44 53.38 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 125.725 1.61 . . . . 0.0 112.129 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.95 -30.65 21.06 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.089 1.859 . . . . 0.0 114.655 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.7 -28.78 60.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.319 1.418 . . . . 0.0 113.027 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.1 -25.19 47.42 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.577 -0.702 . . . . 0.0 112.545 164.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.84 -30.65 67.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 111.953 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.32 -44.67 92.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.261 0.937 . . . . 0.0 111.086 163.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.52 72.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.257 0.935 . . . . 0.0 112.743 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.82 -48.22 72.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.127 1.371 . . . . 0.0 110.196 173.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.72 -42.24 83.43 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.935 0.894 . . . . 0.0 112.204 170.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.69 67.71 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.072 -1.018 . . . . 0.0 111.865 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 m -76.96 -10.7 59.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.583 1.553 . . . . 0.0 113.169 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.477 0.902 0 CA-C-N 119.391 0.996 . . . . 0.0 108.536 162.561 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 120.89 0.376 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 . . . . . 0 C--O 1.236 0.367 0 C-N-CA 127.89 2.476 . . . . 0.0 111.704 -172.655 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.89 70.51 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -74.73 -40.13 61.46 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.678 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -73.92 -9.8 59.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -92.07 -16.21 26.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.436 1.494 . . . . 0.0 113.173 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -19.05 6.63 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.63 166.4 22.82 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -82.72 -65.72 0.98 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.266 1.426 . . . . 0.0 113.013 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -148.42 121.79 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.603 1.561 . . . . 0.0 109.669 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.46 161.54 39.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.3 mt -138.16 123.17 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.645 1.578 . . . . 0.0 107.936 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.0 121.96 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.268 1.427 . . . . 0.0 108.314 -175.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -100.4 107.68 19.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.92 0.888 . . . . 0.0 110.802 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.11 80.74 3.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.721 1.208 . . . . 0.0 109.83 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.87 -178.31 7.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.708 1.203 . . . . 0.0 111.913 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -127.36 139.59 52.76 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.276 -1.515 . . . . 0.0 110.953 161.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -57.3 -32.75 66.97 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.696 1.598 . . . . 0.0 114.02 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -80.66 -37.97 29.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 113.209 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.0 t -57.5 118.13 23.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.934 1.694 . . . . 0.0 113.713 -168.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.48 -24.98 56.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.151 3.234 . . . . 0.0 113.381 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -77.01 -40.94 44.75 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.798 0.727 . . . . 0.0 110.957 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 78.7 m -52.83 -34.66 55.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.754 1.222 . . . . 0.0 113.959 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -55.98 -39.73 72.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.076 0.95 . . . . 0.0 112.303 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -65.2 -47.02 78.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.626 0.77 . . . . 0.0 110.841 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 tpt -60.66 -36.08 77.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.715 1.206 . . . . 0.0 112.176 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.63 -37.77 88.58 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.689 -1.257 . . . . 0.0 112.759 172.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -34.01 74.67 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.818 1.19 . . . . 0.0 112.476 171.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.07 -48.77 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-N 119.14 0.882 . . . . 0.0 110.385 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.97 -34.09 77.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.682 1.193 . . . . 0.0 112.087 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.13 -49.47 75.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.704 1.138 . . . . 0.0 111.475 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -66.57 -33.97 76.85 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.696 -0.627 . . . . 0.0 112.391 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -63.35 -42.61 98.92 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 111.261 170.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.82 -26.52 45.29 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.295 0.95 . . . . 0.0 112.619 -171.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.28 68.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.166 0.986 . . . . 0.0 113.428 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.32 8.27 35.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.618 1.567 . . . . 0.0 114.269 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.22 45.24 0.89 Allowed Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 126.257 1.823 . . . . 0.0 113.202 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.22 -15.74 51.52 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.751 2.967 . . . . 0.0 114.531 -167.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -76.84 -9.18 58.51 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.36 130.53 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.822 1.192 . . . . 0.0 108.529 162.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.57 96.05 6.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.301 0.641 . . . . 0.0 110.674 174.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mt -104.87 130.13 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.135 -0.978 . . . . 0.0 109.48 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.0 p -148.82 170.75 17.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.054 0.942 . . . . 0.0 112.325 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.2 p -129.89 153.63 48.12 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.017 -1.052 . . . . 0.0 112.896 174.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.87 134.54 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.677 1.591 . . . . 0.0 109.154 -168.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.46 121.04 26.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 123.026 1.393 . . . . 0.0 113.159 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 p -62.6 -23.71 67.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.861 1.664 . . . . 0.0 114.979 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.28 -45.1 10.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.031 1.287 . . . . 0.0 111.823 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.07 -26.92 43.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.709 1.204 . . . . 0.0 113.671 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.56 54.51 14.6 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.746 1.618 . . . . 0.0 112.038 -171.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.19 -9.67 13.91 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.318 3.345 . . . . 0.0 113.675 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -66.27 -21.78 66.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.801 0.84 . . . . 0.0 112.509 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.67 -54.25 6.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.77 1.228 . . . . 0.0 110.92 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.5 mtm -55.74 -30.01 60.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -74.2 -14.24 60.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.731 0.812 . . . . 0.0 112.803 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -89.04 -38.71 14.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.656 1.183 . . . . 0.0 110.538 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.46 -22.52 28.23 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 17.27 26.39 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.788 1.661 . . . . 0.0 115.061 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.56 140.58 37.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.016 1.408 . . . . 0.0 110.835 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.98 -59.36 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.618 0.767 . . . . 0.0 112.19 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -157.04 1.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 m -101.64 152.72 38.13 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.796 1.638 . . . . 0.0 113.028 -163.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.86 91.7 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.093 3.196 . . . . 0.0 110.396 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -107.2 124.83 50.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 0.0 112.47 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.56 129.25 37.57 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.274 0.63 . . . . 0.0 109.859 166.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.17 127.98 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.77 1.628 . . . . 0.0 108.401 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -105.64 127.84 53.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.424 1.09 . . . . 0.0 109.757 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.7 115.84 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.055 0.942 . . . . 0.0 108.674 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.43 123.93 50.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.131 1.373 . . . . 0.0 108.879 171.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.58 20.22 11.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.199 1.4 . . . . 0.0 112.681 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.11 12.56 82.29 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 113.694 -172.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -107.71 134.82 50.13 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.699 1.6 . . . . 0.0 109.754 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.74 105.12 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.96 -27.81 13.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -162.05 154.27 19.36 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.035 1.334 . . . . 0.0 110.579 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.2 145.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.878 1.271 . . . . 0.0 110.701 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 144.92 25.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.007 0.923 . . . . 0.0 111.17 165.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 m -111.52 120.17 41.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.122 0.969 . . . . 0.0 110.523 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.74 29.89 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 124.926 1.25 . . . . 0.0 114.382 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm -112.2 140.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.429 1.492 . . . . 0.0 109.7 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.0 mtm -142.6 161.32 38.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.781 0.833 . . . . 0.0 112.338 167.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -76.01 161.06 76.93 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.508 1.523 . . . . 0.0 112.064 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.31 -25.25 22.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.243 1.962 . . . . 0.0 114.453 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -76.67 -35.99 57.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.031 1.287 . . . . 0.0 112.543 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.5 -25.42 50.33 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.017 0.826 . . . . 0.0 112.784 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.29 -25.96 68.15 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.183 -0.948 . . . . 0.0 112.4 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -63.9 -38.76 92.29 Favored 'General case' 0 C--N 1.342 0.281 0 O-C-N 121.553 -0.717 . . . . 0.0 111.877 172.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.31 79.72 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.66 0.664 . . . . 0.0 112.038 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.01 -42.94 79.92 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.26 -43.37 98.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.806 0.843 . . . . 0.0 112.185 171.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.57 87.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.46 -0.775 . . . . 0.0 111.131 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.3 m -66.58 -4.07 7.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.004 1.722 . . . . 0.0 114.846 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 119.082 0.855 . . . . 0.0 110.58 166.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.257 0.551 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 . . . . . 0 C--O 1.235 0.311 0 C-N-CA 125.766 1.626 . . . . 0.0 110.276 -178.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -26.24 66.92 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -68.31 -43.24 78.08 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.123 0.874 . . . . 0.0 110.73 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -75.78 -9.71 58.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.236 1.014 . . . . 0.0 112.907 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.01 -14.33 29.57 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.046 1.338 . . . . 0.0 113.218 167.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.05 -15.71 6.04 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.73 174.29 8.61 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 p -88.37 -60.06 2.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.411 1.485 . . . . 0.0 113.497 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -158.47 115.59 2.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.218 1.407 . . . . 0.0 110.36 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.08 160.74 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -168.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.7 mt -137.43 128.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.949 1.7 . . . . 0.0 109.106 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.73 135.07 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.131 1.372 . . . . 0.0 109.458 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -116.07 114.79 25.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 111.729 172.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -83.94 74.24 10.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.941 1.696 . . . . 0.0 111.31 -175.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.73 -170.14 2.01 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -157.25 170.84 21.56 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.611 1.564 . . . . 0.0 113.323 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -47.57 -102.9 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 128.827 2.851 . . . . 0.0 116.951 -173.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.7 -15.73 41.35 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.015 -1.678 . . . . 0.0 114.629 -168.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -49.18 119.93 9.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.681 1.592 . . . . 0.0 112.494 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.31 -25.71 36.11 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.319 2.679 . . . . 0.0 113.732 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -70.93 -43.23 68.65 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 119.366 0.985 . . . . 0.0 112.179 -168.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -67.22 -25.1 65.94 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -61.68 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.114 0.966 . . . . 0.0 113.595 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -63.21 -44.69 94.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.415 0.686 . . . . 0.0 111.903 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -60.88 -30.63 70.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.416 1.086 . . . . 0.0 113.002 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.74 -35.37 76.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.404 0.682 . . . . 0.0 111.786 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -69.67 -34.09 73.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.525 1.057 . . . . 0.0 111.035 176.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 t -69.62 -46.35 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.014 1.726 . . . . 0.0 109.362 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.8 mt -61.96 -41.67 98.26 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.379 1.872 . . . . 0.0 112.658 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.62 -52.42 64.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.616 1.166 . . . . 0.0 111.97 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -66.47 -32.96 74.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.049 -1.032 . . . . 0.0 112.551 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -68.24 -34.3 75.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.896 1.278 . . . . 0.0 112.311 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.84 46.01 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 121.002 -1.061 . . . . 0.0 112.657 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.96 65.56 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.157 1.383 . . . . 0.0 114.537 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 4.84 23.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.976 1.31 . . . . 0.0 114.086 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.72 40.59 0.62 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.701 1.6 . . . . 0.0 114.034 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -65.56 -13.28 39.01 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.641 2.894 . . . . 0.0 114.685 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -77.83 -9.02 58.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 173.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.75 132.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.21 0.914 . . . . 0.0 108.903 161.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.26 92.65 5.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.332 0.587 . . . . 0.0 110.324 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.8 mt -102.16 131.1 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.253 1.021 . . . . 0.0 109.667 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.5 p -147.16 159.43 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.716 0.806 . . . . 0.0 112.369 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.0 p -98.14 163.6 12.67 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.213 -0.929 . . . . 0.0 111.145 163.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -147.99 129.17 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.602 1.561 . . . . 0.0 108.8 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.12 108.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.685 0.794 . . . . 0.0 110.188 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 p -52.55 -41.18 63.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.897 1.279 . . . . 0.0 111.88 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.14 -22.22 66.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.96 1.704 . . . . 0.0 114.223 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.06 -14.59 22.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.115 1.366 . . . . 0.0 113.4 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -131.9 49.61 4.82 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.79 1.636 . . . . 0.0 113.959 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -67.53 -26.35 40.29 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.431 2.087 . . . . 0.0 112.209 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -60.81 -41.28 95.35 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 0.0 111.703 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.97 -50.34 72.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.735 0.814 . . . . 0.0 110.996 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.9 mtp -57.63 -22.87 48.02 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.629 0.771 . . . . 0.0 113.022 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -14.03 52.94 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.561 1.144 . . . . 0.0 112.813 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -83.58 -41.35 17.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.343 1.057 . . . . 0.0 110.599 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.31 -24.72 32.05 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.47 20.98 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 125.172 1.368 . . . . 0.0 115.018 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -82.14 145.69 29.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.11 1.455 . . . . 0.0 111.508 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -80.91 -75.2 0.29 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 111.343 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -161.13 13.41 0.1 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -166.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.21 155.62 36.2 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 126.389 1.876 . . . . 0.0 113.255 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.56 90.26 1.05 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.16 3.24 . . . . 0.0 110.846 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -99.73 132.45 45.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 112.595 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.56 131.52 35.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.474 1.11 . . . . 0.0 109.71 161.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.65 121.92 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.776 1.631 . . . . 0.0 108.302 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.04 124.12 49.71 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.125 0.97 . . . . 0.0 110.687 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.54 122.74 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.171 1.388 . . . . 0.0 109.51 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -116.9 124.16 48.78 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.445 1.498 . . . . 0.0 109.192 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 62.65 20.54 12.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.166 1.386 . . . . 0.0 112.362 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.71 8.98 86.18 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.083 -1.011 . . . . 0.0 113.521 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -103.74 132.55 49.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.544 1.537 . . . . 0.0 109.073 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.82 105.4 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.324 -0.86 . . . . 0.0 109.039 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.43 -24.75 15.98 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.492 1.117 . . . . 0.0 113.387 -170.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -160.51 146.87 15.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.444 1.498 . . . . 0.0 110.801 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.2 t -147.51 145.52 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 109.826 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.26 151.5 29.2 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.976 0.911 . . . . 0.0 111.44 162.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.8 m -115.95 135.28 54.12 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.624 0.77 . . . . 0.0 111.944 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.89 -149.4 17.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.935 1.255 . . . . 0.0 112.593 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.19 139.65 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.571 1.548 . . . . 0.0 110.76 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -139.22 160.48 39.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.448 1.099 . . . . 0.0 112.044 163.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -74.0 162.11 75.49 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 124.76 1.224 . . . . 0.0 111.869 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.89 -23.71 12.12 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.09 1.86 . . . . 0.0 114.676 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.8 -37.33 67.59 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.137 1.79 . . . . 0.0 112.607 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -78.81 -22.88 45.59 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.653 0.66 . . . . 0.0 112.151 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.64 -29.57 70.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 0.0 112.09 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.74 -39.4 93.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.239 0.927 . . . . 0.0 111.393 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.19 80.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.503 -0.748 . . . . 0.0 111.93 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.41 -44.6 90.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.166 0.586 . . . . 0.0 110.686 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.18 -47.44 86.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.19 0.996 . . . . 0.0 112.693 172.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.16 76.52 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.13 -0.982 . . . . 0.0 112.351 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.1 t -65.58 -14.34 60.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.382 1.473 . . . . 0.0 113.737 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 N--CA 1.48 1.038 0 O-C-N 119.988 -1.695 . . . . 0.0 110.588 172.682 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 125.412 1.485 . . . . 0.0 111.637 -166.349 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 -28.93 63.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -74.16 -39.11 63.46 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.656 -0.652 . . . . 0.0 110.413 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.41 -14.98 61.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 113.302 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -89.49 -20.14 24.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.629 1.172 . . . . 0.0 112.846 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.24 -23.47 6.97 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 124.896 1.236 . . . . 0.0 115.081 -171.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.25 165.65 23.2 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -89.1 -56.22 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.987 1.315 . . . . 0.0 113.003 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -155.34 110.54 3.02 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.898 1.279 . . . . 0.0 110.65 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.84 159.75 42.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.7 mt -135.29 129.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.508 1.523 . . . . 0.0 108.445 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -121.28 124.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.613 1.565 . . . . 0.0 109.57 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -104.06 119.22 38.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -85.05 76.29 10.27 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.098 -1.001 . . . . 0.0 110.455 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 173.08 11.81 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.682 0.753 . . . . 0.0 112.931 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -125.68 147.66 49.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.694 1.198 . . . . 0.0 110.772 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.84 148.27 30.63 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 67.61 -30.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.907 2.883 . . . . 0.0 115.296 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.4 t -52.13 117.55 10.42 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.019 1.728 . . . . 0.0 113.305 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.91 -24.64 74.19 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.194 3.263 . . . . 0.0 113.602 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -72.61 -43.27 63.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.226 0.921 . . . . 0.0 110.585 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.6 -33.26 69.79 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 113.065 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -54.72 -39.8 68.59 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.174 0.989 . . . . 0.0 112.501 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.39 -48.13 81.63 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.549 0.74 . . . . 0.0 110.959 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.738 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.31 -43.09 96.66 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.209 0.913 . . . . 0.0 111.325 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -41.93 85.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.581 0.752 . . . . 0.0 112.43 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.86 -46.96 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.873 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.28 -34.09 77.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.114 1.365 . . . . 0.0 112.609 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.68 -46.46 88.07 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.9 0.773 . . . . 0.0 112.158 169.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -68.86 -35.16 76.59 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.289 -0.882 . . . . 0.0 112.033 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.76 -37.67 88.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.405 1.482 . . . . 0.0 111.848 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.49 -22.02 57.17 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 123.863 0.744 . . . . 0.0 113.369 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.74 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.264 1.026 . . . . 0.0 113.332 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 10.08 41.28 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.327 1.451 . . . . 0.0 114.601 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.75 48.83 0.74 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.629 1.572 . . . . 0.0 113.709 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.36 -16.96 57.89 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.591 2.861 . . . . 0.0 114.023 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -79.09 -8.28 58.84 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.53 134.12 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.545 1.066 . . . . 0.0 108.685 166.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.23 86.73 4.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.466 0.651 . . . . 0.0 110.647 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.5 mt -93.27 127.19 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.748 0.819 . . . . 0.0 109.178 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t -141.52 164.42 30.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.768 1.227 . . . . 0.0 110.906 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -110.42 -175.92 2.85 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 162.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.4 p -167.28 129.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.357 1.863 . . . . 0.0 109.222 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -72.55 114.71 10.98 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.193 0.997 . . . . 0.0 111.075 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 p -54.91 -28.09 48.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 113.601 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -74.9 -26.65 59.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.989 0.813 . . . . 0.0 112.675 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.18 -29.41 15.13 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.942 1.297 . . . . 0.0 113.415 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -127.81 49.83 4.77 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.18 1.392 . . . . 0.0 113.962 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.3 -19.93 49.48 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.937 1.758 . . . . 0.0 112.376 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.26 1.024 . . . . 0.0 112.86 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.85 -54.27 7.58 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.2 mtp -55.53 -33.31 63.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.578 1.151 . . . . 0.0 113.351 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -65.98 -21.29 66.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.695 1.598 . . . . 0.0 113.768 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -76.88 -40.14 48.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.847 0.749 . . . . 0.0 111.968 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.91 -22.56 24.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 11.86 36.41 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.337 1.922 . . . . 0.0 115.179 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.75 130.77 39.17 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.213 1.507 . . . . 0.0 111.68 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -84.12 -55.15 4.35 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.071 0.949 . . . . 0.0 112.169 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -160.41 -0.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.46 154.5 44.38 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 125.554 1.542 . . . . 0.0 113.4 -160.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.8 89.02 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.455 3.437 . . . . 0.0 109.469 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.3 m -105.2 132.67 51.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.829 0.851 . . . . 0.0 112.609 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.96 134.75 33.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.7 1.2 . . . . 0.0 110.471 166.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.5 t -130.31 131.46 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.783 1.633 . . . . 0.0 108.685 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -110.08 128.68 55.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.055 0.942 . . . . 0.0 110.65 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.86 110.49 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.0 123.75 50.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.284 1.433 . . . . 0.0 108.202 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.18 17.49 8.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.758 1.223 . . . . 0.0 112.038 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.52 83.18 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.077 0.846 . . . . 0.0 113.639 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -110.08 135.96 50.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.266 1.826 . . . . 0.0 109.397 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.09 106.29 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.94 -20.88 13.04 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -163.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -159.19 153.74 24.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.99 1.316 . . . . 0.0 111.436 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.65 144.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.734 1.614 . . . . 0.0 110.388 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -154.01 143.36 21.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.539 1.136 . . . . 0.0 112.011 165.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 m -101.19 135.58 42.42 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.927 0.891 . . . . 0.0 112.069 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.69 -162.72 12.32 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.914 1.245 . . . . 0.0 113.682 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.44 140.85 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.778 1.631 . . . . 0.0 111.285 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.8 mtm -134.79 153.21 52.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.467 1.107 . . . . 0.0 110.388 160.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.13 152.57 71.3 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 122.749 0.419 . . . . 0.0 110.978 169.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.81 -27.32 51.86 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.29 1.993 . . . . 0.0 114.264 -156.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -63.89 -30.04 71.17 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.12 -37.79 64.0 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.994 0.816 . . . . 0.0 111.008 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.6 tp -65.3 -28.24 69.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.47 -0.776 . . . . 0.0 112.819 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -59.1 -49.38 78.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.982 0.81 . . . . 0.0 111.574 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.9 -37.6 84.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.578 0.751 . . . . 0.0 111.77 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -67.24 -43.54 81.69 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.837 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.89 -47.01 87.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.425 1.09 . . . . 0.0 112.131 172.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.88 85.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.461 0.573 . . . . 0.0 111.739 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.2 m -62.48 -11.35 15.65 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.655 1.582 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.478 0.951 0 O-C-N 121.08 -1.013 . . . . 0.0 112.032 175.917 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mm . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 . . . . . 0 C--O 1.235 0.314 0 C-N-CA 124.521 1.129 . . . . 0.0 109.893 -179.52 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -25.27 64.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.719 1.208 . . . . 0.0 113.95 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -70.18 -31.16 68.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.105 0.866 . . . . 0.0 111.752 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -75.66 -20.63 58.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.943 0.897 . . . . 0.0 113.003 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.91 82.28 0.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.132 1.773 . . . . 0.0 113.075 -172.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 134.87 3.06 2.98 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 126.313 1.911 . . . . 0.0 116.927 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -74.48 114.33 12.75 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.14 1.97 . . . . 0.0 111.971 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -66.5 -28.33 68.48 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.746 -1.221 . . . . 0.0 114.045 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -155.85 97.06 1.8 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.556 1.542 . . . . 0.0 109.777 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.85 156.77 46.55 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mt -141.29 132.28 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.963 1.305 . . . . 0.0 109.347 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.58 126.57 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.322 1.449 . . . . 0.0 109.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -106.01 108.18 19.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.579 1.152 . . . . 0.0 110.419 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -77.56 76.38 4.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 110.392 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -172.37 2.31 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.847 0.859 . . . . 0.0 111.701 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -147.15 130.61 16.72 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.118 -1.614 . . . . 0.0 112.05 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.85 -23.91 61.4 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 mt -89.86 -15.5 32.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.45 122.26 73.52 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.81 1.644 . . . . 0.0 111.884 -173.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.7 -1.26 9.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.71 3.606 . . . . 0.0 113.04 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -88.43 -44.81 10.46 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.378 0.99 . . . . 0.0 109.741 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 p -61.93 -27.75 69.05 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -50.6 -38.96 48.55 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -71.98 -33.5 68.19 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.019 -0.425 . . . . 0.0 112.128 -168.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.1 tpt -64.0 -24.13 67.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.936 1.294 . . . . 0.0 113.266 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -65.17 -42.92 93.22 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.952 0.797 . . . . 0.0 110.927 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.95 -24.22 55.45 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.998 -1.064 . . . . 0.0 112.215 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.71 -51.9 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.023 0.929 . . . . 0.0 109.923 164.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.1 mt -60.14 -34.76 73.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.147 1.379 . . . . 0.0 112.619 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -58.21 -56.4 22.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.662 1.185 . . . . 0.0 111.972 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -64.5 -32.7 74.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.911 0.485 . . . . 0.0 111.414 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.21 -43.81 81.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.786 1.634 . . . . 0.0 112.979 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.5 57.32 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 120.635 -1.291 . . . . 0.0 111.684 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.44 -29.71 64.4 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 8.04 45.39 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.66 41.8 0.33 Allowed Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.786 1.634 . . . . 0.0 114.836 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.62 -22.19 16.4 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.62 3.547 . . . . 0.0 117.548 -157.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -60.69 -14.51 21.32 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -73.67 129.39 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.716 1.144 . . . . 0.0 111.289 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.8 98.59 11.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 110.797 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.6 mt -103.73 132.15 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.823 0.849 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 t -136.05 133.61 37.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.32 1.048 . . . . 0.0 110.38 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 m -86.12 155.16 20.89 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.622 -1.299 . . . . 0.0 111.531 164.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.3 t -143.72 128.86 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.642 1.577 . . . . 0.0 109.069 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.99 104.47 4.84 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.09 1.356 . . . . 0.0 110.564 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.8 p -56.19 -36.48 68.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.632 1.173 . . . . 0.0 113.468 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.57 -16.84 58.38 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -22.19 19.18 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.944 1.298 . . . . 0.0 112.88 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -116.72 52.92 1.11 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.878 1.671 . . . . 0.0 114.577 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.35 -18.07 26.74 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.7 2.267 . . . . 0.0 113.088 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -64.03 -38.14 89.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.368 0.985 . . . . 0.0 111.776 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.9 -51.99 22.78 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.607 1.163 . . . . 0.0 109.96 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.1 mtm -54.62 -32.18 58.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.095 0.958 . . . . 0.0 113.36 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -70.02 -19.95 63.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.012 1.325 . . . . 0.0 113.925 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -79.05 -39.92 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.769 0.713 . . . . 0.0 112.025 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.07 -22.45 21.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.69 15.77 28.32 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.786 1.66 . . . . 0.0 114.963 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -79.76 156.88 27.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.186 1.493 . . . . 0.0 111.626 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.03 -53.63 3.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.181 0.993 . . . . 0.0 112.654 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 168.67 17.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 129.101 2.96 . . . . 0.0 113.595 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.6 160.15 28.69 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 126.461 1.904 . . . . 0.0 111.912 -170.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -70.06 82.93 0.78 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.021 3.147 . . . . 0.0 112.516 -174.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.2 m -103.01 128.21 49.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.153 0.581 . . . . 0.0 112.363 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -94.22 120.6 34.69 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.541 1.137 . . . . 0.0 109.51 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.71 123.67 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 126.396 1.879 . . . . 0.0 108.1 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.0 120.03 40.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.887 0.875 . . . . 0.0 109.365 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.483 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 10.8 mm -108.23 121.65 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.187 1.395 . . . . 0.0 109.705 -168.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.483 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.37 122.34 47.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.833 1.653 . . . . 0.0 109.101 163.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.09 25.54 14.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 112.621 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.61 90.63 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -105.99 128.74 54.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.404 1.082 . . . . 0.0 108.924 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.07 109.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.416 0.686 . . . . 0.0 109.974 172.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.05 20.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.92 1.288 . . . . 0.0 113.494 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -163.8 152.07 13.26 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.364 1.866 . . . . 0.0 109.456 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.32 144.22 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.782 1.233 . . . . 0.0 110.971 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.17 31.78 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.431 1.493 . . . . 0.0 109.525 168.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -126.04 139.29 53.53 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 112.675 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.78 -154.43 17.02 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.931 1.729 . . . . 0.0 112.626 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.3 mm -118.2 143.83 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.31 1.444 . . . . 0.0 110.765 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -151.49 161.63 42.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.768 0.827 . . . . 0.0 112.418 161.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.38 149.54 86.7 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.021 0.929 . . . . 0.0 111.836 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.62 -31.47 79.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.003 2.469 . . . . 0.0 113.95 -168.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -52.99 -36.19 60.1 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -89.25 -29.99 18.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.757 0.708 . . . . 0.0 111.975 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.0 -30.25 70.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.664 0.786 . . . . 0.0 112.027 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -56.08 -44.24 78.79 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.766 0.712 . . . . 0.0 111.895 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.6 60.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.23 1.012 . . . . 0.0 112.521 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -70.89 -39.24 72.93 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 109.618 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.6 -36.7 73.66 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.046 1.338 . . . . 0.0 112.859 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.51 80.9 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.748 -1.22 . . . . 0.0 112.605 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -59.27 -20.65 56.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.964 0.905 . . . . 0.0 113.04 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.474 0.744 0 O-C-N 121.109 -0.994 . . . . 0.0 109.539 167.193 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 126.552 1.941 . . . . 0.0 109.814 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.52 -29.16 64.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -74.8 -41.35 60.14 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.74 -0.6 . . . . 0.0 110.557 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -72.93 -11.32 60.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.5 -17.3 27.31 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.03 1.332 . . . . 0.0 113.645 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -117.79 -16.19 5.98 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.59 171.0 13.24 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -91.4 -51.96 5.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.978 1.311 . . . . 0.0 113.166 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -160.46 109.05 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.879 1.672 . . . . 0.0 110.095 -171.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.09 158.82 44.56 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -134.64 130.14 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 0.0 109.064 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 t -119.09 125.7 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.563 1.545 . . . . 0.0 109.133 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.04 113.82 27.59 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.492 1.117 . . . . 0.0 111.311 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -78.94 69.38 5.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.48 170.38 16.66 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.843 0.857 . . . . 0.0 112.898 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -129.54 176.93 7.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.38 1.472 . . . . 0.0 111.21 168.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -100.51 -33.02 10.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.985 0.914 . . . . 0.0 113.437 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.38 -68.03 0.57 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.058 0.943 . . . . 0.0 112.934 -167.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.9 m -59.07 150.67 60.66 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.369 1.868 . . . . 0.0 114.138 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.14 -13.79 21.02 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.787 3.658 . . . . 0.0 113.19 171.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -66.83 -48.46 68.82 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 119.014 0.825 . . . . 0.0 111.969 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.0 p -61.14 -29.84 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.107 1.363 . . . . 0.0 113.597 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -55.82 -32.99 64.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.011 1.324 . . . . 0.0 112.557 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -62.94 -48.2 79.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.611 1.164 . . . . 0.0 111.73 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 mmt -63.24 -34.79 78.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.321 -0.862 . . . . 0.0 112.798 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.47 -36.37 73.62 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.267 0.939 . . . . 0.0 112.533 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -79.17 -38.67 35.35 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.29 -51.43 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.046 0.938 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.41 -33.86 75.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.793 1.237 . . . . 0.0 113.001 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.79 -49.96 70.85 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.302 0.641 . . . . 0.0 111.367 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -67.63 -32.14 72.63 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.395 -0.816 . . . . 0.0 112.885 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.36 -39.74 89.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.091 1.356 . . . . 0.0 111.966 170.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.32 -26.14 52.7 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.133 0.873 . . . . 0.0 112.343 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.6 65.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 10.11 34.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.168 1.387 . . . . 0.0 114.297 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.36 50.89 1.18 Allowed Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.102 1.761 . . . . 0.0 112.857 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.01 -14.4 44.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -168.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -78.64 -8.8 59.03 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -78.57 131.48 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.481 1.037 . . . . 0.0 108.357 165.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 96.16 6.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.07 0.548 . . . . 0.0 110.894 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.4 mt -103.84 131.48 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.2 p -148.21 172.76 13.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.918 0.887 . . . . 0.0 112.333 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -121.63 162.96 19.76 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.093 -1.004 . . . . 0.0 111.165 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.9 t -143.78 122.76 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.253 1.421 . . . . 0.0 107.712 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.0 103.92 0.51 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.325 1.45 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -58.76 -36.21 74.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.613 1.165 . . . . 0.0 112.35 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -75.1 -18.2 60.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.181 1.792 . . . . 0.0 113.893 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.07 -26.62 9.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.786 1.235 . . . . 0.0 113.527 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -126.86 51.94 7.19 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 126.171 1.788 . . . . 0.0 112.921 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -65.85 -14.98 47.17 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.746 2.297 . . . . 0.0 112.939 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -57.28 -23.39 48.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 113.182 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.98 -58.1 3.47 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 122.991 0.516 . . . . 0.0 110.682 166.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.8 mtm -57.22 -27.81 62.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.058 1.343 . . . . 0.0 113.748 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.56 -15.94 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.033 1.333 . . . . 0.0 112.726 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -87.29 -36.76 17.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.361 1.064 . . . . 0.0 111.296 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.97 -25.8 22.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 19.16 14.04 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.626 1.584 . . . . 0.0 115.264 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.97 145.85 28.32 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.409 1.605 . . . . 0.0 111.551 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -96.0 -62.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.668 0.787 . . . . 0.0 112.665 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -157.47 2.63 0.12 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.9 m -106.46 150.3 39.35 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 126.028 1.731 . . . . 0.0 112.769 -163.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.13 92.74 0.55 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.23 3.287 . . . . 0.0 109.553 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -105.08 131.98 51.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.865 0.866 . . . . 0.0 111.857 -172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -93.53 134.54 35.7 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.489 1.116 . . . . 0.0 110.247 168.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.97 131.25 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.623 1.569 . . . . 0.0 108.89 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -115.06 123.94 50.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.283 1.033 . . . . 0.0 110.282 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.8 mm -108.08 120.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.141 1.376 . . . . 0.0 108.822 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -113.94 122.93 48.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.298 1.839 . . . . 0.0 108.869 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.7 t70 63.62 20.93 12.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.395 1.078 . . . . 0.0 112.902 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.22 84.46 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.278 -0.888 . . . . 0.0 113.256 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -108.34 133.04 53.09 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.157 1.783 . . . . 0.0 109.285 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.88 107.59 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.41 -0.806 . . . . 0.0 109.508 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.6 -25.2 15.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -160.96 150.85 17.36 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.397 1.479 . . . . 0.0 110.932 -171.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.94 143.23 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.546 1.538 . . . . 0.0 110.529 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -153.38 140.34 19.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.222 1.009 . . . . 0.0 111.404 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.4 p -97.77 133.15 42.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.735 1.214 . . . . 0.0 111.756 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.78 -168.09 13.58 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.112 1.339 . . . . 0.0 113.343 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.18 143.37 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.368 1.467 . . . . 0.0 112.019 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -135.5 163.44 30.08 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.622 1.169 . . . . 0.0 111.947 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -68.14 161.37 68.88 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.629 1.172 . . . . 0.0 111.433 164.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.76 -27.1 15.23 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.965 1.777 . . . . 0.0 113.972 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -72.84 -34.0 66.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.489 1.495 . . . . 0.0 112.646 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.2 -26.33 56.03 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.372 -0.83 . . . . 0.0 112.457 171.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.52 -30.73 71.52 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.845 -1.159 . . . . 0.0 111.941 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -61.11 -44.84 96.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.877 0.762 . . . . 0.0 111.201 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.5 75.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.257 0.623 . . . . 0.0 112.352 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.08 76.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 0.0 109.87 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -45.48 94.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.317 1.047 . . . . 0.0 112.089 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.23 77.7 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.21 -0.931 . . . . 0.0 112.459 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.8 t -63.62 -13.26 40.61 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.857 1.663 . . . . 0.0 113.452 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.471 0.575 0 O-C-N 120.674 -1.266 . . . . 0.0 109.992 169.715 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.625 0 C-N-CA 125.774 1.63 . . . . 0.0 111.312 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.18 -21.18 62.2 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.43 -39.22 19.23 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.615 -0.678 . . . . 0.0 110.57 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -78.62 -7.96 58.15 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.7 -13.47 45.31 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.87 7.86 1.09 Allowed Glycine 0 N--CA 1.478 1.469 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.23 173.06 9.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.971 1.386 . . . . 0.0 113.416 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -83.38 -61.03 1.95 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.113 0.965 . . . . 0.0 112.411 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -157.54 120.81 4.02 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.264 1.826 . . . . 0.0 110.18 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.21 159.19 43.62 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.7 mt -130.95 130.75 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.533 1.533 . . . . 0.0 109.153 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.4 t -120.73 121.97 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.685 1.594 . . . . 0.0 109.273 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.51 114.87 29.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.242 1.017 . . . . 0.0 111.824 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -79.78 72.3 6.48 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.905 1.282 . . . . 0.0 111.073 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.43 170.73 16.16 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.115 0.966 . . . . 0.0 113.147 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -142.13 168.55 19.47 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.741 1.216 . . . . 0.0 111.938 170.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -93.13 -39.65 10.93 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -165.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 mt -77.45 -39.92 45.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.45 0.7 . . . . 0.0 112.718 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.49 128.84 94.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.149 1.379 . . . . 0.0 111.693 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 -13.74 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 124.461 3.44 . . . . 0.0 112.94 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -73.9 -45.65 49.38 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 120.167 1.349 . . . . 0.0 111.918 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.5 m -53.67 -35.81 61.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.82 1.248 . . . . 0.0 113.339 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.5 -31.93 68.33 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.512 1.525 . . . . 0.0 112.889 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -72.47 -44.07 62.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.668 0.787 . . . . 0.0 111.187 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.7 tpt -58.88 -38.85 79.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.483 1.513 . . . . 0.0 112.566 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -53.67 -41.24 66.63 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.514 0.725 . . . . 0.0 112.168 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -72.29 -23.53 61.2 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.928 -1.107 . . . . 0.0 113.693 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -69.65 -45.96 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.109 0.963 . . . . 0.0 109.748 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.8 -37.61 82.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.089 0.955 . . . . 0.0 111.828 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.68 -52.24 66.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.089 0.956 . . . . 0.0 111.948 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.46 -30.03 68.8 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.478 0.711 . . . . 0.0 112.817 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.95 -34.66 76.99 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.922 0.889 . . . . 0.0 111.833 170.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -25.59 61.2 Favored Glycine 0 N--CA 1.471 1.032 0 O-C-N 121.064 -1.023 . . . . 0.0 113.632 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.55 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -171.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 7.41 10.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.209 1.403 . . . . 0.0 114.52 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.95 47.89 2.84 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.86 1.664 . . . . 0.0 113.529 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.75 -16.32 54.7 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.726 2.951 . . . . 0.0 114.431 -169.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -76.81 -6.66 53.24 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -85.1 127.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 162.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.79 103.77 11.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 0.0 109.711 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.6 mt -108.04 128.79 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.056 -1.028 . . . . 0.0 109.367 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -146.98 167.38 24.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.82 165.51 12.99 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.855 -1.153 . . . . 0.0 111.741 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.07 121.46 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.932 1.293 . . . . 0.0 108.33 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.75 102.53 0.35 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.065 1.346 . . . . 0.0 110.42 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.6 p -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.362 0.665 . . . . 0.0 112.421 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.72 -26.69 65.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 113.362 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.16 -27.76 8.99 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.981 1.312 . . . . 0.0 113.661 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -116.26 65.22 2.91 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 127.493 2.317 . . . . 0.0 110.724 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.48 -22.51 33.27 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.516 2.144 . . . . 0.0 111.963 168.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.9 -24.53 66.06 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.639 1.176 . . . . 0.0 113.204 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.48 -59.99 2.48 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.056 0.942 . . . . 0.0 110.052 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.5 mtm -58.51 -25.85 62.83 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 113.371 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -65.7 -24.54 67.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.199 1.0 . . . . 0.0 112.35 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.3 -36.3 17.96 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.533 1.133 . . . . 0.0 111.37 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.92 -24.17 22.53 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.22 13.73 32.62 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.746 1.641 . . . . 0.0 115.161 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.08 146.87 36.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.371 1.585 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.85 -61.81 1.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.602 0.761 . . . . 0.0 112.195 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.98 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.512 1.925 . . . . 0.0 111.614 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.72 150.6 31.0 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.988 1.315 . . . . 0.0 112.457 -166.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.29 85.75 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.284 3.323 . . . . 0.0 109.911 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -102.62 129.76 49.29 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.36 0.664 . . . . 0.0 111.341 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 mp -93.63 126.48 38.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.048 0.939 . . . . 0.0 108.913 164.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.63 129.4 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.122 1.769 . . . . 0.0 108.277 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.59 124.47 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 mm -109.21 122.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.828 1.251 . . . . 0.0 109.179 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -117.75 126.46 52.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.567 1.547 . . . . 0.0 108.574 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 63.28 17.79 10.51 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.429 1.091 . . . . 0.0 112.965 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.07 11.22 81.55 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.282 0.944 . . . . 0.0 113.809 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -109.58 138.5 45.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.568 1.947 . . . . 0.0 109.807 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.74 108.37 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.84 -25.49 15.02 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -160.12 154.07 23.04 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.092 1.757 . . . . 0.0 110.342 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.88 143.85 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.849 1.26 . . . . 0.0 110.19 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.9 143.64 27.52 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.344 1.058 . . . . 0.0 110.87 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 t -110.91 132.68 54.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.859 1.264 . . . . 0.0 110.83 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.46 -152.83 20.36 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.721 1.153 . . . . 0.0 114.324 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.39 146.53 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.688 1.995 . . . . 0.0 110.371 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 ptp -153.22 -169.55 3.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.489 1.516 . . . . 0.0 111.011 169.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.9 163.86 40.71 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.052 1.341 . . . . 0.0 111.072 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.54 -23.33 31.91 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.737 1.625 . . . . 0.0 114.432 -156.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.93 -30.49 69.82 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.715 1.143 . . . . 0.0 113.4 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.32 -35.72 63.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.085 0.954 . . . . 0.0 111.251 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.5 tp -64.94 -24.95 67.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.164 0.585 . . . . 0.0 112.469 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -64.39 -43.78 93.37 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.946 0.794 . . . . 0.0 111.632 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.3 84.06 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.485 0.584 . . . . 0.0 111.611 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.57 -44.25 91.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.523 0.729 . . . . 0.0 111.272 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -45.6 93.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.817 0.847 . . . . 0.0 112.22 170.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.5 74.17 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.009 0.822 . . . . 0.0 111.892 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.4 m -68.31 -5.27 17.72 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.654 1.582 . . . . 0.0 114.564 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.479 1.004 0 O-C-N 121.054 -1.029 . . . . 0.0 110.798 171.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 121.563 0.697 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 . . . . . 0 C--O 1.231 0.118 0 C-N-CA 126.204 1.802 . . . . 0.0 110.541 174.386 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.85 -27.57 67.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -70.61 -39.01 74.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.802 1.183 . . . . 0.0 110.658 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.19 -9.48 58.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 113.077 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.65 -15.66 32.21 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.221 1.408 . . . . 0.0 113.395 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.51 -13.44 4.26 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.89 174.06 9.77 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -96.52 -54.68 3.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -149.5 124.25 9.85 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.006 1.323 . . . . 0.0 109.654 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.27 160.12 43.94 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -140.0 132.11 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 108.436 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 129.66 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.689 1.196 . . . . 0.0 109.288 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -109.07 117.44 34.17 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.807 0.843 . . . . 0.0 112.032 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.92 71.82 8.96 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.844 1.258 . . . . 0.0 110.622 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -174.23 1.05 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.85 0.86 . . . . 0.0 113.271 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -138.73 141.3 38.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.803 -1.186 . . . . 0.0 112.177 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -61.97 -32.18 72.6 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 113.699 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.6 mt -81.68 -83.9 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.901 1.28 . . . . 0.0 111.765 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -44.19 118.98 3.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 127.901 2.48 . . . . 0.0 114.235 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.45 -17.57 23.67 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.042 3.161 . . . . 0.0 113.611 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -63.72 -44.21 94.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 119.037 0.835 . . . . 0.0 111.663 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.3 p -66.91 -27.02 67.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.61 -28.03 69.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.735 1.214 . . . . 0.0 112.515 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -64.63 -39.21 93.3 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.75 0.82 . . . . 0.0 112.502 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.2 tpp -62.28 -35.72 79.87 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.026 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -50.61 -42.01 55.52 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.476 -0.765 . . . . 0.0 112.863 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -84.11 -12.38 55.12 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.278 1.031 . . . . 0.0 113.255 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -78.58 -47.32 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.274 1.43 . . . . 0.0 109.935 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.57 -37.01 74.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.522 1.529 . . . . 0.0 112.65 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.39 -53.86 52.45 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.886 0.874 . . . . 0.0 111.697 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -64.97 -30.68 71.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.629 0.772 . . . . 0.0 112.801 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -70.96 -41.98 70.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.417 1.087 . . . . 0.0 111.379 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.96 -29.75 30.72 Favored Glycine 0 N--CA 1.47 0.943 0 C-N-CA 124.649 1.118 . . . . 0.0 113.206 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.72 67.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 9.5 38.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.686 1.595 . . . . 0.0 114.179 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.93 65.34 73.85 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 125.678 1.591 . . . . 0.0 112.357 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.42 -20.77 71.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.168 2.579 . . . . 0.0 115.144 -171.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -83.42 -6.89 59.6 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 133.04 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.671 1.189 . . . . 0.0 109.442 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.59 14.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.193 0.597 . . . . 0.0 110.682 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -108.24 130.65 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.943 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -151.36 177.56 10.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.193 1.397 . . . . 0.0 112.803 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -124.27 167.04 14.86 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.503 -1.373 . . . . 0.0 113.227 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -149.16 135.69 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.719 2.008 . . . . 0.0 108.272 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.04 119.84 23.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.091 0.948 . . . . 0.0 112.164 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.6 p -61.0 -28.0 68.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.542 1.537 . . . . 0.0 114.12 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -87.31 -34.46 18.86 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.528 0.731 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 -22.95 27.07 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.577 1.151 . . . . 0.0 113.945 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -121.67 42.54 0.59 Allowed Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.654 1.582 . . . . 0.0 114.374 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.01 -19.56 45.55 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.668 2.245 . . . . 0.0 113.052 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.05 -22.67 65.93 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.053 0.941 . . . . 0.0 113.121 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.8 -54.91 5.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.765 0.711 . . . . 0.0 110.415 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 mtm -56.19 -28.88 59.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.664 1.186 . . . . 0.0 113.63 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -68.95 -18.91 64.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.022 1.329 . . . . 0.0 113.004 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.93 -34.65 20.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.435 1.094 . . . . 0.0 110.798 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.76 -25.51 23.37 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.46 15.58 22.67 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.82 1.676 . . . . 0.0 115.296 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.38 144.61 30.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.884 1.842 . . . . 0.0 111.151 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -89.1 -56.52 3.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.983 0.913 . . . . 0.0 112.668 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -169.83 7.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -167.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -100.26 149.71 36.29 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.011 1.724 . . . . 0.0 112.959 -165.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.8 95.22 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.882 3.055 . . . . 0.0 110.292 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.2 m -114.89 130.39 56.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.768 0.827 . . . . 0.0 112.778 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.95 134.67 33.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.725 1.61 . . . . 0.0 109.825 168.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.5 132.3 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.755 1.622 . . . . 0.0 109.216 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -116.93 127.67 54.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.144 0.978 . . . . 0.0 111.016 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -112.62 122.52 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 0.0 109.106 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.6 124.23 49.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.277 1.831 . . . . 0.0 109.004 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 62.04 20.19 11.41 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.729 1.15 . . . . 0.0 113.075 171.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.1 78.16 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.279 0.942 . . . . 0.0 113.477 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -108.07 134.3 51.14 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.317 1.847 . . . . 0.0 109.464 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.37 103.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.94 12.75 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.76 163.47 39.21 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.812 1.245 . . . . 0.0 111.806 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.6 146.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.161 1.785 . . . . 0.0 110.303 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.13 136.84 14.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.157 0.983 . . . . 0.0 111.01 168.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 m -101.79 138.72 38.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 0.0 111.656 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.24 -157.2 15.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.918 1.246 . . . . 0.0 113.213 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.39 142.34 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.526 1.53 . . . . 0.0 111.333 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.2 mtm -139.94 163.16 33.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.234 1.413 . . . . 0.0 111.997 165.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -77.44 161.5 72.17 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.887 1.675 . . . . 0.0 111.742 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.19 -24.97 19.46 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.328 2.019 . . . . 0.0 113.671 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -77.2 -33.83 56.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.461 1.482 . . . . 0.0 112.828 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.75 -30.33 56.51 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.648 0.779 . . . . 0.0 112.374 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.03 -28.2 66.19 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.35 -0.844 . . . . 0.0 112.791 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -62.26 -43.11 99.57 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.759 0.709 . . . . 0.0 111.895 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.25 77.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.447 0.699 . . . . 0.0 111.532 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.13 -48.52 75.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.971 0.908 . . . . 0.0 110.827 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -45.49 94.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.26 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.03 74.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.254 -0.904 . . . . 0.0 111.322 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.7 m -60.49 -31.78 70.81 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.479 1.022 0 CA-C-N 119.738 1.154 . . . . 0.0 110.687 176.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 121.401 0.619 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? . . . . . 0 N--CA 1.467 0.407 0 C-N-CA 126.306 1.842 . . . . 0.0 109.713 -177.812 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.04 62.94 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -86.77 -38.54 16.8 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.976 0.807 . . . . 0.0 111.121 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.93 -12.13 60.56 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.276 -0.89 . . . . 0.0 113.177 -171.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -89.81 -10.18 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.267 1.027 . . . . 0.0 113.617 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.26 -4.03 1.13 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.77 172.21 7.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.538 1.669 . . . . 0.0 114.074 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -82.53 -59.94 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.306 1.043 . . . . 0.0 112.912 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -160.08 115.22 2.33 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.79 1.636 . . . . 0.0 110.166 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.77 44.29 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -131.23 128.1 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 108.168 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.91 117.47 54.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.715 1.606 . . . . 0.0 108.773 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.29 120.68 38.1 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.564 1.146 . . . . 0.0 110.683 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.23 82.06 7.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.109 -1.619 . . . . 0.0 109.848 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 176.72 8.66 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -139.51 137.96 35.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.108 1.363 . . . . 0.0 109.769 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -83.25 -27.22 30.06 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -167.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 mt -76.62 -33.74 58.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.392 1.477 . . . . 0.0 112.925 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -73.83 130.5 83.19 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 126.06 1.744 . . . . 0.0 111.738 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.13 -14.74 18.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.494 3.462 . . . . 0.0 113.3 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -76.04 -47.66 23.88 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.816 1.189 . . . . 0.0 110.695 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.4 m -52.84 -35.56 57.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.031 1.732 . . . . 0.0 113.889 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -55.39 -33.34 63.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.038 1.335 . . . . 0.0 113.135 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.48 -40.72 89.48 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.233 1.013 . . . . 0.0 112.63 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.49 68.9 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.437 -0.79 . . . . 0.0 112.989 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -63.01 -44.24 96.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.667 0.667 . . . . 0.0 111.496 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -63.78 -38.94 92.97 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.77 -49.08 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.582 1.553 . . . . 0.0 110.434 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 mt -64.58 -35.24 80.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.32 1.048 . . . . 0.0 112.772 175.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.23 -50.08 74.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.108 0.963 . . . . 0.0 111.753 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.28 -31.6 72.5 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.099 -1.001 . . . . 0.0 112.584 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.97 -32.52 70.79 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.411 1.084 . . . . 0.0 112.596 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.84 -27.44 38.07 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 120.831 -1.168 . . . . 0.0 113.417 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.81 55.11 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 10.18 12.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.18 72.52 81.88 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.555 1.542 . . . . 0.0 111.556 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.45 -21.05 60.94 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.352 2.702 . . . . 0.0 115.534 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -83.06 -5.21 59.02 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -166.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.9 p -106.83 132.38 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.113 1.365 . . . . 0.0 111.036 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.5 102.52 13.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.171 0.988 . . . . 0.0 110.515 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mt -100.21 130.81 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.312 -0.867 . . . . 0.0 109.913 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -150.38 168.61 23.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.25 1.02 . . . . 0.0 112.028 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -118.45 -179.58 3.83 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.909 -1.119 . . . . 0.0 112.591 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.6 t -149.79 128.34 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 128.102 2.561 . . . . 0.0 108.024 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.19 97.66 0.27 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.584 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.3 p -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.287 -0.883 . . . . 0.0 112.323 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.39 -15.74 62.38 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.644 1.978 . . . . 0.0 114.19 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.84 -39.07 3.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.764 1.225 . . . . 0.0 113.522 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -115.39 54.23 0.91 Allowed Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.843 1.657 . . . . 0.0 113.78 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.0 -13.36 33.97 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -58.69 -24.48 61.42 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.733 1.152 . . . . 0.0 112.954 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.24 -58.54 3.44 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.339 0.518 . . . . 0.0 110.973 165.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.3 mtm -54.74 -33.03 60.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.028 1.331 . . . . 0.0 113.002 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -67.29 -18.82 65.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.709 1.603 . . . . 0.0 114.109 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -77.69 -40.51 41.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.968 0.803 . . . . 0.0 111.644 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.16 -23.93 24.66 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 12.75 28.61 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.108 1.813 . . . . 0.0 115.285 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -81.65 154.14 26.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.758 1.779 . . . . 0.0 111.531 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -102.33 -61.11 1.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.097 0.959 . . . . 0.0 112.152 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -162.69 2.31 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -98.68 155.4 36.76 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 126.598 1.959 . . . . 0.0 112.833 -165.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.7 88.58 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.44 3.427 . . . . 0.0 111.402 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.0 m -104.03 130.53 51.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.672 0.789 . . . . 0.0 110.862 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.06 121.47 41.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 0.0 109.816 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.52 130.86 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.641 1.976 . . . . 0.0 108.546 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -113.12 121.87 45.83 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.1 mm -109.27 116.15 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.486 1.114 . . . . 0.0 108.903 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.85 123.32 49.38 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.375 1.47 . . . . 0.0 107.957 171.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.38 19.76 11.91 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.497 1.119 . . . . 0.0 113.178 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.25 84.44 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.058 -1.026 . . . . 0.0 113.263 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -108.21 133.56 52.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.963 1.705 . . . . 0.0 109.025 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.35 107.47 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.07 -19.92 14.02 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -160.7 150.28 17.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.524 1.53 . . . . 0.0 110.77 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.45 145.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.428 1.491 . . . . 0.0 109.971 169.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.09 152.37 34.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.427 1.491 . . . . 0.0 109.292 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 t -128.95 138.36 51.93 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.926 -1.109 . . . . 0.0 112.589 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.73 -161.69 19.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.002 1.763 . . . . 0.0 112.755 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.3 mm -111.07 143.6 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.691 1.196 . . . . 0.0 111.069 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 67.4 mtm -137.53 158.17 44.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.902 1.281 . . . . 0.0 111.78 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.52 147.92 76.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.054 0.942 . . . . 0.0 111.176 164.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.3 -27.32 63.7 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.931 2.421 . . . . 0.0 113.212 -168.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.85 -29.51 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.56 -24.98 15.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.373 1.069 . . . . 0.0 112.47 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.92 -28.41 68.9 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.435 -0.791 . . . . 0.0 111.998 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -55.56 -50.38 70.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.96 -35.38 74.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.503 0.721 . . . . 0.0 111.852 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.63 -44.7 81.28 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.627 0.771 . . . . 0.0 110.517 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -47.08 85.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 112.151 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.85 82.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.265 0.939 . . . . 0.0 112.077 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 m -58.27 -25.51 61.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.451 1.5 . . . . 0.0 113.842 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.133 0.973 . . . . 0.0 111.196 177.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mm . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.527 1.531 . . . . 0.0 111.572 176.54 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.93 63.23 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -74.49 -39.97 62.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.811 0.732 . . . . 0.0 110.596 169.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.43 -13.4 62.11 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.53 -14.06 41.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 0.0 113.848 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.75 -8.84 1.85 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 117.087 1.595 . . . . 0.0 117.087 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.33 176.74 4.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.219 1.51 . . . . 0.0 114.437 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 p -92.15 -55.96 3.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.805 1.242 . . . . 0.0 113.713 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -159.21 110.22 2.04 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.273 1.829 . . . . 0.0 109.111 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.38 155.27 38.31 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.31 128.76 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.862 1.265 . . . . 0.0 108.682 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 t -114.75 126.14 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.131 1.372 . . . . 0.0 109.285 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -106.87 113.67 27.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.891 0.876 . . . . 0.0 111.604 173.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -77.82 74.15 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.488 1.915 . . . . 0.0 111.022 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.62 -179.28 2.08 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.984 -1.073 . . . . 0.0 112.517 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.19 162.02 32.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.229 1.411 . . . . 0.0 111.942 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -73.9 -38.82 64.24 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.323 -0.861 . . . . 0.0 113.111 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.3 mt -98.83 -32.44 11.34 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.6 123.08 72.49 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.083 1.353 . . . . 0.0 113.68 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -82.47 -2.37 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.489 3.46 . . . . 0.0 112.897 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -89.14 -40.78 12.68 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 119.434 1.015 . . . . 0.0 110.022 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 p -64.37 -26.99 68.71 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.0 -37.59 45.93 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -74.33 -34.45 63.44 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.355 0.662 . . . . 0.0 111.965 -166.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -28.75 69.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.501 -0.762 . . . . 0.0 112.777 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.17 -37.92 84.56 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.193 1.36 . . . . 0.0 112.186 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -34.89 69.82 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.935 -1.103 . . . . 0.0 112.053 173.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.36 -48.34 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.772 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.8 mt -62.0 -42.25 98.95 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.767 1.627 . . . . 0.0 112.319 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.57 -46.95 83.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.305 1.042 . . . . 0.0 111.91 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.26 -27.28 65.3 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.863 -1.148 . . . . 0.0 113.157 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.35 -36.9 71.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.674 0.79 . . . . 0.0 112.059 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.94 -19.94 69.01 Favored Glycine 0 N--CA 1.469 0.864 0 CA-C-N 119.212 0.915 . . . . 0.0 113.301 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -33.7 60.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.668 1.587 . . . . 0.0 114.629 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.72 6.59 11.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.267 1.427 . . . . 0.0 114.276 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.03 79.0 25.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.641 1.576 . . . . 0.0 110.433 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.04 -13.57 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.216 2.611 . . . . 0.0 114.287 -168.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -90.15 -6.98 54.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -168.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 p -99.58 131.92 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.614 1.565 . . . . 0.0 110.181 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.91 100.7 11.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 110.138 174.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.34 131.58 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.437 -0.79 . . . . 0.0 109.967 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.2 p -140.33 160.11 40.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.227 1.013 . . . . 0.0 111.809 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -106.83 165.81 11.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.198 -0.939 . . . . 0.0 110.51 165.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -162.67 152.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.198 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.06 120.16 37.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.327 0.967 . . . . 0.0 112.474 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.9 p -57.83 -36.26 72.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.017 1.327 . . . . 0.0 113.238 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.32 -25.97 42.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 112.051 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.01 -16.29 30.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.936 1.294 . . . . 0.0 113.797 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmt-85 -119.97 48.77 1.27 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 125.624 1.57 . . . . 0.0 113.868 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.85 -27.93 67.44 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.818 1.679 . . . . 0.0 111.75 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.9 -23.58 67.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.661 1.185 . . . . 0.0 113.407 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.75 -56.23 4.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.622 1.169 . . . . 0.0 109.366 170.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.3 mtm -58.01 -28.43 64.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.766 1.226 . . . . 0.0 113.267 -172.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -57.37 -30.46 64.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.965 1.706 . . . . 0.0 113.22 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -88.28 -32.55 18.43 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.417 1.087 . . . . 0.0 111.588 -172.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.4 -24.1 22.0 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.392 0.677 . . . . 0.0 112.799 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.75 15.7 30.83 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.736 1.636 . . . . 0.0 114.992 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -77.14 153.03 34.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.896 1.348 . . . . 0.0 110.797 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 -43.77 4.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.636 1.174 . . . . 0.0 112.729 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -179.82 -3.12 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.87 2.868 . . . . 0.0 116.364 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.89 149.44 85.57 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-N 120.213 1.369 . . . . 0.0 113.455 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.06 81.25 2.6 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.045 3.163 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.56 135.67 33.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -165.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.46 125.26 36.15 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.16 121.98 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.007 1.723 . . . . 0.0 108.84 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -106.69 125.79 51.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.328 1.051 . . . . 0.0 110.582 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.72 119.58 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.27 1.428 . . . . 0.0 108.785 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.32 128.12 55.85 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.967 1.307 . . . . 0.0 108.335 167.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.98 19.18 11.46 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.899 1.28 . . . . 0.0 113.1 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.1 12.51 82.37 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.16 -0.963 . . . . 0.0 113.153 -174.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -107.45 134.47 50.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.341 1.856 . . . . 0.0 109.576 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.71 104.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 171.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.83 -26.71 13.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -167.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -162.11 153.14 17.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.6 1.56 . . . . 0.0 110.951 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.67 146.85 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.738 1.215 . . . . 0.0 111.426 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.81 147.0 23.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.243 1.017 . . . . 0.0 112.198 168.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -96.82 -4.49 40.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -160.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.43 17.93 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-O 122.498 1.054 . . . . 0.0 115.457 -165.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.0 mm -106.11 146.37 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.083 1.753 . . . . 0.0 109.474 165.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.0 ptp -147.75 172.15 14.56 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 167.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -76.76 166.04 47.86 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.551 1.54 . . . . 0.0 112.26 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -34.7 5.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.633 1.555 . . . . 0.0 114.176 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.98 -34.18 77.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.129 1.786 . . . . 0.0 112.589 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -79.63 -21.85 44.35 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.397 0.679 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.22 -30.31 71.19 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.286 -0.884 . . . . 0.0 112.446 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -39.29 94.3 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.356 0.98 . . . . 0.0 111.451 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.19 81.72 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.123 0.874 . . . . 0.0 112.458 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.84 -47.78 79.4 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 110.735 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.48 -45.22 94.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.322 1.049 . . . . 0.0 112.842 173.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.04 80.28 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.265 -0.897 . . . . 0.0 111.956 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 t -68.92 -4.78 17.84 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.706 1.203 . . . . 0.0 114.072 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.477 0.92 0 O-C-N 120.98 -1.075 . . . . 0.0 110.22 167.273 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 126.1 1.76 . . . . 0.0 111.038 -163.236 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.49 67.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -68.31 -41.75 80.44 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.561 -0.712 . . . . 0.0 110.209 170.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -75.41 -6.48 50.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 0.0 113.327 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.88 -18.69 23.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.276 1.43 . . . . 0.0 113.111 170.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.24 -14.31 20.76 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.62 166.79 20.77 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -82.94 -61.24 1.92 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.282 1.033 . . . . 0.0 112.104 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -151.78 128.62 10.94 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.797 1.639 . . . . 0.0 109.771 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.14 164.45 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mt -139.41 124.89 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 107.664 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.56 125.24 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.607 1.563 . . . . 0.0 108.809 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -107.42 110.16 22.06 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.455 1.102 . . . . 0.0 111.584 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -80.0 87.66 5.39 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.09 0.956 . . . . 0.0 110.157 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 -167.89 1.67 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.773 1.229 . . . . 0.0 112.286 173.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -144.41 157.13 44.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.888 -1.133 . . . . 0.0 112.025 153.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -31.08 -82.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 129.117 2.967 . . . . 0.0 116.387 -174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.0 mt -91.53 -38.19 12.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -167.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.3 m -49.25 119.8 9.32 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.894 1.678 . . . . 0.0 112.773 -169.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.84 -22.44 31.72 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.209 3.272 . . . . 0.0 115.077 -161.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -63.09 -44.66 95.1 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 118.849 0.749 . . . . 0.0 112.128 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.8 m -67.47 -31.47 71.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.648 1.179 . . . . 0.0 112.891 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.26 -25.81 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.539 1.136 . . . . 0.0 113.677 -171.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -64.28 -42.81 96.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.848 0.859 . . . . 0.0 112.04 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 tpt -63.78 -28.65 70.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.437 1.095 . . . . 0.0 112.684 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.28 -39.9 84.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.698 0.799 . . . . 0.0 111.352 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -72.93 -29.08 62.84 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.492 -0.755 . . . . 0.0 112.816 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.2 t -67.9 -45.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.258 1.023 . . . . 0.0 109.646 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.45 -37.01 84.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.225 1.41 . . . . 0.0 111.951 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.78 -53.3 59.89 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.224 0.92 . . . . 0.0 111.846 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -64.1 -32.54 74.14 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.396 -0.815 . . . . 0.0 112.758 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.39 -35.6 73.57 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.965 0.906 . . . . 0.0 111.833 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.29 -24.12 61.79 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 119.408 1.004 . . . . 0.0 113.319 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.72 49.02 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.06 9.14 5.26 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.551 1.54 . . . . 0.0 114.502 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.3 61.18 40.89 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 125.657 1.583 . . . . 0.0 112.12 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.34 -15.41 34.91 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.335 2.69 . . . . 0.0 114.431 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -80.81 -9.53 59.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -99.98 137.69 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.187 1.395 . . . . 0.0 110.302 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.71 101.68 11.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.114 0.565 . . . . 0.0 110.443 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.5 mt -99.37 131.84 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.975 0.91 . . . . 0.0 109.218 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.1 p -149.45 170.45 18.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.03 0.932 . . . . 0.0 112.527 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.2 p -133.58 158.69 42.55 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.978 -1.076 . . . . 0.0 111.573 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.46 123.27 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.814 1.246 . . . . 0.0 108.133 -167.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.99 115.11 10.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.041 0.924 . . . . 0.0 109.886 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -58.37 -25.29 61.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.879 1.272 . . . . 0.0 113.36 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.22 -20.65 34.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.703 0.801 . . . . 0.0 112.281 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.74 -35.23 15.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.367 1.067 . . . . 0.0 112.902 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -126.54 61.17 42.53 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.971 1.709 . . . . 0.0 112.803 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.43 -23.7 27.43 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.244 2.63 . . . . 0.0 112.675 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.0 -23.19 67.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.148 0.979 . . . . 0.0 113.169 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.14 -58.15 4.12 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.56 1.144 . . . . 0.0 109.543 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 mtm -60.71 -22.89 64.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 113.512 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -65.9 -23.46 66.64 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.641 1.176 . . . . 0.0 112.552 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.61 -38.19 16.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.585 1.154 . . . . 0.0 111.369 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.66 -23.78 25.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.21 8.57 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.098 1.332 . . . . 0.0 114.506 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.62 169.44 18.0 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.813 1.306 . . . . 0.0 112.753 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.0 11.15 8.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 112.726 -162.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.31 59.93 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.073 2.549 . . . . 0.0 109.257 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -150.03 154.07 36.37 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 127.672 2.389 . . . . 0.0 109.858 -163.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.57 96.18 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.682 2.921 . . . . 0.0 110.648 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -113.47 122.11 46.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 111.833 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.34 125.26 34.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.885 1.274 . . . . 0.0 109.135 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.06 127.65 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -111.13 128.97 56.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.762 0.825 . . . . 0.0 110.948 -174.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.3 mm -112.39 114.11 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.409 1.084 . . . . 0.0 108.883 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.97 121.65 45.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.933 1.293 . . . . 0.0 108.242 171.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 66.75 21.46 10.53 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.006 1.323 . . . . 0.0 112.326 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.53 10.33 84.58 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.428 -173.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -107.68 132.81 52.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.422 1.489 . . . . 0.0 110.194 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.17 101.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.392 1.077 . . . . 0.0 109.187 166.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 -21.18 13.43 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.74 152.64 19.89 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.196 1.798 . . . . 0.0 110.465 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.47 144.08 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.728 1.211 . . . . 0.0 111.275 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.24 146.56 22.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.702 1.201 . . . . 0.0 111.214 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -107.85 138.78 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.02 0.928 . . . . 0.0 111.585 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.98 -161.0 21.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.997 1.76 . . . . 0.0 112.767 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 mm -121.82 145.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.877 1.671 . . . . 0.0 110.733 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.6 ptp -150.63 164.8 35.17 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 163.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -70.08 158.97 86.08 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.312 1.445 . . . . 0.0 112.396 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.32 -26.42 24.94 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.855 2.37 . . . . 0.0 114.401 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -75.33 -30.3 60.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.634 1.561 . . . . 0.0 113.143 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -76.29 -33.2 59.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.11 0.964 . . . . 0.0 111.799 169.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.87 -27.08 68.54 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.841 0.857 . . . . 0.0 111.975 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -58.75 -47.53 84.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.856 0.753 . . . . 0.0 111.923 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.75 0.82 . . . . 0.0 111.38 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.02 -49.76 74.75 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.318 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -46.94 86.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.683 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.68 91.45 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.032 0.833 . . . . 0.0 112.375 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.8 t -60.02 -24.72 64.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.506 1.122 . . . . 0.0 113.401 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.479 0.994 0 C-N-CA 124.325 1.05 . . . . 0.0 111.136 175.585 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 . . . . . 0 N--CA 1.471 0.58 0 C-N-CA 125.146 1.379 . . . . 0.0 111.217 -169.498 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.97 62.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -85.26 -38.91 18.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.074 0.852 . . . . 0.0 111.049 165.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.06 -12.93 61.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.575 0.75 . . . . 0.0 112.821 -172.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.3 -10.97 50.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.749 1.22 . . . . 0.0 114.126 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.97 -5.94 0.97 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.91 169.65 12.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.281 1.54 . . . . 0.0 114.407 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -81.0 -64.7 1.13 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.525 1.13 . . . . 0.0 112.276 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -151.16 123.99 8.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.755 1.622 . . . . 0.0 109.738 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.48 156.24 41.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.92 127.15 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.935 1.294 . . . . 0.0 108.086 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.28 124.45 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.339 1.456 . . . . 0.0 109.406 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -102.82 123.3 46.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.655 1.182 . . . . 0.0 110.24 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -88.25 73.54 8.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.518 1.127 . . . . 0.0 110.138 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.64 -170.51 2.85 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 121.525 -0.734 . . . . 0.0 112.517 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -145.58 177.62 8.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.242 -0.911 . . . . 0.0 112.767 162.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.24 -56.11 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.27 1.028 . . . . 0.0 113.024 -166.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.17 -30.71 19.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -54.61 118.81 17.97 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.791 1.236 . . . . 0.0 113.729 -167.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.88 -23.79 77.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.109 3.206 . . . . 0.0 114.223 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -71.97 -46.86 55.85 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.0 m -56.14 -34.42 66.11 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.482 1.113 . . . . 0.0 113.401 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -56.06 -35.25 66.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 112.825 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -62.76 -49.98 72.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.406 0.682 . . . . 0.0 111.366 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.41 -29.67 70.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -60.68 -45.87 92.51 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.934 0.894 . . . . 0.0 111.013 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -72.0 -34.48 68.9 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.255 -0.903 . . . . 0.0 113.052 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.98 -49.25 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.24 -36.49 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.128 0.971 . . . . 0.0 113.46 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.45 -49.84 76.22 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.307 0.643 . . . . 0.0 112.518 170.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.18 -29.97 68.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.203 -0.935 . . . . 0.0 113.157 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.83 -37.84 79.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.083 1.353 . . . . 0.0 111.584 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.15 -19.34 67.23 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.418 1.009 . . . . 0.0 112.81 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.61 -33.73 66.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.347 1.059 . . . . 0.0 113.462 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 9.16 39.94 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.603 1.561 . . . . 0.0 114.104 174.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.2 66.23 7.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.522 1.529 . . . . 0.0 113.673 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.3 -20.81 69.75 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.905 2.403 . . . . 0.0 115.076 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -88.2 -8.87 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 p -88.25 135.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.45 87.3 5.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.529 0.732 . . . . 0.0 111.013 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 mt -86.24 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.565 -0.709 . . . . 0.0 109.695 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.7 p -147.3 173.1 12.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.609 1.164 . . . . 0.0 111.556 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 t -122.53 -172.52 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.191 -0.943 . . . . 0.0 111.137 168.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -173.55 133.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.729 2.411 . . . . 0.0 109.118 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.83 116.25 18.19 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.929 1.292 . . . . 0.0 111.464 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.3 p -62.28 -26.93 68.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 112.947 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.79 -23.42 62.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.511 1.124 . . . . 0.0 112.518 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.31 -28.84 11.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.073 1.349 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.55 49.03 4.23 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 125.896 1.678 . . . . 0.0 115.46 -170.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -66.72 -19.42 53.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.394 2.063 . . . . 0.0 112.731 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.16 -25.98 68.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.568 1.147 . . . . 0.0 113.124 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -70.48 -55.1 9.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.81 0.732 . . . . 0.0 110.751 166.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.9 mtp -59.14 -28.47 66.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.547 1.539 . . . . 0.0 113.248 -170.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -15.47 61.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.543 1.137 . . . . 0.0 112.753 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -84.68 -38.32 19.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.663 1.185 . . . . 0.0 110.579 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.85 -23.46 31.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.282 0.633 . . . . 0.0 112.677 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.86 20.09 17.66 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.716 1.627 . . . . 0.0 114.773 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -82.5 149.41 27.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.765 1.283 . . . . 0.0 111.883 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.45 -81.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.633 0.773 . . . . 0.0 110.825 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -157.35 6.64 0.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -167.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.89 160.76 25.0 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 126.487 1.915 . . . . 0.0 114.032 -159.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.6 93.34 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.91 3.74 . . . . 0.0 110.942 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 m -109.68 129.22 55.62 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.895 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mp -95.46 130.88 42.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.836 0.855 . . . . 0.0 109.734 167.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -129.24 128.56 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.091 1.757 . . . . 0.0 108.86 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -114.85 124.48 51.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.176 0.99 . . . . 0.0 110.682 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mm -109.05 120.04 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.996 1.318 . . . . 0.0 109.599 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -114.98 125.3 53.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.822 1.649 . . . . 0.0 109.501 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.61 19.47 10.45 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.505 1.522 . . . . 0.0 113.807 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.15 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.823 1.201 . . . . 0.0 114.101 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -112.84 136.51 52.38 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.103 1.761 . . . . 0.0 110.372 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.59 104.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 166.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.96 -30.23 12.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.62 160.41 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.915 1.686 . . . . 0.0 111.76 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.25 144.81 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.593 1.557 . . . . 0.0 110.771 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.28 150.22 25.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 111.972 167.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -105.48 132.34 51.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.183 0.993 . . . . 0.0 111.35 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.18 -158.14 14.86 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.287 1.422 . . . . 0.0 113.448 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.57 139.09 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.692 1.597 . . . . 0.0 111.056 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.0 mtm -140.9 160.28 40.41 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.514 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -72.35 159.84 84.34 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.71 1.204 . . . . 0.0 112.282 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.3 -24.73 31.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.457 2.105 . . . . 0.0 113.724 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -63.23 -49.31 74.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.953 1.251 . . . . 0.0 110.83 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -72.28 -26.15 61.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.626 1.17 . . . . 0.0 111.636 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -26.75 68.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.748 0.819 . . . . 0.0 112.507 170.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -65.64 -45.53 82.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.775 1.17 . . . . 0.0 110.769 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.83 84.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.152 0.581 . . . . 0.0 111.848 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.16 -53.88 51.41 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.249 1.019 . . . . 0.0 110.405 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.92 77.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.361 175.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.26 79.72 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.454 -0.779 . . . . 0.0 112.0 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -60.05 -38.89 84.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.569 0.747 . . . . 0.0 111.861 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.482 1.129 0 O-C-N 121.148 -0.97 . . . . 0.0 110.602 175.056 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 mm . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.573 0 C-N-CA 128.965 2.906 . . . . 0.0 111.892 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.8 ptp . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.47 -26.63 35.09 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.028 0.931 . . . . 0.0 113.498 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -71.23 -40.22 71.22 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.64 -0.663 . . . . 0.0 110.247 162.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -75.65 27.27 0.11 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.452 1.501 . . . . 0.0 112.825 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -82.24 -14.92 54.74 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.84 43.76 0.07 OUTLIER Glycine 0 N--CA 1.474 1.23 0 CA-C-N 119.674 1.124 . . . . 0.0 115.582 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 mt -84.85 103.05 13.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.431 1.093 . . . . 0.0 111.158 -173.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -58.89 -27.56 65.33 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -156.37 94.31 1.48 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.1 1.76 . . . . 0.0 110.296 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.59 46.64 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.9 mt -140.84 135.13 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.389 1.476 . . . . 0.0 109.142 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.33 131.06 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.45 1.5 . . . . 0.0 109.565 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -111.24 103.48 11.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.655 1.182 . . . . 0.0 111.462 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -75.37 70.91 2.31 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.74 1.616 . . . . 0.0 109.959 175.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.34 154.0 42.39 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.117 0.967 . . . . 0.0 113.192 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.04 179.74 7.73 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.335 -0.853 . . . . 0.0 111.728 166.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.77 153.25 30.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.022 1.729 . . . . 0.0 112.457 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 67.85 -46.41 0.51 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 130.304 3.442 . . . . 0.0 114.474 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.0 t -54.91 128.58 64.51 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 127.046 2.139 . . . . 0.0 113.433 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.77 -18.97 59.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.606 3.538 . . . . 0.0 115.529 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -67.79 -48.35 66.55 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 120.364 1.438 . . . . 0.0 112.817 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.1 -22.79 63.96 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.471 -1.393 . . . . 0.0 113.414 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -56.39 -30.79 63.18 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.154 1.381 . . . . 0.0 113.085 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -64.82 -46.1 83.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.957 0.903 . . . . 0.0 112.235 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.3 mmm -63.91 -28.77 70.06 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.338 -0.851 . . . . 0.0 112.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -61.02 -35.81 77.85 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.705 0.684 . . . . 0.0 111.58 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -70.27 -40.6 74.24 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 110.737 174.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.01 -44.62 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.777 1.631 . . . . 0.0 110.788 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.97 -37.33 85.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.306 1.443 . . . . 0.0 112.125 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.89 -47.79 84.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.649 0.78 . . . . 0.0 111.986 171.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -68.51 -32.95 73.28 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.259 0.936 . . . . 0.0 112.11 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -68.63 -35.89 77.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.73 1.212 . . . . 0.0 112.184 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.34 -24.57 53.93 Favored Glycine 0 N--CA 1.469 0.852 0 CA-C-N 119.176 0.898 . . . . 0.0 113.177 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 10.8 38.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.097 1.359 . . . . 0.0 114.139 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.86 85.89 7.46 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.433 1.493 . . . . 0.0 111.68 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.03 -12.09 17.73 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.312 2.675 . . . . 0.0 113.817 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -89.57 -10.04 47.57 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.827 1.194 . . . . 0.0 113.728 -172.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.54 130.78 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.672 1.189 . . . . 0.0 110.254 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.8 98.0 8.26 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.223 0.609 . . . . 0.0 110.036 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -101.42 132.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.628 0.771 . . . . 0.0 109.273 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -145.89 169.2 19.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.97 0.908 . . . . 0.0 111.813 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.2 p -114.2 164.96 13.17 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.634 -1.291 . . . . 0.0 111.538 168.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.54 122.24 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.3 1.44 . . . . 0.0 109.038 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.08 104.76 1.21 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.694 1.198 . . . . 0.0 110.397 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -54.35 -44.26 72.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.857 1.263 . . . . 0.0 112.811 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -78.52 -13.27 59.91 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.84 -17.91 18.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.641 1.176 . . . . 0.0 113.427 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -124.03 43.77 0.89 Allowed Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.062 1.745 . . . . 0.0 113.303 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.85 -22.87 35.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.102 2.535 . . . . 0.0 112.466 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.17 -27.74 68.92 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.293 0.952 . . . . 0.0 112.603 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.58 -50.65 14.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.8 mtm -56.7 -26.41 56.65 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.402 1.081 . . . . 0.0 113.319 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -66.35 -23.35 66.33 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.139 0.976 . . . . 0.0 112.014 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -84.6 -37.97 20.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.935 1.294 . . . . 0.0 111.204 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.06 -24.15 30.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.438 0.695 . . . . 0.0 112.554 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.22 20.03 19.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.374 1.464 . . . . 0.0 115.065 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -84.1 155.08 22.81 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.156 1.478 . . . . 0.0 111.584 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -92.25 -72.21 0.6 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.439 1.096 . . . . 0.0 110.465 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 ptm85 -162.81 3.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -84.63 154.82 62.21 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 127.108 2.163 . . . . 0.0 113.012 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.48 96.35 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.382 3.388 . . . . 0.0 110.336 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.9 m -111.06 124.63 52.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.191 0.996 . . . . 0.0 112.467 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.4 135.02 34.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 109.524 166.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.34 124.38 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.001 1.721 . . . . 0.0 108.034 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -108.11 126.21 52.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.432 0.693 . . . . 0.0 110.782 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.1 mm -110.36 113.11 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.841 0.857 . . . . 0.0 109.178 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 115.56 29.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.321 1.448 . . . . 0.0 109.109 170.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.08 26.67 8.86 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.879 2.072 . . . . 0.0 111.981 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.21 -3.84 83.12 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.832 0.73 . . . . 0.0 113.846 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -96.29 131.11 43.13 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.923 -1.34 . . . . 0.0 110.231 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.38 102.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.869 0.842 . . . . 0.0 109.603 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.32 -17.17 16.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -171.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.91 148.72 19.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.019 1.727 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -150.27 146.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.803 1.641 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.33 148.82 27.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.266 1.026 . . . . 0.0 111.601 161.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -105.77 144.07 33.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.479 -0.763 . . . . 0.0 111.917 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.24 -150.18 17.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.268 1.413 . . . . 0.0 113.377 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.5 mm -112.27 144.36 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.343 1.457 . . . . 0.0 112.285 -170.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.3 ptp -153.01 169.31 23.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 160.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -82.44 161.98 57.6 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.727 1.611 . . . . 0.0 112.485 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.46 -26.48 12.03 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.539 2.159 . . . . 0.0 114.507 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -71.43 -34.23 70.11 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.204 1.365 . . . . 0.0 112.846 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -74.39 -31.42 62.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.591 0.756 . . . . 0.0 112.278 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.1 tp -62.28 -26.87 68.64 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.488 -0.757 . . . . 0.0 112.606 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.72 -47.95 82.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.882 0.764 . . . . 0.0 111.209 174.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.59 71.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.255 0.622 . . . . 0.0 111.778 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.96 -50.44 73.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.807 0.843 . . . . 0.0 110.84 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -45.38 79.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.322 0.649 . . . . 0.0 112.008 175.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.8 86.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.826 0.739 . . . . 0.0 112.031 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.1 m -64.64 -11.79 39.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.399 1.479 . . . . 0.0 114.612 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.476 0.851 0 O-C-N 121.039 -1.038 . . . . 0.0 110.96 173.312 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mm . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 125.382 1.473 . . . . 0.0 111.361 -167.523 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.74 63.0 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -84.53 -39.09 19.23 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 111.168 166.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.11 -9.19 58.42 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.71 -11.11 43.3 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.007 1.323 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.9 -6.36 1.11 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.47 167.29 16.99 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.226 1.513 . . . . 0.0 113.663 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -80.68 -52.55 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -164.76 114.88 1.15 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.946 1.298 . . . . 0.0 110.082 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.71 157.83 41.45 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.98 130.66 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.632 1.573 . . . . 0.0 108.832 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.6 128.23 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.689 1.596 . . . . 0.0 109.393 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.05 111.72 23.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.574 1.15 . . . . 0.0 111.507 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -83.53 73.56 10.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 111.301 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -71.41 174.94 5.9 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 168.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.24 146.34 38.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.388 -1.445 . . . . 0.0 114.054 170.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 30' ' ' LEU 0.319 6.9 p30 17.76 -104.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.388 2.675 . . . . 0.0 116.136 -178.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.456 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 3.6 mm? -107.18 3.15 25.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.68 2.392 . . . . 0.0 113.383 -171.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -49.04 125.61 13.95 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.509 1.523 . . . . 0.0 114.41 -164.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.2 -5.03 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.066 3.178 . . . . 0.0 113.429 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -81.74 -50.38 9.34 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.685 1.129 . . . . 0.0 109.905 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.2 m -60.77 -34.02 73.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -171.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -50.31 -40.72 49.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -72.76 -40.68 65.81 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.209 0.603 . . . . 0.0 110.737 -172.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -62.4 -34.52 76.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.593 1.157 . . . . 0.0 112.519 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -59.55 -39.09 82.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.719 1.145 . . . . 0.0 112.305 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.48 -32.66 71.69 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.91 -1.119 . . . . 0.0 112.789 173.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.46 -50.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.368 0.667 . . . . 0.0 109.967 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.73 -35.67 81.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.293 1.037 . . . . 0.0 112.135 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.73 -52.97 63.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.053 0.941 . . . . 0.0 111.639 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -69.13 -30.24 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.601 -0.687 . . . . 0.0 112.655 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.95 -41.39 91.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.786 1.234 . . . . 0.0 111.49 170.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.58 -27.33 27.45 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 119.098 0.863 . . . . 0.0 113.593 -172.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.77 68.24 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.198 0.999 . . . . 0.0 113.588 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.49 9.4 37.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.964 1.705 . . . . 0.0 114.067 176.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.05 42.31 0.37 Allowed Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 125.534 1.533 . . . . 0.0 113.754 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.57 -5.64 10.55 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.575 2.85 . . . . 0.0 115.58 -166.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -62.92 -8.86 7.92 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.64 135.6 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.194 1.398 . . . . 0.0 110.553 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.06 102.53 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 110.348 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.68 135.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.93 0.892 . . . . 0.0 110.333 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.7 p -144.63 169.02 18.79 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.278 1.031 . . . . 0.0 112.005 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.4 p -125.97 163.37 23.15 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.78 -1.2 . . . . 0.0 111.846 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.2 t -148.82 129.03 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.009 1.323 . . . . 0.0 108.542 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -73.93 98.62 3.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.562 0.696 . . . . 0.0 110.123 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -59.55 -30.33 68.54 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.219 1.008 . . . . 0.0 113.585 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.81 -21.53 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.043 1.337 . . . . 0.0 112.655 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.14 -7.81 38.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.528 1.531 . . . . 0.0 112.976 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 42.95 0.98 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 126.151 1.78 . . . . 0.0 114.07 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.45 -21.01 47.4 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.593 2.196 . . . . 0.0 113.258 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -59.71 -19.44 49.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.226 . . . . 0.0 113.124 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.23 -58.93 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.459 1.103 . . . . 0.0 111.574 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.6 mtm -58.46 -28.55 65.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 113.763 -170.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -69.71 -18.91 63.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.041 1.336 . . . . 0.0 113.345 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.31 -35.62 19.78 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.381 1.073 . . . . 0.0 111.211 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.51 -23.87 21.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.422 0.689 . . . . 0.0 112.857 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.34 21.06 18.34 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.692 1.615 . . . . 0.0 114.716 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.14 160.83 25.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.998 1.399 . . . . 0.0 112.188 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.75 -68.77 0.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.359 1.063 . . . . 0.0 112.869 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.79 22.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -162.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.34 156.97 57.21 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 125.091 1.356 . . . . 0.0 112.831 -166.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.76 88.29 0.92 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.075 3.183 . . . . 0.0 110.206 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -99.89 130.21 46.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.318 1.047 . . . . 0.0 111.893 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 134.38 35.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.318 1.047 . . . . 0.0 110.471 163.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.5 t -130.73 126.17 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.568 1.547 . . . . 0.0 108.417 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -109.95 122.54 47.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 110.639 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.68 121.5 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.403 1.481 . . . . 0.0 108.859 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.54 124.29 50.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.307 1.843 . . . . 0.0 108.774 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 61.19 20.09 10.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.009 1.324 . . . . 0.0 113.355 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.12 69.57 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.229 0.919 . . . . 0.0 113.84 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -117.46 132.11 56.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.449 1.9 . . . . 0.0 109.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.77 109.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.196 -0.94 . . . . 0.0 109.676 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.55 -24.85 14.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -160.16 144.82 14.66 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.123 1.769 . . . . 0.0 110.563 -172.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -148.25 143.87 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.552 1.541 . . . . 0.0 109.384 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -154.59 156.92 37.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.434 1.094 . . . . 0.0 111.026 164.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 p -121.45 145.36 48.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.97 -167.76 12.4 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.335 1.445 . . . . 0.0 113.58 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.06 138.42 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 65.9 mtm -139.42 147.66 41.72 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.973 0.909 . . . . 0.0 111.299 162.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.15 97.88 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.341 0.657 . . . . 0.0 111.346 167.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.19 -27.48 56.5 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.827 2.351 . . . . 0.0 113.551 -166.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -61.01 -29.17 69.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.4 -25.46 16.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.578 0.751 . . . . 0.0 112.562 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.37 -24.69 63.61 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 112.572 171.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -60.35 -41.81 94.4 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.387 0.675 . . . . 0.0 112.336 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.4 77.72 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.952 0.796 . . . . 0.0 111.97 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.01 -47.35 80.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.329 1.052 . . . . 0.0 110.379 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.59 -46.63 87.41 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.374 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.53 75.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.605 1.093 . . . . 0.0 112.705 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -62.77 -17.83 61.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.18 1.392 . . . . 0.0 113.582 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.6 mt . . . . . 0 N--CA 1.475 0.821 0 O-C-N 120.522 -1.361 . . . . 0.0 110.468 172.519 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 130.415 3.486 . . . . 0.0 112.974 179.098 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -21.2 62.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -80.1 -41.33 25.76 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 111.051 166.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -74.72 -13.62 60.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.289 1.036 . . . . 0.0 113.646 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -85.2 80.32 9.25 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.589 1.956 . . . . 0.0 110.342 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 14.19 14.92 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.772 1.177 . . . . 0.0 115.854 166.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.89 167.51 11.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 1.351 . . . . 0.0 112.936 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -75.62 -66.59 0.76 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.261 1.024 . . . . 0.0 112.544 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -149.63 124.72 10.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.392 1.877 . . . . 0.0 109.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.41 160.47 42.53 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.6 mt -138.03 124.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.085 1.754 . . . . 0.0 108.647 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 109.306 -170.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -115.08 113.81 24.53 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.373 0.669 . . . . 0.0 111.948 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -81.45 70.17 8.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.813 1.245 . . . . 0.0 110.722 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.83 170.14 15.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.702 0.763 . . . . 0.0 112.845 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -117.84 162.04 18.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.533 1.533 . . . . 0.0 111.143 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -91.17 -36.17 14.11 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.971 -1.08 . . . . 0.0 111.811 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 mt -80.06 -52.19 8.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.648 1.179 . . . . 0.0 113.4 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.74 119.53 45.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.295 1.438 . . . . 0.0 112.639 -170.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.31 -19.73 55.75 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.739 2.959 . . . . 0.0 114.086 172.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -76.75 -45.57 28.61 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.195 0.907 . . . . 0.0 110.703 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 p -63.72 -21.93 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -54.7 -37.78 66.23 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.123 0.969 . . . . 0.0 112.994 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -62.32 -43.11 99.58 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.736 -0.603 . . . . 0.0 111.832 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.3 tpp -61.01 -34.6 75.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.743 0.817 . . . . 0.0 112.991 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -54.28 -42.93 70.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.437 0.695 . . . . 0.0 111.767 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.69 -27.35 29.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.923 0.889 . . . . 0.0 113.166 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.85 -47.85 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.979 0.911 . . . . 0.0 110.378 166.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -62.04 -36.99 83.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.95 -48.29 82.5 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.96 0.8 . . . . 0.0 111.525 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.33 -33.81 76.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.659 0.784 . . . . 0.0 112.711 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -65.35 -37.58 87.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.861 1.264 . . . . 0.0 111.542 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.31 -23.03 61.64 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 124.704 1.145 . . . . 0.0 113.628 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -31.33 62.39 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.279 1.431 . . . . 0.0 114.713 -171.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.73 6.31 14.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 63.51 57.76 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.916 1.687 . . . . 0.0 112.14 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.61 -15.55 30.48 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.9 3.066 . . . . 0.0 113.725 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -82.05 -4.76 57.51 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.04 135.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.177 1.391 . . . . 0.0 110.235 173.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.93 100.86 11.28 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.814 0.846 . . . . 0.0 110.847 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.11 131.33 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.847 0.859 . . . . 0.0 110.195 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.3 p -146.82 170.06 17.82 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.938 0.895 . . . . 0.0 112.579 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.3 p -132.43 155.16 49.0 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.865 -1.147 . . . . 0.0 111.071 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -142.77 127.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.534 1.133 . . . . 0.0 109.461 -168.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -64.62 101.26 0.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.734 1.614 . . . . 0.0 110.69 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.9 p -55.97 -40.81 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.056 0.943 . . . . 0.0 112.738 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.45 -26.65 65.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.749 1.619 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.69 -15.43 18.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 113.844 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -131.42 52.61 9.67 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.705 1.602 . . . . 0.0 113.009 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.6 -20.47 53.39 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.027 170.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.46 -29.17 69.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.39 1.076 . . . . 0.0 112.767 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.94 -56.84 4.97 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.492 0.717 . . . . 0.0 109.431 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.7 mtp -54.8 -33.6 61.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.514 1.525 . . . . 0.0 112.21 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -61.71 -27.86 69.01 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.864 1.665 . . . . 0.0 113.988 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.34 -38.27 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.358 0.663 . . . . 0.0 112.01 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.77 -21.78 24.93 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 15.52 31.4 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.256 1.884 . . . . 0.0 114.829 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -77.96 140.52 39.23 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.275 1.538 . . . . 0.0 111.801 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.91 -60.04 2.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.408 0.683 . . . . 0.0 112.342 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -167.07 23.05 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -165.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.61 151.88 50.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 125.468 1.507 . . . . 0.0 113.351 -166.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.71 93.94 1.0 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.924 3.083 . . . . 0.0 109.599 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.5 m -104.44 131.73 51.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.524 1.13 . . . . 0.0 112.952 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.56 131.74 34.29 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.24 1.816 . . . . 0.0 109.251 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.69 131.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 108.744 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -114.29 127.85 56.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.636 0.775 . . . . 0.0 111.154 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.1 mm -108.94 122.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.006 1.322 . . . . 0.0 109.269 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -119.4 124.06 45.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.655 1.982 . . . . 0.0 109.19 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 61.88 18.69 10.02 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.947 1.299 . . . . 0.0 113.049 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.59 7.1 67.23 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.236 1.398 . . . . 0.0 114.401 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -113.34 136.94 52.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.877 1.671 . . . . 0.0 110.136 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.01 108.84 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 121.076 -1.015 . . . . 0.0 109.879 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.9 -20.31 14.31 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -170.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -158.67 156.1 29.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.022 1.329 . . . . 0.0 110.67 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.06 145.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 111.204 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.88 146.08 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.546 1.139 . . . . 0.0 111.101 166.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 p -110.77 147.09 35.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.056 . . . . 0.0 113.153 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.71 -149.38 18.12 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.758 1.17 . . . . 0.0 113.056 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.3 mm -118.3 143.89 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.015 1.326 . . . . 0.0 111.976 -171.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.3 mtm -139.13 160.04 40.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.27 1.428 . . . . 0.0 111.014 161.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -70.06 162.29 69.88 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 111.487 167.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 -32.91 14.17 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.987 1.791 . . . . 0.0 113.868 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -71.44 -31.36 67.12 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.842 1.655 . . . . 0.0 112.821 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -79.36 -22.32 44.57 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.95 -26.13 68.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.561 1.073 . . . . 0.0 112.672 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -63.05 -37.32 86.71 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.329 0.968 . . . . 0.0 111.702 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.74 83.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.361 0.982 . . . . 0.0 111.163 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 53.5 tp -65.07 -45.47 85.18 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.323 0.649 . . . . 0.0 110.78 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -44.61 95.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.283 1.033 . . . . 0.0 112.342 173.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.69 84.21 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.123 -0.985 . . . . 0.0 111.482 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.0 m -67.79 -3.84 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.754 1.622 . . . . 0.0 114.232 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 N--CA 1.481 1.085 0 O-C-N 120.903 -1.123 . . . . 0.0 111.382 169.587 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 110.755 -0.091 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.528 0 C-N-CA 126.989 2.116 . . . . 0.0 111.255 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.21 44.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.719 1.208 . . . . 0.0 113.903 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -74.95 -39.71 61.18 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.193 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.95 19.4 0.15 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 113.937 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -16.5 57.92 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.46 45.44 0.12 Allowed Glycine 0 N--CA 1.478 1.448 0 CA-C-N 120.059 1.3 . . . . 0.0 116.257 -174.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.3 mt -88.72 122.35 32.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.086 1.354 . . . . 0.0 109.232 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -53.59 -43.13 68.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.753 1.161 . . . . 0.0 113.478 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -163.04 123.42 2.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.223 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.75 155.76 42.04 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.319 1.448 . . . . 0.0 112.513 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.6 mt -143.18 132.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.364 1.466 . . . . 0.0 110.707 -170.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.54 126.73 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.089 1.356 . . . . 0.0 110.8 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -102.5 117.26 34.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.202 1.401 . . . . 0.0 112.101 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -78.55 73.58 5.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.286 1.434 . . . . 0.0 111.609 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.9 -174.99 4.7 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.705 0.802 . . . . 0.0 112.798 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -144.14 156.02 44.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 111.748 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -64.75 -54.82 25.37 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.77 -38.06 20.07 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -170.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.67 122.16 49.38 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.781 1.232 . . . . 0.0 112.827 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -65.15 -22.65 61.16 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.33 3.354 . . . . 0.0 114.575 173.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -70.7 -46.21 63.54 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 119.303 0.956 . . . . 0.0 111.036 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -58.09 -34.03 69.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.474 1.11 . . . . 0.0 113.595 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -55.79 -34.6 65.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.12 1.368 . . . . 0.0 112.995 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -60.09 -46.73 88.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.341 0.657 . . . . 0.0 111.679 176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -36.04 82.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.287 0.635 . . . . 0.0 112.65 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -53.03 -40.64 64.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.834 0.743 . . . . 0.0 112.293 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -65.77 -28.16 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.039 -1.038 . . . . 0.0 112.775 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 t -75.12 -52.68 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.579 1.552 . . . . 0.0 108.747 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.71 -38.23 77.84 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.715 1.206 . . . . 0.0 112.462 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -58.75 -58.46 8.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.531 1.132 . . . . 0.0 111.513 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -65.28 -31.31 72.38 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.05 -40.37 82.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.311 1.445 . . . . 0.0 112.398 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.2 -26.72 42.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 119.336 0.971 . . . . 0.0 114.06 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -40.83 71.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.925 1.29 . . . . 0.0 114.179 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.71 4.04 37.65 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.78 67.33 77.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 111.573 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.54 -10.1 24.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.331 2.687 . . . . 0.0 114.341 -169.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.28 -14.25 58.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.43 131.04 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.361 1.064 . . . . 0.0 109.77 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.34 91.48 6.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 0.0 110.645 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mt -100.08 132.34 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.029 0.932 . . . . 0.0 109.531 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -144.79 176.01 9.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.127 0.971 . . . . 0.0 111.658 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 86.4 p -113.76 176.3 5.09 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.897 -1.127 . . . . 0.0 110.599 162.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.0 126.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 124.342 1.057 . . . . 0.0 109.664 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.35 110.42 5.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.863 0.84 . . . . 0.0 110.811 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 p -56.48 -27.2 56.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.611 1.164 . . . . 0.0 113.637 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -77.35 -29.59 53.45 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.436 1.016 . . . . 0.0 113.089 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.33 -24.46 19.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.639 1.176 . . . . 0.0 113.017 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 56.39 9.21 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 126.745 2.018 . . . . 0.0 111.92 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.41 -27.79 18.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.983 2.456 . . . . 0.0 112.507 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -68.54 -25.42 64.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.984 0.811 . . . . 0.0 112.558 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.61 -56.19 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.166 0.894 . . . . 0.0 110.122 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.5 mtm -58.48 -21.01 50.25 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -26.66 51.89 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.99 1.716 . . . . 0.0 112.414 174.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -82.72 -46.47 13.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.76 0.824 . . . . 0.0 111.32 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.35 -15.91 51.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 21.72 46.6 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.664 1.126 . . . . 0.0 114.723 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -74.95 -58.9 3.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.404 1.102 . . . . 0.0 111.665 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 73.71 -29.07 0.19 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.08 3.352 . . . . 0.0 113.975 168.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -163.89 17.73 0.06 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -164.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.32 150.96 63.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.487 1.115 . . . . 0.0 113.943 -170.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.43 86.55 1.58 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 124.445 3.43 . . . . 0.0 110.873 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.7 m -98.67 136.01 39.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.415 1.086 . . . . 0.0 112.446 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.13 128.59 38.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.871 163.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.5 t -119.25 129.93 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.563 1.545 . . . . 0.0 109.16 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -117.56 131.09 56.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.125 0.97 . . . . 0.0 111.623 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.27 125.21 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.013 1.325 . . . . 0.0 109.925 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.32 117.4 29.86 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.661 1.984 . . . . 0.0 110.17 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.18 29.56 11.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.873 2.069 . . . . 0.0 111.805 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.54 85.79 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.48 0.562 . . . . 0.0 114.425 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -101.28 133.07 46.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.852 1.261 . . . . 0.0 108.755 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.07 106.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.179 -0.951 . . . . 0.0 109.297 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.04 -22.09 15.89 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -166.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -161.2 155.78 23.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.452 1.501 . . . . 0.0 110.74 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.7 p -152.7 143.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.306 1.442 . . . . 0.0 110.203 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.71 149.43 20.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.517 1.127 . . . . 0.0 111.566 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 t -112.16 140.68 46.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.336 1.054 . . . . 0.0 112.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.27 -164.62 12.43 Favored Glycine 0 C--N 1.344 1.001 0 C-N-CA 125.24 1.4 . . . . 0.0 114.762 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.96 140.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.122 1.369 . . . . 0.0 111.338 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.8 mtm -139.92 161.77 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.062 1.345 . . . . 0.0 111.701 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -68.37 161.29 70.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.277 0.631 . . . . 0.0 111.313 161.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.33 -32.4 16.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 121.932 1.754 . . . . 0.0 113.53 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -68.45 -32.79 73.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 120.884 1.675 . . . . 0.0 112.402 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -74.83 -30.37 61.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.535 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.81 -35.72 79.12 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.328 0.967 . . . . 0.0 111.833 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -39.97 90.72 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.424 1.011 . . . . 0.0 111.715 171.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.61 87.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.675 0.67 . . . . 0.0 111.866 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.8 tp -66.12 -49.6 66.93 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.848 0.859 . . . . 0.0 110.658 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -43.64 77.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.944 1.297 . . . . 0.0 113.21 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.44 76.17 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.103 0.865 . . . . 0.0 112.001 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.8 m -70.04 1.58 4.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.455 1.502 . . . . 0.0 114.091 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.474 0.767 0 O-C-N 120.739 -1.226 . . . . 0.0 111.294 171.665 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 127.774 2.429 . . . . 0.0 107.147 177.816 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.95 -22.2 63.19 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -84.72 -36.81 21.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.288 0.635 . . . . 0.0 111.611 165.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -79.24 -6.54 56.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -171.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.0 -17.75 30.54 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.54 -4.09 13.75 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.857 1.218 . . . . 0.0 116.064 -171.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.89 166.96 18.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.674 1.237 . . . . 0.0 114.182 -171.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -82.52 -65.13 1.05 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.596 1.158 . . . . 0.0 111.944 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -145.83 125.16 13.04 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.748 1.619 . . . . 0.0 110.04 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.99 159.59 43.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.9 mt -134.23 127.82 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.796 1.638 . . . . 0.0 108.477 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -118.71 127.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.552 1.541 . . . . 0.0 108.827 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -111.2 112.48 24.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.497 1.119 . . . . 0.0 111.197 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -80.29 76.8 7.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.374 1.069 . . . . 0.0 110.795 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.37 174.85 10.74 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.268 1.027 . . . . 0.0 112.729 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -134.21 151.32 51.26 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.873 -1.142 . . . . 0.0 111.535 167.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -62.63 -46.88 86.19 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 112.168 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.46 -32.44 42.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.323 1.049 . . . . 0.0 112.791 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.2 t -57.36 122.95 58.56 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.276 1.43 . . . . 0.0 112.392 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.31 -13.95 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.323 3.349 . . . . 0.0 112.293 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -80.08 -47.5 14.72 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.192 0.906 . . . . 0.0 109.451 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m -52.74 -36.61 58.01 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 113.979 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -37.3 66.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.451 1.1 . . . . 0.0 112.926 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -63.17 -45.52 91.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.51 0.724 . . . . 0.0 111.501 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 tpt -61.61 -33.13 73.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.035 0.934 . . . . 0.0 112.782 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -59.1 -40.46 85.38 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.647 0.658 . . . . 0.0 112.032 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -35.53 62.42 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.38 -0.825 . . . . 0.0 112.264 174.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.17 -47.86 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.789 0.835 . . . . 0.0 110.501 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.96 -37.05 85.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.012 1.725 . . . . 0.0 112.304 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.79 -48.48 76.72 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.02 0.827 . . . . 0.0 112.376 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -35.92 81.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.31 -0.869 . . . . 0.0 112.424 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -66.82 -34.25 77.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.967 1.307 . . . . 0.0 111.937 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.52 -25.29 51.23 Favored Glycine 0 N--CA 1.47 0.933 0 O-C-N 121.001 -1.062 . . . . 0.0 113.73 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.71 67.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.92 22.97 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 114.066 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.53 62.11 61.34 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.939 1.696 . . . . 0.0 111.563 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.29 -13.87 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.201 2.6 . . . . 0.0 114.243 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.04 -4.91 54.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.57 131.63 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 110.705 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.56 101.19 10.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.156 0.983 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.5 mt -94.88 130.5 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.507 -0.745 . . . . 0.0 109.689 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -139.16 152.0 47.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 110.863 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.7 m -115.68 149.98 37.51 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.111 -0.993 . . . . 0.0 111.512 167.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.1 t -139.73 122.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.122 1.369 . . . . 0.0 108.4 -171.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -67.85 113.18 5.37 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.498 1.119 . . . . 0.0 111.241 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -56.99 -27.65 61.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.448 1.499 . . . . 0.0 114.252 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -74.94 -27.93 60.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.069 0.849 . . . . 0.0 112.573 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.04 -27.99 16.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.855 1.262 . . . . 0.0 113.295 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 tpt85 -124.62 40.91 0.55 Allowed Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 125.706 1.602 . . . . 0.0 114.707 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -65.71 -19.69 59.5 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.196 1.931 . . . . 0.0 112.929 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.31 -27.4 62.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.731 1.212 . . . . 0.0 113.487 173.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.89 -54.78 5.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.503 1.121 . . . . 0.0 110.5 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtp -56.15 -31.06 63.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.055 1.342 . . . . 0.0 112.797 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.97 -26.83 68.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 113.143 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -86.51 -36.48 18.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.876 1.271 . . . . 0.0 110.799 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.7 -21.27 26.75 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.45 21.29 15.15 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.759 1.647 . . . . 0.0 115.185 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -83.48 143.26 30.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.773 1.287 . . . . 0.0 111.72 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.39 -72.16 0.57 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.717 0.807 . . . . 0.0 111.781 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.46 30.18 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 114.152 -170.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.11 156.52 52.34 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.425 1.49 . . . . 0.0 111.969 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.95 97.6 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.357 2.705 . . . . 0.0 109.952 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 m -109.5 124.58 51.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.984 0.514 . . . . 0.0 111.574 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.23 135.98 33.41 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.199 1.0 . . . . 0.0 109.328 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.86 125.18 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.299 1.84 . . . . 0.0 108.196 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -107.59 123.31 48.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.076 0.95 . . . . 0.0 111.077 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.3 mm -107.7 114.32 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.013 1.325 . . . . 0.0 108.662 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.1 125.0 53.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.867 1.667 . . . . 0.0 108.551 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.8 t70 66.74 20.5 10.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.056 1.343 . . . . 0.0 112.36 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.65 7.44 87.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.203 0.906 . . . . 0.0 113.856 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -108.99 136.53 48.36 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.829 1.652 . . . . 0.0 109.716 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.7 107.63 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.253 168.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.88 -30.91 11.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.302 1.041 . . . . 0.0 113.627 -170.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.6 158.32 42.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.096 1.358 . . . . 0.0 112.064 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -151.04 147.12 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.457 1.903 . . . . 0.0 108.739 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.01 148.99 31.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.536 0.684 . . . . 0.0 111.171 159.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 m -107.58 128.44 54.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.157 0.983 . . . . 0.0 111.32 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.17 -162.85 23.62 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.438 1.494 . . . . 0.0 113.106 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.84 141.67 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.303 1.441 . . . . 0.0 110.459 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 mtm -139.51 154.98 47.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.41 0.684 . . . . 0.0 112.26 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.94 152.2 84.49 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 123.772 0.829 . . . . 0.0 110.963 165.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.32 -25.15 49.67 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.351 2.034 . . . . 0.0 114.021 -165.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -61.07 -32.37 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -85.97 -28.95 23.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 0.0 111.805 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.8 -27.24 69.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.141 -0.974 . . . . 0.0 112.374 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -58.58 -44.53 89.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.793 0.724 . . . . 0.0 111.696 171.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.47 75.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.243 0.617 . . . . 0.0 111.951 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.28 -45.35 84.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.02 0.528 . . . . 0.0 111.168 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -44.51 94.2 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.423 0.689 . . . . 0.0 111.735 173.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.8 -27.07 66.42 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.075 -1.016 . . . . 0.0 111.938 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 m -67.08 -21.05 65.9 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.627 1.171 . . . . 0.0 113.573 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.481 1.101 0 CA-C-N 119.438 1.017 . . . . 0.0 110.107 174.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 124.825 1.25 . . . . 0.0 111.476 -165.939 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.71 67.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.82 -40.18 63.54 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.467 0.576 . . . . 0.0 110.779 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.24 -9.99 59.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.27 1.028 . . . . 0.0 113.274 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.82 -22.84 23.02 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.019 1.328 . . . . 0.0 112.916 169.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.1 -17.08 9.8 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 -168.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.53 166.3 23.5 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -83.54 -64.91 1.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.321 1.448 . . . . 0.0 112.134 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.13 125.7 12.48 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.806 1.642 . . . . 0.0 109.986 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.99 162.6 39.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.2 mt -135.92 120.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.457 1.503 . . . . 0.0 107.674 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.32 128.21 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.972 1.309 . . . . 0.0 109.267 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -108.01 112.16 24.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.599 1.16 . . . . 0.0 111.547 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -78.38 79.39 4.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.941 1.296 . . . . 0.0 110.464 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.11 175.45 9.98 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.58 149.58 37.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.436 1.494 . . . . 0.0 111.291 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -75.72 -34.97 60.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.7 mt -82.36 -23.98 34.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.478 1.111 . . . . 0.0 113.496 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.02 125.43 91.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 113.573 -167.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.02 -2.27 9.54 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.177 3.918 . . . . 0.0 112.779 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -87.46 -42.76 12.57 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 119.696 1.135 . . . . 0.0 109.5 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 88.5 m -57.24 -37.1 71.79 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -50.79 -37.88 45.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -75.82 -41.08 53.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.873 0.469 . . . . 0.0 111.504 -170.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.284 1.034 . . . . 0.0 112.593 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -55.82 -40.94 73.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.607 1.094 . . . . 0.0 112.165 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -75.29 -33.94 61.27 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.492 -0.755 . . . . 0.0 112.659 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.53 -46.3 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.767 0.827 . . . . 0.0 110.855 174.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.31 -33.4 75.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.526 1.131 . . . . 0.0 112.41 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.25 -48.6 75.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.407 1.003 . . . . 0.0 112.564 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.58 -37.83 79.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.757 0.708 . . . . 0.0 112.247 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -67.85 -34.29 76.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 112.511 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.99 -22.72 60.67 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.877 -1.139 . . . . 0.0 113.643 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.93 -29.07 64.85 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -170.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.8 6.5 15.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.69 1.196 . . . . 0.0 114.224 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.96 63.92 17.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.937 1.695 . . . . 0.0 112.601 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.13 -15.19 32.06 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.275 2.65 . . . . 0.0 113.63 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -81.22 -2.95 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.43 134.11 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.241 1.416 . . . . 0.0 110.666 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.87 101.26 10.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.714 0.806 . . . . 0.0 111.339 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.7 mt -97.74 130.09 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.857 -1.152 . . . . 0.0 109.633 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 p -150.42 164.34 36.13 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.075 0.95 . . . . 0.0 111.677 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.5 p -104.34 176.22 5.23 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.66 -1.275 . . . . 0.0 112.601 165.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -156.02 135.46 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.776 1.631 . . . . 0.0 109.451 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -73.77 109.75 7.51 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.301 1.04 . . . . 0.0 111.446 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -55.12 -29.71 58.25 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.671 1.188 . . . . 0.0 113.931 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.09 -23.32 51.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.082 0.953 . . . . 0.0 112.782 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.92 -24.81 16.82 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.85 1.26 . . . . 0.0 112.783 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -117.46 48.6 0.8 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 126.858 2.063 . . . . 0.0 113.273 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.28 -27.09 24.43 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.566 1.511 . . . . 0.0 112.494 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.01 -32.93 74.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.742 0.701 . . . . 0.0 112.165 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.87 -48.04 67.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.002 0.921 . . . . 0.0 108.973 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.2 mtm -56.92 -22.17 35.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.675 -0.641 . . . . 0.0 112.438 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -13.87 53.22 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.371 0.987 . . . . 0.0 113.352 175.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -82.48 -42.3 18.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.482 1.113 . . . . 0.0 110.788 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.43 -23.98 24.32 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.17 21.63 17.27 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.41 1.481 . . . . 0.0 115.512 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.0 153.64 24.86 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.673 1.236 . . . . 0.0 111.919 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.38 -65.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.079 0.952 . . . . 0.0 111.941 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -159.99 2.16 0.08 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 -165.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.8 m -106.66 159.53 29.54 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 127.521 2.328 . . . . 0.0 112.835 -162.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.81 85.84 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.405 3.403 . . . . 0.0 111.859 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 75.7 m -98.79 128.36 44.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.92 137.78 32.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.698 1.199 . . . . 0.0 109.761 165.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.2 122.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.927 1.691 . . . . 0.0 108.662 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -102.67 118.53 37.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.998 0.919 . . . . 0.0 110.031 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.33 113.18 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.833 1.253 . . . . 0.0 108.853 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.77 121.61 45.76 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.045 1.338 . . . . 0.0 107.849 172.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.2 t70 64.59 21.78 12.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 112.261 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 9.23 84.47 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.403 1.001 . . . . 0.0 113.873 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.6 135.16 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 110.277 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.55 108.27 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 167.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.99 -34.42 10.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.82 150.49 33.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.044 1.738 . . . . 0.0 110.998 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -146.74 145.5 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.571 1.548 . . . . 0.0 108.811 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -148.0 136.57 21.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.539 0.736 . . . . 0.0 111.463 163.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 p -98.2 3.44 48.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.997 1.719 . . . . 0.0 115.08 -171.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.33 -166.19 26.61 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.422 1.486 . . . . 0.0 114.435 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.4 141.35 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.473 1.509 . . . . 0.0 110.086 170.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.6 mtm -137.05 176.02 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 170.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.46 156.17 49.44 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 126.759 2.023 . . . . 0.0 110.005 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.76 -38.2 18.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.903 1.735 . . . . 0.0 113.939 -156.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -61.25 -30.55 70.52 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.291 0.951 . . . . 0.0 113.086 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.18 -31.37 27.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.896 0.878 . . . . 0.0 112.006 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.26 -34.49 76.28 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.039 0.836 . . . . 0.0 112.388 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -48.59 76.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.062 0.945 . . . . 0.0 111.088 167.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.86 -34.93 79.28 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.484 0.714 . . . . 0.0 112.337 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.2 -49.18 70.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 110.329 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -42.41 80.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.225 0.61 . . . . 0.0 112.156 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.19 -36.42 81.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.472 0.578 . . . . 0.0 111.457 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -60.02 -34.98 74.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.838 1.255 . . . . 0.0 112.463 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 124.13 0.972 . . . . 0.0 111.056 175.134 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.549 0.69 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.6 p -158.8 162.27 37.02 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.461 1.504 . . . . 0.0 111.209 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.5 -2.41 35.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.71 1.204 . . . . 0.0 113.946 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.6 mm -108.09 112.22 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.626 1.57 . . . . 0.0 108.339 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -128.93 150.08 50.52 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.921 1.288 . . . . 0.0 110.429 -172.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.46 116.0 7.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.847 1.259 . . . . 0.0 110.714 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.3 mt -118.6 112.92 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.919 0.888 . . . . 0.0 109.692 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 p -101.61 -18.29 15.96 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.751 1.221 . . . . 0.0 113.037 164.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 p -69.51 -29.83 67.55 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.863 1.665 . . . . 0.0 113.295 -169.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.01 124.75 14.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.533 1.133 . . . . 0.0 109.336 157.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.38 160.75 15.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.391 1.877 . . . . 0.0 109.933 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.5 -170.08 54.64 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 123.308 0.48 . . . . 0.0 113.045 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -50.01 -37.04 30.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.034 1.334 . . . . 0.0 113.994 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.82 61.25 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -85.71 -32.6 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.048 0.939 . . . . 0.0 111.466 168.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -67.91 -30.96 70.42 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.5 -0.75 . . . . 0.0 111.457 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.2 -15.91 60.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.238 1.415 . . . . 0.0 113.283 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.27 -15.47 30.17 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.159 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pp -102.9 153.79 19.86 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.274 1.537 . . . . 0.0 114.302 -168.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -99.11 -37.73 9.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.212 1.005 . . . . 0.0 113.284 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -159.88 110.96 1.95 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.211 1.404 . . . . 0.0 109.706 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.13 37.82 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.872 0.844 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.05 131.07 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 108.634 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.6 t -124.04 131.0 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.49 1.116 . . . . 0.0 109.521 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -105.27 113.52 27.16 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.994 1.317 . . . . 0.0 112.039 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -82.09 75.64 9.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.162 1.385 . . . . 0.0 110.607 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.24 166.74 22.81 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.866 0.866 . . . . 0.0 113.261 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.35 160.39 25.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.572 1.149 . . . . 0.0 112.31 173.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -74.4 -56.42 4.88 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.26 -64.96 0.79 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.694 1.198 . . . . 0.0 112.067 -170.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -51.21 121.97 17.43 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 127.027 2.131 . . . . 0.0 113.677 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.96 -23.06 76.49 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.402 3.401 . . . . 0.0 114.961 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -62.11 -45.04 95.24 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.925 0.89 . . . . 0.0 112.132 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 m -62.16 -34.63 76.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.605 1.162 . . . . 0.0 112.757 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -60.46 -25.23 65.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.743 1.617 . . . . 0.0 113.863 -171.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.9 -41.07 71.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -62.7 -29.29 70.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.053 0.941 . . . . 0.0 113.201 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -56.85 -43.09 80.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 111.885 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -68.8 -33.83 74.52 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.929 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.77 -48.07 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.709 1.604 . . . . 0.0 110.468 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.59 -34.97 79.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 0.0 112.593 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.31 -52.15 66.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 111.196 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -67.58 -32.66 73.56 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.85 0.86 . . . . 0.0 112.422 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.48 -38.1 80.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.836 1.254 . . . . 0.0 112.408 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.66 -27.8 41.18 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-N 118.911 0.778 . . . . 0.0 112.73 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.84 64.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.348 1.059 . . . . 0.0 113.607 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.43 10.66 37.18 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.769 1.628 . . . . 0.0 114.585 177.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.22 73.32 44.36 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.483 1.513 . . . . 0.0 112.324 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.64 -22.61 73.34 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.566 2.844 . . . . 0.0 115.701 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -86.62 -4.61 59.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -168.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.21 132.11 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.877 1.271 . . . . 0.0 111.057 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.39 105.34 15.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mt -107.86 135.08 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.958 0.903 . . . . 0.0 110.426 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.0 p -149.3 172.17 15.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 0.0 112.152 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.4 p -116.98 170.27 8.76 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.696 -1.253 . . . . 0.0 111.668 167.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.1 128.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.434 1.094 . . . . 0.0 110.074 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.2 111.04 1.8 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.692 1.197 . . . . 0.0 110.467 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.8 p -61.32 -26.55 67.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.131 0.972 . . . . 0.0 113.014 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -78.35 -20.4 51.41 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.879 0.763 . . . . 0.0 112.673 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.06 -26.13 20.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.384 1.074 . . . . 0.0 112.399 168.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -117.61 48.21 0.79 Allowed Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 126.055 1.742 . . . . 0.0 114.928 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.82 -17.08 14.19 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.932 2.421 . . . . 0.0 114.189 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -26.8 64.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.51 1.05 . . . . 0.0 112.616 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.75 -46.83 34.62 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.151 0.432 . . . . 0.0 110.738 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 mtm -55.61 -28.69 56.6 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.929 0.891 . . . . 0.0 113.143 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -60.22 -29.8 68.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.644 1.577 . . . . 0.0 113.361 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -91.33 -36.69 13.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.923 1.289 . . . . 0.0 111.164 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.87 -19.25 30.86 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.5 18.5 30.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.206 1.384 . . . . 0.0 114.835 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -79.36 151.55 30.92 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.265 1.033 . . . . 0.0 111.537 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -94.42 -72.49 0.61 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.761 1.225 . . . . 0.0 111.405 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.27 15.99 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.91 1.684 . . . . 0.0 113.147 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.31 157.3 34.35 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.349 1.46 . . . . 0.0 111.866 -157.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.31 91.28 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.757 2.972 . . . . 0.0 110.48 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.9 m -104.77 126.71 52.13 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 111.606 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.66 126.1 34.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 109.296 165.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.91 125.34 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.862 1.665 . . . . 0.0 108.74 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.58 121.29 44.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.511 1.124 . . . . 0.0 110.312 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.2 mm -108.99 120.73 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 108.978 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -118.47 126.24 51.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.912 1.685 . . . . 0.0 109.419 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.77 19.7 9.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.366 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 2.35 88.37 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.223 -0.923 . . . . 0.0 114.627 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -103.24 135.91 44.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.078 1.751 . . . . 0.0 109.208 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.76 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.018 -1.051 . . . . 0.0 110.284 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -95.49 -20.76 18.78 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.596 1.158 . . . . 0.0 113.386 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -162.85 148.83 12.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.935 2.094 . . . . 0.0 108.828 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -161.77 144.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 110.58 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -157.71 143.03 16.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.42 1.088 . . . . 0.0 112.091 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.3 m -101.88 131.01 48.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.099 0.959 . . . . 0.0 110.955 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.88 -166.84 23.5 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.503 1.525 . . . . 0.0 113.273 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -120.08 146.07 25.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.14 1.776 . . . . 0.0 110.036 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.1 ptp -150.18 163.18 38.9 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 165.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.31 158.89 86.51 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.521 1.128 . . . . 0.0 112.53 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.78 -16.43 26.39 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.677 2.251 . . . . 0.0 113.707 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -68.14 -47.53 67.84 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 110.237 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -79.05 -27.07 43.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.307 1.043 . . . . 0.0 112.79 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.1 tp -61.59 -22.99 65.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.467 -0.771 . . . . 0.0 113.056 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -63.2 -42.05 99.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.226 0.61 . . . . 0.0 111.509 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -33.41 70.74 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.44 0.696 . . . . 0.0 112.15 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -50.14 72.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.761 1.224 . . . . 0.0 109.852 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.02 -44.47 96.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.344 1.058 . . . . 0.0 112.935 172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.17 84.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.989 0.813 . . . . 0.0 111.834 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -55.68 -32.86 63.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.966 1.306 . . . . 0.0 112.849 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 124.578 1.151 . . . . 0.0 110.803 177.647 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.4 m 71.9 -57.32 0.62 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.08 2.552 . . . . 0.0 114.03 169.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.75 36.15 0.49 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.468 1.907 . . . . 0.0 113.268 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 mm -78.39 85.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.206 -0.934 . . . . 0.0 109.425 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.44 175.92 11.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.173 2.189 . . . . 0.0 110.467 -172.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -86.93 114.77 23.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.678 1.191 . . . . 0.0 110.105 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.13 75.65 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -47.5 -27.75 1.91 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.097 2.559 . . . . 0.0 114.521 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 p -75.95 -13.32 60.25 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.406 1.882 . . . . 0.0 114.251 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.97 -20.33 0.15 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 134.79 56.95 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.997 1.271 . . . . 0.0 112.23 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.64 171.26 12.22 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.284 1.421 . . . . 0.0 112.233 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptp -54.41 -35.45 62.91 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -168.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -29.63 68.49 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -75.34 -39.78 59.02 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.614 -0.679 . . . . 0.0 111.295 168.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.42 -13.34 61.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -91.46 -13.42 32.3 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.833 1.253 . . . . 0.0 113.417 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.64 -17.8 3.79 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 -170.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.11 165.91 22.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 114.206 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.2 m -83.54 -50.32 8.37 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -164.96 114.62 1.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.437 1.495 . . . . 0.0 109.955 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.74 160.81 42.84 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.18 122.63 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.916 1.286 . . . . 0.0 107.915 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.79 117.36 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.395 1.478 . . . . 0.0 109.383 -170.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -102.07 115.09 29.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.925 0.89 . . . . 0.0 112.894 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -81.22 78.04 8.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.871 1.268 . . . . 0.0 111.662 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -170.69 3.11 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.649 1.18 . . . . 0.0 113.265 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -142.83 164.91 28.82 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.847 1.659 . . . . 0.0 111.339 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -39.0 -94.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.407 2.283 . . . . 0.0 116.922 -164.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.01 -22.82 16.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 113.842 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 61.0 m -46.71 115.66 3.4 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 127.018 2.127 . . . . 0.0 113.242 -171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -55.2 -24.5 41.86 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.586 3.524 . . . . 0.0 116.196 -175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.94 -48.6 75.45 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.256 0.934 . . . . 0.0 112.186 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 94.4 m -70.13 -25.91 63.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.288 1.035 . . . . 0.0 113.318 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -65.4 -30.02 70.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.253 1.021 . . . . 0.0 112.816 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.24 -51.49 69.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 110.794 169.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.67 -41.22 97.24 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.741 1.216 . . . . 0.0 112.906 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.54 -37.19 65.13 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.502 -0.749 . . . . 0.0 111.766 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.01 -31.35 62.9 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.525 -1.359 . . . . 0.0 112.092 176.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.9 -44.17 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.706 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.42 -40.76 92.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.523 0.729 . . . . 0.0 112.584 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.35 -49.8 75.49 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.544 0.611 . . . . 0.0 112.61 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.14 -37.6 87.92 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.567 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.18 -38.01 89.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.821 1.248 . . . . 0.0 111.763 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.41 -19.11 67.18 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.37 0.986 . . . . 0.0 113.066 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.44 -32.24 68.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.097 0.959 . . . . 0.0 113.453 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 11.01 34.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.575 1.55 . . . . 0.0 114.232 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.68 45.44 0.37 Allowed Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 125.708 1.603 . . . . 0.0 114.328 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.42 -15.46 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.209 2.606 . . . . 0.0 114.088 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.46 -7.93 58.76 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.74 133.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.653 1.115 . . . . 0.0 108.048 163.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.62 85.25 4.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.831 0.824 . . . . 0.0 110.286 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.06 130.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.4 p -144.54 172.05 13.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.088 0.947 . . . . 0.0 112.085 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.6 p -128.28 154.27 46.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.14 -0.975 . . . . 0.0 110.343 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.0 t -139.9 126.32 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.828 1.251 . . . . 0.0 108.528 -169.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.88 100.04 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.152 1.381 . . . . 0.0 110.832 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.0 p -54.44 -36.71 64.34 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.569 1.147 . . . . 0.0 113.146 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.61 -26.95 67.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.311 1.844 . . . . 0.0 114.088 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.09 -17.29 16.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.414 1.486 . . . . 0.0 112.994 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.13 51.05 2.28 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.54 1.936 . . . . 0.0 112.377 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.33 -24.25 43.64 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.737 1.624 . . . . 0.0 111.553 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.48 -26.3 67.87 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 113.073 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.16 -55.18 6.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 109.5 168.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 mtm -57.54 -24.01 53.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.479 1.112 . . . . 0.0 113.369 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -70.37 -28.47 65.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.748 1.619 . . . . 0.0 111.696 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -80.96 -38.05 28.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.255 1.022 . . . . 0.0 111.007 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.93 -22.5 21.94 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.04 22.84 16.35 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.65 1.595 . . . . 0.0 115.024 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.11 153.63 25.97 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.663 1.232 . . . . 0.0 111.76 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.58 -70.6 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.353 1.061 . . . . 0.0 112.377 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -157.34 3.58 0.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -165.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.48 156.88 38.78 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.07 1.748 . . . . 0.0 113.02 -162.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.66 93.33 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.034 3.156 . . . . 0.0 110.261 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.2 m -103.41 129.77 50.58 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.253 1.021 . . . . 0.0 110.429 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.5 tp -110.07 119.52 39.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.89 0.876 . . . . 0.0 110.061 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 t -117.13 129.15 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.343 1.457 . . . . 0.0 109.079 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -111.21 118.73 36.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.824 0.849 . . . . 0.0 109.901 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.426 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 30.1 mm -107.21 114.36 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.18 1.392 . . . . 0.0 109.148 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.426 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -108.28 118.57 37.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.771 1.228 . . . . 0.0 108.586 173.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.05 22.34 13.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.99 1.316 . . . . 0.0 113.209 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.63 10.47 70.15 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.372 0.987 . . . . 0.0 113.149 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -112.51 131.83 55.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.156 1.382 . . . . 0.0 109.37 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.16 106.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.625 -0.672 . . . . 0.0 109.419 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.01 -20.15 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -162.27 153.52 17.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.917 1.687 . . . . 0.0 110.448 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.13 144.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.96 1.304 . . . . 0.0 110.807 172.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.89 162.33 35.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.933 1.293 . . . . 0.0 109.814 165.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -130.98 140.91 50.21 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.411 0.685 . . . . 0.0 112.589 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.74 19.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.693 1.616 . . . . 0.0 112.386 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.1 mm -125.63 145.33 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.222 1.809 . . . . 0.0 110.135 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.8 ptp -147.36 -149.06 0.27 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.746 0.818 . . . . 0.0 111.473 164.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.85 160.06 38.97 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.519 1.528 . . . . 0.0 110.43 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.78 -34.49 11.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.612 1.542 . . . . 0.0 113.815 -153.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -59.14 -32.25 69.7 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.53 -32.55 32.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.083 0.953 . . . . 0.0 111.838 172.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.5 tp -65.62 -30.08 70.75 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.275 -0.891 . . . . 0.0 112.543 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.7 -37.55 73.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.05 0.841 . . . . 0.0 112.015 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.26 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.969 -1.082 . . . . 0.0 112.211 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.19 -39.96 90.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.726 -0.609 . . . . 0.0 111.37 175.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.58 -48.29 80.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.204 1.002 . . . . 0.0 112.123 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.7 -32.89 74.07 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.82 -1.175 . . . . 0.0 112.718 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.3 t -64.57 -13.53 53.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.787 1.635 . . . . 0.0 113.331 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.474 0.736 0 O-C-N 120.658 -1.276 . . . . 0.0 110.719 170.854 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.441 0.639 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 m -74.54 -45.06 48.07 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.855 0.862 . . . . 0.0 112.591 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.76 -15.23 17.02 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.6 mm -117.56 126.1 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.45 1.5 . . . . 0.0 111.081 -169.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.43 160.76 23.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.448 1.099 . . . . 0.0 112.558 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.09 118.45 6.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.82 2.448 . . . . 0.0 112.459 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mt -120.27 55.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 122.648 1.213 . . . . 0.0 111.477 168.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.7 m -48.88 -30.53 5.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.898 2.879 . . . . 0.0 114.556 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -76.77 -69.71 0.5 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.454 1.902 . . . . 0.0 111.328 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -74.51 -25.2 59.2 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.31 117.28 5.02 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 120.624 1.556 . . . . 0.0 112.251 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.25 163.76 16.71 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.22 1.39 . . . . 0.0 113.27 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -52.76 -37.26 59.24 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.356 1.462 . . . . 0.0 114.765 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.8 -25.87 63.06 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -82.82 -32.76 27.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.662 . . . . 0.0 111.916 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.89 -28.83 68.64 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.807 -0.558 . . . . 0.0 111.221 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.41 -7.05 16.81 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.567 -1.333 . . . . 0.0 114.042 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.11 -4.72 61.16 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.151 1.358 . . . . 0.0 115.506 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.3 mt -77.65 159.27 29.29 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.625 1.713 . . . . 0.0 115.215 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -87.09 -51.65 5.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.014 143.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -161.55 135.23 6.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.16 1.784 . . . . 0.0 112.586 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.04 162.98 38.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.218 1.407 . . . . 0.0 112.916 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -139.33 132.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.057 1.343 . . . . 0.0 108.707 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.07 123.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.012 1.325 . . . . 0.0 109.631 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -102.77 110.72 22.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.646 1.178 . . . . 0.0 111.621 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.02 70.29 5.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.962 1.705 . . . . 0.0 110.845 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -171.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.182 0.993 . . . . 0.0 113.561 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -136.27 163.35 30.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.644 1.178 . . . . 0.0 111.329 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -72.39 -60.89 2.01 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.284 1.033 . . . . 0.0 112.716 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.91 -41.9 35.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.648 1.179 . . . . 0.0 112.342 -169.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.2 m -47.59 108.51 0.9 Allowed Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 126.667 1.987 . . . . 0.0 114.191 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -62.09 -30.27 82.32 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.377 2.718 . . . . 0.0 113.926 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.88 -38.26 90.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -61.81 -32.54 72.85 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.955 0.902 . . . . 0.0 113.109 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.67 -29.1 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.709 0.804 . . . . 0.0 112.758 -174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -63.58 -43.47 96.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.573 0.749 . . . . 0.0 111.626 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.9 mmm -66.31 -26.08 67.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.745 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -44.69 89.26 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.531 1.06 . . . . 0.0 111.512 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -62.23 -43.92 97.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.996 -1.065 . . . . 0.0 112.226 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.45 -48.38 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.342 1.057 . . . . 0.0 111.051 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.4 mt -63.47 -37.11 86.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.005 0.922 . . . . 0.0 112.961 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.72 -47.86 81.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.432 0.693 . . . . 0.0 111.119 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.05 -32.54 72.97 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.913 0.885 . . . . 0.0 113.17 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.11 -36.45 83.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.683 1.593 . . . . 0.0 111.782 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.19 -22.5 62.95 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-N 118.917 0.78 . . . . 0.0 112.445 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.09 -28.71 64.85 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.715 1.206 . . . . 0.0 113.904 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 9.79 29.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.503 1.521 . . . . 0.0 114.256 176.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.46 85.73 14.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.381 1.472 . . . . 0.0 111.338 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.02 -15.03 18.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.878 2.385 . . . . 0.0 114.52 -169.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.97 -12.62 24.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.11 1.323 . . . . 0.0 113.874 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.69 129.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 110.226 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.96 92.99 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.371 0.605 . . . . 0.0 110.36 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 mt -92.96 136.24 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 109.988 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.5 p -148.15 168.55 22.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 112.688 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -118.25 168.84 10.22 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.989 -1.069 . . . . 0.0 110.636 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.77 131.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.33 1.052 . . . . 0.0 109.487 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.45 115.51 9.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.875 1.27 . . . . 0.0 111.873 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.7 p -57.05 -27.72 61.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.824 1.25 . . . . 0.0 113.826 172.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.53 -23.32 50.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.306 0.957 . . . . 0.0 112.498 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.79 -39.94 9.2 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.912 1.285 . . . . 0.0 113.108 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -126.89 60.58 41.73 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.544 . . . . 0.0 112.71 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.42 -15.95 34.71 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.395 2.73 . . . . 0.0 111.777 167.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.11 -41.18 68.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.606 1.563 . . . . 0.0 112.156 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.56 -44.05 62.64 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.336 0.654 . . . . 0.0 111.675 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.5 mtp -56.41 -28.94 60.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.711 0.805 . . . . 0.0 112.184 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -17.95 60.77 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.634 1.174 . . . . 0.0 113.505 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -81.06 -40.65 23.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.13 1.372 . . . . 0.0 110.822 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.52 -26.16 38.28 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.325 0.65 . . . . 0.0 112.481 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 16.51 23.78 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.906 1.717 . . . . 0.0 114.791 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.56 140.61 38.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.086 1.443 . . . . 0.0 110.691 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -77.29 -77.17 0.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.955 0.502 . . . . 0.0 110.778 175.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -147.79 4.56 0.76 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.443 1.497 . . . . 0.0 114.88 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.9 m -86.29 155.89 57.17 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 126.579 1.952 . . . . 0.0 113.198 -166.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.43 82.96 2.36 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 124.533 3.489 . . . . 0.0 111.294 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.4 m -96.38 130.88 43.4 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 112.683 -169.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.47 122.96 36.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.79 1.236 . . . . 0.0 108.987 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.17 126.04 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.553 1.541 . . . . 0.0 108.745 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.04 117.11 32.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 109.856 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.1 mm -109.7 126.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.922 1.289 . . . . 0.0 110.101 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -114.31 121.15 42.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.964 1.706 . . . . 0.0 108.622 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.9 t70 60.73 27.71 17.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.666 1.121 . . . . 0.0 111.927 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 -3.14 83.1 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -99.56 132.05 45.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.499 1.52 . . . . 0.0 109.65 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.12 104.02 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.71 -20.49 21.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.252 1.021 . . . . 0.0 113.107 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -163.03 155.61 18.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.21 1.804 . . . . 0.0 110.717 -173.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.35 146.42 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.093 1.357 . . . . 0.0 111.031 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.45 149.49 30.87 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.3 1.44 . . . . 0.0 108.575 169.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -134.01 140.13 46.49 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.133 -0.979 . . . . 0.0 112.08 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.84 -144.53 18.22 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.671 1.129 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.7 mm -116.96 143.26 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.322 1.449 . . . . 0.0 111.399 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.1 ptp -155.73 169.87 23.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 113.185 160.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -83.53 162.44 53.38 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 125.725 1.61 . . . . 0.0 112.129 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.95 -30.65 21.06 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.089 1.859 . . . . 0.0 114.655 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.7 -28.78 60.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.319 1.418 . . . . 0.0 113.027 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.1 -25.19 47.42 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.577 -0.702 . . . . 0.0 112.545 164.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.84 -30.65 67.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 111.953 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.32 -44.67 92.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.261 0.937 . . . . 0.0 111.086 163.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.52 72.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.257 0.935 . . . . 0.0 112.743 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.82 -48.22 72.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.127 1.371 . . . . 0.0 110.196 173.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.72 -42.24 83.43 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.935 0.894 . . . . 0.0 112.204 170.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.69 67.71 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.072 -1.018 . . . . 0.0 111.865 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 m -76.96 -10.7 59.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.583 1.553 . . . . 0.0 113.169 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.477 0.902 0 CA-C-N 119.391 0.996 . . . . 0.0 108.536 162.561 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.9 mtp . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 t -67.03 146.63 54.14 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.678 1.191 . . . . 0.0 112.118 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.6 -9.99 59.05 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm -108.81 124.73 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.281 1.433 . . . . 0.0 110.931 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -175.63 173.43 2.41 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.89 2.476 . . . . 0.0 111.704 -172.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -72.41 120.88 18.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.444 1.098 . . . . 0.0 110.263 159.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.9 mt -91.82 130.01 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.885 0.874 . . . . 0.0 109.499 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.9 p -75.18 -18.0 60.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.641 1.577 . . . . 0.0 114.455 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 m -66.82 -49.29 66.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.568 1.547 . . . . 0.0 111.922 -174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -178.15 141.23 0.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.034 2.133 . . . . 0.0 110.667 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.3 133.88 4.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.668 1.587 . . . . 0.0 110.599 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.19 176.16 14.46 Favored Glycine 0 N--CA 1.47 0.908 0 C-N-CA 124.913 1.244 . . . . 0.0 112.653 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp -56.11 -32.91 64.63 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -165.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.89 70.51 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -74.73 -40.13 61.46 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.678 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -73.92 -9.8 59.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -92.07 -16.21 26.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.436 1.494 . . . . 0.0 113.173 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -19.05 6.63 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.63 166.4 22.82 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -82.72 -65.72 0.98 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.266 1.426 . . . . 0.0 113.013 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -148.42 121.79 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.603 1.561 . . . . 0.0 109.669 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.46 161.54 39.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.3 mt -138.16 123.17 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.645 1.578 . . . . 0.0 107.936 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.0 121.96 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.268 1.427 . . . . 0.0 108.314 -175.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -100.4 107.68 19.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.92 0.888 . . . . 0.0 110.802 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.11 80.74 3.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.721 1.208 . . . . 0.0 109.83 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.87 -178.31 7.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.708 1.203 . . . . 0.0 111.913 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -127.36 139.59 52.76 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.276 -1.515 . . . . 0.0 110.953 161.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -57.3 -32.75 66.97 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.696 1.598 . . . . 0.0 114.02 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -80.66 -37.97 29.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 113.209 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.0 t -57.5 118.13 23.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.934 1.694 . . . . 0.0 113.713 -168.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.48 -24.98 56.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.151 3.234 . . . . 0.0 113.381 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -77.01 -40.94 44.75 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.798 0.727 . . . . 0.0 110.957 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 78.7 m -52.83 -34.66 55.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.754 1.222 . . . . 0.0 113.959 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -55.98 -39.73 72.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.076 0.95 . . . . 0.0 112.303 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -65.2 -47.02 78.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.626 0.77 . . . . 0.0 110.841 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 tpt -60.66 -36.08 77.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.715 1.206 . . . . 0.0 112.176 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.63 -37.77 88.58 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.689 -1.257 . . . . 0.0 112.759 172.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -34.01 74.67 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.818 1.19 . . . . 0.0 112.476 171.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.07 -48.77 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-N 119.14 0.882 . . . . 0.0 110.385 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.97 -34.09 77.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.682 1.193 . . . . 0.0 112.087 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.13 -49.47 75.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.704 1.138 . . . . 0.0 111.475 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -66.57 -33.97 76.85 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.696 -0.627 . . . . 0.0 112.391 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -63.35 -42.61 98.92 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 111.261 170.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.82 -26.52 45.29 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.295 0.95 . . . . 0.0 112.619 -171.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.28 68.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.166 0.986 . . . . 0.0 113.428 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.32 8.27 35.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.618 1.567 . . . . 0.0 114.269 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.22 45.24 0.89 Allowed Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 126.257 1.823 . . . . 0.0 113.202 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.22 -15.74 51.52 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.751 2.967 . . . . 0.0 114.531 -167.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -76.84 -9.18 58.51 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.36 130.53 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.822 1.192 . . . . 0.0 108.529 162.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.57 96.05 6.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.301 0.641 . . . . 0.0 110.674 174.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mt -104.87 130.13 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.135 -0.978 . . . . 0.0 109.48 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.0 p -148.82 170.75 17.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.054 0.942 . . . . 0.0 112.325 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.2 p -129.89 153.63 48.12 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.017 -1.052 . . . . 0.0 112.896 174.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.87 134.54 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.677 1.591 . . . . 0.0 109.154 -168.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.46 121.04 26.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 123.026 1.393 . . . . 0.0 113.159 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 p -62.6 -23.71 67.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.861 1.664 . . . . 0.0 114.979 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.28 -45.1 10.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.031 1.287 . . . . 0.0 111.823 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.07 -26.92 43.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.709 1.204 . . . . 0.0 113.671 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.56 54.51 14.6 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.746 1.618 . . . . 0.0 112.038 -171.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.19 -9.67 13.91 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.318 3.345 . . . . 0.0 113.675 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -66.27 -21.78 66.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.801 0.84 . . . . 0.0 112.509 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.67 -54.25 6.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.77 1.228 . . . . 0.0 110.92 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.5 mtm -55.74 -30.01 60.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -74.2 -14.24 60.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.731 0.812 . . . . 0.0 112.803 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -89.04 -38.71 14.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.656 1.183 . . . . 0.0 110.538 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.46 -22.52 28.23 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 17.27 26.39 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.788 1.661 . . . . 0.0 115.061 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.56 140.58 37.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.016 1.408 . . . . 0.0 110.835 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.98 -59.36 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.618 0.767 . . . . 0.0 112.19 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -157.04 1.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 m -101.64 152.72 38.13 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.796 1.638 . . . . 0.0 113.028 -163.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.86 91.7 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.093 3.196 . . . . 0.0 110.396 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -107.2 124.83 50.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 0.0 112.47 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.56 129.25 37.57 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.274 0.63 . . . . 0.0 109.859 166.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.17 127.98 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.77 1.628 . . . . 0.0 108.401 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -105.64 127.84 53.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.424 1.09 . . . . 0.0 109.757 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.7 115.84 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.055 0.942 . . . . 0.0 108.674 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.43 123.93 50.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.131 1.373 . . . . 0.0 108.879 171.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.58 20.22 11.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.199 1.4 . . . . 0.0 112.681 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.11 12.56 82.29 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 113.694 -172.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -107.71 134.82 50.13 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.699 1.6 . . . . 0.0 109.754 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.74 105.12 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.96 -27.81 13.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -162.05 154.27 19.36 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.035 1.334 . . . . 0.0 110.579 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.2 145.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.878 1.271 . . . . 0.0 110.701 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 144.92 25.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.007 0.923 . . . . 0.0 111.17 165.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 m -111.52 120.17 41.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.122 0.969 . . . . 0.0 110.523 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.74 29.89 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 124.926 1.25 . . . . 0.0 114.382 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm -112.2 140.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.429 1.492 . . . . 0.0 109.7 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.0 mtm -142.6 161.32 38.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.781 0.833 . . . . 0.0 112.338 167.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -76.01 161.06 76.93 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.508 1.523 . . . . 0.0 112.064 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.31 -25.25 22.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.243 1.962 . . . . 0.0 114.453 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -76.67 -35.99 57.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.031 1.287 . . . . 0.0 112.543 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.5 -25.42 50.33 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.017 0.826 . . . . 0.0 112.784 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.29 -25.96 68.15 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.183 -0.948 . . . . 0.0 112.4 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -63.9 -38.76 92.29 Favored 'General case' 0 C--N 1.342 0.281 0 O-C-N 121.553 -0.717 . . . . 0.0 111.877 172.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.31 79.72 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.66 0.664 . . . . 0.0 112.038 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.01 -42.94 79.92 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.26 -43.37 98.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.806 0.843 . . . . 0.0 112.185 171.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.57 87.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.46 -0.775 . . . . 0.0 111.131 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.3 m -66.58 -4.07 7.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.004 1.722 . . . . 0.0 114.846 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 119.082 0.855 . . . . 0.0 110.58 166.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 t -132.4 147.06 52.37 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.35 1.46 . . . . 0.0 112.397 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.08 -6.02 47.27 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.244 1.417 . . . . 0.0 114.041 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.5 mm -100.2 120.74 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 109.799 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 -123.04 148.98 44.98 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.766 1.626 . . . . 0.0 110.276 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -82.07 105.34 13.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.461 0.704 . . . . 0.0 109.128 167.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mt -104.14 60.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 122.199 0.999 . . . . 0.0 109.819 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 m -44.45 -39.32 4.67 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 128.134 2.573 . . . . 0.0 113.303 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 m -69.12 -41.59 77.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.48 1.912 . . . . 0.0 112.195 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -83.73 -23.75 31.48 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.229 1.012 . . . . 0.0 112.244 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.2 51.92 0.44 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.529 1.932 . . . . 0.0 114.796 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.36 148.47 18.7 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 125.201 1.382 . . . . 0.0 110.329 160.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp -55.54 -31.68 62.32 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -26.24 66.92 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -68.31 -43.24 78.08 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.123 0.874 . . . . 0.0 110.73 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -75.78 -9.71 58.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.236 1.014 . . . . 0.0 112.907 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.01 -14.33 29.57 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.046 1.338 . . . . 0.0 113.218 167.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.05 -15.71 6.04 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.73 174.29 8.61 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 p -88.37 -60.06 2.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.411 1.485 . . . . 0.0 113.497 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -158.47 115.59 2.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.218 1.407 . . . . 0.0 110.36 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.08 160.74 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -168.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.7 mt -137.43 128.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.949 1.7 . . . . 0.0 109.106 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.73 135.07 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.131 1.372 . . . . 0.0 109.458 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -116.07 114.79 25.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 111.729 172.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -83.94 74.24 10.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.941 1.696 . . . . 0.0 111.31 -175.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.73 -170.14 2.01 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -157.25 170.84 21.56 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.611 1.564 . . . . 0.0 113.323 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -47.57 -102.9 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 128.827 2.851 . . . . 0.0 116.951 -173.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.7 -15.73 41.35 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.015 -1.678 . . . . 0.0 114.629 -168.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -49.18 119.93 9.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.681 1.592 . . . . 0.0 112.494 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.31 -25.71 36.11 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.319 2.679 . . . . 0.0 113.732 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -70.93 -43.23 68.65 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 119.366 0.985 . . . . 0.0 112.179 -168.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -67.22 -25.1 65.94 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -61.68 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.114 0.966 . . . . 0.0 113.595 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -63.21 -44.69 94.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.415 0.686 . . . . 0.0 111.903 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -60.88 -30.63 70.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.416 1.086 . . . . 0.0 113.002 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.74 -35.37 76.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.404 0.682 . . . . 0.0 111.786 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -69.67 -34.09 73.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.525 1.057 . . . . 0.0 111.035 176.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 t -69.62 -46.35 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.014 1.726 . . . . 0.0 109.362 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.8 mt -61.96 -41.67 98.26 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.379 1.872 . . . . 0.0 112.658 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.62 -52.42 64.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.616 1.166 . . . . 0.0 111.97 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -66.47 -32.96 74.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.049 -1.032 . . . . 0.0 112.551 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -68.24 -34.3 75.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.896 1.278 . . . . 0.0 112.311 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.84 46.01 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 121.002 -1.061 . . . . 0.0 112.657 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.96 65.56 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.157 1.383 . . . . 0.0 114.537 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 4.84 23.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.976 1.31 . . . . 0.0 114.086 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.72 40.59 0.62 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.701 1.6 . . . . 0.0 114.034 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -65.56 -13.28 39.01 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.641 2.894 . . . . 0.0 114.685 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -77.83 -9.02 58.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 173.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.75 132.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.21 0.914 . . . . 0.0 108.903 161.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.26 92.65 5.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.332 0.587 . . . . 0.0 110.324 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.8 mt -102.16 131.1 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.253 1.021 . . . . 0.0 109.667 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.5 p -147.16 159.43 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.716 0.806 . . . . 0.0 112.369 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.0 p -98.14 163.6 12.67 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.213 -0.929 . . . . 0.0 111.145 163.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -147.99 129.17 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.602 1.561 . . . . 0.0 108.8 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.12 108.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.685 0.794 . . . . 0.0 110.188 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 p -52.55 -41.18 63.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.897 1.279 . . . . 0.0 111.88 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.14 -22.22 66.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.96 1.704 . . . . 0.0 114.223 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.06 -14.59 22.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.115 1.366 . . . . 0.0 113.4 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -131.9 49.61 4.82 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.79 1.636 . . . . 0.0 113.959 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -67.53 -26.35 40.29 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.431 2.087 . . . . 0.0 112.209 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -60.81 -41.28 95.35 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 0.0 111.703 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.97 -50.34 72.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.735 0.814 . . . . 0.0 110.996 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.9 mtp -57.63 -22.87 48.02 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.629 0.771 . . . . 0.0 113.022 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -14.03 52.94 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.561 1.144 . . . . 0.0 112.813 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -83.58 -41.35 17.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.343 1.057 . . . . 0.0 110.599 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.31 -24.72 32.05 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.47 20.98 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 125.172 1.368 . . . . 0.0 115.018 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -82.14 145.69 29.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.11 1.455 . . . . 0.0 111.508 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -80.91 -75.2 0.29 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 111.343 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -161.13 13.41 0.1 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -166.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.21 155.62 36.2 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 126.389 1.876 . . . . 0.0 113.255 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.56 90.26 1.05 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.16 3.24 . . . . 0.0 110.846 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -99.73 132.45 45.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 112.595 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.56 131.52 35.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.474 1.11 . . . . 0.0 109.71 161.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.65 121.92 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.776 1.631 . . . . 0.0 108.302 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.04 124.12 49.71 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.125 0.97 . . . . 0.0 110.687 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.54 122.74 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.171 1.388 . . . . 0.0 109.51 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -116.9 124.16 48.78 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.445 1.498 . . . . 0.0 109.192 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 62.65 20.54 12.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.166 1.386 . . . . 0.0 112.362 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.71 8.98 86.18 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.083 -1.011 . . . . 0.0 113.521 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -103.74 132.55 49.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.544 1.537 . . . . 0.0 109.073 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.82 105.4 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.324 -0.86 . . . . 0.0 109.039 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.43 -24.75 15.98 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.492 1.117 . . . . 0.0 113.387 -170.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -160.51 146.87 15.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.444 1.498 . . . . 0.0 110.801 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.2 t -147.51 145.52 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 109.826 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.26 151.5 29.2 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.976 0.911 . . . . 0.0 111.44 162.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.8 m -115.95 135.28 54.12 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.624 0.77 . . . . 0.0 111.944 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.89 -149.4 17.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.935 1.255 . . . . 0.0 112.593 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.19 139.65 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.571 1.548 . . . . 0.0 110.76 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -139.22 160.48 39.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.448 1.099 . . . . 0.0 112.044 163.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -74.0 162.11 75.49 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 124.76 1.224 . . . . 0.0 111.869 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.89 -23.71 12.12 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.09 1.86 . . . . 0.0 114.676 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.8 -37.33 67.59 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.137 1.79 . . . . 0.0 112.607 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -78.81 -22.88 45.59 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.653 0.66 . . . . 0.0 112.151 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.64 -29.57 70.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 0.0 112.09 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.74 -39.4 93.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.239 0.927 . . . . 0.0 111.393 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.19 80.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.503 -0.748 . . . . 0.0 111.93 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.41 -44.6 90.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.166 0.586 . . . . 0.0 110.686 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.18 -47.44 86.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.19 0.996 . . . . 0.0 112.693 172.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.16 76.52 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.13 -0.982 . . . . 0.0 112.351 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.1 t -65.58 -14.34 60.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.382 1.473 . . . . 0.0 113.737 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 N--CA 1.48 1.038 0 O-C-N 119.988 -1.695 . . . . 0.0 110.588 172.682 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtm . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 121.157 0.503 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -76.89 42.57 0.31 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.219 1.408 . . . . 0.0 112.829 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.8 -3.32 37.73 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -103.7 107.86 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.09 1.756 . . . . 0.0 107.548 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -140.4 164.46 30.06 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.412 1.485 . . . . 0.0 111.637 -166.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.48 109.67 0.73 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.789 2.036 . . . . 0.0 111.693 167.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.42 121.21 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.988 1.315 . . . . 0.0 108.902 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.0 p -64.86 -29.81 70.79 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.732 1.613 . . . . 0.0 114.626 -174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.5 p -87.45 -15.24 38.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.432 1.493 . . . . 0.0 113.959 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -124.21 28.16 6.83 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.438 1.495 . . . . 0.0 112.071 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.53 166.78 23.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.745 1.618 . . . . 0.0 111.972 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.65 147.68 22.42 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.889 1.233 . . . . 0.0 111.401 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp -52.33 -31.6 34.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.074 1.35 . . . . 0.0 114.596 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 -28.93 63.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -74.16 -39.11 63.46 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.656 -0.652 . . . . 0.0 110.413 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.41 -14.98 61.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 113.302 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -89.49 -20.14 24.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.629 1.172 . . . . 0.0 112.846 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.24 -23.47 6.97 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 124.896 1.236 . . . . 0.0 115.081 -171.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.25 165.65 23.2 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -89.1 -56.22 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.987 1.315 . . . . 0.0 113.003 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -155.34 110.54 3.02 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.898 1.279 . . . . 0.0 110.65 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.84 159.75 42.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.7 mt -135.29 129.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.508 1.523 . . . . 0.0 108.445 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -121.28 124.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.613 1.565 . . . . 0.0 109.57 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -104.06 119.22 38.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -85.05 76.29 10.27 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.098 -1.001 . . . . 0.0 110.455 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 173.08 11.81 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.682 0.753 . . . . 0.0 112.931 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -125.68 147.66 49.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.694 1.198 . . . . 0.0 110.772 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.84 148.27 30.63 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 67.61 -30.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.907 2.883 . . . . 0.0 115.296 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.4 t -52.13 117.55 10.42 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.019 1.728 . . . . 0.0 113.305 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.91 -24.64 74.19 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.194 3.263 . . . . 0.0 113.602 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -72.61 -43.27 63.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.226 0.921 . . . . 0.0 110.585 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.6 -33.26 69.79 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 113.065 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -54.72 -39.8 68.59 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.174 0.989 . . . . 0.0 112.501 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.39 -48.13 81.63 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.549 0.74 . . . . 0.0 110.959 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.738 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.31 -43.09 96.66 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.209 0.913 . . . . 0.0 111.325 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -41.93 85.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.581 0.752 . . . . 0.0 112.43 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.86 -46.96 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.873 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.28 -34.09 77.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.114 1.365 . . . . 0.0 112.609 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.68 -46.46 88.07 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.9 0.773 . . . . 0.0 112.158 169.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -68.86 -35.16 76.59 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.289 -0.882 . . . . 0.0 112.033 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.76 -37.67 88.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.405 1.482 . . . . 0.0 111.848 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.49 -22.02 57.17 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 123.863 0.744 . . . . 0.0 113.369 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.74 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.264 1.026 . . . . 0.0 113.332 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 10.08 41.28 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.327 1.451 . . . . 0.0 114.601 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.75 48.83 0.74 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.629 1.572 . . . . 0.0 113.709 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.36 -16.96 57.89 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.591 2.861 . . . . 0.0 114.023 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -79.09 -8.28 58.84 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.53 134.12 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.545 1.066 . . . . 0.0 108.685 166.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.23 86.73 4.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.466 0.651 . . . . 0.0 110.647 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.5 mt -93.27 127.19 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.748 0.819 . . . . 0.0 109.178 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t -141.52 164.42 30.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.768 1.227 . . . . 0.0 110.906 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -110.42 -175.92 2.85 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 162.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.4 p -167.28 129.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.357 1.863 . . . . 0.0 109.222 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -72.55 114.71 10.98 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.193 0.997 . . . . 0.0 111.075 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 p -54.91 -28.09 48.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 113.601 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -74.9 -26.65 59.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.989 0.813 . . . . 0.0 112.675 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.18 -29.41 15.13 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.942 1.297 . . . . 0.0 113.415 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -127.81 49.83 4.77 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.18 1.392 . . . . 0.0 113.962 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.3 -19.93 49.48 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.937 1.758 . . . . 0.0 112.376 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.26 1.024 . . . . 0.0 112.86 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.85 -54.27 7.58 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.2 mtp -55.53 -33.31 63.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.578 1.151 . . . . 0.0 113.351 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -65.98 -21.29 66.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.695 1.598 . . . . 0.0 113.768 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -76.88 -40.14 48.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.847 0.749 . . . . 0.0 111.968 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.91 -22.56 24.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 11.86 36.41 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.337 1.922 . . . . 0.0 115.179 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.75 130.77 39.17 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.213 1.507 . . . . 0.0 111.68 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -84.12 -55.15 4.35 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.071 0.949 . . . . 0.0 112.169 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -160.41 -0.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.46 154.5 44.38 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 125.554 1.542 . . . . 0.0 113.4 -160.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.8 89.02 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.455 3.437 . . . . 0.0 109.469 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.3 m -105.2 132.67 51.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.829 0.851 . . . . 0.0 112.609 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.96 134.75 33.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.7 1.2 . . . . 0.0 110.471 166.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.5 t -130.31 131.46 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.783 1.633 . . . . 0.0 108.685 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -110.08 128.68 55.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.055 0.942 . . . . 0.0 110.65 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.86 110.49 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.0 123.75 50.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.284 1.433 . . . . 0.0 108.202 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.18 17.49 8.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.758 1.223 . . . . 0.0 112.038 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.52 83.18 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.077 0.846 . . . . 0.0 113.639 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -110.08 135.96 50.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.266 1.826 . . . . 0.0 109.397 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.09 106.29 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.94 -20.88 13.04 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -163.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -159.19 153.74 24.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.99 1.316 . . . . 0.0 111.436 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.65 144.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.734 1.614 . . . . 0.0 110.388 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -154.01 143.36 21.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.539 1.136 . . . . 0.0 112.011 165.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 m -101.19 135.58 42.42 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.927 0.891 . . . . 0.0 112.069 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.69 -162.72 12.32 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.914 1.245 . . . . 0.0 113.682 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.44 140.85 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.778 1.631 . . . . 0.0 111.285 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.8 mtm -134.79 153.21 52.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.467 1.107 . . . . 0.0 110.388 160.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.13 152.57 71.3 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 122.749 0.419 . . . . 0.0 110.978 169.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.81 -27.32 51.86 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.29 1.993 . . . . 0.0 114.264 -156.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -63.89 -30.04 71.17 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.12 -37.79 64.0 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.994 0.816 . . . . 0.0 111.008 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.6 tp -65.3 -28.24 69.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.47 -0.776 . . . . 0.0 112.819 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -59.1 -49.38 78.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.982 0.81 . . . . 0.0 111.574 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.9 -37.6 84.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.578 0.751 . . . . 0.0 111.77 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -67.24 -43.54 81.69 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.837 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.89 -47.01 87.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.425 1.09 . . . . 0.0 112.131 172.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.88 85.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.461 0.573 . . . . 0.0 111.739 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.2 m -62.48 -11.35 15.65 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.655 1.582 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.478 0.951 0 O-C-N 121.08 -1.013 . . . . 0.0 112.032 175.917 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.5 p -164.81 168.09 18.15 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.437 1.495 . . . . 0.0 112.191 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.86 0.73 14.59 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.54 1.536 . . . . 0.0 114.21 172.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mm -101.52 125.53 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.521 1.929 . . . . 0.0 108.382 -174.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -116.05 146.33 42.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.521 1.129 . . . . 0.0 109.893 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.05 116.09 12.05 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 163.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mt -128.73 49.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 122.183 0.992 . . . . 0.0 111.93 172.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.8 m -46.17 -35.0 4.69 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.038 2.135 . . . . 0.0 113.563 169.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -63.85 -41.53 97.78 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.462 1.905 . . . . 0.0 112.734 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -84.3 -13.74 51.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.387 1.075 . . . . 0.0 113.411 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.08 31.0 0.07 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -168.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.2 148.54 34.53 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.52 1.057 . . . . 0.0 110.541 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -56.77 -29.12 62.33 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -25.27 64.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.719 1.208 . . . . 0.0 113.95 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -70.18 -31.16 68.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.105 0.866 . . . . 0.0 111.752 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -75.66 -20.63 58.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.943 0.897 . . . . 0.0 113.003 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.91 82.28 0.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.132 1.773 . . . . 0.0 113.075 -172.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 134.87 3.06 2.98 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 126.313 1.911 . . . . 0.0 116.927 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -74.48 114.33 12.75 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.14 1.97 . . . . 0.0 111.971 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -66.5 -28.33 68.48 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.746 -1.221 . . . . 0.0 114.045 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -155.85 97.06 1.8 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.556 1.542 . . . . 0.0 109.777 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.85 156.77 46.55 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mt -141.29 132.28 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.963 1.305 . . . . 0.0 109.347 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.58 126.57 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.322 1.449 . . . . 0.0 109.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -106.01 108.18 19.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.579 1.152 . . . . 0.0 110.419 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -77.56 76.38 4.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 110.392 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -172.37 2.31 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.847 0.859 . . . . 0.0 111.701 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -147.15 130.61 16.72 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.118 -1.614 . . . . 0.0 112.05 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.85 -23.91 61.4 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 mt -89.86 -15.5 32.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.45 122.26 73.52 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.81 1.644 . . . . 0.0 111.884 -173.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.7 -1.26 9.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.71 3.606 . . . . 0.0 113.04 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -88.43 -44.81 10.46 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.378 0.99 . . . . 0.0 109.741 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 p -61.93 -27.75 69.05 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -50.6 -38.96 48.55 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -71.98 -33.5 68.19 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.019 -0.425 . . . . 0.0 112.128 -168.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.1 tpt -64.0 -24.13 67.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.936 1.294 . . . . 0.0 113.266 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -65.17 -42.92 93.22 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.952 0.797 . . . . 0.0 110.927 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.95 -24.22 55.45 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.998 -1.064 . . . . 0.0 112.215 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.71 -51.9 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.023 0.929 . . . . 0.0 109.923 164.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.1 mt -60.14 -34.76 73.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.147 1.379 . . . . 0.0 112.619 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -58.21 -56.4 22.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.662 1.185 . . . . 0.0 111.972 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -64.5 -32.7 74.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.911 0.485 . . . . 0.0 111.414 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.21 -43.81 81.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.786 1.634 . . . . 0.0 112.979 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.5 57.32 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 120.635 -1.291 . . . . 0.0 111.684 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.44 -29.71 64.4 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 8.04 45.39 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.66 41.8 0.33 Allowed Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.786 1.634 . . . . 0.0 114.836 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.62 -22.19 16.4 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.62 3.547 . . . . 0.0 117.548 -157.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -60.69 -14.51 21.32 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -73.67 129.39 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.716 1.144 . . . . 0.0 111.289 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.8 98.59 11.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 110.797 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.6 mt -103.73 132.15 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.823 0.849 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 t -136.05 133.61 37.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.32 1.048 . . . . 0.0 110.38 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 m -86.12 155.16 20.89 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.622 -1.299 . . . . 0.0 111.531 164.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.3 t -143.72 128.86 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.642 1.577 . . . . 0.0 109.069 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.99 104.47 4.84 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.09 1.356 . . . . 0.0 110.564 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.8 p -56.19 -36.48 68.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.632 1.173 . . . . 0.0 113.468 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.57 -16.84 58.38 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -22.19 19.18 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.944 1.298 . . . . 0.0 112.88 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -116.72 52.92 1.11 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.878 1.671 . . . . 0.0 114.577 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.35 -18.07 26.74 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.7 2.267 . . . . 0.0 113.088 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -64.03 -38.14 89.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.368 0.985 . . . . 0.0 111.776 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.9 -51.99 22.78 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.607 1.163 . . . . 0.0 109.96 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.1 mtm -54.62 -32.18 58.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.095 0.958 . . . . 0.0 113.36 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -70.02 -19.95 63.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.012 1.325 . . . . 0.0 113.925 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -79.05 -39.92 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.769 0.713 . . . . 0.0 112.025 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.07 -22.45 21.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.69 15.77 28.32 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.786 1.66 . . . . 0.0 114.963 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -79.76 156.88 27.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.186 1.493 . . . . 0.0 111.626 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.03 -53.63 3.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.181 0.993 . . . . 0.0 112.654 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 168.67 17.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 129.101 2.96 . . . . 0.0 113.595 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.6 160.15 28.69 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 126.461 1.904 . . . . 0.0 111.912 -170.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -70.06 82.93 0.78 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.021 3.147 . . . . 0.0 112.516 -174.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.2 m -103.01 128.21 49.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.153 0.581 . . . . 0.0 112.363 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -94.22 120.6 34.69 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.541 1.137 . . . . 0.0 109.51 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.71 123.67 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 126.396 1.879 . . . . 0.0 108.1 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.0 120.03 40.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.887 0.875 . . . . 0.0 109.365 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.483 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 10.8 mm -108.23 121.65 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.187 1.395 . . . . 0.0 109.705 -168.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.483 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.37 122.34 47.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.833 1.653 . . . . 0.0 109.101 163.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.09 25.54 14.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 112.621 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.61 90.63 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -105.99 128.74 54.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.404 1.082 . . . . 0.0 108.924 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.07 109.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.416 0.686 . . . . 0.0 109.974 172.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.05 20.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.92 1.288 . . . . 0.0 113.494 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -163.8 152.07 13.26 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.364 1.866 . . . . 0.0 109.456 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.32 144.22 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.782 1.233 . . . . 0.0 110.971 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.17 31.78 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.431 1.493 . . . . 0.0 109.525 168.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -126.04 139.29 53.53 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 112.675 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.78 -154.43 17.02 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.931 1.729 . . . . 0.0 112.626 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.3 mm -118.2 143.83 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.31 1.444 . . . . 0.0 110.765 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -151.49 161.63 42.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.768 0.827 . . . . 0.0 112.418 161.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.38 149.54 86.7 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.021 0.929 . . . . 0.0 111.836 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.62 -31.47 79.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.003 2.469 . . . . 0.0 113.95 -168.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -52.99 -36.19 60.1 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -89.25 -29.99 18.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.757 0.708 . . . . 0.0 111.975 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.0 -30.25 70.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.664 0.786 . . . . 0.0 112.027 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -56.08 -44.24 78.79 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.766 0.712 . . . . 0.0 111.895 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.6 60.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.23 1.012 . . . . 0.0 112.521 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -70.89 -39.24 72.93 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 109.618 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.6 -36.7 73.66 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.046 1.338 . . . . 0.0 112.859 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.51 80.9 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.748 -1.22 . . . . 0.0 112.605 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -59.27 -20.65 56.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.964 0.905 . . . . 0.0 113.04 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.474 0.744 0 O-C-N 121.109 -0.994 . . . . 0.0 109.539 167.193 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtm . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -76.45 18.19 0.33 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.666 1.986 . . . . 0.0 114.052 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.72 147.98 3.54 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.03 2.932 . . . . 0.0 108.493 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mm -99.36 101.44 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.815 0.846 . . . . 0.0 109.085 -172.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.62 -179.65 7.79 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.552 1.941 . . . . 0.0 109.814 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -81.19 121.01 25.6 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.237 1.015 . . . . 0.0 111.35 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.8 mt -93.61 93.23 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.959 0.904 . . . . 0.0 108.881 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -50.51 -29.77 11.35 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.783 2.033 . . . . 0.0 113.122 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -71.24 -27.68 63.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.268 1.827 . . . . 0.0 112.545 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -165.97 89.6 0.42 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.281 1.432 . . . . 0.0 111.545 -170.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.68 165.14 28.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.389 2.276 . . . . 0.0 110.201 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.02 165.42 36.77 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.889 1.233 . . . . 0.0 112.51 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ptp -54.51 -30.86 54.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -171.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.52 -29.16 64.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -74.8 -41.35 60.14 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.74 -0.6 . . . . 0.0 110.557 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -72.93 -11.32 60.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.5 -17.3 27.31 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.03 1.332 . . . . 0.0 113.645 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -117.79 -16.19 5.98 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.59 171.0 13.24 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -91.4 -51.96 5.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.978 1.311 . . . . 0.0 113.166 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -160.46 109.05 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.879 1.672 . . . . 0.0 110.095 -171.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.09 158.82 44.56 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -134.64 130.14 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 0.0 109.064 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 t -119.09 125.7 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.563 1.545 . . . . 0.0 109.133 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.04 113.82 27.59 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.492 1.117 . . . . 0.0 111.311 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -78.94 69.38 5.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.48 170.38 16.66 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.843 0.857 . . . . 0.0 112.898 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -129.54 176.93 7.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.38 1.472 . . . . 0.0 111.21 168.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -100.51 -33.02 10.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.985 0.914 . . . . 0.0 113.437 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.38 -68.03 0.57 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.058 0.943 . . . . 0.0 112.934 -167.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.9 m -59.07 150.67 60.66 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.369 1.868 . . . . 0.0 114.138 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.14 -13.79 21.02 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.787 3.658 . . . . 0.0 113.19 171.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -66.83 -48.46 68.82 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 119.014 0.825 . . . . 0.0 111.969 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.0 p -61.14 -29.84 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.107 1.363 . . . . 0.0 113.597 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -55.82 -32.99 64.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.011 1.324 . . . . 0.0 112.557 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -62.94 -48.2 79.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.611 1.164 . . . . 0.0 111.73 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 mmt -63.24 -34.79 78.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.321 -0.862 . . . . 0.0 112.798 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.47 -36.37 73.62 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.267 0.939 . . . . 0.0 112.533 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -79.17 -38.67 35.35 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.29 -51.43 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.046 0.938 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.41 -33.86 75.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.793 1.237 . . . . 0.0 113.001 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.79 -49.96 70.85 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.302 0.641 . . . . 0.0 111.367 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -67.63 -32.14 72.63 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.395 -0.816 . . . . 0.0 112.885 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.36 -39.74 89.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.091 1.356 . . . . 0.0 111.966 170.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.32 -26.14 52.7 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.133 0.873 . . . . 0.0 112.343 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.6 65.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 10.11 34.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.168 1.387 . . . . 0.0 114.297 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.36 50.89 1.18 Allowed Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.102 1.761 . . . . 0.0 112.857 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.01 -14.4 44.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -168.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -78.64 -8.8 59.03 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -78.57 131.48 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.481 1.037 . . . . 0.0 108.357 165.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 96.16 6.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.07 0.548 . . . . 0.0 110.894 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.4 mt -103.84 131.48 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.2 p -148.21 172.76 13.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.918 0.887 . . . . 0.0 112.333 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -121.63 162.96 19.76 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.093 -1.004 . . . . 0.0 111.165 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.9 t -143.78 122.76 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.253 1.421 . . . . 0.0 107.712 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.0 103.92 0.51 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.325 1.45 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -58.76 -36.21 74.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.613 1.165 . . . . 0.0 112.35 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -75.1 -18.2 60.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.181 1.792 . . . . 0.0 113.893 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.07 -26.62 9.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.786 1.235 . . . . 0.0 113.527 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -126.86 51.94 7.19 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 126.171 1.788 . . . . 0.0 112.921 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -65.85 -14.98 47.17 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.746 2.297 . . . . 0.0 112.939 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -57.28 -23.39 48.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 113.182 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.98 -58.1 3.47 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 122.991 0.516 . . . . 0.0 110.682 166.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.8 mtm -57.22 -27.81 62.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.058 1.343 . . . . 0.0 113.748 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.56 -15.94 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.033 1.333 . . . . 0.0 112.726 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -87.29 -36.76 17.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.361 1.064 . . . . 0.0 111.296 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.97 -25.8 22.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 19.16 14.04 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.626 1.584 . . . . 0.0 115.264 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.97 145.85 28.32 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.409 1.605 . . . . 0.0 111.551 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -96.0 -62.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.668 0.787 . . . . 0.0 112.665 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -157.47 2.63 0.12 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.9 m -106.46 150.3 39.35 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 126.028 1.731 . . . . 0.0 112.769 -163.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.13 92.74 0.55 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.23 3.287 . . . . 0.0 109.553 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -105.08 131.98 51.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.865 0.866 . . . . 0.0 111.857 -172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -93.53 134.54 35.7 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.489 1.116 . . . . 0.0 110.247 168.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.97 131.25 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.623 1.569 . . . . 0.0 108.89 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -115.06 123.94 50.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.283 1.033 . . . . 0.0 110.282 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.8 mm -108.08 120.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.141 1.376 . . . . 0.0 108.822 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -113.94 122.93 48.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.298 1.839 . . . . 0.0 108.869 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.7 t70 63.62 20.93 12.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.395 1.078 . . . . 0.0 112.902 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.22 84.46 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.278 -0.888 . . . . 0.0 113.256 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -108.34 133.04 53.09 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.157 1.783 . . . . 0.0 109.285 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.88 107.59 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.41 -0.806 . . . . 0.0 109.508 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.6 -25.2 15.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -160.96 150.85 17.36 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.397 1.479 . . . . 0.0 110.932 -171.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.94 143.23 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.546 1.538 . . . . 0.0 110.529 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -153.38 140.34 19.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.222 1.009 . . . . 0.0 111.404 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.4 p -97.77 133.15 42.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.735 1.214 . . . . 0.0 111.756 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.78 -168.09 13.58 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.112 1.339 . . . . 0.0 113.343 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.18 143.37 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.368 1.467 . . . . 0.0 112.019 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -135.5 163.44 30.08 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.622 1.169 . . . . 0.0 111.947 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -68.14 161.37 68.88 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.629 1.172 . . . . 0.0 111.433 164.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.76 -27.1 15.23 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.965 1.777 . . . . 0.0 113.972 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -72.84 -34.0 66.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.489 1.495 . . . . 0.0 112.646 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.2 -26.33 56.03 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.372 -0.83 . . . . 0.0 112.457 171.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.52 -30.73 71.52 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.845 -1.159 . . . . 0.0 111.941 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -61.11 -44.84 96.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.877 0.762 . . . . 0.0 111.201 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.5 75.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.257 0.623 . . . . 0.0 112.352 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.08 76.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 0.0 109.87 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -45.48 94.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.317 1.047 . . . . 0.0 112.089 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.23 77.7 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.21 -0.931 . . . . 0.0 112.459 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.8 t -63.62 -13.26 40.61 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.857 1.663 . . . . 0.0 113.452 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.471 0.575 0 O-C-N 120.674 -1.266 . . . . 0.0 109.992 169.715 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptm . . . . . 0 CA--C 1.539 0.519 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 m 55.56 -121.97 1.77 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.579 1.551 . . . . 0.0 112.517 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.56 0.7 28.79 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -106.71 125.16 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.702 1.201 . . . . 0.0 110.319 -172.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.67 162.4 26.92 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.774 1.63 . . . . 0.0 111.312 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -82.94 112.79 20.04 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.56 1.144 . . . . 0.0 108.39 162.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.8 mt -127.29 123.92 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.095 1.358 . . . . 0.0 109.326 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.8 p -55.37 -33.07 63.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.556 1.542 . . . . 0.0 114.519 -170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.2 p -85.11 -13.24 50.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.898 1.679 . . . . 0.0 114.043 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -130.99 22.4 4.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.993 1.317 . . . . 0.0 113.16 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.88 164.25 35.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.52 1.528 . . . . 0.0 112.555 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.69 153.58 28.27 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.899 1.238 . . . . 0.0 111.487 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp -56.94 -26.77 60.16 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.18 -21.18 62.2 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.43 -39.22 19.23 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.615 -0.678 . . . . 0.0 110.57 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -78.62 -7.96 58.15 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.7 -13.47 45.31 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.87 7.86 1.09 Allowed Glycine 0 N--CA 1.478 1.469 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.23 173.06 9.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.971 1.386 . . . . 0.0 113.416 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -83.38 -61.03 1.95 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.113 0.965 . . . . 0.0 112.411 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -157.54 120.81 4.02 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.264 1.826 . . . . 0.0 110.18 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.21 159.19 43.62 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.7 mt -130.95 130.75 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.533 1.533 . . . . 0.0 109.153 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.4 t -120.73 121.97 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.685 1.594 . . . . 0.0 109.273 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.51 114.87 29.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.242 1.017 . . . . 0.0 111.824 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -79.78 72.3 6.48 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.905 1.282 . . . . 0.0 111.073 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.43 170.73 16.16 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.115 0.966 . . . . 0.0 113.147 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -142.13 168.55 19.47 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.741 1.216 . . . . 0.0 111.938 170.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -93.13 -39.65 10.93 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -165.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 mt -77.45 -39.92 45.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.45 0.7 . . . . 0.0 112.718 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.49 128.84 94.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.149 1.379 . . . . 0.0 111.693 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 -13.74 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 124.461 3.44 . . . . 0.0 112.94 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -73.9 -45.65 49.38 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 120.167 1.349 . . . . 0.0 111.918 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.5 m -53.67 -35.81 61.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.82 1.248 . . . . 0.0 113.339 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.5 -31.93 68.33 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.512 1.525 . . . . 0.0 112.889 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -72.47 -44.07 62.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.668 0.787 . . . . 0.0 111.187 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.7 tpt -58.88 -38.85 79.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.483 1.513 . . . . 0.0 112.566 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -53.67 -41.24 66.63 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.514 0.725 . . . . 0.0 112.168 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -72.29 -23.53 61.2 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.928 -1.107 . . . . 0.0 113.693 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -69.65 -45.96 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.109 0.963 . . . . 0.0 109.748 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.8 -37.61 82.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.089 0.955 . . . . 0.0 111.828 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.68 -52.24 66.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.089 0.956 . . . . 0.0 111.948 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.46 -30.03 68.8 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.478 0.711 . . . . 0.0 112.817 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.95 -34.66 76.99 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.922 0.889 . . . . 0.0 111.833 170.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -25.59 61.2 Favored Glycine 0 N--CA 1.471 1.032 0 O-C-N 121.064 -1.023 . . . . 0.0 113.632 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.55 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -171.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 7.41 10.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.209 1.403 . . . . 0.0 114.52 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.95 47.89 2.84 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.86 1.664 . . . . 0.0 113.529 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.75 -16.32 54.7 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.726 2.951 . . . . 0.0 114.431 -169.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -76.81 -6.66 53.24 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -85.1 127.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 162.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.79 103.77 11.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 0.0 109.711 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.6 mt -108.04 128.79 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.056 -1.028 . . . . 0.0 109.367 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -146.98 167.38 24.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.82 165.51 12.99 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.855 -1.153 . . . . 0.0 111.741 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.07 121.46 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.932 1.293 . . . . 0.0 108.33 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.75 102.53 0.35 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.065 1.346 . . . . 0.0 110.42 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.6 p -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.362 0.665 . . . . 0.0 112.421 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.72 -26.69 65.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 113.362 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.16 -27.76 8.99 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.981 1.312 . . . . 0.0 113.661 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -116.26 65.22 2.91 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 127.493 2.317 . . . . 0.0 110.724 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.48 -22.51 33.27 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.516 2.144 . . . . 0.0 111.963 168.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.9 -24.53 66.06 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.639 1.176 . . . . 0.0 113.204 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.48 -59.99 2.48 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.056 0.942 . . . . 0.0 110.052 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.5 mtm -58.51 -25.85 62.83 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 113.371 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -65.7 -24.54 67.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.199 1.0 . . . . 0.0 112.35 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.3 -36.3 17.96 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.533 1.133 . . . . 0.0 111.37 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.92 -24.17 22.53 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.22 13.73 32.62 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.746 1.641 . . . . 0.0 115.161 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.08 146.87 36.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.371 1.585 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.85 -61.81 1.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.602 0.761 . . . . 0.0 112.195 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.98 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.512 1.925 . . . . 0.0 111.614 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.72 150.6 31.0 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.988 1.315 . . . . 0.0 112.457 -166.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.29 85.75 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.284 3.323 . . . . 0.0 109.911 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -102.62 129.76 49.29 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.36 0.664 . . . . 0.0 111.341 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 mp -93.63 126.48 38.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.048 0.939 . . . . 0.0 108.913 164.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.63 129.4 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.122 1.769 . . . . 0.0 108.277 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.59 124.47 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 mm -109.21 122.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.828 1.251 . . . . 0.0 109.179 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -117.75 126.46 52.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.567 1.547 . . . . 0.0 108.574 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 63.28 17.79 10.51 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.429 1.091 . . . . 0.0 112.965 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.07 11.22 81.55 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.282 0.944 . . . . 0.0 113.809 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -109.58 138.5 45.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.568 1.947 . . . . 0.0 109.807 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.74 108.37 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.84 -25.49 15.02 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -160.12 154.07 23.04 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.092 1.757 . . . . 0.0 110.342 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.88 143.85 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.849 1.26 . . . . 0.0 110.19 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.9 143.64 27.52 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.344 1.058 . . . . 0.0 110.87 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 t -110.91 132.68 54.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.859 1.264 . . . . 0.0 110.83 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.46 -152.83 20.36 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.721 1.153 . . . . 0.0 114.324 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.39 146.53 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.688 1.995 . . . . 0.0 110.371 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 ptp -153.22 -169.55 3.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.489 1.516 . . . . 0.0 111.011 169.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.9 163.86 40.71 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.052 1.341 . . . . 0.0 111.072 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.54 -23.33 31.91 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.737 1.625 . . . . 0.0 114.432 -156.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.93 -30.49 69.82 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.715 1.143 . . . . 0.0 113.4 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.32 -35.72 63.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.085 0.954 . . . . 0.0 111.251 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.5 tp -64.94 -24.95 67.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.164 0.585 . . . . 0.0 112.469 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -64.39 -43.78 93.37 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.946 0.794 . . . . 0.0 111.632 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.3 84.06 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.485 0.584 . . . . 0.0 111.611 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.57 -44.25 91.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.523 0.729 . . . . 0.0 111.272 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -45.6 93.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.817 0.847 . . . . 0.0 112.22 170.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.5 74.17 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.009 0.822 . . . . 0.0 111.892 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.4 m -68.31 -5.27 17.72 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.654 1.582 . . . . 0.0 114.564 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.479 1.004 0 O-C-N 121.054 -1.029 . . . . 0.0 110.798 171.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m -72.93 132.78 43.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.479 1.112 . . . . 0.0 112.157 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.77 104.47 2.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.899 1.28 . . . . 0.0 108.856 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm -86.25 80.39 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.563 0.697 . . . . 0.0 110.798 -165.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -145.48 164.62 31.04 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 126.204 1.802 . . . . 0.0 110.541 174.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -51.93 115.47 1.7 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.806 2.442 . . . . 0.0 112.007 164.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.6 mt -108.06 124.75 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.863 1.265 . . . . 0.0 108.015 166.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.8 p -84.9 -24.13 28.6 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.222 1.409 . . . . 0.0 113.413 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 p -94.46 -76.2 0.49 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.837 1.655 . . . . 0.0 111.813 -167.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.77 -19.27 63.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.233 1.013 . . . . 0.0 113.361 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.63 44.62 0.54 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.63 1.172 . . . . 0.0 113.247 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.69 148.61 18.64 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.329 1.442 . . . . 0.0 110.388 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp -55.92 -30.25 61.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.85 -27.57 67.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -70.61 -39.01 74.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.802 1.183 . . . . 0.0 110.658 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.19 -9.48 58.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 113.077 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.65 -15.66 32.21 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.221 1.408 . . . . 0.0 113.395 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.51 -13.44 4.26 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.89 174.06 9.77 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -96.52 -54.68 3.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -149.5 124.25 9.85 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.006 1.323 . . . . 0.0 109.654 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.27 160.12 43.94 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -140.0 132.11 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 108.436 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 129.66 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.689 1.196 . . . . 0.0 109.288 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -109.07 117.44 34.17 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.807 0.843 . . . . 0.0 112.032 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.92 71.82 8.96 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.844 1.258 . . . . 0.0 110.622 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -174.23 1.05 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.85 0.86 . . . . 0.0 113.271 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -138.73 141.3 38.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.803 -1.186 . . . . 0.0 112.177 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -61.97 -32.18 72.6 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 113.699 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.6 mt -81.68 -83.9 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.901 1.28 . . . . 0.0 111.765 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -44.19 118.98 3.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 127.901 2.48 . . . . 0.0 114.235 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.45 -17.57 23.67 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.042 3.161 . . . . 0.0 113.611 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -63.72 -44.21 94.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 119.037 0.835 . . . . 0.0 111.663 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.3 p -66.91 -27.02 67.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.61 -28.03 69.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.735 1.214 . . . . 0.0 112.515 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -64.63 -39.21 93.3 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.75 0.82 . . . . 0.0 112.502 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.2 tpp -62.28 -35.72 79.87 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.026 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -50.61 -42.01 55.52 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.476 -0.765 . . . . 0.0 112.863 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -84.11 -12.38 55.12 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.278 1.031 . . . . 0.0 113.255 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -78.58 -47.32 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.274 1.43 . . . . 0.0 109.935 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.57 -37.01 74.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.522 1.529 . . . . 0.0 112.65 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.39 -53.86 52.45 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.886 0.874 . . . . 0.0 111.697 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -64.97 -30.68 71.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.629 0.772 . . . . 0.0 112.801 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -70.96 -41.98 70.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.417 1.087 . . . . 0.0 111.379 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.96 -29.75 30.72 Favored Glycine 0 N--CA 1.47 0.943 0 C-N-CA 124.649 1.118 . . . . 0.0 113.206 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.72 67.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 9.5 38.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.686 1.595 . . . . 0.0 114.179 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.93 65.34 73.85 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 125.678 1.591 . . . . 0.0 112.357 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.42 -20.77 71.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.168 2.579 . . . . 0.0 115.144 -171.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -83.42 -6.89 59.6 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 133.04 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.671 1.189 . . . . 0.0 109.442 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.59 14.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.193 0.597 . . . . 0.0 110.682 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -108.24 130.65 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.943 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -151.36 177.56 10.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.193 1.397 . . . . 0.0 112.803 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -124.27 167.04 14.86 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.503 -1.373 . . . . 0.0 113.227 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -149.16 135.69 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.719 2.008 . . . . 0.0 108.272 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.04 119.84 23.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.091 0.948 . . . . 0.0 112.164 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.6 p -61.0 -28.0 68.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.542 1.537 . . . . 0.0 114.12 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -87.31 -34.46 18.86 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.528 0.731 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 -22.95 27.07 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.577 1.151 . . . . 0.0 113.945 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -121.67 42.54 0.59 Allowed Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.654 1.582 . . . . 0.0 114.374 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.01 -19.56 45.55 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.668 2.245 . . . . 0.0 113.052 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.05 -22.67 65.93 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.053 0.941 . . . . 0.0 113.121 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.8 -54.91 5.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.765 0.711 . . . . 0.0 110.415 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 mtm -56.19 -28.88 59.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.664 1.186 . . . . 0.0 113.63 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -68.95 -18.91 64.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.022 1.329 . . . . 0.0 113.004 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.93 -34.65 20.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.435 1.094 . . . . 0.0 110.798 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.76 -25.51 23.37 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.46 15.58 22.67 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.82 1.676 . . . . 0.0 115.296 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.38 144.61 30.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.884 1.842 . . . . 0.0 111.151 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -89.1 -56.52 3.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.983 0.913 . . . . 0.0 112.668 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -169.83 7.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -167.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -100.26 149.71 36.29 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.011 1.724 . . . . 0.0 112.959 -165.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.8 95.22 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.882 3.055 . . . . 0.0 110.292 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.2 m -114.89 130.39 56.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.768 0.827 . . . . 0.0 112.778 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.95 134.67 33.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.725 1.61 . . . . 0.0 109.825 168.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.5 132.3 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.755 1.622 . . . . 0.0 109.216 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -116.93 127.67 54.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.144 0.978 . . . . 0.0 111.016 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -112.62 122.52 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 0.0 109.106 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.6 124.23 49.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.277 1.831 . . . . 0.0 109.004 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 62.04 20.19 11.41 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.729 1.15 . . . . 0.0 113.075 171.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.1 78.16 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.279 0.942 . . . . 0.0 113.477 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -108.07 134.3 51.14 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.317 1.847 . . . . 0.0 109.464 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.37 103.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.94 12.75 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.76 163.47 39.21 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.812 1.245 . . . . 0.0 111.806 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.6 146.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.161 1.785 . . . . 0.0 110.303 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.13 136.84 14.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.157 0.983 . . . . 0.0 111.01 168.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 m -101.79 138.72 38.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 0.0 111.656 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.24 -157.2 15.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.918 1.246 . . . . 0.0 113.213 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.39 142.34 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.526 1.53 . . . . 0.0 111.333 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.2 mtm -139.94 163.16 33.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.234 1.413 . . . . 0.0 111.997 165.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -77.44 161.5 72.17 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.887 1.675 . . . . 0.0 111.742 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.19 -24.97 19.46 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.328 2.019 . . . . 0.0 113.671 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -77.2 -33.83 56.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.461 1.482 . . . . 0.0 112.828 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.75 -30.33 56.51 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.648 0.779 . . . . 0.0 112.374 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.03 -28.2 66.19 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.35 -0.844 . . . . 0.0 112.791 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -62.26 -43.11 99.57 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.759 0.709 . . . . 0.0 111.895 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.25 77.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.447 0.699 . . . . 0.0 111.532 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.13 -48.52 75.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.971 0.908 . . . . 0.0 110.827 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -45.49 94.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.26 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.03 74.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.254 -0.904 . . . . 0.0 111.322 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.7 m -60.49 -31.78 70.81 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.479 1.022 0 CA-C-N 119.738 1.154 . . . . 0.0 110.687 176.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 ptm . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.5 p -159.11 178.17 10.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.54 1.536 . . . . 0.0 112.595 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.61 154.74 25.06 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.62 1.968 . . . . 0.0 110.062 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -98.61 119.74 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.918 1.287 . . . . 0.0 109.577 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -141.85 168.12 20.51 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.306 1.842 . . . . 0.0 109.713 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -73.69 120.48 19.35 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 156.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.5 mt -107.93 97.98 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.469 0.708 . . . . 0.0 109.265 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 p -48.32 -32.79 7.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.423 2.289 . . . . 0.0 114.941 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.7 p -83.4 -9.32 59.1 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.485 1.514 . . . . 0.0 114.422 -174.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.96 -19.08 0.13 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.55 50.17 1.1 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.863 1.665 . . . . 0.0 112.935 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.82 167.79 17.08 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 126.229 1.871 . . . . 0.0 112.873 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -53.97 -30.67 47.9 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.339 1.456 . . . . 0.0 113.894 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.04 62.94 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -86.77 -38.54 16.8 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.976 0.807 . . . . 0.0 111.121 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.93 -12.13 60.56 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.276 -0.89 . . . . 0.0 113.177 -171.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -89.81 -10.18 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.267 1.027 . . . . 0.0 113.617 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.26 -4.03 1.13 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.77 172.21 7.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.538 1.669 . . . . 0.0 114.074 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -82.53 -59.94 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.306 1.043 . . . . 0.0 112.912 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -160.08 115.22 2.33 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.79 1.636 . . . . 0.0 110.166 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.77 44.29 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -131.23 128.1 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 108.168 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.91 117.47 54.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.715 1.606 . . . . 0.0 108.773 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.29 120.68 38.1 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.564 1.146 . . . . 0.0 110.683 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.23 82.06 7.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.109 -1.619 . . . . 0.0 109.848 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 176.72 8.66 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -139.51 137.96 35.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.108 1.363 . . . . 0.0 109.769 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -83.25 -27.22 30.06 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -167.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 mt -76.62 -33.74 58.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.392 1.477 . . . . 0.0 112.925 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -73.83 130.5 83.19 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 126.06 1.744 . . . . 0.0 111.738 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.13 -14.74 18.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.494 3.462 . . . . 0.0 113.3 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -76.04 -47.66 23.88 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.816 1.189 . . . . 0.0 110.695 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.4 m -52.84 -35.56 57.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.031 1.732 . . . . 0.0 113.889 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -55.39 -33.34 63.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.038 1.335 . . . . 0.0 113.135 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.48 -40.72 89.48 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.233 1.013 . . . . 0.0 112.63 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.49 68.9 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.437 -0.79 . . . . 0.0 112.989 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -63.01 -44.24 96.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.667 0.667 . . . . 0.0 111.496 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -63.78 -38.94 92.97 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.77 -49.08 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.582 1.553 . . . . 0.0 110.434 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 mt -64.58 -35.24 80.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.32 1.048 . . . . 0.0 112.772 175.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.23 -50.08 74.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.108 0.963 . . . . 0.0 111.753 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.28 -31.6 72.5 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.099 -1.001 . . . . 0.0 112.584 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.97 -32.52 70.79 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.411 1.084 . . . . 0.0 112.596 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.84 -27.44 38.07 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 120.831 -1.168 . . . . 0.0 113.417 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.81 55.11 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 10.18 12.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.18 72.52 81.88 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.555 1.542 . . . . 0.0 111.556 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.45 -21.05 60.94 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.352 2.702 . . . . 0.0 115.534 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -83.06 -5.21 59.02 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -166.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.9 p -106.83 132.38 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.113 1.365 . . . . 0.0 111.036 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.5 102.52 13.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.171 0.988 . . . . 0.0 110.515 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mt -100.21 130.81 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.312 -0.867 . . . . 0.0 109.913 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -150.38 168.61 23.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.25 1.02 . . . . 0.0 112.028 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -118.45 -179.58 3.83 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.909 -1.119 . . . . 0.0 112.591 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.6 t -149.79 128.34 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 128.102 2.561 . . . . 0.0 108.024 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.19 97.66 0.27 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.584 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.3 p -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.287 -0.883 . . . . 0.0 112.323 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.39 -15.74 62.38 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.644 1.978 . . . . 0.0 114.19 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.84 -39.07 3.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.764 1.225 . . . . 0.0 113.522 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -115.39 54.23 0.91 Allowed Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.843 1.657 . . . . 0.0 113.78 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.0 -13.36 33.97 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -58.69 -24.48 61.42 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.733 1.152 . . . . 0.0 112.954 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.24 -58.54 3.44 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.339 0.518 . . . . 0.0 110.973 165.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.3 mtm -54.74 -33.03 60.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.028 1.331 . . . . 0.0 113.002 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -67.29 -18.82 65.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.709 1.603 . . . . 0.0 114.109 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -77.69 -40.51 41.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.968 0.803 . . . . 0.0 111.644 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.16 -23.93 24.66 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 12.75 28.61 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.108 1.813 . . . . 0.0 115.285 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -81.65 154.14 26.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.758 1.779 . . . . 0.0 111.531 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -102.33 -61.11 1.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.097 0.959 . . . . 0.0 112.152 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -162.69 2.31 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -98.68 155.4 36.76 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 126.598 1.959 . . . . 0.0 112.833 -165.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.7 88.58 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.44 3.427 . . . . 0.0 111.402 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.0 m -104.03 130.53 51.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.672 0.789 . . . . 0.0 110.862 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.06 121.47 41.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 0.0 109.816 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.52 130.86 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.641 1.976 . . . . 0.0 108.546 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -113.12 121.87 45.83 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.1 mm -109.27 116.15 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.486 1.114 . . . . 0.0 108.903 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.85 123.32 49.38 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.375 1.47 . . . . 0.0 107.957 171.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.38 19.76 11.91 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.497 1.119 . . . . 0.0 113.178 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.25 84.44 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.058 -1.026 . . . . 0.0 113.263 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -108.21 133.56 52.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.963 1.705 . . . . 0.0 109.025 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.35 107.47 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.07 -19.92 14.02 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -160.7 150.28 17.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.524 1.53 . . . . 0.0 110.77 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.45 145.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.428 1.491 . . . . 0.0 109.971 169.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.09 152.37 34.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.427 1.491 . . . . 0.0 109.292 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 t -128.95 138.36 51.93 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.926 -1.109 . . . . 0.0 112.589 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.73 -161.69 19.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.002 1.763 . . . . 0.0 112.755 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.3 mm -111.07 143.6 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.691 1.196 . . . . 0.0 111.069 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 67.4 mtm -137.53 158.17 44.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.902 1.281 . . . . 0.0 111.78 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.52 147.92 76.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.054 0.942 . . . . 0.0 111.176 164.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.3 -27.32 63.7 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.931 2.421 . . . . 0.0 113.212 -168.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.85 -29.51 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.56 -24.98 15.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.373 1.069 . . . . 0.0 112.47 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.92 -28.41 68.9 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.435 -0.791 . . . . 0.0 111.998 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -55.56 -50.38 70.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.96 -35.38 74.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.503 0.721 . . . . 0.0 111.852 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.63 -44.7 81.28 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.627 0.771 . . . . 0.0 110.517 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -47.08 85.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 112.151 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.85 82.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.265 0.939 . . . . 0.0 112.077 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 m -58.27 -25.51 61.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.451 1.5 . . . . 0.0 113.842 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.133 0.973 . . . . 0.0 111.196 177.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 p -84.76 -28.8 25.97 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.48 143.66 0.05 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 128.923 2.889 . . . . 0.0 113.959 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mm -122.05 140.25 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.577 1.551 . . . . 0.0 110.291 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -160.35 168.61 24.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.527 1.531 . . . . 0.0 111.572 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -84.28 116.08 22.8 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.873 1.269 . . . . 0.0 109.254 160.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -118.33 76.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.763 1.225 . . . . 0.0 108.928 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -52.88 -25.75 12.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.198 2.199 . . . . 0.0 113.95 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -54.92 -28.46 51.02 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.647 1.979 . . . . 0.0 112.918 172.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.06 -31.05 1.3 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.752 1.221 . . . . 0.0 114.224 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.83 112.27 9.79 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.932 1.242 . . . . 0.0 111.784 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.39 162.77 26.6 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.937 1.732 . . . . 0.0 111.831 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -50.82 -41.58 57.63 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.725 1.21 . . . . 0.0 114.01 -171.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.93 63.23 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -74.49 -39.97 62.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.811 0.732 . . . . 0.0 110.596 169.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.43 -13.4 62.11 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.53 -14.06 41.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 0.0 113.848 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.75 -8.84 1.85 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 117.087 1.595 . . . . 0.0 117.087 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.33 176.74 4.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.219 1.51 . . . . 0.0 114.437 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 p -92.15 -55.96 3.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.805 1.242 . . . . 0.0 113.713 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -159.21 110.22 2.04 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.273 1.829 . . . . 0.0 109.111 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.38 155.27 38.31 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.31 128.76 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.862 1.265 . . . . 0.0 108.682 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 t -114.75 126.14 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.131 1.372 . . . . 0.0 109.285 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -106.87 113.67 27.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.891 0.876 . . . . 0.0 111.604 173.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -77.82 74.15 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.488 1.915 . . . . 0.0 111.022 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.62 -179.28 2.08 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.984 -1.073 . . . . 0.0 112.517 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.19 162.02 32.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.229 1.411 . . . . 0.0 111.942 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -73.9 -38.82 64.24 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.323 -0.861 . . . . 0.0 113.111 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.3 mt -98.83 -32.44 11.34 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.6 123.08 72.49 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.083 1.353 . . . . 0.0 113.68 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -82.47 -2.37 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.489 3.46 . . . . 0.0 112.897 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -89.14 -40.78 12.68 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 119.434 1.015 . . . . 0.0 110.022 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 p -64.37 -26.99 68.71 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.0 -37.59 45.93 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -74.33 -34.45 63.44 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.355 0.662 . . . . 0.0 111.965 -166.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -28.75 69.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.501 -0.762 . . . . 0.0 112.777 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.17 -37.92 84.56 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.193 1.36 . . . . 0.0 112.186 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -34.89 69.82 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.935 -1.103 . . . . 0.0 112.053 173.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.36 -48.34 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.772 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.8 mt -62.0 -42.25 98.95 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.767 1.627 . . . . 0.0 112.319 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.57 -46.95 83.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.305 1.042 . . . . 0.0 111.91 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.26 -27.28 65.3 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.863 -1.148 . . . . 0.0 113.157 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.35 -36.9 71.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.674 0.79 . . . . 0.0 112.059 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.94 -19.94 69.01 Favored Glycine 0 N--CA 1.469 0.864 0 CA-C-N 119.212 0.915 . . . . 0.0 113.301 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -33.7 60.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.668 1.587 . . . . 0.0 114.629 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.72 6.59 11.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.267 1.427 . . . . 0.0 114.276 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.03 79.0 25.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.641 1.576 . . . . 0.0 110.433 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.04 -13.57 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.216 2.611 . . . . 0.0 114.287 -168.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -90.15 -6.98 54.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -168.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 p -99.58 131.92 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.614 1.565 . . . . 0.0 110.181 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.91 100.7 11.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 110.138 174.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.34 131.58 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.437 -0.79 . . . . 0.0 109.967 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.2 p -140.33 160.11 40.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.227 1.013 . . . . 0.0 111.809 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -106.83 165.81 11.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.198 -0.939 . . . . 0.0 110.51 165.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -162.67 152.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.198 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.06 120.16 37.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.327 0.967 . . . . 0.0 112.474 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.9 p -57.83 -36.26 72.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.017 1.327 . . . . 0.0 113.238 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.32 -25.97 42.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 112.051 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.01 -16.29 30.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.936 1.294 . . . . 0.0 113.797 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmt-85 -119.97 48.77 1.27 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 125.624 1.57 . . . . 0.0 113.868 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.85 -27.93 67.44 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.818 1.679 . . . . 0.0 111.75 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.9 -23.58 67.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.661 1.185 . . . . 0.0 113.407 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.75 -56.23 4.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.622 1.169 . . . . 0.0 109.366 170.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.3 mtm -58.01 -28.43 64.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.766 1.226 . . . . 0.0 113.267 -172.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -57.37 -30.46 64.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.965 1.706 . . . . 0.0 113.22 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -88.28 -32.55 18.43 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.417 1.087 . . . . 0.0 111.588 -172.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.4 -24.1 22.0 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.392 0.677 . . . . 0.0 112.799 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.75 15.7 30.83 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.736 1.636 . . . . 0.0 114.992 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -77.14 153.03 34.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.896 1.348 . . . . 0.0 110.797 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 -43.77 4.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.636 1.174 . . . . 0.0 112.729 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -179.82 -3.12 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.87 2.868 . . . . 0.0 116.364 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.89 149.44 85.57 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-N 120.213 1.369 . . . . 0.0 113.455 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.06 81.25 2.6 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.045 3.163 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.56 135.67 33.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -165.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.46 125.26 36.15 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.16 121.98 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.007 1.723 . . . . 0.0 108.84 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -106.69 125.79 51.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.328 1.051 . . . . 0.0 110.582 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.72 119.58 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.27 1.428 . . . . 0.0 108.785 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.32 128.12 55.85 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.967 1.307 . . . . 0.0 108.335 167.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.98 19.18 11.46 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.899 1.28 . . . . 0.0 113.1 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.1 12.51 82.37 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.16 -0.963 . . . . 0.0 113.153 -174.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -107.45 134.47 50.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.341 1.856 . . . . 0.0 109.576 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.71 104.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 171.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.83 -26.71 13.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -167.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -162.11 153.14 17.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.6 1.56 . . . . 0.0 110.951 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.67 146.85 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.738 1.215 . . . . 0.0 111.426 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.81 147.0 23.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.243 1.017 . . . . 0.0 112.198 168.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -96.82 -4.49 40.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -160.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.43 17.93 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-O 122.498 1.054 . . . . 0.0 115.457 -165.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.0 mm -106.11 146.37 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.083 1.753 . . . . 0.0 109.474 165.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.0 ptp -147.75 172.15 14.56 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 167.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -76.76 166.04 47.86 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.551 1.54 . . . . 0.0 112.26 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -34.7 5.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.633 1.555 . . . . 0.0 114.176 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.98 -34.18 77.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.129 1.786 . . . . 0.0 112.589 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -79.63 -21.85 44.35 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.397 0.679 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.22 -30.31 71.19 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.286 -0.884 . . . . 0.0 112.446 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -39.29 94.3 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.356 0.98 . . . . 0.0 111.451 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.19 81.72 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.123 0.874 . . . . 0.0 112.458 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.84 -47.78 79.4 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 110.735 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.48 -45.22 94.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.322 1.049 . . . . 0.0 112.842 173.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.04 80.28 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.265 -0.897 . . . . 0.0 111.956 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 t -68.92 -4.78 17.84 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.706 1.203 . . . . 0.0 114.072 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.477 0.92 0 O-C-N 120.98 -1.075 . . . . 0.0 110.22 167.273 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -61.74 -10.48 8.89 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.5 1.52 . . . . 0.0 114.964 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.29 -16.03 63.13 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 168.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.95 108.4 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.271 1.828 . . . . 0.0 107.78 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -167.87 178.6 5.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.1 1.76 . . . . 0.0 111.038 -163.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -80.14 110.66 15.77 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 157.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -78.13 -41.54 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.073 0.549 . . . . 0.0 111.684 -165.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.2 p -127.88 -100.19 0.36 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.079 1.752 . . . . 0.0 110.536 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -144.47 -53.46 0.32 Allowed 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 127.472 2.309 . . . . 0.0 111.957 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.07 116.56 18.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.015 0.926 . . . . 0.0 112.715 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.72 36.04 0.63 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.834 2.054 . . . . 0.0 110.856 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.75 167.13 25.44 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.703 1.62 . . . . 0.0 112.077 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -56.09 -33.64 65.25 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.49 67.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -68.31 -41.75 80.44 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.561 -0.712 . . . . 0.0 110.209 170.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -75.41 -6.48 50.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 0.0 113.327 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.88 -18.69 23.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.276 1.43 . . . . 0.0 113.111 170.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.24 -14.31 20.76 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.62 166.79 20.77 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -82.94 -61.24 1.92 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.282 1.033 . . . . 0.0 112.104 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -151.78 128.62 10.94 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.797 1.639 . . . . 0.0 109.771 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.14 164.45 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mt -139.41 124.89 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 107.664 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.56 125.24 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.607 1.563 . . . . 0.0 108.809 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -107.42 110.16 22.06 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.455 1.102 . . . . 0.0 111.584 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -80.0 87.66 5.39 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.09 0.956 . . . . 0.0 110.157 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 -167.89 1.67 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.773 1.229 . . . . 0.0 112.286 173.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -144.41 157.13 44.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.888 -1.133 . . . . 0.0 112.025 153.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -31.08 -82.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 129.117 2.967 . . . . 0.0 116.387 -174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.0 mt -91.53 -38.19 12.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -167.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.3 m -49.25 119.8 9.32 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.894 1.678 . . . . 0.0 112.773 -169.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.84 -22.44 31.72 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.209 3.272 . . . . 0.0 115.077 -161.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -63.09 -44.66 95.1 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 118.849 0.749 . . . . 0.0 112.128 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.8 m -67.47 -31.47 71.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.648 1.179 . . . . 0.0 112.891 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.26 -25.81 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.539 1.136 . . . . 0.0 113.677 -171.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -64.28 -42.81 96.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.848 0.859 . . . . 0.0 112.04 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 tpt -63.78 -28.65 70.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.437 1.095 . . . . 0.0 112.684 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.28 -39.9 84.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.698 0.799 . . . . 0.0 111.352 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -72.93 -29.08 62.84 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.492 -0.755 . . . . 0.0 112.816 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.2 t -67.9 -45.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.258 1.023 . . . . 0.0 109.646 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.45 -37.01 84.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.225 1.41 . . . . 0.0 111.951 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.78 -53.3 59.89 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.224 0.92 . . . . 0.0 111.846 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -64.1 -32.54 74.14 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.396 -0.815 . . . . 0.0 112.758 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.39 -35.6 73.57 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.965 0.906 . . . . 0.0 111.833 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.29 -24.12 61.79 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 119.408 1.004 . . . . 0.0 113.319 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.72 49.02 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.06 9.14 5.26 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.551 1.54 . . . . 0.0 114.502 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.3 61.18 40.89 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 125.657 1.583 . . . . 0.0 112.12 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.34 -15.41 34.91 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.335 2.69 . . . . 0.0 114.431 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -80.81 -9.53 59.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -99.98 137.69 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.187 1.395 . . . . 0.0 110.302 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.71 101.68 11.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.114 0.565 . . . . 0.0 110.443 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.5 mt -99.37 131.84 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.975 0.91 . . . . 0.0 109.218 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.1 p -149.45 170.45 18.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.03 0.932 . . . . 0.0 112.527 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.2 p -133.58 158.69 42.55 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.978 -1.076 . . . . 0.0 111.573 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.46 123.27 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.814 1.246 . . . . 0.0 108.133 -167.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.99 115.11 10.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.041 0.924 . . . . 0.0 109.886 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -58.37 -25.29 61.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.879 1.272 . . . . 0.0 113.36 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.22 -20.65 34.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.703 0.801 . . . . 0.0 112.281 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.74 -35.23 15.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.367 1.067 . . . . 0.0 112.902 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -126.54 61.17 42.53 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.971 1.709 . . . . 0.0 112.803 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.43 -23.7 27.43 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.244 2.63 . . . . 0.0 112.675 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.0 -23.19 67.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.148 0.979 . . . . 0.0 113.169 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.14 -58.15 4.12 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.56 1.144 . . . . 0.0 109.543 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 mtm -60.71 -22.89 64.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 113.512 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -65.9 -23.46 66.64 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.641 1.176 . . . . 0.0 112.552 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.61 -38.19 16.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.585 1.154 . . . . 0.0 111.369 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.66 -23.78 25.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.21 8.57 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.098 1.332 . . . . 0.0 114.506 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.62 169.44 18.0 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.813 1.306 . . . . 0.0 112.753 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.0 11.15 8.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 112.726 -162.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.31 59.93 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.073 2.549 . . . . 0.0 109.257 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -150.03 154.07 36.37 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 127.672 2.389 . . . . 0.0 109.858 -163.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.57 96.18 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.682 2.921 . . . . 0.0 110.648 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -113.47 122.11 46.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 111.833 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.34 125.26 34.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.885 1.274 . . . . 0.0 109.135 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.06 127.65 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -111.13 128.97 56.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.762 0.825 . . . . 0.0 110.948 -174.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.3 mm -112.39 114.11 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.409 1.084 . . . . 0.0 108.883 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.97 121.65 45.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.933 1.293 . . . . 0.0 108.242 171.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 66.75 21.46 10.53 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.006 1.323 . . . . 0.0 112.326 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.53 10.33 84.58 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.428 -173.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -107.68 132.81 52.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.422 1.489 . . . . 0.0 110.194 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.17 101.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.392 1.077 . . . . 0.0 109.187 166.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 -21.18 13.43 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.74 152.64 19.89 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.196 1.798 . . . . 0.0 110.465 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.47 144.08 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.728 1.211 . . . . 0.0 111.275 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.24 146.56 22.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.702 1.201 . . . . 0.0 111.214 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -107.85 138.78 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.02 0.928 . . . . 0.0 111.585 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.98 -161.0 21.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.997 1.76 . . . . 0.0 112.767 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 mm -121.82 145.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.877 1.671 . . . . 0.0 110.733 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.6 ptp -150.63 164.8 35.17 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 163.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -70.08 158.97 86.08 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.312 1.445 . . . . 0.0 112.396 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.32 -26.42 24.94 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.855 2.37 . . . . 0.0 114.401 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -75.33 -30.3 60.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.634 1.561 . . . . 0.0 113.143 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -76.29 -33.2 59.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.11 0.964 . . . . 0.0 111.799 169.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.87 -27.08 68.54 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.841 0.857 . . . . 0.0 111.975 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -58.75 -47.53 84.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.856 0.753 . . . . 0.0 111.923 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.75 0.82 . . . . 0.0 111.38 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.02 -49.76 74.75 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.318 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -46.94 86.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.683 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.68 91.45 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.032 0.833 . . . . 0.0 112.375 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.8 t -60.02 -24.72 64.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.506 1.122 . . . . 0.0 113.401 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.479 0.994 0 C-N-CA 124.325 1.05 . . . . 0.0 111.136 175.585 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.2 p -158.36 -114.1 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.686 1.594 . . . . 0.0 111.527 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.76 142.26 7.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.048 1.739 . . . . 0.0 111.37 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.94 123.75 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.078 1.351 . . . . 0.0 108.828 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -162.67 161.88 26.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.146 1.379 . . . . 0.0 111.217 -169.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -73.05 115.42 12.35 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.78 1.232 . . . . 0.0 110.229 170.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.1 mt -107.88 81.12 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.58 1.152 . . . . 0.0 108.446 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 m -52.26 -30.34 27.26 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.79 2.436 . . . . 0.0 114.079 -172.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -77.62 -19.76 54.99 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.301 1.84 . . . . 0.0 113.722 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -112.92 -43.05 3.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.779 1.232 . . . . 0.0 112.643 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.6 135.07 52.32 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.556 1.143 . . . . 0.0 112.278 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.71 150.64 5.25 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 126.022 1.773 . . . . 0.0 111.982 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 ptp -55.39 -30.55 60.59 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.97 62.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -85.26 -38.91 18.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.074 0.852 . . . . 0.0 111.049 165.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.06 -12.93 61.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.575 0.75 . . . . 0.0 112.821 -172.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.3 -10.97 50.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.749 1.22 . . . . 0.0 114.126 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.97 -5.94 0.97 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.91 169.65 12.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.281 1.54 . . . . 0.0 114.407 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -81.0 -64.7 1.13 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.525 1.13 . . . . 0.0 112.276 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -151.16 123.99 8.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.755 1.622 . . . . 0.0 109.738 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.48 156.24 41.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.92 127.15 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.935 1.294 . . . . 0.0 108.086 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.28 124.45 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.339 1.456 . . . . 0.0 109.406 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -102.82 123.3 46.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.655 1.182 . . . . 0.0 110.24 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -88.25 73.54 8.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.518 1.127 . . . . 0.0 110.138 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.64 -170.51 2.85 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 121.525 -0.734 . . . . 0.0 112.517 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -145.58 177.62 8.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.242 -0.911 . . . . 0.0 112.767 162.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.24 -56.11 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.27 1.028 . . . . 0.0 113.024 -166.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.17 -30.71 19.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -54.61 118.81 17.97 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.791 1.236 . . . . 0.0 113.729 -167.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.88 -23.79 77.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.109 3.206 . . . . 0.0 114.223 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -71.97 -46.86 55.85 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.0 m -56.14 -34.42 66.11 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.482 1.113 . . . . 0.0 113.401 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -56.06 -35.25 66.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 112.825 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -62.76 -49.98 72.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.406 0.682 . . . . 0.0 111.366 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.41 -29.67 70.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -60.68 -45.87 92.51 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.934 0.894 . . . . 0.0 111.013 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -72.0 -34.48 68.9 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.255 -0.903 . . . . 0.0 113.052 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.98 -49.25 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.24 -36.49 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.128 0.971 . . . . 0.0 113.46 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.45 -49.84 76.22 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.307 0.643 . . . . 0.0 112.518 170.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.18 -29.97 68.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.203 -0.935 . . . . 0.0 113.157 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.83 -37.84 79.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.083 1.353 . . . . 0.0 111.584 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.15 -19.34 67.23 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.418 1.009 . . . . 0.0 112.81 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.61 -33.73 66.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.347 1.059 . . . . 0.0 113.462 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 9.16 39.94 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.603 1.561 . . . . 0.0 114.104 174.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.2 66.23 7.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.522 1.529 . . . . 0.0 113.673 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.3 -20.81 69.75 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.905 2.403 . . . . 0.0 115.076 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -88.2 -8.87 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 p -88.25 135.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.45 87.3 5.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.529 0.732 . . . . 0.0 111.013 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 mt -86.24 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.565 -0.709 . . . . 0.0 109.695 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.7 p -147.3 173.1 12.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.609 1.164 . . . . 0.0 111.556 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 t -122.53 -172.52 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.191 -0.943 . . . . 0.0 111.137 168.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -173.55 133.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.729 2.411 . . . . 0.0 109.118 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.83 116.25 18.19 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.929 1.292 . . . . 0.0 111.464 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.3 p -62.28 -26.93 68.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 112.947 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.79 -23.42 62.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.511 1.124 . . . . 0.0 112.518 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.31 -28.84 11.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.073 1.349 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.55 49.03 4.23 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 125.896 1.678 . . . . 0.0 115.46 -170.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -66.72 -19.42 53.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.394 2.063 . . . . 0.0 112.731 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.16 -25.98 68.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.568 1.147 . . . . 0.0 113.124 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -70.48 -55.1 9.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.81 0.732 . . . . 0.0 110.751 166.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.9 mtp -59.14 -28.47 66.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.547 1.539 . . . . 0.0 113.248 -170.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -15.47 61.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.543 1.137 . . . . 0.0 112.753 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -84.68 -38.32 19.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.663 1.185 . . . . 0.0 110.579 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.85 -23.46 31.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.282 0.633 . . . . 0.0 112.677 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.86 20.09 17.66 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.716 1.627 . . . . 0.0 114.773 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -82.5 149.41 27.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.765 1.283 . . . . 0.0 111.883 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.45 -81.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.633 0.773 . . . . 0.0 110.825 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -157.35 6.64 0.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -167.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.89 160.76 25.0 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 126.487 1.915 . . . . 0.0 114.032 -159.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.6 93.34 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.91 3.74 . . . . 0.0 110.942 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 m -109.68 129.22 55.62 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.895 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mp -95.46 130.88 42.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.836 0.855 . . . . 0.0 109.734 167.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -129.24 128.56 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.091 1.757 . . . . 0.0 108.86 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -114.85 124.48 51.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.176 0.99 . . . . 0.0 110.682 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mm -109.05 120.04 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.996 1.318 . . . . 0.0 109.599 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -114.98 125.3 53.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.822 1.649 . . . . 0.0 109.501 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.61 19.47 10.45 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.505 1.522 . . . . 0.0 113.807 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.15 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.823 1.201 . . . . 0.0 114.101 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -112.84 136.51 52.38 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.103 1.761 . . . . 0.0 110.372 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.59 104.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 166.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.96 -30.23 12.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.62 160.41 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.915 1.686 . . . . 0.0 111.76 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.25 144.81 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.593 1.557 . . . . 0.0 110.771 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.28 150.22 25.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 111.972 167.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -105.48 132.34 51.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.183 0.993 . . . . 0.0 111.35 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.18 -158.14 14.86 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.287 1.422 . . . . 0.0 113.448 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.57 139.09 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.692 1.597 . . . . 0.0 111.056 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.0 mtm -140.9 160.28 40.41 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.514 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -72.35 159.84 84.34 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.71 1.204 . . . . 0.0 112.282 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.3 -24.73 31.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.457 2.105 . . . . 0.0 113.724 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -63.23 -49.31 74.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.953 1.251 . . . . 0.0 110.83 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -72.28 -26.15 61.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.626 1.17 . . . . 0.0 111.636 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -26.75 68.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.748 0.819 . . . . 0.0 112.507 170.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -65.64 -45.53 82.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.775 1.17 . . . . 0.0 110.769 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.83 84.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.152 0.581 . . . . 0.0 111.848 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.16 -53.88 51.41 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.249 1.019 . . . . 0.0 110.405 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.92 77.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.361 175.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.26 79.72 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.454 -0.779 . . . . 0.0 112.0 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -60.05 -38.89 84.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.569 0.747 . . . . 0.0 111.861 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.482 1.129 0 O-C-N 121.148 -0.97 . . . . 0.0 110.602 175.056 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 t -167.68 164.77 14.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.736 2.014 . . . . 0.0 110.682 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.43 146.66 2.86 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.045 2.138 . . . . 0.0 110.604 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.63 129.6 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.319 1.047 . . . . 0.0 110.988 -173.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.45 171.42 1.58 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.965 2.906 . . . . 0.0 111.892 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -80.48 112.85 18.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.246 1.419 . . . . 0.0 108.718 167.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.8 mt -93.68 129.75 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.928 0.891 . . . . 0.0 110.434 -168.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.7 p -73.41 -18.11 61.19 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.62 1.568 . . . . 0.0 114.772 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -73.89 -41.52 62.03 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.449 1.5 . . . . 0.0 113.458 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -171.62 145.34 2.0 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.325 1.85 . . . . 0.0 111.761 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.96 170.28 16.88 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.126 2.17 . . . . 0.0 110.659 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.66 -170.29 51.28 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 123.903 0.763 . . . . 0.0 113.859 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.8 ptp -54.52 -27.31 37.36 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.47 -26.63 35.09 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.028 0.931 . . . . 0.0 113.498 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -71.23 -40.22 71.22 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.64 -0.663 . . . . 0.0 110.247 162.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -75.65 27.27 0.11 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.452 1.501 . . . . 0.0 112.825 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -82.24 -14.92 54.74 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.84 43.76 0.07 OUTLIER Glycine 0 N--CA 1.474 1.23 0 CA-C-N 119.674 1.124 . . . . 0.0 115.582 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 mt -84.85 103.05 13.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.431 1.093 . . . . 0.0 111.158 -173.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -58.89 -27.56 65.33 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -156.37 94.31 1.48 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.1 1.76 . . . . 0.0 110.296 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.59 46.64 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.9 mt -140.84 135.13 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.389 1.476 . . . . 0.0 109.142 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.33 131.06 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.45 1.5 . . . . 0.0 109.565 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -111.24 103.48 11.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.655 1.182 . . . . 0.0 111.462 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -75.37 70.91 2.31 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.74 1.616 . . . . 0.0 109.959 175.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.34 154.0 42.39 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.117 0.967 . . . . 0.0 113.192 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.04 179.74 7.73 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.335 -0.853 . . . . 0.0 111.728 166.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.77 153.25 30.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.022 1.729 . . . . 0.0 112.457 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 67.85 -46.41 0.51 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 130.304 3.442 . . . . 0.0 114.474 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.0 t -54.91 128.58 64.51 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 127.046 2.139 . . . . 0.0 113.433 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.77 -18.97 59.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.606 3.538 . . . . 0.0 115.529 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -67.79 -48.35 66.55 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 120.364 1.438 . . . . 0.0 112.817 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.1 -22.79 63.96 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.471 -1.393 . . . . 0.0 113.414 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -56.39 -30.79 63.18 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.154 1.381 . . . . 0.0 113.085 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -64.82 -46.1 83.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.957 0.903 . . . . 0.0 112.235 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.3 mmm -63.91 -28.77 70.06 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.338 -0.851 . . . . 0.0 112.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -61.02 -35.81 77.85 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.705 0.684 . . . . 0.0 111.58 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.495 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -70.27 -40.6 74.24 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 110.737 174.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.01 -44.62 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.777 1.631 . . . . 0.0 110.788 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.97 -37.33 85.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.306 1.443 . . . . 0.0 112.125 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.89 -47.79 84.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.649 0.78 . . . . 0.0 111.986 171.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -68.51 -32.95 73.28 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.259 0.936 . . . . 0.0 112.11 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -68.63 -35.89 77.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.73 1.212 . . . . 0.0 112.184 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.34 -24.57 53.93 Favored Glycine 0 N--CA 1.469 0.852 0 CA-C-N 119.176 0.898 . . . . 0.0 113.177 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 10.8 38.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.097 1.359 . . . . 0.0 114.139 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.86 85.89 7.46 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.433 1.493 . . . . 0.0 111.68 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.03 -12.09 17.73 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.312 2.675 . . . . 0.0 113.817 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -89.57 -10.04 47.57 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.827 1.194 . . . . 0.0 113.728 -172.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.54 130.78 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.672 1.189 . . . . 0.0 110.254 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.8 98.0 8.26 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.223 0.609 . . . . 0.0 110.036 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -101.42 132.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.628 0.771 . . . . 0.0 109.273 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -145.89 169.2 19.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.97 0.908 . . . . 0.0 111.813 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.2 p -114.2 164.96 13.17 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.634 -1.291 . . . . 0.0 111.538 168.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.54 122.24 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.3 1.44 . . . . 0.0 109.038 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.08 104.76 1.21 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.694 1.198 . . . . 0.0 110.397 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -54.35 -44.26 72.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.857 1.263 . . . . 0.0 112.811 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -78.52 -13.27 59.91 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.84 -17.91 18.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.641 1.176 . . . . 0.0 113.427 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -124.03 43.77 0.89 Allowed Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.062 1.745 . . . . 0.0 113.303 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.85 -22.87 35.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.102 2.535 . . . . 0.0 112.466 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.17 -27.74 68.92 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.293 0.952 . . . . 0.0 112.603 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.58 -50.65 14.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.8 mtm -56.7 -26.41 56.65 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.402 1.081 . . . . 0.0 113.319 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -66.35 -23.35 66.33 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.139 0.976 . . . . 0.0 112.014 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -84.6 -37.97 20.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.935 1.294 . . . . 0.0 111.204 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.06 -24.15 30.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.438 0.695 . . . . 0.0 112.554 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.22 20.03 19.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.374 1.464 . . . . 0.0 115.065 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -84.1 155.08 22.81 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.156 1.478 . . . . 0.0 111.584 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -92.25 -72.21 0.6 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.439 1.096 . . . . 0.0 110.465 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 ptm85 -162.81 3.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -84.63 154.82 62.21 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 127.108 2.163 . . . . 0.0 113.012 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.48 96.35 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.382 3.388 . . . . 0.0 110.336 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.9 m -111.06 124.63 52.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.191 0.996 . . . . 0.0 112.467 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.4 135.02 34.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 109.524 166.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.34 124.38 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.001 1.721 . . . . 0.0 108.034 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -108.11 126.21 52.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.432 0.693 . . . . 0.0 110.782 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.1 mm -110.36 113.11 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.841 0.857 . . . . 0.0 109.178 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 115.56 29.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.321 1.448 . . . . 0.0 109.109 170.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.08 26.67 8.86 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.879 2.072 . . . . 0.0 111.981 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.21 -3.84 83.12 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.832 0.73 . . . . 0.0 113.846 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -96.29 131.11 43.13 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.923 -1.34 . . . . 0.0 110.231 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.38 102.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.869 0.842 . . . . 0.0 109.603 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.32 -17.17 16.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -171.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.91 148.72 19.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.019 1.727 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -150.27 146.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.803 1.641 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.33 148.82 27.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.266 1.026 . . . . 0.0 111.601 161.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -105.77 144.07 33.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.479 -0.763 . . . . 0.0 111.917 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.24 -150.18 17.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.268 1.413 . . . . 0.0 113.377 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.5 mm -112.27 144.36 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.343 1.457 . . . . 0.0 112.285 -170.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.3 ptp -153.01 169.31 23.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 160.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -82.44 161.98 57.6 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.727 1.611 . . . . 0.0 112.485 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.46 -26.48 12.03 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.539 2.159 . . . . 0.0 114.507 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -71.43 -34.23 70.11 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.204 1.365 . . . . 0.0 112.846 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -74.39 -31.42 62.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.591 0.756 . . . . 0.0 112.278 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.1 tp -62.28 -26.87 68.64 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.488 -0.757 . . . . 0.0 112.606 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.72 -47.95 82.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.882 0.764 . . . . 0.0 111.209 174.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.59 71.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.255 0.622 . . . . 0.0 111.778 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.96 -50.44 73.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.807 0.843 . . . . 0.0 110.84 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -45.38 79.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.322 0.649 . . . . 0.0 112.008 175.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.8 86.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.826 0.739 . . . . 0.0 112.031 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.1 m -64.64 -11.79 39.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.399 1.479 . . . . 0.0 114.612 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.476 0.851 0 O-C-N 121.039 -1.038 . . . . 0.0 110.96 173.312 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 121.259 0.552 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -149.57 145.7 26.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.452 1.501 . . . . 0.0 110.116 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.23 2.75 23.17 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -176.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mm -95.32 103.96 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.02 1.728 . . . . 0.0 108.988 -172.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -143.45 167.38 22.33 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.382 1.473 . . . . 0.0 111.361 -167.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -84.96 105.73 15.94 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.323 1.449 . . . . 0.0 110.149 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.3 mt -121.75 96.45 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.657 1.183 . . . . 0.0 107.991 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -52.46 -32.73 41.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.253 1.821 . . . . 0.0 113.549 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 m -59.37 -28.28 66.73 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.175 1.79 . . . . 0.0 113.019 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -125.36 28.82 6.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.759 1.623 . . . . 0.0 111.829 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.22 170.66 15.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.96 1.304 . . . . 0.0 112.468 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.44 153.25 29.36 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.356 1.455 . . . . 0.0 111.92 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -56.26 -28.63 59.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.267 1.027 . . . . 0.0 113.445 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.74 63.0 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -84.53 -39.09 19.23 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 111.168 166.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.11 -9.19 58.42 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.71 -11.11 43.3 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.007 1.323 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.9 -6.36 1.11 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.47 167.29 16.99 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.226 1.513 . . . . 0.0 113.663 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -80.68 -52.55 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -164.76 114.88 1.15 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.946 1.298 . . . . 0.0 110.082 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.71 157.83 41.45 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.98 130.66 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.632 1.573 . . . . 0.0 108.832 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.6 128.23 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.689 1.596 . . . . 0.0 109.393 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.05 111.72 23.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.574 1.15 . . . . 0.0 111.507 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -83.53 73.56 10.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 111.301 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -71.41 174.94 5.9 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 168.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.24 146.34 38.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.388 -1.445 . . . . 0.0 114.054 170.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 30' ' ' LEU 0.319 6.9 p30 17.76 -104.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.388 2.675 . . . . 0.0 116.136 -178.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.456 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 3.6 mm? -107.18 3.15 25.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.68 2.392 . . . . 0.0 113.383 -171.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -49.04 125.61 13.95 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.509 1.523 . . . . 0.0 114.41 -164.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.2 -5.03 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.066 3.178 . . . . 0.0 113.429 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -81.74 -50.38 9.34 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.685 1.129 . . . . 0.0 109.905 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.2 m -60.77 -34.02 73.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -171.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -50.31 -40.72 49.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -72.76 -40.68 65.81 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.209 0.603 . . . . 0.0 110.737 -172.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -62.4 -34.52 76.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.593 1.157 . . . . 0.0 112.519 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -59.55 -39.09 82.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.719 1.145 . . . . 0.0 112.305 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.48 -32.66 71.69 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.91 -1.119 . . . . 0.0 112.789 173.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.46 -50.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.368 0.667 . . . . 0.0 109.967 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.73 -35.67 81.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.293 1.037 . . . . 0.0 112.135 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.73 -52.97 63.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.053 0.941 . . . . 0.0 111.639 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -69.13 -30.24 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.601 -0.687 . . . . 0.0 112.655 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.95 -41.39 91.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.786 1.234 . . . . 0.0 111.49 170.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.58 -27.33 27.45 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 119.098 0.863 . . . . 0.0 113.593 -172.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.77 68.24 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.198 0.999 . . . . 0.0 113.588 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.49 9.4 37.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.964 1.705 . . . . 0.0 114.067 176.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.05 42.31 0.37 Allowed Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 125.534 1.533 . . . . 0.0 113.754 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.57 -5.64 10.55 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.575 2.85 . . . . 0.0 115.58 -166.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -62.92 -8.86 7.92 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.64 135.6 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.194 1.398 . . . . 0.0 110.553 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.06 102.53 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 110.348 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.68 135.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.93 0.892 . . . . 0.0 110.333 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.7 p -144.63 169.02 18.79 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.278 1.031 . . . . 0.0 112.005 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.4 p -125.97 163.37 23.15 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.78 -1.2 . . . . 0.0 111.846 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.2 t -148.82 129.03 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.009 1.323 . . . . 0.0 108.542 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -73.93 98.62 3.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.562 0.696 . . . . 0.0 110.123 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -59.55 -30.33 68.54 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.219 1.008 . . . . 0.0 113.585 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.81 -21.53 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.043 1.337 . . . . 0.0 112.655 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.14 -7.81 38.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.528 1.531 . . . . 0.0 112.976 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 42.95 0.98 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 126.151 1.78 . . . . 0.0 114.07 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.45 -21.01 47.4 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.593 2.196 . . . . 0.0 113.258 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -59.71 -19.44 49.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.226 . . . . 0.0 113.124 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.23 -58.93 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.459 1.103 . . . . 0.0 111.574 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.6 mtm -58.46 -28.55 65.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 113.763 -170.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -69.71 -18.91 63.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.041 1.336 . . . . 0.0 113.345 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.31 -35.62 19.78 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.381 1.073 . . . . 0.0 111.211 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.51 -23.87 21.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.422 0.689 . . . . 0.0 112.857 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.34 21.06 18.34 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.692 1.615 . . . . 0.0 114.716 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.14 160.83 25.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.998 1.399 . . . . 0.0 112.188 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.75 -68.77 0.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.359 1.063 . . . . 0.0 112.869 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.79 22.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -162.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.34 156.97 57.21 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 125.091 1.356 . . . . 0.0 112.831 -166.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.76 88.29 0.92 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.075 3.183 . . . . 0.0 110.206 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -99.89 130.21 46.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.318 1.047 . . . . 0.0 111.893 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 134.38 35.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.318 1.047 . . . . 0.0 110.471 163.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.5 t -130.73 126.17 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.568 1.547 . . . . 0.0 108.417 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -109.95 122.54 47.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 110.639 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.68 121.5 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.403 1.481 . . . . 0.0 108.859 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.54 124.29 50.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.307 1.843 . . . . 0.0 108.774 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 61.19 20.09 10.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.009 1.324 . . . . 0.0 113.355 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.12 69.57 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.229 0.919 . . . . 0.0 113.84 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -117.46 132.11 56.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.449 1.9 . . . . 0.0 109.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.77 109.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.196 -0.94 . . . . 0.0 109.676 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.55 -24.85 14.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -160.16 144.82 14.66 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.123 1.769 . . . . 0.0 110.563 -172.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -148.25 143.87 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.552 1.541 . . . . 0.0 109.384 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -154.59 156.92 37.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.434 1.094 . . . . 0.0 111.026 164.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 p -121.45 145.36 48.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.97 -167.76 12.4 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.335 1.445 . . . . 0.0 113.58 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.06 138.42 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 65.9 mtm -139.42 147.66 41.72 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.973 0.909 . . . . 0.0 111.299 162.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.15 97.88 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.341 0.657 . . . . 0.0 111.346 167.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.19 -27.48 56.5 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.827 2.351 . . . . 0.0 113.551 -166.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -61.01 -29.17 69.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.4 -25.46 16.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.578 0.751 . . . . 0.0 112.562 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.37 -24.69 63.61 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 112.572 171.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -60.35 -41.81 94.4 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.387 0.675 . . . . 0.0 112.336 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.4 77.72 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.952 0.796 . . . . 0.0 111.97 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.01 -47.35 80.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.329 1.052 . . . . 0.0 110.379 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.59 -46.63 87.41 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.374 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.53 75.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.605 1.093 . . . . 0.0 112.705 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -62.77 -17.83 61.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.18 1.392 . . . . 0.0 113.582 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.6 mt . . . . . 0 N--CA 1.475 0.821 0 O-C-N 120.522 -1.361 . . . . 0.0 110.468 172.519 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 69.82 -56.03 0.58 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.444 2.698 . . . . 0.0 113.358 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.78 131.92 2.6 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.755 2.022 . . . . 0.0 110.404 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.8 mt -91.67 140.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.577 1.151 . . . . 0.0 109.589 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 165.89 -42.98 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 130.415 3.486 . . . . 0.0 112.974 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 t70 175.23 133.91 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 129.945 3.298 . . . . 0.0 110.126 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.55 117.58 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.8 p -61.31 -33.44 73.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.138 1.375 . . . . 0.0 113.953 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -87.02 -12.98 45.77 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.831 1.652 . . . . 0.0 114.264 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -120.0 27.25 8.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.677 1.191 . . . . 0.0 112.192 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -144.36 164.15 31.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.835 1.654 . . . . 0.0 112.015 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.08 152.74 23.07 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 125.017 1.294 . . . . 0.0 112.262 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -56.26 -28.27 58.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.301 1.041 . . . . 0.0 113.065 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -21.2 62.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -80.1 -41.33 25.76 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 111.051 166.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -74.72 -13.62 60.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.289 1.036 . . . . 0.0 113.646 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -85.2 80.32 9.25 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.589 1.956 . . . . 0.0 110.342 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 14.19 14.92 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.772 1.177 . . . . 0.0 115.854 166.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.89 167.51 11.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 1.351 . . . . 0.0 112.936 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -75.62 -66.59 0.76 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.261 1.024 . . . . 0.0 112.544 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -149.63 124.72 10.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.392 1.877 . . . . 0.0 109.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.41 160.47 42.53 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.6 mt -138.03 124.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.085 1.754 . . . . 0.0 108.647 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 109.306 -170.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -115.08 113.81 24.53 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.373 0.669 . . . . 0.0 111.948 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -81.45 70.17 8.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.813 1.245 . . . . 0.0 110.722 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.83 170.14 15.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.702 0.763 . . . . 0.0 112.845 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -117.84 162.04 18.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.533 1.533 . . . . 0.0 111.143 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -91.17 -36.17 14.11 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.971 -1.08 . . . . 0.0 111.811 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 mt -80.06 -52.19 8.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.648 1.179 . . . . 0.0 113.4 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.74 119.53 45.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.295 1.438 . . . . 0.0 112.639 -170.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.31 -19.73 55.75 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.739 2.959 . . . . 0.0 114.086 172.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -76.75 -45.57 28.61 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.195 0.907 . . . . 0.0 110.703 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 p -63.72 -21.93 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -54.7 -37.78 66.23 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.123 0.969 . . . . 0.0 112.994 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -62.32 -43.11 99.58 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.736 -0.603 . . . . 0.0 111.832 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.3 tpp -61.01 -34.6 75.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.743 0.817 . . . . 0.0 112.991 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -54.28 -42.93 70.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.437 0.695 . . . . 0.0 111.767 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.69 -27.35 29.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.923 0.889 . . . . 0.0 113.166 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.85 -47.85 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.979 0.911 . . . . 0.0 110.378 166.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -62.04 -36.99 83.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.95 -48.29 82.5 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.96 0.8 . . . . 0.0 111.525 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.33 -33.81 76.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.659 0.784 . . . . 0.0 112.711 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -65.35 -37.58 87.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.861 1.264 . . . . 0.0 111.542 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.31 -23.03 61.64 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 124.704 1.145 . . . . 0.0 113.628 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -31.33 62.39 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.279 1.431 . . . . 0.0 114.713 -171.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.73 6.31 14.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 63.51 57.76 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.916 1.687 . . . . 0.0 112.14 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.61 -15.55 30.48 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.9 3.066 . . . . 0.0 113.725 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -82.05 -4.76 57.51 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.04 135.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.177 1.391 . . . . 0.0 110.235 173.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.93 100.86 11.28 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.814 0.846 . . . . 0.0 110.847 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.11 131.33 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.847 0.859 . . . . 0.0 110.195 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.3 p -146.82 170.06 17.82 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.938 0.895 . . . . 0.0 112.579 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.3 p -132.43 155.16 49.0 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.865 -1.147 . . . . 0.0 111.071 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -142.77 127.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.534 1.133 . . . . 0.0 109.461 -168.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -64.62 101.26 0.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.734 1.614 . . . . 0.0 110.69 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.9 p -55.97 -40.81 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.056 0.943 . . . . 0.0 112.738 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.45 -26.65 65.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.749 1.619 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.69 -15.43 18.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 113.844 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -131.42 52.61 9.67 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.705 1.602 . . . . 0.0 113.009 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.6 -20.47 53.39 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.027 170.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.46 -29.17 69.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.39 1.076 . . . . 0.0 112.767 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.94 -56.84 4.97 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.492 0.717 . . . . 0.0 109.431 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.7 mtp -54.8 -33.6 61.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.514 1.525 . . . . 0.0 112.21 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -61.71 -27.86 69.01 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.864 1.665 . . . . 0.0 113.988 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.34 -38.27 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.358 0.663 . . . . 0.0 112.01 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.77 -21.78 24.93 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 15.52 31.4 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.256 1.884 . . . . 0.0 114.829 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -77.96 140.52 39.23 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.275 1.538 . . . . 0.0 111.801 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.91 -60.04 2.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.408 0.683 . . . . 0.0 112.342 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -167.07 23.05 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -165.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.61 151.88 50.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 125.468 1.507 . . . . 0.0 113.351 -166.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.71 93.94 1.0 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.924 3.083 . . . . 0.0 109.599 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.5 m -104.44 131.73 51.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.524 1.13 . . . . 0.0 112.952 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.56 131.74 34.29 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.24 1.816 . . . . 0.0 109.251 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.69 131.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 108.744 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -114.29 127.85 56.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.636 0.775 . . . . 0.0 111.154 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.1 mm -108.94 122.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.006 1.322 . . . . 0.0 109.269 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -119.4 124.06 45.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.655 1.982 . . . . 0.0 109.19 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 61.88 18.69 10.02 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.947 1.299 . . . . 0.0 113.049 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.59 7.1 67.23 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.236 1.398 . . . . 0.0 114.401 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -113.34 136.94 52.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.877 1.671 . . . . 0.0 110.136 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.01 108.84 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 121.076 -1.015 . . . . 0.0 109.879 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.9 -20.31 14.31 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -170.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -158.67 156.1 29.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.022 1.329 . . . . 0.0 110.67 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.06 145.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 111.204 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.88 146.08 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.546 1.139 . . . . 0.0 111.101 166.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 p -110.77 147.09 35.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.056 . . . . 0.0 113.153 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.71 -149.38 18.12 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.758 1.17 . . . . 0.0 113.056 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.3 mm -118.3 143.89 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.015 1.326 . . . . 0.0 111.976 -171.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.3 mtm -139.13 160.04 40.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.27 1.428 . . . . 0.0 111.014 161.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -70.06 162.29 69.88 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 111.487 167.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 -32.91 14.17 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.987 1.791 . . . . 0.0 113.868 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -71.44 -31.36 67.12 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.842 1.655 . . . . 0.0 112.821 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -79.36 -22.32 44.57 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.95 -26.13 68.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.561 1.073 . . . . 0.0 112.672 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -63.05 -37.32 86.71 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.329 0.968 . . . . 0.0 111.702 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.74 83.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.361 0.982 . . . . 0.0 111.163 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 53.5 tp -65.07 -45.47 85.18 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.323 0.649 . . . . 0.0 110.78 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -44.61 95.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.283 1.033 . . . . 0.0 112.342 173.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.69 84.21 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.123 -0.985 . . . . 0.0 111.482 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.0 m -67.79 -3.84 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.754 1.622 . . . . 0.0 114.232 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 N--CA 1.481 1.085 0 O-C-N 120.903 -1.123 . . . . 0.0 111.382 169.587 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtm . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m -138.34 151.06 47.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.661 1.584 . . . . 0.0 111.31 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.91 1.05 45.25 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm -102.83 124.46 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.728 1.611 . . . . 0.0 110.755 -171.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.58 173.37 9.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.989 2.116 . . . . 0.0 111.255 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -90.85 115.93 28.29 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.766 1.226 . . . . 0.0 110.639 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.27 122.87 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.5 p -47.33 -41.18 18.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.081 1.752 . . . . 0.0 114.435 -170.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -91.07 -17.19 26.62 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.324 1.85 . . . . 0.0 114.351 -174.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -96.94 50.11 1.09 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 122.994 1.378 . . . . 0.0 112.368 -172.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.56 162.81 39.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.001 2.121 . . . . 0.0 111.216 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.88 153.25 30.12 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.953 1.264 . . . . 0.0 111.848 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -54.78 -27.65 43.12 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.581 1.552 . . . . 0.0 114.198 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.21 44.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.719 1.208 . . . . 0.0 113.903 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -74.95 -39.71 61.18 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.193 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.95 19.4 0.15 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 113.937 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -16.5 57.92 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.46 45.44 0.12 Allowed Glycine 0 N--CA 1.478 1.448 0 CA-C-N 120.059 1.3 . . . . 0.0 116.257 -174.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.3 mt -88.72 122.35 32.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.086 1.354 . . . . 0.0 109.232 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -53.59 -43.13 68.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.753 1.161 . . . . 0.0 113.478 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -163.04 123.42 2.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.223 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.75 155.76 42.04 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.319 1.448 . . . . 0.0 112.513 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.6 mt -143.18 132.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.364 1.466 . . . . 0.0 110.707 -170.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.54 126.73 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.089 1.356 . . . . 0.0 110.8 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -102.5 117.26 34.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.202 1.401 . . . . 0.0 112.101 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -78.55 73.58 5.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.286 1.434 . . . . 0.0 111.609 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.9 -174.99 4.7 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.705 0.802 . . . . 0.0 112.798 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -144.14 156.02 44.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 111.748 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -64.75 -54.82 25.37 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.77 -38.06 20.07 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -170.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.67 122.16 49.38 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.781 1.232 . . . . 0.0 112.827 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -65.15 -22.65 61.16 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.33 3.354 . . . . 0.0 114.575 173.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -70.7 -46.21 63.54 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 119.303 0.956 . . . . 0.0 111.036 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -58.09 -34.03 69.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.474 1.11 . . . . 0.0 113.595 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -55.79 -34.6 65.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.12 1.368 . . . . 0.0 112.995 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -60.09 -46.73 88.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.341 0.657 . . . . 0.0 111.679 176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -36.04 82.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.287 0.635 . . . . 0.0 112.65 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -53.03 -40.64 64.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.834 0.743 . . . . 0.0 112.293 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -65.77 -28.16 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.039 -1.038 . . . . 0.0 112.775 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 t -75.12 -52.68 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.579 1.552 . . . . 0.0 108.747 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.71 -38.23 77.84 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.715 1.206 . . . . 0.0 112.462 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -58.75 -58.46 8.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.531 1.132 . . . . 0.0 111.513 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -65.28 -31.31 72.38 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.05 -40.37 82.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.311 1.445 . . . . 0.0 112.398 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.2 -26.72 42.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 119.336 0.971 . . . . 0.0 114.06 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -40.83 71.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.925 1.29 . . . . 0.0 114.179 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.71 4.04 37.65 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.78 67.33 77.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 111.573 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.54 -10.1 24.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.331 2.687 . . . . 0.0 114.341 -169.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.28 -14.25 58.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.43 131.04 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.361 1.064 . . . . 0.0 109.77 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.34 91.48 6.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 0.0 110.645 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mt -100.08 132.34 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.029 0.932 . . . . 0.0 109.531 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -144.79 176.01 9.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.127 0.971 . . . . 0.0 111.658 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 86.4 p -113.76 176.3 5.09 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.897 -1.127 . . . . 0.0 110.599 162.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.0 126.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 124.342 1.057 . . . . 0.0 109.664 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.35 110.42 5.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.863 0.84 . . . . 0.0 110.811 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 p -56.48 -27.2 56.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.611 1.164 . . . . 0.0 113.637 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -77.35 -29.59 53.45 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.436 1.016 . . . . 0.0 113.089 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.33 -24.46 19.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.639 1.176 . . . . 0.0 113.017 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 56.39 9.21 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 126.745 2.018 . . . . 0.0 111.92 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.41 -27.79 18.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.983 2.456 . . . . 0.0 112.507 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -68.54 -25.42 64.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.984 0.811 . . . . 0.0 112.558 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.61 -56.19 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.166 0.894 . . . . 0.0 110.122 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.5 mtm -58.48 -21.01 50.25 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -26.66 51.89 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.99 1.716 . . . . 0.0 112.414 174.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -82.72 -46.47 13.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.76 0.824 . . . . 0.0 111.32 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.35 -15.91 51.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 21.72 46.6 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.664 1.126 . . . . 0.0 114.723 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -74.95 -58.9 3.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.404 1.102 . . . . 0.0 111.665 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 73.71 -29.07 0.19 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.08 3.352 . . . . 0.0 113.975 168.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -163.89 17.73 0.06 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -164.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.32 150.96 63.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.487 1.115 . . . . 0.0 113.943 -170.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.43 86.55 1.58 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 124.445 3.43 . . . . 0.0 110.873 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.7 m -98.67 136.01 39.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.415 1.086 . . . . 0.0 112.446 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.13 128.59 38.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.871 163.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.5 t -119.25 129.93 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.563 1.545 . . . . 0.0 109.16 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -117.56 131.09 56.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.125 0.97 . . . . 0.0 111.623 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.27 125.21 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.013 1.325 . . . . 0.0 109.925 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.32 117.4 29.86 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.661 1.984 . . . . 0.0 110.17 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.18 29.56 11.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.873 2.069 . . . . 0.0 111.805 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.54 85.79 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.48 0.562 . . . . 0.0 114.425 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -101.28 133.07 46.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.852 1.261 . . . . 0.0 108.755 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.07 106.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.179 -0.951 . . . . 0.0 109.297 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.04 -22.09 15.89 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -166.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -161.2 155.78 23.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.452 1.501 . . . . 0.0 110.74 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.7 p -152.7 143.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.306 1.442 . . . . 0.0 110.203 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.71 149.43 20.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.517 1.127 . . . . 0.0 111.566 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 t -112.16 140.68 46.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.336 1.054 . . . . 0.0 112.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.27 -164.62 12.43 Favored Glycine 0 C--N 1.344 1.001 0 C-N-CA 125.24 1.4 . . . . 0.0 114.762 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.96 140.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.122 1.369 . . . . 0.0 111.338 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.8 mtm -139.92 161.77 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.062 1.345 . . . . 0.0 111.701 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -68.37 161.29 70.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.277 0.631 . . . . 0.0 111.313 161.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.33 -32.4 16.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 121.932 1.754 . . . . 0.0 113.53 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -68.45 -32.79 73.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 120.884 1.675 . . . . 0.0 112.402 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -74.83 -30.37 61.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.535 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.81 -35.72 79.12 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.328 0.967 . . . . 0.0 111.833 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -39.97 90.72 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.424 1.011 . . . . 0.0 111.715 171.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.61 87.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.675 0.67 . . . . 0.0 111.866 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.8 tp -66.12 -49.6 66.93 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.848 0.859 . . . . 0.0 110.658 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -43.64 77.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.944 1.297 . . . . 0.0 113.21 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.44 76.17 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.103 0.865 . . . . 0.0 112.001 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.8 m -70.04 1.58 4.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.455 1.502 . . . . 0.0 114.091 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.474 0.767 0 O-C-N 120.739 -1.226 . . . . 0.0 111.294 171.665 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 mmt . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 m 70.41 -36.09 0.34 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 128.916 2.886 . . . . 0.0 114.652 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.64 143.15 11.33 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.722 2.009 . . . . 0.0 111.042 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.1 mt -106.16 128.46 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.093 1.357 . . . . 0.0 109.432 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -159.35 -164.6 1.4 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.774 2.429 . . . . 0.0 107.147 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.75 140.17 53.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.76 0.709 . . . . 0.0 111.296 161.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.55 133.62 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 165.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.0 p -75.52 -20.67 58.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.158 1.383 . . . . 0.0 114.395 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 p -85.99 -39.32 16.99 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.132 0.973 . . . . 0.0 113.365 -172.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -170.77 145.59 2.46 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.769 1.628 . . . . 0.0 111.86 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.32 148.73 11.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.538 1.935 . . . . 0.0 109.997 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.92 -179.71 24.16 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.922 1.248 . . . . 0.0 112.63 -169.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -57.8 -30.3 65.58 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -167.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.95 -22.2 63.19 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -84.72 -36.81 21.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.288 0.635 . . . . 0.0 111.611 165.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -79.24 -6.54 56.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -171.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.0 -17.75 30.54 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.54 -4.09 13.75 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.857 1.218 . . . . 0.0 116.064 -171.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.89 166.96 18.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.674 1.237 . . . . 0.0 114.182 -171.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -82.52 -65.13 1.05 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.596 1.158 . . . . 0.0 111.944 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -145.83 125.16 13.04 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.748 1.619 . . . . 0.0 110.04 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.99 159.59 43.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.9 mt -134.23 127.82 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.796 1.638 . . . . 0.0 108.477 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -118.71 127.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.552 1.541 . . . . 0.0 108.827 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -111.2 112.48 24.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.497 1.119 . . . . 0.0 111.197 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -80.29 76.8 7.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.374 1.069 . . . . 0.0 110.795 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.37 174.85 10.74 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.268 1.027 . . . . 0.0 112.729 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -134.21 151.32 51.26 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.873 -1.142 . . . . 0.0 111.535 167.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -62.63 -46.88 86.19 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 112.168 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.46 -32.44 42.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.323 1.049 . . . . 0.0 112.791 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.2 t -57.36 122.95 58.56 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.276 1.43 . . . . 0.0 112.392 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.31 -13.95 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.323 3.349 . . . . 0.0 112.293 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -80.08 -47.5 14.72 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.192 0.906 . . . . 0.0 109.451 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m -52.74 -36.61 58.01 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 113.979 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -37.3 66.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.451 1.1 . . . . 0.0 112.926 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -63.17 -45.52 91.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.51 0.724 . . . . 0.0 111.501 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 tpt -61.61 -33.13 73.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.035 0.934 . . . . 0.0 112.782 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -59.1 -40.46 85.38 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.647 0.658 . . . . 0.0 112.032 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -35.53 62.42 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.38 -0.825 . . . . 0.0 112.264 174.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.17 -47.86 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.789 0.835 . . . . 0.0 110.501 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.96 -37.05 85.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.012 1.725 . . . . 0.0 112.304 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.79 -48.48 76.72 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.02 0.827 . . . . 0.0 112.376 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -35.92 81.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.31 -0.869 . . . . 0.0 112.424 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -66.82 -34.25 77.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.967 1.307 . . . . 0.0 111.937 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.52 -25.29 51.23 Favored Glycine 0 N--CA 1.47 0.933 0 O-C-N 121.001 -1.062 . . . . 0.0 113.73 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.71 67.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.92 22.97 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 114.066 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.53 62.11 61.34 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.939 1.696 . . . . 0.0 111.563 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.29 -13.87 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.201 2.6 . . . . 0.0 114.243 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.04 -4.91 54.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.57 131.63 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 110.705 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.56 101.19 10.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.156 0.983 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.5 mt -94.88 130.5 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.507 -0.745 . . . . 0.0 109.689 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -139.16 152.0 47.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 110.863 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.7 m -115.68 149.98 37.51 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.111 -0.993 . . . . 0.0 111.512 167.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.1 t -139.73 122.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.122 1.369 . . . . 0.0 108.4 -171.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -67.85 113.18 5.37 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.498 1.119 . . . . 0.0 111.241 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -56.99 -27.65 61.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.448 1.499 . . . . 0.0 114.252 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -74.94 -27.93 60.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.069 0.849 . . . . 0.0 112.573 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.04 -27.99 16.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.855 1.262 . . . . 0.0 113.295 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 tpt85 -124.62 40.91 0.55 Allowed Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 125.706 1.602 . . . . 0.0 114.707 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -65.71 -19.69 59.5 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.196 1.931 . . . . 0.0 112.929 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.31 -27.4 62.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.731 1.212 . . . . 0.0 113.487 173.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.89 -54.78 5.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.503 1.121 . . . . 0.0 110.5 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtp -56.15 -31.06 63.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.055 1.342 . . . . 0.0 112.797 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.97 -26.83 68.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 113.143 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -86.51 -36.48 18.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.876 1.271 . . . . 0.0 110.799 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.7 -21.27 26.75 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.45 21.29 15.15 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.759 1.647 . . . . 0.0 115.185 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -83.48 143.26 30.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.773 1.287 . . . . 0.0 111.72 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.39 -72.16 0.57 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.717 0.807 . . . . 0.0 111.781 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.46 30.18 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 114.152 -170.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.11 156.52 52.34 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.425 1.49 . . . . 0.0 111.969 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.95 97.6 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.357 2.705 . . . . 0.0 109.952 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 m -109.5 124.58 51.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.984 0.514 . . . . 0.0 111.574 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.23 135.98 33.41 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.199 1.0 . . . . 0.0 109.328 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.86 125.18 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.299 1.84 . . . . 0.0 108.196 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -107.59 123.31 48.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.076 0.95 . . . . 0.0 111.077 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.3 mm -107.7 114.32 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.013 1.325 . . . . 0.0 108.662 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.1 125.0 53.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.867 1.667 . . . . 0.0 108.551 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.8 t70 66.74 20.5 10.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.056 1.343 . . . . 0.0 112.36 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.65 7.44 87.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.203 0.906 . . . . 0.0 113.856 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -108.99 136.53 48.36 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.829 1.652 . . . . 0.0 109.716 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.7 107.63 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.253 168.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.88 -30.91 11.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.302 1.041 . . . . 0.0 113.627 -170.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.6 158.32 42.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.096 1.358 . . . . 0.0 112.064 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -151.04 147.12 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.457 1.903 . . . . 0.0 108.739 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.01 148.99 31.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.536 0.684 . . . . 0.0 111.171 159.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 m -107.58 128.44 54.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.157 0.983 . . . . 0.0 111.32 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.17 -162.85 23.62 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.438 1.494 . . . . 0.0 113.106 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.84 141.67 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.303 1.441 . . . . 0.0 110.459 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 mtm -139.51 154.98 47.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.41 0.684 . . . . 0.0 112.26 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.94 152.2 84.49 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 123.772 0.829 . . . . 0.0 110.963 165.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.32 -25.15 49.67 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.351 2.034 . . . . 0.0 114.021 -165.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -61.07 -32.37 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -85.97 -28.95 23.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 0.0 111.805 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.8 -27.24 69.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.141 -0.974 . . . . 0.0 112.374 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -58.58 -44.53 89.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.793 0.724 . . . . 0.0 111.696 171.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.47 75.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.243 0.617 . . . . 0.0 111.951 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.28 -45.35 84.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.02 0.528 . . . . 0.0 111.168 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -44.51 94.2 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.423 0.689 . . . . 0.0 111.735 173.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.8 -27.07 66.42 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.075 -1.016 . . . . 0.0 111.938 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 m -67.08 -21.05 65.9 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.627 1.171 . . . . 0.0 113.573 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.481 1.101 0 CA-C-N 119.438 1.017 . . . . 0.0 110.107 174.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m 108.08 -26.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 1 C-N-CA 132.215 4.206 . . . . 0.0 111.601 -176.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.49 143.67 2.85 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.903 2.081 . . . . 0.0 110.42 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm -106.96 132.02 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.343 1.457 . . . . 0.0 107.969 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -156.9 158.09 36.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.825 1.25 . . . . 0.0 111.476 -165.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -100.33 96.86 7.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.748 2.419 . . . . 0.0 111.312 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.34 124.76 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.485 1.114 . . . . 0.0 109.274 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.4 p -66.11 -23.88 66.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.547 1.539 . . . . 0.0 113.847 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.7 p -91.79 -13.06 32.13 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.099 1.36 . . . . 0.0 114.09 -173.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -163.2 74.49 0.36 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.86 1.314 . . . . 0.0 112.604 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.82 107.52 3.18 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.156 1.382 . . . . 0.0 109.903 167.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.64 165.03 21.22 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 126.104 1.812 . . . . 0.0 112.847 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp -53.01 -35.34 59.3 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.71 67.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.82 -40.18 63.54 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.467 0.576 . . . . 0.0 110.779 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.24 -9.99 59.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.27 1.028 . . . . 0.0 113.274 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.82 -22.84 23.02 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.019 1.328 . . . . 0.0 112.916 169.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.1 -17.08 9.8 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 -168.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.53 166.3 23.5 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -83.54 -64.91 1.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.321 1.448 . . . . 0.0 112.134 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.13 125.7 12.48 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.806 1.642 . . . . 0.0 109.986 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.99 162.6 39.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.2 mt -135.92 120.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.457 1.503 . . . . 0.0 107.674 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.32 128.21 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.972 1.309 . . . . 0.0 109.267 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -108.01 112.16 24.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.599 1.16 . . . . 0.0 111.547 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -78.38 79.39 4.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.941 1.296 . . . . 0.0 110.464 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.11 175.45 9.98 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.58 149.58 37.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.436 1.494 . . . . 0.0 111.291 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -75.72 -34.97 60.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.7 mt -82.36 -23.98 34.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.478 1.111 . . . . 0.0 113.496 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.02 125.43 91.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 113.573 -167.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.02 -2.27 9.54 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.177 3.918 . . . . 0.0 112.779 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -87.46 -42.76 12.57 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 119.696 1.135 . . . . 0.0 109.5 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 88.5 m -57.24 -37.1 71.79 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -50.79 -37.88 45.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -75.82 -41.08 53.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.873 0.469 . . . . 0.0 111.504 -170.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.284 1.034 . . . . 0.0 112.593 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -55.82 -40.94 73.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.607 1.094 . . . . 0.0 112.165 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -75.29 -33.94 61.27 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.492 -0.755 . . . . 0.0 112.659 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.53 -46.3 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.767 0.827 . . . . 0.0 110.855 174.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.31 -33.4 75.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.526 1.131 . . . . 0.0 112.41 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.25 -48.6 75.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.407 1.003 . . . . 0.0 112.564 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.58 -37.83 79.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.757 0.708 . . . . 0.0 112.247 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -67.85 -34.29 76.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 112.511 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.99 -22.72 60.67 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.877 -1.139 . . . . 0.0 113.643 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.93 -29.07 64.85 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -170.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.8 6.5 15.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.69 1.196 . . . . 0.0 114.224 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.96 63.92 17.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.937 1.695 . . . . 0.0 112.601 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.13 -15.19 32.06 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.275 2.65 . . . . 0.0 113.63 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -81.22 -2.95 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.43 134.11 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.241 1.416 . . . . 0.0 110.666 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.87 101.26 10.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.714 0.806 . . . . 0.0 111.339 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.7 mt -97.74 130.09 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.857 -1.152 . . . . 0.0 109.633 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 p -150.42 164.34 36.13 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.075 0.95 . . . . 0.0 111.677 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.5 p -104.34 176.22 5.23 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.66 -1.275 . . . . 0.0 112.601 165.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -156.02 135.46 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.776 1.631 . . . . 0.0 109.451 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -73.77 109.75 7.51 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.301 1.04 . . . . 0.0 111.446 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -55.12 -29.71 58.25 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.671 1.188 . . . . 0.0 113.931 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.09 -23.32 51.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.082 0.953 . . . . 0.0 112.782 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.92 -24.81 16.82 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.85 1.26 . . . . 0.0 112.783 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -117.46 48.6 0.8 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 126.858 2.063 . . . . 0.0 113.273 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.28 -27.09 24.43 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.566 1.511 . . . . 0.0 112.494 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.01 -32.93 74.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.742 0.701 . . . . 0.0 112.165 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.87 -48.04 67.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.002 0.921 . . . . 0.0 108.973 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.2 mtm -56.92 -22.17 35.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.675 -0.641 . . . . 0.0 112.438 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -13.87 53.22 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.371 0.987 . . . . 0.0 113.352 175.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -82.48 -42.3 18.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.482 1.113 . . . . 0.0 110.788 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.43 -23.98 24.32 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.17 21.63 17.27 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.41 1.481 . . . . 0.0 115.512 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.0 153.64 24.86 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.673 1.236 . . . . 0.0 111.919 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.38 -65.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.079 0.952 . . . . 0.0 111.941 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -159.99 2.16 0.08 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 -165.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.8 m -106.66 159.53 29.54 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 127.521 2.328 . . . . 0.0 112.835 -162.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.81 85.84 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.405 3.403 . . . . 0.0 111.859 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 75.7 m -98.79 128.36 44.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.92 137.78 32.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.698 1.199 . . . . 0.0 109.761 165.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.2 122.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.927 1.691 . . . . 0.0 108.662 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -102.67 118.53 37.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.998 0.919 . . . . 0.0 110.031 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.33 113.18 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.833 1.253 . . . . 0.0 108.853 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.77 121.61 45.76 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.045 1.338 . . . . 0.0 107.849 172.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.2 t70 64.59 21.78 12.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 112.261 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 9.23 84.47 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.403 1.001 . . . . 0.0 113.873 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.6 135.16 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 110.277 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.55 108.27 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 167.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.99 -34.42 10.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.82 150.49 33.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.044 1.738 . . . . 0.0 110.998 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -146.74 145.5 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.571 1.548 . . . . 0.0 108.811 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -148.0 136.57 21.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.539 0.736 . . . . 0.0 111.463 163.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 p -98.2 3.44 48.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.997 1.719 . . . . 0.0 115.08 -171.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.33 -166.19 26.61 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.422 1.486 . . . . 0.0 114.435 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.4 141.35 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.473 1.509 . . . . 0.0 110.086 170.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.6 mtm -137.05 176.02 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 170.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.46 156.17 49.44 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 126.759 2.023 . . . . 0.0 110.005 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.76 -38.2 18.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.903 1.735 . . . . 0.0 113.939 -156.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -61.25 -30.55 70.52 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.291 0.951 . . . . 0.0 113.086 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.18 -31.37 27.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.896 0.878 . . . . 0.0 112.006 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.26 -34.49 76.28 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.039 0.836 . . . . 0.0 112.388 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -48.59 76.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.062 0.945 . . . . 0.0 111.088 167.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.86 -34.93 79.28 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.484 0.714 . . . . 0.0 112.337 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.2 -49.18 70.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 110.329 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -42.41 80.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.225 0.61 . . . . 0.0 112.156 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.19 -36.42 81.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.472 0.578 . . . . 0.0 111.457 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -60.02 -34.98 74.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.838 1.255 . . . . 0.0 112.463 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 124.13 0.972 . . . . 0.0 111.056 175.134 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? . . . . . 0 C--O 1.236 0.389 0 C-N-CA 124.921 1.288 . . . . 0.0 110.429 -172.103 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.82 61.25 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -85.71 -32.6 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.048 0.939 . . . . 0.0 111.466 168.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -67.91 -30.96 70.42 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.5 -0.75 . . . . 0.0 111.457 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.2 -15.91 60.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.238 1.415 . . . . 0.0 113.283 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.27 -15.47 30.17 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.159 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.469 HD11 HG22 ' A' ' 79' ' ' ILE . 1.9 pp -102.9 153.79 19.86 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.274 1.537 . . . . 0.0 114.302 -168.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -99.11 -37.73 9.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.212 1.005 . . . . 0.0 113.284 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -159.88 110.96 1.95 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.211 1.404 . . . . 0.0 109.706 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.13 37.82 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.872 0.844 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.05 131.07 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 108.634 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.6 t -124.04 131.0 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.49 1.116 . . . . 0.0 109.521 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 9.1 t80 -105.27 113.52 27.16 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.994 1.317 . . . . 0.0 112.039 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -82.09 75.64 9.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.162 1.385 . . . . 0.0 110.607 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -77.24 166.74 22.81 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.866 0.866 . . . . 0.0 113.261 176.472 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.35 160.39 25.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.572 1.149 . . . . 0.0 112.31 173.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -74.4 -56.42 4.88 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.26 -64.96 0.79 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.694 1.198 . . . . 0.0 112.067 -170.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -51.21 121.97 17.43 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 127.027 2.131 . . . . 0.0 113.677 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.96 -23.06 76.49 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.402 3.401 . . . . 0.0 114.961 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -62.11 -45.04 95.24 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.925 0.89 . . . . 0.0 112.132 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 m -62.16 -34.63 76.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.605 1.162 . . . . 0.0 112.757 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -60.46 -25.23 65.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.743 1.617 . . . . 0.0 113.863 -171.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.9 -41.07 71.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -62.7 -29.29 70.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.053 0.941 . . . . 0.0 113.201 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -56.85 -43.09 80.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 111.885 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -68.8 -33.83 74.52 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.929 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.77 -48.07 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.709 1.604 . . . . 0.0 110.468 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.59 -34.97 79.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 0.0 112.593 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.31 -52.15 66.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 111.196 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -67.58 -32.66 73.56 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.85 0.86 . . . . 0.0 112.422 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.48 -38.1 80.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.836 1.254 . . . . 0.0 112.408 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.66 -27.8 41.18 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-N 118.911 0.778 . . . . 0.0 112.73 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.84 64.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.348 1.059 . . . . 0.0 113.607 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.43 10.66 37.18 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.769 1.628 . . . . 0.0 114.585 177.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB1' HE22 ' A' ' 50' ' ' GLN . . . -138.22 73.32 44.36 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.483 1.513 . . . . 0.0 112.324 177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.64 -22.61 73.34 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.566 2.844 . . . . 0.0 115.701 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.422 HE22 ' HB1' ' A' ' 48' ' ' ALA . 1.8 pm0 -86.62 -4.61 59.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.21 132.11 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.877 1.271 . . . . 0.0 111.057 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.39 105.34 15.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mt -107.86 135.08 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.958 0.903 . . . . 0.0 110.426 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.0 p -149.3 172.17 15.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 0.0 112.152 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.4 p -116.98 170.27 8.76 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.696 -1.253 . . . . 0.0 111.668 167.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.1 128.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.434 1.094 . . . . 0.0 110.074 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.2 111.04 1.8 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.692 1.197 . . . . 0.0 110.467 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.8 p -61.32 -26.55 67.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.131 0.972 . . . . 0.0 113.014 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -78.35 -20.4 51.41 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.879 0.763 . . . . 0.0 112.673 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.06 -26.13 20.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.384 1.074 . . . . 0.0 112.399 168.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -117.61 48.21 0.79 Allowed Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 126.055 1.742 . . . . 0.0 114.928 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.82 -17.08 14.19 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.932 2.421 . . . . 0.0 114.189 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -26.8 64.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.51 1.05 . . . . 0.0 112.616 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.75 -46.83 34.62 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.151 0.432 . . . . 0.0 110.738 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 mtm -55.61 -28.69 56.6 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.929 0.891 . . . . 0.0 113.143 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -60.22 -29.8 68.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.644 1.577 . . . . 0.0 113.361 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -91.33 -36.69 13.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.923 1.289 . . . . 0.0 111.164 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.87 -19.25 30.86 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.5 18.5 30.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.206 1.384 . . . . 0.0 114.835 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -79.36 151.55 30.92 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.265 1.033 . . . . 0.0 111.537 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -94.42 -72.49 0.61 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.761 1.225 . . . . 0.0 111.405 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.27 15.99 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.91 1.684 . . . . 0.0 113.147 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.31 157.3 34.35 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.349 1.46 . . . . 0.0 111.866 -157.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.31 91.28 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.757 2.972 . . . . 0.0 110.48 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.9 m -104.77 126.71 52.13 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 111.606 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.66 126.1 34.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 109.296 165.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.91 125.34 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.862 1.665 . . . . 0.0 108.74 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.58 121.29 44.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.511 1.124 . . . . 0.0 110.312 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 19' ' ' LEU . 28.2 mm -108.99 120.73 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 108.978 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -118.47 126.24 51.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.912 1.685 . . . . 0.0 109.419 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.77 19.7 9.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.366 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 2.35 88.37 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.223 -0.923 . . . . 0.0 114.627 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -103.24 135.91 44.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.078 1.751 . . . . 0.0 109.208 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.76 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.018 -1.051 . . . . 0.0 110.284 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -95.49 -20.76 18.78 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.596 1.158 . . . . 0.0 113.386 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -162.85 148.83 12.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.935 2.094 . . . . 0.0 108.828 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -161.77 144.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 110.58 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -157.71 143.03 16.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.42 1.088 . . . . 0.0 112.091 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.3 m -101.88 131.01 48.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.099 0.959 . . . . 0.0 110.955 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.88 -166.84 23.5 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.503 1.525 . . . . 0.0 113.273 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -120.08 146.07 25.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.14 1.776 . . . . 0.0 110.036 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.1 ptp -150.18 163.18 38.9 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 165.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.31 158.89 86.51 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.521 1.128 . . . . 0.0 112.53 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.78 -16.43 26.39 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.677 2.251 . . . . 0.0 113.707 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -68.14 -47.53 67.84 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 110.237 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -79.05 -27.07 43.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.307 1.043 . . . . 0.0 112.79 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.1 tp -61.59 -22.99 65.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.467 -0.771 . . . . 0.0 113.056 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -63.2 -42.05 99.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.226 0.61 . . . . 0.0 111.509 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -33.41 70.74 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.44 0.696 . . . . 0.0 112.15 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -50.14 72.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.761 1.224 . . . . 0.0 109.852 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.02 -44.47 96.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.344 1.058 . . . . 0.0 112.935 172.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.17 84.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.989 0.813 . . . . 0.0 111.834 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -55.68 -32.86 63.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.966 1.306 . . . . 0.0 112.849 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 124.578 1.151 . . . . 0.0 110.803 177.647 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 mm . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 127.173 2.189 . . . . 0.0 110.467 -172.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptp . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -29.63 68.49 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -75.34 -39.78 59.02 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.614 -0.679 . . . . 0.0 111.295 168.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.42 -13.34 61.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -91.46 -13.42 32.3 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.833 1.253 . . . . 0.0 113.417 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.64 -17.8 3.79 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 -170.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.11 165.91 22.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 114.206 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.2 m -83.54 -50.32 8.37 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -164.96 114.62 1.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.437 1.495 . . . . 0.0 109.955 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.74 160.81 42.84 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.18 122.63 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.916 1.286 . . . . 0.0 107.915 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.79 117.36 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.395 1.478 . . . . 0.0 109.383 -170.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' HB2' HD13 ' A' ' 76' ' ' LEU . 17.6 t80 -102.07 115.09 29.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.925 0.89 . . . . 0.0 112.894 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -81.22 78.04 8.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.871 1.268 . . . . 0.0 111.662 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -170.69 3.11 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.649 1.18 . . . . 0.0 113.265 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -142.83 164.91 28.82 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.847 1.659 . . . . 0.0 111.339 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -39.0 -94.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.407 2.283 . . . . 0.0 116.922 -164.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.01 -22.82 16.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 113.842 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 61.0 m -46.71 115.66 3.4 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 127.018 2.127 . . . . 0.0 113.242 -171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -55.2 -24.5 41.86 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.586 3.524 . . . . 0.0 116.196 -175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.94 -48.6 75.45 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.256 0.934 . . . . 0.0 112.186 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 94.4 m -70.13 -25.91 63.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.288 1.035 . . . . 0.0 113.318 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -65.4 -30.02 70.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.253 1.021 . . . . 0.0 112.816 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.24 -51.49 69.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 110.794 169.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.67 -41.22 97.24 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.741 1.216 . . . . 0.0 112.906 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.54 -37.19 65.13 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.502 -0.749 . . . . 0.0 111.766 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.01 -31.35 62.9 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.525 -1.359 . . . . 0.0 112.092 176.015 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.9 -44.17 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.706 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.42 -40.76 92.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.523 0.729 . . . . 0.0 112.584 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.35 -49.8 75.49 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.544 0.611 . . . . 0.0 112.61 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.14 -37.6 87.92 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.567 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.18 -38.01 89.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.821 1.248 . . . . 0.0 111.763 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.41 -19.11 67.18 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.37 0.986 . . . . 0.0 113.066 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.44 -32.24 68.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.097 0.959 . . . . 0.0 113.453 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 11.01 34.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.575 1.55 . . . . 0.0 114.232 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.68 45.44 0.37 Allowed Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 125.708 1.603 . . . . 0.0 114.328 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.42 -15.46 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.209 2.606 . . . . 0.0 114.088 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.46 -7.93 58.76 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.74 133.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.653 1.115 . . . . 0.0 108.048 163.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.62 85.25 4.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.831 0.824 . . . . 0.0 110.286 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.06 130.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.4 p -144.54 172.05 13.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.088 0.947 . . . . 0.0 112.085 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.6 p -128.28 154.27 46.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.14 -0.975 . . . . 0.0 110.343 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.0 t -139.9 126.32 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.828 1.251 . . . . 0.0 108.528 -169.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.88 100.04 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.152 1.381 . . . . 0.0 110.832 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.0 p -54.44 -36.71 64.34 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.569 1.147 . . . . 0.0 113.146 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.61 -26.95 67.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.311 1.844 . . . . 0.0 114.088 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.09 -17.29 16.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.414 1.486 . . . . 0.0 112.994 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.13 51.05 2.28 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.54 1.936 . . . . 0.0 112.377 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.33 -24.25 43.64 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.737 1.624 . . . . 0.0 111.553 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.48 -26.3 67.87 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 113.073 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.16 -55.18 6.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 109.5 168.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 mtm -57.54 -24.01 53.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.479 1.112 . . . . 0.0 113.369 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -70.37 -28.47 65.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.748 1.619 . . . . 0.0 111.696 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -80.96 -38.05 28.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.255 1.022 . . . . 0.0 111.007 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.93 -22.5 21.94 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.04 22.84 16.35 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.65 1.595 . . . . 0.0 115.024 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.11 153.63 25.97 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.663 1.232 . . . . 0.0 111.76 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.58 -70.6 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.353 1.061 . . . . 0.0 112.377 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -157.34 3.58 0.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -165.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.48 156.88 38.78 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.07 1.748 . . . . 0.0 113.02 -162.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.66 93.33 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.034 3.156 . . . . 0.0 110.261 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.2 m -103.41 129.77 50.58 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.253 1.021 . . . . 0.0 110.429 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 25' ' ' PHE . 12.5 tp -110.07 119.52 39.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.89 0.876 . . . . 0.0 110.061 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 t -117.13 129.15 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.343 1.457 . . . . 0.0 109.079 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -111.21 118.73 36.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.824 0.849 . . . . 0.0 109.901 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.451 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 30.1 mm -107.21 114.36 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.18 1.392 . . . . 0.0 109.148 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -108.28 118.57 37.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.771 1.228 . . . . 0.0 108.586 173.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.05 22.34 13.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.99 1.316 . . . . 0.0 113.209 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.63 10.47 70.15 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.372 0.987 . . . . 0.0 113.149 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -112.51 131.83 55.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.156 1.382 . . . . 0.0 109.37 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.16 106.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.625 -0.672 . . . . 0.0 109.419 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.01 -20.15 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -162.27 153.52 17.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.917 1.687 . . . . 0.0 110.448 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.13 144.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.96 1.304 . . . . 0.0 110.807 172.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.89 162.33 35.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.933 1.293 . . . . 0.0 109.814 165.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -130.98 140.91 50.21 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.411 0.685 . . . . 0.0 112.589 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.74 19.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.693 1.616 . . . . 0.0 112.386 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.1 mm -125.63 145.33 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.222 1.809 . . . . 0.0 110.135 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.8 ptp -147.36 -149.06 0.27 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.746 0.818 . . . . 0.0 111.473 164.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.85 160.06 38.97 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.519 1.528 . . . . 0.0 110.43 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.78 -34.49 11.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.612 1.542 . . . . 0.0 113.815 -153.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -59.14 -32.25 69.7 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.53 -32.55 32.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.083 0.953 . . . . 0.0 111.838 172.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.5 tp -65.62 -30.08 70.75 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.275 -0.891 . . . . 0.0 112.543 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.7 -37.55 73.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.05 0.841 . . . . 0.0 112.015 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.26 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.969 -1.082 . . . . 0.0 112.211 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.19 -39.96 90.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.726 -0.609 . . . . 0.0 111.37 175.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.58 -48.29 80.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.204 1.002 . . . . 0.0 112.123 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.7 -32.89 74.07 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.82 -1.175 . . . . 0.0 112.718 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.3 t -64.57 -13.53 53.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.787 1.635 . . . . 0.0 113.331 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.474 0.736 0 O-C-N 120.658 -1.276 . . . . 0.0 110.719 170.854 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.6 mm . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 120.268 0.08 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 C-N-CA 124.448 1.099 . . . . 0.0 112.558 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.8 -25.87 63.06 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -82.82 -32.76 27.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.662 . . . . 0.0 111.916 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.89 -28.83 68.64 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.807 -0.558 . . . . 0.0 111.221 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.41 -7.05 16.81 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.567 -1.333 . . . . 0.0 114.042 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.11 -4.72 61.16 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.151 1.358 . . . . 0.0 115.506 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.3 mt -77.65 159.27 29.29 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.625 1.713 . . . . 0.0 115.215 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -87.09 -51.65 5.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.014 143.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -161.55 135.23 6.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.16 1.784 . . . . 0.0 112.586 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.04 162.98 38.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.218 1.407 . . . . 0.0 112.916 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -139.33 132.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.057 1.343 . . . . 0.0 108.707 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.07 123.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.012 1.325 . . . . 0.0 109.631 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -102.77 110.72 22.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.646 1.178 . . . . 0.0 111.621 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.02 70.29 5.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.962 1.705 . . . . 0.0 110.845 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -171.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.182 0.993 . . . . 0.0 113.561 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -136.27 163.35 30.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.644 1.178 . . . . 0.0 111.329 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -72.39 -60.89 2.01 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.284 1.033 . . . . 0.0 112.716 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.91 -41.9 35.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.648 1.179 . . . . 0.0 112.342 -169.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.2 m -47.59 108.51 0.9 Allowed Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 126.667 1.987 . . . . 0.0 114.191 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -62.09 -30.27 82.32 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.377 2.718 . . . . 0.0 113.926 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.88 -38.26 90.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -61.81 -32.54 72.85 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.955 0.902 . . . . 0.0 113.109 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.67 -29.1 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.709 0.804 . . . . 0.0 112.758 -174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -63.58 -43.47 96.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.573 0.749 . . . . 0.0 111.626 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.9 mmm -66.31 -26.08 67.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.745 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -44.69 89.26 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.531 1.06 . . . . 0.0 111.512 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -62.23 -43.92 97.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.996 -1.065 . . . . 0.0 112.226 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.45 -48.38 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.342 1.057 . . . . 0.0 111.051 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.4 mt -63.47 -37.11 86.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.005 0.922 . . . . 0.0 112.961 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.72 -47.86 81.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.432 0.693 . . . . 0.0 111.119 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.05 -32.54 72.97 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.913 0.885 . . . . 0.0 113.17 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.11 -36.45 83.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.683 1.593 . . . . 0.0 111.782 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.19 -22.5 62.95 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-N 118.917 0.78 . . . . 0.0 112.445 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.09 -28.71 64.85 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.715 1.206 . . . . 0.0 113.904 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 9.79 29.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.503 1.521 . . . . 0.0 114.256 176.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.46 85.73 14.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.381 1.472 . . . . 0.0 111.338 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.02 -15.03 18.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.878 2.385 . . . . 0.0 114.52 -169.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.97 -12.62 24.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.11 1.323 . . . . 0.0 113.874 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.69 129.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 110.226 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.96 92.99 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.371 0.605 . . . . 0.0 110.36 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 mt -92.96 136.24 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 109.988 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.5 p -148.15 168.55 22.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 112.688 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -118.25 168.84 10.22 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.989 -1.069 . . . . 0.0 110.636 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.77 131.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.33 1.052 . . . . 0.0 109.487 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.45 115.51 9.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.875 1.27 . . . . 0.0 111.873 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.7 p -57.05 -27.72 61.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.824 1.25 . . . . 0.0 113.826 172.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.53 -23.32 50.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.306 0.957 . . . . 0.0 112.498 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.79 -39.94 9.2 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.912 1.285 . . . . 0.0 113.108 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -126.89 60.58 41.73 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.544 . . . . 0.0 112.71 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.42 -15.95 34.71 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.395 2.73 . . . . 0.0 111.777 167.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.11 -41.18 68.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.606 1.563 . . . . 0.0 112.156 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.56 -44.05 62.64 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.336 0.654 . . . . 0.0 111.675 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.5 mtp -56.41 -28.94 60.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.711 0.805 . . . . 0.0 112.184 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -17.95 60.77 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.634 1.174 . . . . 0.0 113.505 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -81.06 -40.65 23.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.13 1.372 . . . . 0.0 110.822 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.52 -26.16 38.28 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.325 0.65 . . . . 0.0 112.481 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 16.51 23.78 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.906 1.717 . . . . 0.0 114.791 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.56 140.61 38.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.086 1.443 . . . . 0.0 110.691 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -77.29 -77.17 0.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.955 0.502 . . . . 0.0 110.778 175.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -147.79 4.56 0.76 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.443 1.497 . . . . 0.0 114.88 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.9 m -86.29 155.89 57.17 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 126.579 1.952 . . . . 0.0 113.198 -166.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.43 82.96 2.36 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 124.533 3.489 . . . . 0.0 111.294 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.4 m -96.38 130.88 43.4 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 112.683 -169.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.47 122.96 36.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.79 1.236 . . . . 0.0 108.987 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.17 126.04 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.553 1.541 . . . . 0.0 108.745 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.04 117.11 32.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 109.856 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.1 mm -109.7 126.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.922 1.289 . . . . 0.0 110.101 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -114.31 121.15 42.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.964 1.706 . . . . 0.0 108.622 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.9 t70 60.73 27.71 17.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.666 1.121 . . . . 0.0 111.927 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 -3.14 83.1 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -99.56 132.05 45.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.499 1.52 . . . . 0.0 109.65 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.12 104.02 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.71 -20.49 21.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.252 1.021 . . . . 0.0 113.107 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -163.03 155.61 18.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.21 1.804 . . . . 0.0 110.717 -173.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.35 146.42 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.093 1.357 . . . . 0.0 111.031 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.45 149.49 30.87 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.3 1.44 . . . . 0.0 108.575 169.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -134.01 140.13 46.49 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.133 -0.979 . . . . 0.0 112.08 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.84 -144.53 18.22 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.671 1.129 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.7 mm -116.96 143.26 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.322 1.449 . . . . 0.0 111.399 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.1 ptp -155.73 169.87 23.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 113.185 160.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -83.53 162.44 53.38 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 125.725 1.61 . . . . 0.0 112.129 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.95 -30.65 21.06 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.089 1.859 . . . . 0.0 114.655 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.7 -28.78 60.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.319 1.418 . . . . 0.0 113.027 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.1 -25.19 47.42 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.577 -0.702 . . . . 0.0 112.545 164.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.84 -30.65 67.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 111.953 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.32 -44.67 92.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.261 0.937 . . . . 0.0 111.086 163.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.52 72.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.257 0.935 . . . . 0.0 112.743 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.82 -48.22 72.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.127 1.371 . . . . 0.0 110.196 173.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.72 -42.24 83.43 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.935 0.894 . . . . 0.0 112.204 170.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.69 67.71 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.072 -1.018 . . . . 0.0 111.865 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 m -76.96 -10.7 59.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.583 1.553 . . . . 0.0 113.169 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.477 0.902 0 CA-C-N 119.391 0.996 . . . . 0.0 108.536 162.561 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 120.89 0.376 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 . . . . . 0 C--O 1.236 0.367 0 C-N-CA 127.89 2.476 . . . . 0.0 111.704 -172.655 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.89 70.51 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -74.73 -40.13 61.46 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.678 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -73.92 -9.8 59.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -92.07 -16.21 26.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.436 1.494 . . . . 0.0 113.173 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -19.05 6.63 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.63 166.4 22.82 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -82.72 -65.72 0.98 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.266 1.426 . . . . 0.0 113.013 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -148.42 121.79 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.603 1.561 . . . . 0.0 109.669 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.46 161.54 39.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.3 mt -138.16 123.17 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.645 1.578 . . . . 0.0 107.936 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.0 121.96 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.268 1.427 . . . . 0.0 108.314 -175.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -100.4 107.68 19.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.92 0.888 . . . . 0.0 110.802 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.11 80.74 3.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.721 1.208 . . . . 0.0 109.83 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.87 -178.31 7.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.708 1.203 . . . . 0.0 111.913 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -127.36 139.59 52.76 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.276 -1.515 . . . . 0.0 110.953 161.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -57.3 -32.75 66.97 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.696 1.598 . . . . 0.0 114.02 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -80.66 -37.97 29.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 113.209 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.0 t -57.5 118.13 23.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.934 1.694 . . . . 0.0 113.713 -168.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.48 -24.98 56.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.151 3.234 . . . . 0.0 113.381 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -77.01 -40.94 44.75 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.798 0.727 . . . . 0.0 110.957 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 78.7 m -52.83 -34.66 55.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.754 1.222 . . . . 0.0 113.959 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -55.98 -39.73 72.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.076 0.95 . . . . 0.0 112.303 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -65.2 -47.02 78.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.626 0.77 . . . . 0.0 110.841 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 tpt -60.66 -36.08 77.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.715 1.206 . . . . 0.0 112.176 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.63 -37.77 88.58 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.689 -1.257 . . . . 0.0 112.759 172.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -34.01 74.67 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.818 1.19 . . . . 0.0 112.476 171.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.07 -48.77 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-N 119.14 0.882 . . . . 0.0 110.385 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.97 -34.09 77.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.682 1.193 . . . . 0.0 112.087 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.13 -49.47 75.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.704 1.138 . . . . 0.0 111.475 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -66.57 -33.97 76.85 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.696 -0.627 . . . . 0.0 112.391 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -63.35 -42.61 98.92 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 111.261 170.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.82 -26.52 45.29 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.295 0.95 . . . . 0.0 112.619 -171.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.28 68.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.166 0.986 . . . . 0.0 113.428 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.32 8.27 35.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.618 1.567 . . . . 0.0 114.269 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.22 45.24 0.89 Allowed Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 126.257 1.823 . . . . 0.0 113.202 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.22 -15.74 51.52 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.751 2.967 . . . . 0.0 114.531 -167.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -76.84 -9.18 58.51 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.36 130.53 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.822 1.192 . . . . 0.0 108.529 162.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.57 96.05 6.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.301 0.641 . . . . 0.0 110.674 174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mt -104.87 130.13 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.135 -0.978 . . . . 0.0 109.48 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.0 p -148.82 170.75 17.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.054 0.942 . . . . 0.0 112.325 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.2 p -129.89 153.63 48.12 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.017 -1.052 . . . . 0.0 112.896 174.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.87 134.54 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.677 1.591 . . . . 0.0 109.154 -168.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.46 121.04 26.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 123.026 1.393 . . . . 0.0 113.159 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 p -62.6 -23.71 67.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.861 1.664 . . . . 0.0 114.979 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.28 -45.1 10.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.031 1.287 . . . . 0.0 111.823 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.07 -26.92 43.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.709 1.204 . . . . 0.0 113.671 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.56 54.51 14.6 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.746 1.618 . . . . 0.0 112.038 -171.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.19 -9.67 13.91 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.318 3.345 . . . . 0.0 113.675 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -66.27 -21.78 66.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.801 0.84 . . . . 0.0 112.509 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.67 -54.25 6.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.77 1.228 . . . . 0.0 110.92 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.5 mtm -55.74 -30.01 60.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -74.2 -14.24 60.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.731 0.812 . . . . 0.0 112.803 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -89.04 -38.71 14.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.656 1.183 . . . . 0.0 110.538 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.46 -22.52 28.23 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 17.27 26.39 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.788 1.661 . . . . 0.0 115.061 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.56 140.58 37.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.016 1.408 . . . . 0.0 110.835 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.98 -59.36 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.618 0.767 . . . . 0.0 112.19 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -157.04 1.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 m -101.64 152.72 38.13 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.796 1.638 . . . . 0.0 113.028 -163.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.86 91.7 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.093 3.196 . . . . 0.0 110.396 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -107.2 124.83 50.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 0.0 112.47 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.56 129.25 37.57 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.274 0.63 . . . . 0.0 109.859 166.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.17 127.98 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.77 1.628 . . . . 0.0 108.401 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -105.64 127.84 53.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.424 1.09 . . . . 0.0 109.757 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.7 115.84 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.055 0.942 . . . . 0.0 108.674 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.43 123.93 50.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.131 1.373 . . . . 0.0 108.879 171.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.58 20.22 11.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.199 1.4 . . . . 0.0 112.681 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.11 12.56 82.29 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 113.694 -172.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -107.71 134.82 50.13 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.699 1.6 . . . . 0.0 109.754 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.74 105.12 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.96 -27.81 13.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -162.05 154.27 19.36 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.035 1.334 . . . . 0.0 110.579 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.2 145.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.878 1.271 . . . . 0.0 110.701 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 144.92 25.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.007 0.923 . . . . 0.0 111.17 165.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 m -111.52 120.17 41.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.122 0.969 . . . . 0.0 110.523 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.74 29.89 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 124.926 1.25 . . . . 0.0 114.382 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm -112.2 140.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.429 1.492 . . . . 0.0 109.7 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.0 mtm -142.6 161.32 38.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.781 0.833 . . . . 0.0 112.338 167.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -76.01 161.06 76.93 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.508 1.523 . . . . 0.0 112.064 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.31 -25.25 22.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.243 1.962 . . . . 0.0 114.453 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -76.67 -35.99 57.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.031 1.287 . . . . 0.0 112.543 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.5 -25.42 50.33 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.017 0.826 . . . . 0.0 112.784 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.29 -25.96 68.15 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.183 -0.948 . . . . 0.0 112.4 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -63.9 -38.76 92.29 Favored 'General case' 0 C--N 1.342 0.281 0 O-C-N 121.553 -0.717 . . . . 0.0 111.877 172.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.31 79.72 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.66 0.664 . . . . 0.0 112.038 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.01 -42.94 79.92 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.26 -43.37 98.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.806 0.843 . . . . 0.0 112.185 171.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.57 87.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.46 -0.775 . . . . 0.0 111.131 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.3 m -66.58 -4.07 7.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.004 1.722 . . . . 0.0 114.846 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 119.082 0.855 . . . . 0.0 110.58 166.862 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.257 0.551 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 . . . . . 0 C--O 1.235 0.311 0 C-N-CA 125.766 1.626 . . . . 0.0 110.276 -178.258 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -26.24 66.92 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -68.31 -43.24 78.08 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.123 0.874 . . . . 0.0 110.73 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -75.78 -9.71 58.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.236 1.014 . . . . 0.0 112.907 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.01 -14.33 29.57 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.046 1.338 . . . . 0.0 113.218 167.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.05 -15.71 6.04 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.73 174.29 8.61 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 p -88.37 -60.06 2.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.411 1.485 . . . . 0.0 113.497 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -158.47 115.59 2.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.218 1.407 . . . . 0.0 110.36 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.08 160.74 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -168.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.7 mt -137.43 128.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.949 1.7 . . . . 0.0 109.106 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.73 135.07 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.131 1.372 . . . . 0.0 109.458 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -116.07 114.79 25.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 111.729 172.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -83.94 74.24 10.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.941 1.696 . . . . 0.0 111.31 -175.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.73 -170.14 2.01 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -157.25 170.84 21.56 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.611 1.564 . . . . 0.0 113.323 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -47.57 -102.9 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 128.827 2.851 . . . . 0.0 116.951 -173.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.7 -15.73 41.35 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.015 -1.678 . . . . 0.0 114.629 -168.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -49.18 119.93 9.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.681 1.592 . . . . 0.0 112.494 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.31 -25.71 36.11 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.319 2.679 . . . . 0.0 113.732 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -70.93 -43.23 68.65 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 119.366 0.985 . . . . 0.0 112.179 -168.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -67.22 -25.1 65.94 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -61.68 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.114 0.966 . . . . 0.0 113.595 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -63.21 -44.69 94.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.415 0.686 . . . . 0.0 111.903 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -60.88 -30.63 70.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.416 1.086 . . . . 0.0 113.002 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.74 -35.37 76.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.404 0.682 . . . . 0.0 111.786 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' HE3' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -69.67 -34.09 73.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.525 1.057 . . . . 0.0 111.035 176.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 t -69.62 -46.35 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.014 1.726 . . . . 0.0 109.362 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.8 mt -61.96 -41.67 98.26 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.379 1.872 . . . . 0.0 112.658 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.62 -52.42 64.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.616 1.166 . . . . 0.0 111.97 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -66.47 -32.96 74.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.049 -1.032 . . . . 0.0 112.551 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -68.24 -34.3 75.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.896 1.278 . . . . 0.0 112.311 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.84 46.01 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 121.002 -1.061 . . . . 0.0 112.657 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.96 65.56 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.157 1.383 . . . . 0.0 114.537 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 4.84 23.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.976 1.31 . . . . 0.0 114.086 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.72 40.59 0.62 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.701 1.6 . . . . 0.0 114.034 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -65.56 -13.28 39.01 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.641 2.894 . . . . 0.0 114.685 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -77.83 -9.02 58.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 173.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.75 132.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.21 0.914 . . . . 0.0 108.903 161.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.26 92.65 5.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.332 0.587 . . . . 0.0 110.324 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.8 mt -102.16 131.1 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.253 1.021 . . . . 0.0 109.667 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.5 p -147.16 159.43 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.716 0.806 . . . . 0.0 112.369 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.0 p -98.14 163.6 12.67 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.213 -0.929 . . . . 0.0 111.145 163.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -147.99 129.17 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.602 1.561 . . . . 0.0 108.8 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.12 108.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.685 0.794 . . . . 0.0 110.188 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 p -52.55 -41.18 63.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.897 1.279 . . . . 0.0 111.88 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.14 -22.22 66.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.96 1.704 . . . . 0.0 114.223 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.06 -14.59 22.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.115 1.366 . . . . 0.0 113.4 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -131.9 49.61 4.82 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.79 1.636 . . . . 0.0 113.959 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -67.53 -26.35 40.29 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.431 2.087 . . . . 0.0 112.209 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -60.81 -41.28 95.35 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 0.0 111.703 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.97 -50.34 72.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.735 0.814 . . . . 0.0 110.996 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.9 mtp -57.63 -22.87 48.02 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.629 0.771 . . . . 0.0 113.022 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -14.03 52.94 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.561 1.144 . . . . 0.0 112.813 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -83.58 -41.35 17.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.343 1.057 . . . . 0.0 110.599 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.31 -24.72 32.05 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.47 20.98 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 125.172 1.368 . . . . 0.0 115.018 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -82.14 145.69 29.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.11 1.455 . . . . 0.0 111.508 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -80.91 -75.2 0.29 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 111.343 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -161.13 13.41 0.1 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -166.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.21 155.62 36.2 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 126.389 1.876 . . . . 0.0 113.255 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.56 90.26 1.05 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.16 3.24 . . . . 0.0 110.846 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -99.73 132.45 45.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 112.595 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.56 131.52 35.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.474 1.11 . . . . 0.0 109.71 161.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.65 121.92 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.776 1.631 . . . . 0.0 108.302 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.04 124.12 49.71 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.125 0.97 . . . . 0.0 110.687 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.54 122.74 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.171 1.388 . . . . 0.0 109.51 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -116.9 124.16 48.78 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.445 1.498 . . . . 0.0 109.192 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 62.65 20.54 12.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.166 1.386 . . . . 0.0 112.362 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.71 8.98 86.18 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.083 -1.011 . . . . 0.0 113.521 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -103.74 132.55 49.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.544 1.537 . . . . 0.0 109.073 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.82 105.4 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.324 -0.86 . . . . 0.0 109.039 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.43 -24.75 15.98 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.492 1.117 . . . . 0.0 113.387 -170.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -160.51 146.87 15.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.444 1.498 . . . . 0.0 110.801 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.2 t -147.51 145.52 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 109.826 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.26 151.5 29.2 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.976 0.911 . . . . 0.0 111.44 162.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.8 m -115.95 135.28 54.12 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.624 0.77 . . . . 0.0 111.944 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.89 -149.4 17.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.935 1.255 . . . . 0.0 112.593 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.19 139.65 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.571 1.548 . . . . 0.0 110.76 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -139.22 160.48 39.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.448 1.099 . . . . 0.0 112.044 163.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -74.0 162.11 75.49 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 124.76 1.224 . . . . 0.0 111.869 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.89 -23.71 12.12 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.09 1.86 . . . . 0.0 114.676 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.8 -37.33 67.59 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.137 1.79 . . . . 0.0 112.607 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -78.81 -22.88 45.59 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.653 0.66 . . . . 0.0 112.151 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.64 -29.57 70.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 0.0 112.09 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.74 -39.4 93.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.239 0.927 . . . . 0.0 111.393 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.19 80.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.503 -0.748 . . . . 0.0 111.93 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.41 -44.6 90.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.166 0.586 . . . . 0.0 110.686 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.18 -47.44 86.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.19 0.996 . . . . 0.0 112.693 172.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.16 76.52 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.13 -0.982 . . . . 0.0 112.351 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.1 t -65.58 -14.34 60.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.382 1.473 . . . . 0.0 113.737 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 N--CA 1.48 1.038 0 O-C-N 119.988 -1.695 . . . . 0.0 110.588 172.682 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 125.412 1.485 . . . . 0.0 111.637 -166.349 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 -28.93 63.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -74.16 -39.11 63.46 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.656 -0.652 . . . . 0.0 110.413 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.41 -14.98 61.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 113.302 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -89.49 -20.14 24.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.629 1.172 . . . . 0.0 112.846 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.24 -23.47 6.97 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 124.896 1.236 . . . . 0.0 115.081 -171.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.25 165.65 23.2 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -89.1 -56.22 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.987 1.315 . . . . 0.0 113.003 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -155.34 110.54 3.02 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.898 1.279 . . . . 0.0 110.65 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.84 159.75 42.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.7 mt -135.29 129.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.508 1.523 . . . . 0.0 108.445 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -121.28 124.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.613 1.565 . . . . 0.0 109.57 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -104.06 119.22 38.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -85.05 76.29 10.27 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.098 -1.001 . . . . 0.0 110.455 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 173.08 11.81 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.682 0.753 . . . . 0.0 112.931 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -125.68 147.66 49.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.694 1.198 . . . . 0.0 110.772 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.84 148.27 30.63 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 67.61 -30.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.907 2.883 . . . . 0.0 115.296 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.4 t -52.13 117.55 10.42 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.019 1.728 . . . . 0.0 113.305 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.91 -24.64 74.19 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.194 3.263 . . . . 0.0 113.602 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -72.61 -43.27 63.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.226 0.921 . . . . 0.0 110.585 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.6 -33.26 69.79 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 113.065 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -54.72 -39.8 68.59 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.174 0.989 . . . . 0.0 112.501 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.39 -48.13 81.63 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.549 0.74 . . . . 0.0 110.959 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.738 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.31 -43.09 96.66 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.209 0.913 . . . . 0.0 111.325 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -41.93 85.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.581 0.752 . . . . 0.0 112.43 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.86 -46.96 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.873 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.28 -34.09 77.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.114 1.365 . . . . 0.0 112.609 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.68 -46.46 88.07 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.9 0.773 . . . . 0.0 112.158 169.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -68.86 -35.16 76.59 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.289 -0.882 . . . . 0.0 112.033 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.76 -37.67 88.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.405 1.482 . . . . 0.0 111.848 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.49 -22.02 57.17 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 123.863 0.744 . . . . 0.0 113.369 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.74 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.264 1.026 . . . . 0.0 113.332 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 10.08 41.28 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.327 1.451 . . . . 0.0 114.601 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.75 48.83 0.74 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.629 1.572 . . . . 0.0 113.709 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.36 -16.96 57.89 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.591 2.861 . . . . 0.0 114.023 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -79.09 -8.28 58.84 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.53 134.12 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.545 1.066 . . . . 0.0 108.685 166.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.23 86.73 4.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.466 0.651 . . . . 0.0 110.647 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.5 mt -93.27 127.19 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.748 0.819 . . . . 0.0 109.178 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t -141.52 164.42 30.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.768 1.227 . . . . 0.0 110.906 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -110.42 -175.92 2.85 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 162.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.4 p -167.28 129.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.357 1.863 . . . . 0.0 109.222 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -72.55 114.71 10.98 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.193 0.997 . . . . 0.0 111.075 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 p -54.91 -28.09 48.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 113.601 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -74.9 -26.65 59.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.989 0.813 . . . . 0.0 112.675 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.18 -29.41 15.13 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.942 1.297 . . . . 0.0 113.415 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -127.81 49.83 4.77 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.18 1.392 . . . . 0.0 113.962 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.3 -19.93 49.48 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.937 1.758 . . . . 0.0 112.376 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.26 1.024 . . . . 0.0 112.86 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.85 -54.27 7.58 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.2 mtp -55.53 -33.31 63.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.578 1.151 . . . . 0.0 113.351 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -65.98 -21.29 66.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.695 1.598 . . . . 0.0 113.768 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -76.88 -40.14 48.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.847 0.749 . . . . 0.0 111.968 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.91 -22.56 24.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 11.86 36.41 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.337 1.922 . . . . 0.0 115.179 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.75 130.77 39.17 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.213 1.507 . . . . 0.0 111.68 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -84.12 -55.15 4.35 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.071 0.949 . . . . 0.0 112.169 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -160.41 -0.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.46 154.5 44.38 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 125.554 1.542 . . . . 0.0 113.4 -160.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.8 89.02 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.455 3.437 . . . . 0.0 109.469 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.3 m -105.2 132.67 51.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.829 0.851 . . . . 0.0 112.609 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.96 134.75 33.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.7 1.2 . . . . 0.0 110.471 166.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.5 t -130.31 131.46 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.783 1.633 . . . . 0.0 108.685 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -110.08 128.68 55.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.055 0.942 . . . . 0.0 110.65 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.86 110.49 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.0 123.75 50.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.284 1.433 . . . . 0.0 108.202 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.18 17.49 8.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.758 1.223 . . . . 0.0 112.038 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.52 83.18 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.077 0.846 . . . . 0.0 113.639 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -110.08 135.96 50.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.266 1.826 . . . . 0.0 109.397 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.09 106.29 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.94 -20.88 13.04 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -163.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -159.19 153.74 24.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.99 1.316 . . . . 0.0 111.436 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.65 144.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.734 1.614 . . . . 0.0 110.388 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -154.01 143.36 21.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.539 1.136 . . . . 0.0 112.011 165.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 m -101.19 135.58 42.42 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.927 0.891 . . . . 0.0 112.069 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.69 -162.72 12.32 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.914 1.245 . . . . 0.0 113.682 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.44 140.85 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.778 1.631 . . . . 0.0 111.285 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.8 mtm -134.79 153.21 52.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.467 1.107 . . . . 0.0 110.388 160.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.13 152.57 71.3 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 122.749 0.419 . . . . 0.0 110.978 169.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.81 -27.32 51.86 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.29 1.993 . . . . 0.0 114.264 -156.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -63.89 -30.04 71.17 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.12 -37.79 64.0 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.994 0.816 . . . . 0.0 111.008 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.6 tp -65.3 -28.24 69.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.47 -0.776 . . . . 0.0 112.819 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -59.1 -49.38 78.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.982 0.81 . . . . 0.0 111.574 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.9 -37.6 84.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.578 0.751 . . . . 0.0 111.77 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -67.24 -43.54 81.69 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.837 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.89 -47.01 87.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.425 1.09 . . . . 0.0 112.131 172.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.88 85.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.461 0.573 . . . . 0.0 111.739 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.2 m -62.48 -11.35 15.65 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.655 1.582 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.478 0.951 0 O-C-N 121.08 -1.013 . . . . 0.0 112.032 175.917 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mm . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 . . . . . 0 C--O 1.235 0.314 0 C-N-CA 124.521 1.129 . . . . 0.0 109.893 -179.52 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -25.27 64.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.719 1.208 . . . . 0.0 113.95 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -70.18 -31.16 68.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.105 0.866 . . . . 0.0 111.752 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -75.66 -20.63 58.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.943 0.897 . . . . 0.0 113.003 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.91 82.28 0.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.132 1.773 . . . . 0.0 113.075 -172.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 134.87 3.06 2.98 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 126.313 1.911 . . . . 0.0 116.927 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -74.48 114.33 12.75 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.14 1.97 . . . . 0.0 111.971 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -66.5 -28.33 68.48 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.746 -1.221 . . . . 0.0 114.045 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -155.85 97.06 1.8 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.556 1.542 . . . . 0.0 109.777 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.85 156.77 46.55 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mt -141.29 132.28 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.963 1.305 . . . . 0.0 109.347 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.58 126.57 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.322 1.449 . . . . 0.0 109.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -106.01 108.18 19.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.579 1.152 . . . . 0.0 110.419 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -77.56 76.38 4.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 110.392 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -172.37 2.31 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.847 0.859 . . . . 0.0 111.701 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -147.15 130.61 16.72 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.118 -1.614 . . . . 0.0 112.05 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.85 -23.91 61.4 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 mt -89.86 -15.5 32.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.45 122.26 73.52 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.81 1.644 . . . . 0.0 111.884 -173.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.7 -1.26 9.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.71 3.606 . . . . 0.0 113.04 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -88.43 -44.81 10.46 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.378 0.99 . . . . 0.0 109.741 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 p -61.93 -27.75 69.05 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -50.6 -38.96 48.55 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -71.98 -33.5 68.19 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.019 -0.425 . . . . 0.0 112.128 -168.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.1 tpt -64.0 -24.13 67.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.936 1.294 . . . . 0.0 113.266 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -65.17 -42.92 93.22 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.952 0.797 . . . . 0.0 110.927 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.95 -24.22 55.45 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.998 -1.064 . . . . 0.0 112.215 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.71 -51.9 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.023 0.929 . . . . 0.0 109.923 164.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.1 mt -60.14 -34.76 73.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.147 1.379 . . . . 0.0 112.619 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -58.21 -56.4 22.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.662 1.185 . . . . 0.0 111.972 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -64.5 -32.7 74.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.911 0.485 . . . . 0.0 111.414 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.21 -43.81 81.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.786 1.634 . . . . 0.0 112.979 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.5 57.32 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 120.635 -1.291 . . . . 0.0 111.684 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.44 -29.71 64.4 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 8.04 45.39 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.66 41.8 0.33 Allowed Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.786 1.634 . . . . 0.0 114.836 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.62 -22.19 16.4 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.62 3.547 . . . . 0.0 117.548 -157.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -60.69 -14.51 21.32 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -73.67 129.39 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.716 1.144 . . . . 0.0 111.289 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.8 98.59 11.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 110.797 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.6 mt -103.73 132.15 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.823 0.849 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 t -136.05 133.61 37.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.32 1.048 . . . . 0.0 110.38 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 m -86.12 155.16 20.89 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.622 -1.299 . . . . 0.0 111.531 164.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.3 t -143.72 128.86 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.642 1.577 . . . . 0.0 109.069 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.99 104.47 4.84 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.09 1.356 . . . . 0.0 110.564 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.8 p -56.19 -36.48 68.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.632 1.173 . . . . 0.0 113.468 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.57 -16.84 58.38 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -22.19 19.18 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.944 1.298 . . . . 0.0 112.88 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -116.72 52.92 1.11 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.878 1.671 . . . . 0.0 114.577 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.35 -18.07 26.74 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.7 2.267 . . . . 0.0 113.088 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -64.03 -38.14 89.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.368 0.985 . . . . 0.0 111.776 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.9 -51.99 22.78 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.607 1.163 . . . . 0.0 109.96 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.1 mtm -54.62 -32.18 58.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.095 0.958 . . . . 0.0 113.36 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -70.02 -19.95 63.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.012 1.325 . . . . 0.0 113.925 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -79.05 -39.92 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.769 0.713 . . . . 0.0 112.025 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.07 -22.45 21.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.69 15.77 28.32 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.786 1.66 . . . . 0.0 114.963 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -79.76 156.88 27.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.186 1.493 . . . . 0.0 111.626 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.03 -53.63 3.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.181 0.993 . . . . 0.0 112.654 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 168.67 17.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 129.101 2.96 . . . . 0.0 113.595 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.6 160.15 28.69 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 126.461 1.904 . . . . 0.0 111.912 -170.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -70.06 82.93 0.78 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.021 3.147 . . . . 0.0 112.516 -174.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.2 m -103.01 128.21 49.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.153 0.581 . . . . 0.0 112.363 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -94.22 120.6 34.69 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.541 1.137 . . . . 0.0 109.51 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.71 123.67 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 126.396 1.879 . . . . 0.0 108.1 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.0 120.03 40.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.887 0.875 . . . . 0.0 109.365 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.492 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 10.8 mm -108.23 121.65 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.187 1.395 . . . . 0.0 109.705 -168.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.492 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.37 122.34 47.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.833 1.653 . . . . 0.0 109.101 163.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.09 25.54 14.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 112.621 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.61 90.63 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -105.99 128.74 54.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.404 1.082 . . . . 0.0 108.924 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.07 109.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.416 0.686 . . . . 0.0 109.974 172.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.05 20.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.92 1.288 . . . . 0.0 113.494 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -163.8 152.07 13.26 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.364 1.866 . . . . 0.0 109.456 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.32 144.22 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.782 1.233 . . . . 0.0 110.971 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.17 31.78 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.431 1.493 . . . . 0.0 109.525 168.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -126.04 139.29 53.53 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 112.675 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.78 -154.43 17.02 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.931 1.729 . . . . 0.0 112.626 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.3 mm -118.2 143.83 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.31 1.444 . . . . 0.0 110.765 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -151.49 161.63 42.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.768 0.827 . . . . 0.0 112.418 161.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.38 149.54 86.7 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.021 0.929 . . . . 0.0 111.836 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.62 -31.47 79.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.003 2.469 . . . . 0.0 113.95 -168.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -52.99 -36.19 60.1 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -89.25 -29.99 18.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.757 0.708 . . . . 0.0 111.975 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.0 -30.25 70.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.664 0.786 . . . . 0.0 112.027 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -56.08 -44.24 78.79 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.766 0.712 . . . . 0.0 111.895 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.6 60.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.23 1.012 . . . . 0.0 112.521 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -70.89 -39.24 72.93 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 109.618 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.6 -36.7 73.66 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.046 1.338 . . . . 0.0 112.859 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.51 80.9 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.748 -1.22 . . . . 0.0 112.605 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -59.27 -20.65 56.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.964 0.905 . . . . 0.0 113.04 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.474 0.744 0 O-C-N 121.109 -0.994 . . . . 0.0 109.539 167.193 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 126.552 1.941 . . . . 0.0 109.814 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.52 -29.16 64.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -74.8 -41.35 60.14 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.74 -0.6 . . . . 0.0 110.557 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -72.93 -11.32 60.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.5 -17.3 27.31 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.03 1.332 . . . . 0.0 113.645 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -117.79 -16.19 5.98 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.59 171.0 13.24 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -91.4 -51.96 5.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.978 1.311 . . . . 0.0 113.166 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -160.46 109.05 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.879 1.672 . . . . 0.0 110.095 -171.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.09 158.82 44.56 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -134.64 130.14 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 0.0 109.064 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 t -119.09 125.7 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.563 1.545 . . . . 0.0 109.133 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.04 113.82 27.59 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.492 1.117 . . . . 0.0 111.311 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -78.94 69.38 5.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.48 170.38 16.66 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.843 0.857 . . . . 0.0 112.898 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -129.54 176.93 7.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.38 1.472 . . . . 0.0 111.21 168.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -100.51 -33.02 10.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.985 0.914 . . . . 0.0 113.437 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.38 -68.03 0.57 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.058 0.943 . . . . 0.0 112.934 -167.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.9 m -59.07 150.67 60.66 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.369 1.868 . . . . 0.0 114.138 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.14 -13.79 21.02 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.787 3.658 . . . . 0.0 113.19 171.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -66.83 -48.46 68.82 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 119.014 0.825 . . . . 0.0 111.969 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.0 p -61.14 -29.84 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.107 1.363 . . . . 0.0 113.597 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -55.82 -32.99 64.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.011 1.324 . . . . 0.0 112.557 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -62.94 -48.2 79.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.611 1.164 . . . . 0.0 111.73 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 mmt -63.24 -34.79 78.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.321 -0.862 . . . . 0.0 112.798 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.47 -36.37 73.62 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.267 0.939 . . . . 0.0 112.533 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -79.17 -38.67 35.35 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.29 -51.43 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.046 0.938 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.41 -33.86 75.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.793 1.237 . . . . 0.0 113.001 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.79 -49.96 70.85 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.302 0.641 . . . . 0.0 111.367 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -67.63 -32.14 72.63 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.395 -0.816 . . . . 0.0 112.885 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.36 -39.74 89.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.091 1.356 . . . . 0.0 111.966 170.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.32 -26.14 52.7 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.133 0.873 . . . . 0.0 112.343 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.6 65.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 10.11 34.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.168 1.387 . . . . 0.0 114.297 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.36 50.89 1.18 Allowed Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.102 1.761 . . . . 0.0 112.857 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.01 -14.4 44.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -168.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -78.64 -8.8 59.03 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -78.57 131.48 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.481 1.037 . . . . 0.0 108.357 165.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 96.16 6.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.07 0.548 . . . . 0.0 110.894 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.4 mt -103.84 131.48 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.2 p -148.21 172.76 13.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.918 0.887 . . . . 0.0 112.333 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -121.63 162.96 19.76 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.093 -1.004 . . . . 0.0 111.165 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.9 t -143.78 122.76 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.253 1.421 . . . . 0.0 107.712 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.0 103.92 0.51 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.325 1.45 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -58.76 -36.21 74.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.613 1.165 . . . . 0.0 112.35 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -75.1 -18.2 60.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.181 1.792 . . . . 0.0 113.893 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.07 -26.62 9.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.786 1.235 . . . . 0.0 113.527 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -126.86 51.94 7.19 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 126.171 1.788 . . . . 0.0 112.921 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -65.85 -14.98 47.17 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.746 2.297 . . . . 0.0 112.939 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -57.28 -23.39 48.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 113.182 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.98 -58.1 3.47 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 122.991 0.516 . . . . 0.0 110.682 166.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.8 mtm -57.22 -27.81 62.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.058 1.343 . . . . 0.0 113.748 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.56 -15.94 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.033 1.333 . . . . 0.0 112.726 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -87.29 -36.76 17.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.361 1.064 . . . . 0.0 111.296 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.97 -25.8 22.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 19.16 14.04 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.626 1.584 . . . . 0.0 115.264 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.97 145.85 28.32 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.409 1.605 . . . . 0.0 111.551 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -96.0 -62.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.668 0.787 . . . . 0.0 112.665 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -157.47 2.63 0.12 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.9 m -106.46 150.3 39.35 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 126.028 1.731 . . . . 0.0 112.769 -163.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.13 92.74 0.55 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.23 3.287 . . . . 0.0 109.553 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -105.08 131.98 51.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.865 0.866 . . . . 0.0 111.857 -172.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -93.53 134.54 35.7 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.489 1.116 . . . . 0.0 110.247 168.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.97 131.25 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.623 1.569 . . . . 0.0 108.89 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -115.06 123.94 50.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.283 1.033 . . . . 0.0 110.282 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.8 mm -108.08 120.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.141 1.376 . . . . 0.0 108.822 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -113.94 122.93 48.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.298 1.839 . . . . 0.0 108.869 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.7 t70 63.62 20.93 12.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.395 1.078 . . . . 0.0 112.902 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.22 84.46 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.278 -0.888 . . . . 0.0 113.256 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -108.34 133.04 53.09 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.157 1.783 . . . . 0.0 109.285 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.88 107.59 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.41 -0.806 . . . . 0.0 109.508 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.6 -25.2 15.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -160.96 150.85 17.36 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.397 1.479 . . . . 0.0 110.932 -171.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.94 143.23 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.546 1.538 . . . . 0.0 110.529 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -153.38 140.34 19.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.222 1.009 . . . . 0.0 111.404 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.4 p -97.77 133.15 42.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.735 1.214 . . . . 0.0 111.756 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.78 -168.09 13.58 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.112 1.339 . . . . 0.0 113.343 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.18 143.37 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.368 1.467 . . . . 0.0 112.019 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -135.5 163.44 30.08 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.622 1.169 . . . . 0.0 111.947 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -68.14 161.37 68.88 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.629 1.172 . . . . 0.0 111.433 164.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.76 -27.1 15.23 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.965 1.777 . . . . 0.0 113.972 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -72.84 -34.0 66.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.489 1.495 . . . . 0.0 112.646 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.2 -26.33 56.03 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.372 -0.83 . . . . 0.0 112.457 171.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.52 -30.73 71.52 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.845 -1.159 . . . . 0.0 111.941 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -61.11 -44.84 96.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.877 0.762 . . . . 0.0 111.201 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.5 75.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.257 0.623 . . . . 0.0 112.352 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.08 76.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 0.0 109.87 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -45.48 94.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.317 1.047 . . . . 0.0 112.089 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.23 77.7 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.21 -0.931 . . . . 0.0 112.459 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.8 t -63.62 -13.26 40.61 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.857 1.663 . . . . 0.0 113.452 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.471 0.575 0 O-C-N 120.674 -1.266 . . . . 0.0 109.992 169.715 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.625 0 C-N-CA 125.774 1.63 . . . . 0.0 111.312 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.18 -21.18 62.2 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.43 -39.22 19.23 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.615 -0.678 . . . . 0.0 110.57 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -78.62 -7.96 58.15 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.7 -13.47 45.31 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.87 7.86 1.09 Allowed Glycine 0 N--CA 1.478 1.469 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.23 173.06 9.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.971 1.386 . . . . 0.0 113.416 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -83.38 -61.03 1.95 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.113 0.965 . . . . 0.0 112.411 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -157.54 120.81 4.02 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.264 1.826 . . . . 0.0 110.18 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.21 159.19 43.62 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.7 mt -130.95 130.75 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.533 1.533 . . . . 0.0 109.153 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.4 t -120.73 121.97 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.685 1.594 . . . . 0.0 109.273 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.51 114.87 29.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.242 1.017 . . . . 0.0 111.824 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -79.78 72.3 6.48 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.905 1.282 . . . . 0.0 111.073 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.43 170.73 16.16 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.115 0.966 . . . . 0.0 113.147 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -142.13 168.55 19.47 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.741 1.216 . . . . 0.0 111.938 170.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -93.13 -39.65 10.93 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -165.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 mt -77.45 -39.92 45.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.45 0.7 . . . . 0.0 112.718 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.49 128.84 94.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.149 1.379 . . . . 0.0 111.693 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 -13.74 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 124.461 3.44 . . . . 0.0 112.94 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -73.9 -45.65 49.38 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 120.167 1.349 . . . . 0.0 111.918 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.5 m -53.67 -35.81 61.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.82 1.248 . . . . 0.0 113.339 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.5 -31.93 68.33 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.512 1.525 . . . . 0.0 112.889 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -72.47 -44.07 62.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.668 0.787 . . . . 0.0 111.187 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.7 tpt -58.88 -38.85 79.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.483 1.513 . . . . 0.0 112.566 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -53.67 -41.24 66.63 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.514 0.725 . . . . 0.0 112.168 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -72.29 -23.53 61.2 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.928 -1.107 . . . . 0.0 113.693 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -69.65 -45.96 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.109 0.963 . . . . 0.0 109.748 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.8 -37.61 82.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.089 0.955 . . . . 0.0 111.828 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.68 -52.24 66.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.089 0.956 . . . . 0.0 111.948 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.46 -30.03 68.8 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.478 0.711 . . . . 0.0 112.817 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.95 -34.66 76.99 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.922 0.889 . . . . 0.0 111.833 170.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -25.59 61.2 Favored Glycine 0 N--CA 1.471 1.032 0 O-C-N 121.064 -1.023 . . . . 0.0 113.632 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.55 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -171.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 7.41 10.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.209 1.403 . . . . 0.0 114.52 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.95 47.89 2.84 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.86 1.664 . . . . 0.0 113.529 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.75 -16.32 54.7 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.726 2.951 . . . . 0.0 114.431 -169.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -76.81 -6.66 53.24 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -85.1 127.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 162.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.79 103.77 11.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 0.0 109.711 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.6 mt -108.04 128.79 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.056 -1.028 . . . . 0.0 109.367 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -146.98 167.38 24.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.82 165.51 12.99 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.855 -1.153 . . . . 0.0 111.741 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.07 121.46 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.932 1.293 . . . . 0.0 108.33 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.75 102.53 0.35 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.065 1.346 . . . . 0.0 110.42 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.6 p -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.362 0.665 . . . . 0.0 112.421 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.72 -26.69 65.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 113.362 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.16 -27.76 8.99 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.981 1.312 . . . . 0.0 113.661 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -116.26 65.22 2.91 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 127.493 2.317 . . . . 0.0 110.724 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.48 -22.51 33.27 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.516 2.144 . . . . 0.0 111.963 168.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.9 -24.53 66.06 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.639 1.176 . . . . 0.0 113.204 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.48 -59.99 2.48 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.056 0.942 . . . . 0.0 110.052 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.5 mtm -58.51 -25.85 62.83 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 113.371 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -65.7 -24.54 67.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.199 1.0 . . . . 0.0 112.35 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.3 -36.3 17.96 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.533 1.133 . . . . 0.0 111.37 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.92 -24.17 22.53 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.22 13.73 32.62 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.746 1.641 . . . . 0.0 115.161 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.08 146.87 36.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.371 1.585 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.85 -61.81 1.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.602 0.761 . . . . 0.0 112.195 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.98 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.512 1.925 . . . . 0.0 111.614 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.72 150.6 31.0 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.988 1.315 . . . . 0.0 112.457 -166.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.29 85.75 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.284 3.323 . . . . 0.0 109.911 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -102.62 129.76 49.29 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.36 0.664 . . . . 0.0 111.341 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 mp -93.63 126.48 38.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.048 0.939 . . . . 0.0 108.913 164.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.63 129.4 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.122 1.769 . . . . 0.0 108.277 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.59 124.47 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 mm -109.21 122.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.828 1.251 . . . . 0.0 109.179 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -117.75 126.46 52.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.567 1.547 . . . . 0.0 108.574 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 63.28 17.79 10.51 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.429 1.091 . . . . 0.0 112.965 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.07 11.22 81.55 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.282 0.944 . . . . 0.0 113.809 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -109.58 138.5 45.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.568 1.947 . . . . 0.0 109.807 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.74 108.37 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.84 -25.49 15.02 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -160.12 154.07 23.04 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.092 1.757 . . . . 0.0 110.342 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.88 143.85 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.849 1.26 . . . . 0.0 110.19 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.9 143.64 27.52 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.344 1.058 . . . . 0.0 110.87 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 t -110.91 132.68 54.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.859 1.264 . . . . 0.0 110.83 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.46 -152.83 20.36 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.721 1.153 . . . . 0.0 114.324 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.39 146.53 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.688 1.995 . . . . 0.0 110.371 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 ptp -153.22 -169.55 3.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.489 1.516 . . . . 0.0 111.011 169.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.9 163.86 40.71 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.052 1.341 . . . . 0.0 111.072 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.54 -23.33 31.91 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.737 1.625 . . . . 0.0 114.432 -156.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.93 -30.49 69.82 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.715 1.143 . . . . 0.0 113.4 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.32 -35.72 63.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.085 0.954 . . . . 0.0 111.251 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.5 tp -64.94 -24.95 67.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.164 0.585 . . . . 0.0 112.469 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -64.39 -43.78 93.37 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.946 0.794 . . . . 0.0 111.632 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.3 84.06 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.485 0.584 . . . . 0.0 111.611 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.57 -44.25 91.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.523 0.729 . . . . 0.0 111.272 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -45.6 93.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.817 0.847 . . . . 0.0 112.22 170.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.5 74.17 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.009 0.822 . . . . 0.0 111.892 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.4 m -68.31 -5.27 17.72 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.654 1.582 . . . . 0.0 114.564 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.479 1.004 0 O-C-N 121.054 -1.029 . . . . 0.0 110.798 171.892 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 121.563 0.697 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 . . . . . 0 C--O 1.231 0.118 0 C-N-CA 126.204 1.802 . . . . 0.0 110.541 174.386 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.85 -27.57 67.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -70.61 -39.01 74.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.802 1.183 . . . . 0.0 110.658 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.19 -9.48 58.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 113.077 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.65 -15.66 32.21 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.221 1.408 . . . . 0.0 113.395 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.51 -13.44 4.26 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.89 174.06 9.77 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -96.52 -54.68 3.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -149.5 124.25 9.85 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.006 1.323 . . . . 0.0 109.654 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.27 160.12 43.94 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -140.0 132.11 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 108.436 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 129.66 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.689 1.196 . . . . 0.0 109.288 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -109.07 117.44 34.17 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.807 0.843 . . . . 0.0 112.032 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.92 71.82 8.96 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.844 1.258 . . . . 0.0 110.622 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -174.23 1.05 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.85 0.86 . . . . 0.0 113.271 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -138.73 141.3 38.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.803 -1.186 . . . . 0.0 112.177 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -61.97 -32.18 72.6 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 113.699 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.6 mt -81.68 -83.9 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.901 1.28 . . . . 0.0 111.765 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -44.19 118.98 3.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 127.901 2.48 . . . . 0.0 114.235 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.45 -17.57 23.67 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.042 3.161 . . . . 0.0 113.611 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -63.72 -44.21 94.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 119.037 0.835 . . . . 0.0 111.663 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.3 p -66.91 -27.02 67.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.61 -28.03 69.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.735 1.214 . . . . 0.0 112.515 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -64.63 -39.21 93.3 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.75 0.82 . . . . 0.0 112.502 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.2 tpp -62.28 -35.72 79.87 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.026 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -50.61 -42.01 55.52 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.476 -0.765 . . . . 0.0 112.863 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -84.11 -12.38 55.12 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.278 1.031 . . . . 0.0 113.255 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -78.58 -47.32 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.274 1.43 . . . . 0.0 109.935 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.57 -37.01 74.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.522 1.529 . . . . 0.0 112.65 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.39 -53.86 52.45 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.886 0.874 . . . . 0.0 111.697 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -64.97 -30.68 71.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.629 0.772 . . . . 0.0 112.801 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -70.96 -41.98 70.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.417 1.087 . . . . 0.0 111.379 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.96 -29.75 30.72 Favored Glycine 0 N--CA 1.47 0.943 0 C-N-CA 124.649 1.118 . . . . 0.0 113.206 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.72 67.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 9.5 38.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.686 1.595 . . . . 0.0 114.179 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.93 65.34 73.85 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 125.678 1.591 . . . . 0.0 112.357 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.42 -20.77 71.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.168 2.579 . . . . 0.0 115.144 -171.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -83.42 -6.89 59.6 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 133.04 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.671 1.189 . . . . 0.0 109.442 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.59 14.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.193 0.597 . . . . 0.0 110.682 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -108.24 130.65 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.943 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -151.36 177.56 10.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.193 1.397 . . . . 0.0 112.803 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -124.27 167.04 14.86 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.503 -1.373 . . . . 0.0 113.227 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -149.16 135.69 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.719 2.008 . . . . 0.0 108.272 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.04 119.84 23.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.091 0.948 . . . . 0.0 112.164 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.6 p -61.0 -28.0 68.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.542 1.537 . . . . 0.0 114.12 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -87.31 -34.46 18.86 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.528 0.731 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 -22.95 27.07 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.577 1.151 . . . . 0.0 113.945 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -121.67 42.54 0.59 Allowed Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.654 1.582 . . . . 0.0 114.374 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.01 -19.56 45.55 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.668 2.245 . . . . 0.0 113.052 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.05 -22.67 65.93 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.053 0.941 . . . . 0.0 113.121 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.8 -54.91 5.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.765 0.711 . . . . 0.0 110.415 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 mtm -56.19 -28.88 59.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.664 1.186 . . . . 0.0 113.63 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -68.95 -18.91 64.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.022 1.329 . . . . 0.0 113.004 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.93 -34.65 20.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.435 1.094 . . . . 0.0 110.798 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.76 -25.51 23.37 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.46 15.58 22.67 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.82 1.676 . . . . 0.0 115.296 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.38 144.61 30.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.884 1.842 . . . . 0.0 111.151 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -89.1 -56.52 3.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.983 0.913 . . . . 0.0 112.668 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -169.83 7.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -167.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -100.26 149.71 36.29 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.011 1.724 . . . . 0.0 112.959 -165.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.8 95.22 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.882 3.055 . . . . 0.0 110.292 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.2 m -114.89 130.39 56.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.768 0.827 . . . . 0.0 112.778 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.95 134.67 33.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.725 1.61 . . . . 0.0 109.825 168.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.5 132.3 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.755 1.622 . . . . 0.0 109.216 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -116.93 127.67 54.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.144 0.978 . . . . 0.0 111.016 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -112.62 122.52 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 0.0 109.106 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.6 124.23 49.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.277 1.831 . . . . 0.0 109.004 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 62.04 20.19 11.41 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.729 1.15 . . . . 0.0 113.075 171.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.1 78.16 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.279 0.942 . . . . 0.0 113.477 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -108.07 134.3 51.14 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.317 1.847 . . . . 0.0 109.464 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.37 103.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.94 12.75 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.76 163.47 39.21 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.812 1.245 . . . . 0.0 111.806 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.6 146.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.161 1.785 . . . . 0.0 110.303 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.13 136.84 14.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.157 0.983 . . . . 0.0 111.01 168.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 m -101.79 138.72 38.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 0.0 111.656 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.24 -157.2 15.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.918 1.246 . . . . 0.0 113.213 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.39 142.34 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.526 1.53 . . . . 0.0 111.333 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.2 mtm -139.94 163.16 33.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.234 1.413 . . . . 0.0 111.997 165.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -77.44 161.5 72.17 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.887 1.675 . . . . 0.0 111.742 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.19 -24.97 19.46 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.328 2.019 . . . . 0.0 113.671 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -77.2 -33.83 56.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.461 1.482 . . . . 0.0 112.828 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.75 -30.33 56.51 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.648 0.779 . . . . 0.0 112.374 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.03 -28.2 66.19 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.35 -0.844 . . . . 0.0 112.791 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -62.26 -43.11 99.57 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.759 0.709 . . . . 0.0 111.895 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.25 77.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.447 0.699 . . . . 0.0 111.532 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.13 -48.52 75.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.971 0.908 . . . . 0.0 110.827 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -45.49 94.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.26 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.03 74.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.254 -0.904 . . . . 0.0 111.322 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.7 m -60.49 -31.78 70.81 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.479 1.022 0 CA-C-N 119.738 1.154 . . . . 0.0 110.687 176.869 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 121.401 0.619 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? . . . . . 0 N--CA 1.467 0.407 0 C-N-CA 126.306 1.842 . . . . 0.0 109.713 -177.812 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.04 62.94 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -86.77 -38.54 16.8 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.976 0.807 . . . . 0.0 111.121 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.93 -12.13 60.56 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.276 -0.89 . . . . 0.0 113.177 -171.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -89.81 -10.18 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.267 1.027 . . . . 0.0 113.617 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.26 -4.03 1.13 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.77 172.21 7.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.538 1.669 . . . . 0.0 114.074 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -82.53 -59.94 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.306 1.043 . . . . 0.0 112.912 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -160.08 115.22 2.33 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.79 1.636 . . . . 0.0 110.166 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.77 44.29 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -131.23 128.1 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 108.168 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.91 117.47 54.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.715 1.606 . . . . 0.0 108.773 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.29 120.68 38.1 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.564 1.146 . . . . 0.0 110.683 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.23 82.06 7.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.109 -1.619 . . . . 0.0 109.848 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 176.72 8.66 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -139.51 137.96 35.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.108 1.363 . . . . 0.0 109.769 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -83.25 -27.22 30.06 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -167.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 mt -76.62 -33.74 58.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.392 1.477 . . . . 0.0 112.925 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -73.83 130.5 83.19 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 126.06 1.744 . . . . 0.0 111.738 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.13 -14.74 18.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.494 3.462 . . . . 0.0 113.3 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -76.04 -47.66 23.88 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.816 1.189 . . . . 0.0 110.695 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.4 m -52.84 -35.56 57.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.031 1.732 . . . . 0.0 113.889 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -55.39 -33.34 63.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.038 1.335 . . . . 0.0 113.135 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.48 -40.72 89.48 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.233 1.013 . . . . 0.0 112.63 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.49 68.9 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.437 -0.79 . . . . 0.0 112.989 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -63.01 -44.24 96.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.667 0.667 . . . . 0.0 111.496 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -63.78 -38.94 92.97 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.77 -49.08 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.582 1.553 . . . . 0.0 110.434 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 mt -64.58 -35.24 80.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.32 1.048 . . . . 0.0 112.772 175.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.23 -50.08 74.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.108 0.963 . . . . 0.0 111.753 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.28 -31.6 72.5 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.099 -1.001 . . . . 0.0 112.584 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.97 -32.52 70.79 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.411 1.084 . . . . 0.0 112.596 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.84 -27.44 38.07 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 120.831 -1.168 . . . . 0.0 113.417 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.81 55.11 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 10.18 12.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.18 72.52 81.88 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.555 1.542 . . . . 0.0 111.556 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.45 -21.05 60.94 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.352 2.702 . . . . 0.0 115.534 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -83.06 -5.21 59.02 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -166.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.9 p -106.83 132.38 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.113 1.365 . . . . 0.0 111.036 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.5 102.52 13.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.171 0.988 . . . . 0.0 110.515 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mt -100.21 130.81 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.312 -0.867 . . . . 0.0 109.913 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -150.38 168.61 23.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.25 1.02 . . . . 0.0 112.028 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -118.45 -179.58 3.83 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.909 -1.119 . . . . 0.0 112.591 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.6 t -149.79 128.34 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 128.102 2.561 . . . . 0.0 108.024 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.19 97.66 0.27 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.584 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.3 p -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.287 -0.883 . . . . 0.0 112.323 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.39 -15.74 62.38 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.644 1.978 . . . . 0.0 114.19 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.84 -39.07 3.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.764 1.225 . . . . 0.0 113.522 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -115.39 54.23 0.91 Allowed Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.843 1.657 . . . . 0.0 113.78 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.0 -13.36 33.97 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -58.69 -24.48 61.42 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.733 1.152 . . . . 0.0 112.954 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.24 -58.54 3.44 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.339 0.518 . . . . 0.0 110.973 165.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.3 mtm -54.74 -33.03 60.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.028 1.331 . . . . 0.0 113.002 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -67.29 -18.82 65.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.709 1.603 . . . . 0.0 114.109 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -77.69 -40.51 41.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.968 0.803 . . . . 0.0 111.644 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.16 -23.93 24.66 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 12.75 28.61 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.108 1.813 . . . . 0.0 115.285 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -81.65 154.14 26.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.758 1.779 . . . . 0.0 111.531 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -102.33 -61.11 1.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.097 0.959 . . . . 0.0 112.152 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -162.69 2.31 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -98.68 155.4 36.76 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 126.598 1.959 . . . . 0.0 112.833 -165.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.7 88.58 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.44 3.427 . . . . 0.0 111.402 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.0 m -104.03 130.53 51.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.672 0.789 . . . . 0.0 110.862 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.06 121.47 41.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 0.0 109.816 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.52 130.86 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.641 1.976 . . . . 0.0 108.546 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -113.12 121.87 45.83 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.406 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 35.1 mm -109.27 116.15 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.486 1.114 . . . . 0.0 108.903 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.406 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.85 123.32 49.38 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.375 1.47 . . . . 0.0 107.957 171.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.38 19.76 11.91 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.497 1.119 . . . . 0.0 113.178 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.25 84.44 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.058 -1.026 . . . . 0.0 113.263 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -108.21 133.56 52.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.963 1.705 . . . . 0.0 109.025 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.35 107.47 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.07 -19.92 14.02 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -160.7 150.28 17.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.524 1.53 . . . . 0.0 110.77 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.45 145.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.428 1.491 . . . . 0.0 109.971 169.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.09 152.37 34.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.427 1.491 . . . . 0.0 109.292 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 t -128.95 138.36 51.93 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.926 -1.109 . . . . 0.0 112.589 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.73 -161.69 19.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.002 1.763 . . . . 0.0 112.755 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.3 mm -111.07 143.6 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.691 1.196 . . . . 0.0 111.069 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 67.4 mtm -137.53 158.17 44.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.902 1.281 . . . . 0.0 111.78 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.52 147.92 76.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.054 0.942 . . . . 0.0 111.176 164.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.3 -27.32 63.7 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.931 2.421 . . . . 0.0 113.212 -168.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.85 -29.51 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.56 -24.98 15.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.373 1.069 . . . . 0.0 112.47 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.92 -28.41 68.9 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.435 -0.791 . . . . 0.0 111.998 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -55.56 -50.38 70.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.96 -35.38 74.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.503 0.721 . . . . 0.0 111.852 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.63 -44.7 81.28 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.627 0.771 . . . . 0.0 110.517 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -47.08 85.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 112.151 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.85 82.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.265 0.939 . . . . 0.0 112.077 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 m -58.27 -25.51 61.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.451 1.5 . . . . 0.0 113.842 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.133 0.973 . . . . 0.0 111.196 177.955 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mm . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.527 1.531 . . . . 0.0 111.572 176.54 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.93 63.23 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -74.49 -39.97 62.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.811 0.732 . . . . 0.0 110.596 169.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.43 -13.4 62.11 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.53 -14.06 41.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 0.0 113.848 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.75 -8.84 1.85 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 117.087 1.595 . . . . 0.0 117.087 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.33 176.74 4.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.219 1.51 . . . . 0.0 114.437 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 p -92.15 -55.96 3.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.805 1.242 . . . . 0.0 113.713 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -159.21 110.22 2.04 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.273 1.829 . . . . 0.0 109.111 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.38 155.27 38.31 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.31 128.76 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.862 1.265 . . . . 0.0 108.682 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 t -114.75 126.14 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.131 1.372 . . . . 0.0 109.285 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -106.87 113.67 27.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.891 0.876 . . . . 0.0 111.604 173.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -77.82 74.15 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.488 1.915 . . . . 0.0 111.022 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.62 -179.28 2.08 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.984 -1.073 . . . . 0.0 112.517 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.19 162.02 32.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.229 1.411 . . . . 0.0 111.942 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -73.9 -38.82 64.24 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.323 -0.861 . . . . 0.0 113.111 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.3 mt -98.83 -32.44 11.34 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.6 123.08 72.49 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.083 1.353 . . . . 0.0 113.68 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -82.47 -2.37 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.489 3.46 . . . . 0.0 112.897 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -89.14 -40.78 12.68 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 119.434 1.015 . . . . 0.0 110.022 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 p -64.37 -26.99 68.71 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.0 -37.59 45.93 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -74.33 -34.45 63.44 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.355 0.662 . . . . 0.0 111.965 -166.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -28.75 69.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.501 -0.762 . . . . 0.0 112.777 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.17 -37.92 84.56 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.193 1.36 . . . . 0.0 112.186 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -34.89 69.82 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.935 -1.103 . . . . 0.0 112.053 173.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.36 -48.34 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.772 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.8 mt -62.0 -42.25 98.95 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.767 1.627 . . . . 0.0 112.319 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.57 -46.95 83.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.305 1.042 . . . . 0.0 111.91 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.26 -27.28 65.3 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.863 -1.148 . . . . 0.0 113.157 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.35 -36.9 71.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.674 0.79 . . . . 0.0 112.059 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.94 -19.94 69.01 Favored Glycine 0 N--CA 1.469 0.864 0 CA-C-N 119.212 0.915 . . . . 0.0 113.301 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -33.7 60.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.668 1.587 . . . . 0.0 114.629 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.72 6.59 11.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.267 1.427 . . . . 0.0 114.276 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.03 79.0 25.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.641 1.576 . . . . 0.0 110.433 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.04 -13.57 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.216 2.611 . . . . 0.0 114.287 -168.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -90.15 -6.98 54.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -168.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 p -99.58 131.92 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.614 1.565 . . . . 0.0 110.181 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.91 100.7 11.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 110.138 174.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.34 131.58 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.437 -0.79 . . . . 0.0 109.967 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.2 p -140.33 160.11 40.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.227 1.013 . . . . 0.0 111.809 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -106.83 165.81 11.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.198 -0.939 . . . . 0.0 110.51 165.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -162.67 152.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.198 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.06 120.16 37.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.327 0.967 . . . . 0.0 112.474 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.9 p -57.83 -36.26 72.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.017 1.327 . . . . 0.0 113.238 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.32 -25.97 42.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 112.051 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.01 -16.29 30.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.936 1.294 . . . . 0.0 113.797 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmt-85 -119.97 48.77 1.27 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 125.624 1.57 . . . . 0.0 113.868 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.85 -27.93 67.44 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.818 1.679 . . . . 0.0 111.75 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.9 -23.58 67.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.661 1.185 . . . . 0.0 113.407 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.75 -56.23 4.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.622 1.169 . . . . 0.0 109.366 170.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.3 mtm -58.01 -28.43 64.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.766 1.226 . . . . 0.0 113.267 -172.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -57.37 -30.46 64.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.965 1.706 . . . . 0.0 113.22 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -88.28 -32.55 18.43 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.417 1.087 . . . . 0.0 111.588 -172.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.4 -24.1 22.0 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.392 0.677 . . . . 0.0 112.799 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.75 15.7 30.83 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.736 1.636 . . . . 0.0 114.992 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -77.14 153.03 34.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.896 1.348 . . . . 0.0 110.797 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 -43.77 4.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.636 1.174 . . . . 0.0 112.729 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -179.82 -3.12 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.87 2.868 . . . . 0.0 116.364 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.89 149.44 85.57 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-N 120.213 1.369 . . . . 0.0 113.455 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.06 81.25 2.6 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.045 3.163 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.56 135.67 33.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -165.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.46 125.26 36.15 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.16 121.98 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.007 1.723 . . . . 0.0 108.84 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -106.69 125.79 51.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.328 1.051 . . . . 0.0 110.582 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.72 119.58 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.27 1.428 . . . . 0.0 108.785 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.32 128.12 55.85 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.967 1.307 . . . . 0.0 108.335 167.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.98 19.18 11.46 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.899 1.28 . . . . 0.0 113.1 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.1 12.51 82.37 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.16 -0.963 . . . . 0.0 113.153 -174.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -107.45 134.47 50.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.341 1.856 . . . . 0.0 109.576 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.71 104.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 171.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.83 -26.71 13.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -167.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -162.11 153.14 17.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.6 1.56 . . . . 0.0 110.951 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.67 146.85 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.738 1.215 . . . . 0.0 111.426 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.81 147.0 23.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.243 1.017 . . . . 0.0 112.198 168.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -96.82 -4.49 40.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -160.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.43 17.93 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-O 122.498 1.054 . . . . 0.0 115.457 -165.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.0 mm -106.11 146.37 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.083 1.753 . . . . 0.0 109.474 165.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.0 ptp -147.75 172.15 14.56 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 167.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -76.76 166.04 47.86 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.551 1.54 . . . . 0.0 112.26 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -34.7 5.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.633 1.555 . . . . 0.0 114.176 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.98 -34.18 77.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.129 1.786 . . . . 0.0 112.589 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -79.63 -21.85 44.35 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.397 0.679 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.22 -30.31 71.19 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.286 -0.884 . . . . 0.0 112.446 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -39.29 94.3 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.356 0.98 . . . . 0.0 111.451 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.19 81.72 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.123 0.874 . . . . 0.0 112.458 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.84 -47.78 79.4 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 110.735 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.48 -45.22 94.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.322 1.049 . . . . 0.0 112.842 173.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.04 80.28 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.265 -0.897 . . . . 0.0 111.956 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 t -68.92 -4.78 17.84 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.706 1.203 . . . . 0.0 114.072 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.477 0.92 0 O-C-N 120.98 -1.075 . . . . 0.0 110.22 167.273 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 126.1 1.76 . . . . 0.0 111.038 -163.236 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.49 67.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -68.31 -41.75 80.44 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.561 -0.712 . . . . 0.0 110.209 170.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -75.41 -6.48 50.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 0.0 113.327 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.88 -18.69 23.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.276 1.43 . . . . 0.0 113.111 170.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.24 -14.31 20.76 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.62 166.79 20.77 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -82.94 -61.24 1.92 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.282 1.033 . . . . 0.0 112.104 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -151.78 128.62 10.94 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.797 1.639 . . . . 0.0 109.771 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.14 164.45 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mt -139.41 124.89 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 107.664 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.56 125.24 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.607 1.563 . . . . 0.0 108.809 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -107.42 110.16 22.06 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.455 1.102 . . . . 0.0 111.584 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -80.0 87.66 5.39 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.09 0.956 . . . . 0.0 110.157 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 -167.89 1.67 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.773 1.229 . . . . 0.0 112.286 173.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -144.41 157.13 44.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.888 -1.133 . . . . 0.0 112.025 153.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -31.08 -82.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 129.117 2.967 . . . . 0.0 116.387 -174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.0 mt -91.53 -38.19 12.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -167.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.3 m -49.25 119.8 9.32 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.894 1.678 . . . . 0.0 112.773 -169.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.84 -22.44 31.72 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.209 3.272 . . . . 0.0 115.077 -161.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -63.09 -44.66 95.1 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 118.849 0.749 . . . . 0.0 112.128 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.8 m -67.47 -31.47 71.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.648 1.179 . . . . 0.0 112.891 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.26 -25.81 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.539 1.136 . . . . 0.0 113.677 -171.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -64.28 -42.81 96.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.848 0.859 . . . . 0.0 112.04 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 tpt -63.78 -28.65 70.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.437 1.095 . . . . 0.0 112.684 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.28 -39.9 84.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.698 0.799 . . . . 0.0 111.352 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -72.93 -29.08 62.84 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.492 -0.755 . . . . 0.0 112.816 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.2 t -67.9 -45.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.258 1.023 . . . . 0.0 109.646 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.45 -37.01 84.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.225 1.41 . . . . 0.0 111.951 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.78 -53.3 59.89 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.224 0.92 . . . . 0.0 111.846 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -64.1 -32.54 74.14 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.396 -0.815 . . . . 0.0 112.758 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.39 -35.6 73.57 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.965 0.906 . . . . 0.0 111.833 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.29 -24.12 61.79 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 119.408 1.004 . . . . 0.0 113.319 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.72 49.02 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.06 9.14 5.26 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.551 1.54 . . . . 0.0 114.502 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.3 61.18 40.89 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 125.657 1.583 . . . . 0.0 112.12 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.34 -15.41 34.91 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.335 2.69 . . . . 0.0 114.431 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -80.81 -9.53 59.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -99.98 137.69 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.187 1.395 . . . . 0.0 110.302 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.71 101.68 11.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.114 0.565 . . . . 0.0 110.443 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.5 mt -99.37 131.84 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.975 0.91 . . . . 0.0 109.218 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.1 p -149.45 170.45 18.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.03 0.932 . . . . 0.0 112.527 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.2 p -133.58 158.69 42.55 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.978 -1.076 . . . . 0.0 111.573 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.46 123.27 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.814 1.246 . . . . 0.0 108.133 -167.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.99 115.11 10.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.041 0.924 . . . . 0.0 109.886 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -58.37 -25.29 61.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.879 1.272 . . . . 0.0 113.36 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.22 -20.65 34.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.703 0.801 . . . . 0.0 112.281 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.74 -35.23 15.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.367 1.067 . . . . 0.0 112.902 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -126.54 61.17 42.53 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.971 1.709 . . . . 0.0 112.803 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.43 -23.7 27.43 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.244 2.63 . . . . 0.0 112.675 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.0 -23.19 67.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.148 0.979 . . . . 0.0 113.169 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.14 -58.15 4.12 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.56 1.144 . . . . 0.0 109.543 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 mtm -60.71 -22.89 64.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 113.512 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -65.9 -23.46 66.64 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.641 1.176 . . . . 0.0 112.552 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.61 -38.19 16.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.585 1.154 . . . . 0.0 111.369 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.66 -23.78 25.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.21 8.57 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.098 1.332 . . . . 0.0 114.506 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.62 169.44 18.0 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.813 1.306 . . . . 0.0 112.753 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.0 11.15 8.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 112.726 -162.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.31 59.93 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.073 2.549 . . . . 0.0 109.257 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -150.03 154.07 36.37 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 127.672 2.389 . . . . 0.0 109.858 -163.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.57 96.18 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.682 2.921 . . . . 0.0 110.648 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -113.47 122.11 46.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 111.833 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.34 125.26 34.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.885 1.274 . . . . 0.0 109.135 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.06 127.65 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -111.13 128.97 56.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.762 0.825 . . . . 0.0 110.948 -174.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.3 mm -112.39 114.11 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.409 1.084 . . . . 0.0 108.883 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.97 121.65 45.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.933 1.293 . . . . 0.0 108.242 171.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 66.75 21.46 10.53 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.006 1.323 . . . . 0.0 112.326 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.53 10.33 84.58 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.428 -173.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -107.68 132.81 52.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.422 1.489 . . . . 0.0 110.194 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.17 101.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.392 1.077 . . . . 0.0 109.187 166.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 -21.18 13.43 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.74 152.64 19.89 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.196 1.798 . . . . 0.0 110.465 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.47 144.08 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.728 1.211 . . . . 0.0 111.275 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.24 146.56 22.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.702 1.201 . . . . 0.0 111.214 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -107.85 138.78 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.02 0.928 . . . . 0.0 111.585 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.98 -161.0 21.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.997 1.76 . . . . 0.0 112.767 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 mm -121.82 145.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.877 1.671 . . . . 0.0 110.733 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.6 ptp -150.63 164.8 35.17 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 163.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -70.08 158.97 86.08 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.312 1.445 . . . . 0.0 112.396 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.32 -26.42 24.94 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.855 2.37 . . . . 0.0 114.401 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -75.33 -30.3 60.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.634 1.561 . . . . 0.0 113.143 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -76.29 -33.2 59.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.11 0.964 . . . . 0.0 111.799 169.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.87 -27.08 68.54 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.841 0.857 . . . . 0.0 111.975 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -58.75 -47.53 84.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.856 0.753 . . . . 0.0 111.923 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.75 0.82 . . . . 0.0 111.38 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.02 -49.76 74.75 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.318 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -46.94 86.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.683 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.68 91.45 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.032 0.833 . . . . 0.0 112.375 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.8 t -60.02 -24.72 64.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.506 1.122 . . . . 0.0 113.401 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.479 0.994 0 C-N-CA 124.325 1.05 . . . . 0.0 111.136 175.585 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 . . . . . 0 N--CA 1.471 0.58 0 C-N-CA 125.146 1.379 . . . . 0.0 111.217 -169.498 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.97 62.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -85.26 -38.91 18.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.074 0.852 . . . . 0.0 111.049 165.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.06 -12.93 61.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.575 0.75 . . . . 0.0 112.821 -172.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.3 -10.97 50.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.749 1.22 . . . . 0.0 114.126 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.97 -5.94 0.97 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.91 169.65 12.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.281 1.54 . . . . 0.0 114.407 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -81.0 -64.7 1.13 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.525 1.13 . . . . 0.0 112.276 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -151.16 123.99 8.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.755 1.622 . . . . 0.0 109.738 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.48 156.24 41.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.92 127.15 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.935 1.294 . . . . 0.0 108.086 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.28 124.45 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.339 1.456 . . . . 0.0 109.406 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 4.2 t80 -102.82 123.3 46.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.655 1.182 . . . . 0.0 110.24 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -88.25 73.54 8.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.518 1.127 . . . . 0.0 110.138 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -81.64 -170.51 2.85 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 121.525 -0.734 . . . . 0.0 112.517 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -145.58 177.62 8.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.242 -0.911 . . . . 0.0 112.767 162.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.24 -56.11 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.27 1.028 . . . . 0.0 113.024 -166.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.17 -30.71 19.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -54.61 118.81 17.97 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.791 1.236 . . . . 0.0 113.729 -167.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.88 -23.79 77.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.109 3.206 . . . . 0.0 114.223 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -71.97 -46.86 55.85 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.0 m -56.14 -34.42 66.11 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.482 1.113 . . . . 0.0 113.401 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -56.06 -35.25 66.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 112.825 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -62.76 -49.98 72.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.406 0.682 . . . . 0.0 111.366 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.41 -29.67 70.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -60.68 -45.87 92.51 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.934 0.894 . . . . 0.0 111.013 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -72.0 -34.48 68.9 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.255 -0.903 . . . . 0.0 113.052 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.98 -49.25 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.24 -36.49 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.128 0.971 . . . . 0.0 113.46 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.45 -49.84 76.22 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.307 0.643 . . . . 0.0 112.518 170.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.18 -29.97 68.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.203 -0.935 . . . . 0.0 113.157 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.83 -37.84 79.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.083 1.353 . . . . 0.0 111.584 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.15 -19.34 67.23 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.418 1.009 . . . . 0.0 112.81 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.61 -33.73 66.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.347 1.059 . . . . 0.0 113.462 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 9.16 39.94 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.603 1.561 . . . . 0.0 114.104 174.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.2 66.23 7.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.522 1.529 . . . . 0.0 113.673 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.3 -20.81 69.75 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.905 2.403 . . . . 0.0 115.076 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -88.2 -8.87 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 p -88.25 135.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.45 87.3 5.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.529 0.732 . . . . 0.0 111.013 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 mt -86.24 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.565 -0.709 . . . . 0.0 109.695 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.7 p -147.3 173.1 12.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.609 1.164 . . . . 0.0 111.556 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 t -122.53 -172.52 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.191 -0.943 . . . . 0.0 111.137 168.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -173.55 133.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.729 2.411 . . . . 0.0 109.118 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.83 116.25 18.19 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.929 1.292 . . . . 0.0 111.464 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.3 p -62.28 -26.93 68.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 112.947 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.79 -23.42 62.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.511 1.124 . . . . 0.0 112.518 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.31 -28.84 11.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.073 1.349 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.55 49.03 4.23 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 125.896 1.678 . . . . 0.0 115.46 -170.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -66.72 -19.42 53.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.394 2.063 . . . . 0.0 112.731 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.16 -25.98 68.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.568 1.147 . . . . 0.0 113.124 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -70.48 -55.1 9.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.81 0.732 . . . . 0.0 110.751 166.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.9 mtp -59.14 -28.47 66.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.547 1.539 . . . . 0.0 113.248 -170.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -15.47 61.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.543 1.137 . . . . 0.0 112.753 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -84.68 -38.32 19.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.663 1.185 . . . . 0.0 110.579 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.85 -23.46 31.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.282 0.633 . . . . 0.0 112.677 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.86 20.09 17.66 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.716 1.627 . . . . 0.0 114.773 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -82.5 149.41 27.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.765 1.283 . . . . 0.0 111.883 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.45 -81.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.633 0.773 . . . . 0.0 110.825 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -157.35 6.64 0.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -167.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.89 160.76 25.0 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 126.487 1.915 . . . . 0.0 114.032 -159.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.6 93.34 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.91 3.74 . . . . 0.0 110.942 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 m -109.68 129.22 55.62 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.895 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mp -95.46 130.88 42.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.836 0.855 . . . . 0.0 109.734 167.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -129.24 128.56 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.091 1.757 . . . . 0.0 108.86 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -114.85 124.48 51.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.176 0.99 . . . . 0.0 110.682 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mm -109.05 120.04 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.996 1.318 . . . . 0.0 109.599 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -114.98 125.3 53.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.822 1.649 . . . . 0.0 109.501 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.61 19.47 10.45 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.505 1.522 . . . . 0.0 113.807 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.15 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.823 1.201 . . . . 0.0 114.101 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -112.84 136.51 52.38 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.103 1.761 . . . . 0.0 110.372 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.59 104.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 166.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.96 -30.23 12.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.62 160.41 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.915 1.686 . . . . 0.0 111.76 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.25 144.81 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.593 1.557 . . . . 0.0 110.771 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.28 150.22 25.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 111.972 167.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -105.48 132.34 51.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.183 0.993 . . . . 0.0 111.35 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.18 -158.14 14.86 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.287 1.422 . . . . 0.0 113.448 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.57 139.09 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.692 1.597 . . . . 0.0 111.056 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.0 mtm -140.9 160.28 40.41 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.514 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -72.35 159.84 84.34 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.71 1.204 . . . . 0.0 112.282 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.3 -24.73 31.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.457 2.105 . . . . 0.0 113.724 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -63.23 -49.31 74.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.953 1.251 . . . . 0.0 110.83 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -72.28 -26.15 61.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.626 1.17 . . . . 0.0 111.636 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -26.75 68.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.748 0.819 . . . . 0.0 112.507 170.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -65.64 -45.53 82.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.775 1.17 . . . . 0.0 110.769 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.83 84.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.152 0.581 . . . . 0.0 111.848 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.16 -53.88 51.41 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.249 1.019 . . . . 0.0 110.405 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.92 77.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.361 175.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.26 79.72 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.454 -0.779 . . . . 0.0 112.0 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -60.05 -38.89 84.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.569 0.747 . . . . 0.0 111.861 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.482 1.129 0 O-C-N 121.148 -0.97 . . . . 0.0 110.602 175.056 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 mm . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.573 0 C-N-CA 128.965 2.906 . . . . 0.0 111.892 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.8 ptp . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.47 -26.63 35.09 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.028 0.931 . . . . 0.0 113.498 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -71.23 -40.22 71.22 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.64 -0.663 . . . . 0.0 110.247 162.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -75.65 27.27 0.11 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.452 1.501 . . . . 0.0 112.825 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -82.24 -14.92 54.74 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.84 43.76 0.07 OUTLIER Glycine 0 N--CA 1.474 1.23 0 CA-C-N 119.674 1.124 . . . . 0.0 115.582 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 mt -84.85 103.05 13.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.431 1.093 . . . . 0.0 111.158 -173.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -58.89 -27.56 65.33 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -156.37 94.31 1.48 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.1 1.76 . . . . 0.0 110.296 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.59 46.64 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.9 mt -140.84 135.13 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.389 1.476 . . . . 0.0 109.142 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.33 131.06 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.45 1.5 . . . . 0.0 109.565 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -111.24 103.48 11.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.655 1.182 . . . . 0.0 111.462 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -75.37 70.91 2.31 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.74 1.616 . . . . 0.0 109.959 175.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.34 154.0 42.39 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.117 0.967 . . . . 0.0 113.192 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.04 179.74 7.73 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.335 -0.853 . . . . 0.0 111.728 166.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.77 153.25 30.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.022 1.729 . . . . 0.0 112.457 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 67.85 -46.41 0.51 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 130.304 3.442 . . . . 0.0 114.474 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.0 t -54.91 128.58 64.51 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 127.046 2.139 . . . . 0.0 113.433 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.77 -18.97 59.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.606 3.538 . . . . 0.0 115.529 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -67.79 -48.35 66.55 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 120.364 1.438 . . . . 0.0 112.817 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.1 -22.79 63.96 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.471 -1.393 . . . . 0.0 113.414 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -56.39 -30.79 63.18 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.154 1.381 . . . . 0.0 113.085 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -64.82 -46.1 83.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.957 0.903 . . . . 0.0 112.235 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.3 mmm -63.91 -28.77 70.06 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.338 -0.851 . . . . 0.0 112.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -61.02 -35.81 77.85 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.705 0.684 . . . . 0.0 111.58 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -70.27 -40.6 74.24 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 110.737 174.434 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.01 -44.62 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.777 1.631 . . . . 0.0 110.788 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.97 -37.33 85.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.306 1.443 . . . . 0.0 112.125 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.89 -47.79 84.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.649 0.78 . . . . 0.0 111.986 171.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -68.51 -32.95 73.28 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.259 0.936 . . . . 0.0 112.11 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -68.63 -35.89 77.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.73 1.212 . . . . 0.0 112.184 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.34 -24.57 53.93 Favored Glycine 0 N--CA 1.469 0.852 0 CA-C-N 119.176 0.898 . . . . 0.0 113.177 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 10.8 38.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.097 1.359 . . . . 0.0 114.139 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.86 85.89 7.46 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.433 1.493 . . . . 0.0 111.68 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.03 -12.09 17.73 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.312 2.675 . . . . 0.0 113.817 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -89.57 -10.04 47.57 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.827 1.194 . . . . 0.0 113.728 -172.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.54 130.78 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.672 1.189 . . . . 0.0 110.254 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.8 98.0 8.26 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.223 0.609 . . . . 0.0 110.036 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -101.42 132.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.628 0.771 . . . . 0.0 109.273 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -145.89 169.2 19.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.97 0.908 . . . . 0.0 111.813 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.2 p -114.2 164.96 13.17 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.634 -1.291 . . . . 0.0 111.538 168.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.54 122.24 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.3 1.44 . . . . 0.0 109.038 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.08 104.76 1.21 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.694 1.198 . . . . 0.0 110.397 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -54.35 -44.26 72.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.857 1.263 . . . . 0.0 112.811 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -78.52 -13.27 59.91 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.84 -17.91 18.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.641 1.176 . . . . 0.0 113.427 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -124.03 43.77 0.89 Allowed Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.062 1.745 . . . . 0.0 113.303 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.85 -22.87 35.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.102 2.535 . . . . 0.0 112.466 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.17 -27.74 68.92 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.293 0.952 . . . . 0.0 112.603 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.58 -50.65 14.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.8 mtm -56.7 -26.41 56.65 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.402 1.081 . . . . 0.0 113.319 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -66.35 -23.35 66.33 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.139 0.976 . . . . 0.0 112.014 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -84.6 -37.97 20.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.935 1.294 . . . . 0.0 111.204 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.06 -24.15 30.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.438 0.695 . . . . 0.0 112.554 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.22 20.03 19.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.374 1.464 . . . . 0.0 115.065 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -84.1 155.08 22.81 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.156 1.478 . . . . 0.0 111.584 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -92.25 -72.21 0.6 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.439 1.096 . . . . 0.0 110.465 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 ptm85 -162.81 3.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -84.63 154.82 62.21 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 127.108 2.163 . . . . 0.0 113.012 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.48 96.35 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.382 3.388 . . . . 0.0 110.336 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.9 m -111.06 124.63 52.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.191 0.996 . . . . 0.0 112.467 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.4 135.02 34.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 109.524 166.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.34 124.38 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.001 1.721 . . . . 0.0 108.034 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -108.11 126.21 52.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.432 0.693 . . . . 0.0 110.782 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.1 mm -110.36 113.11 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.841 0.857 . . . . 0.0 109.178 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 115.56 29.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.321 1.448 . . . . 0.0 109.109 170.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.08 26.67 8.86 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.879 2.072 . . . . 0.0 111.981 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.21 -3.84 83.12 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.832 0.73 . . . . 0.0 113.846 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -96.29 131.11 43.13 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.923 -1.34 . . . . 0.0 110.231 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.38 102.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.869 0.842 . . . . 0.0 109.603 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.32 -17.17 16.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -171.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.91 148.72 19.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.019 1.727 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -150.27 146.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.803 1.641 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.33 148.82 27.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.266 1.026 . . . . 0.0 111.601 161.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -105.77 144.07 33.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.479 -0.763 . . . . 0.0 111.917 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.24 -150.18 17.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.268 1.413 . . . . 0.0 113.377 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.5 mm -112.27 144.36 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.343 1.457 . . . . 0.0 112.285 -170.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.3 ptp -153.01 169.31 23.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 160.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -82.44 161.98 57.6 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.727 1.611 . . . . 0.0 112.485 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.46 -26.48 12.03 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.539 2.159 . . . . 0.0 114.507 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -71.43 -34.23 70.11 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.204 1.365 . . . . 0.0 112.846 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -74.39 -31.42 62.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.591 0.756 . . . . 0.0 112.278 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.1 tp -62.28 -26.87 68.64 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.488 -0.757 . . . . 0.0 112.606 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.72 -47.95 82.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.882 0.764 . . . . 0.0 111.209 174.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.59 71.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.255 0.622 . . . . 0.0 111.778 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.96 -50.44 73.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.807 0.843 . . . . 0.0 110.84 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -45.38 79.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.322 0.649 . . . . 0.0 112.008 175.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.8 86.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.826 0.739 . . . . 0.0 112.031 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.1 m -64.64 -11.79 39.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.399 1.479 . . . . 0.0 114.612 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.476 0.851 0 O-C-N 121.039 -1.038 . . . . 0.0 110.96 173.312 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mm . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 125.382 1.473 . . . . 0.0 111.361 -167.523 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.74 63.0 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -84.53 -39.09 19.23 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 111.168 166.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.11 -9.19 58.42 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.71 -11.11 43.3 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.007 1.323 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.9 -6.36 1.11 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.47 167.29 16.99 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.226 1.513 . . . . 0.0 113.663 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -80.68 -52.55 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -164.76 114.88 1.15 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.946 1.298 . . . . 0.0 110.082 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.71 157.83 41.45 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.98 130.66 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.632 1.573 . . . . 0.0 108.832 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.6 128.23 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.689 1.596 . . . . 0.0 109.393 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.05 111.72 23.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.574 1.15 . . . . 0.0 111.507 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -83.53 73.56 10.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 111.301 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.41 174.94 5.9 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 168.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.24 146.34 38.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.388 -1.445 . . . . 0.0 114.054 170.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' CG ' ' H ' ' A' ' 30' ' ' LEU 0.319 6.9 p30 17.76 -104.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.388 2.675 . . . . 0.0 116.136 -178.362 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.407 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 3.6 mm? -107.18 3.15 25.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.68 2.392 . . . . 0.0 113.383 -171.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -49.04 125.61 13.95 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.509 1.523 . . . . 0.0 114.41 -164.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.2 -5.03 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.066 3.178 . . . . 0.0 113.429 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -81.74 -50.38 9.34 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.685 1.129 . . . . 0.0 109.905 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.2 m -60.77 -34.02 73.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -171.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -50.31 -40.72 49.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -72.76 -40.68 65.81 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.209 0.603 . . . . 0.0 110.737 -172.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -62.4 -34.52 76.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.593 1.157 . . . . 0.0 112.519 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -59.55 -39.09 82.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.719 1.145 . . . . 0.0 112.305 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.48 -32.66 71.69 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.91 -1.119 . . . . 0.0 112.789 173.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.46 -50.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.368 0.667 . . . . 0.0 109.967 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.73 -35.67 81.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.293 1.037 . . . . 0.0 112.135 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.73 -52.97 63.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.053 0.941 . . . . 0.0 111.639 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -69.13 -30.24 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.601 -0.687 . . . . 0.0 112.655 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.95 -41.39 91.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.786 1.234 . . . . 0.0 111.49 170.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.58 -27.33 27.45 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 119.098 0.863 . . . . 0.0 113.593 -172.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.77 68.24 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.198 0.999 . . . . 0.0 113.588 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.49 9.4 37.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.964 1.705 . . . . 0.0 114.067 176.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.05 42.31 0.37 Allowed Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 125.534 1.533 . . . . 0.0 113.754 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.57 -5.64 10.55 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.575 2.85 . . . . 0.0 115.58 -166.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -62.92 -8.86 7.92 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.64 135.6 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.194 1.398 . . . . 0.0 110.553 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.06 102.53 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 110.348 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.68 135.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.93 0.892 . . . . 0.0 110.333 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.7 p -144.63 169.02 18.79 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.278 1.031 . . . . 0.0 112.005 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.4 p -125.97 163.37 23.15 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.78 -1.2 . . . . 0.0 111.846 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.2 t -148.82 129.03 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.009 1.323 . . . . 0.0 108.542 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -73.93 98.62 3.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.562 0.696 . . . . 0.0 110.123 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -59.55 -30.33 68.54 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.219 1.008 . . . . 0.0 113.585 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.81 -21.53 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.043 1.337 . . . . 0.0 112.655 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.14 -7.81 38.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.528 1.531 . . . . 0.0 112.976 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 42.95 0.98 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 126.151 1.78 . . . . 0.0 114.07 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.45 -21.01 47.4 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.593 2.196 . . . . 0.0 113.258 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -59.71 -19.44 49.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.226 . . . . 0.0 113.124 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.23 -58.93 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.459 1.103 . . . . 0.0 111.574 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.6 mtm -58.46 -28.55 65.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 113.763 -170.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -69.71 -18.91 63.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.041 1.336 . . . . 0.0 113.345 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.31 -35.62 19.78 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.381 1.073 . . . . 0.0 111.211 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.51 -23.87 21.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.422 0.689 . . . . 0.0 112.857 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.34 21.06 18.34 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.692 1.615 . . . . 0.0 114.716 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.14 160.83 25.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.998 1.399 . . . . 0.0 112.188 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.75 -68.77 0.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.359 1.063 . . . . 0.0 112.869 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.79 22.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -162.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.34 156.97 57.21 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 125.091 1.356 . . . . 0.0 112.831 -166.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.76 88.29 0.92 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.075 3.183 . . . . 0.0 110.206 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -99.89 130.21 46.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.318 1.047 . . . . 0.0 111.893 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 134.38 35.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.318 1.047 . . . . 0.0 110.471 163.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.5 t -130.73 126.17 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.568 1.547 . . . . 0.0 108.417 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -109.95 122.54 47.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 110.639 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.68 121.5 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.403 1.481 . . . . 0.0 108.859 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.54 124.29 50.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.307 1.843 . . . . 0.0 108.774 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 61.19 20.09 10.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.009 1.324 . . . . 0.0 113.355 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.12 69.57 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.229 0.919 . . . . 0.0 113.84 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -117.46 132.11 56.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.449 1.9 . . . . 0.0 109.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.77 109.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.196 -0.94 . . . . 0.0 109.676 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.55 -24.85 14.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -160.16 144.82 14.66 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.123 1.769 . . . . 0.0 110.563 -172.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -148.25 143.87 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.552 1.541 . . . . 0.0 109.384 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -154.59 156.92 37.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.434 1.094 . . . . 0.0 111.026 164.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 p -121.45 145.36 48.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.97 -167.76 12.4 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.335 1.445 . . . . 0.0 113.58 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.06 138.42 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 65.9 mtm -139.42 147.66 41.72 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.973 0.909 . . . . 0.0 111.299 162.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.15 97.88 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.341 0.657 . . . . 0.0 111.346 167.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.19 -27.48 56.5 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.827 2.351 . . . . 0.0 113.551 -166.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -61.01 -29.17 69.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.4 -25.46 16.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.578 0.751 . . . . 0.0 112.562 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.37 -24.69 63.61 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 112.572 171.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -60.35 -41.81 94.4 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.387 0.675 . . . . 0.0 112.336 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.4 77.72 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.952 0.796 . . . . 0.0 111.97 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.01 -47.35 80.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.329 1.052 . . . . 0.0 110.379 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.59 -46.63 87.41 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.374 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.53 75.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.605 1.093 . . . . 0.0 112.705 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -62.77 -17.83 61.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.18 1.392 . . . . 0.0 113.582 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.6 mt . . . . . 0 N--CA 1.475 0.821 0 O-C-N 120.522 -1.361 . . . . 0.0 110.468 172.519 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 130.415 3.486 . . . . 0.0 112.974 179.098 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -21.2 62.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -80.1 -41.33 25.76 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 111.051 166.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -74.72 -13.62 60.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.289 1.036 . . . . 0.0 113.646 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -85.2 80.32 9.25 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.589 1.956 . . . . 0.0 110.342 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 14.19 14.92 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.772 1.177 . . . . 0.0 115.854 166.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.89 167.51 11.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 1.351 . . . . 0.0 112.936 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -75.62 -66.59 0.76 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.261 1.024 . . . . 0.0 112.544 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -149.63 124.72 10.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.392 1.877 . . . . 0.0 109.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.41 160.47 42.53 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.6 mt -138.03 124.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.085 1.754 . . . . 0.0 108.647 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 109.306 -170.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -115.08 113.81 24.53 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.373 0.669 . . . . 0.0 111.948 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -81.45 70.17 8.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.813 1.245 . . . . 0.0 110.722 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.83 170.14 15.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.702 0.763 . . . . 0.0 112.845 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -117.84 162.04 18.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.533 1.533 . . . . 0.0 111.143 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -91.17 -36.17 14.11 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.971 -1.08 . . . . 0.0 111.811 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 mt -80.06 -52.19 8.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.648 1.179 . . . . 0.0 113.4 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.74 119.53 45.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.295 1.438 . . . . 0.0 112.639 -170.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.31 -19.73 55.75 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.739 2.959 . . . . 0.0 114.086 172.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -76.75 -45.57 28.61 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.195 0.907 . . . . 0.0 110.703 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 p -63.72 -21.93 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -54.7 -37.78 66.23 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.123 0.969 . . . . 0.0 112.994 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -62.32 -43.11 99.58 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.736 -0.603 . . . . 0.0 111.832 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.3 tpp -61.01 -34.6 75.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.743 0.817 . . . . 0.0 112.991 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -54.28 -42.93 70.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.437 0.695 . . . . 0.0 111.767 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.69 -27.35 29.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.923 0.889 . . . . 0.0 113.166 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.85 -47.85 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.979 0.911 . . . . 0.0 110.378 166.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -62.04 -36.99 83.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.95 -48.29 82.5 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.96 0.8 . . . . 0.0 111.525 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.33 -33.81 76.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.659 0.784 . . . . 0.0 112.711 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -65.35 -37.58 87.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.861 1.264 . . . . 0.0 111.542 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.31 -23.03 61.64 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 124.704 1.145 . . . . 0.0 113.628 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -31.33 62.39 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.279 1.431 . . . . 0.0 114.713 -171.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.73 6.31 14.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 63.51 57.76 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.916 1.687 . . . . 0.0 112.14 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.61 -15.55 30.48 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.9 3.066 . . . . 0.0 113.725 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -82.05 -4.76 57.51 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.04 135.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.177 1.391 . . . . 0.0 110.235 173.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.93 100.86 11.28 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.814 0.846 . . . . 0.0 110.847 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.11 131.33 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.847 0.859 . . . . 0.0 110.195 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.3 p -146.82 170.06 17.82 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.938 0.895 . . . . 0.0 112.579 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.3 p -132.43 155.16 49.0 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.865 -1.147 . . . . 0.0 111.071 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -142.77 127.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.534 1.133 . . . . 0.0 109.461 -168.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -64.62 101.26 0.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.734 1.614 . . . . 0.0 110.69 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.9 p -55.97 -40.81 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.056 0.943 . . . . 0.0 112.738 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.45 -26.65 65.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.749 1.619 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.69 -15.43 18.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 113.844 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -131.42 52.61 9.67 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.705 1.602 . . . . 0.0 113.009 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.6 -20.47 53.39 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.027 170.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.46 -29.17 69.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.39 1.076 . . . . 0.0 112.767 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.94 -56.84 4.97 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.492 0.717 . . . . 0.0 109.431 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.7 mtp -54.8 -33.6 61.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.514 1.525 . . . . 0.0 112.21 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -61.71 -27.86 69.01 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.864 1.665 . . . . 0.0 113.988 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.34 -38.27 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.358 0.663 . . . . 0.0 112.01 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.77 -21.78 24.93 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 15.52 31.4 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.256 1.884 . . . . 0.0 114.829 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -77.96 140.52 39.23 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.275 1.538 . . . . 0.0 111.801 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.91 -60.04 2.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.408 0.683 . . . . 0.0 112.342 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -167.07 23.05 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -165.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.61 151.88 50.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 125.468 1.507 . . . . 0.0 113.351 -166.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.71 93.94 1.0 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.924 3.083 . . . . 0.0 109.599 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.5 m -104.44 131.73 51.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.524 1.13 . . . . 0.0 112.952 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.56 131.74 34.29 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.24 1.816 . . . . 0.0 109.251 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.69 131.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 108.744 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -114.29 127.85 56.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.636 0.775 . . . . 0.0 111.154 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.1 mm -108.94 122.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.006 1.322 . . . . 0.0 109.269 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -119.4 124.06 45.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.655 1.982 . . . . 0.0 109.19 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 61.88 18.69 10.02 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.947 1.299 . . . . 0.0 113.049 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.59 7.1 67.23 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.236 1.398 . . . . 0.0 114.401 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -113.34 136.94 52.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.877 1.671 . . . . 0.0 110.136 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.01 108.84 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 121.076 -1.015 . . . . 0.0 109.879 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.9 -20.31 14.31 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -170.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -158.67 156.1 29.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.022 1.329 . . . . 0.0 110.67 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.06 145.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 111.204 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.88 146.08 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.546 1.139 . . . . 0.0 111.101 166.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 p -110.77 147.09 35.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.056 . . . . 0.0 113.153 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.71 -149.38 18.12 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.758 1.17 . . . . 0.0 113.056 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.3 mm -118.3 143.89 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.015 1.326 . . . . 0.0 111.976 -171.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.3 mtm -139.13 160.04 40.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.27 1.428 . . . . 0.0 111.014 161.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -70.06 162.29 69.88 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 111.487 167.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 -32.91 14.17 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.987 1.791 . . . . 0.0 113.868 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -71.44 -31.36 67.12 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.842 1.655 . . . . 0.0 112.821 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -79.36 -22.32 44.57 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.95 -26.13 68.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.561 1.073 . . . . 0.0 112.672 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -63.05 -37.32 86.71 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.329 0.968 . . . . 0.0 111.702 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.74 83.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.361 0.982 . . . . 0.0 111.163 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 53.5 tp -65.07 -45.47 85.18 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.323 0.649 . . . . 0.0 110.78 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -44.61 95.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.283 1.033 . . . . 0.0 112.342 173.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.69 84.21 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.123 -0.985 . . . . 0.0 111.482 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.0 m -67.79 -3.84 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.754 1.622 . . . . 0.0 114.232 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 N--CA 1.481 1.085 0 O-C-N 120.903 -1.123 . . . . 0.0 111.382 169.587 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 110.755 -0.091 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.528 0 C-N-CA 126.989 2.116 . . . . 0.0 111.255 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.21 44.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.719 1.208 . . . . 0.0 113.903 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -74.95 -39.71 61.18 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.193 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.95 19.4 0.15 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 113.937 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -16.5 57.92 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.46 45.44 0.12 Allowed Glycine 0 N--CA 1.478 1.448 0 CA-C-N 120.059 1.3 . . . . 0.0 116.257 -174.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.3 mt -88.72 122.35 32.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.086 1.354 . . . . 0.0 109.232 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -53.59 -43.13 68.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.753 1.161 . . . . 0.0 113.478 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -163.04 123.42 2.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.223 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.75 155.76 42.04 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.319 1.448 . . . . 0.0 112.513 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.6 mt -143.18 132.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.364 1.466 . . . . 0.0 110.707 -170.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.54 126.73 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.089 1.356 . . . . 0.0 110.8 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -102.5 117.26 34.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.202 1.401 . . . . 0.0 112.101 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -78.55 73.58 5.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.286 1.434 . . . . 0.0 111.609 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.9 -174.99 4.7 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.705 0.802 . . . . 0.0 112.798 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -144.14 156.02 44.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 111.748 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -64.75 -54.82 25.37 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.77 -38.06 20.07 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -170.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.67 122.16 49.38 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.781 1.232 . . . . 0.0 112.827 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -65.15 -22.65 61.16 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.33 3.354 . . . . 0.0 114.575 173.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -70.7 -46.21 63.54 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 119.303 0.956 . . . . 0.0 111.036 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -58.09 -34.03 69.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.474 1.11 . . . . 0.0 113.595 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -55.79 -34.6 65.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.12 1.368 . . . . 0.0 112.995 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -60.09 -46.73 88.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.341 0.657 . . . . 0.0 111.679 176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -36.04 82.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.287 0.635 . . . . 0.0 112.65 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -53.03 -40.64 64.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.834 0.743 . . . . 0.0 112.293 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -65.77 -28.16 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.039 -1.038 . . . . 0.0 112.775 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 t -75.12 -52.68 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.579 1.552 . . . . 0.0 108.747 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.71 -38.23 77.84 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.715 1.206 . . . . 0.0 112.462 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -58.75 -58.46 8.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.531 1.132 . . . . 0.0 111.513 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -65.28 -31.31 72.38 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.05 -40.37 82.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.311 1.445 . . . . 0.0 112.398 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.2 -26.72 42.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 119.336 0.971 . . . . 0.0 114.06 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -40.83 71.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.925 1.29 . . . . 0.0 114.179 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.71 4.04 37.65 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.78 67.33 77.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 111.573 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.54 -10.1 24.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.331 2.687 . . . . 0.0 114.341 -169.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.28 -14.25 58.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.43 131.04 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.361 1.064 . . . . 0.0 109.77 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.34 91.48 6.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 0.0 110.645 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mt -100.08 132.34 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.029 0.932 . . . . 0.0 109.531 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -144.79 176.01 9.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.127 0.971 . . . . 0.0 111.658 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 86.4 p -113.76 176.3 5.09 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.897 -1.127 . . . . 0.0 110.599 162.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.0 126.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 124.342 1.057 . . . . 0.0 109.664 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.35 110.42 5.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.863 0.84 . . . . 0.0 110.811 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 p -56.48 -27.2 56.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.611 1.164 . . . . 0.0 113.637 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -77.35 -29.59 53.45 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.436 1.016 . . . . 0.0 113.089 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.33 -24.46 19.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.639 1.176 . . . . 0.0 113.017 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 56.39 9.21 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 126.745 2.018 . . . . 0.0 111.92 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.41 -27.79 18.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.983 2.456 . . . . 0.0 112.507 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -68.54 -25.42 64.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.984 0.811 . . . . 0.0 112.558 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' HD22 ' A' ' 68' ' ' LEU . 7.7 mt -63.61 -56.19 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.166 0.894 . . . . 0.0 110.122 168.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.412 ' HB3' ' H ' ' A' ' 71' ' ' GLU . 17.5 mtm -58.48 -21.01 50.25 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -26.66 51.89 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.99 1.716 . . . . 0.0 112.414 174.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -82.72 -46.47 13.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.76 0.824 . . . . 0.0 111.32 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -82.35 -15.91 51.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 21.72 46.6 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.664 1.126 . . . . 0.0 114.723 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -74.95 -58.9 3.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.404 1.102 . . . . 0.0 111.665 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 65' ' ' MET . 41.0 mt-10 73.71 -29.07 0.19 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.08 3.352 . . . . 0.0 113.975 168.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -163.89 17.73 0.06 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -164.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.32 150.96 63.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.487 1.115 . . . . 0.0 113.943 -170.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.43 86.55 1.58 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 124.445 3.43 . . . . 0.0 110.873 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.7 m -98.67 136.01 39.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.415 1.086 . . . . 0.0 112.446 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.13 128.59 38.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.871 163.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.5 t -119.25 129.93 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.563 1.545 . . . . 0.0 109.16 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -117.56 131.09 56.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.125 0.97 . . . . 0.0 111.623 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.27 125.21 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.013 1.325 . . . . 0.0 109.925 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.32 117.4 29.86 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.661 1.984 . . . . 0.0 110.17 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.18 29.56 11.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.873 2.069 . . . . 0.0 111.805 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.54 85.79 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.48 0.562 . . . . 0.0 114.425 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -101.28 133.07 46.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.852 1.261 . . . . 0.0 108.755 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.07 106.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.179 -0.951 . . . . 0.0 109.297 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.04 -22.09 15.89 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -166.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -161.2 155.78 23.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.452 1.501 . . . . 0.0 110.74 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.7 p -152.7 143.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.306 1.442 . . . . 0.0 110.203 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.71 149.43 20.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.517 1.127 . . . . 0.0 111.566 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 t -112.16 140.68 46.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.336 1.054 . . . . 0.0 112.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.27 -164.62 12.43 Favored Glycine 0 C--N 1.344 1.001 0 C-N-CA 125.24 1.4 . . . . 0.0 114.762 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.96 140.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.122 1.369 . . . . 0.0 111.338 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.8 mtm -139.92 161.77 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.062 1.345 . . . . 0.0 111.701 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -68.37 161.29 70.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.277 0.631 . . . . 0.0 111.313 161.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.33 -32.4 16.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 121.932 1.754 . . . . 0.0 113.53 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -68.45 -32.79 73.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 120.884 1.675 . . . . 0.0 112.402 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -74.83 -30.37 61.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.535 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.81 -35.72 79.12 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.328 0.967 . . . . 0.0 111.833 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -39.97 90.72 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.424 1.011 . . . . 0.0 111.715 171.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.61 87.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.675 0.67 . . . . 0.0 111.866 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.8 tp -66.12 -49.6 66.93 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.848 0.859 . . . . 0.0 110.658 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -43.64 77.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.944 1.297 . . . . 0.0 113.21 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.44 76.17 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.103 0.865 . . . . 0.0 112.001 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.8 m -70.04 1.58 4.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.455 1.502 . . . . 0.0 114.091 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.474 0.767 0 O-C-N 120.739 -1.226 . . . . 0.0 111.294 171.665 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 127.774 2.429 . . . . 0.0 107.147 177.816 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.95 -22.2 63.19 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -84.72 -36.81 21.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.288 0.635 . . . . 0.0 111.611 165.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -79.24 -6.54 56.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -171.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.0 -17.75 30.54 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.54 -4.09 13.75 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.857 1.218 . . . . 0.0 116.064 -171.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.89 166.96 18.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.674 1.237 . . . . 0.0 114.182 -171.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -82.52 -65.13 1.05 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.596 1.158 . . . . 0.0 111.944 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -145.83 125.16 13.04 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.748 1.619 . . . . 0.0 110.04 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.99 159.59 43.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.9 mt -134.23 127.82 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.796 1.638 . . . . 0.0 108.477 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -118.71 127.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.552 1.541 . . . . 0.0 108.827 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -111.2 112.48 24.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.497 1.119 . . . . 0.0 111.197 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -80.29 76.8 7.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.374 1.069 . . . . 0.0 110.795 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.37 174.85 10.74 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.268 1.027 . . . . 0.0 112.729 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -134.21 151.32 51.26 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.873 -1.142 . . . . 0.0 111.535 167.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -62.63 -46.88 86.19 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 112.168 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.46 -32.44 42.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.323 1.049 . . . . 0.0 112.791 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.2 t -57.36 122.95 58.56 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.276 1.43 . . . . 0.0 112.392 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.31 -13.95 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.323 3.349 . . . . 0.0 112.293 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -80.08 -47.5 14.72 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.192 0.906 . . . . 0.0 109.451 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m -52.74 -36.61 58.01 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 113.979 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -37.3 66.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.451 1.1 . . . . 0.0 112.926 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -63.17 -45.52 91.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.51 0.724 . . . . 0.0 111.501 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 tpt -61.61 -33.13 73.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.035 0.934 . . . . 0.0 112.782 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -59.1 -40.46 85.38 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.647 0.658 . . . . 0.0 112.032 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -35.53 62.42 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.38 -0.825 . . . . 0.0 112.264 174.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.17 -47.86 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.789 0.835 . . . . 0.0 110.501 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.96 -37.05 85.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.012 1.725 . . . . 0.0 112.304 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.79 -48.48 76.72 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.02 0.827 . . . . 0.0 112.376 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -35.92 81.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.31 -0.869 . . . . 0.0 112.424 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -66.82 -34.25 77.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.967 1.307 . . . . 0.0 111.937 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.52 -25.29 51.23 Favored Glycine 0 N--CA 1.47 0.933 0 O-C-N 121.001 -1.062 . . . . 0.0 113.73 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.71 67.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.92 22.97 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 114.066 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.53 62.11 61.34 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.939 1.696 . . . . 0.0 111.563 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.29 -13.87 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.201 2.6 . . . . 0.0 114.243 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.04 -4.91 54.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.57 131.63 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 110.705 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.56 101.19 10.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.156 0.983 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.5 mt -94.88 130.5 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.507 -0.745 . . . . 0.0 109.689 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -139.16 152.0 47.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 110.863 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.7 m -115.68 149.98 37.51 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.111 -0.993 . . . . 0.0 111.512 167.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.1 t -139.73 122.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.122 1.369 . . . . 0.0 108.4 -171.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -67.85 113.18 5.37 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.498 1.119 . . . . 0.0 111.241 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -56.99 -27.65 61.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.448 1.499 . . . . 0.0 114.252 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -74.94 -27.93 60.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.069 0.849 . . . . 0.0 112.573 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.04 -27.99 16.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.855 1.262 . . . . 0.0 113.295 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 tpt85 -124.62 40.91 0.55 Allowed Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 125.706 1.602 . . . . 0.0 114.707 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -65.71 -19.69 59.5 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.196 1.931 . . . . 0.0 112.929 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.31 -27.4 62.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.731 1.212 . . . . 0.0 113.487 173.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.89 -54.78 5.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.503 1.121 . . . . 0.0 110.5 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtp -56.15 -31.06 63.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.055 1.342 . . . . 0.0 112.797 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.97 -26.83 68.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 113.143 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -86.51 -36.48 18.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.876 1.271 . . . . 0.0 110.799 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.7 -21.27 26.75 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.45 21.29 15.15 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.759 1.647 . . . . 0.0 115.185 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -83.48 143.26 30.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.773 1.287 . . . . 0.0 111.72 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.39 -72.16 0.57 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.717 0.807 . . . . 0.0 111.781 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.46 30.18 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 114.152 -170.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.11 156.52 52.34 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.425 1.49 . . . . 0.0 111.969 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.95 97.6 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.357 2.705 . . . . 0.0 109.952 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 m -109.5 124.58 51.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.984 0.514 . . . . 0.0 111.574 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.23 135.98 33.41 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.199 1.0 . . . . 0.0 109.328 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.86 125.18 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.299 1.84 . . . . 0.0 108.196 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -107.59 123.31 48.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.076 0.95 . . . . 0.0 111.077 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.3 mm -107.7 114.32 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.013 1.325 . . . . 0.0 108.662 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.1 125.0 53.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.867 1.667 . . . . 0.0 108.551 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.8 t70 66.74 20.5 10.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.056 1.343 . . . . 0.0 112.36 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.65 7.44 87.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.203 0.906 . . . . 0.0 113.856 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -108.99 136.53 48.36 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.829 1.652 . . . . 0.0 109.716 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.7 107.63 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.253 168.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.88 -30.91 11.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.302 1.041 . . . . 0.0 113.627 -170.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.6 158.32 42.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.096 1.358 . . . . 0.0 112.064 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -151.04 147.12 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.457 1.903 . . . . 0.0 108.739 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.01 148.99 31.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.536 0.684 . . . . 0.0 111.171 159.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 m -107.58 128.44 54.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.157 0.983 . . . . 0.0 111.32 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.17 -162.85 23.62 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.438 1.494 . . . . 0.0 113.106 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.84 141.67 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.303 1.441 . . . . 0.0 110.459 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 mtm -139.51 154.98 47.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.41 0.684 . . . . 0.0 112.26 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.94 152.2 84.49 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 123.772 0.829 . . . . 0.0 110.963 165.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.32 -25.15 49.67 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.351 2.034 . . . . 0.0 114.021 -165.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -61.07 -32.37 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -85.97 -28.95 23.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 0.0 111.805 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.8 -27.24 69.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.141 -0.974 . . . . 0.0 112.374 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -58.58 -44.53 89.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.793 0.724 . . . . 0.0 111.696 171.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.47 75.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.243 0.617 . . . . 0.0 111.951 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.28 -45.35 84.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.02 0.528 . . . . 0.0 111.168 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -44.51 94.2 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.423 0.689 . . . . 0.0 111.735 173.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.8 -27.07 66.42 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.075 -1.016 . . . . 0.0 111.938 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 m -67.08 -21.05 65.9 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.627 1.171 . . . . 0.0 113.573 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.481 1.101 0 CA-C-N 119.438 1.017 . . . . 0.0 110.107 174.991 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 124.825 1.25 . . . . 0.0 111.476 -165.939 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.71 67.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.82 -40.18 63.54 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.467 0.576 . . . . 0.0 110.779 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.24 -9.99 59.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.27 1.028 . . . . 0.0 113.274 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.82 -22.84 23.02 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.019 1.328 . . . . 0.0 112.916 169.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.1 -17.08 9.8 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 -168.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.53 166.3 23.5 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -83.54 -64.91 1.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.321 1.448 . . . . 0.0 112.134 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.13 125.7 12.48 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.806 1.642 . . . . 0.0 109.986 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.99 162.6 39.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.2 mt -135.92 120.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.457 1.503 . . . . 0.0 107.674 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.32 128.21 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.972 1.309 . . . . 0.0 109.267 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -108.01 112.16 24.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.599 1.16 . . . . 0.0 111.547 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -78.38 79.39 4.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.941 1.296 . . . . 0.0 110.464 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.11 175.45 9.98 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.58 149.58 37.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.436 1.494 . . . . 0.0 111.291 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -75.72 -34.97 60.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.7 mt -82.36 -23.98 34.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.478 1.111 . . . . 0.0 113.496 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.02 125.43 91.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 113.573 -167.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.02 -2.27 9.54 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.177 3.918 . . . . 0.0 112.779 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -87.46 -42.76 12.57 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 119.696 1.135 . . . . 0.0 109.5 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 88.5 m -57.24 -37.1 71.79 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -50.79 -37.88 45.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -75.82 -41.08 53.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.873 0.469 . . . . 0.0 111.504 -170.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.284 1.034 . . . . 0.0 112.593 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -55.82 -40.94 73.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.607 1.094 . . . . 0.0 112.165 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -75.29 -33.94 61.27 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.492 -0.755 . . . . 0.0 112.659 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.53 -46.3 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.767 0.827 . . . . 0.0 110.855 174.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.31 -33.4 75.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.526 1.131 . . . . 0.0 112.41 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.25 -48.6 75.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.407 1.003 . . . . 0.0 112.564 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.58 -37.83 79.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.757 0.708 . . . . 0.0 112.247 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -67.85 -34.29 76.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 112.511 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.99 -22.72 60.67 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.877 -1.139 . . . . 0.0 113.643 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.93 -29.07 64.85 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -170.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.8 6.5 15.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.69 1.196 . . . . 0.0 114.224 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.96 63.92 17.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.937 1.695 . . . . 0.0 112.601 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.13 -15.19 32.06 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.275 2.65 . . . . 0.0 113.63 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -81.22 -2.95 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.43 134.11 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.241 1.416 . . . . 0.0 110.666 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.87 101.26 10.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.714 0.806 . . . . 0.0 111.339 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.7 mt -97.74 130.09 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.857 -1.152 . . . . 0.0 109.633 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 p -150.42 164.34 36.13 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.075 0.95 . . . . 0.0 111.677 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.5 p -104.34 176.22 5.23 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.66 -1.275 . . . . 0.0 112.601 165.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -156.02 135.46 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.776 1.631 . . . . 0.0 109.451 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -73.77 109.75 7.51 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.301 1.04 . . . . 0.0 111.446 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -55.12 -29.71 58.25 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.671 1.188 . . . . 0.0 113.931 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.09 -23.32 51.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.082 0.953 . . . . 0.0 112.782 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.92 -24.81 16.82 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.85 1.26 . . . . 0.0 112.783 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -117.46 48.6 0.8 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 126.858 2.063 . . . . 0.0 113.273 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.28 -27.09 24.43 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.566 1.511 . . . . 0.0 112.494 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.01 -32.93 74.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.742 0.701 . . . . 0.0 112.165 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.87 -48.04 67.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.002 0.921 . . . . 0.0 108.973 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.2 mtm -56.92 -22.17 35.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.675 -0.641 . . . . 0.0 112.438 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -13.87 53.22 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.371 0.987 . . . . 0.0 113.352 175.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -82.48 -42.3 18.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.482 1.113 . . . . 0.0 110.788 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.43 -23.98 24.32 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.17 21.63 17.27 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.41 1.481 . . . . 0.0 115.512 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.0 153.64 24.86 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.673 1.236 . . . . 0.0 111.919 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.38 -65.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.079 0.952 . . . . 0.0 111.941 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -159.99 2.16 0.08 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 -165.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.8 m -106.66 159.53 29.54 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 127.521 2.328 . . . . 0.0 112.835 -162.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.81 85.84 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.405 3.403 . . . . 0.0 111.859 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 75.7 m -98.79 128.36 44.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.92 137.78 32.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.698 1.199 . . . . 0.0 109.761 165.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.2 122.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.927 1.691 . . . . 0.0 108.662 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -102.67 118.53 37.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.998 0.919 . . . . 0.0 110.031 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.33 113.18 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.833 1.253 . . . . 0.0 108.853 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.77 121.61 45.76 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.045 1.338 . . . . 0.0 107.849 172.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.2 t70 64.59 21.78 12.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 112.261 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 9.23 84.47 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.403 1.001 . . . . 0.0 113.873 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.6 135.16 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 110.277 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.55 108.27 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 167.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.99 -34.42 10.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.82 150.49 33.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.044 1.738 . . . . 0.0 110.998 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -146.74 145.5 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.571 1.548 . . . . 0.0 108.811 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -148.0 136.57 21.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.539 0.736 . . . . 0.0 111.463 163.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 p -98.2 3.44 48.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.997 1.719 . . . . 0.0 115.08 -171.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.33 -166.19 26.61 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.422 1.486 . . . . 0.0 114.435 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.4 141.35 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.473 1.509 . . . . 0.0 110.086 170.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.6 mtm -137.05 176.02 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 170.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.46 156.17 49.44 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 126.759 2.023 . . . . 0.0 110.005 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.76 -38.2 18.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.903 1.735 . . . . 0.0 113.939 -156.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -61.25 -30.55 70.52 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.291 0.951 . . . . 0.0 113.086 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.18 -31.37 27.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.896 0.878 . . . . 0.0 112.006 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.26 -34.49 76.28 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.039 0.836 . . . . 0.0 112.388 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -48.59 76.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.062 0.945 . . . . 0.0 111.088 167.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.86 -34.93 79.28 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.484 0.714 . . . . 0.0 112.337 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.2 -49.18 70.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 110.329 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -42.41 80.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.225 0.61 . . . . 0.0 112.156 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.19 -36.42 81.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.472 0.578 . . . . 0.0 111.457 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -60.02 -34.98 74.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.838 1.255 . . . . 0.0 112.463 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 124.13 0.972 . . . . 0.0 111.056 175.134 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.549 0.69 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.6 p -158.8 162.27 37.02 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.461 1.504 . . . . 0.0 111.209 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.5 -2.41 35.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.71 1.204 . . . . 0.0 113.946 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.6 mm -108.09 112.22 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.626 1.57 . . . . 0.0 108.339 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -128.93 150.08 50.52 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.921 1.288 . . . . 0.0 110.429 -172.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.46 116.0 7.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.847 1.259 . . . . 0.0 110.714 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.3 mt -118.6 112.92 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.919 0.888 . . . . 0.0 109.692 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 p -101.61 -18.29 15.96 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.751 1.221 . . . . 0.0 113.037 164.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 p -69.51 -29.83 67.55 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.863 1.665 . . . . 0.0 113.295 -169.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.01 124.75 14.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.533 1.133 . . . . 0.0 109.336 157.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.38 160.75 15.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.391 1.877 . . . . 0.0 109.933 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.5 -170.08 54.64 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 123.308 0.48 . . . . 0.0 113.045 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -50.01 -37.04 30.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.034 1.334 . . . . 0.0 113.994 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.82 61.25 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -85.71 -32.6 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.048 0.939 . . . . 0.0 111.466 168.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -67.91 -30.96 70.42 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.5 -0.75 . . . . 0.0 111.457 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.2 -15.91 60.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.238 1.415 . . . . 0.0 113.283 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.27 -15.47 30.17 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.159 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD11 HG22 ' A' ' 79' ' ' ILE . 1.9 pp -102.9 153.79 19.86 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.274 1.537 . . . . 0.0 114.302 -168.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -99.11 -37.73 9.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.212 1.005 . . . . 0.0 113.284 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -159.88 110.96 1.95 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.211 1.404 . . . . 0.0 109.706 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.13 37.82 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.872 0.844 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.05 131.07 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 108.634 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.6 t -124.04 131.0 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.49 1.116 . . . . 0.0 109.521 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 9.1 t80 -105.27 113.52 27.16 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.994 1.317 . . . . 0.0 112.039 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -82.09 75.64 9.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.162 1.385 . . . . 0.0 110.607 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -77.24 166.74 22.81 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.866 0.866 . . . . 0.0 113.261 176.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.35 160.39 25.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.572 1.149 . . . . 0.0 112.31 173.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -74.4 -56.42 4.88 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.26 -64.96 0.79 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.694 1.198 . . . . 0.0 112.067 -170.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -51.21 121.97 17.43 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 127.027 2.131 . . . . 0.0 113.677 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.96 -23.06 76.49 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.402 3.401 . . . . 0.0 114.961 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -62.11 -45.04 95.24 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.925 0.89 . . . . 0.0 112.132 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 m -62.16 -34.63 76.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.605 1.162 . . . . 0.0 112.757 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -60.46 -25.23 65.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.743 1.617 . . . . 0.0 113.863 -171.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.9 -41.07 71.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -62.7 -29.29 70.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.053 0.941 . . . . 0.0 113.201 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -56.85 -43.09 80.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 111.885 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -68.8 -33.83 74.52 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.929 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.77 -48.07 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.709 1.604 . . . . 0.0 110.468 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.59 -34.97 79.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 0.0 112.593 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.31 -52.15 66.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 111.196 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -67.58 -32.66 73.56 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.85 0.86 . . . . 0.0 112.422 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.48 -38.1 80.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.836 1.254 . . . . 0.0 112.408 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.66 -27.8 41.18 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-N 118.911 0.778 . . . . 0.0 112.73 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.84 64.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.348 1.059 . . . . 0.0 113.607 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.43 10.66 37.18 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.769 1.628 . . . . 0.0 114.585 177.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB1' HE22 ' A' ' 50' ' ' GLN . . . -138.22 73.32 44.36 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.483 1.513 . . . . 0.0 112.324 177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.64 -22.61 73.34 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.566 2.844 . . . . 0.0 115.701 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.422 HE22 ' HB1' ' A' ' 48' ' ' ALA . 1.8 pm0 -86.62 -4.61 59.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.21 132.11 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.877 1.271 . . . . 0.0 111.057 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.39 105.34 15.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mt -107.86 135.08 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.958 0.903 . . . . 0.0 110.426 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.0 p -149.3 172.17 15.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 0.0 112.152 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.4 p -116.98 170.27 8.76 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.696 -1.253 . . . . 0.0 111.668 167.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.1 128.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.434 1.094 . . . . 0.0 110.074 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.2 111.04 1.8 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.692 1.197 . . . . 0.0 110.467 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.8 p -61.32 -26.55 67.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.131 0.972 . . . . 0.0 113.014 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -78.35 -20.4 51.41 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.879 0.763 . . . . 0.0 112.673 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.06 -26.13 20.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.384 1.074 . . . . 0.0 112.399 168.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -117.61 48.21 0.79 Allowed Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 126.055 1.742 . . . . 0.0 114.928 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.82 -17.08 14.19 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.932 2.421 . . . . 0.0 114.189 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -26.8 64.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.51 1.05 . . . . 0.0 112.616 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.75 -46.83 34.62 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.151 0.432 . . . . 0.0 110.738 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 mtm -55.61 -28.69 56.6 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.929 0.891 . . . . 0.0 113.143 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -60.22 -29.8 68.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.644 1.577 . . . . 0.0 113.361 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -91.33 -36.69 13.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.923 1.289 . . . . 0.0 111.164 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.87 -19.25 30.86 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.5 18.5 30.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.206 1.384 . . . . 0.0 114.835 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -79.36 151.55 30.92 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.265 1.033 . . . . 0.0 111.537 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -94.42 -72.49 0.61 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.761 1.225 . . . . 0.0 111.405 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.27 15.99 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.91 1.684 . . . . 0.0 113.147 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.31 157.3 34.35 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.349 1.46 . . . . 0.0 111.866 -157.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.31 91.28 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.757 2.972 . . . . 0.0 110.48 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.9 m -104.77 126.71 52.13 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 111.606 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.66 126.1 34.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 109.296 165.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.91 125.34 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.862 1.665 . . . . 0.0 108.74 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.58 121.29 44.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.511 1.124 . . . . 0.0 110.312 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 19' ' ' LEU . 28.2 mm -108.99 120.73 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 108.978 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -118.47 126.24 51.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.912 1.685 . . . . 0.0 109.419 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.77 19.7 9.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.366 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 2.35 88.37 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.223 -0.923 . . . . 0.0 114.627 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -103.24 135.91 44.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.078 1.751 . . . . 0.0 109.208 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.76 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.018 -1.051 . . . . 0.0 110.284 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -95.49 -20.76 18.78 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.596 1.158 . . . . 0.0 113.386 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -162.85 148.83 12.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.935 2.094 . . . . 0.0 108.828 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -161.77 144.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 110.58 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -157.71 143.03 16.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.42 1.088 . . . . 0.0 112.091 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.3 m -101.88 131.01 48.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.099 0.959 . . . . 0.0 110.955 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.88 -166.84 23.5 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.503 1.525 . . . . 0.0 113.273 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -120.08 146.07 25.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.14 1.776 . . . . 0.0 110.036 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.1 ptp -150.18 163.18 38.9 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 165.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.31 158.89 86.51 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.521 1.128 . . . . 0.0 112.53 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.78 -16.43 26.39 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.677 2.251 . . . . 0.0 113.707 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -68.14 -47.53 67.84 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 110.237 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -79.05 -27.07 43.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.307 1.043 . . . . 0.0 112.79 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.1 tp -61.59 -22.99 65.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.467 -0.771 . . . . 0.0 113.056 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -63.2 -42.05 99.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.226 0.61 . . . . 0.0 111.509 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -33.41 70.74 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.44 0.696 . . . . 0.0 112.15 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -50.14 72.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.761 1.224 . . . . 0.0 109.852 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.02 -44.47 96.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.344 1.058 . . . . 0.0 112.935 172.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.17 84.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.989 0.813 . . . . 0.0 111.834 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -55.68 -32.86 63.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.966 1.306 . . . . 0.0 112.849 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 124.578 1.151 . . . . 0.0 110.803 177.647 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.4 m 71.9 -57.32 0.62 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.08 2.552 . . . . 0.0 114.03 169.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.75 36.15 0.49 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.468 1.907 . . . . 0.0 113.268 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 mm -78.39 85.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.206 -0.934 . . . . 0.0 109.425 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.44 175.92 11.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.173 2.189 . . . . 0.0 110.467 -172.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -86.93 114.77 23.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.678 1.191 . . . . 0.0 110.105 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.13 75.65 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -47.5 -27.75 1.91 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.097 2.559 . . . . 0.0 114.521 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 p -75.95 -13.32 60.25 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.406 1.882 . . . . 0.0 114.251 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.97 -20.33 0.15 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 134.79 56.95 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.997 1.271 . . . . 0.0 112.23 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.64 171.26 12.22 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.284 1.421 . . . . 0.0 112.233 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptp -54.41 -35.45 62.91 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -168.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -29.63 68.49 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -75.34 -39.78 59.02 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.614 -0.679 . . . . 0.0 111.295 168.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.42 -13.34 61.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -91.46 -13.42 32.3 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.833 1.253 . . . . 0.0 113.417 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.64 -17.8 3.79 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 -170.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.11 165.91 22.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 114.206 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.2 m -83.54 -50.32 8.37 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -164.96 114.62 1.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.437 1.495 . . . . 0.0 109.955 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.74 160.81 42.84 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.18 122.63 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.916 1.286 . . . . 0.0 107.915 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.79 117.36 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.395 1.478 . . . . 0.0 109.383 -170.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' HB2' HD13 ' A' ' 76' ' ' LEU . 17.6 t80 -102.07 115.09 29.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.925 0.89 . . . . 0.0 112.894 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -81.22 78.04 8.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.871 1.268 . . . . 0.0 111.662 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -170.69 3.11 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.649 1.18 . . . . 0.0 113.265 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -142.83 164.91 28.82 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.847 1.659 . . . . 0.0 111.339 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -39.0 -94.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.407 2.283 . . . . 0.0 116.922 -164.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.01 -22.82 16.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 113.842 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 61.0 m -46.71 115.66 3.4 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 127.018 2.127 . . . . 0.0 113.242 -171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -55.2 -24.5 41.86 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.586 3.524 . . . . 0.0 116.196 -175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.94 -48.6 75.45 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.256 0.934 . . . . 0.0 112.186 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 94.4 m -70.13 -25.91 63.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.288 1.035 . . . . 0.0 113.318 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -65.4 -30.02 70.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.253 1.021 . . . . 0.0 112.816 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.24 -51.49 69.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 110.794 169.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.67 -41.22 97.24 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.741 1.216 . . . . 0.0 112.906 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.54 -37.19 65.13 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.502 -0.749 . . . . 0.0 111.766 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.01 -31.35 62.9 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.525 -1.359 . . . . 0.0 112.092 176.015 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.9 -44.17 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.706 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.42 -40.76 92.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.523 0.729 . . . . 0.0 112.584 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.35 -49.8 75.49 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.544 0.611 . . . . 0.0 112.61 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.14 -37.6 87.92 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.567 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.18 -38.01 89.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.821 1.248 . . . . 0.0 111.763 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.41 -19.11 67.18 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.37 0.986 . . . . 0.0 113.066 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.44 -32.24 68.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.097 0.959 . . . . 0.0 113.453 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 11.01 34.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.575 1.55 . . . . 0.0 114.232 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.68 45.44 0.37 Allowed Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 125.708 1.603 . . . . 0.0 114.328 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.42 -15.46 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.209 2.606 . . . . 0.0 114.088 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.46 -7.93 58.76 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.74 133.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.653 1.115 . . . . 0.0 108.048 163.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.62 85.25 4.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.831 0.824 . . . . 0.0 110.286 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.06 130.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.4 p -144.54 172.05 13.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.088 0.947 . . . . 0.0 112.085 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.6 p -128.28 154.27 46.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.14 -0.975 . . . . 0.0 110.343 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.0 t -139.9 126.32 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.828 1.251 . . . . 0.0 108.528 -169.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.88 100.04 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.152 1.381 . . . . 0.0 110.832 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.0 p -54.44 -36.71 64.34 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.569 1.147 . . . . 0.0 113.146 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.61 -26.95 67.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.311 1.844 . . . . 0.0 114.088 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.09 -17.29 16.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.414 1.486 . . . . 0.0 112.994 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.13 51.05 2.28 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.54 1.936 . . . . 0.0 112.377 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.33 -24.25 43.64 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.737 1.624 . . . . 0.0 111.553 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.48 -26.3 67.87 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 113.073 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.16 -55.18 6.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 109.5 168.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 mtm -57.54 -24.01 53.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.479 1.112 . . . . 0.0 113.369 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -70.37 -28.47 65.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.748 1.619 . . . . 0.0 111.696 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -80.96 -38.05 28.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.255 1.022 . . . . 0.0 111.007 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.93 -22.5 21.94 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.04 22.84 16.35 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.65 1.595 . . . . 0.0 115.024 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.11 153.63 25.97 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.663 1.232 . . . . 0.0 111.76 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.58 -70.6 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.353 1.061 . . . . 0.0 112.377 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -157.34 3.58 0.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -165.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.48 156.88 38.78 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.07 1.748 . . . . 0.0 113.02 -162.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.66 93.33 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.034 3.156 . . . . 0.0 110.261 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.2 m -103.41 129.77 50.58 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.253 1.021 . . . . 0.0 110.429 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 25' ' ' PHE . 12.5 tp -110.07 119.52 39.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.89 0.876 . . . . 0.0 110.061 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 t -117.13 129.15 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.343 1.457 . . . . 0.0 109.079 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -111.21 118.73 36.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.824 0.849 . . . . 0.0 109.901 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.451 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 30.1 mm -107.21 114.36 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.18 1.392 . . . . 0.0 109.148 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -108.28 118.57 37.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.771 1.228 . . . . 0.0 108.586 173.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.05 22.34 13.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.99 1.316 . . . . 0.0 113.209 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.63 10.47 70.15 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.372 0.987 . . . . 0.0 113.149 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -112.51 131.83 55.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.156 1.382 . . . . 0.0 109.37 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.16 106.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.625 -0.672 . . . . 0.0 109.419 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.01 -20.15 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -162.27 153.52 17.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.917 1.687 . . . . 0.0 110.448 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.13 144.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.96 1.304 . . . . 0.0 110.807 172.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.89 162.33 35.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.933 1.293 . . . . 0.0 109.814 165.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -130.98 140.91 50.21 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.411 0.685 . . . . 0.0 112.589 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.74 19.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.693 1.616 . . . . 0.0 112.386 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.1 mm -125.63 145.33 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.222 1.809 . . . . 0.0 110.135 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.8 ptp -147.36 -149.06 0.27 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.746 0.818 . . . . 0.0 111.473 164.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.85 160.06 38.97 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.519 1.528 . . . . 0.0 110.43 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.78 -34.49 11.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.612 1.542 . . . . 0.0 113.815 -153.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -59.14 -32.25 69.7 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.53 -32.55 32.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.083 0.953 . . . . 0.0 111.838 172.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.5 tp -65.62 -30.08 70.75 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.275 -0.891 . . . . 0.0 112.543 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.7 -37.55 73.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.05 0.841 . . . . 0.0 112.015 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.26 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.969 -1.082 . . . . 0.0 112.211 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.19 -39.96 90.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.726 -0.609 . . . . 0.0 111.37 175.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.58 -48.29 80.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.204 1.002 . . . . 0.0 112.123 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.7 -32.89 74.07 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.82 -1.175 . . . . 0.0 112.718 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.3 t -64.57 -13.53 53.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.787 1.635 . . . . 0.0 113.331 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.474 0.736 0 O-C-N 120.658 -1.276 . . . . 0.0 110.719 170.854 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.441 0.639 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 m -74.54 -45.06 48.07 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.855 0.862 . . . . 0.0 112.591 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.76 -15.23 17.02 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.6 mm -117.56 126.1 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.45 1.5 . . . . 0.0 111.081 -169.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.43 160.76 23.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.448 1.099 . . . . 0.0 112.558 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.09 118.45 6.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.82 2.448 . . . . 0.0 112.459 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mt -120.27 55.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 122.648 1.213 . . . . 0.0 111.477 168.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.7 m -48.88 -30.53 5.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.898 2.879 . . . . 0.0 114.556 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -76.77 -69.71 0.5 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.454 1.902 . . . . 0.0 111.328 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -74.51 -25.2 59.2 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.31 117.28 5.02 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 120.624 1.556 . . . . 0.0 112.251 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.25 163.76 16.71 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.22 1.39 . . . . 0.0 113.27 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -52.76 -37.26 59.24 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.356 1.462 . . . . 0.0 114.765 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.8 -25.87 63.06 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -82.82 -32.76 27.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.662 . . . . 0.0 111.916 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.89 -28.83 68.64 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.807 -0.558 . . . . 0.0 111.221 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.41 -7.05 16.81 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.567 -1.333 . . . . 0.0 114.042 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.11 -4.72 61.16 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.151 1.358 . . . . 0.0 115.506 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.3 mt -77.65 159.27 29.29 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.625 1.713 . . . . 0.0 115.215 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -87.09 -51.65 5.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.014 143.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -161.55 135.23 6.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.16 1.784 . . . . 0.0 112.586 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.04 162.98 38.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.218 1.407 . . . . 0.0 112.916 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -139.33 132.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.057 1.343 . . . . 0.0 108.707 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.07 123.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.012 1.325 . . . . 0.0 109.631 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -102.77 110.72 22.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.646 1.178 . . . . 0.0 111.621 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.02 70.29 5.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.962 1.705 . . . . 0.0 110.845 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -171.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.182 0.993 . . . . 0.0 113.561 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -136.27 163.35 30.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.644 1.178 . . . . 0.0 111.329 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -72.39 -60.89 2.01 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.284 1.033 . . . . 0.0 112.716 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.91 -41.9 35.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.648 1.179 . . . . 0.0 112.342 -169.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.2 m -47.59 108.51 0.9 Allowed Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 126.667 1.987 . . . . 0.0 114.191 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -62.09 -30.27 82.32 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.377 2.718 . . . . 0.0 113.926 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.88 -38.26 90.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -61.81 -32.54 72.85 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.955 0.902 . . . . 0.0 113.109 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.67 -29.1 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.709 0.804 . . . . 0.0 112.758 -174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -63.58 -43.47 96.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.573 0.749 . . . . 0.0 111.626 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.9 mmm -66.31 -26.08 67.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.745 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -44.69 89.26 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.531 1.06 . . . . 0.0 111.512 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -62.23 -43.92 97.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.996 -1.065 . . . . 0.0 112.226 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.45 -48.38 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.342 1.057 . . . . 0.0 111.051 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.4 mt -63.47 -37.11 86.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.005 0.922 . . . . 0.0 112.961 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.72 -47.86 81.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.432 0.693 . . . . 0.0 111.119 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.05 -32.54 72.97 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.913 0.885 . . . . 0.0 113.17 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.11 -36.45 83.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.683 1.593 . . . . 0.0 111.782 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.19 -22.5 62.95 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-N 118.917 0.78 . . . . 0.0 112.445 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.09 -28.71 64.85 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.715 1.206 . . . . 0.0 113.904 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 9.79 29.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.503 1.521 . . . . 0.0 114.256 176.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.46 85.73 14.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.381 1.472 . . . . 0.0 111.338 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.02 -15.03 18.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.878 2.385 . . . . 0.0 114.52 -169.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.97 -12.62 24.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.11 1.323 . . . . 0.0 113.874 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.69 129.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 110.226 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.96 92.99 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.371 0.605 . . . . 0.0 110.36 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 mt -92.96 136.24 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 109.988 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.5 p -148.15 168.55 22.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 112.688 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -118.25 168.84 10.22 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.989 -1.069 . . . . 0.0 110.636 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.77 131.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.33 1.052 . . . . 0.0 109.487 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.45 115.51 9.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.875 1.27 . . . . 0.0 111.873 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.7 p -57.05 -27.72 61.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.824 1.25 . . . . 0.0 113.826 172.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.53 -23.32 50.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.306 0.957 . . . . 0.0 112.498 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.79 -39.94 9.2 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.912 1.285 . . . . 0.0 113.108 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -126.89 60.58 41.73 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.544 . . . . 0.0 112.71 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.42 -15.95 34.71 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.395 2.73 . . . . 0.0 111.777 167.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.11 -41.18 68.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.606 1.563 . . . . 0.0 112.156 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.56 -44.05 62.64 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.336 0.654 . . . . 0.0 111.675 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.5 mtp -56.41 -28.94 60.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.711 0.805 . . . . 0.0 112.184 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -17.95 60.77 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.634 1.174 . . . . 0.0 113.505 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -81.06 -40.65 23.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.13 1.372 . . . . 0.0 110.822 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.52 -26.16 38.28 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.325 0.65 . . . . 0.0 112.481 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 16.51 23.78 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.906 1.717 . . . . 0.0 114.791 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.56 140.61 38.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.086 1.443 . . . . 0.0 110.691 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -77.29 -77.17 0.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.955 0.502 . . . . 0.0 110.778 175.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -147.79 4.56 0.76 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.443 1.497 . . . . 0.0 114.88 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.9 m -86.29 155.89 57.17 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 126.579 1.952 . . . . 0.0 113.198 -166.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.43 82.96 2.36 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 124.533 3.489 . . . . 0.0 111.294 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.4 m -96.38 130.88 43.4 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 112.683 -169.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.47 122.96 36.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.79 1.236 . . . . 0.0 108.987 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.17 126.04 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.553 1.541 . . . . 0.0 108.745 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.04 117.11 32.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 109.856 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.1 mm -109.7 126.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.922 1.289 . . . . 0.0 110.101 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -114.31 121.15 42.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.964 1.706 . . . . 0.0 108.622 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.9 t70 60.73 27.71 17.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.666 1.121 . . . . 0.0 111.927 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 -3.14 83.1 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -99.56 132.05 45.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.499 1.52 . . . . 0.0 109.65 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.12 104.02 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.71 -20.49 21.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.252 1.021 . . . . 0.0 113.107 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -163.03 155.61 18.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.21 1.804 . . . . 0.0 110.717 -173.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.35 146.42 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.093 1.357 . . . . 0.0 111.031 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.45 149.49 30.87 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.3 1.44 . . . . 0.0 108.575 169.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -134.01 140.13 46.49 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.133 -0.979 . . . . 0.0 112.08 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.84 -144.53 18.22 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.671 1.129 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.7 mm -116.96 143.26 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.322 1.449 . . . . 0.0 111.399 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.1 ptp -155.73 169.87 23.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 113.185 160.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -83.53 162.44 53.38 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 125.725 1.61 . . . . 0.0 112.129 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.95 -30.65 21.06 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.089 1.859 . . . . 0.0 114.655 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.7 -28.78 60.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.319 1.418 . . . . 0.0 113.027 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.1 -25.19 47.42 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.577 -0.702 . . . . 0.0 112.545 164.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.84 -30.65 67.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 111.953 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.32 -44.67 92.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.261 0.937 . . . . 0.0 111.086 163.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.52 72.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.257 0.935 . . . . 0.0 112.743 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.82 -48.22 72.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.127 1.371 . . . . 0.0 110.196 173.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.72 -42.24 83.43 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.935 0.894 . . . . 0.0 112.204 170.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.69 67.71 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.072 -1.018 . . . . 0.0 111.865 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 m -76.96 -10.7 59.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.583 1.553 . . . . 0.0 113.169 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.477 0.902 0 CA-C-N 119.391 0.996 . . . . 0.0 108.536 162.561 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.9 mtp . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 t -67.03 146.63 54.14 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.678 1.191 . . . . 0.0 112.118 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.6 -9.99 59.05 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm -108.81 124.73 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.281 1.433 . . . . 0.0 110.931 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -175.63 173.43 2.41 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.89 2.476 . . . . 0.0 111.704 -172.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -72.41 120.88 18.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.444 1.098 . . . . 0.0 110.263 159.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.9 mt -91.82 130.01 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.885 0.874 . . . . 0.0 109.499 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.9 p -75.18 -18.0 60.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.641 1.577 . . . . 0.0 114.455 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 m -66.82 -49.29 66.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.568 1.547 . . . . 0.0 111.922 -174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -178.15 141.23 0.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.034 2.133 . . . . 0.0 110.667 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.3 133.88 4.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.668 1.587 . . . . 0.0 110.599 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.19 176.16 14.46 Favored Glycine 0 N--CA 1.47 0.908 0 C-N-CA 124.913 1.244 . . . . 0.0 112.653 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp -56.11 -32.91 64.63 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -165.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.89 70.51 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -74.73 -40.13 61.46 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.678 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -73.92 -9.8 59.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -92.07 -16.21 26.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.436 1.494 . . . . 0.0 113.173 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -19.05 6.63 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.63 166.4 22.82 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -82.72 -65.72 0.98 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.266 1.426 . . . . 0.0 113.013 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -148.42 121.79 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.603 1.561 . . . . 0.0 109.669 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.46 161.54 39.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.3 mt -138.16 123.17 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.645 1.578 . . . . 0.0 107.936 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.0 121.96 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.268 1.427 . . . . 0.0 108.314 -175.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -100.4 107.68 19.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.92 0.888 . . . . 0.0 110.802 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.11 80.74 3.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.721 1.208 . . . . 0.0 109.83 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.87 -178.31 7.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.708 1.203 . . . . 0.0 111.913 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -127.36 139.59 52.76 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.276 -1.515 . . . . 0.0 110.953 161.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -57.3 -32.75 66.97 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.696 1.598 . . . . 0.0 114.02 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -80.66 -37.97 29.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 113.209 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.0 t -57.5 118.13 23.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.934 1.694 . . . . 0.0 113.713 -168.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.48 -24.98 56.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.151 3.234 . . . . 0.0 113.381 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -77.01 -40.94 44.75 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.798 0.727 . . . . 0.0 110.957 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 78.7 m -52.83 -34.66 55.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.754 1.222 . . . . 0.0 113.959 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -55.98 -39.73 72.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.076 0.95 . . . . 0.0 112.303 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -65.2 -47.02 78.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.626 0.77 . . . . 0.0 110.841 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 tpt -60.66 -36.08 77.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.715 1.206 . . . . 0.0 112.176 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.63 -37.77 88.58 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.689 -1.257 . . . . 0.0 112.759 172.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -34.01 74.67 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.818 1.19 . . . . 0.0 112.476 171.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.07 -48.77 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-N 119.14 0.882 . . . . 0.0 110.385 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.97 -34.09 77.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.682 1.193 . . . . 0.0 112.087 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.13 -49.47 75.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.704 1.138 . . . . 0.0 111.475 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -66.57 -33.97 76.85 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.696 -0.627 . . . . 0.0 112.391 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -63.35 -42.61 98.92 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 111.261 170.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.82 -26.52 45.29 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.295 0.95 . . . . 0.0 112.619 -171.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.28 68.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.166 0.986 . . . . 0.0 113.428 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.32 8.27 35.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.618 1.567 . . . . 0.0 114.269 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.22 45.24 0.89 Allowed Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 126.257 1.823 . . . . 0.0 113.202 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.22 -15.74 51.52 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.751 2.967 . . . . 0.0 114.531 -167.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -76.84 -9.18 58.51 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.36 130.53 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.822 1.192 . . . . 0.0 108.529 162.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.57 96.05 6.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.301 0.641 . . . . 0.0 110.674 174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mt -104.87 130.13 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.135 -0.978 . . . . 0.0 109.48 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.0 p -148.82 170.75 17.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.054 0.942 . . . . 0.0 112.325 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.2 p -129.89 153.63 48.12 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.017 -1.052 . . . . 0.0 112.896 174.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.87 134.54 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.677 1.591 . . . . 0.0 109.154 -168.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.46 121.04 26.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 123.026 1.393 . . . . 0.0 113.159 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 p -62.6 -23.71 67.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.861 1.664 . . . . 0.0 114.979 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.28 -45.1 10.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.031 1.287 . . . . 0.0 111.823 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.07 -26.92 43.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.709 1.204 . . . . 0.0 113.671 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.56 54.51 14.6 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.746 1.618 . . . . 0.0 112.038 -171.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.19 -9.67 13.91 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.318 3.345 . . . . 0.0 113.675 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -66.27 -21.78 66.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.801 0.84 . . . . 0.0 112.509 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.67 -54.25 6.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.77 1.228 . . . . 0.0 110.92 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.5 mtm -55.74 -30.01 60.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -74.2 -14.24 60.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.731 0.812 . . . . 0.0 112.803 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -89.04 -38.71 14.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.656 1.183 . . . . 0.0 110.538 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.46 -22.52 28.23 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 17.27 26.39 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.788 1.661 . . . . 0.0 115.061 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.56 140.58 37.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.016 1.408 . . . . 0.0 110.835 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.98 -59.36 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.618 0.767 . . . . 0.0 112.19 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -157.04 1.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 m -101.64 152.72 38.13 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.796 1.638 . . . . 0.0 113.028 -163.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.86 91.7 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.093 3.196 . . . . 0.0 110.396 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -107.2 124.83 50.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 0.0 112.47 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.56 129.25 37.57 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.274 0.63 . . . . 0.0 109.859 166.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.17 127.98 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.77 1.628 . . . . 0.0 108.401 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -105.64 127.84 53.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.424 1.09 . . . . 0.0 109.757 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.7 115.84 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.055 0.942 . . . . 0.0 108.674 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.43 123.93 50.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.131 1.373 . . . . 0.0 108.879 171.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.58 20.22 11.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.199 1.4 . . . . 0.0 112.681 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.11 12.56 82.29 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 113.694 -172.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -107.71 134.82 50.13 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.699 1.6 . . . . 0.0 109.754 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.74 105.12 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.96 -27.81 13.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -162.05 154.27 19.36 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.035 1.334 . . . . 0.0 110.579 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.2 145.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.878 1.271 . . . . 0.0 110.701 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 144.92 25.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.007 0.923 . . . . 0.0 111.17 165.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 m -111.52 120.17 41.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.122 0.969 . . . . 0.0 110.523 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.74 29.89 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 124.926 1.25 . . . . 0.0 114.382 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm -112.2 140.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.429 1.492 . . . . 0.0 109.7 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.0 mtm -142.6 161.32 38.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.781 0.833 . . . . 0.0 112.338 167.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -76.01 161.06 76.93 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.508 1.523 . . . . 0.0 112.064 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.31 -25.25 22.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.243 1.962 . . . . 0.0 114.453 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -76.67 -35.99 57.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.031 1.287 . . . . 0.0 112.543 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.5 -25.42 50.33 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.017 0.826 . . . . 0.0 112.784 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.29 -25.96 68.15 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.183 -0.948 . . . . 0.0 112.4 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -63.9 -38.76 92.29 Favored 'General case' 0 C--N 1.342 0.281 0 O-C-N 121.553 -0.717 . . . . 0.0 111.877 172.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.31 79.72 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.66 0.664 . . . . 0.0 112.038 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.01 -42.94 79.92 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.26 -43.37 98.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.806 0.843 . . . . 0.0 112.185 171.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.57 87.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.46 -0.775 . . . . 0.0 111.131 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.3 m -66.58 -4.07 7.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.004 1.722 . . . . 0.0 114.846 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 119.082 0.855 . . . . 0.0 110.58 166.862 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 t -132.4 147.06 52.37 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.35 1.46 . . . . 0.0 112.397 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.08 -6.02 47.27 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.244 1.417 . . . . 0.0 114.041 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.5 mm -100.2 120.74 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 109.799 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 -123.04 148.98 44.98 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.766 1.626 . . . . 0.0 110.276 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -82.07 105.34 13.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.461 0.704 . . . . 0.0 109.128 167.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mt -104.14 60.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 122.199 0.999 . . . . 0.0 109.819 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 m -44.45 -39.32 4.67 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 128.134 2.573 . . . . 0.0 113.303 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 m -69.12 -41.59 77.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.48 1.912 . . . . 0.0 112.195 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -83.73 -23.75 31.48 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.229 1.012 . . . . 0.0 112.244 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.2 51.92 0.44 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.529 1.932 . . . . 0.0 114.796 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.36 148.47 18.7 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 125.201 1.382 . . . . 0.0 110.329 160.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp -55.54 -31.68 62.32 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -26.24 66.92 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -68.31 -43.24 78.08 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.123 0.874 . . . . 0.0 110.73 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -75.78 -9.71 58.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.236 1.014 . . . . 0.0 112.907 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.01 -14.33 29.57 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.046 1.338 . . . . 0.0 113.218 167.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.05 -15.71 6.04 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.73 174.29 8.61 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 p -88.37 -60.06 2.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.411 1.485 . . . . 0.0 113.497 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -158.47 115.59 2.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.218 1.407 . . . . 0.0 110.36 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.08 160.74 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -168.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.7 mt -137.43 128.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.949 1.7 . . . . 0.0 109.106 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.73 135.07 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.131 1.372 . . . . 0.0 109.458 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -116.07 114.79 25.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 111.729 172.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -83.94 74.24 10.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.941 1.696 . . . . 0.0 111.31 -175.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.73 -170.14 2.01 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -157.25 170.84 21.56 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.611 1.564 . . . . 0.0 113.323 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -47.57 -102.9 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 128.827 2.851 . . . . 0.0 116.951 -173.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.7 -15.73 41.35 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.015 -1.678 . . . . 0.0 114.629 -168.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -49.18 119.93 9.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.681 1.592 . . . . 0.0 112.494 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.31 -25.71 36.11 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.319 2.679 . . . . 0.0 113.732 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -70.93 -43.23 68.65 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 119.366 0.985 . . . . 0.0 112.179 -168.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -67.22 -25.1 65.94 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -61.68 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.114 0.966 . . . . 0.0 113.595 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -63.21 -44.69 94.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.415 0.686 . . . . 0.0 111.903 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -60.88 -30.63 70.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.416 1.086 . . . . 0.0 113.002 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.74 -35.37 76.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.404 0.682 . . . . 0.0 111.786 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' HE3' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -69.67 -34.09 73.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.525 1.057 . . . . 0.0 111.035 176.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 t -69.62 -46.35 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.014 1.726 . . . . 0.0 109.362 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.8 mt -61.96 -41.67 98.26 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.379 1.872 . . . . 0.0 112.658 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.62 -52.42 64.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.616 1.166 . . . . 0.0 111.97 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -66.47 -32.96 74.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.049 -1.032 . . . . 0.0 112.551 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -68.24 -34.3 75.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.896 1.278 . . . . 0.0 112.311 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.84 46.01 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 121.002 -1.061 . . . . 0.0 112.657 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.96 65.56 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.157 1.383 . . . . 0.0 114.537 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 4.84 23.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.976 1.31 . . . . 0.0 114.086 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.72 40.59 0.62 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.701 1.6 . . . . 0.0 114.034 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -65.56 -13.28 39.01 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.641 2.894 . . . . 0.0 114.685 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -77.83 -9.02 58.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 173.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.75 132.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.21 0.914 . . . . 0.0 108.903 161.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.26 92.65 5.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.332 0.587 . . . . 0.0 110.324 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.8 mt -102.16 131.1 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.253 1.021 . . . . 0.0 109.667 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.5 p -147.16 159.43 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.716 0.806 . . . . 0.0 112.369 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.0 p -98.14 163.6 12.67 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.213 -0.929 . . . . 0.0 111.145 163.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -147.99 129.17 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.602 1.561 . . . . 0.0 108.8 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.12 108.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.685 0.794 . . . . 0.0 110.188 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 p -52.55 -41.18 63.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.897 1.279 . . . . 0.0 111.88 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.14 -22.22 66.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.96 1.704 . . . . 0.0 114.223 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.06 -14.59 22.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.115 1.366 . . . . 0.0 113.4 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -131.9 49.61 4.82 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.79 1.636 . . . . 0.0 113.959 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -67.53 -26.35 40.29 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.431 2.087 . . . . 0.0 112.209 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -60.81 -41.28 95.35 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 0.0 111.703 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.97 -50.34 72.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.735 0.814 . . . . 0.0 110.996 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.9 mtp -57.63 -22.87 48.02 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.629 0.771 . . . . 0.0 113.022 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -14.03 52.94 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.561 1.144 . . . . 0.0 112.813 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -83.58 -41.35 17.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.343 1.057 . . . . 0.0 110.599 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.31 -24.72 32.05 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.47 20.98 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 125.172 1.368 . . . . 0.0 115.018 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -82.14 145.69 29.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.11 1.455 . . . . 0.0 111.508 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -80.91 -75.2 0.29 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 111.343 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -161.13 13.41 0.1 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -166.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.21 155.62 36.2 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 126.389 1.876 . . . . 0.0 113.255 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.56 90.26 1.05 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.16 3.24 . . . . 0.0 110.846 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -99.73 132.45 45.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 112.595 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.56 131.52 35.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.474 1.11 . . . . 0.0 109.71 161.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.65 121.92 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.776 1.631 . . . . 0.0 108.302 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.04 124.12 49.71 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.125 0.97 . . . . 0.0 110.687 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.54 122.74 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.171 1.388 . . . . 0.0 109.51 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -116.9 124.16 48.78 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.445 1.498 . . . . 0.0 109.192 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 62.65 20.54 12.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.166 1.386 . . . . 0.0 112.362 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.71 8.98 86.18 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.083 -1.011 . . . . 0.0 113.521 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -103.74 132.55 49.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.544 1.537 . . . . 0.0 109.073 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.82 105.4 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.324 -0.86 . . . . 0.0 109.039 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.43 -24.75 15.98 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.492 1.117 . . . . 0.0 113.387 -170.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -160.51 146.87 15.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.444 1.498 . . . . 0.0 110.801 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.2 t -147.51 145.52 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 109.826 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.26 151.5 29.2 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.976 0.911 . . . . 0.0 111.44 162.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.8 m -115.95 135.28 54.12 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.624 0.77 . . . . 0.0 111.944 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.89 -149.4 17.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.935 1.255 . . . . 0.0 112.593 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.19 139.65 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.571 1.548 . . . . 0.0 110.76 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -139.22 160.48 39.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.448 1.099 . . . . 0.0 112.044 163.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -74.0 162.11 75.49 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 124.76 1.224 . . . . 0.0 111.869 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.89 -23.71 12.12 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.09 1.86 . . . . 0.0 114.676 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.8 -37.33 67.59 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.137 1.79 . . . . 0.0 112.607 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -78.81 -22.88 45.59 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.653 0.66 . . . . 0.0 112.151 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.64 -29.57 70.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 0.0 112.09 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.74 -39.4 93.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.239 0.927 . . . . 0.0 111.393 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.19 80.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.503 -0.748 . . . . 0.0 111.93 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.41 -44.6 90.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.166 0.586 . . . . 0.0 110.686 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.18 -47.44 86.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.19 0.996 . . . . 0.0 112.693 172.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.16 76.52 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.13 -0.982 . . . . 0.0 112.351 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.1 t -65.58 -14.34 60.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.382 1.473 . . . . 0.0 113.737 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 N--CA 1.48 1.038 0 O-C-N 119.988 -1.695 . . . . 0.0 110.588 172.682 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtm . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 121.157 0.503 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -76.89 42.57 0.31 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.219 1.408 . . . . 0.0 112.829 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.8 -3.32 37.73 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -103.7 107.86 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.09 1.756 . . . . 0.0 107.548 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -140.4 164.46 30.06 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.412 1.485 . . . . 0.0 111.637 -166.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.48 109.67 0.73 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.789 2.036 . . . . 0.0 111.693 167.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.42 121.21 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.988 1.315 . . . . 0.0 108.902 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.0 p -64.86 -29.81 70.79 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.732 1.613 . . . . 0.0 114.626 -174.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.5 p -87.45 -15.24 38.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.432 1.493 . . . . 0.0 113.959 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -124.21 28.16 6.83 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.438 1.495 . . . . 0.0 112.071 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.53 166.78 23.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.745 1.618 . . . . 0.0 111.972 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.65 147.68 22.42 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.889 1.233 . . . . 0.0 111.401 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp -52.33 -31.6 34.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.074 1.35 . . . . 0.0 114.596 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 -28.93 63.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -74.16 -39.11 63.46 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.656 -0.652 . . . . 0.0 110.413 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.41 -14.98 61.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 113.302 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -89.49 -20.14 24.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.629 1.172 . . . . 0.0 112.846 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.24 -23.47 6.97 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 124.896 1.236 . . . . 0.0 115.081 -171.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.25 165.65 23.2 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -89.1 -56.22 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.987 1.315 . . . . 0.0 113.003 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -155.34 110.54 3.02 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.898 1.279 . . . . 0.0 110.65 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.84 159.75 42.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.7 mt -135.29 129.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.508 1.523 . . . . 0.0 108.445 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -121.28 124.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.613 1.565 . . . . 0.0 109.57 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -104.06 119.22 38.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -85.05 76.29 10.27 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.098 -1.001 . . . . 0.0 110.455 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 173.08 11.81 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.682 0.753 . . . . 0.0 112.931 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -125.68 147.66 49.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.694 1.198 . . . . 0.0 110.772 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.84 148.27 30.63 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 67.61 -30.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.907 2.883 . . . . 0.0 115.296 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.4 t -52.13 117.55 10.42 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.019 1.728 . . . . 0.0 113.305 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.91 -24.64 74.19 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.194 3.263 . . . . 0.0 113.602 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -72.61 -43.27 63.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.226 0.921 . . . . 0.0 110.585 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.6 -33.26 69.79 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 113.065 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -54.72 -39.8 68.59 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.174 0.989 . . . . 0.0 112.501 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.39 -48.13 81.63 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.549 0.74 . . . . 0.0 110.959 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.738 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.31 -43.09 96.66 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.209 0.913 . . . . 0.0 111.325 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -41.93 85.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.581 0.752 . . . . 0.0 112.43 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.86 -46.96 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.873 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.28 -34.09 77.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.114 1.365 . . . . 0.0 112.609 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.68 -46.46 88.07 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.9 0.773 . . . . 0.0 112.158 169.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -68.86 -35.16 76.59 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.289 -0.882 . . . . 0.0 112.033 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.76 -37.67 88.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.405 1.482 . . . . 0.0 111.848 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.49 -22.02 57.17 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 123.863 0.744 . . . . 0.0 113.369 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.74 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.264 1.026 . . . . 0.0 113.332 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 10.08 41.28 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.327 1.451 . . . . 0.0 114.601 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.75 48.83 0.74 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.629 1.572 . . . . 0.0 113.709 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.36 -16.96 57.89 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.591 2.861 . . . . 0.0 114.023 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -79.09 -8.28 58.84 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.53 134.12 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.545 1.066 . . . . 0.0 108.685 166.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.23 86.73 4.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.466 0.651 . . . . 0.0 110.647 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.5 mt -93.27 127.19 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.748 0.819 . . . . 0.0 109.178 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t -141.52 164.42 30.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.768 1.227 . . . . 0.0 110.906 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -110.42 -175.92 2.85 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 162.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.4 p -167.28 129.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.357 1.863 . . . . 0.0 109.222 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -72.55 114.71 10.98 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.193 0.997 . . . . 0.0 111.075 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 p -54.91 -28.09 48.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 113.601 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -74.9 -26.65 59.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.989 0.813 . . . . 0.0 112.675 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.18 -29.41 15.13 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.942 1.297 . . . . 0.0 113.415 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -127.81 49.83 4.77 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.18 1.392 . . . . 0.0 113.962 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.3 -19.93 49.48 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.937 1.758 . . . . 0.0 112.376 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.26 1.024 . . . . 0.0 112.86 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.85 -54.27 7.58 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.2 mtp -55.53 -33.31 63.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.578 1.151 . . . . 0.0 113.351 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -65.98 -21.29 66.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.695 1.598 . . . . 0.0 113.768 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -76.88 -40.14 48.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.847 0.749 . . . . 0.0 111.968 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.91 -22.56 24.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 11.86 36.41 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.337 1.922 . . . . 0.0 115.179 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.75 130.77 39.17 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.213 1.507 . . . . 0.0 111.68 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -84.12 -55.15 4.35 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.071 0.949 . . . . 0.0 112.169 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -160.41 -0.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.46 154.5 44.38 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 125.554 1.542 . . . . 0.0 113.4 -160.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.8 89.02 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.455 3.437 . . . . 0.0 109.469 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.3 m -105.2 132.67 51.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.829 0.851 . . . . 0.0 112.609 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.96 134.75 33.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.7 1.2 . . . . 0.0 110.471 166.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.5 t -130.31 131.46 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.783 1.633 . . . . 0.0 108.685 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -110.08 128.68 55.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.055 0.942 . . . . 0.0 110.65 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.86 110.49 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.0 123.75 50.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.284 1.433 . . . . 0.0 108.202 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.18 17.49 8.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.758 1.223 . . . . 0.0 112.038 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.52 83.18 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.077 0.846 . . . . 0.0 113.639 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -110.08 135.96 50.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.266 1.826 . . . . 0.0 109.397 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.09 106.29 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.94 -20.88 13.04 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -163.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -159.19 153.74 24.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.99 1.316 . . . . 0.0 111.436 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.65 144.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.734 1.614 . . . . 0.0 110.388 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -154.01 143.36 21.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.539 1.136 . . . . 0.0 112.011 165.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 m -101.19 135.58 42.42 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.927 0.891 . . . . 0.0 112.069 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.69 -162.72 12.32 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.914 1.245 . . . . 0.0 113.682 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.44 140.85 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.778 1.631 . . . . 0.0 111.285 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.8 mtm -134.79 153.21 52.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.467 1.107 . . . . 0.0 110.388 160.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.13 152.57 71.3 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 122.749 0.419 . . . . 0.0 110.978 169.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.81 -27.32 51.86 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.29 1.993 . . . . 0.0 114.264 -156.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -63.89 -30.04 71.17 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.12 -37.79 64.0 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.994 0.816 . . . . 0.0 111.008 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.6 tp -65.3 -28.24 69.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.47 -0.776 . . . . 0.0 112.819 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -59.1 -49.38 78.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.982 0.81 . . . . 0.0 111.574 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.9 -37.6 84.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.578 0.751 . . . . 0.0 111.77 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -67.24 -43.54 81.69 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.837 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.89 -47.01 87.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.425 1.09 . . . . 0.0 112.131 172.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.88 85.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.461 0.573 . . . . 0.0 111.739 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.2 m -62.48 -11.35 15.65 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.655 1.582 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.478 0.951 0 O-C-N 121.08 -1.013 . . . . 0.0 112.032 175.917 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.5 p -164.81 168.09 18.15 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.437 1.495 . . . . 0.0 112.191 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.86 0.73 14.59 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.54 1.536 . . . . 0.0 114.21 172.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mm -101.52 125.53 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.521 1.929 . . . . 0.0 108.382 -174.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -116.05 146.33 42.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.521 1.129 . . . . 0.0 109.893 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.05 116.09 12.05 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 163.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mt -128.73 49.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 122.183 0.992 . . . . 0.0 111.93 172.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.8 m -46.17 -35.0 4.69 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.038 2.135 . . . . 0.0 113.563 169.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -63.85 -41.53 97.78 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.462 1.905 . . . . 0.0 112.734 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -84.3 -13.74 51.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.387 1.075 . . . . 0.0 113.411 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.08 31.0 0.07 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -168.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.2 148.54 34.53 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.52 1.057 . . . . 0.0 110.541 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -56.77 -29.12 62.33 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -25.27 64.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.719 1.208 . . . . 0.0 113.95 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -70.18 -31.16 68.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.105 0.866 . . . . 0.0 111.752 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -75.66 -20.63 58.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.943 0.897 . . . . 0.0 113.003 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.91 82.28 0.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.132 1.773 . . . . 0.0 113.075 -172.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 134.87 3.06 2.98 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 126.313 1.911 . . . . 0.0 116.927 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -74.48 114.33 12.75 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.14 1.97 . . . . 0.0 111.971 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -66.5 -28.33 68.48 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.746 -1.221 . . . . 0.0 114.045 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -155.85 97.06 1.8 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.556 1.542 . . . . 0.0 109.777 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.85 156.77 46.55 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mt -141.29 132.28 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.963 1.305 . . . . 0.0 109.347 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.58 126.57 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.322 1.449 . . . . 0.0 109.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -106.01 108.18 19.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.579 1.152 . . . . 0.0 110.419 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -77.56 76.38 4.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 110.392 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -172.37 2.31 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.847 0.859 . . . . 0.0 111.701 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -147.15 130.61 16.72 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.118 -1.614 . . . . 0.0 112.05 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.85 -23.91 61.4 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 mt -89.86 -15.5 32.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.45 122.26 73.52 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.81 1.644 . . . . 0.0 111.884 -173.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.7 -1.26 9.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.71 3.606 . . . . 0.0 113.04 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -88.43 -44.81 10.46 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.378 0.99 . . . . 0.0 109.741 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 p -61.93 -27.75 69.05 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -50.6 -38.96 48.55 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -71.98 -33.5 68.19 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.019 -0.425 . . . . 0.0 112.128 -168.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.1 tpt -64.0 -24.13 67.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.936 1.294 . . . . 0.0 113.266 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -65.17 -42.92 93.22 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.952 0.797 . . . . 0.0 110.927 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.95 -24.22 55.45 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.998 -1.064 . . . . 0.0 112.215 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.71 -51.9 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.023 0.929 . . . . 0.0 109.923 164.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.1 mt -60.14 -34.76 73.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.147 1.379 . . . . 0.0 112.619 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -58.21 -56.4 22.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.662 1.185 . . . . 0.0 111.972 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -64.5 -32.7 74.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.911 0.485 . . . . 0.0 111.414 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.21 -43.81 81.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.786 1.634 . . . . 0.0 112.979 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.5 57.32 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 120.635 -1.291 . . . . 0.0 111.684 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.44 -29.71 64.4 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 8.04 45.39 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.66 41.8 0.33 Allowed Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.786 1.634 . . . . 0.0 114.836 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.62 -22.19 16.4 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.62 3.547 . . . . 0.0 117.548 -157.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -60.69 -14.51 21.32 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -73.67 129.39 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.716 1.144 . . . . 0.0 111.289 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.8 98.59 11.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 110.797 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.6 mt -103.73 132.15 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.823 0.849 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 t -136.05 133.61 37.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.32 1.048 . . . . 0.0 110.38 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 m -86.12 155.16 20.89 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.622 -1.299 . . . . 0.0 111.531 164.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.3 t -143.72 128.86 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.642 1.577 . . . . 0.0 109.069 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.99 104.47 4.84 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.09 1.356 . . . . 0.0 110.564 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.8 p -56.19 -36.48 68.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.632 1.173 . . . . 0.0 113.468 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.57 -16.84 58.38 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -22.19 19.18 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.944 1.298 . . . . 0.0 112.88 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -116.72 52.92 1.11 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.878 1.671 . . . . 0.0 114.577 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.35 -18.07 26.74 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.7 2.267 . . . . 0.0 113.088 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -64.03 -38.14 89.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.368 0.985 . . . . 0.0 111.776 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.9 -51.99 22.78 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.607 1.163 . . . . 0.0 109.96 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.1 mtm -54.62 -32.18 58.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.095 0.958 . . . . 0.0 113.36 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -70.02 -19.95 63.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.012 1.325 . . . . 0.0 113.925 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -79.05 -39.92 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.769 0.713 . . . . 0.0 112.025 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.07 -22.45 21.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.69 15.77 28.32 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.786 1.66 . . . . 0.0 114.963 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -79.76 156.88 27.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.186 1.493 . . . . 0.0 111.626 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.03 -53.63 3.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.181 0.993 . . . . 0.0 112.654 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 168.67 17.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 129.101 2.96 . . . . 0.0 113.595 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.6 160.15 28.69 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 126.461 1.904 . . . . 0.0 111.912 -170.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -70.06 82.93 0.78 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.021 3.147 . . . . 0.0 112.516 -174.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.2 m -103.01 128.21 49.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.153 0.581 . . . . 0.0 112.363 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -94.22 120.6 34.69 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.541 1.137 . . . . 0.0 109.51 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.71 123.67 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 126.396 1.879 . . . . 0.0 108.1 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.0 120.03 40.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.887 0.875 . . . . 0.0 109.365 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.492 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 10.8 mm -108.23 121.65 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.187 1.395 . . . . 0.0 109.705 -168.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.492 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.37 122.34 47.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.833 1.653 . . . . 0.0 109.101 163.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.09 25.54 14.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 112.621 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.61 90.63 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -105.99 128.74 54.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.404 1.082 . . . . 0.0 108.924 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.07 109.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.416 0.686 . . . . 0.0 109.974 172.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.05 20.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.92 1.288 . . . . 0.0 113.494 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -163.8 152.07 13.26 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.364 1.866 . . . . 0.0 109.456 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.32 144.22 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.782 1.233 . . . . 0.0 110.971 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.17 31.78 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.431 1.493 . . . . 0.0 109.525 168.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -126.04 139.29 53.53 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 112.675 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.78 -154.43 17.02 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.931 1.729 . . . . 0.0 112.626 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.3 mm -118.2 143.83 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.31 1.444 . . . . 0.0 110.765 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -151.49 161.63 42.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.768 0.827 . . . . 0.0 112.418 161.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.38 149.54 86.7 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.021 0.929 . . . . 0.0 111.836 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.62 -31.47 79.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.003 2.469 . . . . 0.0 113.95 -168.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -52.99 -36.19 60.1 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -89.25 -29.99 18.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.757 0.708 . . . . 0.0 111.975 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.0 -30.25 70.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.664 0.786 . . . . 0.0 112.027 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -56.08 -44.24 78.79 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.766 0.712 . . . . 0.0 111.895 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.6 60.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.23 1.012 . . . . 0.0 112.521 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -70.89 -39.24 72.93 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 109.618 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.6 -36.7 73.66 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.046 1.338 . . . . 0.0 112.859 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.51 80.9 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.748 -1.22 . . . . 0.0 112.605 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -59.27 -20.65 56.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.964 0.905 . . . . 0.0 113.04 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.474 0.744 0 O-C-N 121.109 -0.994 . . . . 0.0 109.539 167.193 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtm . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -76.45 18.19 0.33 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.666 1.986 . . . . 0.0 114.052 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.72 147.98 3.54 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.03 2.932 . . . . 0.0 108.493 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mm -99.36 101.44 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.815 0.846 . . . . 0.0 109.085 -172.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.62 -179.65 7.79 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.552 1.941 . . . . 0.0 109.814 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -81.19 121.01 25.6 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.237 1.015 . . . . 0.0 111.35 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.8 mt -93.61 93.23 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.959 0.904 . . . . 0.0 108.881 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -50.51 -29.77 11.35 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.783 2.033 . . . . 0.0 113.122 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -71.24 -27.68 63.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.268 1.827 . . . . 0.0 112.545 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -165.97 89.6 0.42 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.281 1.432 . . . . 0.0 111.545 -170.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.68 165.14 28.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.389 2.276 . . . . 0.0 110.201 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.02 165.42 36.77 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.889 1.233 . . . . 0.0 112.51 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ptp -54.51 -30.86 54.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -171.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.52 -29.16 64.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -74.8 -41.35 60.14 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.74 -0.6 . . . . 0.0 110.557 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -72.93 -11.32 60.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.5 -17.3 27.31 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.03 1.332 . . . . 0.0 113.645 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -117.79 -16.19 5.98 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.59 171.0 13.24 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -91.4 -51.96 5.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.978 1.311 . . . . 0.0 113.166 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -160.46 109.05 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.879 1.672 . . . . 0.0 110.095 -171.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.09 158.82 44.56 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -134.64 130.14 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 0.0 109.064 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 t -119.09 125.7 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.563 1.545 . . . . 0.0 109.133 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.04 113.82 27.59 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.492 1.117 . . . . 0.0 111.311 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -78.94 69.38 5.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.48 170.38 16.66 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.843 0.857 . . . . 0.0 112.898 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -129.54 176.93 7.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.38 1.472 . . . . 0.0 111.21 168.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -100.51 -33.02 10.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.985 0.914 . . . . 0.0 113.437 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.38 -68.03 0.57 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.058 0.943 . . . . 0.0 112.934 -167.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.9 m -59.07 150.67 60.66 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.369 1.868 . . . . 0.0 114.138 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.14 -13.79 21.02 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.787 3.658 . . . . 0.0 113.19 171.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -66.83 -48.46 68.82 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 119.014 0.825 . . . . 0.0 111.969 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.0 p -61.14 -29.84 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.107 1.363 . . . . 0.0 113.597 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -55.82 -32.99 64.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.011 1.324 . . . . 0.0 112.557 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -62.94 -48.2 79.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.611 1.164 . . . . 0.0 111.73 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 mmt -63.24 -34.79 78.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.321 -0.862 . . . . 0.0 112.798 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.47 -36.37 73.62 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.267 0.939 . . . . 0.0 112.533 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -79.17 -38.67 35.35 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.29 -51.43 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.046 0.938 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.41 -33.86 75.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.793 1.237 . . . . 0.0 113.001 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.79 -49.96 70.85 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.302 0.641 . . . . 0.0 111.367 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -67.63 -32.14 72.63 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.395 -0.816 . . . . 0.0 112.885 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.36 -39.74 89.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.091 1.356 . . . . 0.0 111.966 170.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.32 -26.14 52.7 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.133 0.873 . . . . 0.0 112.343 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.6 65.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 10.11 34.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.168 1.387 . . . . 0.0 114.297 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.36 50.89 1.18 Allowed Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.102 1.761 . . . . 0.0 112.857 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.01 -14.4 44.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -168.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -78.64 -8.8 59.03 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -78.57 131.48 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.481 1.037 . . . . 0.0 108.357 165.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 96.16 6.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.07 0.548 . . . . 0.0 110.894 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.4 mt -103.84 131.48 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.2 p -148.21 172.76 13.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.918 0.887 . . . . 0.0 112.333 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -121.63 162.96 19.76 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.093 -1.004 . . . . 0.0 111.165 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.9 t -143.78 122.76 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.253 1.421 . . . . 0.0 107.712 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.0 103.92 0.51 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.325 1.45 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -58.76 -36.21 74.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.613 1.165 . . . . 0.0 112.35 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -75.1 -18.2 60.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.181 1.792 . . . . 0.0 113.893 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.07 -26.62 9.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.786 1.235 . . . . 0.0 113.527 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -126.86 51.94 7.19 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 126.171 1.788 . . . . 0.0 112.921 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -65.85 -14.98 47.17 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.746 2.297 . . . . 0.0 112.939 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -57.28 -23.39 48.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 113.182 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.98 -58.1 3.47 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 122.991 0.516 . . . . 0.0 110.682 166.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.8 mtm -57.22 -27.81 62.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.058 1.343 . . . . 0.0 113.748 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.56 -15.94 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.033 1.333 . . . . 0.0 112.726 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -87.29 -36.76 17.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.361 1.064 . . . . 0.0 111.296 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.97 -25.8 22.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 19.16 14.04 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.626 1.584 . . . . 0.0 115.264 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.97 145.85 28.32 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.409 1.605 . . . . 0.0 111.551 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -96.0 -62.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.668 0.787 . . . . 0.0 112.665 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -157.47 2.63 0.12 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.9 m -106.46 150.3 39.35 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 126.028 1.731 . . . . 0.0 112.769 -163.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.13 92.74 0.55 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.23 3.287 . . . . 0.0 109.553 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -105.08 131.98 51.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.865 0.866 . . . . 0.0 111.857 -172.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -93.53 134.54 35.7 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.489 1.116 . . . . 0.0 110.247 168.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.97 131.25 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.623 1.569 . . . . 0.0 108.89 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -115.06 123.94 50.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.283 1.033 . . . . 0.0 110.282 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.8 mm -108.08 120.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.141 1.376 . . . . 0.0 108.822 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -113.94 122.93 48.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.298 1.839 . . . . 0.0 108.869 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.7 t70 63.62 20.93 12.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.395 1.078 . . . . 0.0 112.902 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.22 84.46 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.278 -0.888 . . . . 0.0 113.256 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -108.34 133.04 53.09 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.157 1.783 . . . . 0.0 109.285 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.88 107.59 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.41 -0.806 . . . . 0.0 109.508 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.6 -25.2 15.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -160.96 150.85 17.36 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.397 1.479 . . . . 0.0 110.932 -171.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.94 143.23 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.546 1.538 . . . . 0.0 110.529 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -153.38 140.34 19.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.222 1.009 . . . . 0.0 111.404 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.4 p -97.77 133.15 42.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.735 1.214 . . . . 0.0 111.756 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.78 -168.09 13.58 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.112 1.339 . . . . 0.0 113.343 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.18 143.37 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.368 1.467 . . . . 0.0 112.019 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -135.5 163.44 30.08 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.622 1.169 . . . . 0.0 111.947 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -68.14 161.37 68.88 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.629 1.172 . . . . 0.0 111.433 164.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.76 -27.1 15.23 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.965 1.777 . . . . 0.0 113.972 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -72.84 -34.0 66.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.489 1.495 . . . . 0.0 112.646 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.2 -26.33 56.03 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.372 -0.83 . . . . 0.0 112.457 171.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.52 -30.73 71.52 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.845 -1.159 . . . . 0.0 111.941 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -61.11 -44.84 96.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.877 0.762 . . . . 0.0 111.201 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.5 75.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.257 0.623 . . . . 0.0 112.352 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.08 76.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 0.0 109.87 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -45.48 94.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.317 1.047 . . . . 0.0 112.089 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.23 77.7 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.21 -0.931 . . . . 0.0 112.459 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.8 t -63.62 -13.26 40.61 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.857 1.663 . . . . 0.0 113.452 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.471 0.575 0 O-C-N 120.674 -1.266 . . . . 0.0 109.992 169.715 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptm . . . . . 0 CA--C 1.539 0.519 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 m 55.56 -121.97 1.77 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.579 1.551 . . . . 0.0 112.517 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.56 0.7 28.79 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -106.71 125.16 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.702 1.201 . . . . 0.0 110.319 -172.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.67 162.4 26.92 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.774 1.63 . . . . 0.0 111.312 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -82.94 112.79 20.04 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.56 1.144 . . . . 0.0 108.39 162.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.8 mt -127.29 123.92 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.095 1.358 . . . . 0.0 109.326 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.8 p -55.37 -33.07 63.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.556 1.542 . . . . 0.0 114.519 -170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.2 p -85.11 -13.24 50.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.898 1.679 . . . . 0.0 114.043 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -130.99 22.4 4.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.993 1.317 . . . . 0.0 113.16 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.88 164.25 35.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.52 1.528 . . . . 0.0 112.555 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.69 153.58 28.27 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.899 1.238 . . . . 0.0 111.487 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp -56.94 -26.77 60.16 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.18 -21.18 62.2 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.43 -39.22 19.23 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.615 -0.678 . . . . 0.0 110.57 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -78.62 -7.96 58.15 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.7 -13.47 45.31 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.87 7.86 1.09 Allowed Glycine 0 N--CA 1.478 1.469 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.23 173.06 9.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.971 1.386 . . . . 0.0 113.416 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -83.38 -61.03 1.95 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.113 0.965 . . . . 0.0 112.411 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -157.54 120.81 4.02 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.264 1.826 . . . . 0.0 110.18 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.21 159.19 43.62 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.7 mt -130.95 130.75 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.533 1.533 . . . . 0.0 109.153 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.4 t -120.73 121.97 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.685 1.594 . . . . 0.0 109.273 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.51 114.87 29.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.242 1.017 . . . . 0.0 111.824 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -79.78 72.3 6.48 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.905 1.282 . . . . 0.0 111.073 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.43 170.73 16.16 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.115 0.966 . . . . 0.0 113.147 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -142.13 168.55 19.47 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.741 1.216 . . . . 0.0 111.938 170.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -93.13 -39.65 10.93 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -165.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 mt -77.45 -39.92 45.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.45 0.7 . . . . 0.0 112.718 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.49 128.84 94.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.149 1.379 . . . . 0.0 111.693 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 -13.74 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 124.461 3.44 . . . . 0.0 112.94 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -73.9 -45.65 49.38 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 120.167 1.349 . . . . 0.0 111.918 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.5 m -53.67 -35.81 61.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.82 1.248 . . . . 0.0 113.339 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.5 -31.93 68.33 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.512 1.525 . . . . 0.0 112.889 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -72.47 -44.07 62.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.668 0.787 . . . . 0.0 111.187 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.7 tpt -58.88 -38.85 79.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.483 1.513 . . . . 0.0 112.566 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -53.67 -41.24 66.63 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.514 0.725 . . . . 0.0 112.168 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -72.29 -23.53 61.2 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.928 -1.107 . . . . 0.0 113.693 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -69.65 -45.96 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.109 0.963 . . . . 0.0 109.748 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.8 -37.61 82.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.089 0.955 . . . . 0.0 111.828 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.68 -52.24 66.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.089 0.956 . . . . 0.0 111.948 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.46 -30.03 68.8 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.478 0.711 . . . . 0.0 112.817 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.95 -34.66 76.99 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.922 0.889 . . . . 0.0 111.833 170.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -25.59 61.2 Favored Glycine 0 N--CA 1.471 1.032 0 O-C-N 121.064 -1.023 . . . . 0.0 113.632 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.55 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -171.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 7.41 10.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.209 1.403 . . . . 0.0 114.52 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.95 47.89 2.84 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.86 1.664 . . . . 0.0 113.529 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.75 -16.32 54.7 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.726 2.951 . . . . 0.0 114.431 -169.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -76.81 -6.66 53.24 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -85.1 127.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 162.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.79 103.77 11.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 0.0 109.711 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.6 mt -108.04 128.79 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.056 -1.028 . . . . 0.0 109.367 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -146.98 167.38 24.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.82 165.51 12.99 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.855 -1.153 . . . . 0.0 111.741 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.07 121.46 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.932 1.293 . . . . 0.0 108.33 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.75 102.53 0.35 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.065 1.346 . . . . 0.0 110.42 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.6 p -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.362 0.665 . . . . 0.0 112.421 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.72 -26.69 65.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 113.362 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.16 -27.76 8.99 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.981 1.312 . . . . 0.0 113.661 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -116.26 65.22 2.91 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 127.493 2.317 . . . . 0.0 110.724 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.48 -22.51 33.27 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.516 2.144 . . . . 0.0 111.963 168.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.9 -24.53 66.06 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.639 1.176 . . . . 0.0 113.204 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.48 -59.99 2.48 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.056 0.942 . . . . 0.0 110.052 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.5 mtm -58.51 -25.85 62.83 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 113.371 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -65.7 -24.54 67.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.199 1.0 . . . . 0.0 112.35 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.3 -36.3 17.96 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.533 1.133 . . . . 0.0 111.37 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.92 -24.17 22.53 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.22 13.73 32.62 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.746 1.641 . . . . 0.0 115.161 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.08 146.87 36.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.371 1.585 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.85 -61.81 1.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.602 0.761 . . . . 0.0 112.195 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.98 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.512 1.925 . . . . 0.0 111.614 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.72 150.6 31.0 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.988 1.315 . . . . 0.0 112.457 -166.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.29 85.75 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.284 3.323 . . . . 0.0 109.911 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -102.62 129.76 49.29 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.36 0.664 . . . . 0.0 111.341 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 mp -93.63 126.48 38.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.048 0.939 . . . . 0.0 108.913 164.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.63 129.4 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.122 1.769 . . . . 0.0 108.277 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.59 124.47 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 mm -109.21 122.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.828 1.251 . . . . 0.0 109.179 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -117.75 126.46 52.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.567 1.547 . . . . 0.0 108.574 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 63.28 17.79 10.51 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.429 1.091 . . . . 0.0 112.965 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.07 11.22 81.55 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.282 0.944 . . . . 0.0 113.809 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -109.58 138.5 45.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.568 1.947 . . . . 0.0 109.807 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.74 108.37 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.84 -25.49 15.02 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -160.12 154.07 23.04 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.092 1.757 . . . . 0.0 110.342 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.88 143.85 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.849 1.26 . . . . 0.0 110.19 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.9 143.64 27.52 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.344 1.058 . . . . 0.0 110.87 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 t -110.91 132.68 54.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.859 1.264 . . . . 0.0 110.83 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.46 -152.83 20.36 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.721 1.153 . . . . 0.0 114.324 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.39 146.53 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.688 1.995 . . . . 0.0 110.371 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 ptp -153.22 -169.55 3.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.489 1.516 . . . . 0.0 111.011 169.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.9 163.86 40.71 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.052 1.341 . . . . 0.0 111.072 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.54 -23.33 31.91 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.737 1.625 . . . . 0.0 114.432 -156.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.93 -30.49 69.82 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.715 1.143 . . . . 0.0 113.4 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.32 -35.72 63.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.085 0.954 . . . . 0.0 111.251 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.5 tp -64.94 -24.95 67.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.164 0.585 . . . . 0.0 112.469 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -64.39 -43.78 93.37 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.946 0.794 . . . . 0.0 111.632 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.3 84.06 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.485 0.584 . . . . 0.0 111.611 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.57 -44.25 91.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.523 0.729 . . . . 0.0 111.272 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -45.6 93.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.817 0.847 . . . . 0.0 112.22 170.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.5 74.17 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.009 0.822 . . . . 0.0 111.892 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.4 m -68.31 -5.27 17.72 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.654 1.582 . . . . 0.0 114.564 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.479 1.004 0 O-C-N 121.054 -1.029 . . . . 0.0 110.798 171.892 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m -72.93 132.78 43.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.479 1.112 . . . . 0.0 112.157 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.77 104.47 2.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.899 1.28 . . . . 0.0 108.856 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm -86.25 80.39 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.563 0.697 . . . . 0.0 110.798 -165.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -145.48 164.62 31.04 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 126.204 1.802 . . . . 0.0 110.541 174.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -51.93 115.47 1.7 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.806 2.442 . . . . 0.0 112.007 164.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.6 mt -108.06 124.75 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.863 1.265 . . . . 0.0 108.015 166.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.8 p -84.9 -24.13 28.6 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.222 1.409 . . . . 0.0 113.413 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 p -94.46 -76.2 0.49 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.837 1.655 . . . . 0.0 111.813 -167.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.77 -19.27 63.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.233 1.013 . . . . 0.0 113.361 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.63 44.62 0.54 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.63 1.172 . . . . 0.0 113.247 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.69 148.61 18.64 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.329 1.442 . . . . 0.0 110.388 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp -55.92 -30.25 61.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.85 -27.57 67.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -70.61 -39.01 74.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.802 1.183 . . . . 0.0 110.658 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.19 -9.48 58.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 113.077 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.65 -15.66 32.21 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.221 1.408 . . . . 0.0 113.395 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.51 -13.44 4.26 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.89 174.06 9.77 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -96.52 -54.68 3.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -149.5 124.25 9.85 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.006 1.323 . . . . 0.0 109.654 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.27 160.12 43.94 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -140.0 132.11 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 108.436 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 129.66 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.689 1.196 . . . . 0.0 109.288 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -109.07 117.44 34.17 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.807 0.843 . . . . 0.0 112.032 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.92 71.82 8.96 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.844 1.258 . . . . 0.0 110.622 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -174.23 1.05 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.85 0.86 . . . . 0.0 113.271 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -138.73 141.3 38.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.803 -1.186 . . . . 0.0 112.177 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -61.97 -32.18 72.6 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 113.699 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.6 mt -81.68 -83.9 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.901 1.28 . . . . 0.0 111.765 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -44.19 118.98 3.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 127.901 2.48 . . . . 0.0 114.235 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.45 -17.57 23.67 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.042 3.161 . . . . 0.0 113.611 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -63.72 -44.21 94.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 119.037 0.835 . . . . 0.0 111.663 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.3 p -66.91 -27.02 67.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.61 -28.03 69.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.735 1.214 . . . . 0.0 112.515 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -64.63 -39.21 93.3 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.75 0.82 . . . . 0.0 112.502 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.2 tpp -62.28 -35.72 79.87 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.026 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -50.61 -42.01 55.52 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.476 -0.765 . . . . 0.0 112.863 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -84.11 -12.38 55.12 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.278 1.031 . . . . 0.0 113.255 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -78.58 -47.32 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.274 1.43 . . . . 0.0 109.935 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.57 -37.01 74.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.522 1.529 . . . . 0.0 112.65 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.39 -53.86 52.45 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.886 0.874 . . . . 0.0 111.697 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -64.97 -30.68 71.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.629 0.772 . . . . 0.0 112.801 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -70.96 -41.98 70.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.417 1.087 . . . . 0.0 111.379 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.96 -29.75 30.72 Favored Glycine 0 N--CA 1.47 0.943 0 C-N-CA 124.649 1.118 . . . . 0.0 113.206 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.72 67.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 9.5 38.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.686 1.595 . . . . 0.0 114.179 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.93 65.34 73.85 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 125.678 1.591 . . . . 0.0 112.357 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.42 -20.77 71.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.168 2.579 . . . . 0.0 115.144 -171.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -83.42 -6.89 59.6 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 133.04 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.671 1.189 . . . . 0.0 109.442 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.59 14.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.193 0.597 . . . . 0.0 110.682 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -108.24 130.65 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.943 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -151.36 177.56 10.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.193 1.397 . . . . 0.0 112.803 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -124.27 167.04 14.86 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.503 -1.373 . . . . 0.0 113.227 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -149.16 135.69 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.719 2.008 . . . . 0.0 108.272 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.04 119.84 23.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.091 0.948 . . . . 0.0 112.164 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.6 p -61.0 -28.0 68.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.542 1.537 . . . . 0.0 114.12 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -87.31 -34.46 18.86 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.528 0.731 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 -22.95 27.07 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.577 1.151 . . . . 0.0 113.945 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -121.67 42.54 0.59 Allowed Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.654 1.582 . . . . 0.0 114.374 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.01 -19.56 45.55 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.668 2.245 . . . . 0.0 113.052 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.05 -22.67 65.93 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.053 0.941 . . . . 0.0 113.121 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.8 -54.91 5.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.765 0.711 . . . . 0.0 110.415 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 mtm -56.19 -28.88 59.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.664 1.186 . . . . 0.0 113.63 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -68.95 -18.91 64.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.022 1.329 . . . . 0.0 113.004 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.93 -34.65 20.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.435 1.094 . . . . 0.0 110.798 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.76 -25.51 23.37 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.46 15.58 22.67 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.82 1.676 . . . . 0.0 115.296 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.38 144.61 30.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.884 1.842 . . . . 0.0 111.151 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -89.1 -56.52 3.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.983 0.913 . . . . 0.0 112.668 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -169.83 7.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -167.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -100.26 149.71 36.29 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.011 1.724 . . . . 0.0 112.959 -165.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.8 95.22 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.882 3.055 . . . . 0.0 110.292 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.2 m -114.89 130.39 56.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.768 0.827 . . . . 0.0 112.778 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.95 134.67 33.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.725 1.61 . . . . 0.0 109.825 168.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.5 132.3 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.755 1.622 . . . . 0.0 109.216 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -116.93 127.67 54.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.144 0.978 . . . . 0.0 111.016 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -112.62 122.52 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 0.0 109.106 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.6 124.23 49.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.277 1.831 . . . . 0.0 109.004 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 62.04 20.19 11.41 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.729 1.15 . . . . 0.0 113.075 171.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.1 78.16 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.279 0.942 . . . . 0.0 113.477 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -108.07 134.3 51.14 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.317 1.847 . . . . 0.0 109.464 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.37 103.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.94 12.75 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.76 163.47 39.21 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.812 1.245 . . . . 0.0 111.806 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.6 146.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.161 1.785 . . . . 0.0 110.303 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.13 136.84 14.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.157 0.983 . . . . 0.0 111.01 168.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 m -101.79 138.72 38.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 0.0 111.656 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.24 -157.2 15.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.918 1.246 . . . . 0.0 113.213 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.39 142.34 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.526 1.53 . . . . 0.0 111.333 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.2 mtm -139.94 163.16 33.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.234 1.413 . . . . 0.0 111.997 165.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -77.44 161.5 72.17 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.887 1.675 . . . . 0.0 111.742 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.19 -24.97 19.46 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.328 2.019 . . . . 0.0 113.671 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -77.2 -33.83 56.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.461 1.482 . . . . 0.0 112.828 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.75 -30.33 56.51 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.648 0.779 . . . . 0.0 112.374 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.03 -28.2 66.19 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.35 -0.844 . . . . 0.0 112.791 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -62.26 -43.11 99.57 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.759 0.709 . . . . 0.0 111.895 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.25 77.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.447 0.699 . . . . 0.0 111.532 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.13 -48.52 75.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.971 0.908 . . . . 0.0 110.827 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -45.49 94.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.26 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.03 74.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.254 -0.904 . . . . 0.0 111.322 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.7 m -60.49 -31.78 70.81 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.479 1.022 0 CA-C-N 119.738 1.154 . . . . 0.0 110.687 176.869 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 ptm . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.5 p -159.11 178.17 10.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.54 1.536 . . . . 0.0 112.595 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.61 154.74 25.06 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.62 1.968 . . . . 0.0 110.062 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -98.61 119.74 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.918 1.287 . . . . 0.0 109.577 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -141.85 168.12 20.51 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.306 1.842 . . . . 0.0 109.713 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -73.69 120.48 19.35 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 156.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.5 mt -107.93 97.98 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.469 0.708 . . . . 0.0 109.265 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 p -48.32 -32.79 7.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.423 2.289 . . . . 0.0 114.941 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.7 p -83.4 -9.32 59.1 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.485 1.514 . . . . 0.0 114.422 -174.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.96 -19.08 0.13 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.55 50.17 1.1 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.863 1.665 . . . . 0.0 112.935 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.82 167.79 17.08 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 126.229 1.871 . . . . 0.0 112.873 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -53.97 -30.67 47.9 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.339 1.456 . . . . 0.0 113.894 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.04 62.94 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -86.77 -38.54 16.8 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.976 0.807 . . . . 0.0 111.121 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.93 -12.13 60.56 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.276 -0.89 . . . . 0.0 113.177 -171.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -89.81 -10.18 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.267 1.027 . . . . 0.0 113.617 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.26 -4.03 1.13 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.77 172.21 7.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.538 1.669 . . . . 0.0 114.074 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -82.53 -59.94 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.306 1.043 . . . . 0.0 112.912 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -160.08 115.22 2.33 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.79 1.636 . . . . 0.0 110.166 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.77 44.29 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -131.23 128.1 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 108.168 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.91 117.47 54.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.715 1.606 . . . . 0.0 108.773 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.29 120.68 38.1 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.564 1.146 . . . . 0.0 110.683 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.23 82.06 7.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.109 -1.619 . . . . 0.0 109.848 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 176.72 8.66 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -139.51 137.96 35.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.108 1.363 . . . . 0.0 109.769 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -83.25 -27.22 30.06 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -167.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 mt -76.62 -33.74 58.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.392 1.477 . . . . 0.0 112.925 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -73.83 130.5 83.19 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 126.06 1.744 . . . . 0.0 111.738 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.13 -14.74 18.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.494 3.462 . . . . 0.0 113.3 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -76.04 -47.66 23.88 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.816 1.189 . . . . 0.0 110.695 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.4 m -52.84 -35.56 57.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.031 1.732 . . . . 0.0 113.889 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -55.39 -33.34 63.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.038 1.335 . . . . 0.0 113.135 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.48 -40.72 89.48 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.233 1.013 . . . . 0.0 112.63 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.49 68.9 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.437 -0.79 . . . . 0.0 112.989 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -63.01 -44.24 96.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.667 0.667 . . . . 0.0 111.496 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -63.78 -38.94 92.97 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.77 -49.08 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.582 1.553 . . . . 0.0 110.434 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 mt -64.58 -35.24 80.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.32 1.048 . . . . 0.0 112.772 175.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.23 -50.08 74.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.108 0.963 . . . . 0.0 111.753 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.28 -31.6 72.5 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.099 -1.001 . . . . 0.0 112.584 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.97 -32.52 70.79 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.411 1.084 . . . . 0.0 112.596 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.84 -27.44 38.07 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 120.831 -1.168 . . . . 0.0 113.417 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.81 55.11 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 10.18 12.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.18 72.52 81.88 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.555 1.542 . . . . 0.0 111.556 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.45 -21.05 60.94 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.352 2.702 . . . . 0.0 115.534 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -83.06 -5.21 59.02 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -166.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.9 p -106.83 132.38 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.113 1.365 . . . . 0.0 111.036 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.5 102.52 13.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.171 0.988 . . . . 0.0 110.515 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mt -100.21 130.81 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.312 -0.867 . . . . 0.0 109.913 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -150.38 168.61 23.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.25 1.02 . . . . 0.0 112.028 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -118.45 -179.58 3.83 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.909 -1.119 . . . . 0.0 112.591 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.6 t -149.79 128.34 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 128.102 2.561 . . . . 0.0 108.024 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.19 97.66 0.27 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.584 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.3 p -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.287 -0.883 . . . . 0.0 112.323 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.39 -15.74 62.38 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.644 1.978 . . . . 0.0 114.19 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.84 -39.07 3.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.764 1.225 . . . . 0.0 113.522 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -115.39 54.23 0.91 Allowed Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.843 1.657 . . . . 0.0 113.78 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.0 -13.36 33.97 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -58.69 -24.48 61.42 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.733 1.152 . . . . 0.0 112.954 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.24 -58.54 3.44 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.339 0.518 . . . . 0.0 110.973 165.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.3 mtm -54.74 -33.03 60.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.028 1.331 . . . . 0.0 113.002 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -67.29 -18.82 65.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.709 1.603 . . . . 0.0 114.109 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -77.69 -40.51 41.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.968 0.803 . . . . 0.0 111.644 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.16 -23.93 24.66 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 12.75 28.61 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.108 1.813 . . . . 0.0 115.285 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -81.65 154.14 26.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.758 1.779 . . . . 0.0 111.531 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -102.33 -61.11 1.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.097 0.959 . . . . 0.0 112.152 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -162.69 2.31 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -98.68 155.4 36.76 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 126.598 1.959 . . . . 0.0 112.833 -165.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.7 88.58 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.44 3.427 . . . . 0.0 111.402 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.0 m -104.03 130.53 51.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.672 0.789 . . . . 0.0 110.862 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.06 121.47 41.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 0.0 109.816 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.52 130.86 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.641 1.976 . . . . 0.0 108.546 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -113.12 121.87 45.83 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.406 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 35.1 mm -109.27 116.15 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.486 1.114 . . . . 0.0 108.903 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.406 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.85 123.32 49.38 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.375 1.47 . . . . 0.0 107.957 171.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.38 19.76 11.91 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.497 1.119 . . . . 0.0 113.178 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.25 84.44 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.058 -1.026 . . . . 0.0 113.263 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -108.21 133.56 52.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.963 1.705 . . . . 0.0 109.025 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.35 107.47 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.07 -19.92 14.02 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -160.7 150.28 17.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.524 1.53 . . . . 0.0 110.77 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.45 145.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.428 1.491 . . . . 0.0 109.971 169.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.09 152.37 34.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.427 1.491 . . . . 0.0 109.292 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 t -128.95 138.36 51.93 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.926 -1.109 . . . . 0.0 112.589 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.73 -161.69 19.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.002 1.763 . . . . 0.0 112.755 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.3 mm -111.07 143.6 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.691 1.196 . . . . 0.0 111.069 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 67.4 mtm -137.53 158.17 44.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.902 1.281 . . . . 0.0 111.78 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.52 147.92 76.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.054 0.942 . . . . 0.0 111.176 164.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.3 -27.32 63.7 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.931 2.421 . . . . 0.0 113.212 -168.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.85 -29.51 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.56 -24.98 15.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.373 1.069 . . . . 0.0 112.47 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.92 -28.41 68.9 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.435 -0.791 . . . . 0.0 111.998 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -55.56 -50.38 70.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.96 -35.38 74.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.503 0.721 . . . . 0.0 111.852 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.63 -44.7 81.28 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.627 0.771 . . . . 0.0 110.517 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -47.08 85.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 112.151 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.85 82.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.265 0.939 . . . . 0.0 112.077 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 m -58.27 -25.51 61.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.451 1.5 . . . . 0.0 113.842 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.133 0.973 . . . . 0.0 111.196 177.955 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 p -84.76 -28.8 25.97 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.48 143.66 0.05 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 128.923 2.889 . . . . 0.0 113.959 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mm -122.05 140.25 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.577 1.551 . . . . 0.0 110.291 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -160.35 168.61 24.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.527 1.531 . . . . 0.0 111.572 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -84.28 116.08 22.8 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.873 1.269 . . . . 0.0 109.254 160.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -118.33 76.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.763 1.225 . . . . 0.0 108.928 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -52.88 -25.75 12.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.198 2.199 . . . . 0.0 113.95 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -54.92 -28.46 51.02 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.647 1.979 . . . . 0.0 112.918 172.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.06 -31.05 1.3 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.752 1.221 . . . . 0.0 114.224 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.83 112.27 9.79 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.932 1.242 . . . . 0.0 111.784 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.39 162.77 26.6 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.937 1.732 . . . . 0.0 111.831 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -50.82 -41.58 57.63 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.725 1.21 . . . . 0.0 114.01 -171.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.93 63.23 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -74.49 -39.97 62.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.811 0.732 . . . . 0.0 110.596 169.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.43 -13.4 62.11 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.53 -14.06 41.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 0.0 113.848 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.75 -8.84 1.85 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 117.087 1.595 . . . . 0.0 117.087 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.33 176.74 4.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.219 1.51 . . . . 0.0 114.437 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 p -92.15 -55.96 3.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.805 1.242 . . . . 0.0 113.713 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -159.21 110.22 2.04 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.273 1.829 . . . . 0.0 109.111 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.38 155.27 38.31 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.31 128.76 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.862 1.265 . . . . 0.0 108.682 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 t -114.75 126.14 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.131 1.372 . . . . 0.0 109.285 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -106.87 113.67 27.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.891 0.876 . . . . 0.0 111.604 173.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -77.82 74.15 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.488 1.915 . . . . 0.0 111.022 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.62 -179.28 2.08 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.984 -1.073 . . . . 0.0 112.517 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.19 162.02 32.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.229 1.411 . . . . 0.0 111.942 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -73.9 -38.82 64.24 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.323 -0.861 . . . . 0.0 113.111 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.3 mt -98.83 -32.44 11.34 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.6 123.08 72.49 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.083 1.353 . . . . 0.0 113.68 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -82.47 -2.37 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.489 3.46 . . . . 0.0 112.897 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -89.14 -40.78 12.68 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 119.434 1.015 . . . . 0.0 110.022 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 p -64.37 -26.99 68.71 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.0 -37.59 45.93 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -74.33 -34.45 63.44 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.355 0.662 . . . . 0.0 111.965 -166.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -28.75 69.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.501 -0.762 . . . . 0.0 112.777 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.17 -37.92 84.56 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.193 1.36 . . . . 0.0 112.186 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -34.89 69.82 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.935 -1.103 . . . . 0.0 112.053 173.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.36 -48.34 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.772 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.8 mt -62.0 -42.25 98.95 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.767 1.627 . . . . 0.0 112.319 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.57 -46.95 83.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.305 1.042 . . . . 0.0 111.91 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.26 -27.28 65.3 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.863 -1.148 . . . . 0.0 113.157 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.35 -36.9 71.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.674 0.79 . . . . 0.0 112.059 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.94 -19.94 69.01 Favored Glycine 0 N--CA 1.469 0.864 0 CA-C-N 119.212 0.915 . . . . 0.0 113.301 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -33.7 60.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.668 1.587 . . . . 0.0 114.629 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.72 6.59 11.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.267 1.427 . . . . 0.0 114.276 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.03 79.0 25.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.641 1.576 . . . . 0.0 110.433 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.04 -13.57 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.216 2.611 . . . . 0.0 114.287 -168.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -90.15 -6.98 54.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -168.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 p -99.58 131.92 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.614 1.565 . . . . 0.0 110.181 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.91 100.7 11.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 110.138 174.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.34 131.58 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.437 -0.79 . . . . 0.0 109.967 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.2 p -140.33 160.11 40.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.227 1.013 . . . . 0.0 111.809 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -106.83 165.81 11.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.198 -0.939 . . . . 0.0 110.51 165.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -162.67 152.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.198 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.06 120.16 37.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.327 0.967 . . . . 0.0 112.474 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.9 p -57.83 -36.26 72.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.017 1.327 . . . . 0.0 113.238 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.32 -25.97 42.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 112.051 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.01 -16.29 30.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.936 1.294 . . . . 0.0 113.797 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmt-85 -119.97 48.77 1.27 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 125.624 1.57 . . . . 0.0 113.868 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.85 -27.93 67.44 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.818 1.679 . . . . 0.0 111.75 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.9 -23.58 67.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.661 1.185 . . . . 0.0 113.407 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.75 -56.23 4.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.622 1.169 . . . . 0.0 109.366 170.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.3 mtm -58.01 -28.43 64.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.766 1.226 . . . . 0.0 113.267 -172.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -57.37 -30.46 64.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.965 1.706 . . . . 0.0 113.22 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -88.28 -32.55 18.43 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.417 1.087 . . . . 0.0 111.588 -172.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.4 -24.1 22.0 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.392 0.677 . . . . 0.0 112.799 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.75 15.7 30.83 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.736 1.636 . . . . 0.0 114.992 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -77.14 153.03 34.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.896 1.348 . . . . 0.0 110.797 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 -43.77 4.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.636 1.174 . . . . 0.0 112.729 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -179.82 -3.12 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.87 2.868 . . . . 0.0 116.364 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.89 149.44 85.57 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-N 120.213 1.369 . . . . 0.0 113.455 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.06 81.25 2.6 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.045 3.163 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.56 135.67 33.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -165.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.46 125.26 36.15 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.16 121.98 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.007 1.723 . . . . 0.0 108.84 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -106.69 125.79 51.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.328 1.051 . . . . 0.0 110.582 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.72 119.58 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.27 1.428 . . . . 0.0 108.785 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.32 128.12 55.85 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.967 1.307 . . . . 0.0 108.335 167.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.98 19.18 11.46 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.899 1.28 . . . . 0.0 113.1 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.1 12.51 82.37 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.16 -0.963 . . . . 0.0 113.153 -174.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -107.45 134.47 50.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.341 1.856 . . . . 0.0 109.576 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.71 104.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 171.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.83 -26.71 13.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -167.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -162.11 153.14 17.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.6 1.56 . . . . 0.0 110.951 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.67 146.85 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.738 1.215 . . . . 0.0 111.426 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.81 147.0 23.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.243 1.017 . . . . 0.0 112.198 168.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -96.82 -4.49 40.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -160.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.43 17.93 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-O 122.498 1.054 . . . . 0.0 115.457 -165.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.0 mm -106.11 146.37 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.083 1.753 . . . . 0.0 109.474 165.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.0 ptp -147.75 172.15 14.56 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 167.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -76.76 166.04 47.86 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.551 1.54 . . . . 0.0 112.26 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -34.7 5.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.633 1.555 . . . . 0.0 114.176 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.98 -34.18 77.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.129 1.786 . . . . 0.0 112.589 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -79.63 -21.85 44.35 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.397 0.679 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.22 -30.31 71.19 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.286 -0.884 . . . . 0.0 112.446 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -39.29 94.3 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.356 0.98 . . . . 0.0 111.451 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.19 81.72 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.123 0.874 . . . . 0.0 112.458 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.84 -47.78 79.4 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 110.735 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.48 -45.22 94.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.322 1.049 . . . . 0.0 112.842 173.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.04 80.28 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.265 -0.897 . . . . 0.0 111.956 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 t -68.92 -4.78 17.84 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.706 1.203 . . . . 0.0 114.072 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.477 0.92 0 O-C-N 120.98 -1.075 . . . . 0.0 110.22 167.273 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -61.74 -10.48 8.89 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.5 1.52 . . . . 0.0 114.964 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.29 -16.03 63.13 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.95 108.4 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.271 1.828 . . . . 0.0 107.78 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -167.87 178.6 5.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.1 1.76 . . . . 0.0 111.038 -163.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -80.14 110.66 15.77 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 157.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -78.13 -41.54 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.073 0.549 . . . . 0.0 111.684 -165.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.2 p -127.88 -100.19 0.36 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.079 1.752 . . . . 0.0 110.536 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -144.47 -53.46 0.32 Allowed 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 127.472 2.309 . . . . 0.0 111.957 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.07 116.56 18.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.015 0.926 . . . . 0.0 112.715 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.72 36.04 0.63 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.834 2.054 . . . . 0.0 110.856 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.75 167.13 25.44 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.703 1.62 . . . . 0.0 112.077 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -56.09 -33.64 65.25 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.49 67.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -68.31 -41.75 80.44 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.561 -0.712 . . . . 0.0 110.209 170.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -75.41 -6.48 50.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 0.0 113.327 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.88 -18.69 23.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.276 1.43 . . . . 0.0 113.111 170.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.24 -14.31 20.76 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.62 166.79 20.77 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -82.94 -61.24 1.92 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.282 1.033 . . . . 0.0 112.104 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -151.78 128.62 10.94 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.797 1.639 . . . . 0.0 109.771 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.14 164.45 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mt -139.41 124.89 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 107.664 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.56 125.24 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.607 1.563 . . . . 0.0 108.809 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -107.42 110.16 22.06 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.455 1.102 . . . . 0.0 111.584 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -80.0 87.66 5.39 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.09 0.956 . . . . 0.0 110.157 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 -167.89 1.67 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.773 1.229 . . . . 0.0 112.286 173.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -144.41 157.13 44.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.888 -1.133 . . . . 0.0 112.025 153.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -31.08 -82.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 129.117 2.967 . . . . 0.0 116.387 -174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.0 mt -91.53 -38.19 12.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -167.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.3 m -49.25 119.8 9.32 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.894 1.678 . . . . 0.0 112.773 -169.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.84 -22.44 31.72 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.209 3.272 . . . . 0.0 115.077 -161.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -63.09 -44.66 95.1 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 118.849 0.749 . . . . 0.0 112.128 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.8 m -67.47 -31.47 71.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.648 1.179 . . . . 0.0 112.891 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.26 -25.81 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.539 1.136 . . . . 0.0 113.677 -171.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -64.28 -42.81 96.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.848 0.859 . . . . 0.0 112.04 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 tpt -63.78 -28.65 70.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.437 1.095 . . . . 0.0 112.684 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.28 -39.9 84.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.698 0.799 . . . . 0.0 111.352 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -72.93 -29.08 62.84 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.492 -0.755 . . . . 0.0 112.816 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.2 t -67.9 -45.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.258 1.023 . . . . 0.0 109.646 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.45 -37.01 84.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.225 1.41 . . . . 0.0 111.951 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.78 -53.3 59.89 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.224 0.92 . . . . 0.0 111.846 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -64.1 -32.54 74.14 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.396 -0.815 . . . . 0.0 112.758 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.39 -35.6 73.57 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.965 0.906 . . . . 0.0 111.833 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.29 -24.12 61.79 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 119.408 1.004 . . . . 0.0 113.319 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.72 49.02 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.06 9.14 5.26 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.551 1.54 . . . . 0.0 114.502 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.3 61.18 40.89 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 125.657 1.583 . . . . 0.0 112.12 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.34 -15.41 34.91 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.335 2.69 . . . . 0.0 114.431 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -80.81 -9.53 59.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -99.98 137.69 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.187 1.395 . . . . 0.0 110.302 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.71 101.68 11.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.114 0.565 . . . . 0.0 110.443 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.5 mt -99.37 131.84 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.975 0.91 . . . . 0.0 109.218 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.1 p -149.45 170.45 18.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.03 0.932 . . . . 0.0 112.527 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.2 p -133.58 158.69 42.55 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.978 -1.076 . . . . 0.0 111.573 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.46 123.27 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.814 1.246 . . . . 0.0 108.133 -167.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.99 115.11 10.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.041 0.924 . . . . 0.0 109.886 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -58.37 -25.29 61.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.879 1.272 . . . . 0.0 113.36 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.22 -20.65 34.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.703 0.801 . . . . 0.0 112.281 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.74 -35.23 15.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.367 1.067 . . . . 0.0 112.902 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -126.54 61.17 42.53 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.971 1.709 . . . . 0.0 112.803 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.43 -23.7 27.43 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.244 2.63 . . . . 0.0 112.675 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.0 -23.19 67.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.148 0.979 . . . . 0.0 113.169 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.14 -58.15 4.12 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.56 1.144 . . . . 0.0 109.543 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 mtm -60.71 -22.89 64.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 113.512 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -65.9 -23.46 66.64 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.641 1.176 . . . . 0.0 112.552 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.61 -38.19 16.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.585 1.154 . . . . 0.0 111.369 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.66 -23.78 25.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.21 8.57 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.098 1.332 . . . . 0.0 114.506 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.62 169.44 18.0 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.813 1.306 . . . . 0.0 112.753 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.0 11.15 8.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 112.726 -162.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.31 59.93 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.073 2.549 . . . . 0.0 109.257 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -150.03 154.07 36.37 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 127.672 2.389 . . . . 0.0 109.858 -163.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.57 96.18 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.682 2.921 . . . . 0.0 110.648 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -113.47 122.11 46.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 111.833 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.34 125.26 34.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.885 1.274 . . . . 0.0 109.135 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.06 127.65 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -111.13 128.97 56.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.762 0.825 . . . . 0.0 110.948 -174.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.3 mm -112.39 114.11 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.409 1.084 . . . . 0.0 108.883 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.97 121.65 45.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.933 1.293 . . . . 0.0 108.242 171.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 66.75 21.46 10.53 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.006 1.323 . . . . 0.0 112.326 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.53 10.33 84.58 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.428 -173.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -107.68 132.81 52.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.422 1.489 . . . . 0.0 110.194 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.17 101.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.392 1.077 . . . . 0.0 109.187 166.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 -21.18 13.43 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.74 152.64 19.89 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.196 1.798 . . . . 0.0 110.465 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.47 144.08 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.728 1.211 . . . . 0.0 111.275 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.24 146.56 22.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.702 1.201 . . . . 0.0 111.214 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -107.85 138.78 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.02 0.928 . . . . 0.0 111.585 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.98 -161.0 21.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.997 1.76 . . . . 0.0 112.767 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 mm -121.82 145.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.877 1.671 . . . . 0.0 110.733 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.6 ptp -150.63 164.8 35.17 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 163.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -70.08 158.97 86.08 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.312 1.445 . . . . 0.0 112.396 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.32 -26.42 24.94 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.855 2.37 . . . . 0.0 114.401 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -75.33 -30.3 60.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.634 1.561 . . . . 0.0 113.143 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -76.29 -33.2 59.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.11 0.964 . . . . 0.0 111.799 169.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.87 -27.08 68.54 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.841 0.857 . . . . 0.0 111.975 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -58.75 -47.53 84.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.856 0.753 . . . . 0.0 111.923 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.75 0.82 . . . . 0.0 111.38 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.02 -49.76 74.75 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.318 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -46.94 86.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.683 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.68 91.45 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.032 0.833 . . . . 0.0 112.375 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.8 t -60.02 -24.72 64.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.506 1.122 . . . . 0.0 113.401 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.479 0.994 0 C-N-CA 124.325 1.05 . . . . 0.0 111.136 175.585 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.2 p -158.36 -114.1 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.686 1.594 . . . . 0.0 111.527 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.76 142.26 7.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.048 1.739 . . . . 0.0 111.37 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.94 123.75 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.078 1.351 . . . . 0.0 108.828 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -162.67 161.88 26.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.146 1.379 . . . . 0.0 111.217 -169.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -73.05 115.42 12.35 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.78 1.232 . . . . 0.0 110.229 170.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.1 mt -107.88 81.12 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.58 1.152 . . . . 0.0 108.446 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 m -52.26 -30.34 27.26 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.79 2.436 . . . . 0.0 114.079 -172.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -77.62 -19.76 54.99 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.301 1.84 . . . . 0.0 113.722 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -112.92 -43.05 3.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.779 1.232 . . . . 0.0 112.643 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.6 135.07 52.32 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.556 1.143 . . . . 0.0 112.278 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.71 150.64 5.25 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 126.022 1.773 . . . . 0.0 111.982 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 ptp -55.39 -30.55 60.59 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.97 62.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -85.26 -38.91 18.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.074 0.852 . . . . 0.0 111.049 165.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.06 -12.93 61.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.575 0.75 . . . . 0.0 112.821 -172.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.3 -10.97 50.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.749 1.22 . . . . 0.0 114.126 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.97 -5.94 0.97 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.91 169.65 12.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.281 1.54 . . . . 0.0 114.407 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -81.0 -64.7 1.13 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.525 1.13 . . . . 0.0 112.276 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -151.16 123.99 8.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.755 1.622 . . . . 0.0 109.738 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.48 156.24 41.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.92 127.15 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.935 1.294 . . . . 0.0 108.086 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.28 124.45 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.339 1.456 . . . . 0.0 109.406 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 4.2 t80 -102.82 123.3 46.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.655 1.182 . . . . 0.0 110.24 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -88.25 73.54 8.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.518 1.127 . . . . 0.0 110.138 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -81.64 -170.51 2.85 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 121.525 -0.734 . . . . 0.0 112.517 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -145.58 177.62 8.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.242 -0.911 . . . . 0.0 112.767 162.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.24 -56.11 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.27 1.028 . . . . 0.0 113.024 -166.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.17 -30.71 19.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -54.61 118.81 17.97 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.791 1.236 . . . . 0.0 113.729 -167.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.88 -23.79 77.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.109 3.206 . . . . 0.0 114.223 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -71.97 -46.86 55.85 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.0 m -56.14 -34.42 66.11 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.482 1.113 . . . . 0.0 113.401 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -56.06 -35.25 66.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 112.825 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -62.76 -49.98 72.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.406 0.682 . . . . 0.0 111.366 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.41 -29.67 70.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -60.68 -45.87 92.51 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.934 0.894 . . . . 0.0 111.013 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -72.0 -34.48 68.9 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.255 -0.903 . . . . 0.0 113.052 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.98 -49.25 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.24 -36.49 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.128 0.971 . . . . 0.0 113.46 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.45 -49.84 76.22 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.307 0.643 . . . . 0.0 112.518 170.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.18 -29.97 68.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.203 -0.935 . . . . 0.0 113.157 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.83 -37.84 79.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.083 1.353 . . . . 0.0 111.584 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.15 -19.34 67.23 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.418 1.009 . . . . 0.0 112.81 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.61 -33.73 66.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.347 1.059 . . . . 0.0 113.462 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 9.16 39.94 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.603 1.561 . . . . 0.0 114.104 174.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.2 66.23 7.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.522 1.529 . . . . 0.0 113.673 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.3 -20.81 69.75 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.905 2.403 . . . . 0.0 115.076 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -88.2 -8.87 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 p -88.25 135.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.45 87.3 5.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.529 0.732 . . . . 0.0 111.013 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 mt -86.24 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.565 -0.709 . . . . 0.0 109.695 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.7 p -147.3 173.1 12.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.609 1.164 . . . . 0.0 111.556 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 t -122.53 -172.52 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.191 -0.943 . . . . 0.0 111.137 168.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -173.55 133.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.729 2.411 . . . . 0.0 109.118 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.83 116.25 18.19 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.929 1.292 . . . . 0.0 111.464 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.3 p -62.28 -26.93 68.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 112.947 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.79 -23.42 62.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.511 1.124 . . . . 0.0 112.518 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.31 -28.84 11.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.073 1.349 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.55 49.03 4.23 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 125.896 1.678 . . . . 0.0 115.46 -170.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -66.72 -19.42 53.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.394 2.063 . . . . 0.0 112.731 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.16 -25.98 68.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.568 1.147 . . . . 0.0 113.124 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -70.48 -55.1 9.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.81 0.732 . . . . 0.0 110.751 166.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.9 mtp -59.14 -28.47 66.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.547 1.539 . . . . 0.0 113.248 -170.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -15.47 61.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.543 1.137 . . . . 0.0 112.753 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -84.68 -38.32 19.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.663 1.185 . . . . 0.0 110.579 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.85 -23.46 31.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.282 0.633 . . . . 0.0 112.677 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.86 20.09 17.66 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.716 1.627 . . . . 0.0 114.773 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -82.5 149.41 27.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.765 1.283 . . . . 0.0 111.883 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.45 -81.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.633 0.773 . . . . 0.0 110.825 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -157.35 6.64 0.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -167.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.89 160.76 25.0 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 126.487 1.915 . . . . 0.0 114.032 -159.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.6 93.34 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.91 3.74 . . . . 0.0 110.942 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 m -109.68 129.22 55.62 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.895 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mp -95.46 130.88 42.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.836 0.855 . . . . 0.0 109.734 167.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -129.24 128.56 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.091 1.757 . . . . 0.0 108.86 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -114.85 124.48 51.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.176 0.99 . . . . 0.0 110.682 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mm -109.05 120.04 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.996 1.318 . . . . 0.0 109.599 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -114.98 125.3 53.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.822 1.649 . . . . 0.0 109.501 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.61 19.47 10.45 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.505 1.522 . . . . 0.0 113.807 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.15 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.823 1.201 . . . . 0.0 114.101 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -112.84 136.51 52.38 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.103 1.761 . . . . 0.0 110.372 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.59 104.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 166.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.96 -30.23 12.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.62 160.41 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.915 1.686 . . . . 0.0 111.76 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.25 144.81 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.593 1.557 . . . . 0.0 110.771 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.28 150.22 25.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 111.972 167.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -105.48 132.34 51.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.183 0.993 . . . . 0.0 111.35 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.18 -158.14 14.86 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.287 1.422 . . . . 0.0 113.448 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.57 139.09 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.692 1.597 . . . . 0.0 111.056 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.0 mtm -140.9 160.28 40.41 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.514 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -72.35 159.84 84.34 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.71 1.204 . . . . 0.0 112.282 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.3 -24.73 31.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.457 2.105 . . . . 0.0 113.724 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -63.23 -49.31 74.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.953 1.251 . . . . 0.0 110.83 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -72.28 -26.15 61.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.626 1.17 . . . . 0.0 111.636 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -26.75 68.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.748 0.819 . . . . 0.0 112.507 170.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -65.64 -45.53 82.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.775 1.17 . . . . 0.0 110.769 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.83 84.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.152 0.581 . . . . 0.0 111.848 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.16 -53.88 51.41 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.249 1.019 . . . . 0.0 110.405 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.92 77.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.361 175.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.26 79.72 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.454 -0.779 . . . . 0.0 112.0 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -60.05 -38.89 84.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.569 0.747 . . . . 0.0 111.861 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.482 1.129 0 O-C-N 121.148 -0.97 . . . . 0.0 110.602 175.056 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 t -167.68 164.77 14.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.736 2.014 . . . . 0.0 110.682 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.43 146.66 2.86 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.045 2.138 . . . . 0.0 110.604 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.63 129.6 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.319 1.047 . . . . 0.0 110.988 -173.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.45 171.42 1.58 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.965 2.906 . . . . 0.0 111.892 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -80.48 112.85 18.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.246 1.419 . . . . 0.0 108.718 167.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.8 mt -93.68 129.75 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.928 0.891 . . . . 0.0 110.434 -168.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.7 p -73.41 -18.11 61.19 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.62 1.568 . . . . 0.0 114.772 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -73.89 -41.52 62.03 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.449 1.5 . . . . 0.0 113.458 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -171.62 145.34 2.0 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.325 1.85 . . . . 0.0 111.761 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.96 170.28 16.88 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.126 2.17 . . . . 0.0 110.659 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.66 -170.29 51.28 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 123.903 0.763 . . . . 0.0 113.859 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.8 ptp -54.52 -27.31 37.36 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.47 -26.63 35.09 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.028 0.931 . . . . 0.0 113.498 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -71.23 -40.22 71.22 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.64 -0.663 . . . . 0.0 110.247 162.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -75.65 27.27 0.11 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.452 1.501 . . . . 0.0 112.825 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -82.24 -14.92 54.74 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.84 43.76 0.07 OUTLIER Glycine 0 N--CA 1.474 1.23 0 CA-C-N 119.674 1.124 . . . . 0.0 115.582 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 mt -84.85 103.05 13.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.431 1.093 . . . . 0.0 111.158 -173.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -58.89 -27.56 65.33 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -156.37 94.31 1.48 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.1 1.76 . . . . 0.0 110.296 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.59 46.64 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.9 mt -140.84 135.13 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.389 1.476 . . . . 0.0 109.142 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.33 131.06 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.45 1.5 . . . . 0.0 109.565 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -111.24 103.48 11.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.655 1.182 . . . . 0.0 111.462 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -75.37 70.91 2.31 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.74 1.616 . . . . 0.0 109.959 175.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.34 154.0 42.39 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.117 0.967 . . . . 0.0 113.192 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.04 179.74 7.73 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.335 -0.853 . . . . 0.0 111.728 166.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.77 153.25 30.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.022 1.729 . . . . 0.0 112.457 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 67.85 -46.41 0.51 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 130.304 3.442 . . . . 0.0 114.474 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.0 t -54.91 128.58 64.51 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 127.046 2.139 . . . . 0.0 113.433 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.77 -18.97 59.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.606 3.538 . . . . 0.0 115.529 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -67.79 -48.35 66.55 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 120.364 1.438 . . . . 0.0 112.817 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.1 -22.79 63.96 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.471 -1.393 . . . . 0.0 113.414 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -56.39 -30.79 63.18 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.154 1.381 . . . . 0.0 113.085 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -64.82 -46.1 83.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.957 0.903 . . . . 0.0 112.235 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.3 mmm -63.91 -28.77 70.06 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.338 -0.851 . . . . 0.0 112.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -61.02 -35.81 77.85 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.705 0.684 . . . . 0.0 111.58 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -70.27 -40.6 74.24 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 110.737 174.434 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.01 -44.62 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.777 1.631 . . . . 0.0 110.788 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.97 -37.33 85.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.306 1.443 . . . . 0.0 112.125 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.89 -47.79 84.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.649 0.78 . . . . 0.0 111.986 171.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -68.51 -32.95 73.28 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.259 0.936 . . . . 0.0 112.11 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -68.63 -35.89 77.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.73 1.212 . . . . 0.0 112.184 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.34 -24.57 53.93 Favored Glycine 0 N--CA 1.469 0.852 0 CA-C-N 119.176 0.898 . . . . 0.0 113.177 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 10.8 38.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.097 1.359 . . . . 0.0 114.139 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.86 85.89 7.46 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.433 1.493 . . . . 0.0 111.68 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.03 -12.09 17.73 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.312 2.675 . . . . 0.0 113.817 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -89.57 -10.04 47.57 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.827 1.194 . . . . 0.0 113.728 -172.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.54 130.78 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.672 1.189 . . . . 0.0 110.254 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.8 98.0 8.26 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.223 0.609 . . . . 0.0 110.036 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -101.42 132.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.628 0.771 . . . . 0.0 109.273 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -145.89 169.2 19.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.97 0.908 . . . . 0.0 111.813 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.2 p -114.2 164.96 13.17 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.634 -1.291 . . . . 0.0 111.538 168.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.54 122.24 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.3 1.44 . . . . 0.0 109.038 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.08 104.76 1.21 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.694 1.198 . . . . 0.0 110.397 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -54.35 -44.26 72.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.857 1.263 . . . . 0.0 112.811 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -78.52 -13.27 59.91 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.84 -17.91 18.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.641 1.176 . . . . 0.0 113.427 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -124.03 43.77 0.89 Allowed Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.062 1.745 . . . . 0.0 113.303 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.85 -22.87 35.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.102 2.535 . . . . 0.0 112.466 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.17 -27.74 68.92 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.293 0.952 . . . . 0.0 112.603 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.58 -50.65 14.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.8 mtm -56.7 -26.41 56.65 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.402 1.081 . . . . 0.0 113.319 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -66.35 -23.35 66.33 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.139 0.976 . . . . 0.0 112.014 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -84.6 -37.97 20.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.935 1.294 . . . . 0.0 111.204 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.06 -24.15 30.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.438 0.695 . . . . 0.0 112.554 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.22 20.03 19.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.374 1.464 . . . . 0.0 115.065 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -84.1 155.08 22.81 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.156 1.478 . . . . 0.0 111.584 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -92.25 -72.21 0.6 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.439 1.096 . . . . 0.0 110.465 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 ptm85 -162.81 3.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -84.63 154.82 62.21 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 127.108 2.163 . . . . 0.0 113.012 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.48 96.35 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.382 3.388 . . . . 0.0 110.336 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.9 m -111.06 124.63 52.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.191 0.996 . . . . 0.0 112.467 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.4 135.02 34.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 109.524 166.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.34 124.38 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.001 1.721 . . . . 0.0 108.034 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -108.11 126.21 52.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.432 0.693 . . . . 0.0 110.782 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.1 mm -110.36 113.11 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.841 0.857 . . . . 0.0 109.178 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 115.56 29.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.321 1.448 . . . . 0.0 109.109 170.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.08 26.67 8.86 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.879 2.072 . . . . 0.0 111.981 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.21 -3.84 83.12 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.832 0.73 . . . . 0.0 113.846 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -96.29 131.11 43.13 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.923 -1.34 . . . . 0.0 110.231 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.38 102.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.869 0.842 . . . . 0.0 109.603 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.32 -17.17 16.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -171.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.91 148.72 19.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.019 1.727 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -150.27 146.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.803 1.641 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.33 148.82 27.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.266 1.026 . . . . 0.0 111.601 161.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -105.77 144.07 33.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.479 -0.763 . . . . 0.0 111.917 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.24 -150.18 17.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.268 1.413 . . . . 0.0 113.377 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.5 mm -112.27 144.36 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.343 1.457 . . . . 0.0 112.285 -170.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.3 ptp -153.01 169.31 23.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 160.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -82.44 161.98 57.6 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.727 1.611 . . . . 0.0 112.485 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.46 -26.48 12.03 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.539 2.159 . . . . 0.0 114.507 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -71.43 -34.23 70.11 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.204 1.365 . . . . 0.0 112.846 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -74.39 -31.42 62.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.591 0.756 . . . . 0.0 112.278 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.1 tp -62.28 -26.87 68.64 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.488 -0.757 . . . . 0.0 112.606 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.72 -47.95 82.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.882 0.764 . . . . 0.0 111.209 174.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.59 71.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.255 0.622 . . . . 0.0 111.778 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.96 -50.44 73.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.807 0.843 . . . . 0.0 110.84 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -45.38 79.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.322 0.649 . . . . 0.0 112.008 175.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.8 86.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.826 0.739 . . . . 0.0 112.031 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.1 m -64.64 -11.79 39.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.399 1.479 . . . . 0.0 114.612 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.476 0.851 0 O-C-N 121.039 -1.038 . . . . 0.0 110.96 173.312 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 121.259 0.552 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -149.57 145.7 26.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.452 1.501 . . . . 0.0 110.116 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.23 2.75 23.17 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -176.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mm -95.32 103.96 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.02 1.728 . . . . 0.0 108.988 -172.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -143.45 167.38 22.33 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.382 1.473 . . . . 0.0 111.361 -167.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -84.96 105.73 15.94 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.323 1.449 . . . . 0.0 110.149 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.3 mt -121.75 96.45 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.657 1.183 . . . . 0.0 107.991 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -52.46 -32.73 41.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.253 1.821 . . . . 0.0 113.549 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 m -59.37 -28.28 66.73 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.175 1.79 . . . . 0.0 113.019 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -125.36 28.82 6.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.759 1.623 . . . . 0.0 111.829 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.22 170.66 15.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.96 1.304 . . . . 0.0 112.468 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.44 153.25 29.36 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.356 1.455 . . . . 0.0 111.92 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -56.26 -28.63 59.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.267 1.027 . . . . 0.0 113.445 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.74 63.0 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -84.53 -39.09 19.23 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 111.168 166.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.11 -9.19 58.42 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.71 -11.11 43.3 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.007 1.323 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.9 -6.36 1.11 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.47 167.29 16.99 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.226 1.513 . . . . 0.0 113.663 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -80.68 -52.55 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -164.76 114.88 1.15 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.946 1.298 . . . . 0.0 110.082 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.71 157.83 41.45 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.98 130.66 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.632 1.573 . . . . 0.0 108.832 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.6 128.23 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.689 1.596 . . . . 0.0 109.393 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.05 111.72 23.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.574 1.15 . . . . 0.0 111.507 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -83.53 73.56 10.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 111.301 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.41 174.94 5.9 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 168.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.24 146.34 38.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.388 -1.445 . . . . 0.0 114.054 170.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' CG ' ' H ' ' A' ' 30' ' ' LEU 0.319 6.9 p30 17.76 -104.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.388 2.675 . . . . 0.0 116.136 -178.362 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.407 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 3.6 mm? -107.18 3.15 25.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.68 2.392 . . . . 0.0 113.383 -171.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -49.04 125.61 13.95 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.509 1.523 . . . . 0.0 114.41 -164.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.2 -5.03 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.066 3.178 . . . . 0.0 113.429 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -81.74 -50.38 9.34 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.685 1.129 . . . . 0.0 109.905 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.2 m -60.77 -34.02 73.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -171.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -50.31 -40.72 49.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -72.76 -40.68 65.81 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.209 0.603 . . . . 0.0 110.737 -172.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -62.4 -34.52 76.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.593 1.157 . . . . 0.0 112.519 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -59.55 -39.09 82.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.719 1.145 . . . . 0.0 112.305 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.48 -32.66 71.69 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.91 -1.119 . . . . 0.0 112.789 173.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.46 -50.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.368 0.667 . . . . 0.0 109.967 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.73 -35.67 81.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.293 1.037 . . . . 0.0 112.135 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.73 -52.97 63.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.053 0.941 . . . . 0.0 111.639 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -69.13 -30.24 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.601 -0.687 . . . . 0.0 112.655 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.95 -41.39 91.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.786 1.234 . . . . 0.0 111.49 170.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.58 -27.33 27.45 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 119.098 0.863 . . . . 0.0 113.593 -172.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.77 68.24 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.198 0.999 . . . . 0.0 113.588 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.49 9.4 37.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.964 1.705 . . . . 0.0 114.067 176.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.05 42.31 0.37 Allowed Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 125.534 1.533 . . . . 0.0 113.754 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.57 -5.64 10.55 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.575 2.85 . . . . 0.0 115.58 -166.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -62.92 -8.86 7.92 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.64 135.6 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.194 1.398 . . . . 0.0 110.553 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.06 102.53 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 110.348 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.68 135.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.93 0.892 . . . . 0.0 110.333 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.7 p -144.63 169.02 18.79 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.278 1.031 . . . . 0.0 112.005 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.4 p -125.97 163.37 23.15 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.78 -1.2 . . . . 0.0 111.846 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.2 t -148.82 129.03 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.009 1.323 . . . . 0.0 108.542 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -73.93 98.62 3.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.562 0.696 . . . . 0.0 110.123 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -59.55 -30.33 68.54 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.219 1.008 . . . . 0.0 113.585 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.81 -21.53 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.043 1.337 . . . . 0.0 112.655 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.14 -7.81 38.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.528 1.531 . . . . 0.0 112.976 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 42.95 0.98 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 126.151 1.78 . . . . 0.0 114.07 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.45 -21.01 47.4 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.593 2.196 . . . . 0.0 113.258 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -59.71 -19.44 49.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.226 . . . . 0.0 113.124 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.23 -58.93 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.459 1.103 . . . . 0.0 111.574 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.6 mtm -58.46 -28.55 65.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 113.763 -170.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -69.71 -18.91 63.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.041 1.336 . . . . 0.0 113.345 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.31 -35.62 19.78 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.381 1.073 . . . . 0.0 111.211 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.51 -23.87 21.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.422 0.689 . . . . 0.0 112.857 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.34 21.06 18.34 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.692 1.615 . . . . 0.0 114.716 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.14 160.83 25.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.998 1.399 . . . . 0.0 112.188 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.75 -68.77 0.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.359 1.063 . . . . 0.0 112.869 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.79 22.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -162.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.34 156.97 57.21 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 125.091 1.356 . . . . 0.0 112.831 -166.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.76 88.29 0.92 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.075 3.183 . . . . 0.0 110.206 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -99.89 130.21 46.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.318 1.047 . . . . 0.0 111.893 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 134.38 35.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.318 1.047 . . . . 0.0 110.471 163.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.5 t -130.73 126.17 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.568 1.547 . . . . 0.0 108.417 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -109.95 122.54 47.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 110.639 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.68 121.5 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.403 1.481 . . . . 0.0 108.859 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.54 124.29 50.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.307 1.843 . . . . 0.0 108.774 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 61.19 20.09 10.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.009 1.324 . . . . 0.0 113.355 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.12 69.57 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.229 0.919 . . . . 0.0 113.84 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -117.46 132.11 56.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.449 1.9 . . . . 0.0 109.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.77 109.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.196 -0.94 . . . . 0.0 109.676 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.55 -24.85 14.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -160.16 144.82 14.66 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.123 1.769 . . . . 0.0 110.563 -172.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -148.25 143.87 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.552 1.541 . . . . 0.0 109.384 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -154.59 156.92 37.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.434 1.094 . . . . 0.0 111.026 164.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 p -121.45 145.36 48.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.97 -167.76 12.4 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.335 1.445 . . . . 0.0 113.58 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.06 138.42 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 65.9 mtm -139.42 147.66 41.72 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.973 0.909 . . . . 0.0 111.299 162.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.15 97.88 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.341 0.657 . . . . 0.0 111.346 167.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.19 -27.48 56.5 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.827 2.351 . . . . 0.0 113.551 -166.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -61.01 -29.17 69.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.4 -25.46 16.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.578 0.751 . . . . 0.0 112.562 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.37 -24.69 63.61 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 112.572 171.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -60.35 -41.81 94.4 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.387 0.675 . . . . 0.0 112.336 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.4 77.72 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.952 0.796 . . . . 0.0 111.97 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.01 -47.35 80.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.329 1.052 . . . . 0.0 110.379 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.59 -46.63 87.41 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.374 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.53 75.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.605 1.093 . . . . 0.0 112.705 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -62.77 -17.83 61.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.18 1.392 . . . . 0.0 113.582 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.6 mt . . . . . 0 N--CA 1.475 0.821 0 O-C-N 120.522 -1.361 . . . . 0.0 110.468 172.519 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 69.82 -56.03 0.58 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.444 2.698 . . . . 0.0 113.358 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.78 131.92 2.6 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.755 2.022 . . . . 0.0 110.404 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.8 mt -91.67 140.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.577 1.151 . . . . 0.0 109.589 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 165.89 -42.98 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 130.415 3.486 . . . . 0.0 112.974 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 t70 175.23 133.91 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 129.945 3.298 . . . . 0.0 110.126 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.55 117.58 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.8 p -61.31 -33.44 73.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.138 1.375 . . . . 0.0 113.953 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -87.02 -12.98 45.77 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.831 1.652 . . . . 0.0 114.264 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -120.0 27.25 8.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.677 1.191 . . . . 0.0 112.192 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -144.36 164.15 31.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.835 1.654 . . . . 0.0 112.015 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.08 152.74 23.07 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 125.017 1.294 . . . . 0.0 112.262 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -56.26 -28.27 58.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.301 1.041 . . . . 0.0 113.065 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -21.2 62.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -80.1 -41.33 25.76 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 111.051 166.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -74.72 -13.62 60.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.289 1.036 . . . . 0.0 113.646 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -85.2 80.32 9.25 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.589 1.956 . . . . 0.0 110.342 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 14.19 14.92 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.772 1.177 . . . . 0.0 115.854 166.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.89 167.51 11.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 1.351 . . . . 0.0 112.936 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -75.62 -66.59 0.76 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.261 1.024 . . . . 0.0 112.544 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -149.63 124.72 10.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.392 1.877 . . . . 0.0 109.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.41 160.47 42.53 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.6 mt -138.03 124.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.085 1.754 . . . . 0.0 108.647 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 109.306 -170.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -115.08 113.81 24.53 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.373 0.669 . . . . 0.0 111.948 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -81.45 70.17 8.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.813 1.245 . . . . 0.0 110.722 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.83 170.14 15.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.702 0.763 . . . . 0.0 112.845 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -117.84 162.04 18.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.533 1.533 . . . . 0.0 111.143 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -91.17 -36.17 14.11 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.971 -1.08 . . . . 0.0 111.811 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 mt -80.06 -52.19 8.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.648 1.179 . . . . 0.0 113.4 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.74 119.53 45.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.295 1.438 . . . . 0.0 112.639 -170.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.31 -19.73 55.75 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.739 2.959 . . . . 0.0 114.086 172.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -76.75 -45.57 28.61 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.195 0.907 . . . . 0.0 110.703 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 p -63.72 -21.93 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -54.7 -37.78 66.23 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.123 0.969 . . . . 0.0 112.994 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -62.32 -43.11 99.58 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.736 -0.603 . . . . 0.0 111.832 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.3 tpp -61.01 -34.6 75.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.743 0.817 . . . . 0.0 112.991 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -54.28 -42.93 70.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.437 0.695 . . . . 0.0 111.767 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.69 -27.35 29.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.923 0.889 . . . . 0.0 113.166 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.85 -47.85 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.979 0.911 . . . . 0.0 110.378 166.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -62.04 -36.99 83.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.95 -48.29 82.5 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.96 0.8 . . . . 0.0 111.525 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.33 -33.81 76.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.659 0.784 . . . . 0.0 112.711 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -65.35 -37.58 87.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.861 1.264 . . . . 0.0 111.542 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.31 -23.03 61.64 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 124.704 1.145 . . . . 0.0 113.628 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -31.33 62.39 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.279 1.431 . . . . 0.0 114.713 -171.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.73 6.31 14.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 63.51 57.76 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.916 1.687 . . . . 0.0 112.14 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.61 -15.55 30.48 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.9 3.066 . . . . 0.0 113.725 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -82.05 -4.76 57.51 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.04 135.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.177 1.391 . . . . 0.0 110.235 173.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.93 100.86 11.28 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.814 0.846 . . . . 0.0 110.847 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.11 131.33 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.847 0.859 . . . . 0.0 110.195 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.3 p -146.82 170.06 17.82 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.938 0.895 . . . . 0.0 112.579 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.3 p -132.43 155.16 49.0 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.865 -1.147 . . . . 0.0 111.071 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -142.77 127.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.534 1.133 . . . . 0.0 109.461 -168.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -64.62 101.26 0.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.734 1.614 . . . . 0.0 110.69 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.9 p -55.97 -40.81 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.056 0.943 . . . . 0.0 112.738 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.45 -26.65 65.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.749 1.619 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.69 -15.43 18.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 113.844 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -131.42 52.61 9.67 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.705 1.602 . . . . 0.0 113.009 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.6 -20.47 53.39 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.027 170.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.46 -29.17 69.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.39 1.076 . . . . 0.0 112.767 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.94 -56.84 4.97 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.492 0.717 . . . . 0.0 109.431 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.7 mtp -54.8 -33.6 61.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.514 1.525 . . . . 0.0 112.21 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -61.71 -27.86 69.01 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.864 1.665 . . . . 0.0 113.988 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.34 -38.27 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.358 0.663 . . . . 0.0 112.01 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.77 -21.78 24.93 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 15.52 31.4 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.256 1.884 . . . . 0.0 114.829 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -77.96 140.52 39.23 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.275 1.538 . . . . 0.0 111.801 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.91 -60.04 2.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.408 0.683 . . . . 0.0 112.342 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -167.07 23.05 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -165.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.61 151.88 50.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 125.468 1.507 . . . . 0.0 113.351 -166.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.71 93.94 1.0 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.924 3.083 . . . . 0.0 109.599 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.5 m -104.44 131.73 51.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.524 1.13 . . . . 0.0 112.952 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.56 131.74 34.29 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.24 1.816 . . . . 0.0 109.251 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.69 131.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 108.744 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -114.29 127.85 56.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.636 0.775 . . . . 0.0 111.154 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.1 mm -108.94 122.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.006 1.322 . . . . 0.0 109.269 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -119.4 124.06 45.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.655 1.982 . . . . 0.0 109.19 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 61.88 18.69 10.02 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.947 1.299 . . . . 0.0 113.049 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.59 7.1 67.23 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.236 1.398 . . . . 0.0 114.401 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -113.34 136.94 52.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.877 1.671 . . . . 0.0 110.136 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.01 108.84 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 121.076 -1.015 . . . . 0.0 109.879 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.9 -20.31 14.31 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -170.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -158.67 156.1 29.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.022 1.329 . . . . 0.0 110.67 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.06 145.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 111.204 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.88 146.08 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.546 1.139 . . . . 0.0 111.101 166.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 p -110.77 147.09 35.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.056 . . . . 0.0 113.153 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.71 -149.38 18.12 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.758 1.17 . . . . 0.0 113.056 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.3 mm -118.3 143.89 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.015 1.326 . . . . 0.0 111.976 -171.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.3 mtm -139.13 160.04 40.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.27 1.428 . . . . 0.0 111.014 161.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -70.06 162.29 69.88 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 111.487 167.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 -32.91 14.17 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.987 1.791 . . . . 0.0 113.868 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -71.44 -31.36 67.12 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.842 1.655 . . . . 0.0 112.821 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -79.36 -22.32 44.57 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.95 -26.13 68.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.561 1.073 . . . . 0.0 112.672 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -63.05 -37.32 86.71 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.329 0.968 . . . . 0.0 111.702 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.74 83.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.361 0.982 . . . . 0.0 111.163 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 53.5 tp -65.07 -45.47 85.18 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.323 0.649 . . . . 0.0 110.78 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -44.61 95.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.283 1.033 . . . . 0.0 112.342 173.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.69 84.21 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.123 -0.985 . . . . 0.0 111.482 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.0 m -67.79 -3.84 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.754 1.622 . . . . 0.0 114.232 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 N--CA 1.481 1.085 0 O-C-N 120.903 -1.123 . . . . 0.0 111.382 169.587 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtm . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m -138.34 151.06 47.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.661 1.584 . . . . 0.0 111.31 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.91 1.05 45.25 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm -102.83 124.46 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.728 1.611 . . . . 0.0 110.755 -171.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.58 173.37 9.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.989 2.116 . . . . 0.0 111.255 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -90.85 115.93 28.29 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.766 1.226 . . . . 0.0 110.639 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.27 122.87 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.5 p -47.33 -41.18 18.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.081 1.752 . . . . 0.0 114.435 -170.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -91.07 -17.19 26.62 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.324 1.85 . . . . 0.0 114.351 -174.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -96.94 50.11 1.09 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 122.994 1.378 . . . . 0.0 112.368 -172.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.56 162.81 39.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.001 2.121 . . . . 0.0 111.216 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.88 153.25 30.12 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.953 1.264 . . . . 0.0 111.848 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -54.78 -27.65 43.12 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.581 1.552 . . . . 0.0 114.198 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.21 44.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.719 1.208 . . . . 0.0 113.903 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -74.95 -39.71 61.18 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.193 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.95 19.4 0.15 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 113.937 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -16.5 57.92 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.46 45.44 0.12 Allowed Glycine 0 N--CA 1.478 1.448 0 CA-C-N 120.059 1.3 . . . . 0.0 116.257 -174.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.3 mt -88.72 122.35 32.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.086 1.354 . . . . 0.0 109.232 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -53.59 -43.13 68.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.753 1.161 . . . . 0.0 113.478 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -163.04 123.42 2.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.223 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.75 155.76 42.04 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.319 1.448 . . . . 0.0 112.513 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.6 mt -143.18 132.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.364 1.466 . . . . 0.0 110.707 -170.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.54 126.73 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.089 1.356 . . . . 0.0 110.8 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -102.5 117.26 34.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.202 1.401 . . . . 0.0 112.101 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -78.55 73.58 5.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.286 1.434 . . . . 0.0 111.609 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.9 -174.99 4.7 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.705 0.802 . . . . 0.0 112.798 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -144.14 156.02 44.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 111.748 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -64.75 -54.82 25.37 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.77 -38.06 20.07 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -170.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.67 122.16 49.38 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.781 1.232 . . . . 0.0 112.827 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -65.15 -22.65 61.16 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.33 3.354 . . . . 0.0 114.575 173.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -70.7 -46.21 63.54 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 119.303 0.956 . . . . 0.0 111.036 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -58.09 -34.03 69.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.474 1.11 . . . . 0.0 113.595 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -55.79 -34.6 65.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.12 1.368 . . . . 0.0 112.995 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -60.09 -46.73 88.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.341 0.657 . . . . 0.0 111.679 176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -36.04 82.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.287 0.635 . . . . 0.0 112.65 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -53.03 -40.64 64.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.834 0.743 . . . . 0.0 112.293 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -65.77 -28.16 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.039 -1.038 . . . . 0.0 112.775 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 t -75.12 -52.68 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.579 1.552 . . . . 0.0 108.747 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.71 -38.23 77.84 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.715 1.206 . . . . 0.0 112.462 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -58.75 -58.46 8.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.531 1.132 . . . . 0.0 111.513 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -65.28 -31.31 72.38 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.05 -40.37 82.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.311 1.445 . . . . 0.0 112.398 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.2 -26.72 42.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 119.336 0.971 . . . . 0.0 114.06 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -40.83 71.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.925 1.29 . . . . 0.0 114.179 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.71 4.04 37.65 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.78 67.33 77.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 111.573 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.54 -10.1 24.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.331 2.687 . . . . 0.0 114.341 -169.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.28 -14.25 58.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.43 131.04 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.361 1.064 . . . . 0.0 109.77 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.34 91.48 6.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 0.0 110.645 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mt -100.08 132.34 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.029 0.932 . . . . 0.0 109.531 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -144.79 176.01 9.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.127 0.971 . . . . 0.0 111.658 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 86.4 p -113.76 176.3 5.09 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.897 -1.127 . . . . 0.0 110.599 162.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.0 126.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 124.342 1.057 . . . . 0.0 109.664 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.35 110.42 5.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.863 0.84 . . . . 0.0 110.811 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 p -56.48 -27.2 56.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.611 1.164 . . . . 0.0 113.637 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -77.35 -29.59 53.45 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.436 1.016 . . . . 0.0 113.089 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.33 -24.46 19.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.639 1.176 . . . . 0.0 113.017 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 56.39 9.21 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 126.745 2.018 . . . . 0.0 111.92 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.41 -27.79 18.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.983 2.456 . . . . 0.0 112.507 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -68.54 -25.42 64.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.984 0.811 . . . . 0.0 112.558 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' HD22 ' A' ' 68' ' ' LEU . 7.7 mt -63.61 -56.19 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.166 0.894 . . . . 0.0 110.122 168.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.412 ' HB3' ' H ' ' A' ' 71' ' ' GLU . 17.5 mtm -58.48 -21.01 50.25 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -26.66 51.89 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.99 1.716 . . . . 0.0 112.414 174.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -82.72 -46.47 13.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.76 0.824 . . . . 0.0 111.32 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -82.35 -15.91 51.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 21.72 46.6 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.664 1.126 . . . . 0.0 114.723 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -74.95 -58.9 3.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.404 1.102 . . . . 0.0 111.665 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 65' ' ' MET . 41.0 mt-10 73.71 -29.07 0.19 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.08 3.352 . . . . 0.0 113.975 168.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -163.89 17.73 0.06 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -164.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.32 150.96 63.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.487 1.115 . . . . 0.0 113.943 -170.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.43 86.55 1.58 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 124.445 3.43 . . . . 0.0 110.873 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.7 m -98.67 136.01 39.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.415 1.086 . . . . 0.0 112.446 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.13 128.59 38.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.871 163.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.5 t -119.25 129.93 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.563 1.545 . . . . 0.0 109.16 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -117.56 131.09 56.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.125 0.97 . . . . 0.0 111.623 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.27 125.21 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.013 1.325 . . . . 0.0 109.925 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.32 117.4 29.86 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.661 1.984 . . . . 0.0 110.17 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.18 29.56 11.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.873 2.069 . . . . 0.0 111.805 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.54 85.79 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.48 0.562 . . . . 0.0 114.425 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -101.28 133.07 46.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.852 1.261 . . . . 0.0 108.755 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.07 106.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.179 -0.951 . . . . 0.0 109.297 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.04 -22.09 15.89 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -166.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -161.2 155.78 23.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.452 1.501 . . . . 0.0 110.74 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.7 p -152.7 143.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.306 1.442 . . . . 0.0 110.203 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.71 149.43 20.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.517 1.127 . . . . 0.0 111.566 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 t -112.16 140.68 46.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.336 1.054 . . . . 0.0 112.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.27 -164.62 12.43 Favored Glycine 0 C--N 1.344 1.001 0 C-N-CA 125.24 1.4 . . . . 0.0 114.762 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.96 140.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.122 1.369 . . . . 0.0 111.338 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.8 mtm -139.92 161.77 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.062 1.345 . . . . 0.0 111.701 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -68.37 161.29 70.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.277 0.631 . . . . 0.0 111.313 161.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.33 -32.4 16.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 121.932 1.754 . . . . 0.0 113.53 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -68.45 -32.79 73.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 120.884 1.675 . . . . 0.0 112.402 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -74.83 -30.37 61.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.535 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.81 -35.72 79.12 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.328 0.967 . . . . 0.0 111.833 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -39.97 90.72 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.424 1.011 . . . . 0.0 111.715 171.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.61 87.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.675 0.67 . . . . 0.0 111.866 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.8 tp -66.12 -49.6 66.93 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.848 0.859 . . . . 0.0 110.658 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -43.64 77.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.944 1.297 . . . . 0.0 113.21 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.44 76.17 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.103 0.865 . . . . 0.0 112.001 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.8 m -70.04 1.58 4.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.455 1.502 . . . . 0.0 114.091 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.474 0.767 0 O-C-N 120.739 -1.226 . . . . 0.0 111.294 171.665 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 mmt . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 m 70.41 -36.09 0.34 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 128.916 2.886 . . . . 0.0 114.652 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.64 143.15 11.33 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.722 2.009 . . . . 0.0 111.042 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.1 mt -106.16 128.46 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.093 1.357 . . . . 0.0 109.432 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -159.35 -164.6 1.4 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.774 2.429 . . . . 0.0 107.147 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.75 140.17 53.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.76 0.709 . . . . 0.0 111.296 161.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.55 133.62 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 165.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.0 p -75.52 -20.67 58.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.158 1.383 . . . . 0.0 114.395 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 p -85.99 -39.32 16.99 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.132 0.973 . . . . 0.0 113.365 -172.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -170.77 145.59 2.46 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.769 1.628 . . . . 0.0 111.86 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.32 148.73 11.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.538 1.935 . . . . 0.0 109.997 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.92 -179.71 24.16 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.922 1.248 . . . . 0.0 112.63 -169.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -57.8 -30.3 65.58 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -167.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.95 -22.2 63.19 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -84.72 -36.81 21.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.288 0.635 . . . . 0.0 111.611 165.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -79.24 -6.54 56.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -171.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.0 -17.75 30.54 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.54 -4.09 13.75 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.857 1.218 . . . . 0.0 116.064 -171.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.89 166.96 18.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.674 1.237 . . . . 0.0 114.182 -171.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -82.52 -65.13 1.05 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.596 1.158 . . . . 0.0 111.944 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -145.83 125.16 13.04 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.748 1.619 . . . . 0.0 110.04 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.99 159.59 43.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.9 mt -134.23 127.82 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.796 1.638 . . . . 0.0 108.477 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -118.71 127.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.552 1.541 . . . . 0.0 108.827 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -111.2 112.48 24.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.497 1.119 . . . . 0.0 111.197 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -80.29 76.8 7.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.374 1.069 . . . . 0.0 110.795 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.37 174.85 10.74 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.268 1.027 . . . . 0.0 112.729 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -134.21 151.32 51.26 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.873 -1.142 . . . . 0.0 111.535 167.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -62.63 -46.88 86.19 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 112.168 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.46 -32.44 42.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.323 1.049 . . . . 0.0 112.791 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.2 t -57.36 122.95 58.56 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.276 1.43 . . . . 0.0 112.392 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.31 -13.95 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.323 3.349 . . . . 0.0 112.293 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -80.08 -47.5 14.72 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.192 0.906 . . . . 0.0 109.451 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m -52.74 -36.61 58.01 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 113.979 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -37.3 66.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.451 1.1 . . . . 0.0 112.926 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -63.17 -45.52 91.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.51 0.724 . . . . 0.0 111.501 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 tpt -61.61 -33.13 73.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.035 0.934 . . . . 0.0 112.782 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -59.1 -40.46 85.38 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.647 0.658 . . . . 0.0 112.032 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -35.53 62.42 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.38 -0.825 . . . . 0.0 112.264 174.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.17 -47.86 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.789 0.835 . . . . 0.0 110.501 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.96 -37.05 85.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.012 1.725 . . . . 0.0 112.304 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.79 -48.48 76.72 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.02 0.827 . . . . 0.0 112.376 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -35.92 81.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.31 -0.869 . . . . 0.0 112.424 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -66.82 -34.25 77.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.967 1.307 . . . . 0.0 111.937 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.52 -25.29 51.23 Favored Glycine 0 N--CA 1.47 0.933 0 O-C-N 121.001 -1.062 . . . . 0.0 113.73 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.71 67.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.92 22.97 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 114.066 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.53 62.11 61.34 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.939 1.696 . . . . 0.0 111.563 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.29 -13.87 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.201 2.6 . . . . 0.0 114.243 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.04 -4.91 54.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.57 131.63 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 110.705 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.56 101.19 10.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.156 0.983 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.5 mt -94.88 130.5 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.507 -0.745 . . . . 0.0 109.689 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -139.16 152.0 47.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 110.863 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.7 m -115.68 149.98 37.51 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.111 -0.993 . . . . 0.0 111.512 167.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.1 t -139.73 122.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.122 1.369 . . . . 0.0 108.4 -171.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -67.85 113.18 5.37 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.498 1.119 . . . . 0.0 111.241 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -56.99 -27.65 61.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.448 1.499 . . . . 0.0 114.252 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -74.94 -27.93 60.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.069 0.849 . . . . 0.0 112.573 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.04 -27.99 16.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.855 1.262 . . . . 0.0 113.295 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 tpt85 -124.62 40.91 0.55 Allowed Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 125.706 1.602 . . . . 0.0 114.707 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -65.71 -19.69 59.5 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.196 1.931 . . . . 0.0 112.929 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.31 -27.4 62.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.731 1.212 . . . . 0.0 113.487 173.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.89 -54.78 5.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.503 1.121 . . . . 0.0 110.5 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtp -56.15 -31.06 63.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.055 1.342 . . . . 0.0 112.797 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.97 -26.83 68.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 113.143 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -86.51 -36.48 18.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.876 1.271 . . . . 0.0 110.799 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.7 -21.27 26.75 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.45 21.29 15.15 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.759 1.647 . . . . 0.0 115.185 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -83.48 143.26 30.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.773 1.287 . . . . 0.0 111.72 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.39 -72.16 0.57 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.717 0.807 . . . . 0.0 111.781 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.46 30.18 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 114.152 -170.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.11 156.52 52.34 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.425 1.49 . . . . 0.0 111.969 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.95 97.6 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.357 2.705 . . . . 0.0 109.952 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 m -109.5 124.58 51.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.984 0.514 . . . . 0.0 111.574 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.23 135.98 33.41 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.199 1.0 . . . . 0.0 109.328 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.86 125.18 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.299 1.84 . . . . 0.0 108.196 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -107.59 123.31 48.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.076 0.95 . . . . 0.0 111.077 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.3 mm -107.7 114.32 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.013 1.325 . . . . 0.0 108.662 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.1 125.0 53.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.867 1.667 . . . . 0.0 108.551 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.8 t70 66.74 20.5 10.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.056 1.343 . . . . 0.0 112.36 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.65 7.44 87.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.203 0.906 . . . . 0.0 113.856 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -108.99 136.53 48.36 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.829 1.652 . . . . 0.0 109.716 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.7 107.63 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.253 168.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.88 -30.91 11.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.302 1.041 . . . . 0.0 113.627 -170.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.6 158.32 42.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.096 1.358 . . . . 0.0 112.064 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -151.04 147.12 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.457 1.903 . . . . 0.0 108.739 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.01 148.99 31.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.536 0.684 . . . . 0.0 111.171 159.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 m -107.58 128.44 54.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.157 0.983 . . . . 0.0 111.32 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.17 -162.85 23.62 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.438 1.494 . . . . 0.0 113.106 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.84 141.67 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.303 1.441 . . . . 0.0 110.459 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 mtm -139.51 154.98 47.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.41 0.684 . . . . 0.0 112.26 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.94 152.2 84.49 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 123.772 0.829 . . . . 0.0 110.963 165.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.32 -25.15 49.67 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.351 2.034 . . . . 0.0 114.021 -165.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -61.07 -32.37 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -85.97 -28.95 23.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 0.0 111.805 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.8 -27.24 69.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.141 -0.974 . . . . 0.0 112.374 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -58.58 -44.53 89.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.793 0.724 . . . . 0.0 111.696 171.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.47 75.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.243 0.617 . . . . 0.0 111.951 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.28 -45.35 84.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.02 0.528 . . . . 0.0 111.168 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -44.51 94.2 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.423 0.689 . . . . 0.0 111.735 173.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.8 -27.07 66.42 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.075 -1.016 . . . . 0.0 111.938 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 m -67.08 -21.05 65.9 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.627 1.171 . . . . 0.0 113.573 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.481 1.101 0 CA-C-N 119.438 1.017 . . . . 0.0 110.107 174.991 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m 108.08 -26.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 1 C-N-CA 132.215 4.206 . . . . 0.0 111.601 -176.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.49 143.67 2.85 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.903 2.081 . . . . 0.0 110.42 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm -106.96 132.02 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.343 1.457 . . . . 0.0 107.969 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -156.9 158.09 36.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.825 1.25 . . . . 0.0 111.476 -165.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -100.33 96.86 7.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.748 2.419 . . . . 0.0 111.312 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.34 124.76 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.485 1.114 . . . . 0.0 109.274 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.4 p -66.11 -23.88 66.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.547 1.539 . . . . 0.0 113.847 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.7 p -91.79 -13.06 32.13 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.099 1.36 . . . . 0.0 114.09 -173.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -163.2 74.49 0.36 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.86 1.314 . . . . 0.0 112.604 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.82 107.52 3.18 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.156 1.382 . . . . 0.0 109.903 167.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.64 165.03 21.22 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 126.104 1.812 . . . . 0.0 112.847 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp -53.01 -35.34 59.3 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.71 67.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.82 -40.18 63.54 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.467 0.576 . . . . 0.0 110.779 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.24 -9.99 59.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.27 1.028 . . . . 0.0 113.274 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.82 -22.84 23.02 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.019 1.328 . . . . 0.0 112.916 169.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.1 -17.08 9.8 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 -168.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.53 166.3 23.5 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -83.54 -64.91 1.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.321 1.448 . . . . 0.0 112.134 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.13 125.7 12.48 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.806 1.642 . . . . 0.0 109.986 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.99 162.6 39.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.2 mt -135.92 120.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.457 1.503 . . . . 0.0 107.674 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.32 128.21 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.972 1.309 . . . . 0.0 109.267 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -108.01 112.16 24.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.599 1.16 . . . . 0.0 111.547 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -78.38 79.39 4.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.941 1.296 . . . . 0.0 110.464 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.11 175.45 9.98 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.58 149.58 37.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.436 1.494 . . . . 0.0 111.291 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -75.72 -34.97 60.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.7 mt -82.36 -23.98 34.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.478 1.111 . . . . 0.0 113.496 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.02 125.43 91.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 113.573 -167.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.02 -2.27 9.54 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.177 3.918 . . . . 0.0 112.779 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -87.46 -42.76 12.57 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 119.696 1.135 . . . . 0.0 109.5 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 88.5 m -57.24 -37.1 71.79 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -50.79 -37.88 45.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -75.82 -41.08 53.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.873 0.469 . . . . 0.0 111.504 -170.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.284 1.034 . . . . 0.0 112.593 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -55.82 -40.94 73.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.607 1.094 . . . . 0.0 112.165 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -75.29 -33.94 61.27 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.492 -0.755 . . . . 0.0 112.659 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.53 -46.3 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.767 0.827 . . . . 0.0 110.855 174.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.31 -33.4 75.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.526 1.131 . . . . 0.0 112.41 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.25 -48.6 75.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.407 1.003 . . . . 0.0 112.564 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.58 -37.83 79.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.757 0.708 . . . . 0.0 112.247 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -67.85 -34.29 76.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 112.511 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.99 -22.72 60.67 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.877 -1.139 . . . . 0.0 113.643 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.93 -29.07 64.85 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -170.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.8 6.5 15.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.69 1.196 . . . . 0.0 114.224 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.96 63.92 17.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.937 1.695 . . . . 0.0 112.601 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.13 -15.19 32.06 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.275 2.65 . . . . 0.0 113.63 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -81.22 -2.95 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.43 134.11 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.241 1.416 . . . . 0.0 110.666 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.87 101.26 10.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.714 0.806 . . . . 0.0 111.339 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.7 mt -97.74 130.09 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.857 -1.152 . . . . 0.0 109.633 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 p -150.42 164.34 36.13 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.075 0.95 . . . . 0.0 111.677 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.5 p -104.34 176.22 5.23 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.66 -1.275 . . . . 0.0 112.601 165.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -156.02 135.46 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.776 1.631 . . . . 0.0 109.451 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -73.77 109.75 7.51 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.301 1.04 . . . . 0.0 111.446 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -55.12 -29.71 58.25 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.671 1.188 . . . . 0.0 113.931 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.09 -23.32 51.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.082 0.953 . . . . 0.0 112.782 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.92 -24.81 16.82 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.85 1.26 . . . . 0.0 112.783 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -117.46 48.6 0.8 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 126.858 2.063 . . . . 0.0 113.273 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.28 -27.09 24.43 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.566 1.511 . . . . 0.0 112.494 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.01 -32.93 74.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.742 0.701 . . . . 0.0 112.165 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.87 -48.04 67.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.002 0.921 . . . . 0.0 108.973 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.2 mtm -56.92 -22.17 35.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.675 -0.641 . . . . 0.0 112.438 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -13.87 53.22 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.371 0.987 . . . . 0.0 113.352 175.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -82.48 -42.3 18.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.482 1.113 . . . . 0.0 110.788 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.43 -23.98 24.32 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.17 21.63 17.27 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.41 1.481 . . . . 0.0 115.512 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.0 153.64 24.86 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.673 1.236 . . . . 0.0 111.919 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.38 -65.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.079 0.952 . . . . 0.0 111.941 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -159.99 2.16 0.08 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 -165.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.8 m -106.66 159.53 29.54 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 127.521 2.328 . . . . 0.0 112.835 -162.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.81 85.84 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.405 3.403 . . . . 0.0 111.859 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 75.7 m -98.79 128.36 44.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.92 137.78 32.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.698 1.199 . . . . 0.0 109.761 165.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.2 122.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.927 1.691 . . . . 0.0 108.662 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -102.67 118.53 37.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.998 0.919 . . . . 0.0 110.031 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.33 113.18 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.833 1.253 . . . . 0.0 108.853 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.77 121.61 45.76 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.045 1.338 . . . . 0.0 107.849 172.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.2 t70 64.59 21.78 12.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 112.261 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 9.23 84.47 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.403 1.001 . . . . 0.0 113.873 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.6 135.16 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 110.277 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.55 108.27 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 167.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.99 -34.42 10.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.82 150.49 33.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.044 1.738 . . . . 0.0 110.998 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -146.74 145.5 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.571 1.548 . . . . 0.0 108.811 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -148.0 136.57 21.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.539 0.736 . . . . 0.0 111.463 163.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 p -98.2 3.44 48.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.997 1.719 . . . . 0.0 115.08 -171.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.33 -166.19 26.61 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.422 1.486 . . . . 0.0 114.435 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.4 141.35 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.473 1.509 . . . . 0.0 110.086 170.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.6 mtm -137.05 176.02 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 170.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.46 156.17 49.44 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 126.759 2.023 . . . . 0.0 110.005 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.76 -38.2 18.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.903 1.735 . . . . 0.0 113.939 -156.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -61.25 -30.55 70.52 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.291 0.951 . . . . 0.0 113.086 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.18 -31.37 27.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.896 0.878 . . . . 0.0 112.006 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.26 -34.49 76.28 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.039 0.836 . . . . 0.0 112.388 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -48.59 76.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.062 0.945 . . . . 0.0 111.088 167.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.86 -34.93 79.28 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.484 0.714 . . . . 0.0 112.337 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.2 -49.18 70.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 110.329 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -42.41 80.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.225 0.61 . . . . 0.0 112.156 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.19 -36.42 81.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.472 0.578 . . . . 0.0 111.457 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -60.02 -34.98 74.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.838 1.255 . . . . 0.0 112.463 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 124.13 0.972 . . . . 0.0 111.056 175.134 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? . . . . . 0 C--O 1.236 0.389 0 C-N-CA 124.921 1.288 . . . . 0.0 110.429 -172.103 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.82 61.25 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -85.71 -32.6 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.048 0.939 . . . . 0.0 111.466 168.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -67.91 -30.96 70.42 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.5 -0.75 . . . . 0.0 111.457 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.2 -15.91 60.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.238 1.415 . . . . 0.0 113.283 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.27 -15.47 30.17 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.159 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.469 HD11 HG22 ' A' ' 79' ' ' ILE . 1.9 pp -102.9 153.79 19.86 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.274 1.537 . . . . 0.0 114.302 -168.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -99.11 -37.73 9.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.212 1.005 . . . . 0.0 113.284 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -159.88 110.96 1.95 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.211 1.404 . . . . 0.0 109.706 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.13 37.82 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.872 0.844 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.05 131.07 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 108.634 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.6 t -124.04 131.0 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.49 1.116 . . . . 0.0 109.521 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 9.1 t80 -105.27 113.52 27.16 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.994 1.317 . . . . 0.0 112.039 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -82.09 75.64 9.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.162 1.385 . . . . 0.0 110.607 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -77.24 166.74 22.81 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.866 0.866 . . . . 0.0 113.261 176.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.35 160.39 25.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.572 1.149 . . . . 0.0 112.31 173.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -74.4 -56.42 4.88 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.26 -64.96 0.79 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.694 1.198 . . . . 0.0 112.067 -170.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -51.21 121.97 17.43 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 127.027 2.131 . . . . 0.0 113.677 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.96 -23.06 76.49 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.402 3.401 . . . . 0.0 114.961 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -62.11 -45.04 95.24 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.925 0.89 . . . . 0.0 112.132 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 m -62.16 -34.63 76.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.605 1.162 . . . . 0.0 112.757 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -60.46 -25.23 65.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.743 1.617 . . . . 0.0 113.863 -171.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.9 -41.07 71.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -62.7 -29.29 70.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.053 0.941 . . . . 0.0 113.201 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -56.85 -43.09 80.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 111.885 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -68.8 -33.83 74.52 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.929 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.77 -48.07 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.709 1.604 . . . . 0.0 110.468 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.59 -34.97 79.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 0.0 112.593 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.31 -52.15 66.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 111.196 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -67.58 -32.66 73.56 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.85 0.86 . . . . 0.0 112.422 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.48 -38.1 80.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.836 1.254 . . . . 0.0 112.408 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.66 -27.8 41.18 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-N 118.911 0.778 . . . . 0.0 112.73 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.84 64.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.348 1.059 . . . . 0.0 113.607 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.43 10.66 37.18 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.769 1.628 . . . . 0.0 114.585 177.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB1' HE22 ' A' ' 50' ' ' GLN . . . -138.22 73.32 44.36 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.483 1.513 . . . . 0.0 112.324 177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.64 -22.61 73.34 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.566 2.844 . . . . 0.0 115.701 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.422 HE22 ' HB1' ' A' ' 48' ' ' ALA . 1.8 pm0 -86.62 -4.61 59.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.21 132.11 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.877 1.271 . . . . 0.0 111.057 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.39 105.34 15.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mt -107.86 135.08 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.958 0.903 . . . . 0.0 110.426 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.0 p -149.3 172.17 15.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 0.0 112.152 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.4 p -116.98 170.27 8.76 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.696 -1.253 . . . . 0.0 111.668 167.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.1 128.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.434 1.094 . . . . 0.0 110.074 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.2 111.04 1.8 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.692 1.197 . . . . 0.0 110.467 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.8 p -61.32 -26.55 67.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.131 0.972 . . . . 0.0 113.014 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -78.35 -20.4 51.41 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.879 0.763 . . . . 0.0 112.673 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.06 -26.13 20.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.384 1.074 . . . . 0.0 112.399 168.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -117.61 48.21 0.79 Allowed Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 126.055 1.742 . . . . 0.0 114.928 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.82 -17.08 14.19 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.932 2.421 . . . . 0.0 114.189 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -26.8 64.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.51 1.05 . . . . 0.0 112.616 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.75 -46.83 34.62 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.151 0.432 . . . . 0.0 110.738 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 mtm -55.61 -28.69 56.6 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.929 0.891 . . . . 0.0 113.143 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -60.22 -29.8 68.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.644 1.577 . . . . 0.0 113.361 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -91.33 -36.69 13.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.923 1.289 . . . . 0.0 111.164 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.87 -19.25 30.86 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.5 18.5 30.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.206 1.384 . . . . 0.0 114.835 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -79.36 151.55 30.92 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.265 1.033 . . . . 0.0 111.537 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -94.42 -72.49 0.61 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.761 1.225 . . . . 0.0 111.405 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.27 15.99 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.91 1.684 . . . . 0.0 113.147 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.31 157.3 34.35 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.349 1.46 . . . . 0.0 111.866 -157.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.31 91.28 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.757 2.972 . . . . 0.0 110.48 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.9 m -104.77 126.71 52.13 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 111.606 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.66 126.1 34.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 109.296 165.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.91 125.34 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.862 1.665 . . . . 0.0 108.74 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.58 121.29 44.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.511 1.124 . . . . 0.0 110.312 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 19' ' ' LEU . 28.2 mm -108.99 120.73 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 108.978 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -118.47 126.24 51.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.912 1.685 . . . . 0.0 109.419 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.77 19.7 9.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.366 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 2.35 88.37 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.223 -0.923 . . . . 0.0 114.627 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -103.24 135.91 44.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.078 1.751 . . . . 0.0 109.208 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.76 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.018 -1.051 . . . . 0.0 110.284 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -95.49 -20.76 18.78 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.596 1.158 . . . . 0.0 113.386 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -162.85 148.83 12.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.935 2.094 . . . . 0.0 108.828 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -161.77 144.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 110.58 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -157.71 143.03 16.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.42 1.088 . . . . 0.0 112.091 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.3 m -101.88 131.01 48.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.099 0.959 . . . . 0.0 110.955 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.88 -166.84 23.5 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.503 1.525 . . . . 0.0 113.273 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -120.08 146.07 25.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.14 1.776 . . . . 0.0 110.036 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.1 ptp -150.18 163.18 38.9 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 165.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.31 158.89 86.51 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.521 1.128 . . . . 0.0 112.53 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.78 -16.43 26.39 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.677 2.251 . . . . 0.0 113.707 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -68.14 -47.53 67.84 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 110.237 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -79.05 -27.07 43.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.307 1.043 . . . . 0.0 112.79 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.1 tp -61.59 -22.99 65.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.467 -0.771 . . . . 0.0 113.056 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -63.2 -42.05 99.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.226 0.61 . . . . 0.0 111.509 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -33.41 70.74 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.44 0.696 . . . . 0.0 112.15 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -50.14 72.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.761 1.224 . . . . 0.0 109.852 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.02 -44.47 96.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.344 1.058 . . . . 0.0 112.935 172.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.17 84.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.989 0.813 . . . . 0.0 111.834 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -55.68 -32.86 63.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.966 1.306 . . . . 0.0 112.849 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 124.578 1.151 . . . . 0.0 110.803 177.647 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 mm . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 127.173 2.189 . . . . 0.0 110.467 -172.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptp . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -29.63 68.49 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -75.34 -39.78 59.02 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.614 -0.679 . . . . 0.0 111.295 168.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.42 -13.34 61.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -91.46 -13.42 32.3 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.833 1.253 . . . . 0.0 113.417 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.64 -17.8 3.79 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 -170.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.11 165.91 22.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 114.206 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.2 m -83.54 -50.32 8.37 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -164.96 114.62 1.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.437 1.495 . . . . 0.0 109.955 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.74 160.81 42.84 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.18 122.63 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.916 1.286 . . . . 0.0 107.915 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.79 117.36 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.395 1.478 . . . . 0.0 109.383 -170.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' HB2' HD13 ' A' ' 76' ' ' LEU . 17.6 t80 -102.07 115.09 29.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.925 0.89 . . . . 0.0 112.894 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -81.22 78.04 8.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.871 1.268 . . . . 0.0 111.662 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -170.69 3.11 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.649 1.18 . . . . 0.0 113.265 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -142.83 164.91 28.82 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.847 1.659 . . . . 0.0 111.339 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -39.0 -94.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.407 2.283 . . . . 0.0 116.922 -164.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.01 -22.82 16.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 113.842 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 61.0 m -46.71 115.66 3.4 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 127.018 2.127 . . . . 0.0 113.242 -171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -55.2 -24.5 41.86 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.586 3.524 . . . . 0.0 116.196 -175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.94 -48.6 75.45 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.256 0.934 . . . . 0.0 112.186 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 94.4 m -70.13 -25.91 63.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.288 1.035 . . . . 0.0 113.318 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -65.4 -30.02 70.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.253 1.021 . . . . 0.0 112.816 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.24 -51.49 69.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 110.794 169.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.67 -41.22 97.24 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.741 1.216 . . . . 0.0 112.906 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.54 -37.19 65.13 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.502 -0.749 . . . . 0.0 111.766 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.01 -31.35 62.9 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.525 -1.359 . . . . 0.0 112.092 176.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.9 -44.17 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.706 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.42 -40.76 92.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.523 0.729 . . . . 0.0 112.584 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.35 -49.8 75.49 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.544 0.611 . . . . 0.0 112.61 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.14 -37.6 87.92 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.567 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.18 -38.01 89.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.821 1.248 . . . . 0.0 111.763 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.41 -19.11 67.18 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.37 0.986 . . . . 0.0 113.066 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.44 -32.24 68.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.097 0.959 . . . . 0.0 113.453 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 11.01 34.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.575 1.55 . . . . 0.0 114.232 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.68 45.44 0.37 Allowed Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 125.708 1.603 . . . . 0.0 114.328 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.42 -15.46 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.209 2.606 . . . . 0.0 114.088 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.46 -7.93 58.76 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.74 133.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.653 1.115 . . . . 0.0 108.048 163.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.62 85.25 4.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.831 0.824 . . . . 0.0 110.286 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.06 130.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.4 p -144.54 172.05 13.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.088 0.947 . . . . 0.0 112.085 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.6 p -128.28 154.27 46.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.14 -0.975 . . . . 0.0 110.343 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.0 t -139.9 126.32 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.828 1.251 . . . . 0.0 108.528 -169.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.88 100.04 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.152 1.381 . . . . 0.0 110.832 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.0 p -54.44 -36.71 64.34 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.569 1.147 . . . . 0.0 113.146 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.61 -26.95 67.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.311 1.844 . . . . 0.0 114.088 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.09 -17.29 16.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.414 1.486 . . . . 0.0 112.994 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.13 51.05 2.28 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.54 1.936 . . . . 0.0 112.377 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.33 -24.25 43.64 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.737 1.624 . . . . 0.0 111.553 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.48 -26.3 67.87 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 113.073 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.16 -55.18 6.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 109.5 168.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 mtm -57.54 -24.01 53.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.479 1.112 . . . . 0.0 113.369 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -70.37 -28.47 65.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.748 1.619 . . . . 0.0 111.696 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -80.96 -38.05 28.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.255 1.022 . . . . 0.0 111.007 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.93 -22.5 21.94 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.04 22.84 16.35 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.65 1.595 . . . . 0.0 115.024 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.11 153.63 25.97 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.663 1.232 . . . . 0.0 111.76 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.58 -70.6 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.353 1.061 . . . . 0.0 112.377 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -157.34 3.58 0.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -165.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.48 156.88 38.78 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.07 1.748 . . . . 0.0 113.02 -162.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.66 93.33 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.034 3.156 . . . . 0.0 110.261 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.2 m -103.41 129.77 50.58 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.253 1.021 . . . . 0.0 110.429 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 25' ' ' PHE . 12.5 tp -110.07 119.52 39.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.89 0.876 . . . . 0.0 110.061 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 t -117.13 129.15 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.343 1.457 . . . . 0.0 109.079 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -111.21 118.73 36.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.824 0.849 . . . . 0.0 109.901 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.451 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 30.1 mm -107.21 114.36 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.18 1.392 . . . . 0.0 109.148 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -108.28 118.57 37.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.771 1.228 . . . . 0.0 108.586 173.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.05 22.34 13.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.99 1.316 . . . . 0.0 113.209 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.63 10.47 70.15 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.372 0.987 . . . . 0.0 113.149 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -112.51 131.83 55.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.156 1.382 . . . . 0.0 109.37 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.16 106.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.625 -0.672 . . . . 0.0 109.419 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.01 -20.15 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -162.27 153.52 17.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.917 1.687 . . . . 0.0 110.448 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.13 144.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.96 1.304 . . . . 0.0 110.807 172.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.89 162.33 35.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.933 1.293 . . . . 0.0 109.814 165.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -130.98 140.91 50.21 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.411 0.685 . . . . 0.0 112.589 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.74 19.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.693 1.616 . . . . 0.0 112.386 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.1 mm -125.63 145.33 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.222 1.809 . . . . 0.0 110.135 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.8 ptp -147.36 -149.06 0.27 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.746 0.818 . . . . 0.0 111.473 164.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.85 160.06 38.97 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.519 1.528 . . . . 0.0 110.43 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.78 -34.49 11.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.612 1.542 . . . . 0.0 113.815 -153.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -59.14 -32.25 69.7 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.53 -32.55 32.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.083 0.953 . . . . 0.0 111.838 172.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.5 tp -65.62 -30.08 70.75 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.275 -0.891 . . . . 0.0 112.543 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.7 -37.55 73.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.05 0.841 . . . . 0.0 112.015 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.26 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.969 -1.082 . . . . 0.0 112.211 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.19 -39.96 90.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.726 -0.609 . . . . 0.0 111.37 175.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.58 -48.29 80.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.204 1.002 . . . . 0.0 112.123 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.7 -32.89 74.07 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.82 -1.175 . . . . 0.0 112.718 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.3 t -64.57 -13.53 53.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.787 1.635 . . . . 0.0 113.331 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.474 0.736 0 O-C-N 120.658 -1.276 . . . . 0.0 110.719 170.854 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.6 mm . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 120.268 0.08 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 C-N-CA 124.448 1.099 . . . . 0.0 112.558 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.8 -25.87 63.06 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -82.82 -32.76 27.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.662 . . . . 0.0 111.916 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.89 -28.83 68.64 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.807 -0.558 . . . . 0.0 111.221 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.41 -7.05 16.81 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.567 -1.333 . . . . 0.0 114.042 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.11 -4.72 61.16 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.151 1.358 . . . . 0.0 115.506 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.3 mt -77.65 159.27 29.29 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.625 1.713 . . . . 0.0 115.215 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -87.09 -51.65 5.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.014 143.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -161.55 135.23 6.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.16 1.784 . . . . 0.0 112.586 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.04 162.98 38.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.218 1.407 . . . . 0.0 112.916 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -139.33 132.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.057 1.343 . . . . 0.0 108.707 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.07 123.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.012 1.325 . . . . 0.0 109.631 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -102.77 110.72 22.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.646 1.178 . . . . 0.0 111.621 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.02 70.29 5.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.962 1.705 . . . . 0.0 110.845 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -171.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.182 0.993 . . . . 0.0 113.561 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -136.27 163.35 30.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.644 1.178 . . . . 0.0 111.329 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -72.39 -60.89 2.01 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.284 1.033 . . . . 0.0 112.716 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.91 -41.9 35.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.648 1.179 . . . . 0.0 112.342 -169.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.2 m -47.59 108.51 0.9 Allowed Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 126.667 1.987 . . . . 0.0 114.191 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -62.09 -30.27 82.32 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.377 2.718 . . . . 0.0 113.926 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.88 -38.26 90.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -61.81 -32.54 72.85 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.955 0.902 . . . . 0.0 113.109 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.67 -29.1 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.709 0.804 . . . . 0.0 112.758 -174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -63.58 -43.47 96.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.573 0.749 . . . . 0.0 111.626 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.9 mmm -66.31 -26.08 67.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.745 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -44.69 89.26 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.531 1.06 . . . . 0.0 111.512 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -62.23 -43.92 97.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.996 -1.065 . . . . 0.0 112.226 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.45 -48.38 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.342 1.057 . . . . 0.0 111.051 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.4 mt -63.47 -37.11 86.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.005 0.922 . . . . 0.0 112.961 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.72 -47.86 81.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.432 0.693 . . . . 0.0 111.119 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.05 -32.54 72.97 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.913 0.885 . . . . 0.0 113.17 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.11 -36.45 83.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.683 1.593 . . . . 0.0 111.782 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.19 -22.5 62.95 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-N 118.917 0.78 . . . . 0.0 112.445 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.09 -28.71 64.85 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.715 1.206 . . . . 0.0 113.904 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 9.79 29.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.503 1.521 . . . . 0.0 114.256 176.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.46 85.73 14.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.381 1.472 . . . . 0.0 111.338 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.02 -15.03 18.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.878 2.385 . . . . 0.0 114.52 -169.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.97 -12.62 24.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.11 1.323 . . . . 0.0 113.874 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.69 129.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 110.226 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.96 92.99 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.371 0.605 . . . . 0.0 110.36 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 mt -92.96 136.24 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 109.988 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.5 p -148.15 168.55 22.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 112.688 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -118.25 168.84 10.22 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.989 -1.069 . . . . 0.0 110.636 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.77 131.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.33 1.052 . . . . 0.0 109.487 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.45 115.51 9.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.875 1.27 . . . . 0.0 111.873 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.7 p -57.05 -27.72 61.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.824 1.25 . . . . 0.0 113.826 172.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.53 -23.32 50.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.306 0.957 . . . . 0.0 112.498 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.79 -39.94 9.2 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.912 1.285 . . . . 0.0 113.108 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -126.89 60.58 41.73 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.544 . . . . 0.0 112.71 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.42 -15.95 34.71 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.395 2.73 . . . . 0.0 111.777 167.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.11 -41.18 68.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.606 1.563 . . . . 0.0 112.156 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.56 -44.05 62.64 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.336 0.654 . . . . 0.0 111.675 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.5 mtp -56.41 -28.94 60.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.711 0.805 . . . . 0.0 112.184 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -17.95 60.77 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.634 1.174 . . . . 0.0 113.505 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -81.06 -40.65 23.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.13 1.372 . . . . 0.0 110.822 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.52 -26.16 38.28 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.325 0.65 . . . . 0.0 112.481 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 16.51 23.78 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.906 1.717 . . . . 0.0 114.791 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.56 140.61 38.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.086 1.443 . . . . 0.0 110.691 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -77.29 -77.17 0.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.955 0.502 . . . . 0.0 110.778 175.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -147.79 4.56 0.76 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.443 1.497 . . . . 0.0 114.88 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.9 m -86.29 155.89 57.17 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 126.579 1.952 . . . . 0.0 113.198 -166.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.43 82.96 2.36 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 124.533 3.489 . . . . 0.0 111.294 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.4 m -96.38 130.88 43.4 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 112.683 -169.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.47 122.96 36.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.79 1.236 . . . . 0.0 108.987 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.17 126.04 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.553 1.541 . . . . 0.0 108.745 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.04 117.11 32.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 109.856 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.1 mm -109.7 126.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.922 1.289 . . . . 0.0 110.101 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -114.31 121.15 42.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.964 1.706 . . . . 0.0 108.622 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.9 t70 60.73 27.71 17.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.666 1.121 . . . . 0.0 111.927 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 -3.14 83.1 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -99.56 132.05 45.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.499 1.52 . . . . 0.0 109.65 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.12 104.02 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.71 -20.49 21.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.252 1.021 . . . . 0.0 113.107 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -163.03 155.61 18.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.21 1.804 . . . . 0.0 110.717 -173.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.35 146.42 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.093 1.357 . . . . 0.0 111.031 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.45 149.49 30.87 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.3 1.44 . . . . 0.0 108.575 169.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -134.01 140.13 46.49 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.133 -0.979 . . . . 0.0 112.08 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.84 -144.53 18.22 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.671 1.129 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.7 mm -116.96 143.26 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.322 1.449 . . . . 0.0 111.399 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.1 ptp -155.73 169.87 23.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 113.185 160.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -83.53 162.44 53.38 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 125.725 1.61 . . . . 0.0 112.129 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.95 -30.65 21.06 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.089 1.859 . . . . 0.0 114.655 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.7 -28.78 60.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.319 1.418 . . . . 0.0 113.027 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.1 -25.19 47.42 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.577 -0.702 . . . . 0.0 112.545 164.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.84 -30.65 67.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 111.953 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.32 -44.67 92.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.261 0.937 . . . . 0.0 111.086 163.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.52 72.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.257 0.935 . . . . 0.0 112.743 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.82 -48.22 72.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.127 1.371 . . . . 0.0 110.196 173.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.72 -42.24 83.43 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.935 0.894 . . . . 0.0 112.204 170.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.69 67.71 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.072 -1.018 . . . . 0.0 111.865 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 m -76.96 -10.7 59.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.583 1.553 . . . . 0.0 113.169 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.477 0.902 0 CA-C-N 119.391 0.996 . . . . 0.0 108.536 162.561 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 120.89 0.376 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 . . . . . 0 C--O 1.236 0.367 0 C-N-CA 127.89 2.476 . . . . 0.0 111.704 -172.655 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.89 70.51 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -74.73 -40.13 61.46 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.678 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -73.92 -9.8 59.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -92.07 -16.21 26.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.436 1.494 . . . . 0.0 113.173 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -19.05 6.63 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.63 166.4 22.82 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -82.72 -65.72 0.98 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.266 1.426 . . . . 0.0 113.013 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -148.42 121.79 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.603 1.561 . . . . 0.0 109.669 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.46 161.54 39.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.3 mt -138.16 123.17 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.645 1.578 . . . . 0.0 107.936 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.0 121.96 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.268 1.427 . . . . 0.0 108.314 -175.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -100.4 107.68 19.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.92 0.888 . . . . 0.0 110.802 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.11 80.74 3.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.721 1.208 . . . . 0.0 109.83 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.87 -178.31 7.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.708 1.203 . . . . 0.0 111.913 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -127.36 139.59 52.76 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.276 -1.515 . . . . 0.0 110.953 161.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -57.3 -32.75 66.97 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.696 1.598 . . . . 0.0 114.02 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -80.66 -37.97 29.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 113.209 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.0 t -57.5 118.13 23.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.934 1.694 . . . . 0.0 113.713 -168.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.48 -24.98 56.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.151 3.234 . . . . 0.0 113.381 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -77.01 -40.94 44.75 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.798 0.727 . . . . 0.0 110.957 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 78.7 m -52.83 -34.66 55.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.754 1.222 . . . . 0.0 113.959 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -55.98 -39.73 72.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.076 0.95 . . . . 0.0 112.303 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -65.2 -47.02 78.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.626 0.77 . . . . 0.0 110.841 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 tpt -60.66 -36.08 77.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.715 1.206 . . . . 0.0 112.176 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.63 -37.77 88.58 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.689 -1.257 . . . . 0.0 112.759 172.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -34.01 74.67 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.818 1.19 . . . . 0.0 112.476 171.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.07 -48.77 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-N 119.14 0.882 . . . . 0.0 110.385 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.97 -34.09 77.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.682 1.193 . . . . 0.0 112.087 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.13 -49.47 75.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.704 1.138 . . . . 0.0 111.475 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -66.57 -33.97 76.85 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.696 -0.627 . . . . 0.0 112.391 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -63.35 -42.61 98.92 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 111.261 170.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.82 -26.52 45.29 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.295 0.95 . . . . 0.0 112.619 -171.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.28 68.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.166 0.986 . . . . 0.0 113.428 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.32 8.27 35.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.618 1.567 . . . . 0.0 114.269 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.22 45.24 0.89 Allowed Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 126.257 1.823 . . . . 0.0 113.202 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.22 -15.74 51.52 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.751 2.967 . . . . 0.0 114.531 -167.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -76.84 -9.18 58.51 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.36 130.53 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.822 1.192 . . . . 0.0 108.529 162.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.57 96.05 6.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.301 0.641 . . . . 0.0 110.674 174.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mt -104.87 130.13 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.135 -0.978 . . . . 0.0 109.48 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.0 p -148.82 170.75 17.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.054 0.942 . . . . 0.0 112.325 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.2 p -129.89 153.63 48.12 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.017 -1.052 . . . . 0.0 112.896 174.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.87 134.54 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.677 1.591 . . . . 0.0 109.154 -168.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.46 121.04 26.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 123.026 1.393 . . . . 0.0 113.159 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 p -62.6 -23.71 67.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.861 1.664 . . . . 0.0 114.979 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.28 -45.1 10.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.031 1.287 . . . . 0.0 111.823 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.07 -26.92 43.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.709 1.204 . . . . 0.0 113.671 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.56 54.51 14.6 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.746 1.618 . . . . 0.0 112.038 -171.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.19 -9.67 13.91 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.318 3.345 . . . . 0.0 113.675 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -66.27 -21.78 66.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.801 0.84 . . . . 0.0 112.509 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.67 -54.25 6.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.77 1.228 . . . . 0.0 110.92 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.5 mtm -55.74 -30.01 60.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -74.2 -14.24 60.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.731 0.812 . . . . 0.0 112.803 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -89.04 -38.71 14.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.656 1.183 . . . . 0.0 110.538 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.46 -22.52 28.23 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 17.27 26.39 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.788 1.661 . . . . 0.0 115.061 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.56 140.58 37.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.016 1.408 . . . . 0.0 110.835 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.98 -59.36 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.618 0.767 . . . . 0.0 112.19 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -157.04 1.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 m -101.64 152.72 38.13 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.796 1.638 . . . . 0.0 113.028 -163.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.86 91.7 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.093 3.196 . . . . 0.0 110.396 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -107.2 124.83 50.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 0.0 112.47 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.56 129.25 37.57 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.274 0.63 . . . . 0.0 109.859 166.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.17 127.98 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.77 1.628 . . . . 0.0 108.401 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -105.64 127.84 53.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.424 1.09 . . . . 0.0 109.757 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.7 115.84 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.055 0.942 . . . . 0.0 108.674 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.43 123.93 50.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.131 1.373 . . . . 0.0 108.879 171.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.58 20.22 11.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.199 1.4 . . . . 0.0 112.681 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.11 12.56 82.29 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 113.694 -172.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -107.71 134.82 50.13 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.699 1.6 . . . . 0.0 109.754 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.74 105.12 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.96 -27.81 13.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -162.05 154.27 19.36 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.035 1.334 . . . . 0.0 110.579 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.2 145.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.878 1.271 . . . . 0.0 110.701 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 144.92 25.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.007 0.923 . . . . 0.0 111.17 165.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 m -111.52 120.17 41.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.122 0.969 . . . . 0.0 110.523 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.74 29.89 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 124.926 1.25 . . . . 0.0 114.382 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm -112.2 140.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.429 1.492 . . . . 0.0 109.7 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.0 mtm -142.6 161.32 38.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.781 0.833 . . . . 0.0 112.338 167.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -76.01 161.06 76.93 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.508 1.523 . . . . 0.0 112.064 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.31 -25.25 22.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.243 1.962 . . . . 0.0 114.453 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -76.67 -35.99 57.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.031 1.287 . . . . 0.0 112.543 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.5 -25.42 50.33 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.017 0.826 . . . . 0.0 112.784 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.29 -25.96 68.15 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.183 -0.948 . . . . 0.0 112.4 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -63.9 -38.76 92.29 Favored 'General case' 0 C--N 1.342 0.281 0 O-C-N 121.553 -0.717 . . . . 0.0 111.877 172.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.31 79.72 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.66 0.664 . . . . 0.0 112.038 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.01 -42.94 79.92 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.26 -43.37 98.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.806 0.843 . . . . 0.0 112.185 171.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.57 87.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.46 -0.775 . . . . 0.0 111.131 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.3 m -66.58 -4.07 7.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.004 1.722 . . . . 0.0 114.846 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 119.082 0.855 . . . . 0.0 110.58 166.862 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.257 0.551 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 . . . . . 0 C--O 1.235 0.311 0 C-N-CA 125.766 1.626 . . . . 0.0 110.276 -178.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -26.24 66.92 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -68.31 -43.24 78.08 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.123 0.874 . . . . 0.0 110.73 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -75.78 -9.71 58.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.236 1.014 . . . . 0.0 112.907 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.01 -14.33 29.57 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.046 1.338 . . . . 0.0 113.218 167.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.05 -15.71 6.04 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.73 174.29 8.61 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 p -88.37 -60.06 2.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.411 1.485 . . . . 0.0 113.497 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -158.47 115.59 2.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.218 1.407 . . . . 0.0 110.36 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.08 160.74 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -168.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.7 mt -137.43 128.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.949 1.7 . . . . 0.0 109.106 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.73 135.07 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.131 1.372 . . . . 0.0 109.458 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -116.07 114.79 25.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 111.729 172.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -83.94 74.24 10.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.941 1.696 . . . . 0.0 111.31 -175.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.73 -170.14 2.01 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -157.25 170.84 21.56 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.611 1.564 . . . . 0.0 113.323 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -47.57 -102.9 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 128.827 2.851 . . . . 0.0 116.951 -173.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.7 -15.73 41.35 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.015 -1.678 . . . . 0.0 114.629 -168.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -49.18 119.93 9.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.681 1.592 . . . . 0.0 112.494 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.31 -25.71 36.11 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.319 2.679 . . . . 0.0 113.732 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -70.93 -43.23 68.65 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 119.366 0.985 . . . . 0.0 112.179 -168.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -67.22 -25.1 65.94 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -61.68 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.114 0.966 . . . . 0.0 113.595 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -63.21 -44.69 94.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.415 0.686 . . . . 0.0 111.903 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -60.88 -30.63 70.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.416 1.086 . . . . 0.0 113.002 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.74 -35.37 76.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.404 0.682 . . . . 0.0 111.786 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' HE3' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -69.67 -34.09 73.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.525 1.057 . . . . 0.0 111.035 176.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 t -69.62 -46.35 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.014 1.726 . . . . 0.0 109.362 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.8 mt -61.96 -41.67 98.26 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.379 1.872 . . . . 0.0 112.658 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.62 -52.42 64.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.616 1.166 . . . . 0.0 111.97 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -66.47 -32.96 74.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.049 -1.032 . . . . 0.0 112.551 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -68.24 -34.3 75.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.896 1.278 . . . . 0.0 112.311 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.84 46.01 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 121.002 -1.061 . . . . 0.0 112.657 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.96 65.56 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.157 1.383 . . . . 0.0 114.537 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 4.84 23.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.976 1.31 . . . . 0.0 114.086 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.72 40.59 0.62 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.701 1.6 . . . . 0.0 114.034 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -65.56 -13.28 39.01 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.641 2.894 . . . . 0.0 114.685 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -77.83 -9.02 58.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 173.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.75 132.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.21 0.914 . . . . 0.0 108.903 161.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.26 92.65 5.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.332 0.587 . . . . 0.0 110.324 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.8 mt -102.16 131.1 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.253 1.021 . . . . 0.0 109.667 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.5 p -147.16 159.43 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.716 0.806 . . . . 0.0 112.369 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.0 p -98.14 163.6 12.67 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.213 -0.929 . . . . 0.0 111.145 163.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -147.99 129.17 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.602 1.561 . . . . 0.0 108.8 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.12 108.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.685 0.794 . . . . 0.0 110.188 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 p -52.55 -41.18 63.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.897 1.279 . . . . 0.0 111.88 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.14 -22.22 66.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.96 1.704 . . . . 0.0 114.223 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.06 -14.59 22.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.115 1.366 . . . . 0.0 113.4 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -131.9 49.61 4.82 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.79 1.636 . . . . 0.0 113.959 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -67.53 -26.35 40.29 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.431 2.087 . . . . 0.0 112.209 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -60.81 -41.28 95.35 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 0.0 111.703 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.97 -50.34 72.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.735 0.814 . . . . 0.0 110.996 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.9 mtp -57.63 -22.87 48.02 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.629 0.771 . . . . 0.0 113.022 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -14.03 52.94 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.561 1.144 . . . . 0.0 112.813 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -83.58 -41.35 17.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.343 1.057 . . . . 0.0 110.599 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.31 -24.72 32.05 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.47 20.98 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 125.172 1.368 . . . . 0.0 115.018 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -82.14 145.69 29.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.11 1.455 . . . . 0.0 111.508 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -80.91 -75.2 0.29 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 111.343 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -161.13 13.41 0.1 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -166.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.21 155.62 36.2 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 126.389 1.876 . . . . 0.0 113.255 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.56 90.26 1.05 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.16 3.24 . . . . 0.0 110.846 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -99.73 132.45 45.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 112.595 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.56 131.52 35.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.474 1.11 . . . . 0.0 109.71 161.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.65 121.92 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.776 1.631 . . . . 0.0 108.302 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.04 124.12 49.71 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.125 0.97 . . . . 0.0 110.687 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.54 122.74 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.171 1.388 . . . . 0.0 109.51 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -116.9 124.16 48.78 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.445 1.498 . . . . 0.0 109.192 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 62.65 20.54 12.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.166 1.386 . . . . 0.0 112.362 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.71 8.98 86.18 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.083 -1.011 . . . . 0.0 113.521 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -103.74 132.55 49.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.544 1.537 . . . . 0.0 109.073 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.82 105.4 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.324 -0.86 . . . . 0.0 109.039 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.43 -24.75 15.98 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.492 1.117 . . . . 0.0 113.387 -170.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -160.51 146.87 15.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.444 1.498 . . . . 0.0 110.801 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.2 t -147.51 145.52 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 109.826 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.26 151.5 29.2 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.976 0.911 . . . . 0.0 111.44 162.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.8 m -115.95 135.28 54.12 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.624 0.77 . . . . 0.0 111.944 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.89 -149.4 17.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.935 1.255 . . . . 0.0 112.593 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.19 139.65 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.571 1.548 . . . . 0.0 110.76 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -139.22 160.48 39.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.448 1.099 . . . . 0.0 112.044 163.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -74.0 162.11 75.49 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 124.76 1.224 . . . . 0.0 111.869 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.89 -23.71 12.12 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.09 1.86 . . . . 0.0 114.676 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.8 -37.33 67.59 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.137 1.79 . . . . 0.0 112.607 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -78.81 -22.88 45.59 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.653 0.66 . . . . 0.0 112.151 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.64 -29.57 70.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 0.0 112.09 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.74 -39.4 93.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.239 0.927 . . . . 0.0 111.393 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.19 80.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.503 -0.748 . . . . 0.0 111.93 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.41 -44.6 90.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.166 0.586 . . . . 0.0 110.686 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.18 -47.44 86.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.19 0.996 . . . . 0.0 112.693 172.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.16 76.52 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.13 -0.982 . . . . 0.0 112.351 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.1 t -65.58 -14.34 60.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.382 1.473 . . . . 0.0 113.737 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 N--CA 1.48 1.038 0 O-C-N 119.988 -1.695 . . . . 0.0 110.588 172.682 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 125.412 1.485 . . . . 0.0 111.637 -166.349 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 -28.93 63.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -74.16 -39.11 63.46 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.656 -0.652 . . . . 0.0 110.413 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.41 -14.98 61.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 113.302 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -89.49 -20.14 24.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.629 1.172 . . . . 0.0 112.846 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.24 -23.47 6.97 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 124.896 1.236 . . . . 0.0 115.081 -171.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.25 165.65 23.2 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -89.1 -56.22 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.987 1.315 . . . . 0.0 113.003 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -155.34 110.54 3.02 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.898 1.279 . . . . 0.0 110.65 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.84 159.75 42.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.7 mt -135.29 129.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.508 1.523 . . . . 0.0 108.445 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -121.28 124.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.613 1.565 . . . . 0.0 109.57 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -104.06 119.22 38.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -85.05 76.29 10.27 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.098 -1.001 . . . . 0.0 110.455 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 173.08 11.81 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.682 0.753 . . . . 0.0 112.931 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -125.68 147.66 49.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.694 1.198 . . . . 0.0 110.772 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.84 148.27 30.63 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 67.61 -30.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.907 2.883 . . . . 0.0 115.296 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.4 t -52.13 117.55 10.42 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.019 1.728 . . . . 0.0 113.305 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.91 -24.64 74.19 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.194 3.263 . . . . 0.0 113.602 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -72.61 -43.27 63.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.226 0.921 . . . . 0.0 110.585 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.6 -33.26 69.79 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 113.065 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -54.72 -39.8 68.59 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.174 0.989 . . . . 0.0 112.501 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.39 -48.13 81.63 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.549 0.74 . . . . 0.0 110.959 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.738 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.31 -43.09 96.66 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.209 0.913 . . . . 0.0 111.325 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -41.93 85.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.581 0.752 . . . . 0.0 112.43 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.86 -46.96 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.873 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.28 -34.09 77.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.114 1.365 . . . . 0.0 112.609 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.68 -46.46 88.07 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.9 0.773 . . . . 0.0 112.158 169.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -68.86 -35.16 76.59 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.289 -0.882 . . . . 0.0 112.033 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.76 -37.67 88.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.405 1.482 . . . . 0.0 111.848 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.49 -22.02 57.17 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 123.863 0.744 . . . . 0.0 113.369 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.74 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.264 1.026 . . . . 0.0 113.332 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 10.08 41.28 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.327 1.451 . . . . 0.0 114.601 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.75 48.83 0.74 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.629 1.572 . . . . 0.0 113.709 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.36 -16.96 57.89 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.591 2.861 . . . . 0.0 114.023 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -79.09 -8.28 58.84 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.53 134.12 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.545 1.066 . . . . 0.0 108.685 166.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.23 86.73 4.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.466 0.651 . . . . 0.0 110.647 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.5 mt -93.27 127.19 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.748 0.819 . . . . 0.0 109.178 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t -141.52 164.42 30.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.768 1.227 . . . . 0.0 110.906 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -110.42 -175.92 2.85 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 162.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.4 p -167.28 129.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.357 1.863 . . . . 0.0 109.222 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -72.55 114.71 10.98 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.193 0.997 . . . . 0.0 111.075 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 p -54.91 -28.09 48.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 113.601 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -74.9 -26.65 59.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.989 0.813 . . . . 0.0 112.675 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.18 -29.41 15.13 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.942 1.297 . . . . 0.0 113.415 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -127.81 49.83 4.77 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.18 1.392 . . . . 0.0 113.962 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.3 -19.93 49.48 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.937 1.758 . . . . 0.0 112.376 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.26 1.024 . . . . 0.0 112.86 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.85 -54.27 7.58 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.2 mtp -55.53 -33.31 63.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.578 1.151 . . . . 0.0 113.351 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -65.98 -21.29 66.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.695 1.598 . . . . 0.0 113.768 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -76.88 -40.14 48.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.847 0.749 . . . . 0.0 111.968 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.91 -22.56 24.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 11.86 36.41 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.337 1.922 . . . . 0.0 115.179 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.75 130.77 39.17 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.213 1.507 . . . . 0.0 111.68 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -84.12 -55.15 4.35 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.071 0.949 . . . . 0.0 112.169 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -160.41 -0.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.46 154.5 44.38 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 125.554 1.542 . . . . 0.0 113.4 -160.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.8 89.02 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.455 3.437 . . . . 0.0 109.469 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.3 m -105.2 132.67 51.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.829 0.851 . . . . 0.0 112.609 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.96 134.75 33.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.7 1.2 . . . . 0.0 110.471 166.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.5 t -130.31 131.46 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.783 1.633 . . . . 0.0 108.685 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -110.08 128.68 55.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.055 0.942 . . . . 0.0 110.65 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.86 110.49 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.0 123.75 50.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.284 1.433 . . . . 0.0 108.202 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.18 17.49 8.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.758 1.223 . . . . 0.0 112.038 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.52 83.18 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.077 0.846 . . . . 0.0 113.639 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -110.08 135.96 50.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.266 1.826 . . . . 0.0 109.397 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.09 106.29 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.94 -20.88 13.04 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -163.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -159.19 153.74 24.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.99 1.316 . . . . 0.0 111.436 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.65 144.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.734 1.614 . . . . 0.0 110.388 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -154.01 143.36 21.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.539 1.136 . . . . 0.0 112.011 165.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 m -101.19 135.58 42.42 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.927 0.891 . . . . 0.0 112.069 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.69 -162.72 12.32 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.914 1.245 . . . . 0.0 113.682 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.44 140.85 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.778 1.631 . . . . 0.0 111.285 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.8 mtm -134.79 153.21 52.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.467 1.107 . . . . 0.0 110.388 160.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.13 152.57 71.3 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 122.749 0.419 . . . . 0.0 110.978 169.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.81 -27.32 51.86 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.29 1.993 . . . . 0.0 114.264 -156.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -63.89 -30.04 71.17 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.12 -37.79 64.0 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.994 0.816 . . . . 0.0 111.008 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.6 tp -65.3 -28.24 69.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.47 -0.776 . . . . 0.0 112.819 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -59.1 -49.38 78.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.982 0.81 . . . . 0.0 111.574 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.9 -37.6 84.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.578 0.751 . . . . 0.0 111.77 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -67.24 -43.54 81.69 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.837 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.89 -47.01 87.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.425 1.09 . . . . 0.0 112.131 172.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.88 85.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.461 0.573 . . . . 0.0 111.739 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.2 m -62.48 -11.35 15.65 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.655 1.582 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.478 0.951 0 O-C-N 121.08 -1.013 . . . . 0.0 112.032 175.917 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mm . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 . . . . . 0 C--O 1.235 0.314 0 C-N-CA 124.521 1.129 . . . . 0.0 109.893 -179.52 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -25.27 64.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.719 1.208 . . . . 0.0 113.95 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -70.18 -31.16 68.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.105 0.866 . . . . 0.0 111.752 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -75.66 -20.63 58.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.943 0.897 . . . . 0.0 113.003 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.91 82.28 0.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.132 1.773 . . . . 0.0 113.075 -172.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 134.87 3.06 2.98 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 126.313 1.911 . . . . 0.0 116.927 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -74.48 114.33 12.75 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.14 1.97 . . . . 0.0 111.971 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -66.5 -28.33 68.48 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.746 -1.221 . . . . 0.0 114.045 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -155.85 97.06 1.8 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.556 1.542 . . . . 0.0 109.777 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.85 156.77 46.55 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mt -141.29 132.28 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.963 1.305 . . . . 0.0 109.347 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.58 126.57 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.322 1.449 . . . . 0.0 109.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -106.01 108.18 19.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.579 1.152 . . . . 0.0 110.419 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -77.56 76.38 4.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 110.392 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -172.37 2.31 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.847 0.859 . . . . 0.0 111.701 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -147.15 130.61 16.72 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.118 -1.614 . . . . 0.0 112.05 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.85 -23.91 61.4 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 mt -89.86 -15.5 32.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.45 122.26 73.52 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.81 1.644 . . . . 0.0 111.884 -173.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.7 -1.26 9.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.71 3.606 . . . . 0.0 113.04 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -88.43 -44.81 10.46 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.378 0.99 . . . . 0.0 109.741 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 p -61.93 -27.75 69.05 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -50.6 -38.96 48.55 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -71.98 -33.5 68.19 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.019 -0.425 . . . . 0.0 112.128 -168.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.1 tpt -64.0 -24.13 67.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.936 1.294 . . . . 0.0 113.266 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -65.17 -42.92 93.22 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.952 0.797 . . . . 0.0 110.927 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.95 -24.22 55.45 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.998 -1.064 . . . . 0.0 112.215 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.71 -51.9 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.023 0.929 . . . . 0.0 109.923 164.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.1 mt -60.14 -34.76 73.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.147 1.379 . . . . 0.0 112.619 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -58.21 -56.4 22.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.662 1.185 . . . . 0.0 111.972 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -64.5 -32.7 74.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.911 0.485 . . . . 0.0 111.414 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.21 -43.81 81.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.786 1.634 . . . . 0.0 112.979 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.5 57.32 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 120.635 -1.291 . . . . 0.0 111.684 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.44 -29.71 64.4 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 8.04 45.39 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.66 41.8 0.33 Allowed Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.786 1.634 . . . . 0.0 114.836 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.62 -22.19 16.4 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.62 3.547 . . . . 0.0 117.548 -157.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -60.69 -14.51 21.32 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -73.67 129.39 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.716 1.144 . . . . 0.0 111.289 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.8 98.59 11.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 110.797 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.6 mt -103.73 132.15 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.823 0.849 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 t -136.05 133.61 37.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.32 1.048 . . . . 0.0 110.38 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 m -86.12 155.16 20.89 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.622 -1.299 . . . . 0.0 111.531 164.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.3 t -143.72 128.86 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.642 1.577 . . . . 0.0 109.069 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.99 104.47 4.84 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.09 1.356 . . . . 0.0 110.564 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.8 p -56.19 -36.48 68.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.632 1.173 . . . . 0.0 113.468 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.57 -16.84 58.38 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -22.19 19.18 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.944 1.298 . . . . 0.0 112.88 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -116.72 52.92 1.11 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.878 1.671 . . . . 0.0 114.577 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.35 -18.07 26.74 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.7 2.267 . . . . 0.0 113.088 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -64.03 -38.14 89.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.368 0.985 . . . . 0.0 111.776 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.9 -51.99 22.78 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.607 1.163 . . . . 0.0 109.96 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.1 mtm -54.62 -32.18 58.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.095 0.958 . . . . 0.0 113.36 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -70.02 -19.95 63.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.012 1.325 . . . . 0.0 113.925 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -79.05 -39.92 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.769 0.713 . . . . 0.0 112.025 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.07 -22.45 21.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.69 15.77 28.32 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.786 1.66 . . . . 0.0 114.963 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -79.76 156.88 27.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.186 1.493 . . . . 0.0 111.626 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.03 -53.63 3.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.181 0.993 . . . . 0.0 112.654 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 168.67 17.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 129.101 2.96 . . . . 0.0 113.595 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.6 160.15 28.69 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 126.461 1.904 . . . . 0.0 111.912 -170.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -70.06 82.93 0.78 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.021 3.147 . . . . 0.0 112.516 -174.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.2 m -103.01 128.21 49.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.153 0.581 . . . . 0.0 112.363 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -94.22 120.6 34.69 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.541 1.137 . . . . 0.0 109.51 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.71 123.67 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 126.396 1.879 . . . . 0.0 108.1 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.0 120.03 40.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.887 0.875 . . . . 0.0 109.365 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.492 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 10.8 mm -108.23 121.65 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.187 1.395 . . . . 0.0 109.705 -168.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.492 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.37 122.34 47.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.833 1.653 . . . . 0.0 109.101 163.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.09 25.54 14.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 112.621 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.61 90.63 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -105.99 128.74 54.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.404 1.082 . . . . 0.0 108.924 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.07 109.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.416 0.686 . . . . 0.0 109.974 172.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.05 20.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.92 1.288 . . . . 0.0 113.494 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -163.8 152.07 13.26 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.364 1.866 . . . . 0.0 109.456 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.32 144.22 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.782 1.233 . . . . 0.0 110.971 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.17 31.78 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.431 1.493 . . . . 0.0 109.525 168.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -126.04 139.29 53.53 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 112.675 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.78 -154.43 17.02 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.931 1.729 . . . . 0.0 112.626 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.3 mm -118.2 143.83 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.31 1.444 . . . . 0.0 110.765 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -151.49 161.63 42.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.768 0.827 . . . . 0.0 112.418 161.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.38 149.54 86.7 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.021 0.929 . . . . 0.0 111.836 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.62 -31.47 79.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.003 2.469 . . . . 0.0 113.95 -168.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -52.99 -36.19 60.1 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -89.25 -29.99 18.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.757 0.708 . . . . 0.0 111.975 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.0 -30.25 70.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.664 0.786 . . . . 0.0 112.027 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -56.08 -44.24 78.79 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.766 0.712 . . . . 0.0 111.895 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.6 60.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.23 1.012 . . . . 0.0 112.521 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -70.89 -39.24 72.93 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 109.618 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.6 -36.7 73.66 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.046 1.338 . . . . 0.0 112.859 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.51 80.9 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.748 -1.22 . . . . 0.0 112.605 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -59.27 -20.65 56.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.964 0.905 . . . . 0.0 113.04 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.474 0.744 0 O-C-N 121.109 -0.994 . . . . 0.0 109.539 167.193 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 126.552 1.941 . . . . 0.0 109.814 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.52 -29.16 64.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -74.8 -41.35 60.14 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.74 -0.6 . . . . 0.0 110.557 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -72.93 -11.32 60.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.5 -17.3 27.31 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.03 1.332 . . . . 0.0 113.645 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -117.79 -16.19 5.98 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.59 171.0 13.24 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -91.4 -51.96 5.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.978 1.311 . . . . 0.0 113.166 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -160.46 109.05 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.879 1.672 . . . . 0.0 110.095 -171.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.09 158.82 44.56 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -134.64 130.14 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 0.0 109.064 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 t -119.09 125.7 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.563 1.545 . . . . 0.0 109.133 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.04 113.82 27.59 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.492 1.117 . . . . 0.0 111.311 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -78.94 69.38 5.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.48 170.38 16.66 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.843 0.857 . . . . 0.0 112.898 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -129.54 176.93 7.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.38 1.472 . . . . 0.0 111.21 168.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -100.51 -33.02 10.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.985 0.914 . . . . 0.0 113.437 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.38 -68.03 0.57 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.058 0.943 . . . . 0.0 112.934 -167.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.9 m -59.07 150.67 60.66 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.369 1.868 . . . . 0.0 114.138 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.14 -13.79 21.02 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.787 3.658 . . . . 0.0 113.19 171.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -66.83 -48.46 68.82 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 119.014 0.825 . . . . 0.0 111.969 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.0 p -61.14 -29.84 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.107 1.363 . . . . 0.0 113.597 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -55.82 -32.99 64.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.011 1.324 . . . . 0.0 112.557 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -62.94 -48.2 79.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.611 1.164 . . . . 0.0 111.73 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 mmt -63.24 -34.79 78.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.321 -0.862 . . . . 0.0 112.798 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.47 -36.37 73.62 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.267 0.939 . . . . 0.0 112.533 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -79.17 -38.67 35.35 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.29 -51.43 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.046 0.938 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.41 -33.86 75.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.793 1.237 . . . . 0.0 113.001 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.79 -49.96 70.85 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.302 0.641 . . . . 0.0 111.367 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -67.63 -32.14 72.63 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.395 -0.816 . . . . 0.0 112.885 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.36 -39.74 89.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.091 1.356 . . . . 0.0 111.966 170.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.32 -26.14 52.7 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.133 0.873 . . . . 0.0 112.343 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.6 65.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 10.11 34.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.168 1.387 . . . . 0.0 114.297 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.36 50.89 1.18 Allowed Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.102 1.761 . . . . 0.0 112.857 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.01 -14.4 44.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -168.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -78.64 -8.8 59.03 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -78.57 131.48 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.481 1.037 . . . . 0.0 108.357 165.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 96.16 6.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.07 0.548 . . . . 0.0 110.894 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.4 mt -103.84 131.48 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.2 p -148.21 172.76 13.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.918 0.887 . . . . 0.0 112.333 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -121.63 162.96 19.76 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.093 -1.004 . . . . 0.0 111.165 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.9 t -143.78 122.76 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.253 1.421 . . . . 0.0 107.712 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.0 103.92 0.51 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.325 1.45 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -58.76 -36.21 74.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.613 1.165 . . . . 0.0 112.35 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -75.1 -18.2 60.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.181 1.792 . . . . 0.0 113.893 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.07 -26.62 9.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.786 1.235 . . . . 0.0 113.527 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -126.86 51.94 7.19 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 126.171 1.788 . . . . 0.0 112.921 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -65.85 -14.98 47.17 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.746 2.297 . . . . 0.0 112.939 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -57.28 -23.39 48.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 113.182 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.98 -58.1 3.47 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 122.991 0.516 . . . . 0.0 110.682 166.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.8 mtm -57.22 -27.81 62.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.058 1.343 . . . . 0.0 113.748 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.56 -15.94 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.033 1.333 . . . . 0.0 112.726 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -87.29 -36.76 17.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.361 1.064 . . . . 0.0 111.296 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.97 -25.8 22.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 19.16 14.04 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.626 1.584 . . . . 0.0 115.264 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.97 145.85 28.32 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.409 1.605 . . . . 0.0 111.551 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -96.0 -62.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.668 0.787 . . . . 0.0 112.665 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -157.47 2.63 0.12 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.9 m -106.46 150.3 39.35 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 126.028 1.731 . . . . 0.0 112.769 -163.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.13 92.74 0.55 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.23 3.287 . . . . 0.0 109.553 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -105.08 131.98 51.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.865 0.866 . . . . 0.0 111.857 -172.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -93.53 134.54 35.7 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.489 1.116 . . . . 0.0 110.247 168.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.97 131.25 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.623 1.569 . . . . 0.0 108.89 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -115.06 123.94 50.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.283 1.033 . . . . 0.0 110.282 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.8 mm -108.08 120.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.141 1.376 . . . . 0.0 108.822 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -113.94 122.93 48.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.298 1.839 . . . . 0.0 108.869 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.7 t70 63.62 20.93 12.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.395 1.078 . . . . 0.0 112.902 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.22 84.46 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.278 -0.888 . . . . 0.0 113.256 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -108.34 133.04 53.09 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.157 1.783 . . . . 0.0 109.285 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.88 107.59 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.41 -0.806 . . . . 0.0 109.508 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.6 -25.2 15.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -160.96 150.85 17.36 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.397 1.479 . . . . 0.0 110.932 -171.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.94 143.23 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.546 1.538 . . . . 0.0 110.529 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -153.38 140.34 19.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.222 1.009 . . . . 0.0 111.404 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.4 p -97.77 133.15 42.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.735 1.214 . . . . 0.0 111.756 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.78 -168.09 13.58 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.112 1.339 . . . . 0.0 113.343 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.18 143.37 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.368 1.467 . . . . 0.0 112.019 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -135.5 163.44 30.08 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.622 1.169 . . . . 0.0 111.947 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -68.14 161.37 68.88 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.629 1.172 . . . . 0.0 111.433 164.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.76 -27.1 15.23 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.965 1.777 . . . . 0.0 113.972 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -72.84 -34.0 66.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.489 1.495 . . . . 0.0 112.646 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.2 -26.33 56.03 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.372 -0.83 . . . . 0.0 112.457 171.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.52 -30.73 71.52 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.845 -1.159 . . . . 0.0 111.941 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -61.11 -44.84 96.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.877 0.762 . . . . 0.0 111.201 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.5 75.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.257 0.623 . . . . 0.0 112.352 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.08 76.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 0.0 109.87 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -45.48 94.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.317 1.047 . . . . 0.0 112.089 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.23 77.7 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.21 -0.931 . . . . 0.0 112.459 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.8 t -63.62 -13.26 40.61 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.857 1.663 . . . . 0.0 113.452 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.471 0.575 0 O-C-N 120.674 -1.266 . . . . 0.0 109.992 169.715 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.625 0 C-N-CA 125.774 1.63 . . . . 0.0 111.312 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.18 -21.18 62.2 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.43 -39.22 19.23 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.615 -0.678 . . . . 0.0 110.57 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -78.62 -7.96 58.15 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.7 -13.47 45.31 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.87 7.86 1.09 Allowed Glycine 0 N--CA 1.478 1.469 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.23 173.06 9.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.971 1.386 . . . . 0.0 113.416 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -83.38 -61.03 1.95 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.113 0.965 . . . . 0.0 112.411 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -157.54 120.81 4.02 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.264 1.826 . . . . 0.0 110.18 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.21 159.19 43.62 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.7 mt -130.95 130.75 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.533 1.533 . . . . 0.0 109.153 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.4 t -120.73 121.97 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.685 1.594 . . . . 0.0 109.273 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.51 114.87 29.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.242 1.017 . . . . 0.0 111.824 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -79.78 72.3 6.48 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.905 1.282 . . . . 0.0 111.073 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.43 170.73 16.16 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.115 0.966 . . . . 0.0 113.147 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -142.13 168.55 19.47 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.741 1.216 . . . . 0.0 111.938 170.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -93.13 -39.65 10.93 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -165.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 mt -77.45 -39.92 45.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.45 0.7 . . . . 0.0 112.718 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.49 128.84 94.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.149 1.379 . . . . 0.0 111.693 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 -13.74 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 124.461 3.44 . . . . 0.0 112.94 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -73.9 -45.65 49.38 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 120.167 1.349 . . . . 0.0 111.918 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.5 m -53.67 -35.81 61.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.82 1.248 . . . . 0.0 113.339 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.5 -31.93 68.33 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.512 1.525 . . . . 0.0 112.889 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -72.47 -44.07 62.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.668 0.787 . . . . 0.0 111.187 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.7 tpt -58.88 -38.85 79.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.483 1.513 . . . . 0.0 112.566 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -53.67 -41.24 66.63 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.514 0.725 . . . . 0.0 112.168 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -72.29 -23.53 61.2 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.928 -1.107 . . . . 0.0 113.693 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -69.65 -45.96 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.109 0.963 . . . . 0.0 109.748 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.8 -37.61 82.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.089 0.955 . . . . 0.0 111.828 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.68 -52.24 66.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.089 0.956 . . . . 0.0 111.948 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.46 -30.03 68.8 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.478 0.711 . . . . 0.0 112.817 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.95 -34.66 76.99 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.922 0.889 . . . . 0.0 111.833 170.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -25.59 61.2 Favored Glycine 0 N--CA 1.471 1.032 0 O-C-N 121.064 -1.023 . . . . 0.0 113.632 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.55 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -171.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 7.41 10.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.209 1.403 . . . . 0.0 114.52 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.95 47.89 2.84 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.86 1.664 . . . . 0.0 113.529 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.75 -16.32 54.7 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.726 2.951 . . . . 0.0 114.431 -169.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -76.81 -6.66 53.24 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -85.1 127.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 162.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.79 103.77 11.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 0.0 109.711 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.6 mt -108.04 128.79 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.056 -1.028 . . . . 0.0 109.367 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -146.98 167.38 24.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.82 165.51 12.99 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.855 -1.153 . . . . 0.0 111.741 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.07 121.46 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.932 1.293 . . . . 0.0 108.33 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.75 102.53 0.35 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.065 1.346 . . . . 0.0 110.42 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.6 p -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.362 0.665 . . . . 0.0 112.421 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.72 -26.69 65.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 113.362 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.16 -27.76 8.99 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.981 1.312 . . . . 0.0 113.661 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -116.26 65.22 2.91 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 127.493 2.317 . . . . 0.0 110.724 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.48 -22.51 33.27 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.516 2.144 . . . . 0.0 111.963 168.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.9 -24.53 66.06 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.639 1.176 . . . . 0.0 113.204 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.48 -59.99 2.48 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.056 0.942 . . . . 0.0 110.052 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.5 mtm -58.51 -25.85 62.83 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 113.371 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -65.7 -24.54 67.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.199 1.0 . . . . 0.0 112.35 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.3 -36.3 17.96 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.533 1.133 . . . . 0.0 111.37 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.92 -24.17 22.53 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.22 13.73 32.62 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.746 1.641 . . . . 0.0 115.161 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.08 146.87 36.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.371 1.585 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.85 -61.81 1.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.602 0.761 . . . . 0.0 112.195 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.98 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.512 1.925 . . . . 0.0 111.614 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.72 150.6 31.0 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.988 1.315 . . . . 0.0 112.457 -166.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.29 85.75 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.284 3.323 . . . . 0.0 109.911 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -102.62 129.76 49.29 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.36 0.664 . . . . 0.0 111.341 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 mp -93.63 126.48 38.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.048 0.939 . . . . 0.0 108.913 164.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.63 129.4 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.122 1.769 . . . . 0.0 108.277 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.59 124.47 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 mm -109.21 122.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.828 1.251 . . . . 0.0 109.179 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -117.75 126.46 52.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.567 1.547 . . . . 0.0 108.574 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 63.28 17.79 10.51 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.429 1.091 . . . . 0.0 112.965 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.07 11.22 81.55 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.282 0.944 . . . . 0.0 113.809 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -109.58 138.5 45.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.568 1.947 . . . . 0.0 109.807 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.74 108.37 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.84 -25.49 15.02 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -160.12 154.07 23.04 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.092 1.757 . . . . 0.0 110.342 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.88 143.85 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.849 1.26 . . . . 0.0 110.19 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.9 143.64 27.52 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.344 1.058 . . . . 0.0 110.87 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 t -110.91 132.68 54.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.859 1.264 . . . . 0.0 110.83 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.46 -152.83 20.36 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.721 1.153 . . . . 0.0 114.324 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.39 146.53 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.688 1.995 . . . . 0.0 110.371 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 ptp -153.22 -169.55 3.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.489 1.516 . . . . 0.0 111.011 169.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.9 163.86 40.71 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.052 1.341 . . . . 0.0 111.072 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.54 -23.33 31.91 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.737 1.625 . . . . 0.0 114.432 -156.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.93 -30.49 69.82 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.715 1.143 . . . . 0.0 113.4 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.32 -35.72 63.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.085 0.954 . . . . 0.0 111.251 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.5 tp -64.94 -24.95 67.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.164 0.585 . . . . 0.0 112.469 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -64.39 -43.78 93.37 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.946 0.794 . . . . 0.0 111.632 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.3 84.06 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.485 0.584 . . . . 0.0 111.611 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.57 -44.25 91.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.523 0.729 . . . . 0.0 111.272 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -45.6 93.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.817 0.847 . . . . 0.0 112.22 170.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.5 74.17 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.009 0.822 . . . . 0.0 111.892 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.4 m -68.31 -5.27 17.72 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.654 1.582 . . . . 0.0 114.564 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.479 1.004 0 O-C-N 121.054 -1.029 . . . . 0.0 110.798 171.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 121.563 0.697 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 . . . . . 0 C--O 1.231 0.118 0 C-N-CA 126.204 1.802 . . . . 0.0 110.541 174.386 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.85 -27.57 67.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -70.61 -39.01 74.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.802 1.183 . . . . 0.0 110.658 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.19 -9.48 58.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 113.077 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.65 -15.66 32.21 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.221 1.408 . . . . 0.0 113.395 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.51 -13.44 4.26 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.89 174.06 9.77 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -96.52 -54.68 3.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -149.5 124.25 9.85 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.006 1.323 . . . . 0.0 109.654 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.27 160.12 43.94 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -140.0 132.11 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 108.436 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 129.66 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.689 1.196 . . . . 0.0 109.288 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -109.07 117.44 34.17 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.807 0.843 . . . . 0.0 112.032 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.92 71.82 8.96 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.844 1.258 . . . . 0.0 110.622 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -174.23 1.05 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.85 0.86 . . . . 0.0 113.271 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -138.73 141.3 38.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.803 -1.186 . . . . 0.0 112.177 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -61.97 -32.18 72.6 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 113.699 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.6 mt -81.68 -83.9 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.901 1.28 . . . . 0.0 111.765 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -44.19 118.98 3.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 127.901 2.48 . . . . 0.0 114.235 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.45 -17.57 23.67 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.042 3.161 . . . . 0.0 113.611 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -63.72 -44.21 94.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 119.037 0.835 . . . . 0.0 111.663 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.3 p -66.91 -27.02 67.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.61 -28.03 69.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.735 1.214 . . . . 0.0 112.515 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -64.63 -39.21 93.3 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.75 0.82 . . . . 0.0 112.502 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.2 tpp -62.28 -35.72 79.87 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.026 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -50.61 -42.01 55.52 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.476 -0.765 . . . . 0.0 112.863 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -84.11 -12.38 55.12 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.278 1.031 . . . . 0.0 113.255 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -78.58 -47.32 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.274 1.43 . . . . 0.0 109.935 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.57 -37.01 74.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.522 1.529 . . . . 0.0 112.65 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.39 -53.86 52.45 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.886 0.874 . . . . 0.0 111.697 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -64.97 -30.68 71.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.629 0.772 . . . . 0.0 112.801 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -70.96 -41.98 70.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.417 1.087 . . . . 0.0 111.379 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.96 -29.75 30.72 Favored Glycine 0 N--CA 1.47 0.943 0 C-N-CA 124.649 1.118 . . . . 0.0 113.206 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.72 67.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 9.5 38.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.686 1.595 . . . . 0.0 114.179 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.93 65.34 73.85 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 125.678 1.591 . . . . 0.0 112.357 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.42 -20.77 71.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.168 2.579 . . . . 0.0 115.144 -171.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -83.42 -6.89 59.6 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 133.04 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.671 1.189 . . . . 0.0 109.442 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.59 14.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.193 0.597 . . . . 0.0 110.682 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -108.24 130.65 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.943 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -151.36 177.56 10.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.193 1.397 . . . . 0.0 112.803 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -124.27 167.04 14.86 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.503 -1.373 . . . . 0.0 113.227 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -149.16 135.69 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.719 2.008 . . . . 0.0 108.272 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.04 119.84 23.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.091 0.948 . . . . 0.0 112.164 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.6 p -61.0 -28.0 68.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.542 1.537 . . . . 0.0 114.12 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -87.31 -34.46 18.86 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.528 0.731 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 -22.95 27.07 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.577 1.151 . . . . 0.0 113.945 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -121.67 42.54 0.59 Allowed Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.654 1.582 . . . . 0.0 114.374 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.01 -19.56 45.55 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.668 2.245 . . . . 0.0 113.052 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.05 -22.67 65.93 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.053 0.941 . . . . 0.0 113.121 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.8 -54.91 5.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.765 0.711 . . . . 0.0 110.415 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 mtm -56.19 -28.88 59.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.664 1.186 . . . . 0.0 113.63 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -68.95 -18.91 64.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.022 1.329 . . . . 0.0 113.004 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.93 -34.65 20.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.435 1.094 . . . . 0.0 110.798 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.76 -25.51 23.37 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.46 15.58 22.67 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.82 1.676 . . . . 0.0 115.296 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.38 144.61 30.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.884 1.842 . . . . 0.0 111.151 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -89.1 -56.52 3.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.983 0.913 . . . . 0.0 112.668 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -169.83 7.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -167.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -100.26 149.71 36.29 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.011 1.724 . . . . 0.0 112.959 -165.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.8 95.22 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.882 3.055 . . . . 0.0 110.292 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.2 m -114.89 130.39 56.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.768 0.827 . . . . 0.0 112.778 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.95 134.67 33.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.725 1.61 . . . . 0.0 109.825 168.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.5 132.3 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.755 1.622 . . . . 0.0 109.216 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -116.93 127.67 54.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.144 0.978 . . . . 0.0 111.016 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -112.62 122.52 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 0.0 109.106 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.6 124.23 49.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.277 1.831 . . . . 0.0 109.004 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 62.04 20.19 11.41 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.729 1.15 . . . . 0.0 113.075 171.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.1 78.16 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.279 0.942 . . . . 0.0 113.477 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -108.07 134.3 51.14 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.317 1.847 . . . . 0.0 109.464 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.37 103.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.94 12.75 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.76 163.47 39.21 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.812 1.245 . . . . 0.0 111.806 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.6 146.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.161 1.785 . . . . 0.0 110.303 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.13 136.84 14.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.157 0.983 . . . . 0.0 111.01 168.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 m -101.79 138.72 38.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 0.0 111.656 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.24 -157.2 15.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.918 1.246 . . . . 0.0 113.213 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.39 142.34 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.526 1.53 . . . . 0.0 111.333 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.2 mtm -139.94 163.16 33.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.234 1.413 . . . . 0.0 111.997 165.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -77.44 161.5 72.17 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.887 1.675 . . . . 0.0 111.742 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.19 -24.97 19.46 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.328 2.019 . . . . 0.0 113.671 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -77.2 -33.83 56.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.461 1.482 . . . . 0.0 112.828 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.75 -30.33 56.51 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.648 0.779 . . . . 0.0 112.374 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.03 -28.2 66.19 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.35 -0.844 . . . . 0.0 112.791 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -62.26 -43.11 99.57 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.759 0.709 . . . . 0.0 111.895 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.25 77.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.447 0.699 . . . . 0.0 111.532 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.13 -48.52 75.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.971 0.908 . . . . 0.0 110.827 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -45.49 94.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.26 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.03 74.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.254 -0.904 . . . . 0.0 111.322 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.7 m -60.49 -31.78 70.81 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.479 1.022 0 CA-C-N 119.738 1.154 . . . . 0.0 110.687 176.869 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 121.401 0.619 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? . . . . . 0 N--CA 1.467 0.407 0 C-N-CA 126.306 1.842 . . . . 0.0 109.713 -177.812 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.04 62.94 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -86.77 -38.54 16.8 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.976 0.807 . . . . 0.0 111.121 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.93 -12.13 60.56 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.276 -0.89 . . . . 0.0 113.177 -171.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -89.81 -10.18 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.267 1.027 . . . . 0.0 113.617 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.26 -4.03 1.13 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.77 172.21 7.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.538 1.669 . . . . 0.0 114.074 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -82.53 -59.94 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.306 1.043 . . . . 0.0 112.912 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -160.08 115.22 2.33 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.79 1.636 . . . . 0.0 110.166 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.77 44.29 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -131.23 128.1 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 108.168 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.91 117.47 54.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.715 1.606 . . . . 0.0 108.773 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.29 120.68 38.1 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.564 1.146 . . . . 0.0 110.683 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.23 82.06 7.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.109 -1.619 . . . . 0.0 109.848 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 176.72 8.66 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -139.51 137.96 35.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.108 1.363 . . . . 0.0 109.769 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -83.25 -27.22 30.06 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -167.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 mt -76.62 -33.74 58.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.392 1.477 . . . . 0.0 112.925 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -73.83 130.5 83.19 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 126.06 1.744 . . . . 0.0 111.738 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.13 -14.74 18.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.494 3.462 . . . . 0.0 113.3 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -76.04 -47.66 23.88 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.816 1.189 . . . . 0.0 110.695 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.4 m -52.84 -35.56 57.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.031 1.732 . . . . 0.0 113.889 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -55.39 -33.34 63.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.038 1.335 . . . . 0.0 113.135 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.48 -40.72 89.48 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.233 1.013 . . . . 0.0 112.63 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.49 68.9 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.437 -0.79 . . . . 0.0 112.989 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -63.01 -44.24 96.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.667 0.667 . . . . 0.0 111.496 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -63.78 -38.94 92.97 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.77 -49.08 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.582 1.553 . . . . 0.0 110.434 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 mt -64.58 -35.24 80.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.32 1.048 . . . . 0.0 112.772 175.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.23 -50.08 74.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.108 0.963 . . . . 0.0 111.753 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.28 -31.6 72.5 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.099 -1.001 . . . . 0.0 112.584 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.97 -32.52 70.79 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.411 1.084 . . . . 0.0 112.596 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.84 -27.44 38.07 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 120.831 -1.168 . . . . 0.0 113.417 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.81 55.11 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 10.18 12.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.18 72.52 81.88 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.555 1.542 . . . . 0.0 111.556 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.45 -21.05 60.94 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.352 2.702 . . . . 0.0 115.534 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -83.06 -5.21 59.02 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -166.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.9 p -106.83 132.38 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.113 1.365 . . . . 0.0 111.036 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.5 102.52 13.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.171 0.988 . . . . 0.0 110.515 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mt -100.21 130.81 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.312 -0.867 . . . . 0.0 109.913 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -150.38 168.61 23.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.25 1.02 . . . . 0.0 112.028 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -118.45 -179.58 3.83 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.909 -1.119 . . . . 0.0 112.591 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.6 t -149.79 128.34 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 128.102 2.561 . . . . 0.0 108.024 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.19 97.66 0.27 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.584 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.3 p -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.287 -0.883 . . . . 0.0 112.323 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.39 -15.74 62.38 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.644 1.978 . . . . 0.0 114.19 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.84 -39.07 3.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.764 1.225 . . . . 0.0 113.522 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -115.39 54.23 0.91 Allowed Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.843 1.657 . . . . 0.0 113.78 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.0 -13.36 33.97 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -58.69 -24.48 61.42 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.733 1.152 . . . . 0.0 112.954 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.24 -58.54 3.44 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.339 0.518 . . . . 0.0 110.973 165.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.3 mtm -54.74 -33.03 60.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.028 1.331 . . . . 0.0 113.002 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -67.29 -18.82 65.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.709 1.603 . . . . 0.0 114.109 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -77.69 -40.51 41.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.968 0.803 . . . . 0.0 111.644 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.16 -23.93 24.66 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 12.75 28.61 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.108 1.813 . . . . 0.0 115.285 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -81.65 154.14 26.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.758 1.779 . . . . 0.0 111.531 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -102.33 -61.11 1.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.097 0.959 . . . . 0.0 112.152 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -162.69 2.31 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -98.68 155.4 36.76 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 126.598 1.959 . . . . 0.0 112.833 -165.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.7 88.58 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.44 3.427 . . . . 0.0 111.402 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.0 m -104.03 130.53 51.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.672 0.789 . . . . 0.0 110.862 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.06 121.47 41.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 0.0 109.816 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.52 130.86 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.641 1.976 . . . . 0.0 108.546 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -113.12 121.87 45.83 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.406 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 35.1 mm -109.27 116.15 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.486 1.114 . . . . 0.0 108.903 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.406 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.85 123.32 49.38 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.375 1.47 . . . . 0.0 107.957 171.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.38 19.76 11.91 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.497 1.119 . . . . 0.0 113.178 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.25 84.44 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.058 -1.026 . . . . 0.0 113.263 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -108.21 133.56 52.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.963 1.705 . . . . 0.0 109.025 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.35 107.47 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.07 -19.92 14.02 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -160.7 150.28 17.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.524 1.53 . . . . 0.0 110.77 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.45 145.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.428 1.491 . . . . 0.0 109.971 169.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.09 152.37 34.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.427 1.491 . . . . 0.0 109.292 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 t -128.95 138.36 51.93 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.926 -1.109 . . . . 0.0 112.589 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.73 -161.69 19.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.002 1.763 . . . . 0.0 112.755 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.3 mm -111.07 143.6 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.691 1.196 . . . . 0.0 111.069 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 67.4 mtm -137.53 158.17 44.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.902 1.281 . . . . 0.0 111.78 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.52 147.92 76.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.054 0.942 . . . . 0.0 111.176 164.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.3 -27.32 63.7 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.931 2.421 . . . . 0.0 113.212 -168.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.85 -29.51 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.56 -24.98 15.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.373 1.069 . . . . 0.0 112.47 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.92 -28.41 68.9 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.435 -0.791 . . . . 0.0 111.998 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -55.56 -50.38 70.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.96 -35.38 74.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.503 0.721 . . . . 0.0 111.852 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.63 -44.7 81.28 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.627 0.771 . . . . 0.0 110.517 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -47.08 85.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 112.151 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.85 82.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.265 0.939 . . . . 0.0 112.077 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 m -58.27 -25.51 61.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.451 1.5 . . . . 0.0 113.842 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.133 0.973 . . . . 0.0 111.196 177.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mm . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 125.527 1.531 . . . . 0.0 111.572 176.54 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.93 63.23 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -74.49 -39.97 62.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.811 0.732 . . . . 0.0 110.596 169.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.43 -13.4 62.11 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.53 -14.06 41.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 0.0 113.848 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.75 -8.84 1.85 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 117.087 1.595 . . . . 0.0 117.087 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.33 176.74 4.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.219 1.51 . . . . 0.0 114.437 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 p -92.15 -55.96 3.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.805 1.242 . . . . 0.0 113.713 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -159.21 110.22 2.04 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.273 1.829 . . . . 0.0 109.111 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.38 155.27 38.31 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.31 128.76 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.862 1.265 . . . . 0.0 108.682 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 t -114.75 126.14 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.131 1.372 . . . . 0.0 109.285 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -106.87 113.67 27.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.891 0.876 . . . . 0.0 111.604 173.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -77.82 74.15 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.488 1.915 . . . . 0.0 111.022 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.62 -179.28 2.08 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.984 -1.073 . . . . 0.0 112.517 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.19 162.02 32.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.229 1.411 . . . . 0.0 111.942 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -73.9 -38.82 64.24 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.323 -0.861 . . . . 0.0 113.111 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.3 mt -98.83 -32.44 11.34 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.6 123.08 72.49 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.083 1.353 . . . . 0.0 113.68 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -82.47 -2.37 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.489 3.46 . . . . 0.0 112.897 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -89.14 -40.78 12.68 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 119.434 1.015 . . . . 0.0 110.022 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 p -64.37 -26.99 68.71 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.0 -37.59 45.93 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -74.33 -34.45 63.44 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.355 0.662 . . . . 0.0 111.965 -166.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -28.75 69.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.501 -0.762 . . . . 0.0 112.777 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.17 -37.92 84.56 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.193 1.36 . . . . 0.0 112.186 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -34.89 69.82 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.935 -1.103 . . . . 0.0 112.053 173.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.36 -48.34 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.772 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.8 mt -62.0 -42.25 98.95 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.767 1.627 . . . . 0.0 112.319 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.57 -46.95 83.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.305 1.042 . . . . 0.0 111.91 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.26 -27.28 65.3 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.863 -1.148 . . . . 0.0 113.157 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.35 -36.9 71.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.674 0.79 . . . . 0.0 112.059 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.94 -19.94 69.01 Favored Glycine 0 N--CA 1.469 0.864 0 CA-C-N 119.212 0.915 . . . . 0.0 113.301 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -33.7 60.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.668 1.587 . . . . 0.0 114.629 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.72 6.59 11.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.267 1.427 . . . . 0.0 114.276 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.03 79.0 25.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.641 1.576 . . . . 0.0 110.433 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.04 -13.57 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.216 2.611 . . . . 0.0 114.287 -168.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -90.15 -6.98 54.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -168.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 p -99.58 131.92 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.614 1.565 . . . . 0.0 110.181 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.91 100.7 11.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 110.138 174.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.34 131.58 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.437 -0.79 . . . . 0.0 109.967 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.2 p -140.33 160.11 40.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.227 1.013 . . . . 0.0 111.809 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -106.83 165.81 11.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.198 -0.939 . . . . 0.0 110.51 165.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -162.67 152.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.198 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.06 120.16 37.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.327 0.967 . . . . 0.0 112.474 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.9 p -57.83 -36.26 72.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.017 1.327 . . . . 0.0 113.238 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.32 -25.97 42.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 112.051 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.01 -16.29 30.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.936 1.294 . . . . 0.0 113.797 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmt-85 -119.97 48.77 1.27 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 125.624 1.57 . . . . 0.0 113.868 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.85 -27.93 67.44 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.818 1.679 . . . . 0.0 111.75 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.9 -23.58 67.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.661 1.185 . . . . 0.0 113.407 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.75 -56.23 4.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.622 1.169 . . . . 0.0 109.366 170.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.3 mtm -58.01 -28.43 64.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.766 1.226 . . . . 0.0 113.267 -172.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -57.37 -30.46 64.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.965 1.706 . . . . 0.0 113.22 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -88.28 -32.55 18.43 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.417 1.087 . . . . 0.0 111.588 -172.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.4 -24.1 22.0 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.392 0.677 . . . . 0.0 112.799 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.75 15.7 30.83 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.736 1.636 . . . . 0.0 114.992 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -77.14 153.03 34.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.896 1.348 . . . . 0.0 110.797 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 -43.77 4.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.636 1.174 . . . . 0.0 112.729 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -179.82 -3.12 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.87 2.868 . . . . 0.0 116.364 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.89 149.44 85.57 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-N 120.213 1.369 . . . . 0.0 113.455 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.06 81.25 2.6 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.045 3.163 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.56 135.67 33.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -165.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.46 125.26 36.15 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.16 121.98 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.007 1.723 . . . . 0.0 108.84 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -106.69 125.79 51.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.328 1.051 . . . . 0.0 110.582 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.72 119.58 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.27 1.428 . . . . 0.0 108.785 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.32 128.12 55.85 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.967 1.307 . . . . 0.0 108.335 167.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.98 19.18 11.46 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.899 1.28 . . . . 0.0 113.1 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.1 12.51 82.37 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.16 -0.963 . . . . 0.0 113.153 -174.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -107.45 134.47 50.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.341 1.856 . . . . 0.0 109.576 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.71 104.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 171.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.83 -26.71 13.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -167.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -162.11 153.14 17.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.6 1.56 . . . . 0.0 110.951 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.67 146.85 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.738 1.215 . . . . 0.0 111.426 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.81 147.0 23.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.243 1.017 . . . . 0.0 112.198 168.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -96.82 -4.49 40.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -160.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.43 17.93 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-O 122.498 1.054 . . . . 0.0 115.457 -165.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.0 mm -106.11 146.37 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.083 1.753 . . . . 0.0 109.474 165.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.0 ptp -147.75 172.15 14.56 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 167.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -76.76 166.04 47.86 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.551 1.54 . . . . 0.0 112.26 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -34.7 5.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.633 1.555 . . . . 0.0 114.176 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.98 -34.18 77.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.129 1.786 . . . . 0.0 112.589 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -79.63 -21.85 44.35 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.397 0.679 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.22 -30.31 71.19 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.286 -0.884 . . . . 0.0 112.446 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -39.29 94.3 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.356 0.98 . . . . 0.0 111.451 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.19 81.72 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.123 0.874 . . . . 0.0 112.458 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.84 -47.78 79.4 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 110.735 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.48 -45.22 94.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.322 1.049 . . . . 0.0 112.842 173.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.04 80.28 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.265 -0.897 . . . . 0.0 111.956 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 t -68.92 -4.78 17.84 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.706 1.203 . . . . 0.0 114.072 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.477 0.92 0 O-C-N 120.98 -1.075 . . . . 0.0 110.22 167.273 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 126.1 1.76 . . . . 0.0 111.038 -163.236 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.49 67.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -68.31 -41.75 80.44 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.561 -0.712 . . . . 0.0 110.209 170.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -75.41 -6.48 50.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 0.0 113.327 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.88 -18.69 23.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.276 1.43 . . . . 0.0 113.111 170.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.24 -14.31 20.76 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.62 166.79 20.77 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -82.94 -61.24 1.92 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.282 1.033 . . . . 0.0 112.104 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -151.78 128.62 10.94 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.797 1.639 . . . . 0.0 109.771 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.14 164.45 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mt -139.41 124.89 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 107.664 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.56 125.24 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.607 1.563 . . . . 0.0 108.809 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -107.42 110.16 22.06 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.455 1.102 . . . . 0.0 111.584 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -80.0 87.66 5.39 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.09 0.956 . . . . 0.0 110.157 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 -167.89 1.67 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.773 1.229 . . . . 0.0 112.286 173.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -144.41 157.13 44.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.888 -1.133 . . . . 0.0 112.025 153.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -31.08 -82.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 129.117 2.967 . . . . 0.0 116.387 -174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.0 mt -91.53 -38.19 12.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -167.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.3 m -49.25 119.8 9.32 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.894 1.678 . . . . 0.0 112.773 -169.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.84 -22.44 31.72 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.209 3.272 . . . . 0.0 115.077 -161.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -63.09 -44.66 95.1 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 118.849 0.749 . . . . 0.0 112.128 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.8 m -67.47 -31.47 71.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.648 1.179 . . . . 0.0 112.891 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.26 -25.81 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.539 1.136 . . . . 0.0 113.677 -171.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -64.28 -42.81 96.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.848 0.859 . . . . 0.0 112.04 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 tpt -63.78 -28.65 70.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.437 1.095 . . . . 0.0 112.684 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.28 -39.9 84.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.698 0.799 . . . . 0.0 111.352 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -72.93 -29.08 62.84 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.492 -0.755 . . . . 0.0 112.816 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.2 t -67.9 -45.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.258 1.023 . . . . 0.0 109.646 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.45 -37.01 84.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.225 1.41 . . . . 0.0 111.951 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.78 -53.3 59.89 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.224 0.92 . . . . 0.0 111.846 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -64.1 -32.54 74.14 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.396 -0.815 . . . . 0.0 112.758 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.39 -35.6 73.57 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.965 0.906 . . . . 0.0 111.833 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.29 -24.12 61.79 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 119.408 1.004 . . . . 0.0 113.319 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.72 49.02 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.06 9.14 5.26 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.551 1.54 . . . . 0.0 114.502 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.3 61.18 40.89 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 125.657 1.583 . . . . 0.0 112.12 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.34 -15.41 34.91 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.335 2.69 . . . . 0.0 114.431 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -80.81 -9.53 59.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -99.98 137.69 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.187 1.395 . . . . 0.0 110.302 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.71 101.68 11.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.114 0.565 . . . . 0.0 110.443 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.5 mt -99.37 131.84 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.975 0.91 . . . . 0.0 109.218 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.1 p -149.45 170.45 18.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.03 0.932 . . . . 0.0 112.527 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.2 p -133.58 158.69 42.55 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.978 -1.076 . . . . 0.0 111.573 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.46 123.27 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.814 1.246 . . . . 0.0 108.133 -167.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.99 115.11 10.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.041 0.924 . . . . 0.0 109.886 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -58.37 -25.29 61.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.879 1.272 . . . . 0.0 113.36 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.22 -20.65 34.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.703 0.801 . . . . 0.0 112.281 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.74 -35.23 15.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.367 1.067 . . . . 0.0 112.902 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -126.54 61.17 42.53 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.971 1.709 . . . . 0.0 112.803 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.43 -23.7 27.43 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.244 2.63 . . . . 0.0 112.675 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.0 -23.19 67.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.148 0.979 . . . . 0.0 113.169 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.14 -58.15 4.12 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.56 1.144 . . . . 0.0 109.543 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 mtm -60.71 -22.89 64.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 113.512 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -65.9 -23.46 66.64 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.641 1.176 . . . . 0.0 112.552 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.61 -38.19 16.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.585 1.154 . . . . 0.0 111.369 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.66 -23.78 25.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.21 8.57 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.098 1.332 . . . . 0.0 114.506 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.62 169.44 18.0 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.813 1.306 . . . . 0.0 112.753 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.0 11.15 8.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 112.726 -162.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.31 59.93 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.073 2.549 . . . . 0.0 109.257 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -150.03 154.07 36.37 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 127.672 2.389 . . . . 0.0 109.858 -163.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.57 96.18 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.682 2.921 . . . . 0.0 110.648 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -113.47 122.11 46.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 111.833 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.34 125.26 34.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.885 1.274 . . . . 0.0 109.135 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.06 127.65 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -111.13 128.97 56.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.762 0.825 . . . . 0.0 110.948 -174.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.3 mm -112.39 114.11 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.409 1.084 . . . . 0.0 108.883 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.97 121.65 45.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.933 1.293 . . . . 0.0 108.242 171.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 66.75 21.46 10.53 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.006 1.323 . . . . 0.0 112.326 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.53 10.33 84.58 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.428 -173.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -107.68 132.81 52.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.422 1.489 . . . . 0.0 110.194 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.17 101.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.392 1.077 . . . . 0.0 109.187 166.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 -21.18 13.43 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.74 152.64 19.89 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.196 1.798 . . . . 0.0 110.465 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.47 144.08 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.728 1.211 . . . . 0.0 111.275 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.24 146.56 22.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.702 1.201 . . . . 0.0 111.214 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -107.85 138.78 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.02 0.928 . . . . 0.0 111.585 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.98 -161.0 21.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.997 1.76 . . . . 0.0 112.767 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 mm -121.82 145.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.877 1.671 . . . . 0.0 110.733 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.6 ptp -150.63 164.8 35.17 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 163.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -70.08 158.97 86.08 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.312 1.445 . . . . 0.0 112.396 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.32 -26.42 24.94 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.855 2.37 . . . . 0.0 114.401 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -75.33 -30.3 60.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.634 1.561 . . . . 0.0 113.143 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -76.29 -33.2 59.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.11 0.964 . . . . 0.0 111.799 169.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.87 -27.08 68.54 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.841 0.857 . . . . 0.0 111.975 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -58.75 -47.53 84.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.856 0.753 . . . . 0.0 111.923 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.75 0.82 . . . . 0.0 111.38 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.02 -49.76 74.75 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.318 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -46.94 86.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.683 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.68 91.45 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.032 0.833 . . . . 0.0 112.375 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.8 t -60.02 -24.72 64.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.506 1.122 . . . . 0.0 113.401 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.479 0.994 0 C-N-CA 124.325 1.05 . . . . 0.0 111.136 175.585 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 . . . . . 0 N--CA 1.471 0.58 0 C-N-CA 125.146 1.379 . . . . 0.0 111.217 -169.498 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.97 62.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -85.26 -38.91 18.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.074 0.852 . . . . 0.0 111.049 165.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.06 -12.93 61.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.575 0.75 . . . . 0.0 112.821 -172.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.3 -10.97 50.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.749 1.22 . . . . 0.0 114.126 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.97 -5.94 0.97 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.91 169.65 12.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.281 1.54 . . . . 0.0 114.407 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -81.0 -64.7 1.13 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.525 1.13 . . . . 0.0 112.276 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -151.16 123.99 8.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.755 1.622 . . . . 0.0 109.738 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.48 156.24 41.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.92 127.15 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.935 1.294 . . . . 0.0 108.086 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.28 124.45 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.339 1.456 . . . . 0.0 109.406 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 4.2 t80 -102.82 123.3 46.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.655 1.182 . . . . 0.0 110.24 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -88.25 73.54 8.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.518 1.127 . . . . 0.0 110.138 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -81.64 -170.51 2.85 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 121.525 -0.734 . . . . 0.0 112.517 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -145.58 177.62 8.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.242 -0.911 . . . . 0.0 112.767 162.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.24 -56.11 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.27 1.028 . . . . 0.0 113.024 -166.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.17 -30.71 19.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -54.61 118.81 17.97 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.791 1.236 . . . . 0.0 113.729 -167.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.88 -23.79 77.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.109 3.206 . . . . 0.0 114.223 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -71.97 -46.86 55.85 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.0 m -56.14 -34.42 66.11 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.482 1.113 . . . . 0.0 113.401 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -56.06 -35.25 66.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 112.825 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -62.76 -49.98 72.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.406 0.682 . . . . 0.0 111.366 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.41 -29.67 70.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -60.68 -45.87 92.51 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.934 0.894 . . . . 0.0 111.013 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -72.0 -34.48 68.9 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.255 -0.903 . . . . 0.0 113.052 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.98 -49.25 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.24 -36.49 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.128 0.971 . . . . 0.0 113.46 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.45 -49.84 76.22 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.307 0.643 . . . . 0.0 112.518 170.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.18 -29.97 68.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.203 -0.935 . . . . 0.0 113.157 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.83 -37.84 79.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.083 1.353 . . . . 0.0 111.584 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.15 -19.34 67.23 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.418 1.009 . . . . 0.0 112.81 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.61 -33.73 66.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.347 1.059 . . . . 0.0 113.462 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 9.16 39.94 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.603 1.561 . . . . 0.0 114.104 174.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.2 66.23 7.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.522 1.529 . . . . 0.0 113.673 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.3 -20.81 69.75 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.905 2.403 . . . . 0.0 115.076 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -88.2 -8.87 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 p -88.25 135.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.45 87.3 5.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.529 0.732 . . . . 0.0 111.013 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 mt -86.24 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.565 -0.709 . . . . 0.0 109.695 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.7 p -147.3 173.1 12.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.609 1.164 . . . . 0.0 111.556 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 t -122.53 -172.52 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.191 -0.943 . . . . 0.0 111.137 168.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -173.55 133.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.729 2.411 . . . . 0.0 109.118 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.83 116.25 18.19 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.929 1.292 . . . . 0.0 111.464 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.3 p -62.28 -26.93 68.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 112.947 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.79 -23.42 62.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.511 1.124 . . . . 0.0 112.518 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.31 -28.84 11.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.073 1.349 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.55 49.03 4.23 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 125.896 1.678 . . . . 0.0 115.46 -170.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -66.72 -19.42 53.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.394 2.063 . . . . 0.0 112.731 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.16 -25.98 68.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.568 1.147 . . . . 0.0 113.124 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -70.48 -55.1 9.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.81 0.732 . . . . 0.0 110.751 166.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.9 mtp -59.14 -28.47 66.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.547 1.539 . . . . 0.0 113.248 -170.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -15.47 61.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.543 1.137 . . . . 0.0 112.753 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -84.68 -38.32 19.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.663 1.185 . . . . 0.0 110.579 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.85 -23.46 31.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.282 0.633 . . . . 0.0 112.677 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.86 20.09 17.66 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.716 1.627 . . . . 0.0 114.773 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -82.5 149.41 27.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.765 1.283 . . . . 0.0 111.883 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.45 -81.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.633 0.773 . . . . 0.0 110.825 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -157.35 6.64 0.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -167.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.89 160.76 25.0 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 126.487 1.915 . . . . 0.0 114.032 -159.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.6 93.34 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.91 3.74 . . . . 0.0 110.942 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 m -109.68 129.22 55.62 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.895 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mp -95.46 130.88 42.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.836 0.855 . . . . 0.0 109.734 167.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -129.24 128.56 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.091 1.757 . . . . 0.0 108.86 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -114.85 124.48 51.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.176 0.99 . . . . 0.0 110.682 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mm -109.05 120.04 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.996 1.318 . . . . 0.0 109.599 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -114.98 125.3 53.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.822 1.649 . . . . 0.0 109.501 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.61 19.47 10.45 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.505 1.522 . . . . 0.0 113.807 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.15 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.823 1.201 . . . . 0.0 114.101 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -112.84 136.51 52.38 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.103 1.761 . . . . 0.0 110.372 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.59 104.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 166.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.96 -30.23 12.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.62 160.41 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.915 1.686 . . . . 0.0 111.76 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.25 144.81 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.593 1.557 . . . . 0.0 110.771 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.28 150.22 25.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 111.972 167.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -105.48 132.34 51.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.183 0.993 . . . . 0.0 111.35 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.18 -158.14 14.86 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.287 1.422 . . . . 0.0 113.448 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.57 139.09 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.692 1.597 . . . . 0.0 111.056 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.0 mtm -140.9 160.28 40.41 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.514 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -72.35 159.84 84.34 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.71 1.204 . . . . 0.0 112.282 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.3 -24.73 31.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.457 2.105 . . . . 0.0 113.724 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -63.23 -49.31 74.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.953 1.251 . . . . 0.0 110.83 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -72.28 -26.15 61.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.626 1.17 . . . . 0.0 111.636 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -26.75 68.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.748 0.819 . . . . 0.0 112.507 170.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -65.64 -45.53 82.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.775 1.17 . . . . 0.0 110.769 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.83 84.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.152 0.581 . . . . 0.0 111.848 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.16 -53.88 51.41 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.249 1.019 . . . . 0.0 110.405 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.92 77.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.361 175.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.26 79.72 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.454 -0.779 . . . . 0.0 112.0 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -60.05 -38.89 84.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.569 0.747 . . . . 0.0 111.861 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.482 1.129 0 O-C-N 121.148 -0.97 . . . . 0.0 110.602 175.056 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 mm . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.573 0 C-N-CA 128.965 2.906 . . . . 0.0 111.892 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.8 ptp . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.47 -26.63 35.09 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.028 0.931 . . . . 0.0 113.498 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -71.23 -40.22 71.22 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.64 -0.663 . . . . 0.0 110.247 162.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -75.65 27.27 0.11 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.452 1.501 . . . . 0.0 112.825 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -82.24 -14.92 54.74 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.84 43.76 0.07 OUTLIER Glycine 0 N--CA 1.474 1.23 0 CA-C-N 119.674 1.124 . . . . 0.0 115.582 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 mt -84.85 103.05 13.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.431 1.093 . . . . 0.0 111.158 -173.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -58.89 -27.56 65.33 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -156.37 94.31 1.48 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.1 1.76 . . . . 0.0 110.296 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.59 46.64 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.9 mt -140.84 135.13 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.389 1.476 . . . . 0.0 109.142 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.33 131.06 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.45 1.5 . . . . 0.0 109.565 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -111.24 103.48 11.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.655 1.182 . . . . 0.0 111.462 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -75.37 70.91 2.31 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.74 1.616 . . . . 0.0 109.959 175.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.34 154.0 42.39 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.117 0.967 . . . . 0.0 113.192 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.04 179.74 7.73 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.335 -0.853 . . . . 0.0 111.728 166.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.77 153.25 30.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.022 1.729 . . . . 0.0 112.457 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 67.85 -46.41 0.51 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 130.304 3.442 . . . . 0.0 114.474 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.0 t -54.91 128.58 64.51 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 127.046 2.139 . . . . 0.0 113.433 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.77 -18.97 59.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.606 3.538 . . . . 0.0 115.529 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -67.79 -48.35 66.55 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 120.364 1.438 . . . . 0.0 112.817 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.1 -22.79 63.96 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.471 -1.393 . . . . 0.0 113.414 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -56.39 -30.79 63.18 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.154 1.381 . . . . 0.0 113.085 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -64.82 -46.1 83.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.957 0.903 . . . . 0.0 112.235 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.3 mmm -63.91 -28.77 70.06 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.338 -0.851 . . . . 0.0 112.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -61.02 -35.81 77.85 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.705 0.684 . . . . 0.0 111.58 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -70.27 -40.6 74.24 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 110.737 174.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.01 -44.62 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.777 1.631 . . . . 0.0 110.788 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.97 -37.33 85.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.306 1.443 . . . . 0.0 112.125 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.89 -47.79 84.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.649 0.78 . . . . 0.0 111.986 171.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -68.51 -32.95 73.28 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.259 0.936 . . . . 0.0 112.11 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -68.63 -35.89 77.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.73 1.212 . . . . 0.0 112.184 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.34 -24.57 53.93 Favored Glycine 0 N--CA 1.469 0.852 0 CA-C-N 119.176 0.898 . . . . 0.0 113.177 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 10.8 38.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.097 1.359 . . . . 0.0 114.139 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.86 85.89 7.46 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.433 1.493 . . . . 0.0 111.68 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.03 -12.09 17.73 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.312 2.675 . . . . 0.0 113.817 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -89.57 -10.04 47.57 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.827 1.194 . . . . 0.0 113.728 -172.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.54 130.78 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.672 1.189 . . . . 0.0 110.254 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.8 98.0 8.26 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.223 0.609 . . . . 0.0 110.036 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -101.42 132.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.628 0.771 . . . . 0.0 109.273 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -145.89 169.2 19.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.97 0.908 . . . . 0.0 111.813 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.2 p -114.2 164.96 13.17 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.634 -1.291 . . . . 0.0 111.538 168.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.54 122.24 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.3 1.44 . . . . 0.0 109.038 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.08 104.76 1.21 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.694 1.198 . . . . 0.0 110.397 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -54.35 -44.26 72.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.857 1.263 . . . . 0.0 112.811 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -78.52 -13.27 59.91 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.84 -17.91 18.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.641 1.176 . . . . 0.0 113.427 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -124.03 43.77 0.89 Allowed Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.062 1.745 . . . . 0.0 113.303 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.85 -22.87 35.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.102 2.535 . . . . 0.0 112.466 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.17 -27.74 68.92 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.293 0.952 . . . . 0.0 112.603 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.58 -50.65 14.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.8 mtm -56.7 -26.41 56.65 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.402 1.081 . . . . 0.0 113.319 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -66.35 -23.35 66.33 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.139 0.976 . . . . 0.0 112.014 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -84.6 -37.97 20.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.935 1.294 . . . . 0.0 111.204 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.06 -24.15 30.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.438 0.695 . . . . 0.0 112.554 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.22 20.03 19.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.374 1.464 . . . . 0.0 115.065 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -84.1 155.08 22.81 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.156 1.478 . . . . 0.0 111.584 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -92.25 -72.21 0.6 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.439 1.096 . . . . 0.0 110.465 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 ptm85 -162.81 3.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -84.63 154.82 62.21 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 127.108 2.163 . . . . 0.0 113.012 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.48 96.35 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.382 3.388 . . . . 0.0 110.336 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.9 m -111.06 124.63 52.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.191 0.996 . . . . 0.0 112.467 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.4 135.02 34.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 109.524 166.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.34 124.38 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.001 1.721 . . . . 0.0 108.034 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -108.11 126.21 52.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.432 0.693 . . . . 0.0 110.782 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.1 mm -110.36 113.11 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.841 0.857 . . . . 0.0 109.178 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 115.56 29.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.321 1.448 . . . . 0.0 109.109 170.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.08 26.67 8.86 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.879 2.072 . . . . 0.0 111.981 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.21 -3.84 83.12 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.832 0.73 . . . . 0.0 113.846 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -96.29 131.11 43.13 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.923 -1.34 . . . . 0.0 110.231 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.38 102.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.869 0.842 . . . . 0.0 109.603 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.32 -17.17 16.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -171.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.91 148.72 19.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.019 1.727 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -150.27 146.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.803 1.641 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.33 148.82 27.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.266 1.026 . . . . 0.0 111.601 161.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -105.77 144.07 33.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.479 -0.763 . . . . 0.0 111.917 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.24 -150.18 17.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.268 1.413 . . . . 0.0 113.377 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.5 mm -112.27 144.36 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.343 1.457 . . . . 0.0 112.285 -170.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.3 ptp -153.01 169.31 23.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 160.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -82.44 161.98 57.6 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.727 1.611 . . . . 0.0 112.485 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.46 -26.48 12.03 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.539 2.159 . . . . 0.0 114.507 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -71.43 -34.23 70.11 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.204 1.365 . . . . 0.0 112.846 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -74.39 -31.42 62.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.591 0.756 . . . . 0.0 112.278 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.1 tp -62.28 -26.87 68.64 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.488 -0.757 . . . . 0.0 112.606 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.72 -47.95 82.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.882 0.764 . . . . 0.0 111.209 174.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.59 71.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.255 0.622 . . . . 0.0 111.778 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.96 -50.44 73.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.807 0.843 . . . . 0.0 110.84 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -45.38 79.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.322 0.649 . . . . 0.0 112.008 175.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.8 86.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.826 0.739 . . . . 0.0 112.031 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.1 m -64.64 -11.79 39.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.399 1.479 . . . . 0.0 114.612 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.476 0.851 0 O-C-N 121.039 -1.038 . . . . 0.0 110.96 173.312 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mm . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 125.382 1.473 . . . . 0.0 111.361 -167.523 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.74 63.0 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -84.53 -39.09 19.23 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 111.168 166.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.11 -9.19 58.42 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.71 -11.11 43.3 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.007 1.323 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.9 -6.36 1.11 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.47 167.29 16.99 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.226 1.513 . . . . 0.0 113.663 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -80.68 -52.55 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -164.76 114.88 1.15 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.946 1.298 . . . . 0.0 110.082 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.71 157.83 41.45 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.98 130.66 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.632 1.573 . . . . 0.0 108.832 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.6 128.23 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.689 1.596 . . . . 0.0 109.393 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.05 111.72 23.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.574 1.15 . . . . 0.0 111.507 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -83.53 73.56 10.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 111.301 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -71.41 174.94 5.9 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 168.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.24 146.34 38.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.388 -1.445 . . . . 0.0 114.054 170.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' CG ' ' H ' ' A' ' 30' ' ' LEU 0.319 6.9 p30 17.76 -104.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.388 2.675 . . . . 0.0 116.136 -178.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.407 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 3.6 mm? -107.18 3.15 25.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.68 2.392 . . . . 0.0 113.383 -171.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -49.04 125.61 13.95 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.509 1.523 . . . . 0.0 114.41 -164.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.2 -5.03 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.066 3.178 . . . . 0.0 113.429 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -81.74 -50.38 9.34 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.685 1.129 . . . . 0.0 109.905 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.2 m -60.77 -34.02 73.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -171.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -50.31 -40.72 49.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -72.76 -40.68 65.81 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.209 0.603 . . . . 0.0 110.737 -172.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -62.4 -34.52 76.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.593 1.157 . . . . 0.0 112.519 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -59.55 -39.09 82.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.719 1.145 . . . . 0.0 112.305 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.48 -32.66 71.69 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.91 -1.119 . . . . 0.0 112.789 173.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.46 -50.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.368 0.667 . . . . 0.0 109.967 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.73 -35.67 81.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.293 1.037 . . . . 0.0 112.135 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.73 -52.97 63.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.053 0.941 . . . . 0.0 111.639 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -69.13 -30.24 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.601 -0.687 . . . . 0.0 112.655 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.95 -41.39 91.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.786 1.234 . . . . 0.0 111.49 170.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.58 -27.33 27.45 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 119.098 0.863 . . . . 0.0 113.593 -172.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.77 68.24 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.198 0.999 . . . . 0.0 113.588 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.49 9.4 37.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.964 1.705 . . . . 0.0 114.067 176.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.05 42.31 0.37 Allowed Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 125.534 1.533 . . . . 0.0 113.754 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.57 -5.64 10.55 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.575 2.85 . . . . 0.0 115.58 -166.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -62.92 -8.86 7.92 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.64 135.6 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.194 1.398 . . . . 0.0 110.553 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.06 102.53 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 110.348 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.68 135.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.93 0.892 . . . . 0.0 110.333 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.7 p -144.63 169.02 18.79 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.278 1.031 . . . . 0.0 112.005 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.4 p -125.97 163.37 23.15 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.78 -1.2 . . . . 0.0 111.846 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.2 t -148.82 129.03 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.009 1.323 . . . . 0.0 108.542 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -73.93 98.62 3.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.562 0.696 . . . . 0.0 110.123 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -59.55 -30.33 68.54 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.219 1.008 . . . . 0.0 113.585 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.81 -21.53 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.043 1.337 . . . . 0.0 112.655 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.14 -7.81 38.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.528 1.531 . . . . 0.0 112.976 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 42.95 0.98 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 126.151 1.78 . . . . 0.0 114.07 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.45 -21.01 47.4 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.593 2.196 . . . . 0.0 113.258 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -59.71 -19.44 49.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.226 . . . . 0.0 113.124 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.23 -58.93 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.459 1.103 . . . . 0.0 111.574 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.6 mtm -58.46 -28.55 65.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 113.763 -170.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -69.71 -18.91 63.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.041 1.336 . . . . 0.0 113.345 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.31 -35.62 19.78 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.381 1.073 . . . . 0.0 111.211 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.51 -23.87 21.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.422 0.689 . . . . 0.0 112.857 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.34 21.06 18.34 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.692 1.615 . . . . 0.0 114.716 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.14 160.83 25.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.998 1.399 . . . . 0.0 112.188 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.75 -68.77 0.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.359 1.063 . . . . 0.0 112.869 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.79 22.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -162.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.34 156.97 57.21 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 125.091 1.356 . . . . 0.0 112.831 -166.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.76 88.29 0.92 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.075 3.183 . . . . 0.0 110.206 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -99.89 130.21 46.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.318 1.047 . . . . 0.0 111.893 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 134.38 35.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.318 1.047 . . . . 0.0 110.471 163.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.5 t -130.73 126.17 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.568 1.547 . . . . 0.0 108.417 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -109.95 122.54 47.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 110.639 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.68 121.5 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.403 1.481 . . . . 0.0 108.859 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.54 124.29 50.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.307 1.843 . . . . 0.0 108.774 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 61.19 20.09 10.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.009 1.324 . . . . 0.0 113.355 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.12 69.57 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.229 0.919 . . . . 0.0 113.84 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -117.46 132.11 56.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.449 1.9 . . . . 0.0 109.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.77 109.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.196 -0.94 . . . . 0.0 109.676 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.55 -24.85 14.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -160.16 144.82 14.66 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.123 1.769 . . . . 0.0 110.563 -172.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -148.25 143.87 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.552 1.541 . . . . 0.0 109.384 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -154.59 156.92 37.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.434 1.094 . . . . 0.0 111.026 164.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 p -121.45 145.36 48.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.97 -167.76 12.4 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.335 1.445 . . . . 0.0 113.58 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.06 138.42 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 65.9 mtm -139.42 147.66 41.72 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.973 0.909 . . . . 0.0 111.299 162.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.15 97.88 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.341 0.657 . . . . 0.0 111.346 167.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.19 -27.48 56.5 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.827 2.351 . . . . 0.0 113.551 -166.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -61.01 -29.17 69.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.4 -25.46 16.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.578 0.751 . . . . 0.0 112.562 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.37 -24.69 63.61 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 112.572 171.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -60.35 -41.81 94.4 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.387 0.675 . . . . 0.0 112.336 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.4 77.72 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.952 0.796 . . . . 0.0 111.97 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.01 -47.35 80.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.329 1.052 . . . . 0.0 110.379 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.59 -46.63 87.41 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.374 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.53 75.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.605 1.093 . . . . 0.0 112.705 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -62.77 -17.83 61.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.18 1.392 . . . . 0.0 113.582 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.6 mt . . . . . 0 N--CA 1.475 0.821 0 O-C-N 120.522 -1.361 . . . . 0.0 110.468 172.519 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 130.415 3.486 . . . . 0.0 112.974 179.098 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -21.2 62.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -80.1 -41.33 25.76 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 111.051 166.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -74.72 -13.62 60.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.289 1.036 . . . . 0.0 113.646 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -85.2 80.32 9.25 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.589 1.956 . . . . 0.0 110.342 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 14.19 14.92 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.772 1.177 . . . . 0.0 115.854 166.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.89 167.51 11.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 1.351 . . . . 0.0 112.936 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -75.62 -66.59 0.76 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.261 1.024 . . . . 0.0 112.544 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -149.63 124.72 10.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.392 1.877 . . . . 0.0 109.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.41 160.47 42.53 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.6 mt -138.03 124.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.085 1.754 . . . . 0.0 108.647 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 109.306 -170.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -115.08 113.81 24.53 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.373 0.669 . . . . 0.0 111.948 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -81.45 70.17 8.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.813 1.245 . . . . 0.0 110.722 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.83 170.14 15.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.702 0.763 . . . . 0.0 112.845 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -117.84 162.04 18.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.533 1.533 . . . . 0.0 111.143 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -91.17 -36.17 14.11 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.971 -1.08 . . . . 0.0 111.811 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 mt -80.06 -52.19 8.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.648 1.179 . . . . 0.0 113.4 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.74 119.53 45.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.295 1.438 . . . . 0.0 112.639 -170.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.31 -19.73 55.75 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.739 2.959 . . . . 0.0 114.086 172.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -76.75 -45.57 28.61 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.195 0.907 . . . . 0.0 110.703 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 p -63.72 -21.93 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -54.7 -37.78 66.23 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.123 0.969 . . . . 0.0 112.994 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -62.32 -43.11 99.58 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.736 -0.603 . . . . 0.0 111.832 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.3 tpp -61.01 -34.6 75.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.743 0.817 . . . . 0.0 112.991 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -54.28 -42.93 70.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.437 0.695 . . . . 0.0 111.767 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.69 -27.35 29.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.923 0.889 . . . . 0.0 113.166 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.85 -47.85 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.979 0.911 . . . . 0.0 110.378 166.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -62.04 -36.99 83.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.95 -48.29 82.5 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.96 0.8 . . . . 0.0 111.525 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.33 -33.81 76.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.659 0.784 . . . . 0.0 112.711 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -65.35 -37.58 87.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.861 1.264 . . . . 0.0 111.542 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.31 -23.03 61.64 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 124.704 1.145 . . . . 0.0 113.628 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -31.33 62.39 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.279 1.431 . . . . 0.0 114.713 -171.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.73 6.31 14.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 63.51 57.76 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.916 1.687 . . . . 0.0 112.14 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.61 -15.55 30.48 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.9 3.066 . . . . 0.0 113.725 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -82.05 -4.76 57.51 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.04 135.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.177 1.391 . . . . 0.0 110.235 173.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.93 100.86 11.28 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.814 0.846 . . . . 0.0 110.847 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.11 131.33 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.847 0.859 . . . . 0.0 110.195 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.3 p -146.82 170.06 17.82 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.938 0.895 . . . . 0.0 112.579 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.3 p -132.43 155.16 49.0 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.865 -1.147 . . . . 0.0 111.071 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -142.77 127.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.534 1.133 . . . . 0.0 109.461 -168.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -64.62 101.26 0.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.734 1.614 . . . . 0.0 110.69 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.9 p -55.97 -40.81 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.056 0.943 . . . . 0.0 112.738 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.45 -26.65 65.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.749 1.619 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.69 -15.43 18.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 113.844 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -131.42 52.61 9.67 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.705 1.602 . . . . 0.0 113.009 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.6 -20.47 53.39 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.027 170.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.46 -29.17 69.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.39 1.076 . . . . 0.0 112.767 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.94 -56.84 4.97 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.492 0.717 . . . . 0.0 109.431 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.7 mtp -54.8 -33.6 61.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.514 1.525 . . . . 0.0 112.21 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -61.71 -27.86 69.01 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.864 1.665 . . . . 0.0 113.988 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.34 -38.27 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.358 0.663 . . . . 0.0 112.01 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.77 -21.78 24.93 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 15.52 31.4 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.256 1.884 . . . . 0.0 114.829 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -77.96 140.52 39.23 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.275 1.538 . . . . 0.0 111.801 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.91 -60.04 2.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.408 0.683 . . . . 0.0 112.342 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -167.07 23.05 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -165.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.61 151.88 50.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 125.468 1.507 . . . . 0.0 113.351 -166.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.71 93.94 1.0 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.924 3.083 . . . . 0.0 109.599 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.5 m -104.44 131.73 51.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.524 1.13 . . . . 0.0 112.952 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.56 131.74 34.29 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.24 1.816 . . . . 0.0 109.251 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.69 131.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 108.744 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -114.29 127.85 56.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.636 0.775 . . . . 0.0 111.154 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.1 mm -108.94 122.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.006 1.322 . . . . 0.0 109.269 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -119.4 124.06 45.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.655 1.982 . . . . 0.0 109.19 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 61.88 18.69 10.02 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.947 1.299 . . . . 0.0 113.049 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.59 7.1 67.23 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.236 1.398 . . . . 0.0 114.401 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -113.34 136.94 52.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.877 1.671 . . . . 0.0 110.136 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.01 108.84 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 121.076 -1.015 . . . . 0.0 109.879 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.9 -20.31 14.31 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -170.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -158.67 156.1 29.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.022 1.329 . . . . 0.0 110.67 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.06 145.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 111.204 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.88 146.08 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.546 1.139 . . . . 0.0 111.101 166.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 p -110.77 147.09 35.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.056 . . . . 0.0 113.153 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.71 -149.38 18.12 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.758 1.17 . . . . 0.0 113.056 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.3 mm -118.3 143.89 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.015 1.326 . . . . 0.0 111.976 -171.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.3 mtm -139.13 160.04 40.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.27 1.428 . . . . 0.0 111.014 161.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -70.06 162.29 69.88 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 111.487 167.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 -32.91 14.17 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.987 1.791 . . . . 0.0 113.868 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -71.44 -31.36 67.12 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.842 1.655 . . . . 0.0 112.821 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -79.36 -22.32 44.57 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.95 -26.13 68.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.561 1.073 . . . . 0.0 112.672 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -63.05 -37.32 86.71 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.329 0.968 . . . . 0.0 111.702 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.74 83.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.361 0.982 . . . . 0.0 111.163 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 53.5 tp -65.07 -45.47 85.18 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.323 0.649 . . . . 0.0 110.78 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -44.61 95.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.283 1.033 . . . . 0.0 112.342 173.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.69 84.21 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.123 -0.985 . . . . 0.0 111.482 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.0 m -67.79 -3.84 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.754 1.622 . . . . 0.0 114.232 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 N--CA 1.481 1.085 0 O-C-N 120.903 -1.123 . . . . 0.0 111.382 169.587 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 110.755 -0.091 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.528 0 C-N-CA 126.989 2.116 . . . . 0.0 111.255 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.21 44.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.719 1.208 . . . . 0.0 113.903 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -74.95 -39.71 61.18 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.193 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.95 19.4 0.15 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 113.937 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -16.5 57.92 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.46 45.44 0.12 Allowed Glycine 0 N--CA 1.478 1.448 0 CA-C-N 120.059 1.3 . . . . 0.0 116.257 -174.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.3 mt -88.72 122.35 32.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.086 1.354 . . . . 0.0 109.232 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -53.59 -43.13 68.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.753 1.161 . . . . 0.0 113.478 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -163.04 123.42 2.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.223 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.75 155.76 42.04 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.319 1.448 . . . . 0.0 112.513 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.6 mt -143.18 132.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.364 1.466 . . . . 0.0 110.707 -170.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.54 126.73 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.089 1.356 . . . . 0.0 110.8 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -102.5 117.26 34.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.202 1.401 . . . . 0.0 112.101 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -78.55 73.58 5.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.286 1.434 . . . . 0.0 111.609 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.9 -174.99 4.7 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.705 0.802 . . . . 0.0 112.798 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -144.14 156.02 44.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 111.748 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -64.75 -54.82 25.37 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.77 -38.06 20.07 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -170.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.67 122.16 49.38 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.781 1.232 . . . . 0.0 112.827 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -65.15 -22.65 61.16 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.33 3.354 . . . . 0.0 114.575 173.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -70.7 -46.21 63.54 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 119.303 0.956 . . . . 0.0 111.036 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -58.09 -34.03 69.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.474 1.11 . . . . 0.0 113.595 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -55.79 -34.6 65.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.12 1.368 . . . . 0.0 112.995 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -60.09 -46.73 88.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.341 0.657 . . . . 0.0 111.679 176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -36.04 82.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.287 0.635 . . . . 0.0 112.65 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -53.03 -40.64 64.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.834 0.743 . . . . 0.0 112.293 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -65.77 -28.16 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.039 -1.038 . . . . 0.0 112.775 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 t -75.12 -52.68 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.579 1.552 . . . . 0.0 108.747 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.71 -38.23 77.84 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.715 1.206 . . . . 0.0 112.462 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -58.75 -58.46 8.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.531 1.132 . . . . 0.0 111.513 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -65.28 -31.31 72.38 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.05 -40.37 82.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.311 1.445 . . . . 0.0 112.398 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.2 -26.72 42.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 119.336 0.971 . . . . 0.0 114.06 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -40.83 71.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.925 1.29 . . . . 0.0 114.179 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.71 4.04 37.65 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.78 67.33 77.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 111.573 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.54 -10.1 24.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.331 2.687 . . . . 0.0 114.341 -169.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.28 -14.25 58.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.43 131.04 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.361 1.064 . . . . 0.0 109.77 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.34 91.48 6.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 0.0 110.645 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mt -100.08 132.34 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.029 0.932 . . . . 0.0 109.531 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -144.79 176.01 9.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.127 0.971 . . . . 0.0 111.658 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 86.4 p -113.76 176.3 5.09 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.897 -1.127 . . . . 0.0 110.599 162.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.0 126.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 124.342 1.057 . . . . 0.0 109.664 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.35 110.42 5.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.863 0.84 . . . . 0.0 110.811 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 p -56.48 -27.2 56.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.611 1.164 . . . . 0.0 113.637 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -77.35 -29.59 53.45 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.436 1.016 . . . . 0.0 113.089 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.33 -24.46 19.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.639 1.176 . . . . 0.0 113.017 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 56.39 9.21 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 126.745 2.018 . . . . 0.0 111.92 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.41 -27.79 18.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.983 2.456 . . . . 0.0 112.507 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -68.54 -25.42 64.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.984 0.811 . . . . 0.0 112.558 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' HD22 ' A' ' 68' ' ' LEU . 7.7 mt -63.61 -56.19 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.166 0.894 . . . . 0.0 110.122 168.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.412 ' HB3' ' H ' ' A' ' 71' ' ' GLU . 17.5 mtm -58.48 -21.01 50.25 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -26.66 51.89 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.99 1.716 . . . . 0.0 112.414 174.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -82.72 -46.47 13.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.76 0.824 . . . . 0.0 111.32 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -82.35 -15.91 51.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 21.72 46.6 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.664 1.126 . . . . 0.0 114.723 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -74.95 -58.9 3.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.404 1.102 . . . . 0.0 111.665 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 65' ' ' MET . 41.0 mt-10 73.71 -29.07 0.19 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.08 3.352 . . . . 0.0 113.975 168.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -163.89 17.73 0.06 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -164.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.32 150.96 63.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.487 1.115 . . . . 0.0 113.943 -170.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.43 86.55 1.58 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 124.445 3.43 . . . . 0.0 110.873 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.7 m -98.67 136.01 39.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.415 1.086 . . . . 0.0 112.446 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.13 128.59 38.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.871 163.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.5 t -119.25 129.93 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.563 1.545 . . . . 0.0 109.16 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -117.56 131.09 56.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.125 0.97 . . . . 0.0 111.623 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.27 125.21 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.013 1.325 . . . . 0.0 109.925 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.32 117.4 29.86 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.661 1.984 . . . . 0.0 110.17 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.18 29.56 11.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.873 2.069 . . . . 0.0 111.805 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.54 85.79 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.48 0.562 . . . . 0.0 114.425 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -101.28 133.07 46.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.852 1.261 . . . . 0.0 108.755 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.07 106.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.179 -0.951 . . . . 0.0 109.297 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.04 -22.09 15.89 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -166.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -161.2 155.78 23.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.452 1.501 . . . . 0.0 110.74 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.7 p -152.7 143.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.306 1.442 . . . . 0.0 110.203 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.71 149.43 20.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.517 1.127 . . . . 0.0 111.566 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 t -112.16 140.68 46.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.336 1.054 . . . . 0.0 112.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.27 -164.62 12.43 Favored Glycine 0 C--N 1.344 1.001 0 C-N-CA 125.24 1.4 . . . . 0.0 114.762 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.96 140.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.122 1.369 . . . . 0.0 111.338 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.8 mtm -139.92 161.77 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.062 1.345 . . . . 0.0 111.701 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -68.37 161.29 70.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.277 0.631 . . . . 0.0 111.313 161.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.33 -32.4 16.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 121.932 1.754 . . . . 0.0 113.53 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -68.45 -32.79 73.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 120.884 1.675 . . . . 0.0 112.402 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -74.83 -30.37 61.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.535 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.81 -35.72 79.12 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.328 0.967 . . . . 0.0 111.833 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -39.97 90.72 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.424 1.011 . . . . 0.0 111.715 171.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.61 87.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.675 0.67 . . . . 0.0 111.866 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.8 tp -66.12 -49.6 66.93 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.848 0.859 . . . . 0.0 110.658 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -43.64 77.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.944 1.297 . . . . 0.0 113.21 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.44 76.17 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.103 0.865 . . . . 0.0 112.001 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.8 m -70.04 1.58 4.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.455 1.502 . . . . 0.0 114.091 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.474 0.767 0 O-C-N 120.739 -1.226 . . . . 0.0 111.294 171.665 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 127.774 2.429 . . . . 0.0 107.147 177.816 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.95 -22.2 63.19 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -84.72 -36.81 21.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.288 0.635 . . . . 0.0 111.611 165.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -79.24 -6.54 56.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -171.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.0 -17.75 30.54 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.54 -4.09 13.75 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.857 1.218 . . . . 0.0 116.064 -171.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.89 166.96 18.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.674 1.237 . . . . 0.0 114.182 -171.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -82.52 -65.13 1.05 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.596 1.158 . . . . 0.0 111.944 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -145.83 125.16 13.04 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.748 1.619 . . . . 0.0 110.04 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.99 159.59 43.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.9 mt -134.23 127.82 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.796 1.638 . . . . 0.0 108.477 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -118.71 127.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.552 1.541 . . . . 0.0 108.827 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -111.2 112.48 24.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.497 1.119 . . . . 0.0 111.197 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -80.29 76.8 7.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.374 1.069 . . . . 0.0 110.795 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.37 174.85 10.74 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.268 1.027 . . . . 0.0 112.729 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -134.21 151.32 51.26 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.873 -1.142 . . . . 0.0 111.535 167.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -62.63 -46.88 86.19 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 112.168 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.46 -32.44 42.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.323 1.049 . . . . 0.0 112.791 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.2 t -57.36 122.95 58.56 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.276 1.43 . . . . 0.0 112.392 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.31 -13.95 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.323 3.349 . . . . 0.0 112.293 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -80.08 -47.5 14.72 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.192 0.906 . . . . 0.0 109.451 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m -52.74 -36.61 58.01 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 113.979 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -37.3 66.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.451 1.1 . . . . 0.0 112.926 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -63.17 -45.52 91.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.51 0.724 . . . . 0.0 111.501 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 tpt -61.61 -33.13 73.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.035 0.934 . . . . 0.0 112.782 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -59.1 -40.46 85.38 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.647 0.658 . . . . 0.0 112.032 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -35.53 62.42 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.38 -0.825 . . . . 0.0 112.264 174.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.17 -47.86 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.789 0.835 . . . . 0.0 110.501 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.96 -37.05 85.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.012 1.725 . . . . 0.0 112.304 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.79 -48.48 76.72 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.02 0.827 . . . . 0.0 112.376 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -35.92 81.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.31 -0.869 . . . . 0.0 112.424 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -66.82 -34.25 77.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.967 1.307 . . . . 0.0 111.937 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.52 -25.29 51.23 Favored Glycine 0 N--CA 1.47 0.933 0 O-C-N 121.001 -1.062 . . . . 0.0 113.73 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.71 67.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.92 22.97 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 114.066 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.53 62.11 61.34 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.939 1.696 . . . . 0.0 111.563 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.29 -13.87 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.201 2.6 . . . . 0.0 114.243 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.04 -4.91 54.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.57 131.63 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 110.705 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.56 101.19 10.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.156 0.983 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.5 mt -94.88 130.5 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.507 -0.745 . . . . 0.0 109.689 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -139.16 152.0 47.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 110.863 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.7 m -115.68 149.98 37.51 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.111 -0.993 . . . . 0.0 111.512 167.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.1 t -139.73 122.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.122 1.369 . . . . 0.0 108.4 -171.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -67.85 113.18 5.37 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.498 1.119 . . . . 0.0 111.241 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -56.99 -27.65 61.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.448 1.499 . . . . 0.0 114.252 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -74.94 -27.93 60.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.069 0.849 . . . . 0.0 112.573 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.04 -27.99 16.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.855 1.262 . . . . 0.0 113.295 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 tpt85 -124.62 40.91 0.55 Allowed Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 125.706 1.602 . . . . 0.0 114.707 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -65.71 -19.69 59.5 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.196 1.931 . . . . 0.0 112.929 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.31 -27.4 62.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.731 1.212 . . . . 0.0 113.487 173.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.89 -54.78 5.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.503 1.121 . . . . 0.0 110.5 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtp -56.15 -31.06 63.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.055 1.342 . . . . 0.0 112.797 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.97 -26.83 68.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 113.143 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -86.51 -36.48 18.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.876 1.271 . . . . 0.0 110.799 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.7 -21.27 26.75 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.45 21.29 15.15 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.759 1.647 . . . . 0.0 115.185 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -83.48 143.26 30.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.773 1.287 . . . . 0.0 111.72 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.39 -72.16 0.57 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.717 0.807 . . . . 0.0 111.781 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.46 30.18 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 114.152 -170.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.11 156.52 52.34 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.425 1.49 . . . . 0.0 111.969 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.95 97.6 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.357 2.705 . . . . 0.0 109.952 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 m -109.5 124.58 51.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.984 0.514 . . . . 0.0 111.574 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.23 135.98 33.41 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.199 1.0 . . . . 0.0 109.328 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.86 125.18 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.299 1.84 . . . . 0.0 108.196 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -107.59 123.31 48.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.076 0.95 . . . . 0.0 111.077 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.3 mm -107.7 114.32 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.013 1.325 . . . . 0.0 108.662 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.1 125.0 53.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.867 1.667 . . . . 0.0 108.551 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.8 t70 66.74 20.5 10.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.056 1.343 . . . . 0.0 112.36 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.65 7.44 87.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.203 0.906 . . . . 0.0 113.856 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -108.99 136.53 48.36 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.829 1.652 . . . . 0.0 109.716 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.7 107.63 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.253 168.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.88 -30.91 11.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.302 1.041 . . . . 0.0 113.627 -170.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.6 158.32 42.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.096 1.358 . . . . 0.0 112.064 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -151.04 147.12 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.457 1.903 . . . . 0.0 108.739 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.01 148.99 31.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.536 0.684 . . . . 0.0 111.171 159.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 m -107.58 128.44 54.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.157 0.983 . . . . 0.0 111.32 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.17 -162.85 23.62 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.438 1.494 . . . . 0.0 113.106 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.84 141.67 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.303 1.441 . . . . 0.0 110.459 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 mtm -139.51 154.98 47.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.41 0.684 . . . . 0.0 112.26 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.94 152.2 84.49 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 123.772 0.829 . . . . 0.0 110.963 165.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.32 -25.15 49.67 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.351 2.034 . . . . 0.0 114.021 -165.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -61.07 -32.37 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -85.97 -28.95 23.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 0.0 111.805 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.8 -27.24 69.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.141 -0.974 . . . . 0.0 112.374 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -58.58 -44.53 89.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.793 0.724 . . . . 0.0 111.696 171.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.47 75.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.243 0.617 . . . . 0.0 111.951 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.28 -45.35 84.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.02 0.528 . . . . 0.0 111.168 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -44.51 94.2 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.423 0.689 . . . . 0.0 111.735 173.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.8 -27.07 66.42 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.075 -1.016 . . . . 0.0 111.938 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 m -67.08 -21.05 65.9 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.627 1.171 . . . . 0.0 113.573 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.481 1.101 0 CA-C-N 119.438 1.017 . . . . 0.0 110.107 174.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 124.825 1.25 . . . . 0.0 111.476 -165.939 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.71 67.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.82 -40.18 63.54 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.467 0.576 . . . . 0.0 110.779 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.24 -9.99 59.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.27 1.028 . . . . 0.0 113.274 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.82 -22.84 23.02 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.019 1.328 . . . . 0.0 112.916 169.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.1 -17.08 9.8 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 -168.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.53 166.3 23.5 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -83.54 -64.91 1.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.321 1.448 . . . . 0.0 112.134 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.13 125.7 12.48 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.806 1.642 . . . . 0.0 109.986 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.99 162.6 39.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.2 mt -135.92 120.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.457 1.503 . . . . 0.0 107.674 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.32 128.21 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.972 1.309 . . . . 0.0 109.267 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -108.01 112.16 24.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.599 1.16 . . . . 0.0 111.547 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -78.38 79.39 4.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.941 1.296 . . . . 0.0 110.464 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.11 175.45 9.98 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.58 149.58 37.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.436 1.494 . . . . 0.0 111.291 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -75.72 -34.97 60.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.7 mt -82.36 -23.98 34.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.478 1.111 . . . . 0.0 113.496 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.02 125.43 91.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 113.573 -167.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.02 -2.27 9.54 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.177 3.918 . . . . 0.0 112.779 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -87.46 -42.76 12.57 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 119.696 1.135 . . . . 0.0 109.5 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 88.5 m -57.24 -37.1 71.79 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -50.79 -37.88 45.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -75.82 -41.08 53.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.873 0.469 . . . . 0.0 111.504 -170.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.284 1.034 . . . . 0.0 112.593 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -55.82 -40.94 73.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.607 1.094 . . . . 0.0 112.165 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -75.29 -33.94 61.27 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.492 -0.755 . . . . 0.0 112.659 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.53 -46.3 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.767 0.827 . . . . 0.0 110.855 174.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.31 -33.4 75.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.526 1.131 . . . . 0.0 112.41 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.25 -48.6 75.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.407 1.003 . . . . 0.0 112.564 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.58 -37.83 79.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.757 0.708 . . . . 0.0 112.247 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -67.85 -34.29 76.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 112.511 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.99 -22.72 60.67 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.877 -1.139 . . . . 0.0 113.643 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.93 -29.07 64.85 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -170.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.8 6.5 15.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.69 1.196 . . . . 0.0 114.224 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.96 63.92 17.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.937 1.695 . . . . 0.0 112.601 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.13 -15.19 32.06 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.275 2.65 . . . . 0.0 113.63 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -81.22 -2.95 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.43 134.11 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.241 1.416 . . . . 0.0 110.666 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.87 101.26 10.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.714 0.806 . . . . 0.0 111.339 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.7 mt -97.74 130.09 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.857 -1.152 . . . . 0.0 109.633 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 p -150.42 164.34 36.13 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.075 0.95 . . . . 0.0 111.677 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.5 p -104.34 176.22 5.23 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.66 -1.275 . . . . 0.0 112.601 165.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -156.02 135.46 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.776 1.631 . . . . 0.0 109.451 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -73.77 109.75 7.51 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.301 1.04 . . . . 0.0 111.446 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -55.12 -29.71 58.25 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.671 1.188 . . . . 0.0 113.931 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.09 -23.32 51.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.082 0.953 . . . . 0.0 112.782 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.92 -24.81 16.82 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.85 1.26 . . . . 0.0 112.783 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -117.46 48.6 0.8 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 126.858 2.063 . . . . 0.0 113.273 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.28 -27.09 24.43 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.566 1.511 . . . . 0.0 112.494 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.01 -32.93 74.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.742 0.701 . . . . 0.0 112.165 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.87 -48.04 67.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.002 0.921 . . . . 0.0 108.973 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.2 mtm -56.92 -22.17 35.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.675 -0.641 . . . . 0.0 112.438 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -13.87 53.22 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.371 0.987 . . . . 0.0 113.352 175.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -82.48 -42.3 18.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.482 1.113 . . . . 0.0 110.788 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.43 -23.98 24.32 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.17 21.63 17.27 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.41 1.481 . . . . 0.0 115.512 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.0 153.64 24.86 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.673 1.236 . . . . 0.0 111.919 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.38 -65.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.079 0.952 . . . . 0.0 111.941 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -159.99 2.16 0.08 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 -165.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.8 m -106.66 159.53 29.54 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 127.521 2.328 . . . . 0.0 112.835 -162.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.81 85.84 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.405 3.403 . . . . 0.0 111.859 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 75.7 m -98.79 128.36 44.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.92 137.78 32.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.698 1.199 . . . . 0.0 109.761 165.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.2 122.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.927 1.691 . . . . 0.0 108.662 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -102.67 118.53 37.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.998 0.919 . . . . 0.0 110.031 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.33 113.18 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.833 1.253 . . . . 0.0 108.853 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.77 121.61 45.76 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.045 1.338 . . . . 0.0 107.849 172.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.2 t70 64.59 21.78 12.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 112.261 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 9.23 84.47 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.403 1.001 . . . . 0.0 113.873 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.6 135.16 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 110.277 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.55 108.27 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 167.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.99 -34.42 10.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.82 150.49 33.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.044 1.738 . . . . 0.0 110.998 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -146.74 145.5 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.571 1.548 . . . . 0.0 108.811 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -148.0 136.57 21.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.539 0.736 . . . . 0.0 111.463 163.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 p -98.2 3.44 48.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.997 1.719 . . . . 0.0 115.08 -171.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.33 -166.19 26.61 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.422 1.486 . . . . 0.0 114.435 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.4 141.35 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.473 1.509 . . . . 0.0 110.086 170.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.6 mtm -137.05 176.02 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 170.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.46 156.17 49.44 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 126.759 2.023 . . . . 0.0 110.005 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.76 -38.2 18.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.903 1.735 . . . . 0.0 113.939 -156.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -61.25 -30.55 70.52 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.291 0.951 . . . . 0.0 113.086 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.18 -31.37 27.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.896 0.878 . . . . 0.0 112.006 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.26 -34.49 76.28 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.039 0.836 . . . . 0.0 112.388 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -48.59 76.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.062 0.945 . . . . 0.0 111.088 167.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.86 -34.93 79.28 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.484 0.714 . . . . 0.0 112.337 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.2 -49.18 70.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 110.329 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -42.41 80.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.225 0.61 . . . . 0.0 112.156 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.19 -36.42 81.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.472 0.578 . . . . 0.0 111.457 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -60.02 -34.98 74.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.838 1.255 . . . . 0.0 112.463 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 124.13 0.972 . . . . 0.0 111.056 175.134 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.549 0.69 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.6 p -158.8 162.27 37.02 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.461 1.504 . . . . 0.0 111.209 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.5 -2.41 35.37 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.71 1.204 . . . . 0.0 113.946 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.6 mm -108.09 112.22 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.626 1.57 . . . . 0.0 108.339 -173.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -128.93 150.08 50.52 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.921 1.288 . . . . 0.0 110.429 -172.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.46 116.0 7.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.847 1.259 . . . . 0.0 110.714 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.3 mt -118.6 112.92 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.919 0.888 . . . . 0.0 109.692 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 p -101.61 -18.29 15.96 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.751 1.221 . . . . 0.0 113.037 164.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 p -69.51 -29.83 67.55 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.863 1.665 . . . . 0.0 113.295 -169.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.01 124.75 14.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.533 1.133 . . . . 0.0 109.336 157.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.38 160.75 15.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.391 1.877 . . . . 0.0 109.933 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.5 -170.08 54.64 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 123.308 0.48 . . . . 0.0 113.045 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -50.01 -37.04 30.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.034 1.334 . . . . 0.0 113.994 -171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -24.82 61.25 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -85.71 -32.6 21.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.048 0.939 . . . . 0.0 111.466 168.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -67.91 -30.96 70.42 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.5 -0.75 . . . . 0.0 111.457 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.2 -15.91 60.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.238 1.415 . . . . 0.0 113.283 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -100.27 -15.47 30.17 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.246 -1.308 . . . . 0.0 115.159 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD11 HG22 ' A' ' 79' ' ' ILE . 1.9 pp -102.9 153.79 19.86 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.274 1.537 . . . . 0.0 114.302 -168.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -99.11 -37.73 9.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.212 1.005 . . . . 0.0 113.284 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -159.88 110.96 1.95 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.211 1.404 . . . . 0.0 109.706 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.97 164.13 37.82 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.872 0.844 . . . . 0.0 113.228 -172.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.05 131.07 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.906 1.682 . . . . 0.0 108.634 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.6 t -124.04 131.0 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.49 1.116 . . . . 0.0 109.521 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 9.1 t80 -105.27 113.52 27.16 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.994 1.317 . . . . 0.0 112.039 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -82.09 75.64 9.01 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.162 1.385 . . . . 0.0 110.607 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -77.24 166.74 22.81 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.866 0.866 . . . . 0.0 113.261 176.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.35 160.39 25.5 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.572 1.149 . . . . 0.0 112.31 173.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -74.4 -56.42 4.88 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.26 -64.96 0.79 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.694 1.198 . . . . 0.0 112.067 -170.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.0 m -51.21 121.97 17.43 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 127.027 2.131 . . . . 0.0 113.677 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.96 -23.06 76.49 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.402 3.401 . . . . 0.0 114.961 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -62.11 -45.04 95.24 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.925 0.89 . . . . 0.0 112.132 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 m -62.16 -34.63 76.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.605 1.162 . . . . 0.0 112.757 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -60.46 -25.23 65.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.743 1.617 . . . . 0.0 113.863 -171.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -70.9 -41.07 71.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.302 1.041 . . . . 0.0 112.572 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.5 tpt -62.7 -29.29 70.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.053 0.941 . . . . 0.0 113.201 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -56.85 -43.09 80.8 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.633 0.773 . . . . 0.0 111.885 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -68.8 -33.83 74.52 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.365 -0.834 . . . . 0.0 110.929 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.77 -48.07 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.709 1.604 . . . . 0.0 110.468 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.59 -34.97 79.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 0.0 112.593 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.31 -52.15 66.87 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.025 0.93 . . . . 0.0 111.196 173.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -67.58 -32.66 73.56 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.85 0.86 . . . . 0.0 112.422 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -68.48 -38.1 80.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.836 1.254 . . . . 0.0 112.408 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.66 -27.8 41.18 Favored Glycine 0 N--CA 1.469 0.878 0 CA-C-N 118.911 0.778 . . . . 0.0 112.73 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.91 -32.84 64.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.348 1.059 . . . . 0.0 113.607 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.43 10.66 37.18 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.769 1.628 . . . . 0.0 114.585 177.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HB1' HE22 ' A' ' 50' ' ' GLN . . . -138.22 73.32 44.36 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.483 1.513 . . . . 0.0 112.324 177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.64 -22.61 73.34 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.566 2.844 . . . . 0.0 115.701 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.422 HE22 ' HB1' ' A' ' 48' ' ' ALA . 1.8 pm0 -86.62 -4.61 59.2 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.21 132.11 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.877 1.271 . . . . 0.0 111.057 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.39 105.34 15.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mt -107.86 135.08 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.958 0.903 . . . . 0.0 110.426 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.0 p -149.3 172.17 15.32 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.427 1.091 . . . . 0.0 112.152 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 82.4 p -116.98 170.27 8.76 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.696 -1.253 . . . . 0.0 111.668 167.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.1 128.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.434 1.094 . . . . 0.0 110.074 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -62.2 111.04 1.8 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.692 1.197 . . . . 0.0 110.467 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.8 p -61.32 -26.55 67.87 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.131 0.972 . . . . 0.0 113.014 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -78.35 -20.4 51.41 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.879 0.763 . . . . 0.0 112.673 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.06 -26.13 20.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.384 1.074 . . . . 0.0 112.399 168.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -117.61 48.21 0.79 Allowed Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 126.055 1.742 . . . . 0.0 114.928 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.82 -17.08 14.19 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.932 2.421 . . . . 0.0 114.189 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.66 -26.8 64.57 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.51 1.05 . . . . 0.0 112.616 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -74.75 -46.83 34.62 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.151 0.432 . . . . 0.0 110.738 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.2 mtm -55.61 -28.69 56.6 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.929 0.891 . . . . 0.0 113.143 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -60.22 -29.8 68.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.644 1.577 . . . . 0.0 113.361 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -91.33 -36.69 13.7 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.923 1.289 . . . . 0.0 111.164 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.87 -19.25 30.86 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.5 18.5 30.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.206 1.384 . . . . 0.0 114.835 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -79.36 151.55 30.92 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.265 1.033 . . . . 0.0 111.537 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -94.42 -72.49 0.61 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.761 1.225 . . . . 0.0 111.405 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.27 15.99 0.16 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.91 1.684 . . . . 0.0 113.147 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.31 157.3 34.35 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 125.349 1.46 . . . . 0.0 111.866 -157.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.31 91.28 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.757 2.972 . . . . 0.0 110.48 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 73.9 m -104.77 126.71 52.13 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 111.606 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.66 126.1 34.77 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 109.296 165.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.91 125.34 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.862 1.665 . . . . 0.0 108.74 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.58 121.29 44.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.511 1.124 . . . . 0.0 110.312 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 19' ' ' LEU . 28.2 mm -108.99 120.73 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.065 1.346 . . . . 0.0 108.978 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -118.47 126.24 51.61 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.912 1.685 . . . . 0.0 109.419 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.77 19.7 9.83 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.366 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.01 2.35 88.37 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 121.223 -0.923 . . . . 0.0 114.627 -174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -103.24 135.91 44.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.078 1.751 . . . . 0.0 109.208 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.76 107.84 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.018 -1.051 . . . . 0.0 110.284 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -95.49 -20.76 18.78 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.596 1.158 . . . . 0.0 113.386 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -162.85 148.83 12.28 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.935 2.094 . . . . 0.0 108.828 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -161.77 144.16 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.391 1.076 . . . . 0.0 110.58 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -157.71 143.03 16.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.42 1.088 . . . . 0.0 112.091 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.3 m -101.88 131.01 48.49 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.099 0.959 . . . . 0.0 110.955 173.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.88 -166.84 23.5 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.503 1.525 . . . . 0.0 113.273 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -120.08 146.07 25.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 126.14 1.776 . . . . 0.0 110.036 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 24.1 ptp -150.18 163.18 38.9 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 165.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.31 158.89 86.51 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.521 1.128 . . . . 0.0 112.53 175.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.78 -16.43 26.39 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.677 2.251 . . . . 0.0 113.707 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -68.14 -47.53 67.84 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.961 1.255 . . . . 0.0 110.237 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -79.05 -27.07 43.09 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.307 1.043 . . . . 0.0 112.79 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.1 tp -61.59 -22.99 65.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.467 -0.771 . . . . 0.0 113.056 174.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -63.2 -42.05 99.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.226 0.61 . . . . 0.0 111.509 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.77 -33.41 70.74 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.44 0.696 . . . . 0.0 112.15 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.46 -50.14 72.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.761 1.224 . . . . 0.0 109.852 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.02 -44.47 96.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.344 1.058 . . . . 0.0 112.935 172.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.68 -38.17 84.07 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.989 0.813 . . . . 0.0 111.834 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -55.68 -32.86 63.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.966 1.306 . . . . 0.0 112.849 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.48 1.041 0 C-N-CA 124.578 1.151 . . . . 0.0 110.803 177.647 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.4 m 71.9 -57.32 0.62 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 128.08 2.552 . . . . 0.0 114.03 169.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.75 36.15 0.49 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.468 1.907 . . . . 0.0 113.268 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 mm -78.39 85.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.206 -0.934 . . . . 0.0 109.425 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.44 175.92 11.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.173 2.189 . . . . 0.0 110.467 -172.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -86.93 114.77 23.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.678 1.191 . . . . 0.0 110.105 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.13 75.65 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 m -47.5 -27.75 1.91 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.097 2.559 . . . . 0.0 114.521 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 p -75.95 -13.32 60.25 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.406 1.882 . . . . 0.0 114.251 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -152.97 -20.33 0.15 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 134.79 56.95 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.997 1.271 . . . . 0.0 112.23 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.64 171.26 12.22 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.284 1.421 . . . . 0.0 112.233 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 ptp -54.41 -35.45 62.91 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -168.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.25 -29.63 68.49 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -75.34 -39.78 59.02 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.614 -0.679 . . . . 0.0 111.295 168.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -71.42 -13.34 61.81 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -91.46 -13.42 32.3 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.833 1.253 . . . . 0.0 113.417 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.64 -17.8 3.79 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 -170.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.11 165.91 22.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.08 1.352 . . . . 0.0 114.206 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.2 m -83.54 -50.32 8.37 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -164.96 114.62 1.1 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.437 1.495 . . . . 0.0 109.955 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.74 160.81 42.84 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.18 122.63 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.916 1.286 . . . . 0.0 107.915 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.79 117.36 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.395 1.478 . . . . 0.0 109.383 -170.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' HB2' HD13 ' A' ' 76' ' ' LEU . 17.6 t80 -102.07 115.09 29.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.925 0.89 . . . . 0.0 112.894 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -81.22 78.04 8.05 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.871 1.268 . . . . 0.0 111.662 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -170.69 3.11 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.649 1.18 . . . . 0.0 113.265 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -142.83 164.91 28.82 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.847 1.659 . . . . 0.0 111.339 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -39.0 -94.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.407 2.283 . . . . 0.0 116.922 -164.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.7 mt -98.01 -22.82 16.07 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.367 1.467 . . . . 0.0 113.842 -174.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 61.0 m -46.71 115.66 3.4 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 127.018 2.127 . . . . 0.0 113.242 -171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -55.2 -24.5 41.86 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.586 3.524 . . . . 0.0 116.196 -175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -55.94 -48.6 75.45 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.256 0.934 . . . . 0.0 112.186 -177.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 94.4 m -70.13 -25.91 63.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.288 1.035 . . . . 0.0 113.318 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -65.4 -30.02 70.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.253 1.021 . . . . 0.0 112.816 -175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.24 -51.49 69.32 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 110.794 169.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.9 tpt -61.67 -41.22 97.24 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.741 1.216 . . . . 0.0 112.906 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -54.54 -37.19 65.13 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.502 -0.749 . . . . 0.0 111.766 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.01 -31.35 62.9 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.525 -1.359 . . . . 0.0 112.092 176.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.9 -44.17 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.706 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.42 -40.76 92.16 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.523 0.729 . . . . 0.0 112.584 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.35 -49.8 75.49 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.544 0.611 . . . . 0.0 112.61 174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.14 -37.6 87.92 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.567 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.18 -38.01 89.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.821 1.248 . . . . 0.0 111.763 172.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.41 -19.11 67.18 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.37 0.986 . . . . 0.0 113.066 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.44 -32.24 68.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.097 0.959 . . . . 0.0 113.453 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 11.01 34.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.575 1.55 . . . . 0.0 114.232 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.68 45.44 0.37 Allowed Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 125.708 1.603 . . . . 0.0 114.328 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.42 -15.46 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.209 2.606 . . . . 0.0 114.088 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -79.46 -7.93 58.76 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.74 133.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.653 1.115 . . . . 0.0 108.048 163.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.62 85.25 4.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.831 0.824 . . . . 0.0 110.286 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mt -92.06 130.32 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.4 p -144.54 172.05 13.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.088 0.947 . . . . 0.0 112.085 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.6 p -128.28 154.27 46.07 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.14 -0.975 . . . . 0.0 110.343 169.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.0 t -139.9 126.32 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.828 1.251 . . . . 0.0 108.528 -169.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.88 100.04 0.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.152 1.381 . . . . 0.0 110.832 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 52.0 p -54.44 -36.71 64.34 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.569 1.147 . . . . 0.0 113.146 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.61 -26.95 67.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.311 1.844 . . . . 0.0 114.088 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.09 -17.29 16.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.414 1.486 . . . . 0.0 112.994 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -121.13 51.05 2.28 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.54 1.936 . . . . 0.0 112.377 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.33 -24.25 43.64 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 121.737 1.624 . . . . 0.0 111.553 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.48 -26.3 67.87 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 113.073 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.16 -55.18 6.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.821 0.848 . . . . 0.0 109.5 168.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 mtm -57.54 -24.01 53.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.479 1.112 . . . . 0.0 113.369 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -70.37 -28.47 65.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.748 1.619 . . . . 0.0 111.696 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -80.96 -38.05 28.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.255 1.022 . . . . 0.0 111.007 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.93 -22.5 21.94 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.04 22.84 16.35 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.65 1.595 . . . . 0.0 115.024 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.11 153.63 25.97 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.663 1.232 . . . . 0.0 111.76 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -102.58 -70.6 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.353 1.061 . . . . 0.0 112.377 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -157.34 3.58 0.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -165.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.48 156.88 38.78 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 126.07 1.748 . . . . 0.0 113.02 -162.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.66 93.33 0.17 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.034 3.156 . . . . 0.0 110.261 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.2 m -103.41 129.77 50.58 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.253 1.021 . . . . 0.0 110.429 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.402 HD13 ' HB2' ' A' ' 25' ' ' PHE . 12.5 tp -110.07 119.52 39.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.89 0.876 . . . . 0.0 110.061 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 t -117.13 129.15 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.343 1.457 . . . . 0.0 109.079 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -111.21 118.73 36.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.824 0.849 . . . . 0.0 109.901 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.451 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 30.1 mm -107.21 114.36 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.18 1.392 . . . . 0.0 109.148 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -108.28 118.57 37.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.771 1.228 . . . . 0.0 108.586 173.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.05 22.34 13.39 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.99 1.316 . . . . 0.0 113.209 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.63 10.47 70.15 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.372 0.987 . . . . 0.0 113.149 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -112.51 131.83 55.39 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.156 1.382 . . . . 0.0 109.37 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.16 106.09 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 121.625 -0.672 . . . . 0.0 109.419 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.01 -20.15 15.52 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -162.27 153.52 17.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.917 1.687 . . . . 0.0 110.448 -175.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.13 144.9 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.96 1.304 . . . . 0.0 110.807 172.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.89 162.33 35.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.933 1.293 . . . . 0.0 109.814 165.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.7 p -130.98 140.91 50.21 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.411 0.685 . . . . 0.0 112.589 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.74 19.05 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.693 1.616 . . . . 0.0 112.386 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 35.1 mm -125.63 145.33 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.222 1.809 . . . . 0.0 110.135 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.8 ptp -147.36 -149.06 0.27 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.746 0.818 . . . . 0.0 111.473 164.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.85 160.06 38.97 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.519 1.528 . . . . 0.0 110.43 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.78 -34.49 11.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.612 1.542 . . . . 0.0 113.815 -153.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -59.14 -32.25 69.7 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.53 -32.55 32.23 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.083 0.953 . . . . 0.0 111.838 172.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.5 tp -65.62 -30.08 70.75 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.275 -0.891 . . . . 0.0 112.543 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.7 -37.55 73.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.05 0.841 . . . . 0.0 112.015 169.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.26 71.47 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 120.969 -1.082 . . . . 0.0 112.211 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.19 -39.96 90.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.726 -0.609 . . . . 0.0 111.37 175.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.58 -48.29 80.1 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.204 1.002 . . . . 0.0 112.123 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.7 -32.89 74.07 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 120.82 -1.175 . . . . 0.0 112.718 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.3 t -64.57 -13.53 53.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.787 1.635 . . . . 0.0 113.331 174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.474 0.736 0 O-C-N 120.658 -1.276 . . . . 0.0 110.719 170.854 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.0 mmm . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 121.441 0.639 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 m -74.54 -45.06 48.07 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.855 0.862 . . . . 0.0 112.591 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.76 -15.23 17.02 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.6 mm -117.56 126.1 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.45 1.5 . . . . 0.0 111.081 -169.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.43 160.76 23.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.448 1.099 . . . . 0.0 112.558 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.09 118.45 6.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.82 2.448 . . . . 0.0 112.459 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mt -120.27 55.92 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 122.648 1.213 . . . . 0.0 111.477 168.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 59.7 m -48.88 -30.53 5.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.898 2.879 . . . . 0.0 114.556 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -76.77 -69.71 0.5 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.454 1.902 . . . . 0.0 111.328 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -74.51 -25.2 59.2 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.31 117.28 5.02 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 120.624 1.556 . . . . 0.0 112.251 -175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 163.25 163.76 16.71 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 125.22 1.39 . . . . 0.0 113.27 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -52.76 -37.26 59.24 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.356 1.462 . . . . 0.0 114.765 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.8 -25.87 63.06 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -82.82 -32.76 27.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.662 . . . . 0.0 111.916 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.89 -28.83 68.64 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.807 -0.558 . . . . 0.0 111.221 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.41 -7.05 16.81 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.567 -1.333 . . . . 0.0 114.042 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.11 -4.72 61.16 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.151 1.358 . . . . 0.0 115.506 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 67.3 mt -77.65 159.27 29.29 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.625 1.713 . . . . 0.0 115.215 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -87.09 -51.65 5.88 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.014 143.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -161.55 135.23 6.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.16 1.784 . . . . 0.0 112.586 -175.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.04 162.98 38.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.218 1.407 . . . . 0.0 112.916 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -139.33 132.5 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.057 1.343 . . . . 0.0 108.707 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.07 123.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 125.012 1.325 . . . . 0.0 109.631 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -102.77 110.72 22.75 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.646 1.178 . . . . 0.0 111.621 175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -79.02 70.29 5.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.962 1.705 . . . . 0.0 110.845 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.81 -171.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.182 0.993 . . . . 0.0 113.561 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -136.27 163.35 30.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.644 1.178 . . . . 0.0 111.329 172.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -72.39 -60.89 2.01 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.284 1.033 . . . . 0.0 112.716 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.91 -41.9 35.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.648 1.179 . . . . 0.0 112.342 -169.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.2 m -47.59 108.51 0.9 Allowed Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 126.667 1.987 . . . . 0.0 114.191 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -62.09 -30.27 82.32 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 123.377 2.718 . . . . 0.0 113.926 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -64.88 -38.26 90.39 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.8 m -61.81 -32.54 72.85 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.955 0.902 . . . . 0.0 113.109 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.67 -29.1 69.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.709 0.804 . . . . 0.0 112.758 -174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -63.58 -43.47 96.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.573 0.749 . . . . 0.0 111.626 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.9 mmm -66.31 -26.08 67.15 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 118.364 -0.827 . . . . 0.0 112.745 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.76 -44.69 89.26 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.531 1.06 . . . . 0.0 111.512 169.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -62.23 -43.92 97.73 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.996 -1.065 . . . . 0.0 112.226 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.45 -48.38 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.342 1.057 . . . . 0.0 111.051 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.4 mt -63.47 -37.11 86.03 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.005 0.922 . . . . 0.0 112.961 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.72 -47.86 81.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.432 0.693 . . . . 0.0 111.119 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.05 -32.54 72.97 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.913 0.885 . . . . 0.0 113.17 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.11 -36.45 83.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.683 1.593 . . . . 0.0 111.782 172.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.19 -22.5 62.95 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-N 118.917 0.78 . . . . 0.0 112.445 -176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.09 -28.71 64.85 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.715 1.206 . . . . 0.0 113.904 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 9.79 29.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.503 1.521 . . . . 0.0 114.256 176.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.46 85.73 14.88 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.381 1.472 . . . . 0.0 111.338 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.02 -15.03 18.78 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.878 2.385 . . . . 0.0 114.52 -169.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -95.97 -12.62 24.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.11 1.323 . . . . 0.0 113.874 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.69 129.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 110.226 -178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.96 92.99 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.371 0.605 . . . . 0.0 110.36 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 mt -92.96 136.24 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 109.988 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.5 p -148.15 168.55 22.16 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.5 1.12 . . . . 0.0 112.688 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -118.25 168.84 10.22 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.989 -1.069 . . . . 0.0 110.636 164.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 p -156.77 131.48 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.33 1.052 . . . . 0.0 109.487 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -70.45 115.51 9.72 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.875 1.27 . . . . 0.0 111.873 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.7 p -57.05 -27.72 61.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.824 1.25 . . . . 0.0 113.826 172.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.53 -23.32 50.19 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.306 0.957 . . . . 0.0 112.498 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.79 -39.94 9.2 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.912 1.285 . . . . 0.0 113.108 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -126.89 60.58 41.73 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.559 1.544 . . . . 0.0 112.71 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -70.42 -15.95 34.71 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.395 2.73 . . . . 0.0 111.777 167.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -54.11 -41.18 68.01 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.606 1.563 . . . . 0.0 112.156 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.56 -44.05 62.64 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.336 0.654 . . . . 0.0 111.675 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.5 mtp -56.41 -28.94 60.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.711 0.805 . . . . 0.0 112.184 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -17.95 60.77 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.634 1.174 . . . . 0.0 113.505 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -81.06 -40.65 23.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.13 1.372 . . . . 0.0 110.822 174.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.52 -26.16 38.28 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.325 0.65 . . . . 0.0 112.481 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.79 16.51 23.78 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.906 1.717 . . . . 0.0 114.791 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -78.56 140.61 38.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.086 1.443 . . . . 0.0 110.691 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -77.29 -77.17 0.15 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.955 0.502 . . . . 0.0 110.778 175.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -147.79 4.56 0.76 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.443 1.497 . . . . 0.0 114.88 -171.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.9 m -86.29 155.89 57.17 Favored Pre-proline 0 N--CA 1.482 1.151 0 C-N-CA 126.579 1.952 . . . . 0.0 113.198 -166.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.43 82.96 2.36 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 124.533 3.489 . . . . 0.0 111.294 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.4 m -96.38 130.88 43.4 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.139 0.976 . . . . 0.0 112.683 -169.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mp -93.47 122.96 36.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.79 1.236 . . . . 0.0 108.987 164.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.17 126.04 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.553 1.541 . . . . 0.0 108.745 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -110.04 117.11 32.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.882 0.873 . . . . 0.0 109.856 -174.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.1 mm -109.7 126.66 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.922 1.289 . . . . 0.0 110.101 -172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -114.31 121.15 42.77 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.964 1.706 . . . . 0.0 108.622 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.9 t70 60.73 27.71 17.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 119.666 1.121 . . . . 0.0 111.927 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.4 -3.14 83.1 Favored Glycine 0 N--CA 1.47 0.944 0 N-CA-C 116.66 1.424 . . . . 0.0 116.66 -174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -99.56 132.05 45.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.499 1.52 . . . . 0.0 109.65 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.12 104.02 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.378 -0.826 . . . . 0.0 109.572 173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.71 -20.49 21.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.252 1.021 . . . . 0.0 113.107 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -163.03 155.61 18.75 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.21 1.804 . . . . 0.0 110.717 -173.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.35 146.42 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.093 1.357 . . . . 0.0 111.031 172.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -149.45 149.49 30.87 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.3 1.44 . . . . 0.0 108.575 169.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.2 t -134.01 140.13 46.49 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.133 -0.979 . . . . 0.0 112.08 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.84 -144.53 18.22 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.671 1.129 . . . . 0.0 112.27 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.7 mm -116.96 143.26 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.322 1.449 . . . . 0.0 111.399 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.1 ptp -155.73 169.87 23.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.937 0.895 . . . . 0.0 113.185 160.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -83.53 162.44 53.38 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 125.725 1.61 . . . . 0.0 112.129 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.95 -30.65 21.06 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.089 1.859 . . . . 0.0 114.655 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.7 -28.78 60.96 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.319 1.418 . . . . 0.0 113.027 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.1 -25.19 47.42 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.577 -0.702 . . . . 0.0 112.545 164.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.84 -30.65 67.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.948 1.249 . . . . 0.0 111.953 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -59.32 -44.67 92.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.261 0.937 . . . . 0.0 111.086 163.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.52 72.56 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.257 0.935 . . . . 0.0 112.743 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.82 -48.22 72.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.127 1.371 . . . . 0.0 110.196 173.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -57.72 -42.24 83.43 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.935 0.894 . . . . 0.0 112.204 170.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.69 67.71 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.072 -1.018 . . . . 0.0 111.865 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.8 m -76.96 -10.7 59.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.583 1.553 . . . . 0.0 113.169 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.477 0.902 0 CA-C-N 119.391 0.996 . . . . 0.0 108.536 162.561 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.9 mtp . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 t -67.03 146.63 54.14 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.678 1.191 . . . . 0.0 112.118 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.6 -9.99 59.05 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.8 mm -108.81 124.73 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.281 1.433 . . . . 0.0 110.931 -170.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -175.63 173.43 2.41 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.89 2.476 . . . . 0.0 111.704 -172.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -72.41 120.88 18.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.444 1.098 . . . . 0.0 110.263 159.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.9 mt -91.82 130.01 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.885 0.874 . . . . 0.0 109.499 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.9 p -75.18 -18.0 60.26 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.641 1.577 . . . . 0.0 114.455 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 m -66.82 -49.29 66.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.568 1.547 . . . . 0.0 111.922 -174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -178.15 141.23 0.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.034 2.133 . . . . 0.0 110.667 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.3 133.88 4.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.668 1.587 . . . . 0.0 110.599 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.19 176.16 14.46 Favored Glycine 0 N--CA 1.47 0.908 0 C-N-CA 124.913 1.244 . . . . 0.0 112.653 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp -56.11 -32.91 64.63 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -165.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.89 70.51 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -74.73 -40.13 61.46 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.609 -0.682 . . . . 0.0 110.678 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -73.92 -9.8 59.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -92.07 -16.21 26.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.436 1.494 . . . . 0.0 113.173 169.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.79 -19.05 6.63 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 -171.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.63 166.4 22.82 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -82.72 -65.72 0.98 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.266 1.426 . . . . 0.0 113.013 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -148.42 121.79 9.05 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.603 1.561 . . . . 0.0 109.669 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.46 161.54 39.47 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 58.3 mt -138.16 123.17 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.645 1.578 . . . . 0.0 107.936 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -114.0 121.96 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.268 1.427 . . . . 0.0 108.314 -175.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -100.4 107.68 19.5 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.92 0.888 . . . . 0.0 110.802 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.11 80.74 3.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.721 1.208 . . . . 0.0 109.83 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.87 -178.31 7.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.708 1.203 . . . . 0.0 111.913 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -127.36 139.59 52.76 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.276 -1.515 . . . . 0.0 110.953 161.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -57.3 -32.75 66.97 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 125.696 1.598 . . . . 0.0 114.02 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -80.66 -37.97 29.93 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 113.209 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.0 t -57.5 118.13 23.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.934 1.694 . . . . 0.0 113.713 -168.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -65.48 -24.98 56.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.151 3.234 . . . . 0.0 113.381 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -77.01 -40.94 44.75 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.798 0.727 . . . . 0.0 110.957 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 78.7 m -52.83 -34.66 55.01 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.754 1.222 . . . . 0.0 113.959 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -55.98 -39.73 72.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.076 0.95 . . . . 0.0 112.303 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -65.2 -47.02 78.36 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.626 0.77 . . . . 0.0 110.841 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 5.6 tpt -60.66 -36.08 77.81 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.715 1.206 . . . . 0.0 112.176 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -63.63 -37.77 88.58 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.689 -1.257 . . . . 0.0 112.759 172.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -34.01 74.67 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.818 1.19 . . . . 0.0 112.476 171.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.07 -48.77 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-N 119.14 0.882 . . . . 0.0 110.385 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.97 -34.09 77.0 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.682 1.193 . . . . 0.0 112.087 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -62.13 -49.47 75.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.704 1.138 . . . . 0.0 111.475 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -66.57 -33.97 76.85 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.696 -0.627 . . . . 0.0 112.391 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -63.35 -42.61 98.92 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.944 1.298 . . . . 0.0 111.261 170.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.82 -26.52 45.29 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 124.295 0.95 . . . . 0.0 112.619 -171.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.28 68.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.166 0.986 . . . . 0.0 113.428 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.32 8.27 35.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.618 1.567 . . . . 0.0 114.269 175.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.22 45.24 0.89 Allowed Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 126.257 1.823 . . . . 0.0 113.202 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.22 -15.74 51.52 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.751 2.967 . . . . 0.0 114.531 -167.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -76.84 -9.18 58.51 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.36 130.53 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.822 1.192 . . . . 0.0 108.529 162.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.57 96.05 6.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.301 0.641 . . . . 0.0 110.674 174.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mt -104.87 130.13 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.135 -0.978 . . . . 0.0 109.48 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.0 p -148.82 170.75 17.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.054 0.942 . . . . 0.0 112.325 -177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.2 p -129.89 153.63 48.12 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.017 -1.052 . . . . 0.0 112.896 174.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.87 134.54 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.677 1.591 . . . . 0.0 109.154 -168.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -83.46 121.04 26.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 123.026 1.393 . . . . 0.0 113.159 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 p -62.6 -23.71 67.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.861 1.664 . . . . 0.0 114.979 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.28 -45.1 10.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.031 1.287 . . . . 0.0 111.823 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.07 -26.92 43.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.709 1.204 . . . . 0.0 113.671 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.56 54.51 14.6 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 125.746 1.618 . . . . 0.0 112.038 -171.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.19 -9.67 13.91 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.318 3.345 . . . . 0.0 113.675 -171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -66.27 -21.78 66.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.801 0.84 . . . . 0.0 112.509 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.67 -54.25 6.05 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.77 1.228 . . . . 0.0 110.92 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.5 mtm -55.74 -30.01 60.51 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -74.2 -14.24 60.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.731 0.812 . . . . 0.0 112.803 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -89.04 -38.71 14.19 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.656 1.183 . . . . 0.0 110.538 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -85.46 -22.52 28.23 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 17.27 26.39 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.788 1.661 . . . . 0.0 115.061 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -79.56 140.58 37.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.016 1.408 . . . . 0.0 110.835 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.98 -59.36 1.78 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.618 0.767 . . . . 0.0 112.19 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -157.04 1.67 0.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 m -101.64 152.72 38.13 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.796 1.638 . . . . 0.0 113.028 -163.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.86 91.7 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 124.093 3.196 . . . . 0.0 110.396 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 56.6 m -107.2 124.83 50.3 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 0.0 112.47 -172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.56 129.25 37.57 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.274 0.63 . . . . 0.0 109.859 166.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.17 127.98 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.77 1.628 . . . . 0.0 108.401 171.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -105.64 127.84 53.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.424 1.09 . . . . 0.0 109.757 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.7 115.84 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.055 0.942 . . . . 0.0 108.674 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.43 123.93 50.8 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.131 1.373 . . . . 0.0 108.879 171.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 65.58 20.22 11.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.199 1.4 . . . . 0.0 112.681 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.11 12.56 82.29 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 113.694 -172.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -107.71 134.82 50.13 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.699 1.6 . . . . 0.0 109.754 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.74 105.12 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.96 -27.81 13.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -162.05 154.27 19.36 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.035 1.334 . . . . 0.0 110.579 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.2 145.77 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.878 1.271 . . . . 0.0 110.701 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.16 144.92 25.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.007 0.923 . . . . 0.0 111.17 165.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 m -111.52 120.17 41.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.122 0.969 . . . . 0.0 110.523 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.53 -164.74 29.89 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 124.926 1.25 . . . . 0.0 114.382 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.3 mm -112.2 140.53 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.429 1.492 . . . . 0.0 109.7 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 56.0 mtm -142.6 161.32 38.39 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.781 0.833 . . . . 0.0 112.338 167.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -76.01 161.06 76.93 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 125.508 1.523 . . . . 0.0 112.064 167.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.31 -25.25 22.06 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.243 1.962 . . . . 0.0 114.453 -173.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -76.67 -35.99 57.59 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.031 1.287 . . . . 0.0 112.543 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -77.5 -25.42 50.33 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.017 0.826 . . . . 0.0 112.784 172.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.29 -25.96 68.15 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.183 -0.948 . . . . 0.0 112.4 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -63.9 -38.76 92.29 Favored 'General case' 0 C--N 1.342 0.281 0 O-C-N 121.553 -0.717 . . . . 0.0 111.877 172.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.88 -35.31 79.72 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.66 0.664 . . . . 0.0 112.038 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.4 tp -68.01 -42.94 79.92 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.467 0.707 . . . . 0.0 111.118 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.26 -43.37 98.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.806 0.843 . . . . 0.0 112.185 171.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.57 87.72 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.46 -0.775 . . . . 0.0 111.131 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 63.3 m -66.58 -4.07 7.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.004 1.722 . . . . 0.0 114.846 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 119.082 0.855 . . . . 0.0 110.58 166.862 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 t -132.4 147.06 52.37 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.35 1.46 . . . . 0.0 112.397 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.08 -6.02 47.27 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.244 1.417 . . . . 0.0 114.041 173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.5 mm -100.2 120.74 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.578 1.551 . . . . 0.0 109.799 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 -123.04 148.98 44.98 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.766 1.626 . . . . 0.0 110.276 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -82.07 105.34 13.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.461 0.704 . . . . 0.0 109.128 167.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mt -104.14 60.84 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 122.199 0.999 . . . . 0.0 109.819 -174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 m -44.45 -39.32 4.67 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 128.134 2.573 . . . . 0.0 113.303 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 m -69.12 -41.59 77.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.48 1.912 . . . . 0.0 112.195 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -83.73 -23.75 31.48 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.229 1.012 . . . . 0.0 112.244 177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.2 51.92 0.44 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.529 1.932 . . . . 0.0 114.796 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.36 148.47 18.7 Favored Glycine 0 N--CA 1.47 0.962 0 C-N-CA 125.201 1.382 . . . . 0.0 110.329 160.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp -55.54 -31.68 62.32 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.71 -26.24 66.92 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -68.31 -43.24 78.08 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.123 0.874 . . . . 0.0 110.73 170.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -75.78 -9.71 58.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.236 1.014 . . . . 0.0 112.907 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -92.01 -14.33 29.57 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.046 1.338 . . . . 0.0 113.218 167.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.05 -15.71 6.04 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -170.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.73 174.29 8.61 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 p -88.37 -60.06 2.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.411 1.485 . . . . 0.0 113.497 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -158.47 115.59 2.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.218 1.407 . . . . 0.0 110.36 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.08 160.74 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -168.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.7 mt -137.43 128.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.949 1.7 . . . . 0.0 109.106 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -115.73 135.07 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.131 1.372 . . . . 0.0 109.458 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -116.07 114.79 25.03 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 111.729 172.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -83.94 74.24 10.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.941 1.696 . . . . 0.0 111.31 -175.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.73 -170.14 2.01 Favored 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.2 ptpt -157.25 170.84 21.56 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.611 1.564 . . . . 0.0 113.323 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -47.57 -102.9 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 128.827 2.851 . . . . 0.0 116.951 -173.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.7 -15.73 41.35 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.015 -1.678 . . . . 0.0 114.629 -168.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -49.18 119.93 9.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 125.681 1.592 . . . . 0.0 112.494 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -68.31 -25.71 36.11 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.319 2.679 . . . . 0.0 113.732 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -70.93 -43.23 68.65 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 119.366 0.985 . . . . 0.0 112.179 -168.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 p -67.22 -25.1 65.94 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -61.68 -28.68 69.57 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.114 0.966 . . . . 0.0 113.595 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -63.21 -44.69 94.6 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.415 0.686 . . . . 0.0 111.903 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -60.88 -30.63 70.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.416 1.086 . . . . 0.0 113.002 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -60.74 -35.37 76.19 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.404 0.682 . . . . 0.0 111.786 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' HE3' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -69.67 -34.09 73.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.525 1.057 . . . . 0.0 111.035 176.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 t -69.62 -46.35 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 126.014 1.726 . . . . 0.0 109.362 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 31.8 mt -61.96 -41.67 98.26 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.379 1.872 . . . . 0.0 112.658 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -56.62 -52.42 64.94 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.616 1.166 . . . . 0.0 111.97 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -66.47 -32.96 74.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.049 -1.032 . . . . 0.0 112.551 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -68.24 -34.3 75.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.896 1.278 . . . . 0.0 112.311 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.84 46.01 Favored Glycine 0 N--CA 1.468 0.788 0 O-C-N 121.002 -1.061 . . . . 0.0 112.657 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.96 65.56 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.157 1.383 . . . . 0.0 114.537 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 4.84 23.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.976 1.31 . . . . 0.0 114.086 175.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.72 40.59 0.62 Allowed Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 125.701 1.6 . . . . 0.0 114.034 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -65.56 -13.28 39.01 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.641 2.894 . . . . 0.0 114.685 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -77.83 -9.02 58.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 173.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.75 132.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.21 0.914 . . . . 0.0 108.903 161.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.26 92.65 5.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.332 0.587 . . . . 0.0 110.324 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.8 mt -102.16 131.1 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.253 1.021 . . . . 0.0 109.667 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.5 p -147.16 159.43 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.716 0.806 . . . . 0.0 112.369 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.0 p -98.14 163.6 12.67 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.213 -0.929 . . . . 0.0 111.145 163.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 t -147.99 129.17 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.602 1.561 . . . . 0.0 108.8 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.12 108.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.685 0.794 . . . . 0.0 110.188 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.6 p -52.55 -41.18 63.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.897 1.279 . . . . 0.0 111.88 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.14 -22.22 66.37 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.96 1.704 . . . . 0.0 114.223 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.06 -14.59 22.8 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.115 1.366 . . . . 0.0 113.4 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 84.4 mmt-85 -131.9 49.61 4.82 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.79 1.636 . . . . 0.0 113.959 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -67.53 -26.35 40.29 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.431 2.087 . . . . 0.0 112.209 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -60.81 -41.28 95.35 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.913 0.885 . . . . 0.0 111.703 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.97 -50.34 72.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.735 0.814 . . . . 0.0 110.996 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 64.9 mtp -57.63 -22.87 48.02 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.629 0.771 . . . . 0.0 113.022 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -14.03 52.94 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.561 1.144 . . . . 0.0 112.813 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -83.58 -41.35 17.98 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.343 1.057 . . . . 0.0 110.599 170.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.31 -24.72 32.05 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.86 21.47 20.98 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 125.172 1.368 . . . . 0.0 115.018 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -82.14 145.69 29.98 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.11 1.455 . . . . 0.0 111.508 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -80.91 -75.2 0.29 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 111.343 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -161.13 13.41 0.1 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -166.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.0 m -100.21 155.62 36.2 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 126.389 1.876 . . . . 0.0 113.255 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.56 90.26 1.05 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.16 3.24 . . . . 0.0 110.846 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -99.73 132.45 45.06 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 112.595 -173.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.56 131.52 35.54 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.474 1.11 . . . . 0.0 109.71 161.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.65 121.92 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.776 1.631 . . . . 0.0 108.302 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -108.04 124.12 49.71 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.125 0.97 . . . . 0.0 110.687 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.1 mm -111.54 122.74 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.171 1.388 . . . . 0.0 109.51 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -116.9 124.16 48.78 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.445 1.498 . . . . 0.0 109.192 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.1 t70 62.65 20.54 12.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.166 1.386 . . . . 0.0 112.362 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.71 8.98 86.18 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.083 -1.011 . . . . 0.0 113.521 -173.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -103.74 132.55 49.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.544 1.537 . . . . 0.0 109.073 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.82 105.4 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.324 -0.86 . . . . 0.0 109.039 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.43 -24.75 15.98 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.492 1.117 . . . . 0.0 113.387 -170.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -160.51 146.87 15.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.444 1.498 . . . . 0.0 110.801 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.2 t -147.51 145.52 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 109.826 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.26 151.5 29.2 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.976 0.911 . . . . 0.0 111.44 162.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 66.8 m -115.95 135.28 54.12 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.624 0.77 . . . . 0.0 111.944 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.89 -149.4 17.83 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.935 1.255 . . . . 0.0 112.593 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.4 mm -118.19 139.65 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.571 1.548 . . . . 0.0 110.76 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -139.22 160.48 39.7 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.448 1.099 . . . . 0.0 112.044 163.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -74.0 162.11 75.49 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 124.76 1.224 . . . . 0.0 111.869 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.89 -23.71 12.12 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.09 1.86 . . . . 0.0 114.676 -173.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -72.8 -37.33 67.59 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 121.137 1.79 . . . . 0.0 112.607 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -78.81 -22.88 45.59 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.653 0.66 . . . . 0.0 112.151 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.6 tp -61.64 -29.57 70.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 0.0 112.09 168.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -64.74 -39.4 93.56 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.239 0.927 . . . . 0.0 111.393 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.51 -36.19 80.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.503 -0.748 . . . . 0.0 111.93 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.41 -44.6 90.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.166 0.586 . . . . 0.0 110.686 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.18 -47.44 86.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.19 0.996 . . . . 0.0 112.693 172.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.16 76.52 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.13 -0.982 . . . . 0.0 112.351 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.1 t -65.58 -14.34 60.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.382 1.473 . . . . 0.0 113.737 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.4 mt . . . . . 0 N--CA 1.48 1.038 0 O-C-N 119.988 -1.695 . . . . 0.0 110.588 172.682 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtm . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 121.157 0.503 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -76.89 42.57 0.31 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.219 1.408 . . . . 0.0 112.829 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.8 -3.32 37.73 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -103.7 107.86 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.09 1.756 . . . . 0.0 107.548 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mmm-85 -140.4 164.46 30.06 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.412 1.485 . . . . 0.0 111.637 -166.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -57.48 109.67 0.73 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.789 2.036 . . . . 0.0 111.693 167.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.42 121.21 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.988 1.315 . . . . 0.0 108.902 176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.0 p -64.86 -29.81 70.79 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.732 1.613 . . . . 0.0 114.626 -174.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.5 p -87.45 -15.24 38.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.432 1.493 . . . . 0.0 113.959 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -124.21 28.16 6.83 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.438 1.495 . . . . 0.0 112.071 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.53 166.78 23.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.745 1.618 . . . . 0.0 111.972 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.65 147.68 22.42 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.889 1.233 . . . . 0.0 111.401 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp -52.33 -31.6 34.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.074 1.35 . . . . 0.0 114.596 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.86 -28.93 63.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -74.16 -39.11 63.46 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.656 -0.652 . . . . 0.0 110.413 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.41 -14.98 61.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 113.302 -174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -89.49 -20.14 24.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.629 1.172 . . . . 0.0 112.846 171.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.24 -23.47 6.97 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 124.896 1.236 . . . . 0.0 115.081 -171.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.25 165.65 23.2 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -172.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -89.1 -56.22 3.37 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.987 1.315 . . . . 0.0 113.003 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -155.34 110.54 3.02 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.898 1.279 . . . . 0.0 110.65 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.84 159.75 42.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.7 mt -135.29 129.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.508 1.523 . . . . 0.0 108.445 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -121.28 124.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.613 1.565 . . . . 0.0 109.57 -175.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -104.06 119.22 38.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 0.0 110.813 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -85.05 76.29 10.27 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.098 -1.001 . . . . 0.0 110.455 175.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.22 173.08 11.81 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.682 0.753 . . . . 0.0 112.931 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -125.68 147.66 49.27 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.694 1.198 . . . . 0.0 110.772 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.84 148.27 30.63 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 67.61 -30.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.907 2.883 . . . . 0.0 115.296 175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.4 t -52.13 117.55 10.42 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 126.019 1.728 . . . . 0.0 113.305 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.91 -24.64 74.19 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.194 3.263 . . . . 0.0 113.602 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -72.61 -43.27 63.52 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 119.226 0.921 . . . . 0.0 110.585 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 83.5 m -58.6 -33.26 69.79 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.023 0.929 . . . . 0.0 113.065 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -54.72 -39.8 68.59 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.174 0.989 . . . . 0.0 112.501 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -58.39 -48.13 81.63 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.549 0.74 . . . . 0.0 110.959 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.5 tpt -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.738 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -60.31 -43.09 96.66 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.209 0.913 . . . . 0.0 111.325 172.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -41.93 85.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.581 0.752 . . . . 0.0 112.43 173.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.86 -46.96 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.873 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.7 mt -65.28 -34.09 77.53 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.114 1.365 . . . . 0.0 112.609 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -62.68 -46.46 88.07 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 118.9 0.773 . . . . 0.0 112.158 169.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -68.86 -35.16 76.59 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.289 -0.882 . . . . 0.0 112.033 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -64.76 -37.67 88.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.405 1.482 . . . . 0.0 111.848 171.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.49 -22.02 57.17 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 123.863 0.744 . . . . 0.0 113.369 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.1 -33.74 67.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.264 1.026 . . . . 0.0 113.332 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.15 10.08 41.28 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.327 1.451 . . . . 0.0 114.601 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.75 48.83 0.74 Allowed Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.629 1.572 . . . . 0.0 113.709 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.36 -16.96 57.89 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.591 2.861 . . . . 0.0 114.023 -169.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -79.09 -8.28 58.84 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -77.53 134.12 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-N 119.545 1.066 . . . . 0.0 108.685 166.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.23 86.73 4.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.466 0.651 . . . . 0.0 110.647 172.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.5 mt -93.27 127.19 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.748 0.819 . . . . 0.0 109.178 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.2 t -141.52 164.42 30.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.768 1.227 . . . . 0.0 110.906 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 t -110.42 -175.92 2.85 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 162.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.4 p -167.28 129.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.357 1.863 . . . . 0.0 109.222 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -72.55 114.71 10.98 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.193 0.997 . . . . 0.0 111.075 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 p -54.91 -28.09 48.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.153 1.381 . . . . 0.0 113.601 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -74.9 -26.65 59.8 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.989 0.813 . . . . 0.0 112.675 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.18 -29.41 15.13 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.942 1.297 . . . . 0.0 113.415 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -127.81 49.83 4.77 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 125.18 1.392 . . . . 0.0 113.962 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.3 -19.93 49.48 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.937 1.758 . . . . 0.0 112.376 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.26 1.024 . . . . 0.0 112.86 174.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.85 -54.27 7.58 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.2 mtp -55.53 -33.31 63.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.578 1.151 . . . . 0.0 113.351 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -65.98 -21.29 66.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.695 1.598 . . . . 0.0 113.768 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -76.88 -40.14 48.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.847 0.749 . . . . 0.0 111.968 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.91 -22.56 24.31 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.81 11.86 36.41 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.337 1.922 . . . . 0.0 115.179 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -75.75 130.77 39.17 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.213 1.507 . . . . 0.0 111.68 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -84.12 -55.15 4.35 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.071 0.949 . . . . 0.0 112.169 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ptt180 -160.41 -0.35 0.07 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.46 154.5 44.38 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 125.554 1.542 . . . . 0.0 113.4 -160.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -72.8 89.02 0.88 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.455 3.437 . . . . 0.0 109.469 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.3 m -105.2 132.67 51.11 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.829 0.851 . . . . 0.0 112.609 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -88.96 134.75 33.86 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.7 1.2 . . . . 0.0 110.471 166.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.5 t -130.31 131.46 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.783 1.633 . . . . 0.0 108.685 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -110.08 128.68 55.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.055 0.942 . . . . 0.0 110.65 -176.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.9 mm -109.86 110.49 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.0 123.75 50.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.284 1.433 . . . . 0.0 108.202 174.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.18 17.49 8.37 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.758 1.223 . . . . 0.0 112.038 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.52 83.18 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.077 0.846 . . . . 0.0 113.639 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -110.08 135.96 50.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.266 1.826 . . . . 0.0 109.397 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.09 106.29 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -107.94 -20.88 13.04 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -163.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -159.19 153.74 24.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.99 1.316 . . . . 0.0 111.436 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.65 144.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.734 1.614 . . . . 0.0 110.388 177.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -154.01 143.36 21.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.539 1.136 . . . . 0.0 112.011 165.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 m -101.19 135.58 42.42 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.927 0.891 . . . . 0.0 112.069 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.69 -162.72 12.32 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.914 1.245 . . . . 0.0 113.682 173.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 44.4 mm -103.44 140.85 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.778 1.631 . . . . 0.0 111.285 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.8 mtm -134.79 153.21 52.12 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.467 1.107 . . . . 0.0 110.388 160.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.13 152.57 71.3 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 122.749 0.419 . . . . 0.0 110.978 169.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.81 -27.32 51.86 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.29 1.993 . . . . 0.0 114.264 -156.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -63.89 -30.04 71.17 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.12 -37.79 64.0 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.994 0.816 . . . . 0.0 111.008 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 22.6 tp -65.3 -28.24 69.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.47 -0.776 . . . . 0.0 112.819 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -59.1 -49.38 78.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.982 0.81 . . . . 0.0 111.574 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.9 -37.6 84.68 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.578 0.751 . . . . 0.0 111.77 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -67.24 -43.54 81.69 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-O 118.755 -0.64 . . . . 0.0 110.837 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.89 -47.01 87.48 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.425 1.09 . . . . 0.0 112.131 172.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.35 -36.88 85.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.461 0.573 . . . . 0.0 111.739 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.2 m -62.48 -11.35 15.65 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.655 1.582 . . . . 0.0 114.372 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.478 0.951 0 O-C-N 121.08 -1.013 . . . . 0.0 112.032 175.917 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.5 p -164.81 168.09 18.15 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.437 1.495 . . . . 0.0 112.191 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.86 0.73 14.59 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.54 1.536 . . . . 0.0 114.21 172.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mm -101.52 125.53 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.521 1.929 . . . . 0.0 108.382 -174.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -116.05 146.33 42.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.521 1.129 . . . . 0.0 109.893 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.05 116.09 12.05 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 163.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mt -128.73 49.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 122.183 0.992 . . . . 0.0 111.93 172.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 72.8 m -46.17 -35.0 4.69 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.038 2.135 . . . . 0.0 113.563 169.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -63.85 -41.53 97.78 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.462 1.905 . . . . 0.0 112.734 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -84.3 -13.74 51.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.387 1.075 . . . . 0.0 113.411 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.08 31.0 0.07 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -168.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.2 148.54 34.53 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.52 1.057 . . . . 0.0 110.541 166.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -56.77 -29.12 62.33 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.95 -25.27 64.46 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.719 1.208 . . . . 0.0 113.95 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -70.18 -31.16 68.5 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.105 0.866 . . . . 0.0 111.752 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -75.66 -20.63 58.32 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.943 0.897 . . . . 0.0 113.003 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.91 82.28 0.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.132 1.773 . . . . 0.0 113.075 -172.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 134.87 3.06 2.98 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 126.313 1.911 . . . . 0.0 116.927 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.5 mt -74.48 114.33 12.75 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 120.14 1.97 . . . . 0.0 111.971 -174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -66.5 -28.33 68.48 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.746 -1.221 . . . . 0.0 114.045 -175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -155.85 97.06 1.8 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.556 1.542 . . . . 0.0 109.777 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.85 156.77 46.55 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mt -141.29 132.28 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.963 1.305 . . . . 0.0 109.347 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -113.58 126.57 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.322 1.449 . . . . 0.0 109.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -106.01 108.18 19.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.579 1.152 . . . . 0.0 110.419 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -77.56 76.38 4.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.852 1.261 . . . . 0.0 110.392 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.98 -172.37 2.31 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.847 0.859 . . . . 0.0 111.701 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -147.15 130.61 16.72 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.118 -1.614 . . . . 0.0 112.05 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.85 -23.91 61.4 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.189 1.552 . . . . 0.0 115.189 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.8 mt -89.86 -15.5 32.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.8 t -85.45 122.26 73.52 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.81 1.644 . . . . 0.0 111.884 -173.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -84.7 -1.26 9.53 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.71 3.606 . . . . 0.0 113.04 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -88.43 -44.81 10.46 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 119.378 0.99 . . . . 0.0 109.741 174.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 p -61.93 -27.75 69.05 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -50.6 -38.96 48.55 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -71.98 -33.5 68.19 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.019 -0.425 . . . . 0.0 112.128 -168.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.1 tpt -64.0 -24.13 67.6 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.936 1.294 . . . . 0.0 113.266 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -65.17 -42.92 93.22 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 118.952 0.797 . . . . 0.0 110.927 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -75.95 -24.22 55.45 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.998 -1.064 . . . . 0.0 112.215 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.71 -51.9 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.023 0.929 . . . . 0.0 109.923 164.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 28.1 mt -60.14 -34.76 73.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.147 1.379 . . . . 0.0 112.619 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -58.21 -56.4 22.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.662 1.185 . . . . 0.0 111.972 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -64.5 -32.7 74.45 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.911 0.485 . . . . 0.0 111.414 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -67.21 -43.81 81.13 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.786 1.634 . . . . 0.0 112.979 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.97 -23.5 57.32 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 120.635 -1.291 . . . . 0.0 111.684 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.44 -29.71 64.4 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 8.04 45.39 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.66 41.8 0.33 Allowed Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.786 1.634 . . . . 0.0 114.836 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.62 -22.19 16.4 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.62 3.547 . . . . 0.0 117.548 -157.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -60.69 -14.51 21.32 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.7 p -73.67 129.39 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 119.716 1.144 . . . . 0.0 111.289 176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.8 98.59 11.8 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.867 0.867 . . . . 0.0 110.797 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.6 mt -103.73 132.15 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.823 0.849 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 t -136.05 133.61 37.58 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.32 1.048 . . . . 0.0 110.38 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 m -86.12 155.16 20.89 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.622 -1.299 . . . . 0.0 111.531 164.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.3 t -143.72 128.86 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.642 1.577 . . . . 0.0 109.069 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -73.99 104.47 4.84 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.09 1.356 . . . . 0.0 110.564 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.8 p -56.19 -36.48 68.44 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.632 1.173 . . . . 0.0 113.468 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.57 -16.84 58.38 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.22 -22.19 19.18 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.944 1.298 . . . . 0.0 112.88 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -116.72 52.92 1.11 Allowed Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 125.878 1.671 . . . . 0.0 114.577 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.35 -18.07 26.74 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.7 2.267 . . . . 0.0 113.088 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -64.03 -38.14 89.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.368 0.985 . . . . 0.0 111.776 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.9 -51.99 22.78 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.607 1.163 . . . . 0.0 109.96 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.1 mtm -54.62 -32.18 58.46 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.095 0.958 . . . . 0.0 113.36 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -70.02 -19.95 63.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.012 1.325 . . . . 0.0 113.925 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -79.05 -39.92 32.64 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.769 0.713 . . . . 0.0 112.025 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.07 -22.45 21.81 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.69 15.77 28.32 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.786 1.66 . . . . 0.0 114.963 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -79.76 156.88 27.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 119.186 1.493 . . . . 0.0 111.626 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -98.03 -53.63 3.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.181 0.993 . . . . 0.0 112.654 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 168.67 17.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 129.101 2.96 . . . . 0.0 113.595 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 m -98.6 160.15 28.69 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 126.461 1.904 . . . . 0.0 111.912 -170.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -70.06 82.93 0.78 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.021 3.147 . . . . 0.0 112.516 -174.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 32.2 m -103.01 128.21 49.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.153 0.581 . . . . 0.0 112.363 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 mp -94.22 120.6 34.69 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.541 1.137 . . . . 0.0 109.51 169.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.71 123.67 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 126.396 1.879 . . . . 0.0 108.1 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -107.0 120.03 40.97 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.887 0.875 . . . . 0.0 109.365 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.492 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 10.8 mm -108.23 121.65 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.187 1.395 . . . . 0.0 109.705 -168.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.492 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.37 122.34 47.15 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.833 1.653 . . . . 0.0 109.101 163.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.5 t70 60.09 25.54 14.83 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.714 1.606 . . . . 0.0 112.621 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.03 1.61 90.63 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.254 1.262 . . . . 0.0 116.254 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -105.99 128.74 54.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.404 1.082 . . . . 0.0 108.924 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -60.07 109.96 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.416 0.686 . . . . 0.0 109.974 172.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.05 20.22 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.92 1.288 . . . . 0.0 113.494 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -163.8 152.07 13.26 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.364 1.866 . . . . 0.0 109.456 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.8 p -151.32 144.22 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.782 1.233 . . . . 0.0 110.971 175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.17 31.78 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.431 1.493 . . . . 0.0 109.525 168.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.8 t -126.04 139.29 53.53 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 112.675 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.78 -154.43 17.02 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 125.931 1.729 . . . . 0.0 112.626 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.3 mm -118.2 143.83 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.31 1.444 . . . . 0.0 110.765 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -151.49 161.63 42.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.768 0.827 . . . . 0.0 112.418 161.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.38 149.54 86.7 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.021 0.929 . . . . 0.0 111.836 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.62 -31.47 79.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.003 2.469 . . . . 0.0 113.95 -168.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -52.99 -36.19 60.1 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -89.25 -29.99 18.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.757 0.708 . . . . 0.0 111.975 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -62.0 -30.25 70.82 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.664 0.786 . . . . 0.0 112.027 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.3 mm-40 -56.08 -44.24 78.79 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.766 0.712 . . . . 0.0 111.895 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.36 -27.6 60.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.23 1.012 . . . . 0.0 112.521 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -70.89 -39.24 72.93 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 109.618 176.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -70.6 -36.7 73.66 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.046 1.338 . . . . 0.0 112.859 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.51 80.9 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.748 -1.22 . . . . 0.0 112.605 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.8 t -59.27 -20.65 56.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.964 0.905 . . . . 0.0 113.04 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.474 0.744 0 O-C-N 121.109 -0.994 . . . . 0.0 109.539 167.193 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtm . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -76.45 18.19 0.33 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 126.666 1.986 . . . . 0.0 114.052 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.72 147.98 3.54 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 129.03 2.932 . . . . 0.0 108.493 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 mm -99.36 101.44 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.815 0.846 . . . . 0.0 109.085 -172.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.62 -179.65 7.79 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.552 1.941 . . . . 0.0 109.814 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -81.19 121.01 25.6 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.237 1.015 . . . . 0.0 111.35 169.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.8 mt -93.61 93.23 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.959 0.904 . . . . 0.0 108.881 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -50.51 -29.77 11.35 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.783 2.033 . . . . 0.0 113.122 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -71.24 -27.68 63.64 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.268 1.827 . . . . 0.0 112.545 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -165.97 89.6 0.42 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.281 1.432 . . . . 0.0 111.545 -170.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -161.68 165.14 28.61 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.389 2.276 . . . . 0.0 110.201 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.02 165.42 36.77 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.889 1.233 . . . . 0.0 112.51 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 ptp -54.51 -30.86 54.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -171.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.52 -29.16 64.46 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -74.8 -41.35 60.14 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.74 -0.6 . . . . 0.0 110.557 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -72.93 -11.32 60.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.5 -17.3 27.31 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.03 1.332 . . . . 0.0 113.645 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -117.79 -16.19 5.98 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.59 171.0 13.24 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 p -91.4 -51.96 5.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.978 1.311 . . . . 0.0 113.166 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -160.46 109.05 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.879 1.672 . . . . 0.0 110.095 -171.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.09 158.82 44.56 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.4 mt -134.64 130.14 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 0.0 109.064 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.5 t -119.09 125.7 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.563 1.545 . . . . 0.0 109.133 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -106.04 113.82 27.59 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.492 1.117 . . . . 0.0 111.311 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -78.94 69.38 5.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.723 1.209 . . . . 0.0 111.637 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -77.48 170.38 16.66 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.843 0.857 . . . . 0.0 112.898 -176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -129.54 176.93 7.59 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.38 1.472 . . . . 0.0 111.21 168.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -100.51 -33.02 10.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.985 0.914 . . . . 0.0 113.437 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.38 -68.03 0.57 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.058 0.943 . . . . 0.0 112.934 -167.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.9 m -59.07 150.67 60.66 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.369 1.868 . . . . 0.0 114.138 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.14 -13.79 21.02 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 124.787 3.658 . . . . 0.0 113.19 171.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -66.83 -48.46 68.82 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 119.014 0.825 . . . . 0.0 111.969 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.0 p -61.14 -29.84 70.02 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.107 1.363 . . . . 0.0 113.597 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -55.82 -32.99 64.05 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.011 1.324 . . . . 0.0 112.557 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -62.94 -48.2 79.91 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.611 1.164 . . . . 0.0 111.73 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 mmt -63.24 -34.79 78.44 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.321 -0.862 . . . . 0.0 112.798 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.47 -36.37 73.62 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.267 0.939 . . . . 0.0 112.533 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -79.17 -38.67 35.35 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.29 -51.43 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.046 0.938 . . . . 0.0 110.946 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.41 -33.86 75.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.793 1.237 . . . . 0.0 113.001 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.79 -49.96 70.85 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.302 0.641 . . . . 0.0 111.367 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -67.63 -32.14 72.63 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.395 -0.816 . . . . 0.0 112.885 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -66.36 -39.74 89.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.091 1.356 . . . . 0.0 111.966 170.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.32 -26.14 52.7 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 124.133 0.873 . . . . 0.0 112.343 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.66 -32.6 65.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 10.11 34.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.168 1.387 . . . . 0.0 114.297 174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.36 50.89 1.18 Allowed Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 126.102 1.761 . . . . 0.0 112.857 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.01 -14.4 44.31 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 123.641 2.894 . . . . 0.0 114.22 -168.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -78.64 -8.8 59.03 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.3 t -78.57 131.48 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.481 1.037 . . . . 0.0 108.357 165.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.53 96.16 6.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.07 0.548 . . . . 0.0 110.894 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.4 mt -103.84 131.48 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.274 -0.891 . . . . 0.0 109.667 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 96.2 p -148.21 172.76 13.82 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.918 0.887 . . . . 0.0 112.333 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.8 p -121.63 162.96 19.76 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.093 -1.004 . . . . 0.0 111.165 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.9 t -143.78 122.76 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.253 1.421 . . . . 0.0 107.712 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.0 103.92 0.51 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.325 1.45 . . . . 0.0 110.527 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.7 p -58.76 -36.21 74.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.613 1.165 . . . . 0.0 112.35 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -75.1 -18.2 60.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.181 1.792 . . . . 0.0 113.893 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.07 -26.62 9.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.786 1.235 . . . . 0.0 113.527 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -126.86 51.94 7.19 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 126.171 1.788 . . . . 0.0 112.921 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -65.85 -14.98 47.17 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.746 2.297 . . . . 0.0 112.939 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -57.28 -23.39 48.12 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.759 1.224 . . . . 0.0 113.182 171.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.98 -58.1 3.47 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 122.991 0.516 . . . . 0.0 110.682 166.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.8 mtm -57.22 -27.81 62.33 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.058 1.343 . . . . 0.0 113.748 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.56 -15.94 62.82 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.033 1.333 . . . . 0.0 112.726 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -87.29 -36.76 17.71 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.361 1.064 . . . . 0.0 111.296 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.97 -25.8 22.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 19.16 14.04 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.626 1.584 . . . . 0.0 115.264 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.97 145.85 28.32 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.409 1.605 . . . . 0.0 111.551 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -96.0 -62.62 1.25 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.668 0.787 . . . . 0.0 112.665 -176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -157.47 2.63 0.12 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -163.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.9 m -106.46 150.3 39.35 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 126.028 1.731 . . . . 0.0 112.769 -163.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.13 92.74 0.55 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.23 3.287 . . . . 0.0 109.553 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.3 m -105.08 131.98 51.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.865 0.866 . . . . 0.0 111.857 -172.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -93.53 134.54 35.7 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.489 1.116 . . . . 0.0 110.247 168.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.97 131.25 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.623 1.569 . . . . 0.0 108.89 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -115.06 123.94 50.32 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.283 1.033 . . . . 0.0 110.282 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.8 mm -108.08 120.69 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.141 1.376 . . . . 0.0 108.822 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -113.94 122.93 48.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.298 1.839 . . . . 0.0 108.869 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.7 t70 63.62 20.93 12.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.395 1.078 . . . . 0.0 112.902 173.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.22 84.46 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.278 -0.888 . . . . 0.0 113.256 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -108.34 133.04 53.09 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.157 1.783 . . . . 0.0 109.285 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.88 107.59 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.41 -0.806 . . . . 0.0 109.508 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.6 -25.2 15.22 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -170.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -160.96 150.85 17.36 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.397 1.479 . . . . 0.0 110.932 -171.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.94 143.23 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.546 1.538 . . . . 0.0 110.529 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -153.38 140.34 19.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.222 1.009 . . . . 0.0 111.404 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.4 p -97.77 133.15 42.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.735 1.214 . . . . 0.0 111.756 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 119.78 -168.09 13.58 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.112 1.339 . . . . 0.0 113.343 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 mm -112.18 143.37 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.368 1.467 . . . . 0.0 112.019 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.1 mtm -135.5 163.44 30.08 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.622 1.169 . . . . 0.0 111.947 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -68.14 161.37 68.88 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.629 1.172 . . . . 0.0 111.433 164.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.76 -27.1 15.23 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.965 1.777 . . . . 0.0 113.972 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -72.84 -34.0 66.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 120.489 1.495 . . . . 0.0 112.646 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.2 -26.33 56.03 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.372 -0.83 . . . . 0.0 112.457 171.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.52 -30.73 71.52 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.845 -1.159 . . . . 0.0 111.941 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.3 mm-40 -61.11 -44.84 96.72 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.877 0.762 . . . . 0.0 111.201 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.5 75.38 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.257 0.623 . . . . 0.0 112.352 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.08 76.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.343 1.057 . . . . 0.0 109.87 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.97 -45.48 94.59 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.317 1.047 . . . . 0.0 112.089 173.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.23 77.7 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.21 -0.931 . . . . 0.0 112.459 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.8 t -63.62 -13.26 40.61 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.857 1.663 . . . . 0.0 113.452 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.471 0.575 0 O-C-N 120.674 -1.266 . . . . 0.0 109.992 169.715 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptm . . . . . 0 CA--C 1.539 0.519 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 m 55.56 -121.97 1.77 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.579 1.551 . . . . 0.0 112.517 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.56 0.7 28.79 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -106.71 125.16 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.702 1.201 . . . . 0.0 110.319 -172.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.67 162.4 26.92 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.774 1.63 . . . . 0.0 111.312 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -82.94 112.79 20.04 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.56 1.144 . . . . 0.0 108.39 162.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.8 mt -127.29 123.92 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.095 1.358 . . . . 0.0 109.326 -172.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.8 p -55.37 -33.07 63.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.556 1.542 . . . . 0.0 114.519 -170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.2 p -85.11 -13.24 50.88 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.898 1.679 . . . . 0.0 114.043 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -130.99 22.4 4.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.993 1.317 . . . . 0.0 113.16 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.88 164.25 35.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.52 1.528 . . . . 0.0 112.555 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.69 153.58 28.27 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.899 1.238 . . . . 0.0 111.487 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.9 ptp -56.94 -26.77 60.16 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.18 -21.18 62.2 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -84.43 -39.22 19.23 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.615 -0.678 . . . . 0.0 110.57 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -78.62 -7.96 58.15 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.023 1.119 . . . . 0.0 114.023 -169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.7 -13.47 45.31 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.87 7.86 1.09 Allowed Glycine 0 N--CA 1.478 1.469 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.23 173.06 9.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.971 1.386 . . . . 0.0 113.416 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -83.38 -61.03 1.95 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.113 0.965 . . . . 0.0 112.411 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -157.54 120.81 4.02 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.264 1.826 . . . . 0.0 110.18 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.21 159.19 43.62 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.7 mt -130.95 130.75 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.533 1.533 . . . . 0.0 109.153 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.4 t -120.73 121.97 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.685 1.594 . . . . 0.0 109.273 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.51 114.87 29.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.242 1.017 . . . . 0.0 111.824 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -79.78 72.3 6.48 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.905 1.282 . . . . 0.0 111.073 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.43 170.73 16.16 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 124.115 0.966 . . . . 0.0 113.147 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -142.13 168.55 19.47 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.741 1.216 . . . . 0.0 111.938 170.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -93.13 -39.65 10.93 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -165.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 mt -77.45 -39.92 45.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.45 0.7 . . . . 0.0 112.718 -173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.5 t -65.49 128.84 94.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.149 1.379 . . . . 0.0 111.693 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.26 -13.74 18.75 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 124.461 3.44 . . . . 0.0 112.94 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -73.9 -45.65 49.38 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 120.167 1.349 . . . . 0.0 111.918 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.5 m -53.67 -35.81 61.45 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.82 1.248 . . . . 0.0 113.339 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.5 -31.93 68.33 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.512 1.525 . . . . 0.0 112.889 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -72.47 -44.07 62.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.668 0.787 . . . . 0.0 111.187 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.7 tpt -58.88 -38.85 79.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.483 1.513 . . . . 0.0 112.566 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -53.67 -41.24 66.63 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.514 0.725 . . . . 0.0 112.168 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -72.29 -23.53 61.2 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.928 -1.107 . . . . 0.0 113.693 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.7 t -69.65 -45.96 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.109 0.963 . . . . 0.0 109.748 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.8 -37.61 82.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.089 0.955 . . . . 0.0 111.828 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -57.68 -52.24 66.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.089 0.956 . . . . 0.0 111.948 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -68.46 -30.03 68.8 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.478 0.711 . . . . 0.0 112.817 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.95 -34.66 76.99 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.922 0.889 . . . . 0.0 111.833 170.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -25.59 61.2 Favored Glycine 0 N--CA 1.471 1.032 0 O-C-N 121.064 -1.023 . . . . 0.0 113.632 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.55 63.24 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -171.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 7.41 10.88 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.209 1.403 . . . . 0.0 114.52 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.95 47.89 2.84 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.86 1.664 . . . . 0.0 113.529 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.75 -16.32 54.7 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.726 2.951 . . . . 0.0 114.431 -169.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -76.81 -6.66 53.24 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.7 t -85.1 127.49 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 162.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.79 103.77 11.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 0.0 109.711 170.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.6 mt -108.04 128.79 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.056 -1.028 . . . . 0.0 109.367 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -146.98 167.38 24.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.866 0.866 . . . . 0.0 112.125 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.82 165.51 12.99 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.855 -1.153 . . . . 0.0 111.741 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.07 121.46 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.932 1.293 . . . . 0.0 108.33 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.75 102.53 0.35 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.065 1.346 . . . . 0.0 110.42 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 79.6 p -58.93 -31.23 68.48 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.362 0.665 . . . . 0.0 112.421 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.72 -26.69 65.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.592 1.957 . . . . 0.0 113.362 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.16 -27.76 8.99 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.981 1.312 . . . . 0.0 113.661 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.8 mpp_? -116.26 65.22 2.91 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 127.493 2.317 . . . . 0.0 110.724 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.48 -22.51 33.27 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.516 2.144 . . . . 0.0 111.963 168.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.9 -24.53 66.06 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.639 1.176 . . . . 0.0 113.204 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.48 -59.99 2.48 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.056 0.942 . . . . 0.0 110.052 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.5 mtm -58.51 -25.85 62.83 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 113.371 -173.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -65.7 -24.54 67.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.199 1.0 . . . . 0.0 112.35 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -87.3 -36.3 17.96 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.533 1.133 . . . . 0.0 111.37 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.92 -24.17 22.53 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.22 13.73 32.62 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.746 1.641 . . . . 0.0 115.161 175.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -77.08 146.87 36.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.371 1.585 . . . . 0.0 111.209 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -101.85 -61.81 1.34 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.602 0.761 . . . . 0.0 112.195 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.98 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.512 1.925 . . . . 0.0 111.614 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.72 150.6 31.0 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.988 1.315 . . . . 0.0 112.457 -166.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.29 85.75 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.284 3.323 . . . . 0.0 109.911 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.2 m -102.62 129.76 49.29 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.36 0.664 . . . . 0.0 111.341 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 mp -93.63 126.48 38.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.048 0.939 . . . . 0.0 108.913 164.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.63 129.4 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.122 1.769 . . . . 0.0 108.277 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -110.59 124.47 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 mm -109.21 122.79 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.828 1.251 . . . . 0.0 109.179 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -117.75 126.46 52.5 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.567 1.547 . . . . 0.0 108.574 170.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.1 t70 63.28 17.79 10.51 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.429 1.091 . . . . 0.0 112.965 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.07 11.22 81.55 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.282 0.944 . . . . 0.0 113.809 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -109.58 138.5 45.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.568 1.947 . . . . 0.0 109.807 176.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.74 108.37 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.84 -25.49 15.02 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -174.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -160.12 154.07 23.04 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.092 1.757 . . . . 0.0 110.342 -174.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.88 143.85 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.849 1.26 . . . . 0.0 110.19 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.9 143.64 27.52 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.344 1.058 . . . . 0.0 110.87 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 t -110.91 132.68 54.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.859 1.264 . . . . 0.0 110.83 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.46 -152.83 20.36 Favored Glycine 0 N--CA 1.468 0.813 0 C-N-CA 124.721 1.153 . . . . 0.0 114.324 171.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.0 mm -122.39 146.53 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 126.688 1.995 . . . . 0.0 110.371 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 16.9 ptp -153.22 -169.55 3.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.489 1.516 . . . . 0.0 111.011 169.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.9 163.86 40.71 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.052 1.341 . . . . 0.0 111.072 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.54 -23.33 31.91 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.737 1.625 . . . . 0.0 114.432 -156.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -67.93 -30.49 69.82 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.715 1.143 . . . . 0.0 113.4 171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -74.32 -35.72 63.66 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.085 0.954 . . . . 0.0 111.251 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.5 tp -64.94 -24.95 67.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.164 0.585 . . . . 0.0 112.469 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -64.39 -43.78 93.37 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.946 0.794 . . . . 0.0 111.632 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.52 -38.3 84.06 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.485 0.584 . . . . 0.0 111.611 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.57 -44.25 91.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.523 0.729 . . . . 0.0 111.272 177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -45.6 93.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.817 0.847 . . . . 0.0 112.22 170.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.38 -32.5 74.17 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.009 0.822 . . . . 0.0 111.892 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.4 m -68.31 -5.27 17.72 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.654 1.582 . . . . 0.0 114.564 173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.479 1.004 0 O-C-N 121.054 -1.029 . . . . 0.0 110.798 171.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m -72.93 132.78 43.89 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.479 1.112 . . . . 0.0 112.157 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.77 104.47 2.52 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.899 1.28 . . . . 0.0 108.856 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm -86.25 80.39 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.563 0.697 . . . . 0.0 110.798 -165.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -145.48 164.62 31.04 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 126.204 1.802 . . . . 0.0 110.541 174.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -51.93 115.47 1.7 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.806 2.442 . . . . 0.0 112.007 164.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.6 mt -108.06 124.75 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.863 1.265 . . . . 0.0 108.015 166.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.8 p -84.9 -24.13 28.6 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.222 1.409 . . . . 0.0 113.413 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 p -94.46 -76.2 0.49 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.837 1.655 . . . . 0.0 111.813 -167.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.77 -19.27 63.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.233 1.013 . . . . 0.0 113.361 -170.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.63 44.62 0.54 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.63 1.172 . . . . 0.0 113.247 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.69 148.61 18.64 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.329 1.442 . . . . 0.0 110.388 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.3 ptp -55.92 -30.25 61.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.85 -27.57 67.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -70.61 -39.01 74.02 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.802 1.183 . . . . 0.0 110.658 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -72.19 -9.48 58.5 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.328 1.051 . . . . 0.0 113.077 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.65 -15.66 32.21 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.221 1.408 . . . . 0.0 113.395 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.51 -13.44 4.26 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.636 1.414 . . . . 0.0 116.636 -168.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.89 174.06 9.77 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -96.52 -54.68 3.17 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -149.5 124.25 9.85 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.006 1.323 . . . . 0.0 109.654 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.27 160.12 43.94 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.3 mt -140.0 132.11 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.231 1.412 . . . . 0.0 108.436 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 t -125.66 129.66 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.689 1.196 . . . . 0.0 109.288 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -109.07 117.44 34.17 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.807 0.843 . . . . 0.0 112.032 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -81.92 71.82 8.96 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.844 1.258 . . . . 0.0 110.622 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -174.23 1.05 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.85 0.86 . . . . 0.0 113.271 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -138.73 141.3 38.89 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.803 -1.186 . . . . 0.0 112.177 170.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -61.97 -32.18 72.6 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.345 1.058 . . . . 0.0 113.699 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.6 mt -81.68 -83.9 0.11 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.901 1.28 . . . . 0.0 111.765 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 71.0 m -44.19 118.98 3.29 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 127.901 2.48 . . . . 0.0 114.235 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.45 -17.57 23.67 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.042 3.161 . . . . 0.0 113.611 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -63.72 -44.21 94.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 119.037 0.835 . . . . 0.0 111.663 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.3 p -66.91 -27.02 67.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -62.61 -28.03 69.62 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.735 1.214 . . . . 0.0 112.515 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -64.63 -39.21 93.3 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.75 0.82 . . . . 0.0 112.502 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.2 tpp -62.28 -35.72 79.87 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.559 1.144 . . . . 0.0 112.026 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -50.61 -42.01 55.52 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.476 -0.765 . . . . 0.0 112.863 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -84.11 -12.38 55.12 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.278 1.031 . . . . 0.0 113.255 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 69.8 t -78.58 -47.32 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 125.274 1.43 . . . . 0.0 109.935 168.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.57 -37.01 74.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.522 1.529 . . . . 0.0 112.65 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.39 -53.86 52.45 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.886 0.874 . . . . 0.0 111.697 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -64.97 -30.68 71.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.629 0.772 . . . . 0.0 112.801 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -70.96 -41.98 70.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.417 1.087 . . . . 0.0 111.379 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.96 -29.75 30.72 Favored Glycine 0 N--CA 1.47 0.943 0 C-N-CA 124.649 1.118 . . . . 0.0 113.206 -170.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -33.72 67.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.95 9.5 38.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.686 1.595 . . . . 0.0 114.179 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.93 65.34 73.85 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 125.678 1.591 . . . . 0.0 112.357 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.42 -20.77 71.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.168 2.579 . . . . 0.0 115.144 -171.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -83.42 -6.89 59.6 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -171.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 133.04 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.671 1.189 . . . . 0.0 109.442 171.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.42 102.59 14.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.193 0.597 . . . . 0.0 110.682 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.9 mt -108.24 130.65 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.889 0.876 . . . . 0.0 110.943 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 89.8 p -151.36 177.56 10.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.193 1.397 . . . . 0.0 112.803 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -124.27 167.04 14.86 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.503 -1.373 . . . . 0.0 113.227 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -149.16 135.69 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.719 2.008 . . . . 0.0 108.272 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.04 119.84 23.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.091 0.948 . . . . 0.0 112.164 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.6 p -61.0 -28.0 68.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.542 1.537 . . . . 0.0 114.12 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -87.31 -34.46 18.86 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.528 0.731 . . . . 0.0 111.919 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.98 -22.95 27.07 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.577 1.151 . . . . 0.0 113.945 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -121.67 42.54 0.59 Allowed Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 125.654 1.582 . . . . 0.0 114.374 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -68.01 -19.56 45.55 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.668 2.245 . . . . 0.0 113.052 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.05 -22.67 65.93 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.053 0.941 . . . . 0.0 113.121 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.8 -54.91 5.39 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.765 0.711 . . . . 0.0 110.415 166.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 mtm -56.19 -28.88 59.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.664 1.186 . . . . 0.0 113.63 -174.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -68.95 -18.91 64.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.022 1.329 . . . . 0.0 113.004 177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -85.93 -34.65 20.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.435 1.094 . . . . 0.0 110.798 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.76 -25.51 23.37 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.46 15.58 22.67 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.82 1.676 . . . . 0.0 115.296 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.38 144.61 30.41 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.884 1.842 . . . . 0.0 111.151 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -89.1 -56.52 3.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.983 0.913 . . . . 0.0 112.668 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -169.83 7.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -167.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -100.26 149.71 36.29 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.011 1.724 . . . . 0.0 112.959 -165.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.8 95.22 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.882 3.055 . . . . 0.0 110.292 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.2 m -114.89 130.39 56.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.768 0.827 . . . . 0.0 112.778 -170.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.95 134.67 33.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.725 1.61 . . . . 0.0 109.825 168.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.5 132.3 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.755 1.622 . . . . 0.0 109.216 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -116.93 127.67 54.46 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.144 0.978 . . . . 0.0 111.016 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -112.62 122.52 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.259 1.424 . . . . 0.0 109.106 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -116.6 124.23 49.3 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.277 1.831 . . . . 0.0 109.004 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 62.04 20.19 11.41 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.729 1.15 . . . . 0.0 113.075 171.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.1 78.16 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.279 0.942 . . . . 0.0 113.477 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -108.07 134.3 51.14 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.317 1.847 . . . . 0.0 109.464 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.37 103.7 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 169.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.08 -30.94 12.75 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.76 163.47 39.21 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.812 1.245 . . . . 0.0 111.806 -173.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.6 146.9 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.161 1.785 . . . . 0.0 110.303 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.13 136.84 14.36 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.157 0.983 . . . . 0.0 111.01 168.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.3 m -101.79 138.72 38.39 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.13 0.972 . . . . 0.0 111.656 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.24 -157.2 15.13 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.918 1.246 . . . . 0.0 113.213 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.39 142.34 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.526 1.53 . . . . 0.0 111.333 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 51.2 mtm -139.94 163.16 33.4 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.234 1.413 . . . . 0.0 111.997 165.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -77.44 161.5 72.17 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 125.887 1.675 . . . . 0.0 111.742 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.19 -24.97 19.46 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.328 2.019 . . . . 0.0 113.671 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -77.2 -33.83 56.25 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.461 1.482 . . . . 0.0 112.828 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -76.75 -30.33 56.51 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.648 0.779 . . . . 0.0 112.374 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.03 -28.2 66.19 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.35 -0.844 . . . . 0.0 112.791 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -62.26 -43.11 99.57 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.759 0.709 . . . . 0.0 111.895 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.89 -36.25 77.85 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.447 0.699 . . . . 0.0 111.532 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.13 -48.52 75.74 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.971 0.908 . . . . 0.0 110.827 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -45.49 94.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.441 0.696 . . . . 0.0 112.26 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.03 74.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.254 -0.904 . . . . 0.0 111.322 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.7 m -60.49 -31.78 70.81 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.6 mt . . . . . 0 N--CA 1.479 1.022 0 CA-C-N 119.738 1.154 . . . . 0.0 110.687 176.869 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 ptm . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.5 p -159.11 178.17 10.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.54 1.536 . . . . 0.0 112.595 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.61 154.74 25.06 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.62 1.968 . . . . 0.0 110.062 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -98.61 119.74 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.918 1.287 . . . . 0.0 109.577 -175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -141.85 168.12 20.51 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.306 1.842 . . . . 0.0 109.713 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -73.69 120.48 19.35 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 156.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.5 mt -107.93 97.98 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.469 0.708 . . . . 0.0 109.265 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 p -48.32 -32.79 7.89 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.423 2.289 . . . . 0.0 114.941 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.7 p -83.4 -9.32 59.1 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.485 1.514 . . . . 0.0 114.422 -174.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.96 -19.08 0.13 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.55 50.17 1.1 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.863 1.665 . . . . 0.0 112.935 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.82 167.79 17.08 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 126.229 1.871 . . . . 0.0 112.873 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -53.97 -30.67 47.9 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.339 1.456 . . . . 0.0 113.894 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.42 -20.04 62.94 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -86.77 -38.54 16.8 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.976 0.807 . . . . 0.0 111.121 165.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -73.93 -12.13 60.56 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.276 -0.89 . . . . 0.0 113.177 -171.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -89.81 -10.18 46.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.267 1.027 . . . . 0.0 113.617 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.26 -4.03 1.13 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 117.383 1.713 . . . . 0.0 117.383 -170.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.77 172.21 7.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.538 1.669 . . . . 0.0 114.074 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -82.53 -59.94 2.36 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.306 1.043 . . . . 0.0 112.912 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -160.08 115.22 2.33 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.79 1.636 . . . . 0.0 110.166 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.3 158.77 44.29 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -131.23 128.1 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.131 1.372 . . . . 0.0 108.168 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.91 117.47 54.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.715 1.606 . . . . 0.0 108.773 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -97.29 120.68 38.1 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.564 1.146 . . . . 0.0 110.683 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -87.23 82.06 7.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 120.109 -1.619 . . . . 0.0 109.848 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 176.72 8.66 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -139.51 137.96 35.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.108 1.363 . . . . 0.0 109.769 167.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -83.25 -27.22 30.06 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -167.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 21.3 mt -76.62 -33.74 58.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.392 1.477 . . . . 0.0 112.925 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -73.83 130.5 83.19 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 126.06 1.744 . . . . 0.0 111.738 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.13 -14.74 18.65 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.494 3.462 . . . . 0.0 113.3 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -76.04 -47.66 23.88 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.816 1.189 . . . . 0.0 110.695 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.4 m -52.84 -35.56 57.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.031 1.732 . . . . 0.0 113.889 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -55.39 -33.34 63.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.038 1.335 . . . . 0.0 113.135 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -66.48 -40.72 89.48 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.233 1.013 . . . . 0.0 112.63 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.49 68.9 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.437 -0.79 . . . . 0.0 112.989 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -63.01 -44.24 96.52 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.667 0.667 . . . . 0.0 111.496 170.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -63.78 -38.94 92.97 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.831 -1.168 . . . . 0.0 111.409 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.77 -49.08 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.582 1.553 . . . . 0.0 110.434 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 34.0 mt -64.58 -35.24 80.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.32 1.048 . . . . 0.0 112.772 175.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.23 -50.08 74.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.108 0.963 . . . . 0.0 111.753 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.28 -31.6 72.5 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.099 -1.001 . . . . 0.0 112.584 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -69.97 -32.52 70.79 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.411 1.084 . . . . 0.0 112.596 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.84 -27.44 38.07 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 120.831 -1.168 . . . . 0.0 113.417 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.81 55.11 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 10.18 12.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.18 72.52 81.88 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.555 1.542 . . . . 0.0 111.556 -175.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.45 -21.05 60.94 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.352 2.702 . . . . 0.0 115.534 -172.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -83.06 -5.21 59.02 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -166.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.9 p -106.83 132.38 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.113 1.365 . . . . 0.0 111.036 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.5 102.52 13.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.171 0.988 . . . . 0.0 110.515 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mt -100.21 130.81 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.312 -0.867 . . . . 0.0 109.913 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.0 p -150.38 168.61 23.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.25 1.02 . . . . 0.0 112.028 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.3 t -118.45 -179.58 3.83 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.909 -1.119 . . . . 0.0 112.591 171.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.6 t -149.79 128.34 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 128.102 2.561 . . . . 0.0 108.024 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.19 97.66 0.27 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.584 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.3 p -59.06 -30.99 68.47 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.287 -0.883 . . . . 0.0 112.323 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.39 -15.74 62.38 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.644 1.978 . . . . 0.0 114.19 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.84 -39.07 3.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.764 1.225 . . . . 0.0 113.522 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -115.39 54.23 0.91 Allowed Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 125.843 1.657 . . . . 0.0 113.78 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -70.0 -13.36 33.97 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -58.69 -24.48 61.42 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.733 1.152 . . . . 0.0 112.954 171.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.24 -58.54 3.44 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.339 0.518 . . . . 0.0 110.973 165.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 29.3 mtm -54.74 -33.03 60.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.028 1.331 . . . . 0.0 113.002 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -67.29 -18.82 65.35 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.709 1.603 . . . . 0.0 114.109 175.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -77.69 -40.51 41.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.968 0.803 . . . . 0.0 111.644 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.16 -23.93 24.66 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 12.75 28.61 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.108 1.813 . . . . 0.0 115.285 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -81.65 154.14 26.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.758 1.779 . . . . 0.0 111.531 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -102.33 -61.11 1.43 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.097 0.959 . . . . 0.0 112.152 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -162.69 2.31 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.169 1.914 . . . . 0.0 116.169 -168.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -98.68 155.4 36.76 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 126.598 1.959 . . . . 0.0 112.833 -165.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.7 88.58 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.44 3.427 . . . . 0.0 111.402 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 29.0 m -104.03 130.53 51.71 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.672 0.789 . . . . 0.0 110.862 -172.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.06 121.47 41.03 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 0.0 109.816 169.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.52 130.86 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.641 1.976 . . . . 0.0 108.546 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -113.12 121.87 45.83 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.406 ' C ' ' HE ' ' A' ' 80' ' ' ARG . 35.1 mm -109.27 116.15 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.486 1.114 . . . . 0.0 108.903 -179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.406 ' HE ' ' C ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.85 123.32 49.38 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.375 1.47 . . . . 0.0 107.957 171.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.3 t70 64.38 19.76 11.91 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.497 1.119 . . . . 0.0 113.178 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.25 84.44 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.058 -1.026 . . . . 0.0 113.263 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -108.21 133.56 52.29 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.963 1.705 . . . . 0.0 109.025 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.35 107.47 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.07 -19.92 14.02 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -168.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -160.7 150.28 17.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.524 1.53 . . . . 0.0 110.77 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.45 145.27 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.428 1.491 . . . . 0.0 109.971 169.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.09 152.37 34.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.427 1.491 . . . . 0.0 109.292 169.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.5 t -128.95 138.36 51.93 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.926 -1.109 . . . . 0.0 112.589 178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.73 -161.69 19.15 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.002 1.763 . . . . 0.0 112.755 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.3 mm -111.07 143.6 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.691 1.196 . . . . 0.0 111.069 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 67.4 mtm -137.53 158.17 44.96 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.902 1.281 . . . . 0.0 111.78 166.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.52 147.92 76.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.054 0.942 . . . . 0.0 111.176 164.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -64.3 -27.32 63.7 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.931 2.421 . . . . 0.0 113.212 -168.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.85 -29.51 62.93 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.56 -24.98 15.79 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.373 1.069 . . . . 0.0 112.47 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.92 -28.41 68.9 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.435 -0.791 . . . . 0.0 111.998 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -55.56 -50.38 70.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.856 0.862 . . . . 0.0 111.533 172.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.96 -35.38 74.43 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.503 0.721 . . . . 0.0 111.852 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.63 -44.7 81.28 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.627 0.771 . . . . 0.0 110.517 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -47.08 85.01 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.728 0.811 . . . . 0.0 112.151 171.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.25 -35.85 82.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.265 0.939 . . . . 0.0 112.077 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.5 m -58.27 -25.51 61.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.451 1.5 . . . . 0.0 113.842 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.8 mt . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.133 0.973 . . . . 0.0 111.196 177.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 p -84.76 -28.8 25.97 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 70.48 143.66 0.05 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 128.923 2.889 . . . . 0.0 113.959 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mm -122.05 140.25 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.577 1.551 . . . . 0.0 110.291 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -160.35 168.61 24.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.527 1.531 . . . . 0.0 111.572 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -84.28 116.08 22.8 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.873 1.269 . . . . 0.0 109.254 160.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -118.33 76.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.763 1.225 . . . . 0.0 108.928 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m -52.88 -25.75 12.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.198 2.199 . . . . 0.0 113.95 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.4 m -54.92 -28.46 51.02 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.647 1.979 . . . . 0.0 112.918 172.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.06 -31.05 1.3 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.752 1.221 . . . . 0.0 114.224 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.83 112.27 9.79 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 119.932 1.242 . . . . 0.0 111.784 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.39 162.77 26.6 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.937 1.732 . . . . 0.0 111.831 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -50.82 -41.58 57.63 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.725 1.21 . . . . 0.0 114.01 -171.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.65 -25.93 63.23 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -74.49 -39.97 62.12 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.811 0.732 . . . . 0.0 110.596 169.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -70.43 -13.4 62.11 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -87.53 -14.06 41.32 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 0.0 113.848 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -134.75 -8.84 1.85 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 117.087 1.595 . . . . 0.0 117.087 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.33 176.74 4.36 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.219 1.51 . . . . 0.0 114.437 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 p -92.15 -55.96 3.24 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.805 1.242 . . . . 0.0 113.713 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -159.21 110.22 2.04 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.273 1.829 . . . . 0.0 109.111 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.38 155.27 38.31 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.31 128.76 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.862 1.265 . . . . 0.0 108.682 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 t -114.75 126.14 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.131 1.372 . . . . 0.0 109.285 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -106.87 113.67 27.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.891 0.876 . . . . 0.0 111.604 173.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -77.82 74.15 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.488 1.915 . . . . 0.0 111.022 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.62 -179.28 2.08 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.984 -1.073 . . . . 0.0 112.517 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -133.19 162.02 32.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.229 1.411 . . . . 0.0 111.942 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -73.9 -38.82 64.24 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.323 -0.861 . . . . 0.0 113.111 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.3 mt -98.83 -32.44 11.34 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -172.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -60.6 123.08 72.49 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.083 1.353 . . . . 0.0 113.68 -167.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -82.47 -2.37 11.03 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.489 3.46 . . . . 0.0 112.897 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -89.14 -40.78 12.68 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 119.434 1.015 . . . . 0.0 110.022 171.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 p -64.37 -26.99 68.71 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -51.0 -37.59 45.93 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -74.33 -34.45 63.44 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.355 0.662 . . . . 0.0 111.965 -166.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -28.75 69.85 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.501 -0.762 . . . . 0.0 112.777 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -67.17 -37.92 84.56 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.193 1.36 . . . . 0.0 112.186 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -34.89 69.82 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.935 -1.103 . . . . 0.0 112.053 173.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.36 -48.34 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.772 174.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.8 mt -62.0 -42.25 98.95 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.767 1.627 . . . . 0.0 112.319 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.57 -46.95 83.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.305 1.042 . . . . 0.0 111.91 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.26 -27.28 65.3 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.863 -1.148 . . . . 0.0 113.157 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -71.35 -36.9 71.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.674 0.79 . . . . 0.0 112.059 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.94 -19.94 69.01 Favored Glycine 0 N--CA 1.469 0.864 0 CA-C-N 119.212 0.915 . . . . 0.0 113.301 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.48 -33.7 60.2 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.668 1.587 . . . . 0.0 114.629 -174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.72 6.59 11.57 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.267 1.427 . . . . 0.0 114.276 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.03 79.0 25.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.641 1.576 . . . . 0.0 110.433 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.04 -13.57 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.216 2.611 . . . . 0.0 114.287 -168.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -90.15 -6.98 54.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -168.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 p -99.58 131.92 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.614 1.565 . . . . 0.0 110.181 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.91 100.7 11.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.438 1.095 . . . . 0.0 110.138 174.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 mt -98.34 131.58 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.437 -0.79 . . . . 0.0 109.967 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.2 p -140.33 160.11 40.69 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.227 1.013 . . . . 0.0 111.809 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.9 p -106.83 165.81 11.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.198 -0.939 . . . . 0.0 110.51 165.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -162.67 152.14 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.198 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -98.06 120.16 37.96 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.327 0.967 . . . . 0.0 112.474 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.9 p -57.83 -36.26 72.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.017 1.327 . . . . 0.0 113.238 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -79.32 -25.97 42.26 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.275 0.63 . . . . 0.0 112.051 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.01 -16.29 30.09 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.936 1.294 . . . . 0.0 113.797 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmt-85 -119.97 48.77 1.27 Allowed Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 125.624 1.57 . . . . 0.0 113.868 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.85 -27.93 67.44 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.818 1.679 . . . . 0.0 111.75 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.9 -23.58 67.4 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.661 1.185 . . . . 0.0 113.407 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -81.75 -56.23 4.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.622 1.169 . . . . 0.0 109.366 170.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.3 mtm -58.01 -28.43 64.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.766 1.226 . . . . 0.0 113.267 -172.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -57.37 -30.46 64.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.965 1.706 . . . . 0.0 113.22 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -88.28 -32.55 18.43 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.417 1.087 . . . . 0.0 111.588 -172.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.4 -24.1 22.0 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.392 0.677 . . . . 0.0 112.799 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.75 15.7 30.83 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.736 1.636 . . . . 0.0 114.992 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -77.14 153.03 34.62 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.896 1.348 . . . . 0.0 110.797 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.72 -43.77 4.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.636 1.174 . . . . 0.0 112.729 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -179.82 -3.12 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 128.87 2.868 . . . . 0.0 116.364 -171.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.2 m -61.89 149.44 85.57 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-N 120.213 1.369 . . . . 0.0 113.455 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.06 81.25 2.6 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.045 3.163 . . . . 0.0 111.353 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.56 135.67 33.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -165.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.46 125.26 36.15 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -122.16 121.98 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 126.007 1.723 . . . . 0.0 108.84 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -106.69 125.79 51.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.328 1.051 . . . . 0.0 110.582 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.72 119.58 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.27 1.428 . . . . 0.0 108.785 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.32 128.12 55.85 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.967 1.307 . . . . 0.0 108.335 167.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.98 19.18 11.46 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.899 1.28 . . . . 0.0 113.1 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.1 12.51 82.37 Favored Glycine 0 CA--C 1.532 1.154 0 O-C-N 121.16 -0.963 . . . . 0.0 113.153 -174.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -107.45 134.47 50.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.341 1.856 . . . . 0.0 109.576 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.71 104.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 171.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -100.83 -26.71 13.67 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -167.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -162.11 153.14 17.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.6 1.56 . . . . 0.0 110.951 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.67 146.85 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.738 1.215 . . . . 0.0 111.426 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.81 147.0 23.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.243 1.017 . . . . 0.0 112.198 168.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -96.82 -4.49 40.3 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -160.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.45 -164.43 17.93 Favored Glycine 0 N--CA 1.471 0.99 0 CA-C-O 122.498 1.054 . . . . 0.0 115.457 -165.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 25.0 mm -106.11 146.37 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.083 1.753 . . . . 0.0 109.474 165.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.0 ptp -147.75 172.15 14.56 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 167.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -76.76 166.04 47.86 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 125.551 1.54 . . . . 0.0 112.26 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -34.7 5.73 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.633 1.555 . . . . 0.0 114.176 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.98 -34.18 77.51 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 121.129 1.786 . . . . 0.0 112.589 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -79.63 -21.85 44.35 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.397 0.679 . . . . 0.0 112.765 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.7 tp -65.22 -30.31 71.19 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.286 -0.884 . . . . 0.0 112.446 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.05 -39.29 94.3 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.356 0.98 . . . . 0.0 111.451 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.79 -37.19 81.72 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.123 0.874 . . . . 0.0 112.458 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -63.84 -47.78 79.4 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.647 0.779 . . . . 0.0 110.735 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.48 -45.22 94.55 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.322 1.049 . . . . 0.0 112.842 173.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.04 80.28 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.265 -0.897 . . . . 0.0 111.956 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.4 t -68.92 -4.78 17.84 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.706 1.203 . . . . 0.0 114.072 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.477 0.92 0 O-C-N 120.98 -1.075 . . . . 0.0 110.22 167.273 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 m -61.74 -10.48 8.89 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.5 1.52 . . . . 0.0 114.964 -174.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.29 -16.03 63.13 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 168.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.95 108.4 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.271 1.828 . . . . 0.0 107.78 175.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -167.87 178.6 5.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.1 1.76 . . . . 0.0 111.038 -163.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -80.14 110.66 15.77 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 157.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -78.13 -41.54 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.073 0.549 . . . . 0.0 111.684 -165.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.2 p -127.88 -100.19 0.36 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.079 1.752 . . . . 0.0 110.536 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -144.47 -53.46 0.32 Allowed 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 127.472 2.309 . . . . 0.0 111.957 -164.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.07 116.56 18.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.015 0.926 . . . . 0.0 112.715 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.72 36.04 0.63 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.834 2.054 . . . . 0.0 110.856 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.75 167.13 25.44 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.703 1.62 . . . . 0.0 112.077 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -56.09 -33.64 65.25 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.93 -29.49 67.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -68.31 -41.75 80.44 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.561 -0.712 . . . . 0.0 110.209 170.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -75.41 -6.48 50.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.17 0.988 . . . . 0.0 113.327 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -91.88 -18.69 23.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.276 1.43 . . . . 0.0 113.111 170.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.24 -14.31 20.76 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -172.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 pp -80.62 166.79 20.77 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.8 m -82.94 -61.24 1.92 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.282 1.033 . . . . 0.0 112.104 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -151.78 128.62 10.94 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.797 1.639 . . . . 0.0 109.771 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.14 164.45 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mt -139.41 124.89 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.224 1.81 . . . . 0.0 107.664 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 t -120.56 125.24 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.607 1.563 . . . . 0.0 108.809 -175.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -107.42 110.16 22.06 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.455 1.102 . . . . 0.0 111.584 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -80.0 87.66 5.39 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.09 0.956 . . . . 0.0 110.157 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -95.91 -167.89 1.67 Allowed 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.773 1.229 . . . . 0.0 112.286 173.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -144.41 157.13 44.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.888 -1.133 . . . . 0.0 112.025 153.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -31.08 -82.16 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 129.117 2.967 . . . . 0.0 116.387 -174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.0 mt -91.53 -38.19 12.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -167.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.3 m -49.25 119.8 9.32 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 125.894 1.678 . . . . 0.0 112.773 -169.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.84 -22.44 31.72 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.209 3.272 . . . . 0.0 115.077 -161.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -63.09 -44.66 95.1 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 118.849 0.749 . . . . 0.0 112.128 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.8 m -67.47 -31.47 71.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.648 1.179 . . . . 0.0 112.891 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -61.26 -25.81 67.34 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.539 1.136 . . . . 0.0 113.677 -171.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -64.28 -42.81 96.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.848 0.859 . . . . 0.0 112.04 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 tpt -63.78 -28.65 70.02 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.437 1.095 . . . . 0.0 112.684 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -59.28 -39.9 84.38 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.698 0.799 . . . . 0.0 111.352 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -72.93 -29.08 62.84 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.492 -0.755 . . . . 0.0 112.816 174.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.2 t -67.9 -45.86 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.258 1.023 . . . . 0.0 109.646 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 mp -66.45 -37.01 84.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.225 1.41 . . . . 0.0 111.951 176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.78 -53.3 59.89 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.224 0.92 . . . . 0.0 111.846 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -64.1 -32.54 74.14 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.396 -0.815 . . . . 0.0 112.758 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -70.39 -35.6 73.57 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.965 0.906 . . . . 0.0 111.833 173.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.29 -24.12 61.79 Favored Glycine 0 N--CA 1.47 0.936 0 CA-C-N 119.408 1.004 . . . . 0.0 113.319 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.56 -20.72 49.02 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.06 9.14 5.26 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.551 1.54 . . . . 0.0 114.502 174.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.3 61.18 40.89 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 125.657 1.583 . . . . 0.0 112.12 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.34 -15.41 34.91 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.335 2.69 . . . . 0.0 114.431 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -80.81 -9.53 59.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -99.98 137.69 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.187 1.395 . . . . 0.0 110.302 169.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.71 101.68 11.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.114 0.565 . . . . 0.0 110.443 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.5 mt -99.37 131.84 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.975 0.91 . . . . 0.0 109.218 -178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.1 p -149.45 170.45 18.56 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.03 0.932 . . . . 0.0 112.527 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.2 p -133.58 158.69 42.55 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.978 -1.076 . . . . 0.0 111.573 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.46 123.27 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.814 1.246 . . . . 0.0 108.133 -167.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -71.99 115.11 10.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 122.041 0.924 . . . . 0.0 109.886 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.3 p -58.37 -25.29 61.87 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.879 1.272 . . . . 0.0 113.36 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.22 -20.65 34.2 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.703 0.801 . . . . 0.0 112.281 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.74 -35.23 15.01 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.367 1.067 . . . . 0.0 112.902 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -126.54 61.17 42.53 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.971 1.709 . . . . 0.0 112.803 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.43 -23.7 27.43 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.244 2.63 . . . . 0.0 112.675 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.0 -23.19 67.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.148 0.979 . . . . 0.0 113.169 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.14 -58.15 4.12 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.56 1.144 . . . . 0.0 109.543 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 mtm -60.71 -22.89 64.43 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.721 1.208 . . . . 0.0 113.512 -173.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -65.9 -23.46 66.64 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.641 1.176 . . . . 0.0 112.552 174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.61 -38.19 16.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.585 1.154 . . . . 0.0 111.369 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.66 -23.78 25.51 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.07 32.21 8.57 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.098 1.332 . . . . 0.0 114.506 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.62 169.44 18.0 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.813 1.306 . . . . 0.0 112.753 -176.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.0 11.15 8.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 112.726 -162.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.31 59.93 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.073 2.549 . . . . 0.0 109.257 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -150.03 154.07 36.37 Favored Pre-proline 0 N--CA 1.472 0.657 0 C-N-CA 127.672 2.389 . . . . 0.0 109.858 -163.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.57 96.18 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.682 2.921 . . . . 0.0 110.648 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -113.47 122.11 46.31 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 111.833 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.34 125.26 34.6 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.885 1.274 . . . . 0.0 109.135 169.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.4 t -122.06 127.65 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 108.509 177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -111.13 128.97 56.06 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.762 0.825 . . . . 0.0 110.948 -174.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.3 mm -112.39 114.11 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.409 1.084 . . . . 0.0 108.883 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.97 121.65 45.74 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.933 1.293 . . . . 0.0 108.242 171.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 t70 66.75 21.46 10.53 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.006 1.323 . . . . 0.0 112.326 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.53 10.33 84.58 Favored Glycine 0 CA--C 1.536 1.345 0 O-C-N 121.219 -0.926 . . . . 0.0 113.428 -173.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -107.68 132.81 52.94 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.422 1.489 . . . . 0.0 110.194 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.1 m -65.17 101.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.392 1.077 . . . . 0.0 109.187 166.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -104.67 -21.18 13.43 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -166.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -160.74 152.64 19.89 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.196 1.798 . . . . 0.0 110.465 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.47 144.08 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.728 1.211 . . . . 0.0 111.275 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.24 146.56 22.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.702 1.201 . . . . 0.0 111.214 169.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.5 p -107.85 138.78 43.49 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.02 0.928 . . . . 0.0 111.585 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.98 -161.0 21.92 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.997 1.76 . . . . 0.0 112.767 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 40.5 mm -121.82 145.98 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.877 1.671 . . . . 0.0 110.733 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.6 ptp -150.63 164.8 35.17 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 163.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -70.08 158.97 86.08 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 125.312 1.445 . . . . 0.0 112.396 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.32 -26.42 24.94 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.855 2.37 . . . . 0.0 114.401 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -75.33 -30.3 60.26 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 120.634 1.561 . . . . 0.0 113.143 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -76.29 -33.2 59.09 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.11 0.964 . . . . 0.0 111.799 169.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -61.87 -27.08 68.54 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.841 0.857 . . . . 0.0 111.975 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -58.75 -47.53 84.32 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.856 0.753 . . . . 0.0 111.923 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.56 -35.27 75.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.75 0.82 . . . . 0.0 111.38 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -62.02 -49.76 74.75 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.318 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -46.94 86.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.744 0.818 . . . . 0.0 112.683 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.98 -40.68 91.45 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.032 0.833 . . . . 0.0 112.375 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.8 t -60.02 -24.72 64.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.506 1.122 . . . . 0.0 113.401 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.479 0.994 0 C-N-CA 124.325 1.05 . . . . 0.0 111.136 175.585 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.2 p -158.36 -114.1 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.686 1.594 . . . . 0.0 111.527 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.76 142.26 7.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.048 1.739 . . . . 0.0 111.37 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.5 mm -111.94 123.75 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.078 1.351 . . . . 0.0 108.828 176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -162.67 161.88 26.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.146 1.379 . . . . 0.0 111.217 -169.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -73.05 115.42 12.35 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.78 1.232 . . . . 0.0 110.229 170.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.1 mt -107.88 81.12 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.58 1.152 . . . . 0.0 108.446 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 m -52.26 -30.34 27.26 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.79 2.436 . . . . 0.0 114.079 -172.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -77.62 -19.76 54.99 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.301 1.84 . . . . 0.0 113.722 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -112.92 -43.05 3.46 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.779 1.232 . . . . 0.0 112.643 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.6 135.07 52.32 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.556 1.143 . . . . 0.0 112.278 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 145.71 150.64 5.25 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 126.022 1.773 . . . . 0.0 111.982 -176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.4 ptp -55.39 -30.55 60.59 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.63 -19.97 62.78 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -85.26 -38.91 18.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.074 0.852 . . . . 0.0 111.049 165.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -73.06 -12.93 61.09 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.575 0.75 . . . . 0.0 112.821 -172.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.3 -10.97 50.93 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.749 1.22 . . . . 0.0 114.126 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -140.97 -5.94 0.97 Allowed Glycine 0 N--CA 1.48 1.625 0 N-CA-C 117.564 1.786 . . . . 0.0 117.564 -169.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.91 169.65 12.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.281 1.54 . . . . 0.0 114.407 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -81.0 -64.7 1.13 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.525 1.13 . . . . 0.0 112.276 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -151.16 123.99 8.6 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.755 1.622 . . . . 0.0 109.738 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.48 156.24 41.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -133.92 127.15 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.935 1.294 . . . . 0.0 108.086 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.28 124.45 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.339 1.456 . . . . 0.0 109.406 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 27' ' ' HIS . 4.2 t80 -102.82 123.3 46.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.655 1.182 . . . . 0.0 110.24 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -88.25 73.54 8.87 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.518 1.127 . . . . 0.0 110.138 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -81.64 -170.51 2.85 Favored 'General case' 0 CA--C 1.557 1.225 0 O-C-N 121.525 -0.734 . . . . 0.0 112.517 179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -145.58 177.62 8.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.242 -0.911 . . . . 0.0 112.767 162.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.24 -56.11 6.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.27 1.028 . . . . 0.0 113.024 -166.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.17 -30.71 19.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -54.61 118.81 17.97 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.791 1.236 . . . . 0.0 113.729 -167.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.88 -23.79 77.78 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.109 3.206 . . . . 0.0 114.223 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -71.97 -46.86 55.85 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 119.464 1.029 . . . . 0.0 110.121 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 92.0 m -56.14 -34.42 66.11 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.482 1.113 . . . . 0.0 113.401 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -56.06 -35.25 66.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.05 0.94 . . . . 0.0 112.825 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -62.76 -49.98 72.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.406 0.682 . . . . 0.0 111.366 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.41 -29.67 70.73 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -60.68 -45.87 92.51 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.934 0.894 . . . . 0.0 111.013 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -72.0 -34.48 68.9 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.255 -0.903 . . . . 0.0 113.052 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.98 -49.25 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.24 -36.49 81.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.128 0.971 . . . . 0.0 113.46 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.45 -49.84 76.22 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.307 0.643 . . . . 0.0 112.518 170.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -69.18 -29.97 68.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.203 -0.935 . . . . 0.0 113.157 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -68.83 -37.84 79.44 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.083 1.353 . . . . 0.0 111.584 171.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.15 -19.34 67.23 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.418 1.009 . . . . 0.0 112.81 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.61 -33.73 66.54 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.347 1.059 . . . . 0.0 113.462 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.39 9.16 39.94 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.603 1.561 . . . . 0.0 114.104 174.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.2 66.23 7.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.522 1.529 . . . . 0.0 113.673 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -61.3 -20.81 69.75 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.905 2.403 . . . . 0.0 115.076 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -88.2 -8.87 54.65 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 p -88.25 135.37 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.45 87.3 5.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.529 0.732 . . . . 0.0 111.013 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 mt -86.24 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.565 -0.709 . . . . 0.0 109.695 177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 87.7 p -147.3 173.1 12.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.609 1.164 . . . . 0.0 111.556 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 t -122.53 -172.52 2.49 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.191 -0.943 . . . . 0.0 111.137 168.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -173.55 133.76 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 127.729 2.411 . . . . 0.0 109.118 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.83 116.25 18.19 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 124.929 1.292 . . . . 0.0 111.464 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 80.3 p -62.28 -26.93 68.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.261 1.024 . . . . 0.0 112.947 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.79 -23.42 62.38 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.511 1.124 . . . . 0.0 112.518 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.31 -28.84 11.15 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.073 1.349 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.55 49.03 4.23 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 125.896 1.678 . . . . 0.0 115.46 -170.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -66.72 -19.42 53.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.394 2.063 . . . . 0.0 112.731 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -62.16 -25.98 68.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.568 1.147 . . . . 0.0 113.124 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mt -70.48 -55.1 9.76 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.81 0.732 . . . . 0.0 110.751 166.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.9 mtp -59.14 -28.47 66.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.547 1.539 . . . . 0.0 113.248 -170.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -15.47 61.46 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.543 1.137 . . . . 0.0 112.753 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -84.68 -38.32 19.92 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.663 1.185 . . . . 0.0 110.579 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -83.85 -23.46 31.33 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.282 0.633 . . . . 0.0 112.677 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.86 20.09 17.66 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 125.716 1.627 . . . . 0.0 114.773 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -82.5 149.41 27.56 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.765 1.283 . . . . 0.0 111.883 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -78.45 -81.04 0.11 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.633 0.773 . . . . 0.0 110.825 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -157.35 6.64 0.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -167.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.89 160.76 25.0 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 126.487 1.915 . . . . 0.0 114.032 -159.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.6 93.34 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 124.91 3.74 . . . . 0.0 110.942 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 m -109.68 129.22 55.62 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.234 0.614 . . . . 0.0 111.895 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mp -95.46 130.88 42.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.836 0.855 . . . . 0.0 109.734 167.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -129.24 128.56 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.091 1.757 . . . . 0.0 108.86 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -114.85 124.48 51.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.176 0.99 . . . . 0.0 110.682 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.6 mm -109.05 120.04 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.996 1.318 . . . . 0.0 109.599 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -114.98 125.3 53.46 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.822 1.649 . . . . 0.0 109.501 171.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.61 19.47 10.45 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.505 1.522 . . . . 0.0 113.807 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.08 65.15 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.823 1.201 . . . . 0.0 114.101 -175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -112.84 136.51 52.38 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.103 1.761 . . . . 0.0 110.372 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.59 104.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 166.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.96 -30.23 12.84 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.62 160.41 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.915 1.686 . . . . 0.0 111.76 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.25 144.81 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.593 1.557 . . . . 0.0 110.771 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.28 150.22 25.12 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 111.972 167.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -105.48 132.34 51.77 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.183 0.993 . . . . 0.0 111.35 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.18 -158.14 14.86 Favored Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.287 1.422 . . . . 0.0 113.448 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 42.6 mm -116.57 139.09 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.692 1.597 . . . . 0.0 111.056 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.0 mtm -140.9 160.28 40.41 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.0 112.514 166.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -72.35 159.84 84.34 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.71 1.204 . . . . 0.0 112.282 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.3 -24.73 31.46 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.457 2.105 . . . . 0.0 113.724 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -63.23 -49.31 74.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.953 1.251 . . . . 0.0 110.83 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -72.28 -26.15 61.86 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.626 1.17 . . . . 0.0 111.636 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -26.75 68.55 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.748 0.819 . . . . 0.0 112.507 170.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -65.64 -45.53 82.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.775 1.17 . . . . 0.0 110.769 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.74 -36.83 84.71 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.152 0.581 . . . . 0.0 111.848 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.16 -53.88 51.41 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.249 1.019 . . . . 0.0 110.405 174.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -47.92 77.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.819 1.248 . . . . 0.0 112.361 175.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.19 -35.26 79.72 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.454 -0.779 . . . . 0.0 112.0 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.7 t -60.05 -38.89 84.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.569 0.747 . . . . 0.0 111.861 173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.482 1.129 0 O-C-N 121.148 -0.97 . . . . 0.0 110.602 175.056 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 t -167.68 164.77 14.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.736 2.014 . . . . 0.0 110.682 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.43 146.66 2.86 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.045 2.138 . . . . 0.0 110.604 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 mm -106.63 129.6 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.319 1.047 . . . . 0.0 110.988 -173.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.45 171.42 1.58 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.965 2.906 . . . . 0.0 111.892 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -80.48 112.85 18.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.246 1.419 . . . . 0.0 108.718 167.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.8 mt -93.68 129.75 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.928 0.891 . . . . 0.0 110.434 -168.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.7 p -73.41 -18.11 61.19 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.62 1.568 . . . . 0.0 114.772 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -73.89 -41.52 62.03 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.449 1.5 . . . . 0.0 113.458 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -171.62 145.34 2.0 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.325 1.85 . . . . 0.0 111.761 -177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.96 170.28 16.88 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.126 2.17 . . . . 0.0 110.659 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.66 -170.29 51.28 Favored Glycine 0 N--CA 1.471 0.992 0 C-N-CA 123.903 0.763 . . . . 0.0 113.859 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.8 ptp -54.52 -27.31 37.36 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -171.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.47 -26.63 35.09 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.028 0.931 . . . . 0.0 113.498 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -71.23 -40.22 71.22 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.64 -0.663 . . . . 0.0 110.247 162.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -75.65 27.27 0.11 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.452 1.501 . . . . 0.0 112.825 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -82.24 -14.92 54.74 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 177.84 43.76 0.07 OUTLIER Glycine 0 N--CA 1.474 1.23 0 CA-C-N 119.674 1.124 . . . . 0.0 115.582 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.4 mt -84.85 103.05 13.57 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.431 1.093 . . . . 0.0 111.158 -173.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -58.89 -27.56 65.33 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -156.37 94.31 1.48 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.1 1.76 . . . . 0.0 110.296 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.59 46.64 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.9 mt -140.84 135.13 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.389 1.476 . . . . 0.0 109.142 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.33 131.06 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.45 1.5 . . . . 0.0 109.565 -174.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -111.24 103.48 11.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.655 1.182 . . . . 0.0 111.462 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -75.37 70.91 2.31 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.74 1.616 . . . . 0.0 109.959 175.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.34 154.0 42.39 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.117 0.967 . . . . 0.0 113.192 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -81.04 179.74 7.73 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 121.335 -0.853 . . . . 0.0 111.728 166.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.77 153.25 30.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.022 1.729 . . . . 0.0 112.457 177.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 67.85 -46.41 0.51 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 130.304 3.442 . . . . 0.0 114.474 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.0 t -54.91 128.58 64.51 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 127.046 2.139 . . . . 0.0 113.433 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.77 -18.97 59.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.606 3.538 . . . . 0.0 115.529 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -67.79 -48.35 66.55 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 120.364 1.438 . . . . 0.0 112.817 -172.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.1 -22.79 63.96 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.471 -1.393 . . . . 0.0 113.414 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -56.39 -30.79 63.18 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.154 1.381 . . . . 0.0 113.085 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -64.82 -46.1 83.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.957 0.903 . . . . 0.0 112.235 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.3 mmm -63.91 -28.77 70.06 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.338 -0.851 . . . . 0.0 112.897 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -61.02 -35.81 77.85 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.705 0.684 . . . . 0.0 111.58 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HE3' ' N ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -70.27 -40.6 74.24 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.279 -0.888 . . . . 0.0 110.737 174.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.01 -44.62 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.777 1.631 . . . . 0.0 110.788 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.8 mp -65.97 -37.33 85.71 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.306 1.443 . . . . 0.0 112.125 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.89 -47.79 84.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.649 0.78 . . . . 0.0 111.986 171.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -68.51 -32.95 73.28 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.259 0.936 . . . . 0.0 112.11 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -68.63 -35.89 77.91 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.73 1.212 . . . . 0.0 112.184 172.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.34 -24.57 53.93 Favored Glycine 0 N--CA 1.469 0.852 0 CA-C-N 119.176 0.898 . . . . 0.0 113.177 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.1 -33.0 68.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 10.8 38.74 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.097 1.359 . . . . 0.0 114.139 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.86 85.89 7.46 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 125.433 1.493 . . . . 0.0 111.68 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.03 -12.09 17.73 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.312 2.675 . . . . 0.0 113.817 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -89.57 -10.04 47.57 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.827 1.194 . . . . 0.0 113.728 -172.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.54 130.78 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.672 1.189 . . . . 0.0 110.254 176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.8 98.0 8.26 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.223 0.609 . . . . 0.0 110.036 170.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -101.42 132.98 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.628 0.771 . . . . 0.0 109.273 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -145.89 169.2 19.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.97 0.908 . . . . 0.0 111.813 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 97.2 p -114.2 164.96 13.17 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.634 -1.291 . . . . 0.0 111.538 168.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.9 t -143.54 122.24 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.3 1.44 . . . . 0.0 109.038 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.08 104.76 1.21 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.694 1.198 . . . . 0.0 110.397 176.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -54.35 -44.26 72.0 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.857 1.263 . . . . 0.0 112.811 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -78.52 -13.27 59.91 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.84 -17.91 18.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.641 1.176 . . . . 0.0 113.427 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -124.03 43.77 0.89 Allowed Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 126.062 1.745 . . . . 0.0 113.303 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.85 -22.87 35.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 123.102 2.535 . . . . 0.0 112.466 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -65.17 -27.74 68.92 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.293 0.952 . . . . 0.0 112.603 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.58 -50.65 14.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.8 mtm -56.7 -26.41 56.65 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.402 1.081 . . . . 0.0 113.319 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -66.35 -23.35 66.33 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.139 0.976 . . . . 0.0 112.014 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -84.6 -37.97 20.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.935 1.294 . . . . 0.0 111.204 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.06 -24.15 30.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.438 0.695 . . . . 0.0 112.554 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.22 20.03 19.29 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.374 1.464 . . . . 0.0 115.065 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -84.1 155.08 22.81 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.156 1.478 . . . . 0.0 111.584 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -92.25 -72.21 0.6 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.439 1.096 . . . . 0.0 110.465 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 ptm85 -162.81 3.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 115.772 1.768 . . . . 0.0 115.772 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.3 m -84.63 154.82 62.21 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 127.108 2.163 . . . . 0.0 113.012 -171.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.48 96.35 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.382 3.388 . . . . 0.0 110.336 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.9 m -111.06 124.63 52.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.191 0.996 . . . . 0.0 112.467 -173.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.4 135.02 34.85 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.475 1.51 . . . . 0.0 109.524 166.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.34 124.38 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.001 1.721 . . . . 0.0 108.034 -175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -108.11 126.21 52.49 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.432 0.693 . . . . 0.0 110.782 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.1 mm -110.36 113.11 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.841 0.857 . . . . 0.0 109.178 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 115.56 29.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.321 1.448 . . . . 0.0 109.109 170.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.08 26.67 8.86 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.879 2.072 . . . . 0.0 111.981 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.21 -3.84 83.12 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.832 0.73 . . . . 0.0 113.846 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -96.29 131.11 43.13 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.923 -1.34 . . . . 0.0 110.231 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.38 102.8 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-O 121.869 0.842 . . . . 0.0 109.603 168.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.32 -17.17 16.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -171.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -158.91 148.72 19.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.019 1.727 . . . . 0.0 110.088 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.7 t -150.27 146.05 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.803 1.641 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -153.33 148.82 27.21 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.266 1.026 . . . . 0.0 111.601 161.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.8 p -105.77 144.07 33.02 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.479 -0.763 . . . . 0.0 111.917 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.24 -150.18 17.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.268 1.413 . . . . 0.0 113.377 176.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.5 mm -112.27 144.36 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.343 1.457 . . . . 0.0 112.285 -170.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.3 ptp -153.01 169.31 23.22 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 160.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -82.44 161.98 57.6 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.727 1.611 . . . . 0.0 112.485 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.46 -26.48 12.03 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.539 2.159 . . . . 0.0 114.507 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -71.43 -34.23 70.11 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 120.204 1.365 . . . . 0.0 112.846 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -74.39 -31.42 62.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.591 0.756 . . . . 0.0 112.278 171.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.1 tp -62.28 -26.87 68.64 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.488 -0.757 . . . . 0.0 112.606 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -61.72 -47.95 82.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.882 0.764 . . . . 0.0 111.209 174.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.23 -36.59 71.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.255 0.622 . . . . 0.0 111.778 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.96 -50.44 73.75 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.807 0.843 . . . . 0.0 110.84 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.2 -45.38 79.86 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.322 0.649 . . . . 0.0 112.008 175.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.99 -38.8 86.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.826 0.739 . . . . 0.0 112.031 -175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.1 m -64.64 -11.79 39.1 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.399 1.479 . . . . 0.0 114.612 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.476 0.851 0 O-C-N 121.039 -1.038 . . . . 0.0 110.96 173.312 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 121.259 0.552 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -149.57 145.7 26.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.452 1.501 . . . . 0.0 110.116 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.23 2.75 23.17 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -176.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.8 mm -95.32 103.96 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.02 1.728 . . . . 0.0 108.988 -172.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -143.45 167.38 22.33 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.382 1.473 . . . . 0.0 111.361 -167.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -84.96 105.73 15.94 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.323 1.449 . . . . 0.0 110.149 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.3 mt -121.75 96.45 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.657 1.183 . . . . 0.0 107.991 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -52.46 -32.73 41.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.253 1.821 . . . . 0.0 113.549 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 m -59.37 -28.28 66.73 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.175 1.79 . . . . 0.0 113.019 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -125.36 28.82 6.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.759 1.623 . . . . 0.0 111.829 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.22 170.66 15.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.96 1.304 . . . . 0.0 112.468 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.44 153.25 29.36 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.356 1.455 . . . . 0.0 111.92 -176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -56.26 -28.63 59.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.267 1.027 . . . . 0.0 113.445 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.1 -22.74 63.0 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -84.53 -39.09 19.23 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 111.168 166.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -76.11 -9.19 58.42 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.71 -11.11 43.3 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.007 1.323 . . . . 0.0 114.106 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -139.9 -6.36 1.11 Allowed Glycine 0 N--CA 1.477 1.405 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.47 167.29 16.99 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.226 1.513 . . . . 0.0 113.663 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -80.68 -52.55 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -164.76 114.88 1.15 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.946 1.298 . . . . 0.0 110.082 -172.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.71 157.83 41.45 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.98 130.66 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.632 1.573 . . . . 0.0 108.832 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.6 128.23 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.689 1.596 . . . . 0.0 109.393 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.05 111.72 23.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.574 1.15 . . . . 0.0 111.507 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -83.53 73.56 10.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 111.301 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -71.41 174.94 5.9 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 168.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.24 146.34 38.51 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 120.388 -1.445 . . . . 0.0 114.054 170.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' CG ' ' H ' ' A' ' 30' ' ' LEU 0.319 6.9 p30 17.76 -104.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 128.388 2.675 . . . . 0.0 116.136 -178.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.407 ' H ' ' CG ' ' A' ' 29' ' ' ASN . 3.6 mm? -107.18 3.15 25.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.68 2.392 . . . . 0.0 113.383 -171.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -49.04 125.61 13.95 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.509 1.523 . . . . 0.0 114.41 -164.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.2 -5.03 16.46 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.066 3.178 . . . . 0.0 113.429 177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -81.74 -50.38 9.34 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 119.685 1.129 . . . . 0.0 109.905 167.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 73.2 m -60.77 -34.02 73.84 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -171.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -50.31 -40.72 49.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -72.76 -40.68 65.81 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.209 0.603 . . . . 0.0 110.737 -172.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.9 tpt -62.4 -34.52 76.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.593 1.157 . . . . 0.0 112.519 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -59.55 -39.09 82.85 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.719 1.145 . . . . 0.0 112.305 173.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -69.48 -32.66 71.69 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.91 -1.119 . . . . 0.0 112.789 173.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.46 -50.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.368 0.667 . . . . 0.0 109.967 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.73 -35.67 81.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.293 1.037 . . . . 0.0 112.135 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.73 -52.97 63.23 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.053 0.941 . . . . 0.0 111.639 173.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -69.13 -30.24 68.47 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.601 -0.687 . . . . 0.0 112.655 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.95 -41.39 91.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.786 1.234 . . . . 0.0 111.49 170.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.58 -27.33 27.45 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 119.098 0.863 . . . . 0.0 113.593 -172.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.42 -33.77 68.24 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.198 0.999 . . . . 0.0 113.588 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.49 9.4 37.63 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.964 1.705 . . . . 0.0 114.067 176.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.05 42.31 0.37 Allowed Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 125.534 1.533 . . . . 0.0 113.754 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.57 -5.64 10.55 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 123.575 2.85 . . . . 0.0 115.58 -166.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -62.92 -8.86 7.92 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.64 135.6 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.194 1.398 . . . . 0.0 110.553 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.06 102.53 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.918 0.887 . . . . 0.0 110.348 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.68 135.08 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.93 0.892 . . . . 0.0 110.333 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.7 p -144.63 169.02 18.79 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.278 1.031 . . . . 0.0 112.005 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 80.4 p -125.97 163.37 23.15 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.78 -1.2 . . . . 0.0 111.846 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.2 t -148.82 129.03 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.009 1.323 . . . . 0.0 108.542 -169.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -73.93 98.62 3.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.562 0.696 . . . . 0.0 110.123 170.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 87.4 p -59.55 -30.33 68.54 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.219 1.008 . . . . 0.0 113.585 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -74.81 -21.53 59.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.043 1.337 . . . . 0.0 112.655 178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.14 -7.81 38.21 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.528 1.531 . . . . 0.0 112.976 168.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 42.95 0.98 Allowed Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 126.151 1.78 . . . . 0.0 114.07 -176.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.45 -21.01 47.4 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.593 2.196 . . . . 0.0 113.258 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -59.71 -19.44 49.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.764 1.226 . . . . 0.0 113.124 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -80.23 -58.93 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.459 1.103 . . . . 0.0 111.574 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 14.6 mtm -58.46 -28.55 65.43 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.619 1.168 . . . . 0.0 113.763 -170.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -69.71 -18.91 63.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.041 1.336 . . . . 0.0 113.345 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -86.31 -35.62 19.78 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.381 1.073 . . . . 0.0 111.211 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.51 -23.87 21.94 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.422 0.689 . . . . 0.0 112.857 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.34 21.06 18.34 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.692 1.615 . . . . 0.0 114.716 175.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -80.14 160.83 25.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.998 1.399 . . . . 0.0 112.188 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -108.75 -68.77 0.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.359 1.063 . . . . 0.0 112.869 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.79 22.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -162.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.34 156.97 57.21 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 125.091 1.356 . . . . 0.0 112.831 -166.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.76 88.29 0.92 Allowed 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.075 3.183 . . . . 0.0 110.206 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -99.89 130.21 46.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.318 1.047 . . . . 0.0 111.893 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 134.38 35.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.318 1.047 . . . . 0.0 110.471 163.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.5 t -130.73 126.17 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.568 1.547 . . . . 0.0 108.417 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -109.95 122.54 47.79 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.013 0.925 . . . . 0.0 110.639 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.68 121.5 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.403 1.481 . . . . 0.0 108.859 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -115.54 124.29 50.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.307 1.843 . . . . 0.0 108.774 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 61.19 20.09 10.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.009 1.324 . . . . 0.0 113.355 175.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.12 69.57 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.229 0.919 . . . . 0.0 113.84 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -117.46 132.11 56.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.449 1.9 . . . . 0.0 109.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.77 109.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.196 -0.94 . . . . 0.0 109.676 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.55 -24.85 14.07 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -171.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -160.16 144.82 14.66 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.123 1.769 . . . . 0.0 110.563 -172.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -148.25 143.87 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.552 1.541 . . . . 0.0 109.384 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -154.59 156.92 37.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.434 1.094 . . . . 0.0 111.026 164.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 65.6 p -121.45 145.36 48.0 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.97 -167.76 12.4 Favored Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.335 1.445 . . . . 0.0 113.58 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.06 138.42 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.871 1.268 . . . . 0.0 111.411 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 65.9 mtm -139.42 147.66 41.72 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.973 0.909 . . . . 0.0 111.299 162.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.02 149.15 97.88 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.341 0.657 . . . . 0.0 111.346 167.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.19 -27.48 56.5 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.827 2.351 . . . . 0.0 113.551 -166.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -61.01 -29.17 69.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 176.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -94.4 -25.46 16.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.578 0.751 . . . . 0.0 112.562 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.37 -24.69 63.61 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 112.572 171.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -60.35 -41.81 94.4 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.387 0.675 . . . . 0.0 112.336 173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.4 77.72 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.952 0.796 . . . . 0.0 111.97 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -64.01 -47.35 80.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.329 1.052 . . . . 0.0 110.379 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.59 -46.63 87.41 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.374 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.53 75.95 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.605 1.093 . . . . 0.0 112.705 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.5 t -62.77 -17.83 61.66 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.18 1.392 . . . . 0.0 113.582 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.6 mt . . . . . 0 N--CA 1.475 0.821 0 O-C-N 120.522 -1.361 . . . . 0.0 110.468 172.519 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 69.82 -56.03 0.58 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.444 2.698 . . . . 0.0 113.358 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.78 131.92 2.6 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.755 2.022 . . . . 0.0 110.404 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.8 mt -91.67 140.34 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.577 1.151 . . . . 0.0 109.589 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 165.89 -42.98 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 130.415 3.486 . . . . 0.0 112.974 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 t70 175.23 133.91 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 129.945 3.298 . . . . 0.0 110.126 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 mp -138.55 117.58 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.8 p -61.31 -33.44 73.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.138 1.375 . . . . 0.0 113.953 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -87.02 -12.98 45.77 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.831 1.652 . . . . 0.0 114.264 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -120.0 27.25 8.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.677 1.191 . . . . 0.0 112.192 -174.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -144.36 164.15 31.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.835 1.654 . . . . 0.0 112.015 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.08 152.74 23.07 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 125.017 1.294 . . . . 0.0 112.262 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -56.26 -28.27 58.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.301 1.041 . . . . 0.0 113.065 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -21.2 62.16 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -80.1 -41.33 25.76 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.639 -0.663 . . . . 0.0 111.051 166.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -74.72 -13.62 60.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.289 1.036 . . . . 0.0 113.646 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -85.2 80.32 9.25 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.589 1.956 . . . . 0.0 110.342 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.54 14.19 14.92 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.772 1.177 . . . . 0.0 115.854 166.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.89 167.51 11.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 1.351 . . . . 0.0 112.936 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -75.62 -66.59 0.76 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.261 1.024 . . . . 0.0 112.544 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -149.63 124.72 10.05 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.392 1.877 . . . . 0.0 109.717 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.41 160.47 42.53 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.6 mt -138.03 124.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.085 1.754 . . . . 0.0 108.647 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 t -123.68 126.51 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 125.459 1.503 . . . . 0.0 109.306 -170.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -115.08 113.81 24.53 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.373 0.669 . . . . 0.0 111.948 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -81.45 70.17 8.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.813 1.245 . . . . 0.0 110.722 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.83 170.14 15.31 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 121.702 0.763 . . . . 0.0 112.845 -176.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -117.84 162.04 18.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.533 1.533 . . . . 0.0 111.143 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -91.17 -36.17 14.11 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.971 -1.08 . . . . 0.0 111.811 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 mt -80.06 -52.19 8.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.648 1.179 . . . . 0.0 113.4 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -60.74 119.53 45.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.295 1.438 . . . . 0.0 112.639 -170.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -66.31 -19.73 55.75 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.739 2.959 . . . . 0.0 114.086 172.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -76.75 -45.57 28.61 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.195 0.907 . . . . 0.0 110.703 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 p -63.72 -21.93 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -54.7 -37.78 66.23 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.123 0.969 . . . . 0.0 112.994 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -62.32 -43.11 99.58 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.736 -0.603 . . . . 0.0 111.832 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 32.3 tpp -61.01 -34.6 75.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.743 0.817 . . . . 0.0 112.991 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -54.28 -42.93 70.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.437 0.695 . . . . 0.0 111.767 172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -83.69 -27.35 29.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.923 0.889 . . . . 0.0 113.166 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.85 -47.85 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.979 0.911 . . . . 0.0 110.378 166.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -62.04 -36.99 83.25 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.134 1.374 . . . . 0.0 112.842 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -60.95 -48.29 82.5 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.96 0.8 . . . . 0.0 111.525 172.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -66.33 -33.81 76.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.659 0.784 . . . . 0.0 112.711 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -65.35 -37.58 87.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.861 1.264 . . . . 0.0 111.542 170.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.31 -23.03 61.64 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 124.704 1.145 . . . . 0.0 113.628 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.72 -31.33 62.39 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.279 1.431 . . . . 0.0 114.713 -171.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.73 6.31 14.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.17 63.51 57.76 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.916 1.687 . . . . 0.0 112.14 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.61 -15.55 30.48 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.9 3.066 . . . . 0.0 113.725 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -82.05 -4.76 57.51 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -110.04 135.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.177 1.391 . . . . 0.0 110.235 173.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.93 100.86 11.28 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.814 0.846 . . . . 0.0 110.847 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.6 mt -99.11 131.33 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.847 0.859 . . . . 0.0 110.195 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.3 p -146.82 170.06 17.82 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.938 0.895 . . . . 0.0 112.579 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 78.3 p -132.43 155.16 49.0 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.865 -1.147 . . . . 0.0 111.071 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.0 t -142.77 127.62 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.534 1.133 . . . . 0.0 109.461 -168.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -64.62 101.26 0.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.734 1.614 . . . . 0.0 110.69 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.9 p -55.97 -40.81 73.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.056 0.943 . . . . 0.0 112.738 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.45 -26.65 65.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.749 1.619 . . . . 0.0 112.805 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.69 -15.43 18.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.507 1.123 . . . . 0.0 113.844 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -131.42 52.61 9.67 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 125.705 1.602 . . . . 0.0 113.009 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -66.6 -20.47 53.39 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.127 1.885 . . . . 0.0 112.027 170.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.46 -29.17 69.79 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.39 1.076 . . . . 0.0 112.767 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.94 -56.84 4.97 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.492 0.717 . . . . 0.0 109.431 169.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.7 mtp -54.8 -33.6 61.69 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.514 1.525 . . . . 0.0 112.21 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -61.71 -27.86 69.01 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.864 1.665 . . . . 0.0 113.988 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.34 -38.27 65.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.358 0.663 . . . . 0.0 112.01 174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.77 -21.78 24.93 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.72 15.52 31.4 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.256 1.884 . . . . 0.0 114.829 175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -77.96 140.52 39.23 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.275 1.538 . . . . 0.0 111.801 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -85.91 -60.04 2.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.408 0.683 . . . . 0.0 112.342 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -167.07 23.05 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -165.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.61 151.88 50.45 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 125.468 1.507 . . . . 0.0 113.351 -166.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.71 93.94 1.0 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.924 3.083 . . . . 0.0 109.599 178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.5 m -104.44 131.73 51.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.524 1.13 . . . . 0.0 112.952 -172.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.56 131.74 34.29 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.24 1.816 . . . . 0.0 109.251 166.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.69 131.09 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 108.744 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -114.29 127.85 56.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.636 0.775 . . . . 0.0 111.154 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.1 mm -108.94 122.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.006 1.322 . . . . 0.0 109.269 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -119.4 124.06 45.64 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.655 1.982 . . . . 0.0 109.19 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.5 t70 61.88 18.69 10.02 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.947 1.299 . . . . 0.0 113.049 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.59 7.1 67.23 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.236 1.398 . . . . 0.0 114.401 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -113.34 136.94 52.21 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.877 1.671 . . . . 0.0 110.136 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.01 108.84 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 121.076 -1.015 . . . . 0.0 109.879 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.9 -20.31 14.31 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.43 1.271 . . . . 0.0 114.43 -170.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -158.67 156.1 29.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.022 1.329 . . . . 0.0 110.67 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.06 145.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 111.204 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -155.88 146.08 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.546 1.139 . . . . 0.0 111.101 166.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 p -110.77 147.09 35.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.341 1.056 . . . . 0.0 113.153 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.71 -149.38 18.12 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.758 1.17 . . . . 0.0 113.056 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.3 mm -118.3 143.89 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.015 1.326 . . . . 0.0 111.976 -171.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.3 mtm -139.13 160.04 40.72 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.27 1.428 . . . . 0.0 111.014 161.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -70.06 162.29 69.88 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 124.486 1.115 . . . . 0.0 111.487 167.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 -32.91 14.17 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.987 1.791 . . . . 0.0 113.868 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -71.44 -31.36 67.12 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.842 1.655 . . . . 0.0 112.821 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -79.36 -22.32 44.57 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.8 tp -64.95 -26.13 68.17 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.561 1.073 . . . . 0.0 112.672 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -63.05 -37.32 86.71 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.329 0.968 . . . . 0.0 111.702 169.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.59 -37.74 83.03 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.361 0.982 . . . . 0.0 111.163 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 53.5 tp -65.07 -45.47 85.18 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.323 0.649 . . . . 0.0 110.78 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -44.61 95.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.283 1.033 . . . . 0.0 112.342 173.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.82 -36.69 84.21 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.123 -0.985 . . . . 0.0 111.482 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 64.0 m -67.79 -3.84 10.67 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.754 1.622 . . . . 0.0 114.232 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 N--CA 1.481 1.085 0 O-C-N 120.903 -1.123 . . . . 0.0 111.382 169.587 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.7 mtm . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m -138.34 151.06 47.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.661 1.584 . . . . 0.0 111.31 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.91 1.05 45.25 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.5 mm -102.83 124.46 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.728 1.611 . . . . 0.0 110.755 -171.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.58 173.37 9.82 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.989 2.116 . . . . 0.0 111.255 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -90.85 115.93 28.29 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.766 1.226 . . . . 0.0 110.639 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.27 122.87 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 168.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.5 p -47.33 -41.18 18.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.081 1.752 . . . . 0.0 114.435 -170.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -91.07 -17.19 26.62 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 126.324 1.85 . . . . 0.0 114.351 -174.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -96.94 50.11 1.09 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 122.994 1.378 . . . . 0.0 112.368 -172.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.56 162.81 39.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.001 2.121 . . . . 0.0 111.216 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.88 153.25 30.12 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.953 1.264 . . . . 0.0 111.848 -177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -54.78 -27.65 43.12 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.581 1.552 . . . . 0.0 114.198 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.21 44.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.719 1.208 . . . . 0.0 113.903 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -74.95 -39.71 61.18 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.193 164.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -74.95 19.4 0.15 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.235 1.414 . . . . 0.0 113.937 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.11 -16.5 57.92 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -171.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.46 45.44 0.12 Allowed Glycine 0 N--CA 1.478 1.448 0 CA-C-N 120.059 1.3 . . . . 0.0 116.257 -174.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 15.3 mt -88.72 122.35 32.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.086 1.354 . . . . 0.0 109.232 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 p -53.59 -43.13 68.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.753 1.161 . . . . 0.0 113.478 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -163.04 123.42 2.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.433 1.893 . . . . 0.0 111.223 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.75 155.76 42.04 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.319 1.448 . . . . 0.0 112.513 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.6 mt -143.18 132.65 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.364 1.466 . . . . 0.0 110.707 -170.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.54 126.73 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.089 1.356 . . . . 0.0 110.8 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -102.5 117.26 34.31 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.202 1.401 . . . . 0.0 112.101 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -78.55 73.58 5.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.286 1.434 . . . . 0.0 111.609 175.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.9 -174.99 4.7 Favored 'General case' 0 CA--C 1.56 1.332 0 C-N-CA 123.705 0.802 . . . . 0.0 112.798 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -144.14 156.02 44.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 111.748 171.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -64.75 -54.82 25.37 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -171.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.77 -38.06 20.07 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -170.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.67 122.16 49.38 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.781 1.232 . . . . 0.0 112.827 -171.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -65.15 -22.65 61.16 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 124.33 3.354 . . . . 0.0 114.575 173.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -70.7 -46.21 63.54 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 119.303 0.956 . . . . 0.0 111.036 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 85.7 m -58.09 -34.03 69.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.474 1.11 . . . . 0.0 113.595 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -55.79 -34.6 65.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.12 1.368 . . . . 0.0 112.995 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -60.09 -46.73 88.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.341 0.657 . . . . 0.0 111.679 176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -36.04 82.71 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.287 0.635 . . . . 0.0 112.65 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -53.03 -40.64 64.05 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.834 0.743 . . . . 0.0 112.293 176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -65.77 -28.16 68.82 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.039 -1.038 . . . . 0.0 112.775 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 t -75.12 -52.68 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.579 1.552 . . . . 0.0 108.747 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.71 -38.23 77.84 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.715 1.206 . . . . 0.0 112.462 171.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -58.75 -58.46 8.51 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.531 1.132 . . . . 0.0 111.513 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -65.28 -31.31 72.38 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -68.05 -40.37 82.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.311 1.445 . . . . 0.0 112.398 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.2 -26.72 42.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 119.336 0.971 . . . . 0.0 114.06 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.34 -40.83 71.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.925 1.29 . . . . 0.0 114.179 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.71 4.04 37.65 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.78 67.33 77.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.801 1.64 . . . . 0.0 111.573 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.54 -10.1 24.87 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.331 2.687 . . . . 0.0 114.341 -169.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.28 -14.25 58.55 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.43 131.04 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.361 1.064 . . . . 0.0 109.77 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -81.34 91.48 6.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.777 0.831 . . . . 0.0 110.645 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mt -100.08 132.34 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.029 0.932 . . . . 0.0 109.531 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.1 p -144.79 176.01 9.76 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.127 0.971 . . . . 0.0 111.658 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 86.4 p -113.76 176.3 5.09 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 120.897 -1.127 . . . . 0.0 110.599 162.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -152.0 126.96 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 124.342 1.057 . . . . 0.0 109.664 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.35 110.42 5.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 121.863 0.84 . . . . 0.0 110.811 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.2 p -56.48 -27.2 56.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.611 1.164 . . . . 0.0 113.637 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -77.35 -29.59 53.45 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.436 1.016 . . . . 0.0 113.089 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.33 -24.46 19.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.639 1.176 . . . . 0.0 113.017 177.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.18 56.39 9.21 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 126.745 2.018 . . . . 0.0 111.92 177.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.41 -27.79 18.8 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.983 2.456 . . . . 0.0 112.507 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -68.54 -25.42 64.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.984 0.811 . . . . 0.0 112.558 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' HD22 ' A' ' 68' ' ' LEU . 7.7 mt -63.61 -56.19 17.77 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.166 0.894 . . . . 0.0 110.122 168.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.412 ' HB3' ' H ' ' A' ' 71' ' ' GLU . 17.5 mtm -58.48 -21.01 50.25 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.41 -26.66 51.89 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.99 1.716 . . . . 0.0 112.414 174.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -82.72 -46.47 13.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.76 0.824 . . . . 0.0 111.32 172.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -82.35 -15.91 51.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.56 21.72 46.6 Favored Glycine 0 N--CA 1.475 1.256 0 C-N-CA 124.664 1.126 . . . . 0.0 114.723 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -74.95 -58.9 3.0 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.404 1.102 . . . . 0.0 111.665 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 65' ' ' MET . 41.0 mt-10 73.71 -29.07 0.19 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 130.08 3.352 . . . . 0.0 113.975 168.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -163.89 17.73 0.06 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -164.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.32 150.96 63.04 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.487 1.115 . . . . 0.0 113.943 -170.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -81.43 86.55 1.58 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 124.445 3.43 . . . . 0.0 110.873 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.7 m -98.67 136.01 39.34 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.415 1.086 . . . . 0.0 112.446 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.13 128.59 38.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.871 163.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.5 t -119.25 129.93 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.563 1.545 . . . . 0.0 109.16 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -117.56 131.09 56.75 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.125 0.97 . . . . 0.0 111.623 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.27 125.21 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.013 1.325 . . . . 0.0 109.925 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -116.32 117.4 29.86 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.661 1.984 . . . . 0.0 110.17 167.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.18 29.56 11.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.873 2.069 . . . . 0.0 111.805 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.92 6.54 85.79 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.48 0.562 . . . . 0.0 114.425 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -101.28 133.07 46.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.852 1.261 . . . . 0.0 108.755 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 p -70.07 106.06 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.179 -0.951 . . . . 0.0 109.297 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.04 -22.09 15.89 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -166.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -161.2 155.78 23.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.452 1.501 . . . . 0.0 110.74 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.7 p -152.7 143.92 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.306 1.442 . . . . 0.0 110.203 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.71 149.43 20.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.517 1.127 . . . . 0.0 111.566 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 t -112.16 140.68 46.66 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.336 1.054 . . . . 0.0 112.975 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.27 -164.62 12.43 Favored Glycine 0 C--N 1.344 1.001 0 C-N-CA 125.24 1.4 . . . . 0.0 114.762 167.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.4 mm -95.96 140.21 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.122 1.369 . . . . 0.0 111.338 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.8 mtm -139.92 161.77 36.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.062 1.345 . . . . 0.0 111.701 164.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -68.37 161.29 70.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.277 0.631 . . . . 0.0 111.313 161.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.33 -32.4 16.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 121.932 1.754 . . . . 0.0 113.53 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -68.45 -32.79 73.06 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 120.884 1.675 . . . . 0.0 112.402 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -74.83 -30.37 61.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.76 0.824 . . . . 0.0 112.535 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.81 -35.72 79.12 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.328 0.967 . . . . 0.0 111.833 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -39.97 90.72 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.424 1.011 . . . . 0.0 111.715 171.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.61 87.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.675 0.67 . . . . 0.0 111.866 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.8 tp -66.12 -49.6 66.93 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.848 0.859 . . . . 0.0 110.658 172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -43.64 77.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.944 1.297 . . . . 0.0 113.21 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.44 76.17 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.103 0.865 . . . . 0.0 112.001 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.8 m -70.04 1.58 4.46 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.455 1.502 . . . . 0.0 114.091 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.474 0.767 0 O-C-N 120.739 -1.226 . . . . 0.0 111.294 171.665 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 mmt . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.9 m 70.41 -36.09 0.34 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 128.916 2.886 . . . . 0.0 114.652 176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.64 143.15 11.33 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.722 2.009 . . . . 0.0 111.042 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.1 mt -106.16 128.46 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.093 1.357 . . . . 0.0 109.432 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -159.35 -164.6 1.4 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.774 2.429 . . . . 0.0 107.147 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -69.75 140.17 53.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.76 0.709 . . . . 0.0 111.296 161.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.55 133.62 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 165.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.0 p -75.52 -20.67 58.56 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.158 1.383 . . . . 0.0 114.395 -171.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 p -85.99 -39.32 16.99 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.132 0.973 . . . . 0.0 113.365 -172.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -170.77 145.59 2.46 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.769 1.628 . . . . 0.0 111.86 -176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.32 148.73 11.43 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.538 1.935 . . . . 0.0 109.997 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.92 -179.71 24.16 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.922 1.248 . . . . 0.0 112.63 -169.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -57.8 -30.3 65.58 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -167.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.95 -22.2 63.19 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -84.72 -36.81 21.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.288 0.635 . . . . 0.0 111.611 165.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -79.24 -6.54 56.87 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -171.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -88.0 -17.75 30.54 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -118.54 -4.09 13.75 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.857 1.218 . . . . 0.0 116.064 -171.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.89 166.96 18.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.674 1.237 . . . . 0.0 114.182 -171.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 p -82.52 -65.13 1.05 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.596 1.158 . . . . 0.0 111.944 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -145.83 125.16 13.04 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.748 1.619 . . . . 0.0 110.04 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.99 159.59 43.05 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 177.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.9 mt -134.23 127.82 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.796 1.638 . . . . 0.0 108.477 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 t -118.71 127.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 125.552 1.541 . . . . 0.0 108.827 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -111.2 112.48 24.29 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.497 1.119 . . . . 0.0 111.197 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -80.29 76.8 7.07 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.374 1.069 . . . . 0.0 110.795 175.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.37 174.85 10.74 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 124.268 1.027 . . . . 0.0 112.729 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -134.21 151.32 51.26 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.873 -1.142 . . . . 0.0 111.535 167.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -62.63 -46.88 86.19 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.821 0.848 . . . . 0.0 112.168 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.46 -32.44 42.63 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.323 1.049 . . . . 0.0 112.791 -171.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.2 t -57.36 122.95 58.56 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.276 1.43 . . . . 0.0 112.392 -174.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.31 -13.95 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.323 3.349 . . . . 0.0 112.293 173.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -80.08 -47.5 14.72 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.192 0.906 . . . . 0.0 109.451 177.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 97.7 m -52.74 -36.61 58.01 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.044 1.338 . . . . 0.0 113.979 -177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -37.3 66.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.451 1.1 . . . . 0.0 112.926 -177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -63.17 -45.52 91.45 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.51 0.724 . . . . 0.0 111.501 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.6 tpt -61.61 -33.13 73.37 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.035 0.934 . . . . 0.0 112.782 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -59.1 -40.46 85.38 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.647 0.658 . . . . 0.0 112.032 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 -35.53 62.42 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.38 -0.825 . . . . 0.0 112.264 174.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.17 -47.86 88.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.789 0.835 . . . . 0.0 110.501 175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.96 -37.05 85.01 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.012 1.725 . . . . 0.0 112.304 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.79 -48.48 76.72 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.02 0.827 . . . . 0.0 112.376 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -35.92 81.9 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.31 -0.869 . . . . 0.0 112.424 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -66.82 -34.25 77.4 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.967 1.307 . . . . 0.0 111.937 172.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.52 -25.29 51.23 Favored Glycine 0 N--CA 1.47 0.933 0 O-C-N 121.001 -1.062 . . . . 0.0 113.73 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -33.71 67.39 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -171.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.84 5.92 22.97 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 114.066 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.53 62.11 61.34 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 125.939 1.696 . . . . 0.0 111.563 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.29 -13.87 31.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.201 2.6 . . . . 0.0 114.243 -173.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -80.04 -4.91 54.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.57 131.63 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.166 1.386 . . . . 0.0 110.705 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.56 101.19 10.59 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.156 0.983 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.5 mt -94.88 130.5 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 121.507 -0.745 . . . . 0.0 109.689 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -139.16 152.0 47.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 110.863 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.7 m -115.68 149.98 37.51 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.111 -0.993 . . . . 0.0 111.512 167.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 73.1 t -139.73 122.25 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.122 1.369 . . . . 0.0 108.4 -171.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -67.85 113.18 5.37 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.498 1.119 . . . . 0.0 111.241 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -56.99 -27.65 61.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.448 1.499 . . . . 0.0 114.252 174.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -74.94 -27.93 60.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.069 0.849 . . . . 0.0 112.573 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.04 -27.99 16.65 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.855 1.262 . . . . 0.0 113.295 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.4 tpt85 -124.62 40.91 0.55 Allowed Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 125.706 1.602 . . . . 0.0 114.707 -172.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -65.71 -19.69 59.5 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.196 1.931 . . . . 0.0 112.929 177.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.31 -27.4 62.14 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.731 1.212 . . . . 0.0 113.487 173.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.89 -54.78 5.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.503 1.121 . . . . 0.0 110.5 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 67.1 mtp -56.15 -31.06 63.01 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.055 1.342 . . . . 0.0 112.797 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -63.97 -26.83 68.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 113.143 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -86.51 -36.48 18.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.876 1.271 . . . . 0.0 110.799 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.7 -21.27 26.75 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.45 21.29 15.15 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.759 1.647 . . . . 0.0 115.185 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -83.48 143.26 30.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.773 1.287 . . . . 0.0 111.72 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.39 -72.16 0.57 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.717 0.807 . . . . 0.0 111.781 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.46 30.18 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.199 1.4 . . . . 0.0 114.152 -170.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.2 m -119.11 156.52 52.34 Favored Pre-proline 0 N--CA 1.485 1.292 0 C-N-CA 125.425 1.49 . . . . 0.0 111.969 -169.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -60.95 97.6 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.357 2.705 . . . . 0.0 109.952 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 m -109.5 124.58 51.31 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.984 0.514 . . . . 0.0 111.574 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.23 135.98 33.41 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.199 1.0 . . . . 0.0 109.328 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.0 t -130.86 125.18 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 126.299 1.84 . . . . 0.0 108.196 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -107.59 123.31 48.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.076 0.95 . . . . 0.0 111.077 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.3 mm -107.7 114.32 46.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.013 1.325 . . . . 0.0 108.662 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.1 125.0 53.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.867 1.667 . . . . 0.0 108.551 171.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 34.8 t70 66.74 20.5 10.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.056 1.343 . . . . 0.0 112.36 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.65 7.44 87.42 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.203 0.906 . . . . 0.0 113.856 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -108.99 136.53 48.36 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.829 1.652 . . . . 0.0 109.716 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.7 107.63 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 121.219 -0.925 . . . . 0.0 109.253 168.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -99.88 -30.91 11.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.302 1.041 . . . . 0.0 113.627 -170.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.6 158.32 42.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.096 1.358 . . . . 0.0 112.064 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.7 t -151.04 147.12 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.457 1.903 . . . . 0.0 108.739 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.01 148.99 31.32 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.536 0.684 . . . . 0.0 111.171 159.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.5 m -107.58 128.44 54.53 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.157 0.983 . . . . 0.0 111.32 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 131.17 -162.85 23.62 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.438 1.494 . . . . 0.0 113.106 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.84 141.67 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.303 1.441 . . . . 0.0 110.459 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 63.4 mtm -139.51 154.98 47.8 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.41 0.684 . . . . 0.0 112.26 168.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.94 152.2 84.49 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 123.772 0.829 . . . . 0.0 110.963 165.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.32 -25.15 49.67 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.351 2.034 . . . . 0.0 114.021 -165.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -61.07 -32.37 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -85.97 -28.95 23.92 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.593 0.757 . . . . 0.0 111.805 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.8 -27.24 69.17 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.141 -0.974 . . . . 0.0 112.374 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -58.58 -44.53 89.82 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.793 0.724 . . . . 0.0 111.696 171.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.47 75.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.243 0.617 . . . . 0.0 111.951 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.28 -45.35 84.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.02 0.528 . . . . 0.0 111.168 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -44.51 94.2 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.423 0.689 . . . . 0.0 111.735 173.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.8 -27.07 66.42 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.075 -1.016 . . . . 0.0 111.938 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 m -67.08 -21.05 65.9 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.627 1.171 . . . . 0.0 113.573 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.481 1.101 0 CA-C-N 119.438 1.017 . . . . 0.0 110.107 174.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m 108.08 -26.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 1 C-N-CA 132.215 4.206 . . . . 0.0 111.601 -176.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.49 143.67 2.85 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.903 2.081 . . . . 0.0 110.42 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm -106.96 132.02 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.343 1.457 . . . . 0.0 107.969 169.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -156.9 158.09 36.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.825 1.25 . . . . 0.0 111.476 -165.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -100.33 96.86 7.72 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.748 2.419 . . . . 0.0 111.312 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.34 124.76 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.485 1.114 . . . . 0.0 109.274 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.4 p -66.11 -23.88 66.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.547 1.539 . . . . 0.0 113.847 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.7 p -91.79 -13.06 32.13 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.099 1.36 . . . . 0.0 114.09 -173.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -163.2 74.49 0.36 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.86 1.314 . . . . 0.0 112.604 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.82 107.52 3.18 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.156 1.382 . . . . 0.0 109.903 167.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.64 165.03 21.22 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 126.104 1.812 . . . . 0.0 112.847 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptp -53.01 -35.34 59.3 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.71 67.61 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.82 -40.18 63.54 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.467 0.576 . . . . 0.0 110.779 169.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -75.24 -9.99 59.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.27 1.028 . . . . 0.0 113.274 -175.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -88.82 -22.84 23.02 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.019 1.328 . . . . 0.0 112.916 169.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -110.1 -17.08 9.8 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 -168.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.53 166.3 23.5 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -172.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -83.54 -64.91 1.08 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.321 1.448 . . . . 0.0 112.134 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -147.13 125.7 12.48 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.806 1.642 . . . . 0.0 109.986 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.99 162.6 39.58 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.2 mt -135.92 120.19 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.457 1.503 . . . . 0.0 107.674 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.32 128.21 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.972 1.309 . . . . 0.0 109.267 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -108.01 112.16 24.6 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.599 1.16 . . . . 0.0 111.547 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -78.38 79.39 4.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.941 1.296 . . . . 0.0 110.464 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.11 175.45 9.98 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.58 149.58 37.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.436 1.494 . . . . 0.0 111.291 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -75.72 -34.97 60.37 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -171.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.7 mt -82.36 -23.98 34.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.478 1.111 . . . . 0.0 113.496 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.02 125.43 91.54 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 113.573 -167.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -85.02 -2.27 9.54 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 125.177 3.918 . . . . 0.0 112.779 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -87.46 -42.76 12.57 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 119.696 1.135 . . . . 0.0 109.5 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 88.5 m -57.24 -37.1 71.79 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -50.79 -37.88 45.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -75.82 -41.08 53.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.873 0.469 . . . . 0.0 111.504 -170.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -37.72 75.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.284 1.034 . . . . 0.0 112.593 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -55.82 -40.94 73.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.607 1.094 . . . . 0.0 112.165 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -75.29 -33.94 61.27 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.492 -0.755 . . . . 0.0 112.659 176.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.9 t -63.53 -46.3 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.767 0.827 . . . . 0.0 110.855 174.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.31 -33.4 75.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.526 1.131 . . . . 0.0 112.41 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -64.25 -48.6 75.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.407 1.003 . . . . 0.0 112.564 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.58 -37.83 79.58 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.757 0.708 . . . . 0.0 112.247 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -67.85 -34.29 76.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.562 1.145 . . . . 0.0 112.511 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.99 -22.72 60.67 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 120.877 -1.139 . . . . 0.0 113.643 -177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.93 -29.07 64.85 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -170.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.8 6.5 15.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.69 1.196 . . . . 0.0 114.224 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.96 63.92 17.21 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.937 1.695 . . . . 0.0 112.601 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.13 -15.19 32.06 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.275 2.65 . . . . 0.0 113.63 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -81.22 -2.95 50.74 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.43 134.11 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.241 1.416 . . . . 0.0 110.666 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.87 101.26 10.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.714 0.806 . . . . 0.0 111.339 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.7 mt -97.74 130.09 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 120.857 -1.152 . . . . 0.0 109.633 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 p -150.42 164.34 36.13 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.075 0.95 . . . . 0.0 111.677 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.5 p -104.34 176.22 5.23 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.66 -1.275 . . . . 0.0 112.601 165.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -156.02 135.46 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.776 1.631 . . . . 0.0 109.451 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -73.77 109.75 7.51 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.301 1.04 . . . . 0.0 111.446 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 77.8 p -55.12 -29.71 58.25 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.671 1.188 . . . . 0.0 113.931 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.09 -23.32 51.91 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.082 0.953 . . . . 0.0 112.782 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.92 -24.81 16.82 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.85 1.26 . . . . 0.0 112.783 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -117.46 48.6 0.8 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 126.858 2.063 . . . . 0.0 113.273 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -70.28 -27.09 24.43 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.566 1.511 . . . . 0.0 112.494 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.01 -32.93 74.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.742 0.701 . . . . 0.0 112.165 174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.87 -48.04 67.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.002 0.921 . . . . 0.0 108.973 174.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 23.2 mtm -56.92 -22.17 35.51 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.675 -0.641 . . . . 0.0 112.438 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -13.87 53.22 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.371 0.987 . . . . 0.0 113.352 175.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -82.48 -42.3 18.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.482 1.113 . . . . 0.0 110.788 169.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.43 -23.98 24.32 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.17 21.63 17.27 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.41 1.481 . . . . 0.0 115.512 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -83.0 153.64 24.86 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.673 1.236 . . . . 0.0 111.919 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.38 -65.85 0.98 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.079 0.952 . . . . 0.0 111.941 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -159.99 2.16 0.08 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 -165.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.8 m -106.66 159.53 29.54 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 127.521 2.328 . . . . 0.0 112.835 -162.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.81 85.84 0.75 Allowed 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 124.405 3.403 . . . . 0.0 111.859 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 75.7 m -98.79 128.36 44.99 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.92 137.78 32.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.698 1.199 . . . . 0.0 109.761 165.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.7 t -132.2 122.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.927 1.691 . . . . 0.0 108.662 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -102.67 118.53 37.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.998 0.919 . . . . 0.0 110.031 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.5 mm -103.33 113.18 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.833 1.253 . . . . 0.0 108.853 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.77 121.61 45.76 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.045 1.338 . . . . 0.0 107.849 172.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.2 t70 64.59 21.78 12.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.089 1.356 . . . . 0.0 112.261 174.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 9.23 84.47 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.403 1.001 . . . . 0.0 113.873 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -110.6 135.16 51.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.308 1.843 . . . . 0.0 110.277 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.55 108.27 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.353 -0.842 . . . . 0.0 108.971 167.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -97.99 -34.42 10.82 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.82 150.49 33.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.044 1.738 . . . . 0.0 110.998 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -146.74 145.5 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.571 1.548 . . . . 0.0 108.811 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -148.0 136.57 21.64 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.539 0.736 . . . . 0.0 111.463 163.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.0 p -98.2 3.44 48.95 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.997 1.719 . . . . 0.0 115.08 -171.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.33 -166.19 26.61 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.422 1.486 . . . . 0.0 114.435 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 29.3 mm -104.4 141.35 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.473 1.509 . . . . 0.0 110.086 170.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.6 mtm -137.05 176.02 9.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 170.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.46 156.17 49.44 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 126.759 2.023 . . . . 0.0 110.005 173.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.76 -38.2 18.54 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.903 1.735 . . . . 0.0 113.939 -156.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -61.25 -30.55 70.52 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.291 0.951 . . . . 0.0 113.086 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -83.18 -31.37 27.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.896 0.878 . . . . 0.0 112.006 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.26 -34.49 76.28 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.039 0.836 . . . . 0.0 112.388 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -48.59 76.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.062 0.945 . . . . 0.0 111.088 167.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.86 -34.93 79.28 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.484 0.714 . . . . 0.0 112.337 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.2 -49.18 70.73 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.232 1.013 . . . . 0.0 110.329 175.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -42.41 80.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.225 0.61 . . . . 0.0 112.156 173.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.19 -36.42 81.71 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.472 0.578 . . . . 0.0 111.457 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -60.02 -34.98 74.1 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.838 1.255 . . . . 0.0 112.463 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 32.2 mt . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 124.13 0.972 . . . . 0.0 111.056 175.134 . . . . . . . . 0 0 . 1 stop_ save_